assays_RELATITY,assays_ASSSUBCELFR,assays_T,assays_CEI,assays_ASSTR,assays_ASSTT,assays_DOI,assays_ASSTIS,assays_ASOR,assays_ASSCA,assays_BFOR,assays_SRASI,assays_Des,assays_CHEI,assays_ASTAI,assays_ASSI,assays_ASST,assays_SI,assays_CUB,assays_ASCTY,assays_VARI,assays_TISI,assays_CONSCO
N,,50597,,,In vivo,9866,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,CHEMBL618647,10116.0,7524,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,9866,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,CHEMBL618648,10116.0,7525,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,9866,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,CHEMBL618649,10116.0,7526,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,CHEMBL618650,10116.0,7527,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,CHEMBL618651,10116.0,7528,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,CHEMBL876497,10116.0,7529,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,CHEMBL618652,10116.0,7530,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,9866,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,CHEMBL618653,10116.0,7531,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,9866,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,CHEMBL618654,10116.0,7532,A,1,Intermediate,,,2048.0,1
N,,50597,,,,6351,,Rattus norvegicus,,BAO_0000218,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,CHEMBL618655,10116.0,7533,A,1,Intermediate,,,,1
N,,50597,,,,1465,,Rattus norvegicus,,BAO_0000218,,Compound was tested for solubility in water,CHEMBL618656,10116.0,7534,A,1,Intermediate,,,,1
U,,22229,,,,5182,,,,BAO_0000100,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),CHEMBL618657,,7535,P,1,Intermediate,,,,0
N,,50597,,,,17847,,Rattus norvegicus,,BAO_0000218,,Solubility was determined,CHEMBL618658,10116.0,7536,A,1,Intermediate,,,,1
N,,50597,,,,15339,,Rattus norvegicus,,BAO_0000218,,solubility in water (ug/mL) at 37 degree C.,CHEMBL618659,10116.0,7537,A,1,Intermediate,,,,1
N,,50597,,,,5202,,Rattus norvegicus,,BAO_0000218,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,CHEMBL618660,10116.0,7538,A,1,Intermediate,,,,1
N,,50597,,,,1088,,Rattus norvegicus,,BAO_0000218,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,CHEMBL618661,10116.0,7539,A,1,Intermediate,,,,1
N,,50597,,,,3169,,Rattus norvegicus,,BAO_0000218,,Half life in rats,CHEMBL873807,10116.0,7540,A,1,Intermediate,,,,1
N,,50597,,,,5353,,Rattus norvegicus,,BAO_0000218,,Half life in Dawley rat,CHEMBL618662,10116.0,7541,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2864,,Rattus norvegicus,,BAO_0000218,,Half life period after 3 mg/kg iv administration,CHEMBL618663,10116.0,7542,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2864,,Rattus norvegicus,,BAO_0000218,,Half life period after 3 mg/kg iv administration in rat,CHEMBL618664,10116.0,7543,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2864,,Rattus norvegicus,,BAO_0000218,,Half life period after 3 mg/kg iv administration in the rat,CHEMBL618665,10116.0,7544,A,1,Intermediate,,,,1
N,,50597,,,,6362,,Rattus norvegicus,,BAO_0000218,,Half life period in female Sprague-Dawley rats,CHEMBL876498,10116.0,7545,A,1,Intermediate,,,,1
N,,50597,,,,6249,,Rattus norvegicus,,BAO_0000218,,Half life period in rat,CHEMBL618666,10116.0,7546,A,1,Intermediate,,,,1
N,,50597,,,,3169,,Rattus norvegicus,,BAO_0000218,,Half-life in rats was determined,CHEMBL620440,10116.0,7547,A,1,Intermediate,,,,1
N,,50597,,,,3169,,Rattus norvegicus,,BAO_0000218,,Half-life in rats with metabolic oxidation,CHEMBL620441,10116.0,7548,A,1,Intermediate,,,,1
N,,50597,,,,3169,,Rattus norvegicus,,BAO_0000218,,Half-life in rats,CHEMBL620442,10116.0,7549,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17260,,Rattus norvegicus,,BAO_0000218,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,CHEMBL620443,10116.0,7550,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17260,,Rattus norvegicus,,BAO_0000218,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,CHEMBL620444,10116.0,7551,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17260,,Rattus norvegicus,,BAO_0000218,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,CHEMBL620445,10116.0,7552,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17260,,Rattus norvegicus,,BAO_0000218,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,CHEMBL620446,10116.0,7553,A,1,Intermediate,,,,1
N,,50597,,,,2879,Plasma,Rattus norvegicus,,BAO_0000218,,Biological half-life measured in plasma of rat,CHEMBL620447,10116.0,7554,A,1,Intermediate,,,1969.0,1
N,,50597,,,,2879,Plasma,Rattus norvegicus,,BAO_0000218,,Biological half-life measured in plasma of rat; 22-25,CHEMBL621129,10116.0,7555,A,1,Intermediate,,,1969.0,1
N,,50597,,,,2879,Plasma,Rattus norvegicus,,BAO_0000218,,Biological half-life measured in plasma of rat; 9-16,CHEMBL621130,10116.0,7556,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,3184,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for its half life when administered intravenously in rat,CHEMBL873808,10116.0,7557,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4891,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,CHEMBL876598,10116.0,7558,A,1,Intermediate,,,,1
N,,50597,,,In vivo,429,,Rattus norvegicus,,BAO_0000218,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,CHEMBL621131,10116.0,7559,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5656,,Rattus norvegicus,,BAO_0000218,,Half life (T1/2) after oral administration in rat,CHEMBL621132,10116.0,7560,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4413,,Rattus norvegicus,,BAO_0000218,,Half life of compound after iv administration of 20 mg/kg dose in rat,CHEMBL621133,10116.0,7561,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3598,,Rattus norvegicus,,BAO_0000218,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,CHEMBL621312,10116.0,7562,A,1,Expert,,,,1
N,,50597,,,,17267,,Rattus norvegicus,,BAO_0000218,,Half life of compound was determined in rat,CHEMBL621313,10116.0,7563,A,1,Intermediate,,,,1
N,,50597,,,,4727,Blood,Rattus norvegicus,,BAO_0000218,,Half life of compound was determined in rat blood,CHEMBL621314,10116.0,7564,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,17651,,Rattus norvegicus,,BAO_0000218,,Half life at 1 mg/kg was determined in rat,CHEMBL621315,10116.0,7565,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17651,,Rattus norvegicus,,BAO_0000218,,Half life at 10 mg/kg was determined in rat,CHEMBL621316,10116.0,7566,A,1,Intermediate,,,,1
N,,50597,,,,401,,Rattus norvegicus,,BAO_0000218,,Half life in rats,CHEMBL621317,10116.0,7567,A,1,Intermediate,,,,1
N,,50597,,,,4942,,Rattus norvegicus,,BAO_0000218,,Half life in rats in hours,CHEMBL621318,10116.0,7568,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17735,,Rattus norvegicus,,BAO_0000218,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,CHEMBL621319,10116.0,7569,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6056,,Rattus norvegicus,,BAO_0000218,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,CHEMBL621377,10116.0,7570,A,1,Intermediate,,,,1
N,,50597,,,,5213,,Rattus norvegicus,,BAO_0000218,,Half life was determined,CHEMBL621378,10116.0,7571,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6616,,Rattus norvegicus,,BAO_0000218,,Half life after i.v. administration,CHEMBL876599,10116.0,7572,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5937,,Rattus norvegicus,,BAO_0000218,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,CHEMBL621379,10116.0,7573,A,1,Intermediate,,,,1
N,,50597,,,,5819,Plasma,Rattus norvegicus,,BAO_0000218,,Half life in rat plasma,CHEMBL621380,10116.0,7574,A,1,Intermediate,,,1969.0,1
N,,50597,,,,5819,Plasma,Rattus norvegicus,,BAO_0000218,,Half life in rat plasma; Not detected,CHEMBL621381,10116.0,7575,A,1,Intermediate,,,1969.0,1
N,,50597,,,,6803,,Rattus norvegicus,,BAO_0000218,,Half life in rats,CHEMBL618515,10116.0,7576,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17804,,Rattus norvegicus,,BAO_0000218,,Half life period of compound was determined after peroral administration,CHEMBL618516,10116.0,7577,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17804,,Rattus norvegicus,,BAO_0000218,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,CHEMBL618517,10116.0,7578,A,1,Intermediate,,,,1
N,,50597,,,,5948,,Rattus norvegicus,,BAO_0000218,,Half life period in rat,CHEMBL618518,10116.0,7579,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1916,,Rattus norvegicus,,BAO_0000218,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,CHEMBL618519,10116.0,7580,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1916,,Rattus norvegicus,,BAO_0000218,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,CHEMBL618698,10116.0,7581,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1916,,Rattus norvegicus,,BAO_0000218,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,CHEMBL618862,10116.0,7582,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4890,,Rattus norvegicus,,BAO_0000218,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,CHEMBL618863,10116.0,7583,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17764,,Rattus norvegicus,,BAO_0000218,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,CHEMBL618864,10116.0,7584,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4727,,Rattus norvegicus,,BAO_0000218,,Half life time in rat the dose of 2 mg/kg,CHEMBL618865,10116.0,7585,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17509,,Rattus norvegicus,,BAO_0000218,,Half-life 24 hr after 10 mg/kg iv administration in rats,CHEMBL618866,10116.0,7586,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17509,,Rattus norvegicus,,BAO_0000218,,Half-life 24 hr after 2 mg/kg iv administration in rats,CHEMBL618867,10116.0,7587,A,1,Intermediate,,,,1
N,,50597,,,,6597,,Rattus norvegicus,,BAO_0000218,,Half-life consistent with the observed metabolic steady state in rats,CHEMBL875828,10116.0,7588,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17735,,Rattus norvegicus,,BAO_0000218,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,CHEMBL618868,10116.0,7589,A,1,Intermediate,,,,1
N,,50597,,,,6597,,Rattus norvegicus,,BAO_0000218,,Half-life for oxidative metabolic stability was determined using male human,CHEMBL618869,10116.0,7590,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17670,,Rattus norvegicus,,BAO_0000218,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",CHEMBL618870,10116.0,7591,A,1,Intermediate,,,,1
N,,50597,,,,1696,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life in rat plasma,CHEMBL618871,10116.0,7592,A,1,Intermediate,,,1969.0,1
N,,50597,,,,1742,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life in rat plasma was determined,CHEMBL618872,10116.0,7593,A,1,Intermediate,,,1969.0,1
N,,50597,,,,17800,,Rattus norvegicus,,BAO_0000218,,Half-life in rats was determined,CHEMBL873816,10116.0,7594,A,1,Intermediate,,,,1
U,,22224,,,,12923,,,,BAO_0000218,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,CHEMBL618873,,7595,A,1,Autocuration,,,,0
U,,22224,,,,11954,,,,BAO_0000019,,Area under curve after oral dose of 0.1 mg//kg,CHEMBL621602,,7596,A,1,Autocuration,,,,0
U,,22224,,,,11954,,,,BAO_0000218,,Area under curve after oral dose of 0.3 mg/kg,CHEMBL621603,,7597,A,1,Autocuration,,,,0
U,,22224,,,,11954,,,,BAO_0000218,,Area under curve after oral dose of 1 mg/kg,CHEMBL621604,,7598,A,1,Autocuration,,,,0
U,,22224,,,,11954,,,,BAO_0000218,,Area under curve after oral dose of 10 mg/kg,CHEMBL621605,,7599,A,1,Autocuration,,,,0
U,,22224,,,,11954,,,,BAO_0000218,,Area under curve after oral dose of 23.4 mg/kg,CHEMBL621606,,7600,A,1,Autocuration,,,,0
U,,22224,,,,11954,,,,BAO_0000218,,Area under curve after oral dose of 3 mg/kg,CHEMBL621607,,7601,A,1,Autocuration,,,,0
U,,22224,,,,11954,,,,BAO_0000218,,Area under curve after oral dose of 3.87 mg/kg,CHEMBL621608,,7602,A,1,Autocuration,,,,0
U,,22224,,,,5237,,,,BAO_0000019,,Area under curve was determined,CHEMBL621609,,7603,A,1,Autocuration,,,,0
U,,22224,,,,4026,,,,BAO_0000218,,Area under curve at a dose of 10 mg/kg,CHEMBL621610,,7604,A,1,Autocuration,,,,0
N,,50597,,,,5237,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined; ND=No data,CHEMBL621611,10116.0,7605,A,1,Intermediate,,,,1
N,,50597,,,,14793,,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,CHEMBL621612,10116.0,7606,A,1,Intermediate,,,,1
N,,50597,,,,14793,,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,CHEMBL622308,10116.0,7607,A,1,Intermediate,,,,1
N,,50597,,,,14793,,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,CHEMBL622309,10116.0,7608,A,1,Intermediate,,,,1
N,,50597,,,,14793,,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,CHEMBL622310,10116.0,7609,A,1,Intermediate,,,,1
N,,50597,,,,14793,,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,CHEMBL622311,10116.0,7610,A,1,Intermediate,,,,1
N,,50597,,,,14793,,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,CHEMBL622312,10116.0,7611,A,1,Intermediate,,,,1
N,,50597,,,,14793,,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,CHEMBL622931,10116.0,7612,A,1,Intermediate,,,,1
N,,50597,,,,14793,,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,CHEMBL622932,10116.0,7613,A,1,Intermediate,,,,1
N,,50597,,,,14793,Plasma,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,CHEMBL622736,10116.0,7614,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14793,Plasma,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,CHEMBL622737,10116.0,7615,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14793,Plasma,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,CHEMBL622738,10116.0,7616,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14793,Plasma,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,CHEMBL622739,10116.0,7617,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14793,Plasma,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,CHEMBL622740,10116.0,7618,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14793,Plasma,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,CHEMBL622741,10116.0,7619,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14793,Plasma,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,CHEMBL622742,10116.0,7620,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14793,Plasma,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,CHEMBL622743,10116.0,7621,A,1,Intermediate,,,1969.0,1
N,,50594,,,,11637,Plasma,Mus musculus,,BAO_0000218,,AUC in mice,CHEMBL622744,10090.0,7622,A,1,Intermediate,,,1969.0,1
U,,22224,,,,11149,,,,BAO_0000019,,Area under curve was measured from the graph obtained from concentration Vs time,CHEMBL624134,,7623,A,1,Autocuration,,,,0
U,,22224,,,,10016,,,,BAO_0000019,,Area under curve value of compound per hour after oral administration,CHEMBL624135,,7624,A,1,Autocuration,,,,0
N,,50597,,,,17796,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined after oral administration in rats,CHEMBL624136,10116.0,7625,A,1,Intermediate,,,,1
N,,50597,,,,17796,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined after oral administration in rats; No data,CHEMBL624137,10116.0,7626,A,1,Intermediate,,,,1
N,,50597,,,,17796,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined after oral administration in rats;No data,CHEMBL624320,10116.0,7627,A,1,Intermediate,,,,1
N,,50588,,,,12923,,Canis lupus familiaris,,BAO_0000218,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,CHEMBL624321,9615.0,7628,A,1,Intermediate,,,,1
N,,50597,,,,15372,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,CHEMBL624322,10116.0,7629,A,1,Intermediate,,,,1
N,,50597,,,,15372,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined for the compound after iv dose of 5.06 in rats,CHEMBL624323,10116.0,7630,A,1,Intermediate,,,,1
N,,50597,,,,15372,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,CHEMBL624324,10116.0,7631,A,1,Intermediate,,,,1
N,,50597,,,,15372,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,CHEMBL624325,10116.0,7632,A,1,Intermediate,,,,1
N,,50597,,,,15372,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,CHEMBL624326,10116.0,7633,A,1,Intermediate,,,,1
N,,50597,,,,15372,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,CHEMBL624327,10116.0,7634,A,1,Intermediate,,,,1
N,,50597,,,,15372,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,CHEMBL624328,10116.0,7635,A,1,Intermediate,,,,1
N,,50588,,,,14169,,Canis lupus familiaris,,BAO_0000218,,Area under curve was determined in Dogs after peroral administration,CHEMBL627848,9615.0,7636,A,1,Intermediate,,,,1
N,,50597,,,,14169,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined in Rats after peroral administration,CHEMBL627849,10116.0,7637,A,1,Intermediate,,,,1
N,,50597,,,,14258,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined in carotid blood of rat when administered intradermally,CHEMBL627850,10116.0,7638,A,1,Intermediate,,,,1
N,,50597,,,,14258,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined in portal blood of rat when administered intradermally,CHEMBL627851,10116.0,7639,A,1,Intermediate,,,,1
N,,50594,,,,15011,,Mus musculus,,BAO_0000218,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,CHEMBL627852,10090.0,7640,A,1,Intermediate,,,,1
N,,50594,,,,15011,,Mus musculus,,BAO_0000218,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,CHEMBL627853,10090.0,7641,A,1,Intermediate,,,,1
N,,50594,,,,15011,,Mus musculus,,BAO_0000218,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),CHEMBL627854,10090.0,7642,A,1,Intermediate,,,,1
N,,50594,,,,15011,,Mus musculus,,BAO_0000218,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,CHEMBL627855,10090.0,7643,A,1,Intermediate,,,,1
N,,50594,,,,15011,,Mus musculus,,BAO_0000218,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),CHEMBL627856,10090.0,7644,A,1,Intermediate,,,,1
N,,50594,,,,15011,,Mus musculus,,BAO_0000218,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,CHEMBL875339,10090.0,7645,A,1,Intermediate,,,,1
N,,50594,,,,15011,,Mus musculus,,BAO_0000218,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),CHEMBL627857,10090.0,7646,A,1,Intermediate,,,,1
N,,50597,,,In vivo,11195,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,CHEMBL627858,10116.0,7647,A,1,Intermediate,,,2106.0,1
N,,50597,,,,10130,Blood,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,CHEMBL627859,10116.0,7648,A,1,Intermediate,,,178.0,1
N,,50597,,,,10130,Brain,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,CHEMBL627860,10116.0,7649,A,1,Intermediate,,,955.0,1
N,,50597,,,,10130,Heart,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,CHEMBL627019,10116.0,7650,A,1,Intermediate,,,948.0,1
N,,50597,,,,10130,Liver,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,CHEMBL627020,10116.0,7651,A,1,Intermediate,,,2107.0,1
N,,50597,,,,10130,Lung,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,CHEMBL627021,10116.0,7652,A,1,Intermediate,,,2048.0,1
N,,50597,,,,10130,Muscle tissue,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,CHEMBL627022,10116.0,7653,A,1,Intermediate,,,2385.0,1
N,,50597,,,,10130,,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,CHEMBL627023,10116.0,7654,A,1,Intermediate,,,,1
N,,50597,,,,10130,Spleen,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,CHEMBL627024,10116.0,7655,A,1,Intermediate,,,2106.0,1
N,,50597,,,,10130,Thyroid gland,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,CHEMBL627025,10116.0,7656,A,1,Intermediate,,,2046.0,1
N,,50597,,,,10130,Kidney,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,CHEMBL627026,10116.0,7657,A,1,Intermediate,,,2113.0,1
N,,50597,,,,10130,Blood,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,CHEMBL627027,10116.0,7658,A,1,Intermediate,,,178.0,1
N,,50597,,,,10130,Brain,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,CHEMBL627028,10116.0,7659,A,1,Intermediate,,,955.0,1
N,,50597,,,,10130,Heart,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,CHEMBL627029,10116.0,7660,A,1,Intermediate,,,948.0,1
N,,50597,,,,10130,Kidney,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,CHEMBL627030,10116.0,7661,A,1,Intermediate,,,2113.0,1
N,,50597,,,,10130,Liver,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,CHEMBL627031,10116.0,7662,A,1,Intermediate,,,2107.0,1
N,,50597,,,,10130,Lung,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,CHEMBL627032,10116.0,7663,A,1,Intermediate,,,2048.0,1
N,,50597,,,,10130,Muscle tissue,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,CHEMBL627033,10116.0,7664,A,1,Intermediate,,,2385.0,1
N,,50597,,,,10130,,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,CHEMBL627034,10116.0,7665,A,1,Intermediate,,,,1
N,,50597,,,,10130,Spleen,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,CHEMBL627035,10116.0,7666,A,1,Intermediate,,,2106.0,1
N,,50597,,,,10130,Thyroid gland,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,CHEMBL627036,10116.0,7667,A,1,Intermediate,,,2046.0,1
N,,50597,,,,10130,Blood,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,CHEMBL875340,10116.0,7668,A,1,Intermediate,,,178.0,1
N,,50597,,,,10130,Heart,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,CHEMBL627037,10116.0,7669,A,1,Intermediate,,,948.0,1
N,,50597,,,,10130,Kidney,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,CHEMBL627038,10116.0,7670,A,1,Intermediate,,,2113.0,1
N,,50597,,,,10130,Liver,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,CHEMBL627039,10116.0,7671,A,1,Intermediate,,,2107.0,1
N,,50597,,,,10130,Muscle tissue,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,CHEMBL627040,10116.0,7672,A,1,Intermediate,,,2385.0,1
N,,50597,,,,10130,Spleen,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,CHEMBL624663,10116.0,7673,A,1,Intermediate,,,2106.0,1
N,,50597,,,,10130,Thyroid gland,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,CHEMBL625963,10116.0,7674,A,1,Intermediate,,,2046.0,1
N,,50597,,,,10130,Brain,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,CHEMBL876799,10116.0,7675,A,1,Intermediate,,,955.0,1
N,,50597,,,,10130,Lung,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,CHEMBL626133,10116.0,7676,A,1,Intermediate,,,2048.0,1
N,,50597,,,,10130,,Rattus norvegicus,,BAO_0000218,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,CHEMBL626134,10116.0,7677,A,1,Intermediate,,,,1
N,,50597,,,,6295,,Rattus norvegicus,,BAO_0000218,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,CHEMBL626135,10116.0,7678,A,1,Intermediate,,,,1
N,,50597,,,,6296,,Rattus norvegicus,,BAO_0000218,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,CHEMBL626136,10116.0,7679,A,1,Intermediate,,,,1
N,,50597,,,,6296,,Rattus norvegicus,,BAO_0000218,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,CHEMBL626137,10116.0,7680,A,1,Intermediate,,,,1
N,,50597,,,,6295,,Rattus norvegicus,,BAO_0000218,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,CHEMBL626138,10116.0,7681,A,1,Intermediate,,,,1
N,,50597,,,,6296,,Rattus norvegicus,,BAO_0000218,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,CHEMBL626139,10116.0,7682,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17260,,Rattus norvegicus,,BAO_0000218,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,CHEMBL626140,10116.0,7683,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17260,,Rattus norvegicus,,BAO_0000218,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,CHEMBL626141,10116.0,7684,A,1,Intermediate,,,,1
N,,50597,,,,17686,,Rattus norvegicus,,BAO_0000218,,C24h in rat p.o. at 20 mg/kg concentration,CHEMBL626142,10116.0,7685,A,1,Intermediate,,,,1
N,,50597,,,In vivo,9866,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,CHEMBL627930,10116.0,7686,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9866,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,CHEMBL627931,10116.0,7687,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9866,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,CHEMBL627932,10116.0,7688,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9866,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,CHEMBL627933,10116.0,7689,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,9866,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,CHEMBL627934,10116.0,7690,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,9866,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,CHEMBL627935,10116.0,7691,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,CHEMBL627936,10116.0,7692,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,CHEMBL627937,10116.0,7693,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,CHEMBL627938,10116.0,7694,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,CHEMBL627939,10116.0,7695,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,CHEMBL627940,10116.0,7696,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,CHEMBL627941,10116.0,7697,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,CHEMBL876800,10116.0,7698,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,CHEMBL627942,10116.0,7699,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,CHEMBL627943,10116.0,7700,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,CHEMBL627944,10116.0,7701,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,CHEMBL627945,10116.0,7702,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,CHEMBL628584,10116.0,7703,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,CHEMBL628585,10116.0,7704,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,CHEMBL628586,10116.0,7705,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,CHEMBL628587,10116.0,7706,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,CHEMBL628588,10116.0,7707,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,CHEMBL628589,10116.0,7708,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,CHEMBL625304,10116.0,7709,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,CHEMBL625305,10116.0,7710,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,CHEMBL625306,10116.0,7711,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,CHEMBL625307,10116.0,7712,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,CHEMBL625308,10116.0,7713,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,CHEMBL627740,10116.0,7714,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,CHEMBL627741,10116.0,7715,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,CHEMBL627742,10116.0,7716,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,CHEMBL627743,10116.0,7717,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,CHEMBL627744,10116.0,7718,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,CHEMBL627745,10116.0,7719,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,CHEMBL627746,10116.0,7720,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,CHEMBL627747,10116.0,7721,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,CHEMBL876810,10116.0,7722,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,CHEMBL627748,10116.0,7723,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,CHEMBL627749,10116.0,7724,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,CHEMBL627750,10116.0,7725,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,CHEMBL618728,10116.0,7726,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,CHEMBL618729,10116.0,7727,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,CHEMBL618730,10116.0,7728,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,CHEMBL618731,10116.0,7729,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,CHEMBL618732,10116.0,7730,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,CHEMBL618733,10116.0,7731,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,CHEMBL618734,10116.0,7732,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,CHEMBL618735,10116.0,7733,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,CHEMBL876602,10116.0,7734,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,CHEMBL618736,10116.0,7735,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,CHEMBL618737,10116.0,7736,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,CHEMBL618738,10116.0,7737,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,CHEMBL618739,10116.0,7738,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,CHEMBL618740,10116.0,7739,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,CHEMBL618741,10116.0,7740,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,CHEMBL618742,10116.0,7741,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,9866,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,CHEMBL618743,10116.0,7742,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,17752,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life from rat plasma at a single oral dose of 25 mg/kg,CHEMBL618744,10116.0,7743,A,1,Intermediate,,,1969.0,1
N,,50597,,,,5610,,Rattus norvegicus,,BAO_0000218,,Half-life in male rat,CHEMBL618745,10116.0,7744,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5939,,Rattus norvegicus,,BAO_0000218,,Half-life in rat after peroral administration at 10 mg/kg concentration,CHEMBL620479,10116.0,7745,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5939,,Rattus norvegicus,,BAO_0000218,,Half-life in rat after peroral administration at 5 mg/kg concentration,CHEMBL620480,10116.0,7746,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17771,,Rattus norvegicus,,BAO_0000218,,Half-life in rat at a dose of 3 mg/kg,CHEMBL620481,10116.0,7747,A,1,Intermediate,,,,1
N,,50597,,,,1974,,Rattus norvegicus,,BAO_0000218,,Half-life was evaluated in rats,CHEMBL620482,10116.0,7748,A,1,Intermediate,,,,1
N,,50597,,,,4239,,Rattus norvegicus,,BAO_0000218,,Half-life was measured in rat,CHEMBL876603,10116.0,7749,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6681,,Rattus norvegicus,,BAO_0000218,,Half-life period for the compound was determined in rats at 50 mg/kg dose,CHEMBL620483,10116.0,7750,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17752,,Rattus norvegicus,,BAO_0000218,,Half-life period in rats after intravenous administration at 5 mg/kg,CHEMBL620484,10116.0,7751,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6046,,Rattus norvegicus,,BAO_0000218,,Half-life period in rat at 10 mg/kg,CHEMBL620485,10116.0,7752,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6685,,Rattus norvegicus,,BAO_0000218,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",CHEMBL620486,10116.0,7753,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6685,,Rattus norvegicus,,BAO_0000218,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",CHEMBL620487,10116.0,7754,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6685,,Rattus norvegicus,,BAO_0000218,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",CHEMBL620488,10116.0,7755,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4727,,Rattus norvegicus,,BAO_0000218,,Half-life time in rat the dose of 2 mg/kg,CHEMBL620489,10116.0,7756,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1088,,Rattus norvegicus,,BAO_0000218,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,CHEMBL620490,10116.0,7757,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5610,,Rattus norvegicus,,BAO_0000218,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,CHEMBL620491,10116.0,7758,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3032,Plasma,Rattus norvegicus,,BAO_0000218,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",CHEMBL876604,10116.0,7759,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5199,,Rattus norvegicus,,BAO_0000218,,Oral half life was determined,CHEMBL620492,10116.0,7760,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14941,,Rattus norvegicus,,BAO_0000218,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",CHEMBL620493,10116.0,7761,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4408,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (t1/2) in rat,CHEMBL620494,10116.0,7762,A,1,Intermediate,,,,1
N,,50597,,,,2552,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma elimination half-life was determined,CHEMBL620495,10116.0,7763,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5199,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,CHEMBL620496,10116.0,7764,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15662,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half life was observed after intravenous administration in rat,CHEMBL620497,10116.0,7765,A,1,Intermediate,,,1969.0,1
N,,50597,,,,1465,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half-life was determined,CHEMBL620498,10116.0,7766,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,1446,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half-life following oral administration in Fisher rats,CHEMBL620499,10116.0,7767,A,1,Intermediate,,,1969.0,1
N,,50597,,,,6824,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half-life in rat,CHEMBL620500,10116.0,7768,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17533,Plasma,Rattus norvegicus,,BAO_0000218,,Plasmatic Half-life after intravenous administration to rat,CHEMBL873809,10116.0,7769,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5979,,Rattus norvegicus,,BAO_0000218,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,CHEMBL620501,10116.0,7770,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4689,,Rattus norvegicus,,BAO_0000218,,Terminal half life after intravenous administration (1 mg/kg) in rat,CHEMBL620502,10116.0,7771,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4689,,Rattus norvegicus,,BAO_0000218,,Terminal half life in Rat at a oral dose of 5 mg/kg,CHEMBL620503,10116.0,7772,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2463,,Rattus norvegicus,,BAO_0000218,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,CHEMBL620504,10116.0,7773,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4883,,Rattus norvegicus,,BAO_0000218,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,CHEMBL876605,10116.0,7774,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4883,,Rattus norvegicus,,BAO_0000218,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,CHEMBL620505,10116.0,7775,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15662,Plasma,Rattus norvegicus,,BAO_0000218,,plasma half life was observed after intravenous administration in rat,CHEMBL873811,10116.0,7776,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,3598,,Rattus norvegicus,,BAO_0000218,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,CHEMBL624016,10116.0,7777,A,1,Expert,,,,1
N,,50597,,,,4576,,Rattus norvegicus,,BAO_0000218,,Half life of compound determined in rat,CHEMBL624017,10116.0,7778,A,1,Intermediate,,,,1
N,,50597,,,,4576,,Rattus norvegicus,,BAO_0000218,,Mean residence time determined in rat,CHEMBL624018,10116.0,7779,A,1,Intermediate,,,,1
N,,50597,,,,4576,,Rattus norvegicus,,BAO_0000218,,Plasma half life determined in rat,CHEMBL624019,10116.0,7780,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4910,Brain,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,CHEMBL624020,10116.0,7781,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,4891,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for pharmacokinetic parameter maximum time period,CHEMBL624201,10116.0,7782,A,1,Intermediate,,,,1
N,,50597,,,In vivo,429,,Rattus norvegicus,,BAO_0000218,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,CHEMBL872528,10116.0,7783,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,CHEMBL624202,10116.0,7784,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,CHEMBL624203,10116.0,7785,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,CHEMBL624350,10116.0,7786,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,CHEMBL621320,10116.0,7787,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17582,,Rattus norvegicus,,BAO_0000218,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,CHEMBL621321,10116.0,7788,A,1,Intermediate,,,,1
N,,50597,,,,4026,,Rattus norvegicus,,BAO_0000218,,Maximum time (Tmax) required to reach Cmax in rats,CHEMBL621322,10116.0,7789,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4890,,Rattus norvegicus,,BAO_0000218,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,CHEMBL621323,10116.0,7790,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6571,,Rattus norvegicus,,BAO_0000218,,Maximum time of clearance of compound in rats after peroral administration,CHEMBL621324,10116.0,7791,A,1,Intermediate,,,,1
N,,50597,,,,4727,,Rattus norvegicus,,BAO_0000218,,Maximum time at the dose of 2 mg/kg in rat,CHEMBL621325,10116.0,7792,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17651,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,CHEMBL875837,10116.0,7793,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17651,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,CHEMBL621326,10116.0,7794,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14465,,Rattus norvegicus,,BAO_0000218,,Tmax in Guinea pig (PO dose),CHEMBL621327,10116.0,7795,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14941,,Rattus norvegicus,,BAO_0000218,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",CHEMBL621328,10116.0,7796,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5960,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter (Tmax) in rat,CHEMBL621329,10116.0,7797,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5022,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter (Tmax) was estimated,CHEMBL621330,10116.0,7798,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4408,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (Tmax) in rat,CHEMBL621331,10116.0,7799,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5983,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,CHEMBL621332,10116.0,7800,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4689,,Rattus norvegicus,,BAO_0000218,,T max in Rat at a oral dose of 5 mg/kg,CHEMBL621333,10116.0,7801,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2792,,Rattus norvegicus,,BAO_0000218,,T max was determined at 10 mg/kg po dose in rats,CHEMBL621334,10116.0,7802,A,1,Intermediate,,,,1
N,,50594,,,,15011,,Mus musculus,,BAO_0000218,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),CHEMBL621335,10090.0,7803,A,1,Intermediate,,,,1
N,,50588,,,,14180,,Canis lupus familiaris,,BAO_0000218,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,CHEMBL621336,9615.0,7804,A,1,Intermediate,,,,1
N,,50597,,,,14180,,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,CHEMBL621337,10116.0,7805,A,1,Intermediate,,,,1
N,,50588,,,,14599,,Canis lupus familiaris,,BAO_0000218,,Area under curve was measured after i.v. administration into Beagle dog.,CHEMBL621338,9615.0,7806,A,1,Intermediate,,,,1
N,,50588,,,,14599,,Canis lupus familiaris,,BAO_0000218,,Area under curve was measured after iv administration into Beagle dog,CHEMBL875838,9615.0,7807,A,1,Intermediate,,,,1
N,,50588,,,,14599,,Canis lupus familiaris,,BAO_0000218,,Area under curve was measured after po administration into Beagle dog,CHEMBL621339,9615.0,7808,A,1,Intermediate,,,,1
N,,50588,,,,14599,,Canis lupus familiaris,,BAO_0000218,,Area under curve was measured after po administration into Beagle dog.,CHEMBL621340,9615.0,7809,A,1,Intermediate,,,,1
U,,22224,,,,15675,,,,BAO_0000218,,Area under curve was measured at peroral dose of 3 mg/kg,CHEMBL621341,,7810,A,1,Autocuration,,,,0
U,,22224,,,,12706,,,,BAO_0000019,,Area under curve was measured by using concentration Vs time,CHEMBL621342,,7811,A,1,Autocuration,,,,0
U,,22224,,,,12706,,,,BAO_0000019,,Area under curve was measured by using concentration Vs time; not tested,CHEMBL621343,,7812,A,1,Autocuration,,,,0
N,,50594,,,,9750,,Mus musculus,,BAO_0000218,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),CHEMBL621344,10090.0,7813,A,1,Intermediate,,,,1
N,,50594,,,,9750,,Mus musculus,,BAO_0000218,,Area under curve(AUC) was measured in mice after oral administration.,CHEMBL621345,10090.0,7814,A,1,Intermediate,,,,1
U,,22224,,,,14691,,,,BAO_0000019,,Area under curve(AUC) value of the compound,CHEMBL621346,,7815,A,1,Autocuration,,,,0
U,,22224,,,,14691,,,,BAO_0000218,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,CHEMBL621347,,7816,A,1,Autocuration,,,,0
N,,50588,,,,14691,,Canis lupus familiaris,,BAO_0000218,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,CHEMBL621348,9615.0,7817,A,1,Intermediate,,,,1
U,,22224,,,,2939,Blood,,,BAO_0000019,,Area under curve(carotid artery) was determined by the availability in blood,CHEMBL621349,,7818,A,1,Autocuration,,,178.0,0
U,,22224,,,,2939,Blood,,,BAO_0000019,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,CHEMBL621350,,7819,A,1,Autocuration,,,178.0,0
U,,22224,,,,2939,Blood,,,BAO_0000019,,Area under curve(carotid artery) was determined by the availability in blood; No data,CHEMBL875839,,7820,A,1,Autocuration,,,178.0,0
U,,22224,,,,2939,Blood,,,BAO_0000019,,Area under curve(portal vein) was determined by the availability in blood,CHEMBL620211,,7821,A,1,Autocuration,,,178.0,0
U,,22224,,,,2939,Blood,,,BAO_0000019,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,CHEMBL620212,,7822,A,1,Autocuration,,,178.0,0
U,,22224,,,,2939,Blood,,,BAO_0000019,,Area under curve(portal vein) was determined by the availability in blood; No data,CHEMBL620213,,7823,A,1,Autocuration,,,178.0,0
N,,50797,,,,9552,Plasma,Macaca mulatta,,BAO_0000218,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",CHEMBL620214,9544.0,7824,A,1,Intermediate,,,1969.0,1
N,,50797,,,,9552,Plasma,Macaca mulatta,,BAO_0000218,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",CHEMBL620215,9544.0,7825,A,1,Intermediate,,,1969.0,1
N,,50797,,,,9552,Plasma,Macaca mulatta,,BAO_0000218,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,CHEMBL620216,9544.0,7826,A,1,Intermediate,,,1969.0,1
N,,50588,,,,9552,Plasma,Canis lupus familiaris,,BAO_0000218,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",CHEMBL620888,9615.0,7827,A,1,Intermediate,,,1969.0,1
N,,50588,,,,9552,Plasma,Canis lupus familiaris,,BAO_0000218,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",CHEMBL620889,9615.0,7828,A,1,Intermediate,,,1969.0,1
U,,22224,,,,9552,Plasma,,,BAO_0000019,,Area under plasma concentration vs time curve observed in rats for 0-3 h,CHEMBL620890,,7829,A,1,Autocuration,,,1969.0,0
N,,50597,,,,11911,Plasma,Rattus norvegicus,,BAO_0000218,,Area under plasma time curve determined in male rat,CHEMBL620891,10116.0,7830,A,1,Intermediate,,,1969.0,1
U,,22224,,,,16618,,,,BAO_0000019,,Area under the MAP curve measured over 5 min.,CHEMBL620892,,7831,A,1,Autocuration,,,,0
N,,50594,,,,14387,,Mus musculus,,BAO_0000218,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,CHEMBL621079,10090.0,7832,A,1,Intermediate,,,,1
N,,50594,,,,14387,,Mus musculus,,BAO_0000218,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,CHEMBL621080,10090.0,7833,A,1,Intermediate,,,,1
N,,50588,,,,12836,,Canis lupus familiaris,,BAO_0000218,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,CHEMBL621081,9615.0,7834,A,1,Intermediate,,,,1
N,,100712,,,,12836,,Cricetinae,,BAO_0000218,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,CHEMBL621082,10026.0,7835,A,1,Intermediate,,,,1
N,,50597,,,,12836,,Rattus norvegicus,,BAO_0000218,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,CHEMBL621083,10116.0,7836,A,1,Intermediate,,,,1
N,,50588,,,,14339,,Canis lupus familiaris,,BAO_0000218,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,CHEMBL621084,9615.0,7837,A,1,Intermediate,,,,1
N,,50588,,,,14339,,Canis lupus familiaris,,BAO_0000218,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,CHEMBL621085,9615.0,7838,A,1,Intermediate,,,,1
N,,50588,,,,14339,,Canis lupus familiaris,,BAO_0000218,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,CHEMBL621086,9615.0,7839,A,1,Intermediate,,,,1
N,,50588,,,,10524,,Canis lupus familiaris,,BAO_0000218,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),CHEMBL621087,9615.0,7840,A,1,Intermediate,,,,1
N,,50588,,,,9994,,Canis lupus familiaris,,BAO_0000218,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),CHEMBL622607,9615.0,7841,A,1,Intermediate,,,,1
N,,50588,,,,11325,,Canis lupus familiaris,,BAO_0000218,,Serum AUC in marmosets (IV dose),CHEMBL622608,9615.0,7842,A,1,Intermediate,,,,1
U,,22224,,,,12536,,,,BAO_0000019,,Area under the curve after intravenous administration at a dose of 10 umol/kg,CHEMBL624481,,7843,A,1,Autocuration,,,,0
U,,22224,,,,12536,,,,BAO_0000019,,Area under the curve after intravenous administration at a dose of 2 umol/kg,CHEMBL624482,,7844,A,1,Autocuration,,,,0
U,,22224,,,,12536,,,,BAO_0000019,,Area under the curve after intravenous administration at a dose of 4 umol/kg,CHEMBL624483,,7845,A,1,Autocuration,,,,0
U,,22224,,,,12536,,,,BAO_0000019,,Area under the curve after intravenous administration at a dose of 40 umol/kg,CHEMBL624484,,7846,A,1,Autocuration,,,,0
U,,22224,,,,12536,,,,BAO_0000019,,Area under the curve after intravenous administration at a dose of 5 umol/kg,CHEMBL624485,,7847,A,1,Autocuration,,,,0
N,,50597,,,,15556,,Rattus norvegicus,,BAO_0000218,,Area under the curve for fumarate salt was evaluated in F344 Rats.,CHEMBL624486,10116.0,7848,A,1,Intermediate,,,,1
U,,22224,,,,2809,,,,BAO_0000019,,Area under the curve for the compound was calculated.,CHEMBL624487,,7849,A,1,Autocuration,,,,0
U,,22224,,,,9511,,,,BAO_0000019,,Area under the curve in concentration/ time,CHEMBL624488,,7850,A,1,Autocuration,,,,0
N,,50597,,,,12818,,Rattus norvegicus,,BAO_0000218,,Area under the curve administered intraintestinal in rats.,CHEMBL624489,10116.0,7851,A,1,Intermediate,,,,1
N,,50597,,,,12818,,Rattus norvegicus,,BAO_0000218,,Area under the curve administered intravenously in rats.,CHEMBL625184,10116.0,7852,A,1,Intermediate,,,,1
U,,22224,,,,15118,,,,BAO_0000019,,Area under the curve during intravenous administration,CHEMBL625185,,7853,A,1,Autocuration,,,,0
U,,22224,,,,15118,,,,BAO_0000019,,Area under the curve during intravenous administration; Not determined,CHEMBL875954,,7854,A,1,Autocuration,,,,0
U,,22224,,,,15118,,,,BAO_0000019,,Area under the curve during systemic administration,CHEMBL625186,,7855,A,1,Autocuration,,,,0
U,,22224,,,,15118,,,,BAO_0000019,,Area under the curve during systemic administration; Not determined,CHEMBL625187,,7856,A,1,Autocuration,,,,0
U,,22224,,,,2632,,,,BAO_0000019,,Area under the curve was calculated for the compound.,CHEMBL625188,,7857,A,1,Autocuration,,,,0
N,,50588,,,,14346,,Canis lupus familiaris,,BAO_0000218,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,CHEMBL625189,9615.0,7858,A,1,Intermediate,,,,1
N,,50588,,,,14346,,Canis lupus familiaris,,BAO_0000218,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,CHEMBL625190,9615.0,7859,A,1,Intermediate,,,,1
N,,50597,,,,14346,,Rattus norvegicus,,BAO_0000218,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,CHEMBL621733,10116.0,7860,A,1,Intermediate,,,,1
N,,50597,,,,14346,,Rattus norvegicus,,BAO_0000218,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,CHEMBL621734,10116.0,7861,A,1,Intermediate,,,,1
N,,50597,,,,11149,,Rattus norvegicus,,BAO_0000218,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,CHEMBL621735,10116.0,7862,A,1,Intermediate,,,,1
N,,50597,,,,17796,Plasma,Rattus norvegicus,,BAO_0000218,,Clearance of the drug was measured in the plasma of rat; No data,CHEMBL621736,10116.0,7863,A,1,Intermediate,,,1969.0,1
N,,50597,,,,5247,Plasma,Rattus norvegicus,,BAO_0000218,,The pharmacokinetic parameter plasma clearance in vivo in rats,CHEMBL621737,10116.0,7864,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4727,,Rattus norvegicus,,BAO_0000218,,Plasma clearance at the dose of 2 mg/kg in rat,CHEMBL621738,10116.0,7865,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5654,,Rattus norvegicus,,BAO_0000218,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,CHEMBL622806,10116.0,7866,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5654,,Rattus norvegicus,,BAO_0000218,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,CHEMBL623519,10116.0,7867,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17260,,Rattus norvegicus,,BAO_0000218,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,CHEMBL623520,10116.0,7868,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17065,,Rattus norvegicus,,BAO_0000218,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,CHEMBL623521,10116.0,7869,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17671,,Rattus norvegicus,,BAO_0000218,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,CHEMBL623522,10116.0,7870,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6672,,Rattus norvegicus,,BAO_0000218,,Clearance rate in rat,CHEMBL623523,10116.0,7871,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6673,,Rattus norvegicus,,BAO_0000218,,Clearance rate in rat,CHEMBL623690,10116.0,7872,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL623691,10116.0,7873,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL623692,10116.0,7874,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL623693,10116.0,7875,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL623694,10116.0,7876,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4413,,Rattus norvegicus,,BAO_0000218,,Clearance of compound after iv administration of 20 mg/kg dose in rat,CHEMBL623695,10116.0,7877,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2661,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,CHEMBL623696,10116.0,7878,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2661,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,CHEMBL623697,10116.0,7879,A,1,Intermediate,,,,1
U,,22224,,,In vivo,5005,Plasma,Macaca mulatta,,BAO_0000218,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,CHEMBL623698,9544.0,7880,A,1,Intermediate,,,1969.0,0
U,,22224,,,In vivo,5005,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,CHEMBL623699,10116.0,7881,A,1,Intermediate,,,1969.0,0
N,,50597,,,In vivo,15765,,Rattus norvegicus,,BAO_0000218,,Mean (%CV) PK parameters for CL(mL/min/kg).,CHEMBL623700,10116.0,7882,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3747,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,CHEMBL623701,10116.0,7883,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16366,Plasma,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,CHEMBL623702,10116.0,7884,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4199,,Rattus norvegicus,,BAO_0000218,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,CHEMBL623703,10116.0,7885,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17267,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat was determined,CHEMBL623704,10116.0,7886,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6535,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat after administration of 2 mg/kg iv,CHEMBL623705,10116.0,7887,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6535,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat after administration of 2 mg/kg iv,CHEMBL623706,10116.0,7888,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5041,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was determined,CHEMBL623707,10116.0,7889,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5960,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat,CHEMBL623708,10116.0,7890,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5937,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,CHEMBL623709,10116.0,7891,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5871,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat by iv administration,CHEMBL623710,10116.0,7892,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5874,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,CHEMBL623711,10116.0,7893,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6504,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat p.o.,CHEMBL623712,10116.0,7894,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6803,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rats,CHEMBL623713,10116.0,7895,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5041,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was determined; ND denotes no data,CHEMBL623714,10116.0,7896,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5041,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was determined; ND denotes not determined,CHEMBL623715,10116.0,7897,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1916,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,CHEMBL623716,10116.0,7898,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5199,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,CHEMBL622980,10116.0,7899,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16367,,Rattus norvegicus,,BAO_0000218,,Plasma administration to rats,CHEMBL622981,10116.0,7900,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6362,,Rattus norvegicus,,BAO_0000218,,Plasma clearance of the compound in female Sprague-Dawley rats,CHEMBL622982,10116.0,7901,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15662,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was observed after intravenous administration in rat,CHEMBL622983,10116.0,7902,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6215,,Rattus norvegicus,,BAO_0000218,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,CHEMBL622984,10116.0,7903,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1466,,Rattus norvegicus,,BAO_0000218,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,CHEMBL622985,10116.0,7904,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15662,Plasma,Rattus norvegicus,,BAO_0000218,,plasma clearance was observed after intravenous administration in rat,CHEMBL623631,10116.0,7905,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4723,,Rattus norvegicus,,BAO_0000218,,In vivo CL/F determined,CHEMBL623632,10116.0,7906,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2792,Plasma,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,CHEMBL623633,10116.0,7907,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,2792,Plasma,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,CHEMBL623634,10116.0,7908,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5213,,Rattus norvegicus,,BAO_0000218,,Compound was tested for the lower blood clearance in rat,CHEMBL623635,10116.0,7909,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4687,,Rattus norvegicus,,BAO_0000218,,Evaluated for the low clearance in rat (in vivo),CHEMBL621195,10116.0,7910,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3371,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (CLb)of the compound was determined in rat,CHEMBL621196,10116.0,7911,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4690,,Rattus norvegicus,,BAO_0000218,,Rapid clearance after intravenous administration in rat was determined,CHEMBL875287,10116.0,7912,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5702,,Rattus norvegicus,,BAO_0000218,,Clearance measured in rat,CHEMBL621197,10116.0,7913,A,1,Intermediate,,,,1
N,,50597,,,In vivo,740,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for plasma clearance in rat,CHEMBL621198,10116.0,7914,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4853,Plasma,Rattus norvegicus,,BAO_0000218,,Low plasma clearance was calculated in rat,CHEMBL621199,10116.0,7915,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5789,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (Clp) in rat,CHEMBL621200,10116.0,7916,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4527,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,CHEMBL621201,10116.0,7917,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4527,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,CHEMBL621202,10116.0,7918,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6518,,Rattus norvegicus,,BAO_0000218,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,CHEMBL621203,10116.0,7919,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6518,,Rattus norvegicus,,BAO_0000218,,Plasma clearance after IV dosing at 1 mg/kg in rat,CHEMBL621204,10116.0,7920,A,1,Intermediate,,,,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,CHEMBL621205,10116.0,7921,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,CHEMBL621206,10116.0,7922,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,CHEMBL621207,10116.0,7923,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,CHEMBL621208,10116.0,7924,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,CHEMBL621209,10116.0,7925,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,CHEMBL876484,10116.0,7926,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,CHEMBL621210,10116.0,7927,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,CHEMBL621211,10116.0,7928,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,CHEMBL621212,10116.0,7929,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,CHEMBL621213,10116.0,7930,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,CHEMBL621214,10116.0,7931,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,CHEMBL621215,10116.0,7932,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,CHEMBL621216,10116.0,7933,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,CHEMBL621217,10116.0,7934,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,CHEMBL621218,10116.0,7935,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,CHEMBL621219,10116.0,7936,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,CHEMBL621220,10116.0,7937,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,CHEMBL621221,10116.0,7938,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,CHEMBL621222,10116.0,7939,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,CHEMBL621223,10116.0,7940,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,CHEMBL876485,10116.0,7941,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,CHEMBL621224,10116.0,7942,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,CHEMBL621225,10116.0,7943,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,CHEMBL621226,10116.0,7944,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9866,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,CHEMBL621227,10116.0,7945,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,9866,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,CHEMBL621228,10116.0,7946,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,9866,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,CHEMBL621229,10116.0,7947,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,9866,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,CHEMBL621230,10116.0,7948,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,9866,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,CHEMBL621231,10116.0,7949,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,9866,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,CHEMBL621232,10116.0,7950,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,9866,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,CHEMBL621233,10116.0,7951,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,9866,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,CHEMBL621234,10116.0,7952,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,9866,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,CHEMBL621235,10116.0,7953,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,9866,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,CHEMBL621236,10116.0,7954,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,9866,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,CHEMBL621237,10116.0,7955,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,9866,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,CHEMBL876486,10116.0,7956,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,9866,Intestine,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,CHEMBL622436,10116.0,7957,A,1,Intermediate,,,160.0,1
N,,50597,,,In vivo,9866,Intestine,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,CHEMBL622437,10116.0,7958,A,1,Intermediate,,,160.0,1
N,,50597,,,In vivo,9866,Intestine,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,CHEMBL622438,10116.0,7959,A,1,Intermediate,,,160.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,CHEMBL622439,10116.0,7960,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,CHEMBL622440,10116.0,7961,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,CHEMBL622441,10116.0,7962,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,CHEMBL622442,10116.0,7963,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,CHEMBL622443,10116.0,7964,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,CHEMBL622444,10116.0,7965,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,CHEMBL622445,10116.0,7966,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,CHEMBL622446,10116.0,7967,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,CHEMBL622447,10116.0,7968,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,CHEMBL622448,10116.0,7969,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,CHEMBL622449,10116.0,7970,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,CHEMBL622450,10116.0,7971,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,CHEMBL622451,10116.0,7972,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,CHEMBL622452,10116.0,7973,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,CHEMBL622453,10116.0,7974,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,CHEMBL622454,10116.0,7975,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,CHEMBL622455,10116.0,7976,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,CHEMBL876024,10116.0,7977,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,2792,,Rattus norvegicus,,BAO_0000218,,T max was determined at 3 mg/kg po dose in rats,CHEMBL622456,10116.0,7978,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15078,,Rattus norvegicus,,BAO_0000218,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL622457,10116.0,7979,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15078,,Rattus norvegicus,,BAO_0000218,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",CHEMBL622458,10116.0,7980,A,1,Intermediate,,,,1
N,,50597,,,,15022,,Rattus norvegicus,,BAO_0000218,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,CHEMBL622459,10116.0,7981,A,1,Intermediate,,,,1
N,,50597,,,,15022,,Rattus norvegicus,,BAO_0000218,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,CHEMBL873343,10116.0,7982,A,1,Intermediate,,,,1
N,,50597,,,,15022,,Rattus norvegicus,,BAO_0000218,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,CHEMBL622460,10116.0,7983,A,1,Intermediate,,,,1
N,,50597,,,,4576,Plasma,Rattus norvegicus,,BAO_0000218,,Time for maximum plasma concentration determined in rat,CHEMBL622461,10116.0,7984,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6681,Plasma,Rattus norvegicus,,BAO_0000218,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,CHEMBL622462,10116.0,7985,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,16365,,Rattus norvegicus,,BAO_0000218,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,CHEMBL622463,10116.0,7986,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16365,,Rattus norvegicus,,BAO_0000218,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,CHEMBL622464,10116.0,7987,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16365,,Rattus norvegicus,,BAO_0000218,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,CHEMBL622465,10116.0,7988,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16365,,Rattus norvegicus,,BAO_0000218,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,CHEMBL622466,10116.0,7989,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16365,,Rattus norvegicus,,BAO_0000218,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,CHEMBL622467,10116.0,7990,A,1,Intermediate,,,,1
N,,50597,,,,6824,Plasma,Rattus norvegicus,,BAO_0000218,,Time of maximum plasma concentration in rat,CHEMBL622468,10116.0,7991,A,1,Intermediate,,,1969.0,1
N,,50597,,,,6685,Plasma,Rattus norvegicus,,BAO_0000218,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",CHEMBL876025,10116.0,7992,A,1,Intermediate,,,1969.0,1
N,,50597,,,,6685,Plasma,Rattus norvegicus,,BAO_0000218,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",CHEMBL622469,10116.0,7993,A,1,Intermediate,,,1969.0,1
N,,50597,,,,6685,Plasma,Rattus norvegicus,,BAO_0000218,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",CHEMBL622470,10116.0,7994,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15662,,Rattus norvegicus,,BAO_0000218,,Time required to reach maximum concentration (Cmax) after oral administration in rat,CHEMBL622471,10116.0,7995,A,1,Intermediate,,,,1
N,,50597,,,,1742,Plasma,Rattus norvegicus,,BAO_0000218,,Time required to reach maximum concentration in rat plasma,CHEMBL622472,10116.0,7996,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,2774,Plasma,Rattus norvegicus,,BAO_0000218,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,CHEMBL622473,10116.0,7997,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5199,Plasma,Rattus norvegicus,,BAO_0000218,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,CHEMBL624282,10116.0,7998,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,12873,Plasma,Rattus norvegicus,,BAO_0000218,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,CHEMBL624283,10116.0,7999,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,12873,Plasma,Rattus norvegicus,,BAO_0000218,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,CHEMBL624284,10116.0,8000,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,1916,Plasma,Rattus norvegicus,,BAO_0000218,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,CHEMBL624285,10116.0,8001,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,16367,,Rattus norvegicus,,BAO_0000218,,Time to reach Cmax after oral administration to rats,CHEMBL624286,10116.0,8002,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16366,,Rattus norvegicus,,BAO_0000218,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,CHEMBL624287,10116.0,8003,A,1,Intermediate,,,,1
N,,50597,,,,216,,Rattus norvegicus,,BAO_0000218,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,CHEMBL624288,10116.0,8004,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6410,Plasma,Rattus norvegicus,,BAO_0000218,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,CHEMBL624289,10116.0,8005,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6410,Plasma,Rattus norvegicus,,BAO_0000218,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,CHEMBL873344,10116.0,8006,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6215,,Rattus norvegicus,,BAO_0000218,,Tmax after peroral administration (10 mg/kg) was determined in rat,CHEMBL619623,10116.0,8007,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3598,,Rattus norvegicus,,BAO_0000218,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,CHEMBL621399,10116.0,8008,A,1,Expert,,,,1
N,,50597,,,In vivo,4527,,Rattus norvegicus,,BAO_0000218,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,CHEMBL621400,10116.0,8009,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17670,,Rattus norvegicus,,BAO_0000218,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",CHEMBL621401,10116.0,8010,A,1,Intermediate,,,,1
N,,50597,,,,1465,,Rattus norvegicus,,BAO_0000218,,Tmax was determined,CHEMBL621402,10116.0,8011,A,1,Intermediate,,,,1
N,,50597,,,,2552,,Rattus norvegicus,,BAO_0000218,,Tmax was determined,CHEMBL621403,10116.0,8012,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5656,,Rattus norvegicus,,BAO_0000218,,Tmax after oral administration in rat,CHEMBL621121,10116.0,8013,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17764,,Rattus norvegicus,,BAO_0000218,,Tmax after peroral administration in rats at 2.4 uM/kg,CHEMBL872525,10116.0,8014,A,1,Intermediate,,,,1
N,,50597,,,,5610,,Rattus norvegicus,,BAO_0000218,,Tmax in male rat,CHEMBL621122,10116.0,8015,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6046,,Rattus norvegicus,,BAO_0000218,,Tmax in rat at 10 mg/kg,CHEMBL621123,10116.0,8016,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5874,,Rattus norvegicus,,BAO_0000218,,Tmax in rat by po administration at a dose of 40 mg/kg,CHEMBL621124,10116.0,8017,A,1,Intermediate,,,,1
N,,50597,,,,17596,,Rattus norvegicus,,BAO_0000218,,Tmax in rats,CHEMBL621125,10116.0,8018,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17804,,Rattus norvegicus,,BAO_0000218,,Tmax was measured in rats after peroral administration at 5 mg/kg,CHEMBL621126,10116.0,8019,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1908,,Rattus norvegicus,,BAO_0000218,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,CHEMBL621127,10116.0,8020,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2959,,Rattus norvegicus,,BAO_0000218,,Tmax value after administration of 20 mg/Kg oral dose in rat,CHEMBL621128,10116.0,8021,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6757,,Rattus norvegicus,,BAO_0000218,,Tmax value at a dose of 10 mg/kg in male SD rats,CHEMBL618263,10116.0,8022,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6757,,Rattus norvegicus,,BAO_0000218,,Tmax value at a dose of 100 mg/kg in male SD rats,CHEMBL618264,10116.0,8023,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6757,,Rattus norvegicus,,BAO_0000218,,Tmax value at a dose of 50 mg/kg in male SD rats,CHEMBL618265,10116.0,8024,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4186,Plasma,Rattus norvegicus,,BAO_0000218,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,CHEMBL618266,10116.0,8025,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15662,,Rattus norvegicus,,BAO_0000218,,time required to reach maximum concentration (Cmax) after oral administration in rat,CHEMBL618267,10116.0,8026,A,1,Intermediate,,,,1
N,,50597,,,,429,Urine,Rattus norvegicus,,BAO_0000218,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),CHEMBL618450,10116.0,8027,A,1,Intermediate,,,1088.0,1
N,,50597,,,,429,Urine,Rattus norvegicus,,BAO_0000218,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),CHEMBL618451,10116.0,8028,A,1,Intermediate,,,1088.0,1
N,,50597,,,,5546,,Rattus norvegicus,,BAO_0000218,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,CHEMBL618452,10116.0,8029,A,1,Intermediate,,,,1
N,,50597,,,,3173,Urine,Rattus norvegicus,,BAO_0000218,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,CHEMBL618453,10116.0,8030,A,1,Intermediate,,,1088.0,1
N,,50597,,,,3173,Urine,Rattus norvegicus,,BAO_0000218,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,CHEMBL618454,10116.0,8031,A,1,Intermediate,,,1088.0,1
N,,50597,,,,3173,Urine,Rattus norvegicus,,BAO_0000218,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,CHEMBL618455,10116.0,8032,A,1,Intermediate,,,1088.0,1
N,,50597,,,In vivo,4257,,Rattus norvegicus,,BAO_0000218,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,CHEMBL618456,10116.0,8033,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6011,,Rattus norvegicus,,BAO_0000218,,Compound distribution in rat tissues was determined,CHEMBL618457,10116.0,8034,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5472,,Rattus norvegicus,,BAO_0000218,,Volume of distribution was evaluated in rat,CHEMBL618458,10116.0,8035,A,1,Intermediate,,,,1
N,,50597,,,,14346,,Rattus norvegicus,,BAO_0000218,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,CHEMBL618459,10116.0,8036,A,1,Intermediate,,,,1
N,,50597,,,,14346,,Rattus norvegicus,,BAO_0000218,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,CHEMBL876733,10116.0,8037,A,1,Intermediate,,,,1
N,,50588,,,,14346,,Canis lupus familiaris,,BAO_0000218,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,CHEMBL618460,9615.0,8038,A,1,Intermediate,,,,1
N,,50597,,,,14346,,Rattus norvegicus,,BAO_0000218,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,CHEMBL618461,10116.0,8039,A,1,Intermediate,,,,1
U,,22224,,,,15469,,,,BAO_0000019,,Area under the curve was determined after oral administration (300 uM/Kg),CHEMBL618462,,8040,A,1,Autocuration,,,,0
N,,50597,,,,14346,,Rattus norvegicus,,BAO_0000218,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,CHEMBL618463,10116.0,8041,A,1,Intermediate,,,,1
N,,50597,,,,14346,,Rattus norvegicus,,BAO_0000218,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,CHEMBL618464,10116.0,8042,A,1,Intermediate,,,,1
N,,50597,,,,14346,,Rattus norvegicus,,BAO_0000218,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,CHEMBL618465,10116.0,8043,A,1,Intermediate,,,,1
N,,50597,,,,14346,,Rattus norvegicus,,BAO_0000218,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,CHEMBL618466,10116.0,8044,A,1,Intermediate,,,,1
N,,50597,,,,14346,,Rattus norvegicus,,BAO_0000218,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,CHEMBL618467,10116.0,8045,A,1,Intermediate,,,,1
N,,50597,,,,15372,,Rattus norvegicus,,BAO_0000218,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,CHEMBL618468,10116.0,8046,A,1,Intermediate,,,,1
N,,50588,,,,12935,Plasma,Canis lupus familiaris,,BAO_0000218,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,CHEMBL618469,9615.0,8047,A,1,Intermediate,,,1969.0,1
N,,50588,,,,12935,Plasma,Canis lupus familiaris,,BAO_0000218,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,CHEMBL618470,9615.0,8048,A,1,Intermediate,,,1969.0,1
U,,22224,,,,14813,,,,BAO_0000218,,Plasma drug AUC in rat (PO dose),CHEMBL618471,,8049,A,1,Autocuration,,,,0
N,,50594,,,,15792,,Mus musculus,,BAO_0000218,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,CHEMBL618472,10090.0,8050,A,1,Intermediate,,,,1
U,,22224,,,,3579,,,,BAO_0000218,,Area under was determined at a dose of 30 mg/kg,CHEMBL618473,,8051,A,1,Autocuration,,,,0
N,,50506,,,,12487,,Mustela putorius furo,,BAO_0000218,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,CHEMBL621699,9669.0,8052,A,1,Intermediate,,,,1
N,,50597,,,,12487,,Rattus norvegicus,,BAO_0000218,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,CHEMBL621700,10116.0,8053,A,1,Intermediate,,,,1
N,,50597,,,,12487,,Rattus norvegicus,,BAO_0000218,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,CHEMBL621701,10116.0,8054,A,1,Intermediate,,,,1
N,,50506,,,,12487,,Mustela putorius furo,,BAO_0000218,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,CHEMBL621702,9669.0,8055,A,1,Intermediate,,,,1
N,,50588,,,,12487,,Canis lupus familiaris,,BAO_0000218,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,CHEMBL621703,9615.0,8056,A,1,Intermediate,,,,1
N,,50588,,,,12487,,Canis lupus familiaris,,BAO_0000218,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,CHEMBL621704,9615.0,8057,A,1,Intermediate,,,,1
N,,50597,,,,12902,,Rattus norvegicus,,BAO_0000218,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",CHEMBL624259,10116.0,8058,A,1,Intermediate,,,,1
N,,50597,,,,12902,,Rattus norvegicus,,BAO_0000218,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",CHEMBL624260,10116.0,8059,A,1,Intermediate,,,,1
N,,50597,,,,12902,,Rattus norvegicus,,BAO_0000218,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",CHEMBL624430,10116.0,8060,A,1,Intermediate,,,,1
N,,50597,,,,12902,,Rattus norvegicus,,BAO_0000218,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",CHEMBL624431,10116.0,8061,A,1,Intermediate,,,,1
N,,50597,,,,12902,,Rattus norvegicus,,BAO_0000218,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",CHEMBL624432,10116.0,8062,A,1,Intermediate,,,,1
N,,50597,,,,12902,,Rattus norvegicus,,BAO_0000218,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",CHEMBL624433,10116.0,8063,A,1,Intermediate,,,,1
N,,50597,,,,12902,,Rattus norvegicus,,BAO_0000218,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",CHEMBL624434,10116.0,8064,A,1,Intermediate,,,,1
N,,50597,,,,12902,,Rattus norvegicus,,BAO_0000218,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",CHEMBL624435,10116.0,8065,A,1,Intermediate,,,,1
N,,50594,,,,12745,,Mus musculus,,BAO_0000218,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,CHEMBL618570,10090.0,8066,A,1,Intermediate,,,,1
N,,50594,,,,12745,,Mus musculus,,BAO_0000218,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),CHEMBL618571,10090.0,8067,A,1,Intermediate,,,,1
N,,50594,,,,12745,,Mus musculus,,BAO_0000218,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,CHEMBL618572,10090.0,8068,A,1,Intermediate,,,,1
N,,50594,,,,12745,,Mus musculus,,BAO_0000218,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),CHEMBL618573,10090.0,8069,A,1,Intermediate,,,,1
N,,50594,,,,12745,,Mus musculus,,BAO_0000218,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,CHEMBL619267,10090.0,8070,A,1,Intermediate,,,,1
N,,50594,,,,12745,,Mus musculus,,BAO_0000218,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),CHEMBL619431,10090.0,8071,A,1,Intermediate,,,,1
N,,50594,,,,12745,,Mus musculus,,BAO_0000218,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,CHEMBL619432,10090.0,8072,A,1,Intermediate,,,,1
N,,50594,,,,12745,,Mus musculus,,BAO_0000218,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),CHEMBL619433,10090.0,8073,A,1,Intermediate,,,,1
U,,22224,,,,13298,Plasma,,,BAO_0000218,,AUC in mice after oral dose (50 mg/kg),CHEMBL619434,,8074,A,1,Autocuration,,,1969.0,0
N,,50594,,,,12226,Serum,Mus musculus,,BAO_0000218,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,CHEMBL619435,10090.0,8075,A,1,Intermediate,,,1977.0,1
U,,22224,,,,12634,Plasma,,,BAO_0000019,,AUC (0-4 hr) ug/ml/h,CHEMBL619436,,8076,A,1,Autocuration,,,1969.0,0
N,,50597,,,,14810,,Rattus norvegicus,,BAO_0000218,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,CHEMBL619437,10116.0,8077,A,1,Intermediate,,,,1
U,,22224,,,,13889,,,,BAO_0000218,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,CHEMBL619438,,8078,A,1,Autocuration,,,,0
N,,50594,,,,10018,,Mus musculus,,BAO_0000218,,Compound was evaluated for Area under curve in mice,CHEMBL619439,10090.0,8079,A,1,Intermediate,,,,1
N,,50597,,,,8758,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,CHEMBL619440,10116.0,8080,A,1,Intermediate,,,,1
U,,22224,,,,8758,,,,BAO_0000218,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,CHEMBL619441,,8081,F,1,Autocuration,,,,0
N,,50597,,,,8758,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,CHEMBL619442,10116.0,8082,A,1,Intermediate,,,,1
U,,22224,,,,2249,,,,BAO_0000019,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,CHEMBL875156,,8083,A,1,Autocuration,,,,0
U,,22224,,,,2249,,,,BAO_0000019,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,CHEMBL619443,,8084,A,1,Autocuration,,,,0
U,,22224,,,,2249,,,,BAO_0000019,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,CHEMBL619444,,8085,A,1,Autocuration,,,,0
U,,22224,,,,2249,,,,BAO_0000019,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,CHEMBL623464,,8086,A,1,Autocuration,,,,0
N,,50594,,,,15115,,Mus musculus,,BAO_0000218,,Compound was evaluated for area under curve when administered through oral route in mouse,CHEMBL623465,10090.0,8087,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6518,,Rattus norvegicus,,BAO_0000218,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,CHEMBL623466,10116.0,8088,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6518,,Rattus norvegicus,,BAO_0000218,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,CHEMBL623467,10116.0,8089,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6249,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat,CHEMBL623468,10116.0,8090,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2463,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,CHEMBL622660,10116.0,8091,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4969,,Rattus norvegicus,,BAO_0000218,,Plasma clearance rate in Sprague-Dawley rats,CHEMBL622661,10116.0,8092,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17720,,Rattus norvegicus,,BAO_0000218,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,CHEMBL622662,10116.0,8093,F,1,Intermediate,,,,1
N,,50597,,,In vivo,3457,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (total body clearance) in rat,CHEMBL622663,10116.0,8094,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5983,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,CHEMBL622664,10116.0,8095,A,1,Intermediate,,,,1
N,,50597,,,,6295,,Rattus norvegicus,,BAO_0000218,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,CHEMBL622665,10116.0,8096,A,1,Intermediate,,,,1
N,,50597,,,,6296,,Rattus norvegicus,,BAO_0000218,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,CHEMBL622666,10116.0,8097,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17686,,Rattus norvegicus,,BAO_0000218,,Cl in rat i.v. at 2 mg/kg concentration,CHEMBL621615,10116.0,8098,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17764,,Rattus norvegicus,,BAO_0000218,,Clearance of compound after intravenous administration in rats at 24 uM/kg,CHEMBL621616,10116.0,8099,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5503,,Rattus norvegicus,,BAO_0000218,,Clearance was determined,CHEMBL621617,10116.0,8100,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4368,,Rattus norvegicus,,BAO_0000218,,Clearance by intravenous administration of 3.4 mg/kg in rat,CHEMBL621618,10116.0,8101,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6005,,Rattus norvegicus,,BAO_0000218,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,CHEMBL621619,10116.0,8102,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5031,,Rattus norvegicus,,BAO_0000218,,Clearance rate after i.v. administration in rats,CHEMBL621620,10116.0,8103,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4890,,Rattus norvegicus,,BAO_0000218,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,CHEMBL621786,10116.0,8104,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5182,,Rattus norvegicus,,BAO_0000218,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,CHEMBL621787,10116.0,8105,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5979,,Rattus norvegicus,,BAO_0000218,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,CHEMBL621788,10116.0,8106,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5656,,Rattus norvegicus,,BAO_0000218,,Clearance (Cl) after oral administration in rat,CHEMBL621789,10116.0,8107,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17804,,Rattus norvegicus,,BAO_0000218,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,CHEMBL621790,10116.0,8108,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4839,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was tested for plasma clearance in rat,CHEMBL621791,10116.0,8109,A,1,Intermediate,,,1969.0,1
N,Microsomes,50597,,,In vitro,5041,,Rattus norvegicus,,BAO_0000218,,In vitro microsome metabolism clearance in rat was determined,CHEMBL621792,10116.0,8110,A,1,Intermediate,,,,1
N,Microsomes,50597,,,In vitro,5041,,Rattus norvegicus,,BAO_0000218,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,CHEMBL621793,10116.0,8111,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,CHEMBL621794,10116.0,8112,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5496,Plasma,Rattus norvegicus,,BAO_0000218,,In vivo plasma clearance was determined,CHEMBL621795,10116.0,8113,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5739,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,CHEMBL621796,10116.0,8114,A,1,Intermediate,,,,1
N,,50597,401.0,,In vivo,5676,Liver,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,CHEMBL621797,10116.0,8115,A,1,Intermediate,Hepatocyte,,2107.0,1
N,,50597,,,In vivo,4239,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (Plasma clearance) was measured in rat,CHEMBL621798,10116.0,8116,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5676,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (clearance) in rat i.v.,CHEMBL621799,10116.0,8117,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1918,,Rattus norvegicus,,BAO_0000218,,"Plasma Clearance was evaluated in rats, iv",CHEMBL621800,10116.0,8118,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17800,,Rattus norvegicus,,BAO_0000218,,Plasma clearance (in vivo) in rats was determined,CHEMBL621801,10116.0,8119,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6056,,Rattus norvegicus,,BAO_0000218,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,CHEMBL621802,10116.0,8120,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5496,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was determined,CHEMBL618596,10116.0,8121,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5939,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,CHEMBL618597,10116.0,8122,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5939,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,CHEMBL618598,10116.0,8123,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17752,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rats,CHEMBL618599,10116.0,8124,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4576,,Rattus norvegicus,,BAO_0000218,,Plasma clearance rate determined in rat,CHEMBL618600,10116.0,8125,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6011,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was determined in rat,CHEMBL618601,10116.0,8126,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5510,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was determined,CHEMBL618602,10116.0,8127,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5948,,Rattus norvegicus,,BAO_0000218,,Plasma clearance value in rat,CHEMBL618603,10116.0,8128,A,1,Intermediate,,,,1
N,,50597,,,Ex vivo,6125,Liver,Rattus norvegicus,,BAO_0000218,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,CHEMBL618604,10116.0,8129,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,4839,,Rattus norvegicus,,BAO_0000218,,Clearance in rat,CHEMBL618605,10116.0,8130,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17686,,Rattus norvegicus,,BAO_0000218,,Total body clearance in rat i.v. at 2 mg/kg concentration,CHEMBL618606,10116.0,8131,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6571,,Rattus norvegicus,,BAO_0000218,,Clearance of compound in rats after intravenous administration,CHEMBL618607,10116.0,8132,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3364,,Rattus norvegicus,,BAO_0000218,,Clearance after iv administration to rats,CHEMBL618608,10116.0,8133,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13569,,Rattus norvegicus,,BAO_0000218,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,CHEMBL618609,10116.0,8134,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13569,,Rattus norvegicus,,BAO_0000218,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,CHEMBL618610,10116.0,8135,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13569,,Rattus norvegicus,,BAO_0000218,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,CHEMBL618611,10116.0,8136,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13569,,Rattus norvegicus,,BAO_0000218,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,CHEMBL618612,10116.0,8137,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13569,,Rattus norvegicus,,BAO_0000218,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,CHEMBL618613,10116.0,8138,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13569,,Rattus norvegicus,,BAO_0000218,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,CHEMBL621076,10116.0,8139,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13569,,Rattus norvegicus,,BAO_0000218,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,CHEMBL621077,10116.0,8140,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17670,,Rattus norvegicus,,BAO_0000218,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",CHEMBL621078,10116.0,8141,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5970,,Rattus norvegicus,,BAO_0000218,,Clearance in rat,CHEMBL621251,10116.0,8142,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6495,,Rattus norvegicus,,BAO_0000218,,Clearance in rat after oral administration at 10 mg/kg,CHEMBL621252,10116.0,8143,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4590,,Rattus norvegicus,,BAO_0000218,,Clearance in rat.,CHEMBL621253,10116.0,8144,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6193,,Rattus norvegicus,,BAO_0000218,,Clearance rate following an oral dose of 20 mg/kg in rats,CHEMBL621254,10116.0,8145,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2832,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,CHEMBL621255,10116.0,8146,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1052,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,CHEMBL621256,10116.0,8147,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,CHEMBL621257,10116.0,8148,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,CHEMBL621258,10116.0,8149,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,CHEMBL621259,10116.0,8150,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,CHEMBL621260,10116.0,8151,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,CHEMBL876494,10116.0,8152,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,CHEMBL621261,10116.0,8153,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,CHEMBL621262,10116.0,8154,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,CHEMBL621263,10116.0,8155,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,CHEMBL621264,10116.0,8156,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9866,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,CHEMBL621265,10116.0,8157,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9866,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,CHEMBL621266,10116.0,8158,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9866,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,CHEMBL621267,10116.0,8159,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9866,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,CHEMBL621268,10116.0,8160,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9866,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,CHEMBL621269,10116.0,8161,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9866,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,CHEMBL621270,10116.0,8162,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9866,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,CHEMBL621271,10116.0,8163,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9866,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,CHEMBL621272,10116.0,8164,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9866,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,CHEMBL621273,10116.0,8165,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9866,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,CHEMBL621274,10116.0,8166,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9866,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,CHEMBL876495,10116.0,8167,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9866,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,CHEMBL621275,10116.0,8168,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9866,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,CHEMBL621276,10116.0,8169,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9866,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,CHEMBL621277,10116.0,8170,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9866,Intestine,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,CHEMBL621278,10116.0,8171,A,1,Intermediate,,,160.0,1
N,,50597,,,In vivo,9866,Intestine,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,CHEMBL621279,10116.0,8172,A,1,Intermediate,,,160.0,1
N,,50597,,,In vivo,9866,Intestine,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),CHEMBL621280,10116.0,8173,A,1,Intermediate,,,160.0,1
N,,50597,,,In vivo,9866,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,CHEMBL621281,10116.0,8174,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,9866,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,CHEMBL621282,10116.0,8175,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,9866,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,CHEMBL621283,10116.0,8176,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,9866,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,CHEMBL621284,10116.0,8177,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,9866,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,CHEMBL621285,10116.0,8178,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,9866,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,CHEMBL621286,10116.0,8179,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,9866,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,CHEMBL623220,10116.0,8180,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,9866,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,CHEMBL623221,10116.0,8181,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,9866,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,CHEMBL876029,10116.0,8182,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,9866,Stomach,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,CHEMBL623222,10116.0,8183,A,1,Intermediate,,,945.0,1
N,,50597,,,In vivo,9866,Stomach,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,CHEMBL623223,10116.0,8184,A,1,Intermediate,,,945.0,1
N,,50597,,,In vivo,9866,Stomach,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,CHEMBL621445,10116.0,8185,A,1,Intermediate,,,945.0,1
N,,50597,,,In vivo,13950,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL621446,10116.0,8186,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13950,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,CHEMBL621447,10116.0,8187,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13950,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL619681,10116.0,8188,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13950,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,CHEMBL619682,10116.0,8189,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13950,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL619683,10116.0,8190,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13950,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL619684,10116.0,8191,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13950,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,CHEMBL619685,10116.0,8192,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13950,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL619686,10116.0,8193,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13950,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,CHEMBL619687,10116.0,8194,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13950,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL619688,10116.0,8195,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13950,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL619689,10116.0,8196,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13950,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,CHEMBL619690,10116.0,8197,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13950,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL619691,10116.0,8198,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,6062,,Rattus norvegicus,,BAO_0000218,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,CHEMBL619692,10116.0,8199,A,1,Intermediate,,,,1
N,,50597,,,,3598,,Rattus norvegicus,,BAO_0000218,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,CHEMBL619693,10116.0,8200,A,1,Expert,,,,1
N,,50597,,,In vivo,1908,,Rattus norvegicus,,BAO_0000218,,Vc value after IV dose at a dose of 5 mg/kg in rats.,CHEMBL619694,10116.0,8201,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17596,,Rattus norvegicus,,BAO_0000218,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,CHEMBL619695,10116.0,8202,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4891,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for pharmacokinetic parameter volume of distribution,CHEMBL619696,10116.0,8203,A,1,Intermediate,,,,1
N,,50597,,,In vivo,740,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for volume of distribution in rat,CHEMBL619697,10116.0,8204,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16366,,Rattus norvegicus,,BAO_0000218,,Steady state volume distribution was determined; steady state(ss),CHEMBL619698,10116.0,8205,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3364,,Rattus norvegicus,,BAO_0000218,,Steady state volume of distribution after iv administration to rats,CHEMBL619699,10116.0,8206,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2552,,Rattus norvegicus,,BAO_0000218,,Steady state volume of distribution dosing at 3 mg/kg iv,CHEMBL619700,10116.0,8207,A,1,Intermediate,,,,1
N,,50597,,,In vivo,406,,Rattus norvegicus,,BAO_0000218,,The compound was evaluated for volume of distribution in rat,CHEMBL619701,10116.0,8208,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12500,,Rattus norvegicus,,BAO_0000218,,The compound was tested for volume of distribution in rat,CHEMBL619702,10116.0,8209,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12500,,Rattus norvegicus,,BAO_0000218,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,CHEMBL620335,10116.0,8210,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5656,,Rattus norvegicus,,BAO_0000218,,Volume distribution (VD) after oral administration in rat,CHEMBL620336,10116.0,8211,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17671,,Rattus norvegicus,,BAO_0000218,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,CHEMBL620337,10116.0,8212,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1094,,Rattus norvegicus,,BAO_0000218,,Volume distribution in rat,CHEMBL620520,10116.0,8213,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5833,,Rattus norvegicus,,BAO_0000218,,Volume distribution in rat,CHEMBL620521,10116.0,8214,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5939,,Rattus norvegicus,,BAO_0000218,,Volume distribution in rat after peroral administration at 10 mg/kg,CHEMBL875825,10116.0,8215,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5939,,Rattus norvegicus,,BAO_0000218,,Volume distribution in rat after peroral administration at 5 mg/kg,CHEMBL620522,10116.0,8216,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6005,,Rattus norvegicus,,BAO_0000218,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,CHEMBL620523,10116.0,8217,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1696,,Rattus norvegicus,,BAO_0000218,,Volume of distribution in rat.,CHEMBL620524,10116.0,8218,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6672,,Rattus norvegicus,,BAO_0000218,,Volume of distribution in rat,CHEMBL620525,10116.0,8219,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6673,,Rattus norvegicus,,BAO_0000218,,Volume of distribution in rat,CHEMBL620526,10116.0,8220,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5871,,Rattus norvegicus,,BAO_0000218,,Volume of distribution in rat by iv administration,CHEMBL620527,10116.0,8221,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6803,,Rattus norvegicus,,BAO_0000218,,Volume of distribution in rats,CHEMBL620528,10116.0,8222,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5199,,Rattus norvegicus,,BAO_0000218,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,CHEMBL620529,10116.0,8223,A,1,Intermediate,,,,1
N,,50597,,,,4727,,Rattus norvegicus,,BAO_0000218,,Volume distribution at the dose of 2 mg/kg in rat,CHEMBL620530,10116.0,8224,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16367,,Rattus norvegicus,,BAO_0000218,,Steady state volume of distribution was determined,CHEMBL620531,10116.0,8225,A,1,Intermediate,,,,1
U,,22224,,,In vivo,5005,,Macaca mulatta,,BAO_0000218,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,CHEMBL620532,9544.0,8226,A,1,Intermediate,,,,0
U,,22224,,,In vivo,5005,,Rattus norvegicus,,BAO_0000218,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,CHEMBL620533,10116.0,8227,A,1,Intermediate,,,,0
U,,22224,,,In vivo,5005,,Rattus norvegicus,,BAO_0000218,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,CHEMBL620534,10116.0,8228,A,1,Intermediate,,,,0
N,,50597,,,In vivo,15765,,Rattus norvegicus,,BAO_0000218,,Mean (%CV) PK parameters for Vdss(mL/kg).,CHEMBL620535,10116.0,8229,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2792,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,CHEMBL875826,10116.0,8230,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2792,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,CHEMBL620536,10116.0,8231,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5334,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,CHEMBL620537,10116.0,8232,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5334,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,CHEMBL618526,10116.0,8233,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5739,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,CHEMBL618527,10116.0,8234,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5789,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (Vdss) in rat,CHEMBL618528,10116.0,8235,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4239,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (vdss) was measured in rat,CHEMBL618529,10116.0,8236,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4709,,Rattus norvegicus,,BAO_0000218,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,CHEMBL618530,10116.0,8237,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6642,,Rattus norvegicus,,BAO_0000218,,Volume of distribution in rat,CHEMBL618531,10116.0,8238,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5247,,Rattus norvegicus,,BAO_0000218,,The pharmacokinetic parameter volume of distribution in vivo in rats,CHEMBL618532,10116.0,8239,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17720,,Rattus norvegicus,,BAO_0000218,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,CHEMBL618533,10116.0,8240,F,1,Intermediate,,,,1
N,,50597,,,In vivo,17686,,Rattus norvegicus,,BAO_0000218,,Vdss in rat i.v. at 2 mg/kg concentration,CHEMBL618534,10116.0,8241,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4689,,Rattus norvegicus,,BAO_0000218,,Volume distribution after intravenous administration (1 mg/kg) in rat,CHEMBL618535,10116.0,8242,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5654,,Rattus norvegicus,,BAO_0000218,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,CHEMBL618536,10116.0,8243,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5654,,Rattus norvegicus,,BAO_0000218,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,CHEMBL618537,10116.0,8244,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4527,,Rattus norvegicus,,BAO_0000218,,Volume distribution at a dose of 10 uM/kg in rat was determined,CHEMBL618538,10116.0,8245,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4521,,Rattus norvegicus,,BAO_0000218,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,CHEMBL618539,10116.0,8246,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6057,,Rattus norvegicus,,BAO_0000218,,Volume distribution was calculated in rat,CHEMBL618540,10116.0,8247,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5510,,Rattus norvegicus,,BAO_0000218,,Volume distribution was determined,CHEMBL618541,10116.0,8248,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2938,,Rattus norvegicus,,BAO_0000218,,Volume of distribution after intravenous administration was evaluated in rat,CHEMBL618542,10116.0,8249,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6679,,Rattus norvegicus,,BAO_0000218,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,CHEMBL622544,10116.0,8250,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6685,,Rattus norvegicus,,BAO_0000218,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",CHEMBL622545,10116.0,8251,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6685,,Rattus norvegicus,,BAO_0000218,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",CHEMBL622546,10116.0,8252,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6685,,Rattus norvegicus,,BAO_0000218,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",CHEMBL622547,10116.0,8253,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5145,,Rattus norvegicus,,BAO_0000218,,Volume of distribution in steady state was determined in rat,CHEMBL622548,10116.0,8254,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6467,,Rattus norvegicus,,BAO_0000218,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,CHEMBL622549,10116.0,8255,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6467,,Rattus norvegicus,,BAO_0000218,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,CHEMBL622550,10116.0,8256,A,1,Intermediate,,,,1
N,,50594,,,,15115,,Mus musculus,,BAO_0000218,,Compound was evaluated for area under curve when administered through oral route to mouse,CHEMBL622551,10090.0,8257,A,1,Intermediate,,,,1
N,,50597,,,,8758,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,CHEMBL622552,10116.0,8258,A,1,Intermediate,,,,1
N,,50597,,,,8758,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,CHEMBL622553,10116.0,8259,A,1,Intermediate,,,,1
U,,22224,,,In vivo,8267,,,,BAO_0000218,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,CHEMBL622554,,8260,F,1,Autocuration,,,,0
N,,50588,,,,8267,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,CHEMBL622555,9615.0,8261,A,1,Intermediate,,,,1
N,,50594,,,,14239,,Mus musculus,,BAO_0000218,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,CHEMBL622556,10090.0,8262,A,1,Intermediate,,,,1
N,,50594,,,,14239,,Mus musculus,,BAO_0000218,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,CHEMBL622557,10090.0,8263,A,1,Intermediate,,,,1
N,,50594,,,,10754,Blood,Mus musculus,,BAO_0000218,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,CHEMBL622558,10090.0,8264,A,1,Intermediate,,,178.0,1
N,,50594,,,,10754,Blood,Mus musculus,,BAO_0000218,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,CHEMBL622559,10090.0,8265,A,1,Intermediate,,,178.0,1
N,,50588,,,,10754,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,CHEMBL622560,9615.0,8266,A,1,Intermediate,,,,1
N,,50597,,,,14681,,Rattus norvegicus,,BAO_0000218,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,CHEMBL622561,10116.0,8267,A,1,Intermediate,,,,1
N,,50597,,,,14681,,Rattus norvegicus,,BAO_0000218,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,CHEMBL622562,10116.0,8268,A,1,Intermediate,,,,1
N,,50597,,,,14681,,Rattus norvegicus,,BAO_0000218,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,CHEMBL622563,10116.0,8269,A,1,Intermediate,,,,1
U,,22224,,,,13118,,,,BAO_0000019,,Concentration of compound in Central nervous system,CHEMBL622564,,8270,A,1,Autocuration,,,,0
U,,22224,,,,13118,,,,BAO_0000019,,Concentration of compound in Central nervous system; Not detectable,CHEMBL622565,,8271,A,1,Autocuration,,,,0
N,,50594,,,,13318,,Mus musculus,,BAO_0000218,,"Concentration of diester in the blood, following oral administration in mice",CHEMBL622566,10090.0,8272,A,1,Intermediate,,,,1
N,,50594,,,,13318,,Mus musculus,,BAO_0000218,,"Concentration of monoester in the blood, following oral administration in mice",CHEMBL624515,10090.0,8273,A,1,Intermediate,,,,1
N,,50594,,,,13318,,Mus musculus,,BAO_0000218,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,CHEMBL624516,10090.0,8274,A,1,Intermediate,,,,1
U,,22224,,,,15692,,,,BAO_0000019,,Evaluated for Pharmacokinetic property: Area under the curve,CHEMBL624517,,8275,A,1,Autocuration,,,,0
N,,50594,,,,14839,,Mus musculus,,BAO_0000218,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,CHEMBL624518,10090.0,8276,A,1,Intermediate,,,,1
N,,100710,,,,14839,,Macaca fascicularis,,BAO_0000218,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,CHEMBL624519,9541.0,8277,A,1,Intermediate,,,,1
N,,100710,,,,14839,,Macaca fascicularis,,BAO_0000218,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,CHEMBL624520,9541.0,8278,A,1,Intermediate,,,,1
N,,100710,,,,14839,,Macaca fascicularis,,BAO_0000218,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,CHEMBL624521,9541.0,8279,A,1,Intermediate,,,,1
N,,100710,,,,14839,,Macaca fascicularis,,BAO_0000218,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,CHEMBL624522,9541.0,8280,A,1,Intermediate,,,,1
N,,100710,,,,14839,,Macaca fascicularis,,BAO_0000218,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,CHEMBL624523,9541.0,8281,A,1,Intermediate,,,,1
N,,100710,,,,14839,,Macaca fascicularis,,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",CHEMBL624409,9541.0,8282,A,1,Intermediate,,,,1
N,,100710,,,,14839,,Macaca fascicularis,,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",CHEMBL624410,9541.0,8283,A,1,Intermediate,,,,1
N,,100710,,,,14839,,Macaca fascicularis,,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",CHEMBL624411,9541.0,8284,A,1,Intermediate,,,,1
N,,100710,,,,14839,,Macaca fascicularis,,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",CHEMBL623531,9541.0,8285,A,1,Intermediate,,,,1
N,,100710,,,,14839,,Macaca fascicularis,,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",CHEMBL623532,9541.0,8286,A,1,Intermediate,,,,1
N,,100710,,,,14839,,Macaca fascicularis,,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",CHEMBL623533,9541.0,8287,A,1,Intermediate,,,,1
N,,100710,,,,14839,,Macaca fascicularis,,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",CHEMBL623534,9541.0,8288,A,1,Intermediate,,,,1
N,,50594,,,,14839,,Mus musculus,,BAO_0000218,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,CHEMBL623535,10090.0,8289,A,1,Intermediate,,,,1
N,,50594,,,,14839,,Mus musculus,,BAO_0000218,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,CHEMBL623536,10090.0,8290,A,1,Intermediate,,,,1
N,,50594,,,,14839,,Mus musculus,,BAO_0000218,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,CHEMBL623537,10090.0,8291,A,1,Intermediate,,,,1
N,,50594,,,,14839,,Mus musculus,,BAO_0000218,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,CHEMBL623538,10090.0,8292,A,1,Intermediate,,,,1
N,,50594,,,,14839,,Mus musculus,,BAO_0000218,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,CHEMBL623539,10090.0,8293,A,1,Intermediate,,,,1
N,,50594,,,,14839,,Mus musculus,,BAO_0000218,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,CHEMBL623540,10090.0,8294,A,1,Intermediate,,,,1
N,,50594,,,,14839,,Mus musculus,,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",CHEMBL623541,10090.0,8295,A,1,Intermediate,,,,1
N,,50594,,,,14839,,Mus musculus,,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",CHEMBL623542,10090.0,8296,A,1,Intermediate,,,,1
N,,50594,,,,14839,,Mus musculus,,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",CHEMBL623543,10090.0,8297,A,1,Intermediate,,,,1
N,,50594,,,,14839,,Mus musculus,,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",CHEMBL623544,10090.0,8298,A,1,Intermediate,,,,1
N,,50594,,,,14839,,Mus musculus,,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",CHEMBL623545,10090.0,8299,A,1,Intermediate,,,,1
N,,50594,,,,14839,,Mus musculus,,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",CHEMBL623546,10090.0,8300,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5408,Plasma,Rattus norvegicus,,BAO_0000218,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,CHEMBL623547,10116.0,8301,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6827,,Rattus norvegicus,,BAO_0000218,,High i.v. clearance in Dawley rats,CHEMBL623548,10116.0,8302,A,1,Intermediate,,,,1
N,Microsomes,50597,,,In vitro,17538,Liver,Rattus norvegicus,,BAO_0000218,,In vitro clearance in rat liver microsomes,CHEMBL623549,10116.0,8303,A,1,Intermediate,,,2107.0,1
N,Microsomes,50597,,,In vitro,6331,Liver,Rattus norvegicus,,BAO_0000218,,Intrinsic clearance in rat liver microsomes was determined,CHEMBL623550,10116.0,8304,A,1,Intermediate,,,2107.0,1
N,,50597,401.0,,In vitro,5948,Liver,Rattus norvegicus,,BAO_0000218,,Intrinsic clearance in rat hepatocytes was determined,CHEMBL875276,10116.0,8305,A,1,Intermediate,Hepatocyte,,2107.0,1
N,,50597,,,In vivo,4026,,Rattus norvegicus,,BAO_0000218,,Plasma Clearance was determined,CHEMBL621872,10116.0,8306,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6647,,Rattus norvegicus,,BAO_0000218,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,CHEMBL621873,10116.0,8307,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1696,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat.,CHEMBL621874,10116.0,8308,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6597,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rats,CHEMBL621875,10116.0,8309,A,1,Intermediate,,,,1
N,,50597,,,In vivo,347,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,CHEMBL621876,10116.0,8310,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16423,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,CHEMBL621877,10116.0,8311,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2879,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was measured in rat,CHEMBL621878,10116.0,8312,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4883,,Rattus norvegicus,,BAO_0000218,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,CHEMBL621879,10116.0,8313,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5328,Plasma,Rattus norvegicus,,BAO_0000218,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",CHEMBL621880,10116.0,8314,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5160,,Rattus norvegicus,,BAO_0000218,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,CHEMBL621881,10116.0,8315,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17582,,Rattus norvegicus,,BAO_0000218,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,CHEMBL621882,10116.0,8316,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17651,,Rattus norvegicus,,BAO_0000218,,Total clearance at 1 mg/kg was determined in rat,CHEMBL875283,10116.0,8317,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17651,,Rattus norvegicus,,BAO_0000218,,Total clearance at 10 mg/kg was determined in rat,CHEMBL621883,10116.0,8318,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6596,,Rattus norvegicus,,BAO_0000218,,Clearance in rat,CHEMBL621884,10116.0,8319,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4796,,Rattus norvegicus,,BAO_0000218,,Plasma clearance rate determined in rats,CHEMBL621885,10116.0,8320,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6850,,Rattus norvegicus,,BAO_0000218,,Clearance of compound in rat was evaluated,CHEMBL621886,10116.0,8321,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5932,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,CHEMBL621887,10116.0,8322,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,3371,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (blood clearance) in rat,CHEMBL621888,10116.0,8323,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2083,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat,CHEMBL621889,10116.0,8324,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4942,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rats,CHEMBL621890,10116.0,8325,A,1,Intermediate,,,,1
N,Microsomes,50597,,,In vitro,6838,Liver,Rattus norvegicus,,BAO_0000218,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,CHEMBL621891,10116.0,8326,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,5353,,Rattus norvegicus,,BAO_0000218,,Clearance in Dawley rat,CHEMBL621892,10116.0,8327,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6641,,Rattus norvegicus,,BAO_0000218,,Clearance rat,CHEMBL621893,10116.0,8328,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6641,,Rattus norvegicus,,BAO_0000218,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),CHEMBL621894,10116.0,8329,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6641,,Rattus norvegicus,,BAO_0000218,,Clearance rat; Not determined,CHEMBL621895,10116.0,8330,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6444,,Rattus norvegicus,,BAO_0000218,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,CHEMBL875284,10116.0,8331,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6444,,Rattus norvegicus,,BAO_0000218,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,CHEMBL618699,10116.0,8332,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6444,,Rattus norvegicus,,BAO_0000218,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,CHEMBL618700,10116.0,8333,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6211,,Rattus norvegicus,,BAO_0000218,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,CHEMBL618701,10116.0,8334,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12873,Plasma,Rattus norvegicus,,BAO_0000218,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",CHEMBL876600,10116.0,8335,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6570,,Rattus norvegicus,,BAO_0000218,,Clearance of compound in rat after 1 mg/kg i.v. administration,CHEMBL618702,10116.0,8336,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3341,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for Hepatic clearance in rat,CHEMBL618703,10116.0,8337,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4891,,Rattus norvegicus,,BAO_0000218,,In vivo clearance after 5 mg/kg dose,CHEMBL618704,10116.0,8338,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1094,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was tested for plasma clearance in rats,CHEMBL618705,10116.0,8339,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,2938,,Rattus norvegicus,,BAO_0000218,,Hepatic clearance after intravenous administration was evaluated in rat,CHEMBL618706,10116.0,8340,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17853,,Rattus norvegicus,,BAO_0000218,,Lower clearance in rat (i.v.) at 0.5 mpk,CHEMBL618707,10116.0,8341,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6049,Plasma,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter expressed as plasma clearance in rat,CHEMBL618708,10116.0,8342,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5789,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (Clp) in rat,CHEMBL618709,10116.0,8343,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4514,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in Sprague-Dawley rats,CHEMBL618710,10116.0,8344,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6448,,Rattus norvegicus,,BAO_0000218,,Plasma clearance (Clp) in rat,CHEMBL618711,10116.0,8345,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6062,,Rattus norvegicus,,BAO_0000218,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,CHEMBL618712,10116.0,8346,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5710,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,CHEMBL618713,10116.0,8347,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4709,,Rattus norvegicus,,BAO_0000218,,Plasma clearance after intravenous administration of 1 mg/kg in rat,CHEMBL618714,10116.0,8348,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4521,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,CHEMBL618715,10116.0,8349,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1742,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat was determined,CHEMBL618716,10116.0,8350,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6057,,Rattus norvegicus,,BAO_0000218,,Plasma clearance measured in rat,CHEMBL876601,10116.0,8351,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6057,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was calculated in rat,CHEMBL618717,10116.0,8352,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5145,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat,CHEMBL618718,10116.0,8353,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5833,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat,CHEMBL618719,10116.0,8354,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6453,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat,CHEMBL618720,10116.0,8355,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6640,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat,CHEMBL618721,10116.0,8356,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6305,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rats,CHEMBL621477,10116.0,8357,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6642,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat,CHEMBL621478,10116.0,8358,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5472,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was evaluated in rat,CHEMBL621479,10116.0,8359,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5472,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was evaluated in rat; Not tested,CHEMBL621480,10116.0,8360,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5144,,Rattus norvegicus,,BAO_0000218,,Plasma clearance rate was determined for the compound in rat,CHEMBL621481,10116.0,8361,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6685,,Rattus norvegicus,,BAO_0000218,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",CHEMBL621482,10116.0,8362,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6685,,Rattus norvegicus,,BAO_0000218,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",CHEMBL621483,10116.0,8363,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6685,,Rattus norvegicus,,BAO_0000218,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",CHEMBL621484,10116.0,8364,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13950,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,CHEMBL621485,10116.0,8365,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13950,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL621486,10116.0,8366,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13950,Intestine,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL621487,10116.0,8367,A,1,Intermediate,,,160.0,1
N,,50597,,,In vivo,13950,Intestine,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,CHEMBL621488,10116.0,8368,A,1,Intermediate,,,160.0,1
N,,50597,,,In vivo,13950,Intestine,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL621489,10116.0,8369,A,1,Intermediate,,,160.0,1
N,,50597,,,In vivo,13950,Intestine,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,CHEMBL621490,10116.0,8370,A,1,Intermediate,,,160.0,1
N,,50597,,,In vivo,13950,Intestine,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL621491,10116.0,8371,A,1,Intermediate,,,160.0,1
N,,50597,,,In vivo,13950,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL621492,10116.0,8372,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13950,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,CHEMBL621493,10116.0,8373,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13950,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL621494,10116.0,8374,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13950,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,CHEMBL621495,10116.0,8375,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13950,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL621496,10116.0,8376,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13950,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL621497,10116.0,8377,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13950,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,CHEMBL621498,10116.0,8378,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13950,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL621499,10116.0,8379,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13950,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,CHEMBL618634,10116.0,8380,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13950,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL618635,10116.0,8381,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13950,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL618636,10116.0,8382,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13950,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,CHEMBL619737,10116.0,8383,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13950,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL619738,10116.0,8384,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13950,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,CHEMBL624329,10116.0,8385,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13950,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL624330,10116.0,8386,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13950,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL624331,10116.0,8387,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,13950,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,CHEMBL624332,10116.0,8388,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,13950,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL624333,10116.0,8389,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,13950,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,CHEMBL624334,10116.0,8390,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,13950,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL624335,10116.0,8391,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,13950,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL620016,10116.0,8392,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,13950,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,CHEMBL620169,10116.0,8393,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,13950,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL620170,10116.0,8394,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,13950,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,CHEMBL620171,10116.0,8395,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,13950,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL620172,10116.0,8396,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,13950,Stomach,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,CHEMBL620173,10116.0,8397,A,1,Intermediate,,,945.0,1
N,,50597,,,In vivo,13950,Stomach,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,CHEMBL620174,10116.0,8398,A,1,Intermediate,,,945.0,1
N,,50597,,,In vivo,13950,Stomach,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,CHEMBL620175,10116.0,8399,A,1,Intermediate,,,945.0,1
N,,50597,,,In vivo,13950,Stomach,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,CHEMBL620176,10116.0,8400,A,1,Intermediate,,,945.0,1
N,,50597,,,In vivo,13950,Stomach,Rattus norvegicus,,BAO_0000218,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,CHEMBL620177,10116.0,8401,A,1,Intermediate,,,945.0,1
N,,50597,,,,13950,Cerebellum,Rattus norvegicus,,BAO_0000218,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,CHEMBL620178,10116.0,8402,A,1,Intermediate,,,2037.0,1
N,,50597,,,,13950,Cerebellum,Rattus norvegicus,,BAO_0000218,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,CHEMBL620179,10116.0,8403,A,1,Intermediate,,,2037.0,1
N,,50597,,,,13950,,Rattus norvegicus,,BAO_0000218,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,CHEMBL620180,10116.0,8404,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6570,,Rattus norvegicus,,BAO_0000218,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,CHEMBL620181,10116.0,8405,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6571,,Rattus norvegicus,,BAO_0000218,,Volume of distribution of compound in rats after intravenous administration,CHEMBL620182,10116.0,8406,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6453,,Rattus norvegicus,,BAO_0000218,,Volume of distribution in rat,CHEMBL620183,10116.0,8407,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6444,,Rattus norvegicus,,BAO_0000218,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,CHEMBL620184,10116.0,8408,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6444,,Rattus norvegicus,,BAO_0000218,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,CHEMBL620185,10116.0,8409,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6444,,Rattus norvegicus,,BAO_0000218,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,CHEMBL620186,10116.0,8410,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5353,,Rattus norvegicus,,BAO_0000218,,Volume of distribution was determined in Dawley rat,CHEMBL620187,10116.0,8411,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5334,,Rattus norvegicus,,BAO_0000218,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,CHEMBL620188,10116.0,8412,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5334,,Rattus norvegicus,,BAO_0000218,,Volume of distribution was reported in Sprague-Dawley rat,CHEMBL620189,10116.0,8413,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6641,,Rattus norvegicus,,BAO_0000218,,Volumes of distribution in rat after peroral administration,CHEMBL620190,10116.0,8414,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6641,,Rattus norvegicus,,BAO_0000218,,Volumes of distribution in rat after po administration,CHEMBL620191,10116.0,8415,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6641,,Rattus norvegicus,,BAO_0000218,,Volumes of distribution in rat after po administration; Not determined,CHEMBL620192,10116.0,8416,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5676,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (Volume) in rat i.v.,CHEMBL620193,10116.0,8417,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6410,,Rattus norvegicus,,BAO_0000218,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,CHEMBL620194,10116.0,8418,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17670,,Rattus norvegicus,,BAO_0000218,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",CHEMBL876730,10116.0,8419,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6495,,Rattus norvegicus,,BAO_0000218,,Volume distribution in rat after oral administration at 10 mg/kg,CHEMBL620195,10116.0,8420,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5408,,Rattus norvegicus,,BAO_0000218,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,CHEMBL620196,10116.0,8421,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4883,,Rattus norvegicus,,BAO_0000218,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,CHEMBL620197,10116.0,8422,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6647,,Rattus norvegicus,,BAO_0000218,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,CHEMBL620198,10116.0,8423,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6495,,Rattus norvegicus,,BAO_0000218,,Volume of distribution in rats,CHEMBL620199,10116.0,8424,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2661,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,CHEMBL620200,10116.0,8425,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2661,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,CHEMBL620201,10116.0,8426,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,CHEMBL620202,10116.0,8427,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,CHEMBL620203,10116.0,8428,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,CHEMBL620204,10116.0,8429,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,CHEMBL620205,10116.0,8430,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5960,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter (Vss) in rat,CHEMBL624664,10116.0,8431,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5676,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (Volume) in rat i.v.,CHEMBL624665,10116.0,8432,A,1,Intermediate,,,,1
N,,50597,,,,5948,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (Vss) in rat,CHEMBL624666,10116.0,8433,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5979,,Rattus norvegicus,,BAO_0000218,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,CHEMBL624667,10116.0,8434,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,CHEMBL624668,10116.0,8435,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL624669,10116.0,8436,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL624670,10116.0,8437,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL624671,10116.0,8438,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6448,,Rattus norvegicus,,BAO_0000218,,Steady state volume distribution in rat,CHEMBL624672,10116.0,8439,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12873,Plasma,Rattus norvegicus,,BAO_0000218,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",CHEMBL624673,10116.0,8440,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4576,,Rattus norvegicus,,BAO_0000218,,Steady state volume of distribution determined in rat,CHEMBL624674,10116.0,8441,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17582,,Rattus norvegicus,,BAO_0000218,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,CHEMBL624675,10116.0,8442,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1466,,Rattus norvegicus,,BAO_0000218,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,CHEMBL621728,10116.0,8443,A,1,Intermediate,,,,1
N,,50597,,,,5182,,Rattus norvegicus,,BAO_0000218,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,CHEMBL621729,10116.0,8444,A,1,Intermediate,,,,1
N,,50597,,,,5182,,Rattus norvegicus,,BAO_0000218,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,CHEMBL621730,10116.0,8445,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6535,,Rattus norvegicus,,BAO_0000218,,Volume distribution in rat after administration of 2 mg/kg iv,CHEMBL621731,10116.0,8446,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6535,,Rattus norvegicus,,BAO_0000218,,Volume distribution in rat after administration of 2 mg/kg iv,CHEMBL621732,10116.0,8447,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5041,,Rattus norvegicus,,BAO_0000218,,Volume in steady state distribution value was determined,CHEMBL621908,10116.0,8448,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5041,,Rattus norvegicus,,BAO_0000218,,Volume in steady state distribution value was determined; ND denotes no data,CHEMBL875347,10116.0,8449,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5041,,Rattus norvegicus,,BAO_0000218,,Volume in steady state distribution value was determined; ND denotes not determined,CHEMBL621909,10116.0,8450,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17065,,Rattus norvegicus,,BAO_0000218,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,CHEMBL621910,10116.0,8451,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6597,,Rattus norvegicus,,BAO_0000218,,Volume of distribution at steady state was evaluated in rats,CHEMBL621911,10116.0,8452,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15662,,Rattus norvegicus,,BAO_0000218,,Volume of distribution at steady state was observed after intravenous administration in rat,CHEMBL621912,10116.0,8453,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6485,,Rattus norvegicus,,BAO_0000218,,Volume of distribution in steady state was determined in rat,CHEMBL621913,10116.0,8454,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17655,,Rattus norvegicus,,BAO_0000218,,Volume of distribution in steady state was determined in rat,CHEMBL621914,10116.0,8455,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6616,,Rattus norvegicus,,BAO_0000218,,Volume of distribution after i.v. administration,CHEMBL621915,10116.0,8456,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1916,,Rattus norvegicus,,BAO_0000218,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,CHEMBL621916,10116.0,8457,A,1,Intermediate,,,,1
N,,50594,,,In vivo,16438,Liver,Mus musculus,,BAO_0000218,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",CHEMBL621917,10090.0,8458,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,16438,Liver,Mus musculus,,BAO_0000218,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",CHEMBL621918,10090.0,8459,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,16438,Spleen,Mus musculus,,BAO_0000218,,Biodistribution of compound (oxidized form) in spleen tissue,CHEMBL621919,10090.0,8460,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,16438,Spleen,Mus musculus,,BAO_0000218,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",CHEMBL621920,10090.0,8461,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,16438,Spleen,Mus musculus,,BAO_0000218,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",CHEMBL621921,10090.0,8462,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,16438,Spleen,Mus musculus,,BAO_0000218,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",CHEMBL622401,10090.0,8463,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,16438,Spleen,Mus musculus,,BAO_0000218,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",CHEMBL875348,10090.0,8464,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,16438,Spleen,Mus musculus,,BAO_0000218,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",CHEMBL622402,10090.0,8465,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,16438,Blood,Mus musculus,,BAO_0000218,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,CHEMBL622403,10090.0,8466,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,16438,Blood,Mus musculus,,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",CHEMBL622404,10090.0,8467,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,16438,Brain,Mus musculus,,BAO_0000218,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,CHEMBL622405,10090.0,8468,A,1,Intermediate,,,955.0,1
N,,50594,,,In vivo,16438,Brain,Mus musculus,,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",CHEMBL622406,10090.0,8469,A,1,Intermediate,,,955.0,1
N,,50594,,,In vivo,16438,Brain,Mus musculus,,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",CHEMBL622407,10090.0,8470,A,1,Intermediate,,,955.0,1
N,,50594,,,In vivo,16438,Heart,Mus musculus,,BAO_0000218,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,CHEMBL622408,10090.0,8471,A,1,Intermediate,,,948.0,1
N,,50594,,,In vivo,16438,Heart,Mus musculus,,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",CHEMBL622409,10090.0,8472,A,1,Intermediate,,,948.0,1
N,,50594,,,In vivo,16438,Heart,Mus musculus,,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",CHEMBL622410,10090.0,8473,A,1,Intermediate,,,948.0,1
N,,50594,,,In vivo,16438,Kidney,Mus musculus,,BAO_0000218,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,CHEMBL622411,10090.0,8474,A,1,Intermediate,,,2113.0,1
N,,50594,,,In vivo,16438,Kidney,Mus musculus,,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",CHEMBL627864,10090.0,8475,A,1,Intermediate,,,2113.0,1
N,,50594,,,In vivo,16438,Kidney,Mus musculus,,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",CHEMBL627865,10090.0,8476,A,1,Intermediate,,,2113.0,1
N,,50594,,,In vivo,16438,Liver,Mus musculus,,BAO_0000218,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,CHEMBL627866,10090.0,8477,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,16438,Liver,Mus musculus,,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",CHEMBL627751,10090.0,8478,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,16438,Spleen,Mus musculus,,BAO_0000218,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,CHEMBL627752,10090.0,8479,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,16438,Spleen,Mus musculus,,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",CHEMBL627753,10090.0,8480,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,16438,Spleen,Mus musculus,,BAO_0000218,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",CHEMBL627754,10090.0,8481,A,1,Intermediate,,,2106.0,1
N,,50594,,,,12467,,Mus musculus,,BAO_0000218,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,CHEMBL627755,10090.0,8482,A,1,Intermediate,,,,1
N,,50594,,,In vivo,17208,Brain,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),CHEMBL627756,10090.0,8483,A,1,Intermediate,,,955.0,1
N,,50594,,,In vivo,17208,Brain,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL627757,10090.0,8484,A,1,Intermediate,,,955.0,1
N,,50594,,,In vivo,17208,Brain,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL627758,10090.0,8485,A,1,Intermediate,,,955.0,1
N,,50594,,,In vivo,17208,Brain,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL627759,10090.0,8486,A,1,Intermediate,,,955.0,1
N,,50594,,,In vivo,17208,Brain,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL627760,10090.0,8487,A,1,Intermediate,,,955.0,1
N,,50594,,,In vivo,17208,Brain,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL627761,10090.0,8488,A,1,Intermediate,,,955.0,1
N,,50594,,,In vivo,17208,Heart,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),CHEMBL876811,10090.0,8489,A,1,Intermediate,,,948.0,1
N,,50594,,,In vivo,17208,Heart,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL627762,10090.0,8490,A,1,Intermediate,,,948.0,1
N,,50594,,,In vivo,17208,Heart,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL627763,10090.0,8491,A,1,Intermediate,,,948.0,1
N,,50594,,,In vivo,17208,Heart,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL627764,10090.0,8492,A,1,Intermediate,,,948.0,1
N,,50594,,,In vivo,17208,Heart,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL627765,10090.0,8493,A,1,Intermediate,,,948.0,1
N,,50594,,,In vivo,17208,Heart,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL627766,10090.0,8494,A,1,Intermediate,,,948.0,1
N,,50594,,,In vivo,17208,Kidney,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),CHEMBL627767,10090.0,8495,A,1,Intermediate,,,2113.0,1
N,,50594,,,In vivo,17208,Kidney,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL627768,10090.0,8496,A,1,Intermediate,,,2113.0,1
N,,50594,,,In vivo,17208,Kidney,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL628422,10090.0,8497,A,1,Intermediate,,,2113.0,1
N,,50594,,,In vivo,17208,Kidney,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL628423,10090.0,8498,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,5089,,Rattus norvegicus,,BAO_0000218,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,CHEMBL628424,10116.0,8499,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5089,,Rattus norvegicus,,BAO_0000218,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,CHEMBL628425,10116.0,8500,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4257,,Rattus norvegicus,,BAO_0000218,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,CHEMBL628426,10116.0,8501,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6679,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,CHEMBL628427,10116.0,8502,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5546,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,CHEMBL626938,10116.0,8503,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6141,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,CHEMBL626939,10116.0,8504,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5334,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,CHEMBL626940,10116.0,8505,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5334,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,CHEMBL626941,10116.0,8506,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5334,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was reported in Sprague-Dawley rat,CHEMBL626942,10116.0,8507,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4689,,Rattus norvegicus,,BAO_0000218,,Plasma clearance after intravenous administration (1 mg/kg) in rat,CHEMBL876812,10116.0,8508,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6848,,Rattus norvegicus,,BAO_0000218,,Plasma clearance of compound in rats was evaluated,CHEMBL626943,10116.0,8509,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6848,,Rattus norvegicus,,BAO_0000218,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,CHEMBL626944,10116.0,8510,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6467,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,CHEMBL626945,10116.0,8511,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6467,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,CHEMBL626946,10116.0,8512,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4956,,Rattus norvegicus,,BAO_0000218,,Plasma clearance rate in Sprague-Dawley rats,CHEMBL626856,10116.0,8513,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5529,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),CHEMBL626857,10116.0,8514,A,1,Intermediate,,,,1
N,,50597,,,In vivo,406,Plasma,Rattus norvegicus,,BAO_0000218,,The compound was evaluated for plasma clearance in rat,CHEMBL626858,10116.0,8515,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17655,Plasma,Rattus norvegicus,,BAO_0000218,,Total plasma clearance in rat,CHEMBL627018,10116.0,8516,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,3293,Blood,Rattus norvegicus,,BAO_0000218,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,CHEMBL625331,10116.0,8517,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,4075,Blood,Rattus norvegicus,,BAO_0000218,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,CHEMBL625332,10116.0,8518,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,2792,,Rattus norvegicus,,BAO_0000218,,C max was determined at 10 mg/kg po dose in rats,CHEMBL877590,10116.0,8519,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2792,,Rattus norvegicus,,BAO_0000218,,C max was determined at 3 mg/kg po dose in rats,CHEMBL625333,10116.0,8520,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17594,,Rattus norvegicus,,BAO_0000218,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,CHEMBL625334,10116.0,8521,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17594,,Rattus norvegicus,,BAO_0000218,,Cmax after single intravenous bolus of 1 mg/kg in rats,CHEMBL625335,10116.0,8522,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4762,,Rattus norvegicus,,BAO_0000218,,Cmax of compound at 5 mg/kg after po administration was determined in rat,CHEMBL625336,10116.0,8523,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17509,,Rattus norvegicus,,BAO_0000218,,Cmax 24 hr after 10 mg/kg oral administration in rats,CHEMBL625337,10116.0,8524,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17509,,Rattus norvegicus,,BAO_0000218,,Cmax 24 hr after 2 mg/kg oral administration in rats,CHEMBL625338,10116.0,8525,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1466,Plasma,Rattus norvegicus,,BAO_0000218,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,CHEMBL625339,10116.0,8526,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6535,,Rattus norvegicus,,BAO_0000218,,Cmax in rat after administration of 2 mg/kg iv,CHEMBL625340,10116.0,8527,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6535,,Rattus norvegicus,,BAO_0000218,,Cmax in rat after administration of 2 mg/kg iv,CHEMBL625341,10116.0,8528,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3169,,Rattus norvegicus,,BAO_0000218,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,CHEMBL622687,10116.0,8529,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6515,Plasma,Rattus norvegicus,,BAO_0000218,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,CHEMBL622688,10116.0,8530,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,11149,Blood,Rattus norvegicus,,BAO_0000218,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,CHEMBL622689,10116.0,8531,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,11149,Blood,Rattus norvegicus,,BAO_0000218,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,CHEMBL620295,10116.0,8532,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,17858,,Rattus norvegicus,,BAO_0000218,,Cmax after 10 mg/kg oral administration in rat,CHEMBL620296,10116.0,8533,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6518,,Rattus norvegicus,,BAO_0000218,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,CHEMBL620297,10116.0,8534,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6518,,Rattus norvegicus,,BAO_0000218,,Cmax after IV dosing at 1 mg/kg in rat; no data,CHEMBL620298,10116.0,8535,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4426,,Rattus norvegicus,,BAO_0000218,,Cmax after oral administration at 20 mpk in rats,CHEMBL620299,10116.0,8536,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4426,,Rattus norvegicus,,BAO_0000218,,Cmax after oral administration at 20 mpk in rats; Not performed.,CHEMBL620300,10116.0,8537,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4426,,Rattus norvegicus,,BAO_0000218,,Cmax after oral administration at 20 mpk in rats d; Not performed.,CHEMBL620301,10116.0,8538,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5656,,Rattus norvegicus,,BAO_0000218,,Cmax after oral administration in rat,CHEMBL620302,10116.0,8539,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6518,,Rattus norvegicus,,BAO_0000218,,Cmax after oral administration at a dose of 2 mg/kg in rat,CHEMBL620303,10116.0,8540,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6518,,Rattus norvegicus,,BAO_0000218,,Cmax after oral administration at a dose of 4 mg/kg in rat,CHEMBL620304,10116.0,8541,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6113,,Rattus norvegicus,,BAO_0000218,,Cmax in rats after 20 mg/kg oral dose,CHEMBL620305,10116.0,8542,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17764,,Rattus norvegicus,,BAO_0000218,,Cmax after peroral administration in rats at 2.4 uM/kg,CHEMBL620306,10116.0,8543,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4756,,Rattus norvegicus,,BAO_0000218,,Cmax at the dose of 2 mg/Kg administered perorally in rats,CHEMBL620307,10116.0,8544,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4756,,Rattus norvegicus,,BAO_0000218,,Cmax at the dose of 5 mg/Kg administered perorally in rats,CHEMBL620308,10116.0,8545,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6402,,Rattus norvegicus,,BAO_0000218,,Cmax by administering at 20 mg/kg p.o. in rats,CHEMBL620309,10116.0,8546,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5610,,Rattus norvegicus,,BAO_0000218,,Cmax in male rat,CHEMBL620310,10116.0,8547,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5207,,Rattus norvegicus,,BAO_0000218,,Cmax in rat,CHEMBL620311,10116.0,8548,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6011,,Rattus norvegicus,,BAO_0000218,,Cmax in rat,CHEMBL620312,10116.0,8549,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6504,,Rattus norvegicus,,BAO_0000218,,Cmax in rat,CHEMBL620313,10116.0,8550,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6046,,Rattus norvegicus,,BAO_0000218,,Cmax in rat at 10 mg/kg,CHEMBL620314,10116.0,8551,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6504,,Rattus norvegicus,,BAO_0000218,,Cmax in rat at the dose of 1 mg/kg i.v.,CHEMBL620315,10116.0,8552,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5874,,Rattus norvegicus,,BAO_0000218,,Cmax in rat by po administration at a dose of 40 mg/kg,CHEMBL620316,10116.0,8553,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17686,,Rattus norvegicus,,BAO_0000218,,Cmax in rat p.o. at 20 mg/kg concentration,CHEMBL620317,10116.0,8554,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5836,,Rattus norvegicus,,BAO_0000218,,Cmax in rats,CHEMBL620318,10116.0,8555,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17596,,Rattus norvegicus,,BAO_0000218,,Cmax in rats,CHEMBL620319,10116.0,8556,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16423,,Rattus norvegicus,,BAO_0000218,,Cmax was evaluated after 20 uM/kg of peroral administration,CHEMBL620320,10116.0,8557,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17804,,Rattus norvegicus,,BAO_0000218,,Cmax was measured in rats after peroral administration at 3 mg/kg,CHEMBL620321,10116.0,8558,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1908,,Rattus norvegicus,,BAO_0000218,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,CHEMBL620322,10116.0,8559,A,1,Intermediate,,,,1
N,,50597,,,,13950,,Rattus norvegicus,,BAO_0000218,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,CHEMBL620323,10116.0,8560,A,1,Intermediate,,,,1
N,,50597,,,,13950,Frontal cortex,Rattus norvegicus,,BAO_0000218,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,CHEMBL620324,10116.0,8561,A,1,Intermediate,,,1870.0,1
N,,50597,,,,13950,Frontal cortex,Rattus norvegicus,,BAO_0000218,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,CHEMBL620325,10116.0,8562,A,1,Intermediate,,,1870.0,1
N,,50597,,,,13950,Hippocampus,Rattus norvegicus,,BAO_0000218,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,CHEMBL620326,10116.0,8563,A,1,Intermediate,,,10000000.0,1
N,,50597,,,,13950,Hippocampus,Rattus norvegicus,,BAO_0000218,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,CHEMBL620327,10116.0,8564,A,1,Intermediate,,,10000000.0,1
N,,50597,,,,13950,,Rattus norvegicus,,BAO_0000218,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,CHEMBL620328,10116.0,8565,A,1,Intermediate,,,,1
N,,50597,,,,13950,,Rattus norvegicus,,BAO_0000218,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,CHEMBL620329,10116.0,8566,A,1,Intermediate,,,,1
N,,50597,,,,13950,Midbrain,Rattus norvegicus,,BAO_0000218,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,CHEMBL620330,10116.0,8567,A,1,Intermediate,,,1891.0,1
N,,50597,,,,13950,Midbrain,Rattus norvegicus,,BAO_0000218,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,CHEMBL875286,10116.0,8568,A,1,Intermediate,,,1891.0,1
N,,50597,,,,13950,,Rattus norvegicus,,BAO_0000218,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,CHEMBL620331,10116.0,8569,A,1,Intermediate,,,,1
N,,50597,,,,13950,,Rattus norvegicus,,BAO_0000218,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,CHEMBL620332,10116.0,8570,A,1,Intermediate,,,,1
N,,50597,,,,13950,Striatum,Rattus norvegicus,,BAO_0000218,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,CHEMBL620333,10116.0,8571,A,1,Intermediate,,,2435.0,1
N,,50597,,,,13950,Striatum,Rattus norvegicus,,BAO_0000218,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,CHEMBL620334,10116.0,8572,A,1,Intermediate,,,2435.0,1
N,,50597,,,,16434,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL621015,10116.0,8573,A,1,Intermediate,,,178.0,1
N,,50597,,,,16434,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL621016,10116.0,8574,A,1,Intermediate,,,178.0,1
N,,50597,,,,16434,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL621191,10116.0,8575,A,1,Intermediate,,,178.0,1
N,,50597,,,,16434,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL621192,10116.0,8576,A,1,Intermediate,,,178.0,1
N,,50597,,,,16434,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL621193,10116.0,8577,A,1,Intermediate,,,178.0,1
N,,50597,,,,16434,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL621194,10116.0,8578,A,1,Intermediate,,,178.0,1
N,,50597,,,,16434,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL624204,10116.0,8579,A,1,Intermediate,,,178.0,1
N,,50597,,,,16434,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,CHEMBL624205,10116.0,8580,A,1,Intermediate,,,178.0,1
N,,50597,,,,16435,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL624206,10116.0,8581,A,1,Intermediate,,,178.0,1
N,,50597,,,,16435,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL624207,10116.0,8582,A,1,Intermediate,,,178.0,1
N,,50597,,,,16435,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL624208,10116.0,8583,A,1,Intermediate,,,178.0,1
N,,50597,,,,16435,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL624209,10116.0,8584,A,1,Intermediate,,,178.0,1
N,,50597,,,,16435,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL624210,10116.0,8585,A,1,Intermediate,,,178.0,1
N,,50597,,,,16435,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL624211,10116.0,8586,A,1,Intermediate,,,178.0,1
N,,50597,,,,16435,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL624212,10116.0,8587,A,1,Intermediate,,,178.0,1
N,,50597,,,,16435,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL624213,10116.0,8588,A,1,Intermediate,,,178.0,1
N,,50597,,,,16434,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL876611,10116.0,8589,A,1,Intermediate,,,178.0,1
N,,50597,,,,16434,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL624214,10116.0,8590,A,1,Intermediate,,,178.0,1
N,,50597,,,,16434,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL624215,10116.0,8591,A,1,Intermediate,,,178.0,1
N,,50597,,,,16435,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL624216,10116.0,8592,A,1,Intermediate,,,178.0,1
N,,50597,,,,16435,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL624217,10116.0,8593,A,1,Intermediate,,,178.0,1
N,,50597,,,,16435,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL624218,10116.0,8594,A,1,Intermediate,,,178.0,1
N,,50597,,,,16435,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL624219,10116.0,8595,A,1,Intermediate,,,178.0,1
N,,50597,,,,16435,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL624220,10116.0,8596,A,1,Intermediate,,,178.0,1
N,,50597,,,,16435,Blood,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL624221,10116.0,8597,A,1,Intermediate,,,178.0,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL624222,10116.0,8598,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL624223,10116.0,8599,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL624224,10116.0,8600,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL624225,10116.0,8601,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17764,,Rattus norvegicus,,BAO_0000218,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,CHEMBL622420,10116.0,8602,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5031,,Rattus norvegicus,,BAO_0000218,,Volume of steady state distribution after i.v. administration in rats,CHEMBL622421,10116.0,8603,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6215,,Rattus norvegicus,,BAO_0000218,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,CHEMBL622422,10116.0,8604,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17671,,Rattus norvegicus,,BAO_0000218,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,CHEMBL622423,10116.0,8605,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17752,,Rattus norvegicus,,BAO_0000218,,Vss was determined,CHEMBL622424,10116.0,8606,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6596,,Rattus norvegicus,,BAO_0000218,,Vss in rat,CHEMBL622425,10116.0,8607,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16423,,Rattus norvegicus,,BAO_0000218,,Vss was evaluated after 10 uM/kg of intra arterial administration,CHEMBL876612,10116.0,8608,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15662,,Rattus norvegicus,,BAO_0000218,,volume of distribution at steady state was observed after intravenous administration in rat,CHEMBL622426,10116.0,8609,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6062,,Rattus norvegicus,,BAO_0000218,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,CHEMBL622427,10116.0,8610,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5874,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic (PK) parameter Vz in rat,CHEMBL622428,10116.0,8611,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4942,,Rattus norvegicus,,BAO_0000218,,Volume distribution in rats,CHEMBL622429,10116.0,8612,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17796,,Rattus norvegicus,,BAO_0000218,,Volume of distribution in rat; No data,CHEMBL622430,10116.0,8613,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4890,,Rattus norvegicus,,BAO_0000218,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,CHEMBL622431,10116.0,8614,A,1,Intermediate,,,,1
N,,50597,,,,15765,Ileum,Rattus norvegicus,,BAO_0000218,,% absorption predicted from in vitro rat ileum transport studies,CHEMBL622432,10116.0,8615,A,1,Intermediate,,,2116.0,1
N,,50597,,,In vivo,13569,,Rattus norvegicus,,BAO_0000218,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,CHEMBL622433,10116.0,8616,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13569,,Rattus norvegicus,,BAO_0000218,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,CHEMBL622434,10116.0,8617,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13569,,Rattus norvegicus,,BAO_0000218,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,CHEMBL622435,10116.0,8618,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13569,,Rattus norvegicus,,BAO_0000218,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),CHEMBL618748,10116.0,8619,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13569,,Rattus norvegicus,,BAO_0000218,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,CHEMBL618749,10116.0,8620,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13569,,Rattus norvegicus,,BAO_0000218,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,CHEMBL618750,10116.0,8621,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13569,,Rattus norvegicus,,BAO_0000218,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,CHEMBL618751,10116.0,8622,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13569,,Rattus norvegicus,,BAO_0000218,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,CHEMBL618752,10116.0,8623,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4576,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL618753,10116.0,8624,A,1,Intermediate,,,,1
N,,50597,,,In vivo,750,Plasma,Rattus norvegicus,,BAO_0000218,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,CHEMBL618754,10116.0,8625,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,750,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL618755,10116.0,8626,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4590,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL618756,10116.0,8627,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1716,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL618757,10116.0,8628,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1974,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL618758,10116.0,8629,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4502,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 30 mg/kg),CHEMBL621088,10116.0,8630,A,1,Intermediate,,,,1
N,,50597,,,,3371,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (cLogP) in rat,CHEMBL621089,10116.0,8631,A,1,Intermediate,,,,1
N,,50597,,,,9099,Blood,Rattus norvegicus,,BAO_0000218,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,CHEMBL621090,10116.0,8632,F,1,Intermediate,,,178.0,1
N,,50597,,,,9099,Blood,Rattus norvegicus,,BAO_0000218,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,CHEMBL621091,10116.0,8633,F,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,4590,,Rattus norvegicus,,BAO_0000218,,Clearance in rat.,CHEMBL876731,10116.0,8634,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3184,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for its clearance when administered intravenously in rat,CHEMBL621092,10116.0,8635,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16456,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,CHEMBL621093,10116.0,8636,A,1,Intermediate,,,,1
N,,50597,,,,4199,,Rattus norvegicus,,BAO_0000218,,Blood: Brain distribution ratio is determined in rat,CHEMBL621094,10116.0,8637,A,1,Intermediate,,,,1
N,,50597,,,,4199,,Rattus norvegicus,,BAO_0000218,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,CHEMBL621095,10116.0,8638,A,1,Intermediate,,,,1
N,,50597,,,,4199,,Rattus norvegicus,,BAO_0000218,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,CHEMBL621096,10116.0,8639,A,1,Intermediate,,,,1
N,,50597,,,In vivo,8677,Kidney,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL621097,10116.0,8640,A,1,Intermediate,,,2113.0,1
N,,50597,,,,7449,,Rattus norvegicus,,BAO_0000218,,Percent dose excreted in 0-48 hours administered ip to male rat,CHEMBL621098,10116.0,8641,F,1,Intermediate,,,,1
N,,50597,,,,11977,Cerebellum,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621099,10116.0,8642,A,1,Intermediate,,,2037.0,1
N,,50597,,,,11977,Cerebellum,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621100,10116.0,8643,A,1,Intermediate,,,2037.0,1
N,,50597,,,,11977,Cerebellum,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL621101,10116.0,8644,A,1,Intermediate,,,2037.0,1
N,,50597,,,,11977,Cerebellum,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621102,10116.0,8645,A,1,Intermediate,,,2037.0,1
N,,50597,,,,11977,Cerebellum,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL876732,10116.0,8646,A,1,Intermediate,,,2037.0,1
N,,50597,,,,11977,,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621103,10116.0,8647,A,1,Intermediate,,,,1
N,,50597,,,,11977,,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621104,10116.0,8648,A,1,Intermediate,,,,1
N,,50597,,,,11977,,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL621105,10116.0,8649,A,1,Intermediate,,,,1
N,,50597,,,,11977,,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621106,10116.0,8650,A,1,Intermediate,,,,1
N,,50597,,,,11977,,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621107,10116.0,8651,A,1,Intermediate,,,,1
N,,50597,,,,11977,,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621108,10116.0,8652,A,1,Intermediate,,,,1
N,,50597,,,,11977,,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621109,10116.0,8653,A,1,Intermediate,,,,1
N,,50594,,,In vivo,17208,Kidney,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL621110,10090.0,8654,A,1,Intermediate,,,2113.0,1
N,,50594,,,In vivo,17208,Kidney,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL621111,10090.0,8655,A,1,Intermediate,,,2113.0,1
N,,50594,,,In vivo,17208,Liver,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),CHEMBL622541,10090.0,8656,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,17208,Liver,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL622542,10090.0,8657,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,17208,Liver,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL622543,10090.0,8658,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,17208,Liver,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL624412,10090.0,8659,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,17208,Liver,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL624413,10090.0,8660,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,17208,Liver,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL624414,10090.0,8661,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,17208,Lung,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),CHEMBL624415,10090.0,8662,A,1,Intermediate,,,2048.0,1
N,,50594,,,In vivo,17208,Lung,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL624416,10090.0,8663,A,1,Intermediate,,,2048.0,1
N,,50594,,,In vivo,17208,Lung,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL624417,10090.0,8664,A,1,Intermediate,,,2048.0,1
N,,50594,,,In vivo,17208,Lung,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL624418,10090.0,8665,A,1,Intermediate,,,2048.0,1
N,,50594,,,In vivo,17208,Lung,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL624419,10090.0,8666,A,1,Intermediate,,,2048.0,1
N,,50594,,,In vivo,17208,Lung,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL624420,10090.0,8667,A,1,Intermediate,,,2048.0,1
N,,50594,,,In vivo,17208,Muscle tissue,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),CHEMBL624421,10090.0,8668,A,1,Intermediate,,,2385.0,1
N,,50594,,,In vivo,17208,Muscle tissue,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL624422,10090.0,8669,A,1,Intermediate,,,2385.0,1
N,,50594,,,In vivo,17208,Muscle tissue,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL624423,10090.0,8670,A,1,Intermediate,,,2385.0,1
N,,50594,,,In vivo,17208,Muscle tissue,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL625123,10090.0,8671,A,1,Intermediate,,,2385.0,1
N,,50594,,,In vivo,17208,Muscle tissue,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL625124,10090.0,8672,A,1,Intermediate,,,2385.0,1
N,,50594,,,In vivo,17208,Muscle tissue,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL625125,10090.0,8673,A,1,Intermediate,,,2385.0,1
N,,50594,,,In vivo,17208,Zone of skin,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),CHEMBL625126,10090.0,8674,A,1,Intermediate,,,14.0,1
N,,50594,,,In vivo,17208,Zone of skin,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL626947,10090.0,8675,A,1,Intermediate,,,14.0,1
N,,50594,,,In vivo,17208,Zone of skin,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL626948,10090.0,8676,A,1,Intermediate,,,14.0,1
N,,50594,,,In vivo,17208,Zone of skin,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL626949,10090.0,8677,A,1,Intermediate,,,14.0,1
N,,50594,,,In vivo,17208,Zone of skin,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL626950,10090.0,8678,A,1,Intermediate,,,14.0,1
N,,50594,,,In vivo,17208,Zone of skin,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL626951,10090.0,8679,A,1,Intermediate,,,14.0,1
N,,50594,,,In vivo,17208,Spleen,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),CHEMBL626952,10090.0,8680,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,17208,Spleen,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL626953,10090.0,8681,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,17208,Spleen,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL626954,10090.0,8682,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,17208,Spleen,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL626955,10090.0,8683,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,17208,Spleen,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL626956,10090.0,8684,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,17208,Spleen,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL626957,10090.0,8685,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,17208,Blood,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),CHEMBL626958,10090.0,8686,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,17208,Blood,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),CHEMBL626959,10090.0,8687,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,17208,Blood,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL626960,10090.0,8688,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,17208,Blood,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),CHEMBL626961,10090.0,8689,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,17208,Blood,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),CHEMBL627589,10090.0,8690,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,17208,Blood,Mus musculus,,BAO_0000218,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),CHEMBL627590,10090.0,8691,A,1,Intermediate,,,178.0,1
N,,50594,,,,3132,,Mus musculus,,BAO_0000218,,Time taken for EC90 was determined when tested in mouse,CHEMBL627591,10090.0,8692,A,1,Intermediate,,,,1
N,,50594,,,,3132,,Mus musculus,,BAO_0000218,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,CHEMBL627592,10090.0,8693,A,1,Intermediate,,,,1
N,,50594,,,In vivo,16597,,Mus musculus,,BAO_0000218,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),CHEMBL627593,10090.0,8694,A,1,Intermediate,,,,1
N,,50594,,,,5727,,Mus musculus,,BAO_0000218,,Half life in mice,CHEMBL627594,10090.0,8695,A,1,Intermediate,,,,1
N,,50594,,,In vivo,5302,,Mus musculus,,BAO_0000218,,Half life period in mouse after 10 mg/Kg dose,CHEMBL876813,10090.0,8696,A,1,Intermediate,,,,1
N,,50594,,,In vivo,5302,,Mus musculus,,BAO_0000218,,Half life period in mouse after 10 mg/kg dose,CHEMBL627595,10090.0,8697,A,1,Intermediate,,,,1
N,,50594,,,In vivo,6348,,Mus musculus,,BAO_0000218,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,CHEMBL627596,10090.0,8698,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5964,,Rattus norvegicus,,BAO_0000218,,Cmax value at 5 mg/kg po was determined in rat,CHEMBL627597,10116.0,8699,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6078,,Rattus norvegicus,,BAO_0000218,,Cmax value evaluated in rat,CHEMBL627598,10116.0,8700,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5206,Brain,Rattus norvegicus,,BAO_0000218,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,CHEMBL627599,10116.0,8701,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,2959,,Rattus norvegicus,,BAO_0000218,,Cmax value after administration of 20 mg/Kg oral dose in rat,CHEMBL627600,10116.0,8702,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5964,,Rattus norvegicus,,BAO_0000218,,Cmax value at 1 mg/kg po in rat,CHEMBL627601,10116.0,8703,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5964,,Rattus norvegicus,,BAO_0000218,,Cmax value at 5 mg/kg po in rat,CHEMBL627776,10116.0,8704,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6757,,Rattus norvegicus,,BAO_0000218,,Cmax value at a dose of 10 mg/kg in male SD rats,CHEMBL627777,10116.0,8705,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6757,,Rattus norvegicus,,BAO_0000218,,Cmax value at a dose of 100 mg/kg in male SD rats,CHEMBL627778,10116.0,8706,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6757,,Rattus norvegicus,,BAO_0000218,,Cmax value at a dose of 50 mg/kg in male SD rats,CHEMBL627779,10116.0,8707,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17617,,Rattus norvegicus,,BAO_0000218,,Cmax value in rats at 10 mg/kg,CHEMBL876814,10116.0,8708,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1445,,Rattus norvegicus,,BAO_0000218,,Cmax value was evaluated in rats at a dose of 20 mg/kg,CHEMBL627780,10116.0,8709,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6082,,Rattus norvegicus,,BAO_0000218,,Cmax value was determined after peroral administration of 20 mg/kg in rat,CHEMBL627781,10116.0,8710,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1446,,Rattus norvegicus,,BAO_0000218,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,CHEMBL627782,10116.0,8711,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5407,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,CHEMBL627783,10116.0,8712,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,2690,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,CHEMBL627784,10116.0,8713,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,2661,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,CHEMBL627785,10116.0,8714,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2661,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,CHEMBL627786,10116.0,8715,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4891,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,CHEMBL627787,10116.0,8716,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,2807,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,CHEMBL627788,10116.0,8717,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,2807,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,CHEMBL626579,10116.0,8718,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,2807,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,CHEMBL626580,10116.0,8719,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,3634,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,CHEMBL876815,10116.0,8720,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1881,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,CHEMBL626581,10116.0,8721,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,1881,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,CHEMBL626582,10116.0,8722,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,429,,Rattus norvegicus,,BAO_0000218,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,CHEMBL626583,10116.0,8723,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,CHEMBL626205,10116.0,8724,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,CHEMBL626206,10116.0,8725,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,CHEMBL626207,10116.0,8726,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,CHEMBL623882,10116.0,8727,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17582,,Rattus norvegicus,,BAO_0000218,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,CHEMBL623883,10116.0,8728,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17582,,Rattus norvegicus,,BAO_0000218,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,CHEMBL623884,10116.0,8729,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3032,Plasma,Rattus norvegicus,,BAO_0000218,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",CHEMBL623885,10116.0,8730,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6295,Plasma,Rattus norvegicus,,BAO_0000218,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,CHEMBL623886,10116.0,8731,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6619,,Rattus norvegicus,,BAO_0000218,,Maximal concentration in rat was determined,CHEMBL623887,10116.0,8732,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6616,,Rattus norvegicus,,BAO_0000218,,Maximal concentration after i.v. administration,CHEMBL623888,10116.0,8733,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3249,Plasma,Rattus norvegicus,,BAO_0000218,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,CHEMBL623889,10116.0,8734,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17791,Plasma,Rattus norvegicus,,BAO_0000218,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,CHEMBL623890,10116.0,8735,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17791,Plasma,Rattus norvegicus,,BAO_0000218,,Cmax in rat plasma after oral dose (50 mg/Kg),CHEMBL623891,10116.0,8736,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,1360,Plasma,Rattus norvegicus,,BAO_0000218,,Maximal plasma concentration was determined.,CHEMBL623892,10116.0,8737,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,2552,Plasma,Rattus norvegicus,,BAO_0000218,,Maximal plasma drug concentration was determined,CHEMBL623893,10116.0,8738,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6571,,Rattus norvegicus,,BAO_0000218,,Maximal concentration in rats after peroral administration,CHEMBL877616,10116.0,8739,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6570,,Rattus norvegicus,,BAO_0000218,,Maximum concentration in rat after 2 mg/kg peroral administration,CHEMBL623894,10116.0,8740,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6567,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,CHEMBL623895,10116.0,8741,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,3031,,Rattus norvegicus,,BAO_0000218,,Maximum concentration of compound in rat was evaluated.,CHEMBL623896,10116.0,8742,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3436,,Rattus norvegicus,,BAO_0000218,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,CHEMBL623897,10116.0,8743,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3436,,Rattus norvegicus,,BAO_0000218,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,CHEMBL623898,10116.0,8744,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2083,,Rattus norvegicus,,BAO_0000218,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,CHEMBL623899,10116.0,8745,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3436,,Rattus norvegicus,,BAO_0000218,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,CHEMBL623900,10116.0,8746,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4527,,Rattus norvegicus,,BAO_0000218,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,CHEMBL623901,10116.0,8747,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1974,,Rattus norvegicus,,BAO_0000218,,Maximum concentration was evaluated in rats,CHEMBL623902,10116.0,8748,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3307,Cerebrospinal fluid,Rattus norvegicus,,BAO_0000218,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,CHEMBL623903,10116.0,8749,A,1,Intermediate,,,1359.0,1
N,,50597,,,In vivo,3307,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,CHEMBL623904,10116.0,8750,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,1916,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,CHEMBL877617,10116.0,8751,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,1500,,Rattus norvegicus,,BAO_0000218,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,CHEMBL623905,10116.0,8752,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1500,,Rattus norvegicus,,BAO_0000218,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,CHEMBL623906,10116.0,8753,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4186,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,CHEMBL623907,10116.0,8754,A,1,Intermediate,,,1969.0,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL623908,10116.0,8755,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,CHEMBL623909,10116.0,8756,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL623910,10116.0,8757,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,CHEMBL623911,10116.0,8758,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL623912,10116.0,8759,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL624616,10116.0,8760,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL624617,10116.0,8761,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL624618,10116.0,8762,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL624619,10116.0,8763,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL624794,10116.0,8764,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL624795,10116.0,8765,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL623921,10116.0,8766,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL623922,10116.0,8767,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL623923,10116.0,8768,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL623924,10116.0,8769,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL623925,10116.0,8770,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL623926,10116.0,8771,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL623927,10116.0,8772,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL623928,10116.0,8773,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL623929,10116.0,8774,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL623930,10116.0,8775,A,1,Intermediate,,,,1
N,,50597,,,,16434,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL623931,10116.0,8776,A,1,Intermediate,,,955.0,1
N,,50597,,,,16434,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL622165,10116.0,8777,A,1,Intermediate,,,955.0,1
N,,50597,,,,16434,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL621249,10116.0,8778,A,1,Intermediate,,,955.0,1
N,,50597,,,,16434,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL621250,10116.0,8779,A,1,Intermediate,,,955.0,1
N,,50597,,,,16434,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL621448,10116.0,8780,A,1,Intermediate,,,955.0,1
N,,50597,,,,16434,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL621449,10116.0,8781,A,1,Intermediate,,,955.0,1
N,,50597,,,,16434,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL621450,10116.0,8782,A,1,Intermediate,,,955.0,1
N,,50597,,,,16434,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,CHEMBL621451,10116.0,8783,A,1,Intermediate,,,955.0,1
N,,50597,,,,16435,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL621452,10116.0,8784,A,1,Intermediate,,,955.0,1
N,,50597,,,,16435,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL621453,10116.0,8785,A,1,Intermediate,,,955.0,1
N,,50597,,,,16435,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL621454,10116.0,8786,A,1,Intermediate,,,955.0,1
N,,50597,,,,16435,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL621455,10116.0,8787,A,1,Intermediate,,,955.0,1
N,,50597,,,,16435,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL621456,10116.0,8788,A,1,Intermediate,,,955.0,1
N,,50597,,,,16435,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL625145,10116.0,8789,A,1,Intermediate,,,955.0,1
N,,50597,,,,16435,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL875847,10116.0,8790,A,1,Intermediate,,,955.0,1
N,,50597,,,,16435,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL625146,10116.0,8791,A,1,Intermediate,,,955.0,1
N,,50597,,,,16434,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL625147,10116.0,8792,A,1,Intermediate,,,955.0,1
N,,50597,,,,16434,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL625148,10116.0,8793,A,1,Intermediate,,,955.0,1
N,,50597,,,,16434,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL625149,10116.0,8794,A,1,Intermediate,,,955.0,1
N,,50597,,,,16435,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL625150,10116.0,8795,A,1,Intermediate,,,955.0,1
N,,50597,,,,16435,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL625151,10116.0,8796,A,1,Intermediate,,,955.0,1
N,,50597,,,,16435,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL625152,10116.0,8797,A,1,Intermediate,,,955.0,1
N,,50597,,,,16435,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL625153,10116.0,8798,A,1,Intermediate,,,955.0,1
N,,50597,,,,16435,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL625154,10116.0,8799,A,1,Intermediate,,,955.0,1
N,,50597,,,,16435,Brain,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL625155,10116.0,8800,A,1,Intermediate,,,955.0,1
N,,50597,,,,11977,,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL625156,10116.0,8801,A,1,Intermediate,,,,1
N,,50597,,,,11977,,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624354,10116.0,8802,A,1,Intermediate,,,,1
N,,50597,,,,11977,Hippocampus,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624355,10116.0,8803,A,1,Intermediate,,,10000000.0,1
N,,50597,,,,11977,Hippocampus,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624356,10116.0,8804,A,1,Intermediate,,,10000000.0,1
N,,50597,,,,11977,Hippocampus,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624357,10116.0,8805,A,1,Intermediate,,,10000000.0,1
N,,50597,,,,11977,Hippocampus,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624358,10116.0,8806,A,1,Intermediate,,,10000000.0,1
N,,50597,,,,11977,Striatum,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624359,10116.0,8807,A,1,Intermediate,,,2435.0,1
N,,50597,,,,11977,Striatum,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624360,10116.0,8808,A,1,Intermediate,,,2435.0,1
N,,50597,,,,11977,Striatum,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL624361,10116.0,8809,A,1,Intermediate,,,2435.0,1
N,,50597,,,,11977,Striatum,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624362,10116.0,8810,A,1,Intermediate,,,2435.0,1
N,,50597,,,,11977,Striatum,Rattus norvegicus,,BAO_0000218,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624363,10116.0,8811,A,1,Intermediate,,,2435.0,1
N,,50597,,,In vivo,11977,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624364,10116.0,8812,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,11977,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624365,10116.0,8813,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,11977,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624366,10116.0,8814,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,11977,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624367,10116.0,8815,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,11977,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624368,10116.0,8816,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,11977,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL624369,10116.0,8817,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,11977,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL624370,10116.0,8818,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,11977,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625069,10116.0,8819,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,11977,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625070,10116.0,8820,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,11977,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL626051,10116.0,8821,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,11977,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL626052,10116.0,8822,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,11977,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL626053,10116.0,8823,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,11977,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL626054,10116.0,8824,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,11977,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL626055,10116.0,8825,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,11977,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL626056,10116.0,8826,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,11977,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL626057,10116.0,8827,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,11977,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625193,10116.0,8828,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,11977,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625194,10116.0,8829,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,11977,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625195,10116.0,8830,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,11977,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625196,10116.0,8831,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,11977,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL625197,10116.0,8832,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,11977,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625198,10116.0,8833,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,11977,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL627929,10116.0,8834,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,11977,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL627074,10116.0,8835,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,11977,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL627075,10116.0,8836,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,11977,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL627076,10116.0,8837,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,11977,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL627077,10116.0,8838,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,11977,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL627078,10116.0,8839,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,11977,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),CHEMBL627079,10116.0,8840,A,1,Intermediate,,,2385.0,1
N,,50594,,,In vivo,4573,,Mus musculus,,BAO_0000218,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,CHEMBL873824,10090.0,8841,A,1,Intermediate,,,,1
N,,50594,,,In vivo,3132,Plasma,Mus musculus,,BAO_0000218,,Half life in mouse plasma was determined at dose 25 mg/kg,CHEMBL627080,10090.0,8842,A,1,Intermediate,,,1969.0,1
N,,50594,,,,17718,,Mus musculus,,BAO_0000218,,Half life was determined,CHEMBL627081,10090.0,8843,A,1,Intermediate,,,,1
N,,50594,,,In vivo,17728,,Mus musculus,,BAO_0000218,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,CHEMBL627082,10090.0,8844,A,1,Intermediate,,,,1
N,,50594,,,In vivo,5961,,Mus musculus,,BAO_0000218,,Half-life in male mice after 1 mg/kg intravenous dose,CHEMBL627083,10090.0,8845,A,1,Intermediate,,,,1
N,,50594,,,,17731,Plasma,Mus musculus,,BAO_0000218,,Half life in mice plasma,CHEMBL627085,10090.0,8847,A,1,Intermediate,,,1969.0,1
N,,50594,,,,17592,,Mus musculus,,BAO_0000218,,Half life in mouse,CHEMBL627086,10090.0,8848,A,1,Intermediate,,,,1
N,,50594,,,In vivo,3132,Plasma,Mus musculus,,BAO_0000218,,Half life in mouse plasma at dose 25 mg/kg,CHEMBL627087,10090.0,8849,A,1,Intermediate,,,1969.0,1
N,,50594,,,In vivo,17729,,Mus musculus,,BAO_0000218,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,CHEMBL627088,10090.0,8850,A,1,Intermediate,,,,1
N,,50594,,,In vivo,17729,,Mus musculus,,BAO_0000218,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,CHEMBL627089,10090.0,8851,A,1,Intermediate,,,,1
N,,50594,,,In vivo,17729,,Mus musculus,,BAO_0000218,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,CHEMBL627090,10090.0,8852,A,1,Intermediate,,,,1
N,,50594,,,In vivo,3277,,Mus musculus,,BAO_0000218,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),CHEMBL627091,10090.0,8853,A,1,Intermediate,,,,1
N,,50594,,,In vivo,3760,,Mus musculus,,BAO_0000218,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",CHEMBL627092,10090.0,8854,A,1,Intermediate,,,,1
N,,50594,,,In vivo,3760,,Mus musculus,,BAO_0000218,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",CHEMBL876785,10090.0,8855,A,1,Intermediate,,,,1
N,,50594,,,In vivo,2862,,Mus musculus,,BAO_0000218,,Half-life by iv administration in mouse,CHEMBL627093,10090.0,8856,A,1,Intermediate,,,,1
N,,50594,,,In vivo,2862,,Mus musculus,,BAO_0000218,,Half-life by oral administration in mouse,CHEMBL627094,10090.0,8857,A,1,Intermediate,,,,1
N,,50594,,,,5980,,Mus musculus,,BAO_0000218,,Half-life in mice,CHEMBL627095,10090.0,8858,A,1,Intermediate,,,,1
N,,50594,,,,6159,Brain,Mus musculus,,BAO_0000218,,Half-life using mouse brain homogenate,CHEMBL627096,10090.0,8859,A,1,Intermediate,,,955.0,1
N,,50594,,,,6254,,Mus musculus,,BAO_0000218,,Half-life was measured in mice,CHEMBL627097,10090.0,8860,A,1,Intermediate,,,,1
N,,50594,,,In vivo,6062,,Mus musculus,,BAO_0000218,,Half-life was measured in mouse after an iv dose of 1 mg/kg,CHEMBL627098,10090.0,8861,A,1,Intermediate,,,,1
N,,50594,,,,1574,Blood,Mus musculus,,BAO_0000218,,Half-life period was determined in mouse blood,CHEMBL627099,10090.0,8862,A,1,Intermediate,,,178.0,1
N,,50594,,,,56,Brain,Mus musculus,,BAO_0000218,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",CHEMBL627100,10090.0,8863,A,1,Intermediate,,,955.0,1
N,,50594,,,,993,Plasma,Mus musculus,,BAO_0000218,,Plasma half life in mouse,CHEMBL627101,10090.0,8864,A,1,Intermediate,,,1969.0,1
N,,50594,,,,6652,,Mus musculus,,BAO_0000218,,Stability of the peptide in the presence of mouse serum,CHEMBL627102,10090.0,8865,A,1,Intermediate,,,,1
N,,50594,,,,17852,,Mus musculus,,BAO_0000218,,Terminal half life of compound was determined in mouse,CHEMBL627103,10090.0,8866,A,1,Intermediate,,,,1
N,,50594,,,In vivo,2675,,Mus musculus,,BAO_0000218,,Terminal half life was evaluated in mice after intravenous administration,CHEMBL627104,10090.0,8867,A,1,Intermediate,,,,1
N,,50594,,,In vivo,2675,,Mus musculus,,BAO_0000218,,Terminal half life was evaluated in mice after oral administration,CHEMBL627105,10090.0,8868,A,1,Intermediate,,,,1
N,,50594,,,,499,,Mus musculus,,BAO_0000218,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,CHEMBL876786,10090.0,8869,A,1,Intermediate,,,,1
N,,50594,,,,499,,Mus musculus,,BAO_0000218,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,CHEMBL873825,10090.0,8870,A,1,Intermediate,,,,1
N,,50594,,,,499,,Mus musculus,,BAO_0000218,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,CHEMBL627106,10090.0,8871,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14239,,Mus musculus,,BAO_0000218,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,CHEMBL626336,10090.0,8872,A,1,Intermediate,,,,1
N,,50594,,,In vivo,5506,,Mus musculus,,BAO_0000218,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",CHEMBL877462,10090.0,8873,A,1,Intermediate,,,,1
N,,50594,,,In vivo,5506,,Mus musculus,,BAO_0000218,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",CHEMBL626337,10090.0,8874,A,1,Intermediate,,,,1
N,,50594,,,,17734,,Mus musculus,,BAO_0000218,,Half life after intraperitoneal administration of 100 mg/kg in mice,CHEMBL626338,10090.0,8875,A,1,Intermediate,,,,1
N,,50594,,,In vivo,17728,,Mus musculus,,BAO_0000218,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,CHEMBL626339,10090.0,8876,A,1,Intermediate,,,,1
N,,50594,,,In vivo,17728,,Mus musculus,,BAO_0000218,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,CHEMBL626340,10090.0,8877,A,1,Intermediate,,,,1
N,,50594,,,In vivo,17728,,Mus musculus,,BAO_0000218,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,CHEMBL625377,10090.0,8878,A,1,Intermediate,,,,1
N,,50594,,,In vivo,17728,,Mus musculus,,BAO_0000218,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,CHEMBL625378,10090.0,8879,A,1,Intermediate,,,,1
N,,50594,,,In vivo,17728,,Mus musculus,,BAO_0000218,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,CHEMBL625379,10090.0,8880,A,1,Intermediate,,,,1
U,Microsomes,22224,,,,14294,,Sus scrofa,,BAO_0000251,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),CHEMBL625380,9823.0,8881,A,1,Autocuration,,,,0
U,Microsomes,22224,,,,14294,,Sus scrofa,,BAO_0000251,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),CHEMBL625381,9823.0,8882,A,1,Autocuration,,,,0
U,,22224,,,,6056,,Sus scrofa,,BAO_0000019,,Stability to porcine renal DHP-I,CHEMBL625382,9823.0,8883,A,1,Autocuration,,,,0
U,,22224,,,In vivo,1317,,Sus scrofa,,BAO_0000218,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,CHEMBL873828,9823.0,8884,A,1,Autocuration,,,,0
U,,22224,,,In vivo,1317,,Sus scrofa,,BAO_0000218,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,CHEMBL625383,9823.0,8885,A,1,Autocuration,,,,0
U,,22224,,,,5229,,Sus scrofa,,BAO_0000019,,Half-life of the parent prodrug in porcine esterase solution,CHEMBL625384,9823.0,8886,A,1,Autocuration,,,,0
U,,22224,,,,4231,,Sus scrofa,,BAO_0000019,,"First order rate constant, k was determined in in pig liver Esterase",CHEMBL625385,9823.0,8887,A,1,Autocuration,,,,0
U,,22224,,,,4231,Liver,Sus scrofa,,BAO_0000221,,Half life of the in pig liver Esterase,CHEMBL625386,9823.0,8888,A,1,Autocuration,,,2107.0,0
U,,22224,,,,5318,Liver,Sus scrofa,,BAO_0000221,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,CHEMBL623571,9823.0,8889,A,1,Autocuration,,,2107.0,0
U,,22224,,,,5318,Liver,Sus scrofa,,BAO_0000221,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,CHEMBL623572,9823.0,8890,A,1,Autocuration,,,2107.0,0
U,,22224,,,,5318,Liver,Sus scrofa,,BAO_0000221,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,CHEMBL623573,9823.0,8891,A,1,Autocuration,,,2107.0,0
U,,22224,,,,3305,Liver,Sus scrofa,,BAO_0000221,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,CHEMBL623574,9823.0,8892,A,1,Autocuration,,,2107.0,0
U,,22224,,,,3305,Liver,Sus scrofa,,BAO_0000221,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,CHEMBL623575,9823.0,8893,A,1,Autocuration,,,2107.0,0
U,,22224,,,,2842,Liver,Sus scrofa,,BAO_0000221,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,CHEMBL623749,9823.0,8894,A,1,Autocuration,,,2107.0,0
U,,22224,,,,2842,Liver,Sus scrofa,,BAO_0000221,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,CHEMBL623750,9823.0,8895,A,1,Autocuration,,,2107.0,0
U,,22224,,,In vitro,889,Liver,Sus scrofa,,BAO_0000221,,Half-life in vitro in pig liver,CHEMBL623751,9823.0,8896,A,1,Autocuration,,,2107.0,0
U,,22224,,,,1904,Liver,Sus scrofa,,BAO_0000221,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,CHEMBL623752,9823.0,8897,A,1,Autocuration,,,2107.0,0
N,,50597,,,In vivo,4186,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,CHEMBL623753,10116.0,8898,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,2774,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,CHEMBL623754,10116.0,8899,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,1742,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration in rat plasma was determined,CHEMBL623755,10116.0,8900,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,3169,,Rattus norvegicus,,BAO_0000218,,Maximum concentration in rats,CHEMBL623756,10116.0,8901,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3169,,Rattus norvegicus,,BAO_0000218,,Maximum concentration in rats at 1-2 hours,CHEMBL623757,10116.0,8902,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2081,,Rattus norvegicus,,BAO_0000218,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,CHEMBL623758,10116.0,8903,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3307,Brain,Rattus norvegicus,,BAO_0000218,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,CHEMBL623759,10116.0,8904,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,4727,,Rattus norvegicus,,BAO_0000218,,Maximum concentration at the dose of 2 mg/kg in rat,CHEMBL623760,10116.0,8905,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6597,,Rattus norvegicus,,BAO_0000218,,Maximum concentration was evaluated in rats,CHEMBL623761,10116.0,8906,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16365,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,CHEMBL623762,10116.0,8907,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,16365,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,CHEMBL877594,10116.0,8908,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,16365,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,CHEMBL623763,10116.0,8909,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,16365,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,CHEMBL623764,10116.0,8910,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,16365,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,CHEMBL623765,10116.0,8911,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,2591,Blood,Rattus norvegicus,,BAO_0000218,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,CHEMBL623766,10116.0,8912,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,2591,Blood,Rattus norvegicus,,BAO_0000218,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,CHEMBL623767,10116.0,8913,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,2591,Blood,Rattus norvegicus,,BAO_0000218,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,CHEMBL623768,10116.0,8914,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,5978,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,CHEMBL623769,10116.0,8915,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5978,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,CHEMBL623770,10116.0,8916,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5978,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,CHEMBL623771,10116.0,8917,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5978,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,CHEMBL623772,10116.0,8918,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5978,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,CHEMBL623773,10116.0,8919,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5978,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,CHEMBL623774,10116.0,8920,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5978,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,CHEMBL623775,10116.0,8921,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14465,,Rattus norvegicus,,BAO_0000218,,Cmax in rat (PO dose),CHEMBL623776,10116.0,8922,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4723,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL622191,10116.0,8923,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4723,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL622192,10116.0,8924,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4576,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration determined in rat,CHEMBL622193,10116.0,8925,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,12873,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,CHEMBL622194,10116.0,8926,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,12873,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,CHEMBL622195,10116.0,8927,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6824,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration in rat,CHEMBL622196,10116.0,8928,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17065,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,CHEMBL622197,10116.0,8929,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,2932,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,CHEMBL622198,10116.0,8930,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,2932,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,CHEMBL622199,10116.0,8931,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,2879,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration of compound was measured in rat,CHEMBL622200,10116.0,8932,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,2864,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration after 20 mg/kg oral administration in rat,CHEMBL622201,10116.0,8933,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,16367,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration after oral administration to rats,CHEMBL623990,10116.0,8934,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17717,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,CHEMBL623991,10116.0,8935,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17717,Plasma,Rattus norvegicus,,BAO_0000218,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",CHEMBL623992,10116.0,8936,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17717,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,CHEMBL623993,10116.0,8937,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17717,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,CHEMBL623994,10116.0,8938,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17720,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,CHEMBL623995,10116.0,8939,F,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17720,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,CHEMBL623996,10116.0,8940,F,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17720,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,CHEMBL623997,10116.0,8941,F,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4516,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration dosed orally in rats,CHEMBL623998,10116.0,8942,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4516,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration dosed orally in rats after 6 hours,CHEMBL623999,10116.0,8943,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4516,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,CHEMBL624000,10116.0,8944,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5199,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,CHEMBL624001,10116.0,8945,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17538,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration in rat after po administration,CHEMBL624002,10116.0,8946,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6685,Plasma,Rattus norvegicus,,BAO_0000218,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",CHEMBL624003,10116.0,8947,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6685,Plasma,Rattus norvegicus,,BAO_0000218,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",CHEMBL624004,10116.0,8948,A,1,Intermediate,,,1969.0,1
N,,50597,,,,16434,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL624005,10116.0,8949,A,1,Intermediate,,,948.0,1
N,,50597,,,,16434,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL624006,10116.0,8950,A,1,Intermediate,,,948.0,1
N,,50597,,,,16434,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL624007,10116.0,8951,A,1,Intermediate,,,948.0,1
N,,50597,,,,16434,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL624008,10116.0,8952,A,1,Intermediate,,,948.0,1
N,,50597,,,,16434,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL624009,10116.0,8953,A,1,Intermediate,,,948.0,1
N,,50597,,,,16434,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL874387,10116.0,8954,A,1,Intermediate,,,948.0,1
N,,50597,,,,16434,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL624010,10116.0,8955,A,1,Intermediate,,,948.0,1
N,,50597,,,,16434,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,CHEMBL624011,10116.0,8956,A,1,Intermediate,,,948.0,1
N,,50597,,,,16435,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL624012,10116.0,8957,A,1,Intermediate,,,948.0,1
N,,50597,,,,16435,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL624013,10116.0,8958,A,1,Intermediate,,,948.0,1
N,,50597,,,,16435,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL624736,10116.0,8959,A,1,Intermediate,,,948.0,1
N,,50597,,,,16435,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL624737,10116.0,8960,A,1,Intermediate,,,948.0,1
N,,50597,,,,16434,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL624738,10116.0,8961,A,1,Intermediate,,,948.0,1
N,,50597,,,,16434,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL624739,10116.0,8962,A,1,Intermediate,,,948.0,1
N,,50597,,,,16434,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL624740,10116.0,8963,A,1,Intermediate,,,948.0,1
N,,50597,,,,16435,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL624896,10116.0,8964,A,1,Intermediate,,,948.0,1
N,,50597,,,,16435,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL624897,10116.0,8965,A,1,Intermediate,,,948.0,1
N,,50597,,,,16435,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL624108,10116.0,8966,A,1,Intermediate,,,948.0,1
N,,50597,,,,16435,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL624109,10116.0,8967,A,1,Intermediate,,,948.0,1
N,,50597,,,,16435,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL624110,10116.0,8968,A,1,Intermediate,,,948.0,1
N,,50597,,,,16435,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL624111,10116.0,8969,A,1,Intermediate,,,948.0,1
N,,50597,,,,16435,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL624112,10116.0,8970,A,1,Intermediate,,,948.0,1
N,,50597,,,,16435,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL624113,10116.0,8971,A,1,Intermediate,,,948.0,1
N,,50597,,,,16435,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL619709,10116.0,8972,A,1,Intermediate,,,948.0,1
N,,50597,,,,16435,Heart,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL619710,10116.0,8973,A,1,Intermediate,,,948.0,1
N,,50597,,,,16434,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL619711,10116.0,8974,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16434,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL619712,10116.0,8975,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16434,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL619713,10116.0,8976,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16434,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL619714,10116.0,8977,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16434,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL619715,10116.0,8978,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16434,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL619716,10116.0,8979,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16434,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL619717,10116.0,8980,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16434,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,CHEMBL619718,10116.0,8981,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16435,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL619719,10116.0,8982,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16435,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL875329,10116.0,8983,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16435,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL619720,10116.0,8984,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16435,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL619721,10116.0,8985,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16435,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL619722,10116.0,8986,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16435,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL619723,10116.0,8987,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16435,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL619724,10116.0,8988,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16435,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL619725,10116.0,8989,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16434,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL619726,10116.0,8990,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16434,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL619727,10116.0,8991,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16434,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL619728,10116.0,8992,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16435,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL619729,10116.0,8993,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,11977,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL619730,10116.0,8994,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,11977,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL619731,10116.0,8995,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,11977,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL619732,10116.0,8996,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,11977,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL619733,10116.0,8997,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,11977,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL619734,10116.0,8998,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,11977,Zone of skin,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL619735,10116.0,8999,A,1,Intermediate,,,14.0,1
N,,50597,,,In vivo,11977,Zone of skin,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL875330,10116.0,9000,A,1,Intermediate,,,14.0,1
N,,50597,,,In vivo,11977,Zone of skin,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL628465,10116.0,9001,A,1,Intermediate,,,14.0,1
N,,50597,,,In vivo,11977,Zone of skin,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL628466,10116.0,9002,A,1,Intermediate,,,14.0,1
N,,50597,,,In vivo,11977,Zone of skin,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL628467,10116.0,9003,A,1,Intermediate,,,14.0,1
N,,50597,,,In vivo,11977,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL628468,10116.0,9004,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,11977,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL628469,10116.0,9005,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,11977,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL628470,10116.0,9006,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,11977,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL628471,10116.0,9007,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,11977,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL628472,10116.0,9008,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,11977,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625191,10116.0,9009,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,11977,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL625192,10116.0,9010,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,11977,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),CHEMBL875337,10116.0,9011,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,11977,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),CHEMBL626341,10116.0,9012,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,11977,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),CHEMBL626342,10116.0,9013,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,11977,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),CHEMBL621943,10116.0,9014,A,1,Intermediate,,,2107.0,1
N,,50597,,,,3748,,Rattus norvegicus,,BAO_0000218,,Half life in rats,CHEMBL621944,10116.0,9015,A,1,Intermediate,,,,1
N,,50597,,,,15765,,Rattus norvegicus,,BAO_0000218,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,CHEMBL621945,10116.0,9016,A,1,Intermediate,,,,1
N,,50597,,,,4871,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),CHEMBL621946,10116.0,9017,A,1,Intermediate,,,,1
N,,50597,,,,4871,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,CHEMBL621947,10116.0,9018,A,1,Intermediate,,,,1
N,,50597,,,,4872,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),CHEMBL621948,10116.0,9019,A,1,Intermediate,,,,1
N,,50597,,,,4872,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,CHEMBL621949,10116.0,9020,A,1,Intermediate,,,,1
N,,50597,,,,5413,,Rattus norvegicus,,BAO_0000218,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),CHEMBL621950,10116.0,9021,A,1,Intermediate,,,,1
N,,50597,,,,5413,,Rattus norvegicus,,BAO_0000218,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,CHEMBL621951,10116.0,9022,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15272,Blood,Rattus norvegicus,,BAO_0000218,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,CHEMBL621952,10116.0,9023,A,1,Intermediate,,,178.0,1
N,,50597,,,,4689,Liver,Rattus norvegicus,,BAO_0000218,,Stability (%) in rat liver microsomes,CHEMBL621953,10116.0,9024,A,1,Intermediate,,,2107.0,1
N,,50597,,,,6057,,Rattus norvegicus,,BAO_0000218,,Area under curve was calculated after intravenous administration,CHEMBL621954,10116.0,9025,A,1,Intermediate,,,,1
N,,50597,,,,6057,,Rattus norvegicus,,BAO_0000218,,Area under the curve was calculated after iv administration in rat,CHEMBL621955,10116.0,9026,A,1,Intermediate,,,,1
N,,50597,,,,6057,,Rattus norvegicus,,BAO_0000218,,Area under the curve was calculated in rat after peroral administration,CHEMBL621956,10116.0,9027,A,1,Intermediate,,,,1
N,,50597,,,,6211,,Rattus norvegicus,,BAO_0000218,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,CHEMBL621957,10116.0,9028,A,1,Intermediate,,,,1
N,,50597,,,,5710,,Rattus norvegicus,,BAO_0000218,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,CHEMBL621958,10116.0,9029,A,1,Intermediate,,,,1
N,,50597,,,,5710,,Rattus norvegicus,,BAO_0000218,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,CHEMBL621959,10116.0,9030,A,1,Intermediate,,,,1
N,,50597,,,,17853,,Rattus norvegicus,,BAO_0000218,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,CHEMBL621960,10116.0,9031,A,1,Intermediate,,,,1
N,,50597,,,,17853,,Rattus norvegicus,,BAO_0000218,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,CHEMBL621961,10116.0,9032,A,1,Intermediate,,,,1
N,,50597,,,,15765,,Rattus norvegicus,,BAO_0000218,,p value of the compound,CHEMBL621962,10116.0,9033,A,1,Intermediate,,,,1
N,,50597,,,,15765,,Rattus norvegicus,,BAO_0000218,,p value of the compound,CHEMBL876787,10116.0,9034,F,1,Intermediate,,,,1
N,,50597,,,,15765,,Rattus norvegicus,,BAO_0000218,,p value of the compound,CHEMBL621963,10116.0,9035,A,1,Intermediate,,,,1
N,,50597,,,,6175,Stomach,Rattus norvegicus,,BAO_0000218,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),CHEMBL622637,10116.0,9036,A,1,Intermediate,,,945.0,1
N,,50597,,,,6175,Stomach,Rattus norvegicus,,BAO_0000218,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),CHEMBL622638,10116.0,9037,A,1,Intermediate,,,945.0,1
N,,50597,,,,6175,Stomach,Rattus norvegicus,,BAO_0000218,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),CHEMBL626561,10116.0,9038,A,1,Intermediate,,,945.0,1
U,,22224,,,,7991,,Oryctolagus cuniculus,,BAO_0000019,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),CHEMBL626562,9986.0,9039,F,1,Autocuration,,,,0
U,,22224,,,,429,,Oryctolagus cuniculus,,BAO_0000218,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),CHEMBL626563,9986.0,9040,A,1,Autocuration,,,,0
U,,22224,,,,429,,Oryctolagus cuniculus,,BAO_0000218,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),CHEMBL626564,9986.0,9041,A,1,Autocuration,,,,0
U,,22224,,,In vivo,6253,,Oryctolagus cuniculus,,BAO_0000218,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,CHEMBL626565,9986.0,9042,A,1,Autocuration,,,,0
U,,22224,,,In vivo,6253,,Oryctolagus cuniculus,,BAO_0000218,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,CHEMBL626566,9986.0,9043,A,1,Autocuration,,,,0
U,,22224,,,In vivo,3615,,Oryctolagus cuniculus,,BAO_0000218,,Clearance rate in rabbits,CHEMBL626567,9986.0,9044,A,1,Autocuration,,,,0
U,,22224,,,In vivo,4059,,Oryctolagus cuniculus,,BAO_0000218,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,CHEMBL626568,9986.0,9045,A,1,Autocuration,,,,0
U,,22224,,,In vivo,5124,,Oryctolagus cuniculus,,BAO_0000218,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,CHEMBL626569,9986.0,9046,A,1,Autocuration,,,,0
U,,22224,,,In vivo,5124,,Oryctolagus cuniculus,,BAO_0000218,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,CHEMBL626570,9986.0,9047,A,1,Autocuration,,,,0
U,,22224,,,In vivo,5124,,Oryctolagus cuniculus,,BAO_0000218,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,CHEMBL626571,9986.0,9048,A,1,Autocuration,,,,0
U,,22224,,,In vivo,429,,Oryctolagus cuniculus,,BAO_0000218,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,CHEMBL626572,9986.0,9049,A,1,Autocuration,,,,0
U,,22224,,,In vivo,4059,Plasma,Oryctolagus cuniculus,,BAO_0000218,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,CHEMBL626573,9986.0,9050,A,1,Autocuration,,,1969.0,0
U,Microsomes,22224,,,,9659,Liver,Oryctolagus cuniculus,,BAO_0000251,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,CHEMBL626574,9986.0,9051,A,1,Autocuration,,,2107.0,0
U,Microsomes,22224,,,,9659,Liver,Oryctolagus cuniculus,,BAO_0000251,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,CHEMBL626575,9986.0,9052,A,1,Autocuration,,,2107.0,0
U,,22224,,,,3639,,Oryctolagus cuniculus,,BAO_0000218,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,CHEMBL626576,9986.0,9053,A,1,Autocuration,,,,0
U,,22224,,,,3639,,Oryctolagus cuniculus,,BAO_0000218,,Dose at which bioavailability of perorally administered compound was tested in rabbit,CHEMBL626577,9986.0,9054,A,1,Autocuration,,,,0
U,,22224,,,In vivo,3639,,Oryctolagus cuniculus,,BAO_0000218,,The compound was tested for its bioavailability in rabbit (by oral dosage).,CHEMBL626578,9986.0,9055,A,1,Autocuration,,,,0
U,,22224,,,In vivo,5124,,Oryctolagus cuniculus,,BAO_0000218,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,CHEMBL625263,9986.0,9056,A,1,Autocuration,,,,0
U,,22224,,,In vivo,5124,,Oryctolagus cuniculus,,BAO_0000218,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,CHEMBL625264,9986.0,9057,A,1,Autocuration,,,,0
U,,22224,,,In vivo,5124,,Oryctolagus cuniculus,,BAO_0000218,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,CHEMBL625265,9986.0,9058,A,1,Autocuration,,,,0
U,Microsomes,22224,,,,14294,,Oryctolagus cuniculus,,BAO_0000251,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),CHEMBL625266,9986.0,9059,A,1,Autocuration,,,,0
U,Microsomes,22224,,,,14294,,Oryctolagus cuniculus,,BAO_0000251,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),CHEMBL876796,9986.0,9060,A,1,Autocuration,,,,0
U,,22224,,,In vivo,429,,Oryctolagus cuniculus,,BAO_0000218,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,CHEMBL625267,9986.0,9061,A,1,Autocuration,,,,0
U,,22224,,,In vivo,5124,Plasma,Oryctolagus cuniculus,,BAO_0000218,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,CHEMBL625268,9986.0,9062,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,5124,Plasma,Oryctolagus cuniculus,,BAO_0000218,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,CHEMBL625269,9986.0,9063,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,5124,Plasma,Oryctolagus cuniculus,,BAO_0000218,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,CHEMBL624689,9986.0,9064,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,429,,Oryctolagus cuniculus,,BAO_0000218,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,CHEMBL624690,9986.0,9065,A,1,Autocuration,,,,0
U,,22224,,,,429,Urine,Oryctolagus cuniculus,,BAO_0000218,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),CHEMBL624691,9986.0,9066,A,1,Autocuration,,,1088.0,0
U,,22224,,,,429,Urine,Oryctolagus cuniculus,,BAO_0000218,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),CHEMBL624692,9986.0,9067,A,1,Autocuration,,,1088.0,0
U,,22224,,,In vivo,4059,,Oryctolagus cuniculus,,BAO_0000218,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,CHEMBL624693,9986.0,9068,A,1,Autocuration,,,,0
U,,22224,,,In vivo,4137,,Oryctolagus cuniculus,,BAO_0000218,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,CHEMBL624694,9986.0,9069,A,1,Autocuration,,,,0
U,,22224,,,In vitro,11672,,Oryctolagus cuniculus,,BAO_0000221,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,CHEMBL877596,9986.0,9070,A,1,Autocuration,,,,0
U,,22224,,,,12886,,Oryctolagus cuniculus,,BAO_0000019,,Time within which only 10% of the drug was degraded,CHEMBL624695,9986.0,9071,A,1,Autocuration,,,,0
U,,22224,,,,3853,Liver,Oryctolagus cuniculus,,BAO_0000221,,Half life period in rabbit liver homogenate,CHEMBL624696,9986.0,9072,A,1,Autocuration,,,2107.0,0
U,,22224,,,,3615,,Oryctolagus cuniculus,,BAO_0000019,,Half life value in rabbits,CHEMBL624697,9986.0,9073,A,1,Autocuration,,,,0
U,,22224,,,In vivo,6253,Blood,Oryctolagus cuniculus,,BAO_0000218,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,CHEMBL624698,9986.0,9074,A,1,Autocuration,,,178.0,0
U,,22224,,,In vivo,6253,Blood,Oryctolagus cuniculus,,BAO_0000218,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,CHEMBL624699,9986.0,9075,A,1,Autocuration,,,178.0,0
U,,22224,,,In vivo,6077,,Oryctolagus cuniculus,,BAO_0000218,,Half-life period in rabbits following intravenous administration at 2 mg/kg,CHEMBL624700,9986.0,9076,A,1,Autocuration,,,,0
N,,50597,,,,17617,Plasma,Rattus norvegicus,,BAO_0000218,,AUC 0-8 hr value in rats at 10 mg/kg,CHEMBL622903,10116.0,9077,A,1,Intermediate,,,1969.0,1
N,,50597,,,,17594,Plasma,Rattus norvegicus,,BAO_0000218,,AUC after administration at 2000 mg/kg/day in rats,CHEMBL622904,10116.0,9078,A,1,Intermediate,,,1969.0,1
N,,50597,,,,6149,Plasma,Rattus norvegicus,,BAO_0000218,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,CHEMBL622905,10116.0,9079,A,1,Intermediate,,,1969.0,1
N,,50597,,,,17260,Plasma,Rattus norvegicus,,BAO_0000218,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,CHEMBL622906,10116.0,9080,A,1,Intermediate,,,1969.0,1
N,,50597,,,,17260,Plasma,Rattus norvegicus,,BAO_0000218,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,CHEMBL622907,10116.0,9081,A,1,Intermediate,,,1969.0,1
N,,50597,,,,6644,Plasma,Rattus norvegicus,,BAO_0000218,,AUC in rat after oral administration at 10.5 mg/kg dose,CHEMBL622908,10116.0,9082,A,1,Intermediate,,,1969.0,1
N,,50597,,,,6644,Plasma,Rattus norvegicus,,BAO_0000218,,AUC in rat after oral administration at 11.2 mg/kg dose,CHEMBL622909,10116.0,9083,A,1,Intermediate,,,1969.0,1
N,,50597,,,,6644,Plasma,Rattus norvegicus,,BAO_0000218,,AUC in rat after oral administration at 9.7 mg/kg dose,CHEMBL622910,10116.0,9084,A,1,Intermediate,,,1969.0,1
N,,50597,,,,6495,Brain,Rattus norvegicus,,BAO_0000218,,AUC in rat brain after oral administration at 10 mg/kg,CHEMBL622911,10116.0,9085,A,1,Intermediate,,,955.0,1
N,,50597,,,,6504,Plasma,Rattus norvegicus,,BAO_0000218,,AUC in rat p.o.,CHEMBL622912,10116.0,9086,A,1,Intermediate,,,1969.0,1
N,,50597,,,,17686,Plasma,Rattus norvegicus,,BAO_0000218,,AUC in rat p.o. at 20 mg/kg concentration,CHEMBL622913,10116.0,9087,A,1,Intermediate,,,1969.0,1
N,,50597,,,,6495,Plasma,Rattus norvegicus,,BAO_0000218,,AUC in rat plasma after oral administration at 10 mg/kg,CHEMBL622914,10116.0,9088,A,1,Intermediate,,,1969.0,1
N,,50597,,,,216,Plasma,Rattus norvegicus,,BAO_0000218,,AUC in rats,CHEMBL622915,10116.0,9089,A,1,Intermediate,,,1969.0,1
N,,50597,,,,1908,Plasma,Rattus norvegicus,,BAO_0000218,,AUC value after IV dose at a dose of 5 mg/kg in rats.,CHEMBL622916,10116.0,9090,A,1,Intermediate,,,1969.0,1
N,,50597,,,,1908,Plasma,Rattus norvegicus,,BAO_0000218,,AUC value after oral dose at a dose of 10 mg/kg in rats.,CHEMBL622917,10116.0,9091,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6685,Plasma,Rattus norvegicus,,BAO_0000218,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",CHEMBL622918,10116.0,9092,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,216,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,CHEMBL622919,10116.0,9093,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6049,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration was evaluated in rat,CHEMBL622920,10116.0,9094,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,2463,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,CHEMBL622921,10116.0,9095,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6679,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,CHEMBL622922,10116.0,9096,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6681,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,CHEMBL622923,10116.0,9097,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4890,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,CHEMBL877604,10116.0,9098,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6410,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,CHEMBL622924,10116.0,9099,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6410,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,CHEMBL622925,10116.0,9100,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,16366,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,CHEMBL622926,10116.0,9101,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6227,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,CHEMBL623625,10116.0,9102,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,3598,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,CHEMBL623626,10116.0,9103,A,1,Expert,,,1969.0,1
N,,50597,,,In vivo,1465,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma drug concentration was determined,CHEMBL623627,10116.0,9104,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4368,,Rattus norvegicus,,BAO_0000218,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,CHEMBL623628,10116.0,9105,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15662,Plasma,Rattus norvegicus,,BAO_0000218,,Mean peak plasma concentration was observed after intravenous administration in rat,CHEMBL623629,10116.0,9106,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15662,Plasma,Rattus norvegicus,,BAO_0000218,,Mean peak plasma concentration was observed after oral administration in rat,CHEMBL623630,10116.0,9107,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5355,,Rattus norvegicus,,BAO_0000218,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,CHEMBL623804,10116.0,9108,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5355,,Rattus norvegicus,,BAO_0000218,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,CHEMBL623805,10116.0,9109,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1567,Plasma,Rattus norvegicus,,BAO_0000218,,Peak oral plasma concentration was determined in rats by oral administration,CHEMBL623806,10116.0,9110,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4026,Plasma,Rattus norvegicus,,BAO_0000218,,Peak plasma concentration (Cmax) was determined,CHEMBL623807,10116.0,9111,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6193,Plasma,Rattus norvegicus,,BAO_0000218,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,CHEMBL623808,10116.0,9112,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4026,Plasma,Rattus norvegicus,,BAO_0000218,,Peak plasma concentration (Cmax) in rats,CHEMBL623809,10116.0,9113,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6485,Plasma,Rattus norvegicus,,BAO_0000218,,Peak plasma concentration at 1 mg/kg peroral administration,CHEMBL623810,10116.0,9114,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17655,Plasma,Rattus norvegicus,,BAO_0000218,,Peak plasma concentration in rat,CHEMBL623811,10116.0,9115,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14941,Plasma,Rattus norvegicus,,BAO_0000218,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",CHEMBL623812,10116.0,9116,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5394,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,CHEMBL877605,10116.0,9117,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4408,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (Cmax) in rat,CHEMBL623813,10116.0,9118,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5983,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,CHEMBL623814,10116.0,9119,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4878,,Rattus norvegicus,,BAO_0000218,,Cmax in rat after 3mg/kg oral dose,CHEMBL623815,10116.0,9120,A,1,Intermediate,,,,1
N,,50597,,Sprague-Dawley,In vivo,5862,,Rattus norvegicus,,BAO_0000218,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,CHEMBL623816,10116.0,9121,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4517,,Rattus norvegicus,,BAO_0000218,,Cmax in rats after 20 mg/kg oral dose,CHEMBL623145,10116.0,9122,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5932,Plasma,Rattus norvegicus,,BAO_0000218,,Cmax in rat plasma after 30mg/kg oral dose,CHEMBL623146,10116.0,9123,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5436,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma concentration after oral administration of 100 mg/kg to rats,CHEMBL623147,10116.0,9124,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4910,Brain,Rattus norvegicus,,BAO_0000218,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,CHEMBL623042,10116.0,9125,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,4950,,Rattus norvegicus,,BAO_0000218,,Tested for the Cmax in rat at 10 mg/kg per orally,CHEMBL623043,10116.0,9126,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15078,,Rattus norvegicus,,BAO_0000218,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL623044,10116.0,9127,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15078,,Rattus norvegicus,,BAO_0000218,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",CHEMBL623045,10116.0,9128,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3360,,Rattus norvegicus,,BAO_0000218,,Bioavailability as oral Cmax in rats at 30 mins,CHEMBL623046,10116.0,9129,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3360,,Rattus norvegicus,,BAO_0000218,,Bioavailability as oral Cmax in rats at 6hr,CHEMBL623226,10116.0,9130,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15022,,Rattus norvegicus,,BAO_0000218,,The maximum concentration of compound was measured at the dose of 100 umol/kg,CHEMBL623227,10116.0,9131,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15022,,Rattus norvegicus,,BAO_0000218,,The maximum concentration of compound was measured at the dose of 300 umol/kg,CHEMBL623228,10116.0,9132,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15022,,Rattus norvegicus,,BAO_0000218,,The maximum concentration of compound was measured at the dose of 30 umol/kg,CHEMBL623229,10116.0,9133,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5160,Plasma,Rattus norvegicus,,BAO_0000218,,The maximum plasma levels for the compounds were determined by LC-MS.,CHEMBL623230,10116.0,9134,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15662,Plasma,Rattus norvegicus,,BAO_0000218,,mean peak plasma concentration was observed after intravenous administration in rat,CHEMBL623231,10116.0,9135,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15662,Plasma,Rattus norvegicus,,BAO_0000218,,mean peak plasma concentration was observed after oral administration in rat,CHEMBL623232,10116.0,9136,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4709,,Rattus norvegicus,,BAO_0000218,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,CHEMBL623233,10116.0,9137,A,1,Intermediate,,,,1
N,,50597,,,,3535,,Rattus norvegicus,,BAO_0000218,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,CHEMBL623234,10116.0,9138,A,1,Intermediate,,,,1
N,,50597,,,,3535,,Rattus norvegicus,,BAO_0000218,,Concentration in plasma (portal) following oral dose in rats at 1 hr,CHEMBL623235,10116.0,9139,A,1,Intermediate,,,,1
N,,50597,,,,3535,,Rattus norvegicus,,BAO_0000218,,Concentration in plasma (portal) following oral dose in rats at 2 hr,CHEMBL623236,10116.0,9140,A,1,Intermediate,,,,1
N,,50597,,,,3535,,Rattus norvegicus,,BAO_0000218,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,CHEMBL623237,10116.0,9141,A,1,Intermediate,,,,1
N,,50597,,,,3535,,Rattus norvegicus,,BAO_0000218,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,CHEMBL623238,10116.0,9142,A,1,Intermediate,,,,1
N,,50597,,,,3535,,Rattus norvegicus,,BAO_0000218,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,CHEMBL623239,10116.0,9143,A,1,Intermediate,,,,1
U,,22224,,,In vivo,5005,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,CHEMBL623240,10116.0,9144,A,1,Intermediate,,,1969.0,0
N,,50597,,,,6326,Hypothalamus,Rattus norvegicus,,BAO_0000218,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",CHEMBL623241,10116.0,9145,A,1,Intermediate,,,1898.0,1
N,,50597,,,,6326,Hypothalamus,Rattus norvegicus,,BAO_0000218,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",CHEMBL623242,10116.0,9146,A,1,Intermediate,,,1898.0,1
N,,50597,,,,6326,,Rattus norvegicus,,BAO_0000218,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",CHEMBL874394,10116.0,9147,A,1,Intermediate,,,,1
N,,50597,,,,6326,,Rattus norvegicus,,BAO_0000218,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",CHEMBL623243,10116.0,9148,A,1,Intermediate,,,,1
N,,50597,,,,17411,,Rattus norvegicus,,BAO_0000218,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL623244,10116.0,9149,A,1,Intermediate,,,,1
N,,50597,,,,16435,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL623245,10116.0,9150,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16435,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL623246,10116.0,9151,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16435,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL623247,10116.0,9152,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16435,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL623248,10116.0,9153,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16435,Kidney,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL623249,10116.0,9154,A,1,Intermediate,,,2113.0,1
N,,50597,,,,16434,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL625072,10116.0,9155,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16434,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL625073,10116.0,9156,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16434,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL625074,10116.0,9157,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16434,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL625075,10116.0,9158,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16434,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,CHEMBL625076,10116.0,9159,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16434,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL625077,10116.0,9160,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16434,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL625078,10116.0,9161,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16434,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,CHEMBL874395,10116.0,9162,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16435,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL625079,10116.0,9163,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16435,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL625080,10116.0,9164,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16435,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL625081,10116.0,9165,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16435,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL625082,10116.0,9166,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16435,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL625083,10116.0,9167,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16435,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL625084,10116.0,9168,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16435,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL625085,10116.0,9169,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16435,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL625086,10116.0,9170,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16434,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL625087,10116.0,9171,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16434,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL625088,10116.0,9172,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16434,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL622205,10116.0,9173,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16435,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL622206,10116.0,9174,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16435,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL622207,10116.0,9175,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16435,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL622366,10116.0,9176,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16435,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL622367,10116.0,9177,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16435,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL875331,10116.0,9178,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16435,Liver,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL622368,10116.0,9179,A,1,Intermediate,,,2107.0,1
N,,50597,,,,16434,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL622369,10116.0,9180,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16434,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL622370,10116.0,9181,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16434,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL622371,10116.0,9182,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16434,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL622372,10116.0,9183,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16434,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL622373,10116.0,9184,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16434,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL622374,10116.0,9185,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16434,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL622375,10116.0,9186,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16434,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,CHEMBL622376,10116.0,9187,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16435,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL622377,10116.0,9188,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16435,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL622378,10116.0,9189,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16435,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL622379,10116.0,9190,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16435,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL622380,10116.0,9191,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16435,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL622381,10116.0,9192,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16435,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL622382,10116.0,9193,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16434,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,CHEMBL622383,10116.0,9194,A,1,Intermediate,,,2048.0,1
N,,50597,,,,6175,Stomach,Rattus norvegicus,,BAO_0000218,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),CHEMBL875332,10116.0,9195,A,1,Intermediate,,,945.0,1
N,,50597,,,,6175,Stomach,Rattus norvegicus,,BAO_0000218,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),CHEMBL622384,10116.0,9196,A,1,Intermediate,,,945.0,1
N,,50597,,,,6175,Stomach,Rattus norvegicus,,BAO_0000218,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),CHEMBL622385,10116.0,9197,A,1,Intermediate,,,945.0,1
N,,50597,,,,6175,Stomach,Rattus norvegicus,,BAO_0000218,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),CHEMBL622386,10116.0,9198,A,1,Intermediate,,,945.0,1
N,,50597,,,,10839,,Rattus norvegicus,,BAO_0000218,,The compound was tested for the plasma binding in rat,CHEMBL622387,10116.0,9199,A,1,Intermediate,,,,1
N,,50597,,,,16459,,Rattus norvegicus,,BAO_0000218,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",CHEMBL622388,10116.0,9200,A,1,Intermediate,,,,1
N,,50597,,,,16459,,Rattus norvegicus,,BAO_0000218,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",CHEMBL622389,10116.0,9201,A,1,Intermediate,,,,1
N,,50597,,,,16459,,Rattus norvegicus,,BAO_0000218,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",CHEMBL622390,10116.0,9202,A,1,Intermediate,,,,1
N,,50597,,,,16459,,Rattus norvegicus,,BAO_0000218,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),CHEMBL622391,10116.0,9203,A,1,Intermediate,,,,1
N,,50597,,,,16459,,Rattus norvegicus,,BAO_0000218,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),CHEMBL622392,10116.0,9204,A,1,Intermediate,,,,1
N,,50597,,,,16459,,Rattus norvegicus,,BAO_0000218,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),CHEMBL622393,10116.0,9205,A,1,Intermediate,,,,1
N,,50597,,,,3278,,Rattus norvegicus,,BAO_0000218,,Plasma level at 2 hr after administration of the compound,CHEMBL622394,10116.0,9206,A,1,Intermediate,,,,1
N,,50597,,,,3278,,Rattus norvegicus,,BAO_0000218,,plasma level at 2 hr after administration of the compound,CHEMBL622395,10116.0,9207,A,1,Intermediate,,,,1
N,,50597,,,,4684,Serum,Rattus norvegicus,,BAO_0000218,,Stability in rat serum measured as % recovery at 1 min,CHEMBL622396,10116.0,9208,A,1,Intermediate,,,1977.0,1
N,,50597,,,,4684,Serum,Rattus norvegicus,,BAO_0000218,,Stability in rat serum measured as % recovery at 10 min,CHEMBL624894,10116.0,9209,A,1,Intermediate,,,1977.0,1
N,,50597,,,,4684,Serum,Rattus norvegicus,,BAO_0000218,,Stability in rat serum measured as % recovery at 10 mins,CHEMBL624895,10116.0,9210,A,1,Intermediate,,,1977.0,1
N,,50597,,,,4684,Serum,Rattus norvegicus,,BAO_0000218,,Stability in rat serum measured as % recovery at 2 hr,CHEMBL624058,10116.0,9211,A,1,Intermediate,,,1977.0,1
N,,50597,,,,4684,Serum,Rattus norvegicus,,BAO_0000218,,Stability in rat serum measured as % recovery at 3 min,CHEMBL624059,10116.0,9212,A,1,Intermediate,,,1977.0,1
N,,50597,,,,4684,Serum,Rattus norvegicus,,BAO_0000218,,Stability in rat serum measured as % recovery at 3 mins,CHEMBL624060,10116.0,9213,A,1,Intermediate,,,1977.0,1
N,,50597,,,,4684,Serum,Rattus norvegicus,,BAO_0000218,,Stability in rat serum measured as % recovery at 5 min,CHEMBL624061,10116.0,9214,A,1,Intermediate,,,1977.0,1
N,,50597,,,,4684,Serum,Rattus norvegicus,,BAO_0000218,,Stability in rat serum measured as % recovery at 5 mins,CHEMBL624062,10116.0,9215,A,1,Intermediate,,,1977.0,1
N,,50597,,,In vivo,16456,,Rattus norvegicus,,BAO_0000218,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,CHEMBL624063,10116.0,9216,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16456,,Rattus norvegicus,,BAO_0000218,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,CHEMBL624064,10116.0,9217,A,1,Intermediate,,,,1
N,,50597,,,,723,Plasma,Rattus norvegicus,,BAO_0000218,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,CHEMBL624065,10116.0,9218,A,1,Intermediate,,,1969.0,1
N,,50597,,,,723,Plasma,Rattus norvegicus,,BAO_0000218,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,CHEMBL624066,10116.0,9219,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5160,,Rattus norvegicus,,BAO_0000218,,Half life tested in mature male rat at a dose of 30 mg/kg,CHEMBL877490,10116.0,9220,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4709,,Rattus norvegicus,,BAO_0000218,,Half life after intravenous administration of 1 mg/kg in rat,CHEMBL874442,10116.0,9221,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5633,,Rattus norvegicus,,BAO_0000218,,Half life period after administration (30 mg/kg) in rat,CHEMBL626890,10116.0,9222,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5302,,Rattus norvegicus,,BAO_0000218,,Half life period in rat after 5 mg/Kg dose,CHEMBL626891,10116.0,9223,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5302,,Rattus norvegicus,,BAO_0000218,,Half life period in rat after 5 mg/kg dose,CHEMBL626892,10116.0,9224,A,1,Intermediate,,,,1
N,,50597,,,,17791,,Rattus norvegicus,,BAO_0000218,,Half life period was determined,CHEMBL626893,10116.0,9225,A,1,Intermediate,,,,1
N,,50597,,,,17791,,Rattus norvegicus,,BAO_0000218,,Half life period was evaluated in rat,CHEMBL626894,10116.0,9226,A,1,Intermediate,,,,1
N,,50597,,,,17791,,Rattus norvegicus,,BAO_0000218,,Half life period was evaluated in rat; 0.5-1.0,CHEMBL626895,10116.0,9227,A,1,Intermediate,,,,1
N,,50597,,,,17791,,Rattus norvegicus,,BAO_0000218,,Half life period was evaluated in rat; 5.9-7.5,CHEMBL626896,10116.0,9228,A,1,Intermediate,,,,1
N,,50597,,,,14512,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life in rat plasma,CHEMBL626897,10116.0,9229,A,1,Intermediate,,,1969.0,1
N,,50597,,,,6230,,Rattus norvegicus,,BAO_0000218,,Half-life time in rat was determined,CHEMBL626898,10116.0,9230,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3364,,Rattus norvegicus,,BAO_0000218,,Terminal half-life after iv administration to rats,CHEMBL626899,10116.0,9231,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6874,,Rattus norvegicus,,BAO_0000218,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,CHEMBL626900,10116.0,9232,A,1,Intermediate,,,,1
N,,50597,,,,857,,Rattus norvegicus,,BAO_0000218,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,CHEMBL626901,10116.0,9233,A,1,Intermediate,,,,1
N,,50597,,,In vivo,858,,Rattus norvegicus,,BAO_0000218,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),CHEMBL626902,10116.0,9234,A,1,Intermediate,,,,1
N,,50597,,,In vivo,858,,Rattus norvegicus,,BAO_0000218,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),CHEMBL626903,10116.0,9235,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5355,,Rattus norvegicus,,BAO_0000218,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,CHEMBL874443,10116.0,9236,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5355,,Rattus norvegicus,,BAO_0000218,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,CHEMBL626904,10116.0,9237,A,1,Intermediate,,,,1
N,,50597,,,,6305,,Rattus norvegicus,,BAO_0000218,,Half life in rats,CHEMBL626905,10116.0,9238,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13501,Plasma,Rattus norvegicus,,BAO_0000218,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,CHEMBL873830,10116.0,9239,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17594,,Rattus norvegicus,,BAO_0000218,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,CHEMBL626906,10116.0,9240,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4186,Plasma,Rattus norvegicus,,BAO_0000218,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,CHEMBL631076,10116.0,9241,A,1,Intermediate,,,1969.0,1
N,,50597,,,,2932,Plasma,Rattus norvegicus,,BAO_0000218,,Biological half-life was measured in plasma of rats,CHEMBL631077,10116.0,9242,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17065,,Rattus norvegicus,,BAO_0000218,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,CHEMBL631078,10116.0,9243,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15765,,Rattus norvegicus,,BAO_0000218,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,CHEMBL631079,10116.0,9244,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2713,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,CHEMBL631080,10116.0,9245,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2661,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,CHEMBL631081,10116.0,9246,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2661,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,CHEMBL631239,10116.0,9247,A,1,Intermediate,,,,1
N,,50597,,,,740,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for plasma half life in rat,CHEMBL631240,10116.0,9248,A,1,Intermediate,,,1969.0,1
N,,50597,,,,6597,Plasma,Rattus norvegicus,,BAO_0000218,,AUC value at a dose of 5 mg/kg (p.o.) in rats,CHEMBL631241,10116.0,9249,A,1,Intermediate,,,1969.0,1
N,,50597,,,,2959,Plasma,Rattus norvegicus,,BAO_0000218,,AUC value after administration of 20 mg/Kg oral dose in rat,CHEMBL631242,10116.0,9250,A,1,Intermediate,,,1969.0,1
N,,50597,,,,17594,Plasma,Rattus norvegicus,,BAO_0000218,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,CHEMBL631243,10116.0,9251,A,1,Intermediate,,,1969.0,1
N,,50597,,,,17596,Plasma,Rattus norvegicus,,BAO_0000218,,AUC0-96 after administration at 50 mg/kg,CHEMBL874444,10116.0,9252,A,1,Intermediate,,,1969.0,1
N,,50597,,,,17594,Plasma,Rattus norvegicus,,BAO_0000218,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,CHEMBL631244,10116.0,9253,A,1,Intermediate,,,1969.0,1
N,,50597,,,,3293,,Rattus norvegicus,,BAO_0000218,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",CHEMBL631245,10116.0,9254,A,1,Intermediate,,,,1
N,,50597,,,,6757,,Rattus norvegicus,,BAO_0000218,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,CHEMBL627162,10116.0,9255,A,1,Intermediate,,,,1
N,,50597,,,,6757,,Rattus norvegicus,,BAO_0000218,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,CHEMBL627163,10116.0,9256,A,1,Intermediate,,,,1
N,,50597,,,,6757,,Rattus norvegicus,,BAO_0000218,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,CHEMBL627164,10116.0,9257,A,1,Intermediate,,,,1
N,,50597,,,,5979,Kidney,Rattus norvegicus,,BAO_0000218,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,CHEMBL627165,10116.0,9258,A,1,Intermediate,,,2113.0,1
N,,50597,,,,5979,,Rattus norvegicus,,BAO_0000218,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,CHEMBL627166,10116.0,9259,A,1,Intermediate,,,,1
N,,50597,,,,5979,,Rattus norvegicus,,BAO_0000218,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,CHEMBL627167,10116.0,9260,A,1,Intermediate,,,,1
N,,50597,,,,4026,,Rattus norvegicus,,BAO_0000218,,Area under curve (AUC) at a dose of 30 mg/kg in rats,CHEMBL627822,10116.0,9261,A,1,Intermediate,,,,1
N,,50597,,,,5355,,Rattus norvegicus,,BAO_0000218,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,CHEMBL627823,10116.0,9262,A,1,Intermediate,,,,1
N,,50597,,,,5355,,Rattus norvegicus,,BAO_0000218,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,CHEMBL627824,10116.0,9263,A,1,Intermediate,,,,1
N,,50597,,,,5355,,Rattus norvegicus,,BAO_0000218,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,CHEMBL627825,10116.0,9264,A,1,Intermediate,,,,1
N,,50597,,,,5633,,Rattus norvegicus,,BAO_0000218,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,CHEMBL627826,10116.0,9265,A,1,Intermediate,,,,1
N,,50597,,,,1716,,Rattus norvegicus,,BAO_0000218,,Area under curve (Pharmacokinetic property) was determined,CHEMBL627827,10116.0,9266,A,1,Intermediate,,,,1
N,,50597,,,,1716,,Rattus norvegicus,,BAO_0000218,,Area under curve (Pharmacokinetic property) of the compound; Not determined,CHEMBL627828,10116.0,9267,A,1,Intermediate,,,,1
N,,50597,,,,4689,,Rattus norvegicus,,BAO_0000218,,Area under curve after intravenous administration (1 mg/kg) in rat,CHEMBL627829,10116.0,9268,A,1,Intermediate,,,,1
N,,50597,,,,4527,,Rattus norvegicus,,BAO_0000218,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,CHEMBL627830,10116.0,9269,A,1,Intermediate,,,,1
N,,50597,,,,4527,,Rattus norvegicus,,BAO_0000218,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,CHEMBL627831,10116.0,9270,A,1,Intermediate,,,,1
N,,50597,,,,15662,,Rattus norvegicus,,BAO_0000218,,Area under curve in male SD rats was observed after oral administration in rat,CHEMBL627832,10116.0,9271,A,1,Intermediate,,,,1
N,,50597,,,,4413,,Rattus norvegicus,,BAO_0000218,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,CHEMBL627833,10116.0,9272,A,1,Intermediate,,,,1
N,,50597,,,,3598,,Rattus norvegicus,,BAO_0000218,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,CHEMBL627834,10116.0,9273,A,1,Expert,,,,1
N,,50597,,,,3598,,Rattus norvegicus,,BAO_0000218,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,CHEMBL628004,10116.0,9274,A,1,Expert,,,,1
N,,50597,,,,5964,,Rattus norvegicus,,BAO_0000218,,Area under curve at 5 mg/kg po was determined in rat,CHEMBL628005,10116.0,9275,A,1,Intermediate,,,,1
N,,50597,,,,4689,,Rattus norvegicus,,BAO_0000218,,Area under curve in Rat at a oral dose of 5 mg/kg,CHEMBL628006,10116.0,9276,A,1,Intermediate,,,,1
N,,50597,,,,4186,,Rattus norvegicus,,BAO_0000218,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,CHEMBL628007,10116.0,9277,A,1,Intermediate,,,,1
N,,50597,,,,5510,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined,CHEMBL625676,10116.0,9278,A,1,Intermediate,,,,1
N,,50597,,,,17858,,Rattus norvegicus,,BAO_0000218,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,CHEMBL631309,10116.0,9279,A,1,Intermediate,,,,1
N,,50597,,,,17804,,Rattus norvegicus,,BAO_0000218,,Area under curve after intravenous administration at 3 mg/kg,CHEMBL631310,10116.0,9280,A,1,Intermediate,,,,1
N,,50597,,,,6106,,Rattus norvegicus,,BAO_0000218,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,CHEMBL631311,10116.0,9281,A,1,Intermediate,,,,1
N,,50597,,,,5964,,Rattus norvegicus,,BAO_0000218,,Area under curve at 4 hr in rat,CHEMBL631312,10116.0,9282,A,1,Intermediate,,,,1
N,,50597,,,,4026,,Rattus norvegicus,,BAO_0000218,,Area under curve at a dose of 30 mg/kg,CHEMBL631313,10116.0,9283,A,1,Intermediate,,,,1
N,,50597,,,,4756,,Rattus norvegicus,,BAO_0000218,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,CHEMBL631314,10116.0,9284,A,1,Intermediate,,,,1
N,,50597,,,,4756,,Rattus norvegicus,,BAO_0000218,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,CHEMBL631315,10116.0,9285,A,1,Intermediate,,,,1
N,,50597,,,,5862,,Rattus norvegicus,,BAO_0000218,,Area under curve for a 2-mpk po dose in SD rats,CHEMBL631316,10116.0,9286,A,1,Intermediate,,,,1
N,,50597,,,,5862,,Rattus norvegicus,,BAO_0000218,,Area under curve in SD rats,CHEMBL631317,10116.0,9287,A,1,Intermediate,,,,1
N,,50597,,,,6644,,Rattus norvegicus,,BAO_0000218,,Area under curve in rat after oral administration at 13 mg/kg dose,CHEMBL874471,10116.0,9288,A,1,Intermediate,,,,1
N,,50597,,,,5871,,Rattus norvegicus,,BAO_0000218,,Area under curve in rat by po administration at 0-24 hr,CHEMBL631318,10116.0,9289,A,1,Intermediate,,,,1
N,,50597,,,,5919,Plasma,Rattus norvegicus,,BAO_0000218,,Area under curve in rat plasma,CHEMBL631319,10116.0,9290,A,1,Intermediate,,,1969.0,1
N,,50597,,,,5939,,Rattus norvegicus,,BAO_0000218,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,CHEMBL631320,10116.0,9291,A,1,Intermediate,,,,1
N,,50597,,,,5939,,Rattus norvegicus,,BAO_0000218,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,CHEMBL631321,10116.0,9292,A,1,Intermediate,,,,1
N,,50597,,,,10,,Rattus norvegicus,,BAO_0000218,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,CHEMBL631322,10116.0,9293,A,1,Intermediate,,,,1
N,,50597,,,,11149,,Rattus norvegicus,,BAO_0000218,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,CHEMBL631323,10116.0,9294,A,1,Intermediate,,,,1
N,,50597,,,,5302,,Rattus norvegicus,,BAO_0000218,,Area under curve value in rat at a dose of 5 mg/kg,CHEMBL631324,10116.0,9295,A,1,Intermediate,,,,1
N,,50597,,,,17796,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined after oral administration in rats,CHEMBL631325,10116.0,9296,A,1,Intermediate,,,,1
N,,50597,,,,4890,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,CHEMBL631326,10116.0,9297,A,1,Intermediate,,,,1
N,,50597,,,,6011,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined after peroral administration in rat,CHEMBL631327,10116.0,9298,A,1,Intermediate,,,,1
N,,50597,,,,5375,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined at a dose 30 mpk administered orally.,CHEMBL631328,10116.0,9299,A,1,Intermediate,,,,1
N,,50597,,,,17764,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,CHEMBL631329,10116.0,9300,A,1,Intermediate,,,,1
N,,50597,,,,4368,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,CHEMBL627217,10116.0,9301,A,1,Intermediate,,,,1
N,,50597,,,,5610,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined in male rat,CHEMBL626352,10116.0,9302,A,1,Intermediate,,,,1
N,,50597,,,,5833,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined in rat after PO administration,CHEMBL626353,10116.0,9303,A,1,Intermediate,,,,1
N,,50597,,,,4257,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined in rat after a 3 mg/kg of oral dose,CHEMBL626354,10116.0,9304,A,1,Intermediate,,,,1
N,,50597,,,,5937,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,CHEMBL626355,10116.0,9305,A,1,Intermediate,,,,1
N,,50597,,,,5932,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,CHEMBL626356,10116.0,9306,A,1,Intermediate,,,,1
N,,50597,,,,5932,,Rattus norvegicus,,BAO_0000218,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,CHEMBL626357,10116.0,9307,A,1,Intermediate,,,,1
N,,50597,,,,17411,,Rattus norvegicus,,BAO_0000218,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL626358,10116.0,9308,A,1,Intermediate,,,,1
N,,50597,,,,17411,,Rattus norvegicus,,BAO_0000218,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL626359,10116.0,9309,A,1,Intermediate,,,,1
N,,50597,,,,17771,Plasma,Rattus norvegicus,,BAO_0000218,,Peak plasma concentration in rat at a dose of 3 mg/kg,CHEMBL626360,10116.0,9310,A,1,Intermediate,,,1969.0,1
N,,50597,,,,1628,,Rattus norvegicus,,BAO_0000218,,Plasma concentration at 2 hr in rats was evaluated.,CHEMBL626361,10116.0,9311,A,1,Intermediate,,,,1
N,,50597,,,,1628,,Rattus norvegicus,,BAO_0000218,,Plasma concentration at 2 hr in rats was evaluated; Not available,CHEMBL626362,10116.0,9312,A,1,Intermediate,,,,1
N,,50597,,,,17411,,Rattus norvegicus,,BAO_0000218,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL626363,10116.0,9313,A,1,Intermediate,,,,1
N,,50597,,,,4910,,Rattus norvegicus,,BAO_0000218,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,CHEMBL626970,10116.0,9314,A,1,Intermediate,,,,1
N,,50597,,,,4910,,Rattus norvegicus,,BAO_0000218,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,CHEMBL626971,10116.0,9315,A,1,Intermediate,,,,1
N,,50597,,,,4910,Plasma,Rattus norvegicus,,BAO_0000218,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,CHEMBL626972,10116.0,9316,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4910,Plasma,Rattus norvegicus,,BAO_0000218,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,CHEMBL626973,10116.0,9317,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4910,Plasma,Rattus norvegicus,,BAO_0000218,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,CHEMBL626974,10116.0,9318,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4910,Plasma,Rattus norvegicus,,BAO_0000218,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,CHEMBL874592,10116.0,9319,A,1,Intermediate,,,1969.0,1
N,,50597,,,,5510,,Rattus norvegicus,,BAO_0000218,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,CHEMBL626975,10116.0,9320,A,1,Intermediate,,,,1
N,,50597,,,,5510,,Rattus norvegicus,,BAO_0000218,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,CHEMBL626976,10116.0,9321,A,1,Intermediate,,,,1
N,,50597,,,,5510,,Rattus norvegicus,,BAO_0000218,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,CHEMBL626977,10116.0,9322,A,1,Intermediate,,,,1
N,,50597,,,,5510,,Rattus norvegicus,,BAO_0000218,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,CHEMBL626978,10116.0,9323,A,1,Intermediate,,,,1
N,,50597,,,,16427,,Rattus norvegicus,,BAO_0000218,,PK study was carried to determine the relative absorption ranking in rat.,CHEMBL626979,10116.0,9324,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4689,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,CHEMBL626980,10116.0,9325,A,1,Intermediate,,,1969.0,1
N,,50597,,,,11450,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",CHEMBL626981,10116.0,9326,A,1,Intermediate,,,178.0,1
N,,50597,,,,11450,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",CHEMBL626982,10116.0,9327,A,1,Intermediate,,,178.0,1
N,,50597,,,,11450,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",CHEMBL626983,10116.0,9328,A,1,Intermediate,,,178.0,1
N,,50597,,,,11450,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",CHEMBL622522,10116.0,9329,A,1,Intermediate,,,178.0,1
N,,50597,,,,11450,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",CHEMBL622523,10116.0,9330,A,1,Intermediate,,,178.0,1
N,,50597,,,,11450,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",CHEMBL622524,10116.0,9331,A,1,Intermediate,,,178.0,1
N,,50597,,,,11450,Brain,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",CHEMBL622525,10116.0,9332,A,1,Intermediate,,,955.0,1
N,,50597,,,,11450,Brain,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",CHEMBL622526,10116.0,9333,A,1,Intermediate,,,955.0,1
N,,50597,,,,11450,Brain,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",CHEMBL619849,10116.0,9334,A,1,Intermediate,,,955.0,1
N,,50597,,,,11450,Brain,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",CHEMBL619850,10116.0,9335,A,1,Intermediate,,,955.0,1
N,,50597,,,,11450,Brain,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",CHEMBL623864,10116.0,9336,A,1,Intermediate,,,955.0,1
N,,50597,,,,11450,Brain,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",CHEMBL623865,10116.0,9337,A,1,Intermediate,,,955.0,1
N,,50597,,,,11450,Heart,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",CHEMBL623866,10116.0,9338,A,1,Intermediate,,,948.0,1
N,,50597,,,,11450,Heart,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",CHEMBL623867,10116.0,9339,A,1,Intermediate,,,948.0,1
N,,50597,,,,11450,Heart,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",CHEMBL877615,10116.0,9340,A,1,Intermediate,,,948.0,1
N,,50597,,,,11450,Heart,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",CHEMBL623868,10116.0,9341,A,1,Intermediate,,,948.0,1
N,,50597,,,,11450,Heart,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",CHEMBL623869,10116.0,9342,A,1,Intermediate,,,948.0,1
N,,50597,,,,11450,Heart,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",CHEMBL623870,10116.0,9343,A,1,Intermediate,,,948.0,1
N,,50597,,,,16434,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,CHEMBL623871,10116.0,9344,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16434,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL623872,10116.0,9345,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16435,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL622129,10116.0,9346,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16435,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL622130,10116.0,9347,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16435,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL622131,10116.0,9348,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16435,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL622132,10116.0,9349,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16435,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL622133,10116.0,9350,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16435,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL622134,10116.0,9351,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16435,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL622135,10116.0,9352,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16435,Lung,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL622136,10116.0,9353,A,1,Intermediate,,,2048.0,1
N,,50597,,,,16434,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL622137,10116.0,9354,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16434,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL622138,10116.0,9355,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16434,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL623017,10116.0,9356,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16434,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL623018,10116.0,9357,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16434,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL623019,10116.0,9358,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16434,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL623020,10116.0,9359,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16434,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,CHEMBL623021,10116.0,9360,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16434,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,CHEMBL623022,10116.0,9361,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16435,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL623023,10116.0,9362,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16435,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL623024,10116.0,9363,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16435,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL623025,10116.0,9364,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16435,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL620545,10116.0,9365,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16435,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL620546,10116.0,9366,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16435,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL620547,10116.0,9367,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16435,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL620548,10116.0,9368,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16435,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL620549,10116.0,9369,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16434,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL620550,10116.0,9370,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16434,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,CHEMBL620551,10116.0,9371,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16434,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL620552,10116.0,9372,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16435,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL620553,10116.0,9373,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16435,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL620554,10116.0,9374,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16435,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL875845,10116.0,9375,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16435,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL620555,10116.0,9376,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16435,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL620556,10116.0,9377,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16435,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL620557,10116.0,9378,A,1,Intermediate,,,2385.0,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL620558,10116.0,9379,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL620559,10116.0,9380,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL622939,10116.0,9381,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL622940,10116.0,9382,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL622941,10116.0,9383,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL622942,10116.0,9384,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL622943,10116.0,9385,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,CHEMBL622944,10116.0,9386,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL622945,10116.0,9387,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL622946,10116.0,9388,A,1,Intermediate,,,,1
N,,50597,,,,3341,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for terminal half life in rat,CHEMBL622947,10116.0,9389,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3634,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,CHEMBL622948,10116.0,9390,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,3634,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,CHEMBL622949,10116.0,9391,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4839,,Rattus norvegicus,,BAO_0000218,,Compound was tested for its half life in rat,CHEMBL622950,10116.0,9392,A,1,Intermediate,,,,1
U,,22224,,,In vivo,5005,Plasma,Macaca mulatta,,BAO_0000218,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,CHEMBL622951,9544.0,9393,A,1,Intermediate,,,1969.0,0
U,,22224,,,,5005,Plasma,Rattus norvegicus,,BAO_0000366,,Compound was tested for its plasma half life in Sprague Dawley rats,CHEMBL622952,10116.0,9394,A,1,Intermediate,,,1969.0,0
U,,22224,,,,5005,Plasma,Rattus norvegicus,,BAO_0000366,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,CHEMBL622953,10116.0,9395,A,1,Intermediate,,,1969.0,0
N,,50597,,,,1094,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was tested for plasma half-life period in rat,CHEMBL873818,10116.0,9396,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5031,,Rattus norvegicus,,BAO_0000218,,Elimination half life after i.v. administration of compound in rats,CHEMBL622954,10116.0,9397,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6518,,Rattus norvegicus,,BAO_0000218,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,CHEMBL622955,10116.0,9398,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6518,,Rattus norvegicus,,BAO_0000218,,Elimination half-life after IV dosing at 1 mg/kg in rat,CHEMBL875229,10116.0,9399,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6518,,Rattus norvegicus,,BAO_0000218,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,CHEMBL622956,10116.0,9400,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6518,,Rattus norvegicus,,BAO_0000218,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,CHEMBL622957,10116.0,9401,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5408,Brain,Rattus norvegicus,,BAO_0000218,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,CHEMBL622958,10116.0,9402,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,5408,Plasma,Rattus norvegicus,,BAO_0000218,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,CHEMBL622959,10116.0,9403,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5408,Brain,Rattus norvegicus,,BAO_0000218,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,CHEMBL622960,10116.0,9404,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,5408,Plasma,Rattus norvegicus,,BAO_0000218,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,CHEMBL622961,10116.0,9405,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4687,,Rattus norvegicus,,BAO_0000218,,Evaluated for the half life in rat (in vivo),CHEMBL622962,10116.0,9406,A,1,Intermediate,,,,1
N,,50597,,,,6640,,Rattus norvegicus,,BAO_0000218,,Hafl life in rat,CHEMBL622963,10116.0,9407,A,1,Intermediate,,,,1
N,,50597,,,,6640,,Rattus norvegicus,,BAO_0000218,,Hafl life rat,CHEMBL622964,10116.0,9408,A,1,Intermediate,,,,1
N,,50597,,,,6641,,Rattus norvegicus,,BAO_0000218,,Hafl life rat,CHEMBL622965,10116.0,9409,A,1,Intermediate,,,,1
N,,50597,,,,6640,,Rattus norvegicus,,BAO_0000218,,Hafl life rat; Not determined,CHEMBL622966,10116.0,9410,A,1,Intermediate,,,,1
N,,50597,,,,6641,,Rattus norvegicus,,BAO_0000218,,Hafl life rat; Not determined,CHEMBL622967,10116.0,9411,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17411,Kidney,Rattus norvegicus,,BAO_0000218,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL622968,10116.0,9412,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,17411,Liver,Rattus norvegicus,,BAO_0000218,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL622969,10116.0,9413,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,17411,Lung,Rattus norvegicus,,BAO_0000218,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL875327,10116.0,9414,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,6570,,Rattus norvegicus,,BAO_0000218,,Half life in rat after 1 mg/kg i.v. administration,CHEMBL628638,10116.0,9415,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6570,,Rattus norvegicus,,BAO_0000218,,Half life in rat after 2 mg/kg peroral administration,CHEMBL628639,10116.0,9416,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17411,,Rattus norvegicus,,BAO_0000218,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL625840,10116.0,9417,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4722,,Rattus norvegicus,,BAO_0000218,,Half life of 10 mg/kg oral dose determined in rats,CHEMBL625841,10116.0,9418,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL625842,10116.0,9419,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL625843,10116.0,9420,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL625844,10116.0,9421,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL873822,10116.0,9422,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL625845,10116.0,9423,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL627059,10116.0,9424,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL627060,10116.0,9425,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,CHEMBL627061,10116.0,9426,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4762,,Rattus norvegicus,,BAO_0000218,,Half life of compound at 5 mg/kg after po administration was determined in rat,CHEMBL627709,10116.0,9427,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5327,,Rattus norvegicus,,BAO_0000218,,Half life of compound determined after intravenous administration to rat,CHEMBL627710,10116.0,9428,A,1,Intermediate,,,,1
N,,50597,,,,4847,,Rattus norvegicus,,BAO_0000218,,Half life of compound was determined in rat,CHEMBL627711,10116.0,9429,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17720,Plasma,Rattus norvegicus,,BAO_0000218,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,CHEMBL627712,10116.0,9430,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4723,,Rattus norvegicus,,BAO_0000218,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL627713,10116.0,9431,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4723,,Rattus norvegicus,,BAO_0000218,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL627714,10116.0,9432,A,1,Intermediate,,,,1
U,,22224,,,In vivo,4256,,Macaca fascicularis,,BAO_0000218,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,CHEMBL627889,9541.0,9433,A,1,Intermediate,,,,0
U,,22224,,,In vivo,4256,,Rattus norvegicus,,BAO_0000218,,Half life determined in rat by intravenous administration,CHEMBL627890,10116.0,9434,A,1,Intermediate,,,,0
N,,50597,,,In vivo,4722,,Rattus norvegicus,,BAO_0000218,,Half life determined in rats after iv administration,CHEMBL627891,10116.0,9435,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6535,Plasma,Rattus norvegicus,,BAO_0000218,,Half life in rat plasma after administration of 2 mg/kg iv,CHEMBL627892,10116.0,9436,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6535,Plasma,Rattus norvegicus,,BAO_0000218,,Half life in rat plasma after administration of 2 mg/kg iv,CHEMBL627893,10116.0,9437,A,1,Intermediate,,,1969.0,1
N,,50597,,,,1435,Plasma,Rattus norvegicus,,BAO_0000218,,Half life in rat plasma was determined,CHEMBL627894,10116.0,9438,A,1,Intermediate,,,1969.0,1
N,,50597,,,,1435,Plasma,Rattus norvegicus,,BAO_0000218,,Half life in rat plasma was determined; NA means not applicable,CHEMBL627895,10116.0,9439,A,1,Intermediate,,,1969.0,1
N,,50597,,,,5206,,Rattus norvegicus,,BAO_0000218,,Half life in rat was tested,CHEMBL627896,10116.0,9440,A,1,Intermediate,,,,1
N,,50597,,,,6080,Plasma,Rattus norvegicus,,BAO_0000218,,Half life measured in rat plasma,CHEMBL627897,10116.0,9441,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4449,,Rattus norvegicus,,BAO_0000218,,Half life recorded in rats,CHEMBL627898,10116.0,9442,A,1,Intermediate,,,,1
N,,50597,,,,6057,,Rattus norvegicus,,BAO_0000218,,Half life was calculated,CHEMBL627899,10116.0,9443,A,1,Intermediate,,,,1
N,,50597,,,,6057,,Rattus norvegicus,,BAO_0000218,,Half life was calculated in rat,CHEMBL873823,10116.0,9444,A,1,Intermediate,,,,1
N,,50597,,,,3747,,Rattus norvegicus,,BAO_0000218,,Half life was determined,CHEMBL627900,10116.0,9445,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17858,,Rattus norvegicus,,BAO_0000218,,Half life after 10 mg/kg oral administration in rat,CHEMBL627901,10116.0,9446,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16365,,Rattus norvegicus,,BAO_0000218,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,CHEMBL627902,10116.0,9447,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16365,,Rattus norvegicus,,BAO_0000218,,Half life after administering orally a dose of 30 mg/kg,CHEMBL627903,10116.0,9448,A,1,Intermediate,,,,1
N,,50597,,,,5031,,Rattus norvegicus,,BAO_0000218,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,CHEMBL627904,10116.0,9449,A,1,Intermediate,,,,1
N,,50597,,,,4722,,Rattus norvegicus,,BAO_0000218,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,CHEMBL627905,10116.0,9450,A,1,Intermediate,,,,1
N,,50597,,,,6078,,Rattus norvegicus,,BAO_0000218,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,CHEMBL627906,10116.0,9451,A,1,Intermediate,,,,1
N,,50597,,,,6078,,Rattus norvegicus,,BAO_0000218,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,CHEMBL627907,10116.0,9452,A,1,Intermediate,,,,1
N,,50597,,,,6078,,Rattus norvegicus,,BAO_0000218,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,CHEMBL876783,10116.0,9453,A,1,Intermediate,,,,1
N,,50597,,,,6078,,Rattus norvegicus,,BAO_0000218,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,CHEMBL627908,10116.0,9454,A,1,Intermediate,,,,1
N,,50597,,,,17065,,Rattus norvegicus,,BAO_0000218,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,CHEMBL627909,10116.0,9455,A,1,Intermediate,,,,1
N,,50597,,,,1353,,Rattus norvegicus,,BAO_0000218,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,CHEMBL627910,10116.0,9456,A,1,Intermediate,,,,1
N,,50597,,,,1353,,Rattus norvegicus,,BAO_0000218,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),CHEMBL627911,10116.0,9457,A,1,Intermediate,,,,1
N,,50597,,,,1353,,Rattus norvegicus,,BAO_0000218,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),CHEMBL627912,10116.0,9458,A,1,Intermediate,,,,1
N,,50597,,,,1353,,Rattus norvegicus,,BAO_0000218,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),CHEMBL627913,10116.0,9459,A,1,Intermediate,,,,1
N,,50597,,,,1353,,Rattus norvegicus,,BAO_0000218,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),CHEMBL627914,10116.0,9460,A,1,Intermediate,,,,1
N,,50597,,,,16423,,Rattus norvegicus,,BAO_0000218,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,CHEMBL627915,10116.0,9461,A,1,Intermediate,,,,1
N,,50597,,,,16423,,Rattus norvegicus,,BAO_0000218,,Area under the curve was evaluated after 20 uM/kg of peroral administration,CHEMBL627916,10116.0,9462,A,1,Intermediate,,,,1
N,,50597,,,,6062,,Rattus norvegicus,,BAO_0000218,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,CHEMBL627917,10116.0,9463,A,1,Intermediate,,,,1
N,,50597,,,,6056,,Rattus norvegicus,,BAO_0000218,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,CHEMBL627918,10116.0,9464,A,1,Intermediate,,,,1
N,,50597,,,,5182,,Rattus norvegicus,,BAO_0000218,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,CHEMBL627919,10116.0,9465,A,1,Intermediate,,,,1
N,,50597,,,,6410,,Rattus norvegicus,,BAO_0000218,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,CHEMBL627920,10116.0,9466,A,1,Intermediate,,,,1
N,,50597,,,,6410,,Rattus norvegicus,,BAO_0000218,,Area under the curve was evaluated at an oral dose of 30 mg/kg,CHEMBL627921,10116.0,9467,A,1,Intermediate,,,,1
N,,50597,,,,4723,,Rattus norvegicus,,BAO_0000218,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL627922,10116.0,9468,A,1,Intermediate,,,,1
N,,50597,,,,4723,,Rattus norvegicus,,BAO_0000218,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL876784,10116.0,9469,A,1,Intermediate,,,,1
N,,50597,,,,4723,,Rattus norvegicus,,BAO_0000218,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL627923,10116.0,9470,A,1,Intermediate,,,,1
N,,50597,,,,4723,,Rattus norvegicus,,BAO_0000218,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL626208,10116.0,9471,A,1,Intermediate,,,,1
N,,50597,,,,4723,,Rattus norvegicus,,BAO_0000218,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL626209,10116.0,9472,A,1,Intermediate,,,,1
N,,50597,,,,4723,,Rattus norvegicus,,BAO_0000218,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL626210,10116.0,9473,A,1,Intermediate,,,,1
N,,50597,,,,2463,Plasma,Rattus norvegicus,,BAO_0000218,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,CHEMBL627994,10116.0,9474,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4709,,Rattus norvegicus,,BAO_0000218,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,CHEMBL627995,10116.0,9475,A,1,Intermediate,,,,1
N,,50597,,,,4075,,Rattus norvegicus,,BAO_0000218,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,CHEMBL627996,10116.0,9476,A,1,Intermediate,,,,1
N,,50597,,,,5394,,Rattus norvegicus,,BAO_0000218,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,CHEMBL627997,10116.0,9477,A,1,Intermediate,,,,1
N,,50597,,,,2661,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,CHEMBL627998,10116.0,9478,A,1,Intermediate,,,,1
N,,50597,,,,2661,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,CHEMBL628640,10116.0,9479,A,1,Intermediate,,,,1
N,,50597,,,,2661,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,CHEMBL628641,10116.0,9480,A,1,Intermediate,,,,1
N,,50597,,,,2661,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,CHEMBL628642,10116.0,9481,A,1,Intermediate,,,,1
N,,50597,,,,17791,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for area under the curve expressed as (h*ug/ml),CHEMBL628643,10116.0,9482,A,1,Intermediate,,,,1
N,,50597,,,,2591,,Rattus norvegicus,,BAO_0000218,,Compound was tested for area under curve in rat,CHEMBL628644,10116.0,9483,A,1,Intermediate,,,,1
N,,50597,,,,6567,,Rattus norvegicus,,BAO_0000218,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,CHEMBL628645,10116.0,9484,A,1,Intermediate,,,,1
N,,50597,,,,6211,,Rattus norvegicus,,BAO_0000218,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,CHEMBL628646,10116.0,9485,A,1,Intermediate,,,,1
N,,50597,,,,5529,,Rattus norvegicus,,BAO_0000218,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),CHEMBL628647,10116.0,9486,A,1,Intermediate,,,,1
N,,50597,,,,5408,,Rattus norvegicus,,BAO_0000218,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,CHEMBL628648,10116.0,9487,A,1,Intermediate,,,,1
N,,50597,,,,5408,,Rattus norvegicus,,BAO_0000218,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,CHEMBL625358,10116.0,9488,A,1,Intermediate,,,,1
N,,50597,,,,5408,,Rattus norvegicus,,BAO_0000218,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,CHEMBL625359,10116.0,9489,A,1,Intermediate,,,,1
N,,50597,,,,5408,,Rattus norvegicus,,BAO_0000218,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,CHEMBL625360,10116.0,9490,A,1,Intermediate,,,,1
N,,50597,,,,429,,Rattus norvegicus,,BAO_0000218,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),CHEMBL625361,10116.0,9491,A,1,Intermediate,,,,1
N,,50597,,,,429,,Rattus norvegicus,,BAO_0000218,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),CHEMBL625362,10116.0,9492,A,1,Intermediate,,,,1
N,,50597,,,,429,,Rattus norvegicus,,BAO_0000218,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),CHEMBL625363,10116.0,9493,A,1,Intermediate,,,,1
N,,50597,,,,4796,,Rattus norvegicus,,BAO_0000218,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,CHEMBL625364,10116.0,9494,A,1,Intermediate,,,,1
N,,50597,,,,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,CHEMBL625365,10116.0,9495,A,1,Intermediate,,,,1
N,,50597,,,,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,CHEMBL625366,10116.0,9496,A,1,Intermediate,,,,1
N,,50597,,,,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,CHEMBL625367,10116.0,9497,A,1,Intermediate,,,,1
N,,50597,,,,11450,Kidney,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",CHEMBL625368,10116.0,9498,A,1,Intermediate,,,2113.0,1
N,,50597,,,,11450,Kidney,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",CHEMBL625369,10116.0,9499,A,1,Intermediate,,,2113.0,1
N,,50597,,,,11450,Kidney,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",CHEMBL625370,10116.0,9500,A,1,Intermediate,,,2113.0,1
N,,50597,,,,11450,Kidney,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",CHEMBL625371,10116.0,9501,A,1,Intermediate,,,2113.0,1
N,,50597,,,,11450,Kidney,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",CHEMBL625372,10116.0,9502,A,1,Intermediate,,,2113.0,1
N,,50597,,,,11450,Kidney,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",CHEMBL625373,10116.0,9503,A,1,Intermediate,,,2113.0,1
N,,50597,,,,11450,Liver,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",CHEMBL625374,10116.0,9504,A,1,Intermediate,,,2107.0,1
N,,50597,,,,11450,Liver,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",CHEMBL877593,10116.0,9505,A,1,Intermediate,,,2107.0,1
N,,50597,,,,11450,Liver,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",CHEMBL625375,10116.0,9506,A,1,Intermediate,,,2107.0,1
N,,50597,,,,11450,Liver,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",CHEMBL625376,10116.0,9507,A,1,Intermediate,,,2107.0,1
N,,50597,,,,11450,Liver,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",CHEMBL621973,10116.0,9508,A,1,Intermediate,,,2107.0,1
N,,50597,,,,11450,Liver,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",CHEMBL621974,10116.0,9509,A,1,Intermediate,,,2107.0,1
N,,50597,,,,11450,Lung,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",CHEMBL621975,10116.0,9510,A,1,Intermediate,,,2048.0,1
N,,50597,,,,11450,Lung,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",CHEMBL622166,10116.0,9511,A,1,Intermediate,,,2048.0,1
N,,50597,,,,11450,Lung,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",CHEMBL622167,10116.0,9512,A,1,Intermediate,,,2048.0,1
N,,50597,,,,11450,Lung,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",CHEMBL622168,10116.0,9513,A,1,Intermediate,,,2048.0,1
N,,50597,,,,11450,Lung,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",CHEMBL622169,10116.0,9514,A,1,Intermediate,,,2048.0,1
N,,50597,,,,11450,Lung,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",CHEMBL622170,10116.0,9515,A,1,Intermediate,,,2048.0,1
N,,50597,,,,11450,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",CHEMBL622171,10116.0,9516,A,1,Intermediate,,,2046.0,1
N,,50597,,,,11450,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",CHEMBL622172,10116.0,9517,A,1,Intermediate,,,2046.0,1
N,,50597,,,,11450,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",CHEMBL622173,10116.0,9518,A,1,Intermediate,,,2046.0,1
N,,50597,,,,11450,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",CHEMBL622174,10116.0,9519,A,1,Intermediate,,,2046.0,1
N,,50597,,,,11450,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",CHEMBL622175,10116.0,9520,A,1,Intermediate,,,2046.0,1
N,,50597,,,,11450,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",CHEMBL622176,10116.0,9521,A,1,Intermediate,,,2046.0,1
N,,50597,,,,11450,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",CHEMBL622177,10116.0,9522,A,1,Intermediate,,,2046.0,1
N,,50597,,,,11450,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",CHEMBL622178,10116.0,9523,A,1,Intermediate,,,2046.0,1
N,,50597,,,,11450,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",CHEMBL622179,10116.0,9524,A,1,Intermediate,,,2046.0,1
N,,50597,,,,11450,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",CHEMBL622180,10116.0,9525,A,1,Intermediate,,,2046.0,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL622181,10116.0,9526,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL622182,10116.0,9527,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL622183,10116.0,9528,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL622184,10116.0,9529,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL622185,10116.0,9530,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL622186,10116.0,9531,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL622187,10116.0,9532,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,CHEMBL625002,10116.0,9533,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,CHEMBL622090,10116.0,9534,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL622091,10116.0,9535,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL622092,10116.0,9536,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL622093,10116.0,9537,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL622094,10116.0,9538,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL622095,10116.0,9539,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL622264,10116.0,9540,A,1,Intermediate,,,,1
N,,50597,,,,16434,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL622265,10116.0,9541,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16434,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL622266,10116.0,9542,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16434,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL622267,10116.0,9543,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16434,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL622268,10116.0,9544,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16434,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL622269,10116.0,9545,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16434,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL625071,10116.0,9546,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16434,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL621621,10116.0,9547,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16434,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,CHEMBL621622,10116.0,9548,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16435,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL621623,10116.0,9549,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16435,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL621624,10116.0,9550,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16435,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL621625,10116.0,9551,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16435,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL621626,10116.0,9552,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16435,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL621627,10116.0,9553,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16435,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL621628,10116.0,9554,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16435,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL875328,10116.0,9555,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16435,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL621629,10116.0,9556,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16434,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL621630,10116.0,9557,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16434,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL621631,10116.0,9558,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16434,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL621632,10116.0,9559,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16435,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL621633,10116.0,9560,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16435,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL621634,10116.0,9561,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16435,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL621635,10116.0,9562,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16435,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL621636,10116.0,9563,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16435,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL621637,10116.0,9564,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16435,Spleen,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL621638,10116.0,9565,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL618883,10116.0,9566,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,CHEMBL618884,10116.0,9567,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL628627,10116.0,9568,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL628628,10116.0,9569,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,CHEMBL628629,10116.0,9570,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16365,,Rattus norvegicus,,BAO_0000218,,Half life after administering orally a dose of 3 mg/kg,CHEMBL628630,10116.0,9571,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16365,,Rattus norvegicus,,BAO_0000218,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,CHEMBL628631,10116.0,9572,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16365,,Rattus norvegicus,,BAO_0000218,,Half life after administering intravenously a dose of 1 mg/kg,CHEMBL628632,10116.0,9573,A,1,Intermediate,,,,1
N,,50597,,,In vivo,526,,Rattus norvegicus,,BAO_0000218,,Half life after oral dosing in rats,CHEMBL628633,10116.0,9574,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16365,,Rattus norvegicus,,BAO_0000218,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,CHEMBL628634,10116.0,9575,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4368,,Rattus norvegicus,,BAO_0000218,,Half life by intravenous administration of 3.4 mg/kg in rat,CHEMBL627789,10116.0,9576,A,1,Intermediate,,,,1
N,,50597,,,,3371,,Rattus norvegicus,,BAO_0000218,,Half life in rat,CHEMBL627790,10116.0,9577,A,1,Intermediate,,,,1
N,,50597,,,,6448,,Rattus norvegicus,,BAO_0000218,,Half life in rat,CHEMBL627791,10116.0,9578,A,1,Intermediate,,,,1
N,,50597,,,,6453,,Rattus norvegicus,,BAO_0000218,,Half life in rat,CHEMBL627792,10116.0,9579,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4353,,Rattus norvegicus,,BAO_0000218,,Half life in rat after intravenous administration of the compound,CHEMBL627793,10116.0,9580,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4353,Plasma,Rattus norvegicus,,BAO_0000218,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,CHEMBL627794,10116.0,9581,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4353,,Rattus norvegicus,,BAO_0000218,,Half life in rat after po administration of the compound,CHEMBL627795,10116.0,9582,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4353,,Rattus norvegicus,,BAO_0000218,,Half life in rat after po administration of the compound; ND means Not determined,CHEMBL627796,10116.0,9583,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4353,Plasma,Rattus norvegicus,,BAO_0000218,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,CHEMBL875335,10116.0,9584,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4353,Plasma,Rattus norvegicus,,BAO_0000218,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,CHEMBL627797,10116.0,9585,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5789,,Rattus norvegicus,,BAO_0000218,,Half life in rat i.v.,CHEMBL627798,10116.0,9586,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17686,,Rattus norvegicus,,BAO_0000218,,Half life in rat i.v. at 2 mg/kg concentration,CHEMBL627799,10116.0,9587,A,1,Intermediate,,,,1
N,,50597,,,,6495,,Rattus norvegicus,,BAO_0000218,,Half life in rats,CHEMBL627800,10116.0,9588,A,1,Intermediate,,,,1
N,,50597,,,In vivo,484,,Rattus norvegicus,,BAO_0000218,,Half life in rats after intravenous administration,CHEMBL627801,10116.0,9589,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6467,,Rattus norvegicus,,BAO_0000218,,Half life in rats at the dose of 1.0 mpk by i.v. administration,CHEMBL627802,10116.0,9590,A,1,Intermediate,,,,1
N,,50597,,,,6642,,Rattus norvegicus,,BAO_0000218,,Half life in rat,CHEMBL627803,10116.0,9591,A,1,Expert,,,,1
N,,50597,,,In vivo,16367,,Rattus norvegicus,,BAO_0000218,,Half life was evaluated after intravenous administration to rats,CHEMBL873820,10116.0,9592,A,1,Intermediate,,,,1
N,,50597,,,,1369,,Rattus norvegicus,,BAO_0000218,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),CHEMBL627804,10116.0,9593,A,1,Intermediate,,,,1
N,,50597,,,,5472,,Rattus norvegicus,,BAO_0000218,,Half life was evaluated in rat,CHEMBL627805,10116.0,9594,A,1,Intermediate,,,,1
N,,50597,,,,6049,,Rattus norvegicus,,BAO_0000218,,Half life was evaluated in rat,CHEMBL627806,10116.0,9595,A,1,Intermediate,,,,1
N,,50597,,,,5472,,Rattus norvegicus,,BAO_0000218,,Half life was evaluated in rat; Not tested,CHEMBL627107,10116.0,9596,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16366,,Rattus norvegicus,,BAO_0000218,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,CHEMBL627108,10116.0,9597,A,1,Intermediate,,,,1
N,,50597,,,In vivo,11149,,Rattus norvegicus,,BAO_0000218,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,CHEMBL627109,10116.0,9598,A,1,Intermediate,,,,1
N,,50597,,,In vivo,11149,Blood,Rattus norvegicus,,BAO_0000218,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,CHEMBL627110,10116.0,9599,A,1,Intermediate,,,178.0,1
U,,22224,,,In vivo,2891,,Primates,,BAO_0000218,,Half life was measured in monkey at dose of 10 mg/kg by po administration,CHEMBL627111,9443.0,9600,A,1,Intermediate,,,,0
U,,22224,,,In vivo,2891,,Primates,,BAO_0000218,,Half life was measured in monkey at dose of 10 mg/kg by po administration,CHEMBL627112,9443.0,9601,A,1,Intermediate,,,,0
U,,22224,,,In vivo,2891,,Rattus norvegicus,,BAO_0000218,,Half life was measured in rat at dose of 30 mg/kg by iv administration,CHEMBL627113,10116.0,9602,A,1,Intermediate,,,,0
U,,22224,,,In vivo,2891,,Rattus norvegicus,,BAO_0000218,,Half life was measured in rat at dose of 30 mg/kg by po administration,CHEMBL627114,10116.0,9603,A,1,Intermediate,,,,0
N,,50597,,,,4026,,Rattus norvegicus,,BAO_0000218,,Half life (t1/2) was determined,CHEMBL627115,10116.0,9604,A,1,Intermediate,,,,1
N,,50597,,,,4527,,Rattus norvegicus,,BAO_0000218,,Half life period at a dose of 10 uM/kg in rat was determined,CHEMBL627116,10116.0,9605,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4527,,Rattus norvegicus,,BAO_0000218,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,CHEMBL627117,10116.0,9606,A,1,Intermediate,,,,1
N,,50597,,,,5503,,Rattus norvegicus,,BAO_0000218,,Half life period was determined,CHEMBL627118,10116.0,9607,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4426,,Rattus norvegicus,,BAO_0000218,,Half life period after intravenous administration at 20 mpk in rats,CHEMBL627119,10116.0,9608,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4426,,Rattus norvegicus,,BAO_0000218,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,CHEMBL627120,10116.0,9609,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6109,,Rattus norvegicus,,BAO_0000218,,Half life period after intravenous administration in rat,CHEMBL626922,10116.0,9610,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5654,,Rattus norvegicus,,BAO_0000218,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,CHEMBL626923,10116.0,9611,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5654,,Rattus norvegicus,,BAO_0000218,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,CHEMBL626924,10116.0,9612,A,1,Intermediate,,,,1
N,,50597,,,,4755,Plasma,Rattus norvegicus,,BAO_0000218,,Half life period in 80% rat plasma at 37 degree Centigrade,CHEMBL626925,10116.0,9613,A,1,Intermediate,,,1969.0,1
N,,50597,,,,5862,,Rattus norvegicus,,BAO_0000218,,Half life period in SD rats,CHEMBL626926,10116.0,9614,A,1,Intermediate,,,,1
N,,50597,,,,1515,Plasma,Rattus norvegicus,,BAO_0000218,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),CHEMBL626927,10116.0,9615,A,1,Intermediate,,,1969.0,1
N,,50597,,,,1515,Plasma,Rattus norvegicus,,BAO_0000218,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),CHEMBL626928,10116.0,9616,A,1,Intermediate,,,1969.0,1
N,,50597,,,,1515,Plasma,Rattus norvegicus,,BAO_0000218,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,CHEMBL626929,10116.0,9617,A,1,Intermediate,,,1969.0,1
N,,50597,,,,1515,Plasma,Rattus norvegicus,,BAO_0000218,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,CHEMBL626930,10116.0,9618,A,1,Intermediate,,,1969.0,1
N,,50597,,,,5960,,Rattus norvegicus,,BAO_0000218,,Half life period in rat,CHEMBL626931,10116.0,9619,A,1,Intermediate,,,,1
N,,50597,,,,6103,,Rattus norvegicus,,BAO_0000218,,Half life period in rat,CHEMBL626932,10116.0,9620,A,1,Intermediate,,,,1
N,,50597,,,,6317,,Rattus norvegicus,,BAO_0000218,,Half life period in rat,CHEMBL626933,10116.0,9621,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6644,,Rattus norvegicus,,BAO_0000218,,Half life period in rat after oral administration at 10.5 mg/kg dose,CHEMBL873826,10116.0,9622,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6644,,Rattus norvegicus,,BAO_0000218,,Half life period in rat after oral administration at 11.2 mg/kg dose,CHEMBL626934,10116.0,9623,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6644,,Rattus norvegicus,,BAO_0000218,,Half life period in rat after oral administration at 13 mg/kg dose,CHEMBL626935,10116.0,9624,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6644,,Rattus norvegicus,,BAO_0000218,,Half life period in rat after oral administration at 9.7 mg/kg dose,CHEMBL626936,10116.0,9625,A,1,Intermediate,,,,1
N,,50597,,,,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,CHEMBL626937,10116.0,9626,A,1,Intermediate,,,,1
N,,50597,,,,6295,,Rattus norvegicus,,BAO_0000218,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,CHEMBL625906,10116.0,9627,A,1,Intermediate,,,,1
N,,50597,,,,6296,,Rattus norvegicus,,BAO_0000218,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,CHEMBL625907,10116.0,9628,A,1,Intermediate,,,,1
N,,50597,,,,16427,,Rattus norvegicus,,BAO_0000218,,PK study was carried to determine AUC (area under curve) value in rat,CHEMBL625908,10116.0,9629,A,1,Intermediate,,,,1
N,,50597,,,,16367,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter AUC after intravenous administration to rats,CHEMBL625909,10116.0,9630,A,1,Intermediate,,,,1
N,,50597,,,,16367,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter AUC after oral administration to rats,CHEMBL625910,10116.0,9631,A,1,Intermediate,,,,1
N,,50597,,,,16365,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,CHEMBL625911,10116.0,9632,A,1,Intermediate,,,,1
N,,50597,,,,16365,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,CHEMBL625912,10116.0,9633,A,1,Intermediate,,,,1
N,,50597,,,,16365,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,CHEMBL626538,10116.0,9634,A,1,Intermediate,,,,1
N,,50597,,,,16365,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,CHEMBL876794,10116.0,9635,A,1,Intermediate,,,,1
N,,50597,,,,16365,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,CHEMBL626539,10116.0,9636,A,1,Intermediate,,,,1
N,,50597,,,,16365,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,CHEMBL626540,10116.0,9637,A,1,Intermediate,,,,1
N,,50597,,,,5394,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,CHEMBL626541,10116.0,9638,A,1,Intermediate,,,,1
N,,50597,,,,5394,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,CHEMBL626542,10116.0,9639,A,1,Intermediate,,,,1
N,,50597,,,,2792,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,CHEMBL626543,10116.0,9640,A,1,Intermediate,,,,1
N,,50597,,,,2792,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,CHEMBL626544,10116.0,9641,A,1,Intermediate,,,,1
N,,50597,,,,2792,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,CHEMBL626545,10116.0,9642,A,1,Intermediate,,,,1
N,,50597,,,,2792,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,CHEMBL626546,10116.0,9643,A,1,Intermediate,,,,1
N,,50597,,,,5334,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter area under curve was reported,CHEMBL626547,10116.0,9644,A,1,Intermediate,,,,1
N,,50597,,,,4408,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (AUC) in rat,CHEMBL626548,10116.0,9645,A,1,Intermediate,,,,1
N,,50597,,,,5983,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,CHEMBL626549,10116.0,9646,A,1,Intermediate,,,,1
N,,50597,,,,4397,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,CHEMBL626550,10116.0,9647,A,1,Intermediate,,,,1
N,,50597,,,,4397,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,CHEMBL626551,10116.0,9648,A,1,Intermediate,,,,1
N,,50597,,,,5491,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property was determined,CHEMBL623777,10116.0,9649,A,1,Intermediate,,,,1
N,,50597,,,,5491,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,CHEMBL623778,10116.0,9650,A,1,Intermediate,,,,1
N,,50597,,,,5491,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,CHEMBL623779,10116.0,9651,A,1,Intermediate,,,,1
N,,50597,,,,4199,Plasma,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,CHEMBL623780,10116.0,9652,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4199,Plasma,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,CHEMBL622015,10116.0,9653,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4199,Plasma,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,CHEMBL622016,10116.0,9654,A,1,Intermediate,,,1969.0,1
N,,50597,,,,5173,,Rattus norvegicus,,BAO_0000218,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",CHEMBL622017,10116.0,9655,A,1,Intermediate,,,,1
N,,50597,,,,5173,,Rattus norvegicus,,BAO_0000218,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",CHEMBL622018,10116.0,9656,A,1,Intermediate,,,,1
N,,50597,,,,5173,,Rattus norvegicus,,BAO_0000218,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",CHEMBL622019,10116.0,9657,A,1,Intermediate,,,,1
N,,50597,,,,5173,,Rattus norvegicus,,BAO_0000218,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",CHEMBL622020,10116.0,9658,A,1,Intermediate,,,,1
N,,50597,,,,16366,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,CHEMBL622021,10116.0,9659,A,1,Intermediate,,,,1
N,,50597,,,,16366,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,CHEMBL622022,10116.0,9660,A,1,Intermediate,,,,1
N,,50597,,,,5327,,Rattus norvegicus,,BAO_0000218,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,CHEMBL622023,10116.0,9661,A,1,Intermediate,,,,1
N,,50597,,,,6681,,Rattus norvegicus,,BAO_0000218,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,CHEMBL622024,10116.0,9662,A,1,Intermediate,,,,1
N,,50597,,,,12873,,Rattus norvegicus,,BAO_0000218,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),CHEMBL622693,10116.0,9663,A,1,Intermediate,,,,1
N,,50597,,,,12873,,Rattus norvegicus,,BAO_0000218,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),CHEMBL622694,10116.0,9664,A,1,Intermediate,,,,1
N,,50597,,,,6685,,Rattus norvegicus,,BAO_0000218,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",CHEMBL622695,10116.0,9665,A,1,Intermediate,,,,1
N,,50597,,,,6685,,Rattus norvegicus,,BAO_0000218,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",CHEMBL622696,10116.0,9666,A,1,Intermediate,,,,1
N,,50597,,,,6685,,Rattus norvegicus,,BAO_0000218,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",CHEMBL622697,10116.0,9667,A,1,Intermediate,,,,1
N,,50597,,,,6619,,Rattus norvegicus,,BAO_0000218,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",CHEMBL622874,10116.0,9668,A,1,Intermediate,,,,1
N,,50597,,,,6619,,Rattus norvegicus,,BAO_0000218,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",CHEMBL622875,10116.0,9669,A,1,Intermediate,,,,1
N,,50597,,,,10363,,Rattus norvegicus,,BAO_0000218,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,CHEMBL622876,10116.0,9670,A,1,Intermediate,,,,1
N,,50597,,,,4796,,Rattus norvegicus,,BAO_0000218,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,CHEMBL622877,10116.0,9671,A,1,Intermediate,,,,1
N,,50597,,,,4910,,Rattus norvegicus,,BAO_0000218,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,CHEMBL622878,10116.0,9672,A,1,Intermediate,,,,1
N,,50597,,,,4910,Plasma,Rattus norvegicus,,BAO_0000218,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,CHEMBL622879,10116.0,9673,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4839,,Rattus norvegicus,,BAO_0000218,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,CHEMBL877602,10116.0,9674,A,1,Intermediate,,,,1
N,,50597,,,,15078,,Rattus norvegicus,,BAO_0000218,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL622880,10116.0,9675,A,1,Intermediate,,,,1
N,,50597,,,,15078,,Rattus norvegicus,,BAO_0000218,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",CHEMBL622881,10116.0,9676,A,1,Intermediate,,,,1
N,,50597,,,,15078,,Rattus norvegicus,,BAO_0000218,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL622882,10116.0,9677,A,1,Intermediate,,,,1
N,,50597,,,,15078,,Rattus norvegicus,,BAO_0000218,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",CHEMBL622883,10116.0,9678,A,1,Intermediate,,,,1
N,,50597,,,,11450,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",CHEMBL622884,10116.0,9679,A,1,Intermediate,,,2046.0,1
N,,50597,,,,11450,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",CHEMBL622885,10116.0,9680,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8151,,Rattus norvegicus,,BAO_0000218,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,CHEMBL622886,10116.0,9681,A,1,Intermediate,,,,1
N,,50597,,,,8151,,Rattus norvegicus,,BAO_0000218,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,CHEMBL622887,10116.0,9682,A,1,Intermediate,,,,1
N,,50597,,,,8151,Urine,Rattus norvegicus,,BAO_0000218,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,CHEMBL622888,10116.0,9683,A,1,Intermediate,,,1088.0,1
N,,50597,,,In vivo,8677,Blood,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622889,10116.0,9684,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,8677,Blood,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622890,10116.0,9685,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,8677,Blood,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622891,10116.0,9686,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,8677,Blood,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL877603,10116.0,9687,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,8677,Brain,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622892,10116.0,9688,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,8677,Brain,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622893,10116.0,9689,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,8677,Brain,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622894,10116.0,9690,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,8677,Brain,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622895,10116.0,9691,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,8677,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,CHEMBL622896,10116.0,9692,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,8677,Heart,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622897,10116.0,9693,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,8677,Heart,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622898,10116.0,9694,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,8677,Heart,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622899,10116.0,9695,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,8677,Kidney,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622900,10116.0,9696,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,8677,Kidney,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624114,10116.0,9697,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,8677,Kidney,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL624115,10116.0,9698,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,8677,Kidney,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624116,10116.0,9699,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,8677,Liver,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL624117,10116.0,9700,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,8677,Liver,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624118,10116.0,9701,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,8677,Liver,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL624119,10116.0,9702,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,8677,Liver,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624120,10116.0,9703,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,8677,Lung,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL624121,10116.0,9704,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,8677,Lung,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624122,10116.0,9705,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,8677,Lung,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL624123,10116.0,9706,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,8677,Lung,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624124,10116.0,9707,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,8677,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL624125,10116.0,9708,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,8677,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624126,10116.0,9709,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,8677,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL624127,10116.0,9710,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,8677,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624128,10116.0,9711,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,8677,Zone of skin,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL624129,10116.0,9712,A,1,Intermediate,,,14.0,1
N,,50597,,,In vivo,8677,Zone of skin,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL624130,10116.0,9713,A,1,Intermediate,,,14.0,1
N,,50597,,,In vivo,8677,Zone of skin,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622340,10116.0,9714,A,1,Intermediate,,,14.0,1
N,,50597,,,In vivo,8677,Zone of skin,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622341,10116.0,9715,A,1,Intermediate,,,14.0,1
N,,50597,,,In vivo,8677,Intestine,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622342,10116.0,9716,A,1,Intermediate,,,160.0,1
N,,50597,,,In vivo,8677,Intestine,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622343,10116.0,9717,A,1,Intermediate,,,160.0,1
N,,50597,,,In vivo,8677,Intestine,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622344,10116.0,9718,A,1,Intermediate,,,160.0,1
N,,50597,,,In vivo,8677,Intestine,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622345,10116.0,9719,A,1,Intermediate,,,160.0,1
N,,50597,,,In vivo,8677,Spleen,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622346,10116.0,9720,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,8677,Spleen,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622347,10116.0,9721,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,8677,Spleen,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622348,10116.0,9722,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,8677,Spleen,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622349,10116.0,9723,A,1,Intermediate,,,2106.0,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,CHEMBL622350,10116.0,9724,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,CHEMBL622351,10116.0,9725,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,CHEMBL622352,10116.0,9726,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,CHEMBL622353,10116.0,9727,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,CHEMBL622354,10116.0,9728,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,CHEMBL622355,10116.0,9729,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,CHEMBL622356,10116.0,9730,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,CHEMBL622357,10116.0,9731,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,CHEMBL622358,10116.0,9732,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,CHEMBL622359,10116.0,9733,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,CHEMBL874393,10116.0,9734,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL622872,10116.0,9735,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL622873,10116.0,9736,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL623047,10116.0,9737,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL623048,10116.0,9738,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL623049,10116.0,9739,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL623050,10116.0,9740,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL623051,10116.0,9741,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL623052,10116.0,9742,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL626343,10116.0,9743,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,CHEMBL626344,10116.0,9744,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,CHEMBL626345,10116.0,9745,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,CHEMBL626346,10116.0,9746,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,CHEMBL626347,10116.0,9747,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,CHEMBL626348,10116.0,9748,A,1,Intermediate,,,,1
N,,50597,,,,16434,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,CHEMBL626349,10116.0,9749,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,CHEMBL626350,10116.0,9750,F,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,CHEMBL626351,10116.0,9751,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,CHEMBL627650,10116.0,9752,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,CHEMBL627651,10116.0,9753,F,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,CHEMBL627652,10116.0,9754,A,1,Intermediate,,,,1
N,,50597,,,,16435,,Rattus norvegicus,,BAO_0000218,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,CHEMBL627653,10116.0,9755,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,CHEMBL627654,10116.0,9756,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,CHEMBL627835,10116.0,9757,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,CHEMBL627836,10116.0,9758,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,CHEMBL627837,10116.0,9759,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,CHEMBL627838,10116.0,9760,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,CHEMBL875338,10116.0,9761,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,CHEMBL627839,10116.0,9762,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,CHEMBL627840,10116.0,9763,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,CHEMBL627841,10116.0,9764,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,CHEMBL627842,10116.0,9765,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,CHEMBL627843,10116.0,9766,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,CHEMBL627844,10116.0,9767,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,CHEMBL627845,10116.0,9768,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5874,,Rattus norvegicus,,BAO_0000218,,Half life period in rat by iv administration at a dose of 3 mg/kg,CHEMBL627846,10116.0,9769,A,1,Intermediate,,,,1
N,,50597,,,,1515,Plasma,Rattus norvegicus,,BAO_0000218,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),CHEMBL627847,10116.0,9770,A,1,Intermediate,,,1969.0,1
N,,50597,,,,1515,Plasma,Rattus norvegicus,,BAO_0000218,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),CHEMBL873821,10116.0,9771,A,1,Intermediate,,,1969.0,1
N,,50597,,,,1515,Plasma,Rattus norvegicus,,BAO_0000218,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,CHEMBL626079,10116.0,9772,A,1,Intermediate,,,1969.0,1
N,,50597,,,,1515,Plasma,Rattus norvegicus,,BAO_0000218,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,CHEMBL626080,10116.0,9773,A,1,Intermediate,,,1969.0,1
N,,50597,,,,5491,Plasma,Rattus norvegicus,,BAO_0000218,,Half life period was evaluated in rat plasma,CHEMBL626081,10116.0,9774,A,1,Intermediate,,,1969.0,1
N,,50597,,,,5491,Plasma,Rattus norvegicus,,BAO_0000218,,Half life period was evaluated in rat plasma; Not tested,CHEMBL875344,10116.0,9775,A,1,Intermediate,,,1969.0,1
N,,50597,,,,1918,,Rattus norvegicus,,BAO_0000218,,Half life period was evaluated in rats,CHEMBL626082,10116.0,9776,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1918,,Rattus norvegicus,,BAO_0000218,,"Half life period was evaluated in rats, iv",CHEMBL626250,10116.0,9777,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6113,,Rattus norvegicus,,BAO_0000218,,Half life period after intravenous administration at 5 mg/kg in rat,CHEMBL626251,10116.0,9778,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5546,,Rattus norvegicus,,BAO_0000218,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,CHEMBL626252,10116.0,9779,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5553,,Rattus norvegicus,,BAO_0000218,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,CHEMBL626253,10116.0,9780,A,1,Intermediate,,,,1
N,,50597,,,,4188,Plasma,Rattus norvegicus,,BAO_0000218,,Half life stability of compound was evaluated in rat plasma,CHEMBL626254,10116.0,9781,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6215,,Rattus norvegicus,,BAO_0000218,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,CHEMBL626255,10116.0,9782,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6141,,Rattus norvegicus,,BAO_0000218,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,CHEMBL626256,10116.0,9783,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5182,,Rattus norvegicus,,BAO_0000218,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,CHEMBL626257,10116.0,9784,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5182,,Rattus norvegicus,,BAO_0000218,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,CHEMBL626258,10116.0,9785,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5710,,Rattus norvegicus,,BAO_0000218,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,CHEMBL626259,10116.0,9786,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5789,,Rattus norvegicus,,BAO_0000218,,Half in rat i.v.,CHEMBL626260,10116.0,9787,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6011,,Rattus norvegicus,,BAO_0000218,,Half period in rat after intravenous administration,CHEMBL875345,10116.0,9788,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17594,,Rattus norvegicus,,BAO_0000218,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,CHEMBL626261,10116.0,9789,A,1,Intermediate,,,,1
N,,50597,,,In vitro,12357,Liver,Rattus norvegicus,,BAO_0000218,,Half-life measured in in vitro Cathepsin B assay in rat liver,CHEMBL626262,10116.0,9790,A,1,Intermediate,,,2107.0,1
N,,50597,,,,5210,,Rattus norvegicus,,BAO_0000218,,Half-life of compound was determined in rats,CHEMBL626263,10116.0,9791,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17596,,Rattus norvegicus,,BAO_0000218,,Half-life at 10 mg/kg in rat upon intravenous administration,CHEMBL625270,10116.0,9792,A,1,Intermediate,,,,1
N,,50597,,,,6672,,Rattus norvegicus,,BAO_0000218,,Half-life determined in rat,CHEMBL625271,10116.0,9793,A,1,Intermediate,,,,1
N,,50597,,,,6673,,Rattus norvegicus,,BAO_0000218,,Half-life determined in rat,CHEMBL625272,10116.0,9794,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4910,Brain,Rattus norvegicus,,BAO_0000218,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,CHEMBL625273,10116.0,9795,A,1,Intermediate,,,955.0,1
N,,50597,,,,3741,Plasma,Rattus norvegicus,,BAO_0000218,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",CHEMBL625274,10116.0,9796,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17671,,Rattus norvegicus,,BAO_0000218,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,CHEMBL625275,10116.0,9797,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4910,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,CHEMBL625276,10116.0,9798,A,1,Intermediate,,,1969.0,1
N,,50597,,,,17537,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life in rat plasma,CHEMBL625277,10116.0,9799,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4965,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life in rat plasma was determined,CHEMBL625278,10116.0,9800,A,1,Intermediate,,,1969.0,1
N,,50597,,,,17537,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life in rat plasma; Not tested,CHEMBL625279,10116.0,9801,A,1,Intermediate,,,1969.0,1
N,,50597,,,,6124,Serum,Rattus norvegicus,,BAO_0000218,,Half-life in rat serum,CHEMBL625280,10116.0,9802,A,1,Intermediate,,,1977.0,1
N,,50597,,,,6124,Serum,Rattus norvegicus,,BAO_0000218,,Half-life in rat serum; na is not available,CHEMBL876797,10116.0,9803,A,1,Intermediate,,,1977.0,1
N,,50597,,,,6078,,Rattus norvegicus,,BAO_0000218,,Half-life was calculated in rat,CHEMBL625281,10116.0,9804,A,1,Intermediate,,,,1
N,,50597,,,,17668,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life was calculated in rat plasma,CHEMBL873827,10116.0,9805,A,1,Intermediate,,,1969.0,1
N,,50597,,,,3185,,Rattus norvegicus,,BAO_0000218,,Half-life was determined,CHEMBL625282,10116.0,9806,A,1,Intermediate,,,,1
N,,50597,,,,4883,,Rattus norvegicus,,BAO_0000218,,Half-life was determined,CHEMBL625283,10116.0,9807,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2959,,Rattus norvegicus,,BAO_0000218,,Half-life after administration of 20 mg/Kg oral dose in rat,CHEMBL625284,10116.0,9808,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4029,,Rattus norvegicus,,BAO_0000218,,Half-life after administration of 3.2 mg/kg intravenously in male rat,CHEMBL625285,10116.0,9809,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4029,,Rattus norvegicus,,BAO_0000218,,Half-life after intravenous administration in female rat,CHEMBL625286,10116.0,9810,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4029,,Rattus norvegicus,,BAO_0000218,,Half-life after intravenous administration in male rat,CHEMBL625287,10116.0,9811,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6180,,Rattus norvegicus,,BAO_0000218,,Half-life after intravenous dose in rat,CHEMBL625288,10116.0,9812,A,1,Intermediate,,,,1
N,,50597,,,,1557,Liver,Rattus norvegicus,,BAO_0000218,,Half-life in a rat liver homogenate preparation,CHEMBL625289,10116.0,9813,A,1,Intermediate,,,2107.0,1
N,,50597,,,,12500,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life in plasma of rat,CHEMBL625290,10116.0,9814,A,1,Intermediate,,,1969.0,1
N,,50597,,,,12500,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life in plasma of rat at dose of 3-10 mgkg,CHEMBL876798,10116.0,9815,A,1,Intermediate,,,1969.0,1
N,,50597,,,,5064,,Rattus norvegicus,,BAO_0000218,,Half-life in rat,CHEMBL625291,10116.0,9816,A,1,Intermediate,,,,1
N,,50597,,,,5145,,Rattus norvegicus,,BAO_0000218,,Half-life in rat,CHEMBL625292,10116.0,9817,A,1,Intermediate,,,,1
N,,50597,,,,5147,,Rattus norvegicus,,BAO_0000218,,Half-life in rat,CHEMBL625293,10116.0,9818,A,1,Intermediate,,,,1
N,,50597,,,,5833,,Rattus norvegicus,,BAO_0000218,,Half-life in rat,CHEMBL622832,10116.0,9819,A,1,Intermediate,,,,1
N,,50597,,,,6596,,Rattus norvegicus,,BAO_0000218,,Half-life in rat,CHEMBL622833,10116.0,9820,A,1,Intermediate,,,,1
N,,50597,,,,17655,,Rattus norvegicus,,BAO_0000218,,Half-life in rat,CHEMBL622834,10116.0,9821,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6495,,Rattus norvegicus,,BAO_0000218,,Half-life in rat after oral administration at 10 mg/kg,CHEMBL622835,10116.0,9822,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17538,,Rattus norvegicus,,BAO_0000218,,Half-life in rat after po administration at a dose of 10 mg/kg,CHEMBL622836,10116.0,9823,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17538,,Rattus norvegicus,,BAO_0000218,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,CHEMBL622837,10116.0,9824,A,1,Intermediate,,,,1
N,,50597,,,In vivo,10,,Rattus norvegicus,,BAO_0000218,,Half-life in rat at 3 mg/kg dose administered intravenously,CHEMBL622838,10116.0,9825,A,1,Intermediate,,,,1
N,,50597,,,,17669,Brain,Rattus norvegicus,,BAO_0000218,,Half-life in rat brain homogenate,CHEMBL622839,10116.0,9826,A,1,Intermediate,,,955.0,1
N,,50597,,,,17065,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life in rat plasma,CHEMBL622840,10116.0,9827,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4333,,Rattus norvegicus,,BAO_0000218,,Half-life in rats,CHEMBL622841,10116.0,9828,A,1,Intermediate,,,,1
N,,50597,,,,6827,,Rattus norvegicus,,BAO_0000218,,Half-life in Dawley rats,CHEMBL622842,10116.0,9829,A,1,Intermediate,,,,1
N,,50597,,,In vitro,889,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life in vitro in rat plasma,CHEMBL622843,10116.0,9830,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vitro,889,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,CHEMBL622844,10116.0,9831,A,1,Intermediate,,,1969.0,1
N,,50597,,,,3747,,Rattus norvegicus,,BAO_0000218,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",CHEMBL622845,10116.0,9832,A,1,Intermediate,,,,1
N,,50597,,,,15022,,Rattus norvegicus,,BAO_0000218,,The area under the curve of compound was measured at the dose of 100 umol/kg,CHEMBL622846,10116.0,9833,A,1,Intermediate,,,,1
N,,50597,,,,15022,,Rattus norvegicus,,BAO_0000218,,The area under the curve of compound was measured at the dose of 300 umol/kg,CHEMBL622847,10116.0,9834,A,1,Intermediate,,,,1
N,,50597,,,,15022,,Rattus norvegicus,,BAO_0000218,,The area under the curve of compound was measured at the dose of 30 umol/kg,CHEMBL622848,10116.0,9835,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3360,,Rattus norvegicus,,BAO_0000218,,Bioavailability as oral AUC in rats,CHEMBL622849,10116.0,9836,A,1,Intermediate,,,,1
N,,50597,,,,5334,Plasma,Rattus norvegicus,,BAO_0000218,,The plasma concentration versus time curve (AUC) was determined,CHEMBL622850,10116.0,9837,A,1,Intermediate,,,1969.0,1
N,,50597,,,,17411,,Rattus norvegicus,,BAO_0000218,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL876807,10116.0,9838,A,1,Intermediate,,,,1
N,,50597,,,,17411,,Rattus norvegicus,,BAO_0000218,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL622851,10116.0,9839,A,1,Intermediate,,,,1
N,,50597,,,,17411,,Rattus norvegicus,,BAO_0000218,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL622852,10116.0,9840,A,1,Intermediate,,,,1
N,,50597,,,,6570,,Rattus norvegicus,,BAO_0000218,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,CHEMBL622853,10116.0,9841,A,1,Intermediate,,,,1
N,,50597,,,,6570,,Rattus norvegicus,,BAO_0000218,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,CHEMBL622854,10116.0,9842,A,1,Intermediate,,,,1
N,,50597,,,,17411,,Rattus norvegicus,,BAO_0000218,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,CHEMBL622855,10116.0,9843,A,1,Intermediate,,,,1
N,,50597,,,,14941,Plasma,Rattus norvegicus,,BAO_0000218,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",CHEMBL622856,10116.0,9844,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14941,Plasma,Rattus norvegicus,,BAO_0000218,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",CHEMBL622857,10116.0,9845,A,1,Intermediate,,,1969.0,1
N,,50597,,,,17538,Plasma,Rattus norvegicus,,BAO_0000218,,AUC in rat after po administration at a dose of 10 mg/kg,CHEMBL622858,10116.0,9846,A,1,Intermediate,,,1969.0,1
N,,50597,,,,17752,Plasma,Rattus norvegicus,,BAO_0000218,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,CHEMBL622859,10116.0,9847,A,1,Intermediate,,,1969.0,1
N,,50597,,,,17509,,Rattus norvegicus,,BAO_0000218,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,CHEMBL622860,10116.0,9848,A,1,Intermediate,,,,1
N,,50597,,,,17509,,Rattus norvegicus,,BAO_0000218,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,CHEMBL622861,10116.0,9849,A,1,Intermediate,,,,1
N,,50597,,,,17509,,Rattus norvegicus,,BAO_0000218,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,CHEMBL622862,10116.0,9850,A,1,Intermediate,,,,1
N,,50597,,,,17509,,Rattus norvegicus,,BAO_0000218,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,CHEMBL622863,10116.0,9851,A,1,Intermediate,,,,1
N,,50597,,,,17509,,Rattus norvegicus,,BAO_0000218,,Area under curve value 6 hr after po administration in rat,CHEMBL623817,10116.0,9852,A,1,Intermediate,,,,1
N,,50597,,,,17717,,Rattus norvegicus,,BAO_0000218,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,CHEMBL623818,10116.0,9853,A,1,Intermediate,,,,1
N,,50597,,,,17717,,Rattus norvegicus,,BAO_0000218,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",CHEMBL623819,10116.0,9854,A,1,Intermediate,,,,1
N,,50597,,,,17717,,Rattus norvegicus,,BAO_0000218,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,CHEMBL623820,10116.0,9855,A,1,Intermediate,,,,1
N,,50597,,,,17717,,Rattus norvegicus,,BAO_0000218,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,CHEMBL623821,10116.0,9856,A,1,Intermediate,,,,1
N,,50597,,,,6642,Plasma,Rattus norvegicus,,BAO_0000218,,AUC normalized for dose (AUCN) in rat,CHEMBL623822,10116.0,9857,A,1,Intermediate,,,1969.0,1
N,,50597,,,,6640,,Rattus norvegicus,,BAO_0000218,,Area under curve in rat after p.o. administration,CHEMBL623823,10116.0,9858,A,1,Intermediate,,,,1
N,,50597,,,,6641,,Rattus norvegicus,,BAO_0000218,,Area under curve in rat after p.o. administration,CHEMBL623824,10116.0,9859,A,1,Intermediate,,,,1
N,,50597,,,,6641,,Rattus norvegicus,,BAO_0000218,,Area under curve in rat after p.o. administration; Not determined,CHEMBL623825,10116.0,9860,A,1,Intermediate,,,,1
N,,50597,,,,6641,,Rattus norvegicus,,BAO_0000218,,Area under curve in rat after peroral administration,CHEMBL622070,10116.0,9861,A,1,Intermediate,,,,1
N,,50597,,,,3603,,Rattus norvegicus,,BAO_0000218,,Area under curve (carotid artery) value of the compound,CHEMBL622071,10116.0,9862,A,1,Intermediate,,,,1
N,,50597,,,,3550,,Rattus norvegicus,,BAO_0000218,,Bioavailability expressed as the area under curve of rat carotid artery,CHEMBL622072,10116.0,9863,A,1,Intermediate,,,,1
N,,50597,,,,15662,,Rattus norvegicus,,BAO_0000218,,Area under curve in male SD rats was observed after intravenous administration in rat,CHEMBL622073,10116.0,9864,A,1,Intermediate,,,,1
N,,50597,,,,17720,,Rattus norvegicus,,BAO_0000218,,Area under curve of the compound was determined,CHEMBL622074,10116.0,9865,A,1,Intermediate,,,,1
N,,50597,,,,5407,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,CHEMBL622075,10116.0,9866,A,1,Intermediate,,,,1
N,,50597,,,,17752,Plasma,Rattus norvegicus,,BAO_0000218,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,CHEMBL622076,10116.0,9867,A,1,Intermediate,,,1969.0,1
N,,50597,,,,17752,Plasma,Rattus norvegicus,,BAO_0000218,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,CHEMBL622077,10116.0,9868,A,1,Intermediate,,,1969.0,1
N,,50597,,,,3603,,Rattus norvegicus,,BAO_0000218,,Area under curve (portal vein) value of the compound,CHEMBL622078,10116.0,9869,A,1,Intermediate,,,,1
N,,50597,,,,3550,,Rattus norvegicus,,BAO_0000218,,Bioavailability expressed as the area under curve of rat portal vein,CHEMBL622079,10116.0,9870,A,1,Intermediate,,,,1
N,,50597,,,,17655,Plasma,Rattus norvegicus,,BAO_0000218,,Area Under plasma concentration time curve in rat upon peroral administration,CHEMBL622080,10116.0,9871,A,1,Intermediate,,,1969.0,1
N,,50597,,,,17582,,Rattus norvegicus,,BAO_0000218,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,CHEMBL877612,10116.0,9872,A,1,Intermediate,,,,1
N,,50597,,,,17582,,Rattus norvegicus,,BAO_0000218,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,CHEMBL622081,10116.0,9873,A,1,Intermediate,,,,1
N,,50597,,,,17791,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for oral bioavailability in rats,CHEMBL622082,10116.0,9874,A,1,Intermediate,,,,1
N,,50597,,,,17791,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for oral bioavailability in rats after iv administration,CHEMBL622083,10116.0,9875,A,1,Intermediate,,,,1
N,,50597,,,,17791,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for oral bioavailability in rats; 30-80,CHEMBL622084,10116.0,9876,A,1,Intermediate,,,,1
N,,50597,,,,17791,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for oral bioavailability in rats; 50-60,CHEMBL622085,10116.0,9877,A,1,Intermediate,,,,1
N,,50597,,,,17791,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for oral bioavailability in rats; no data,CHEMBL622086,10116.0,9878,A,1,Intermediate,,,,1
N,,50597,,,,17791,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for oral bioavailability in rats; peptide,CHEMBL622087,10116.0,9879,A,1,Intermediate,,,,1
N,,50597,,,,7768,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",CHEMBL622088,10116.0,9880,A,1,Intermediate,,,178.0,1
N,,50597,,,,7768,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",CHEMBL622089,10116.0,9881,A,1,Intermediate,,,178.0,1
N,,50597,,,,7768,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",CHEMBL623685,10116.0,9882,A,1,Intermediate,,,178.0,1
N,,50597,,,,7768,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",CHEMBL623686,10116.0,9883,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,8677,Stomach,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL623687,10116.0,9884,A,1,Intermediate,,,945.0,1
N,,50597,,,In vivo,8677,Stomach,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL623688,10116.0,9885,A,1,Intermediate,,,945.0,1
N,,50597,,,In vivo,8677,Stomach,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL623689,10116.0,9886,A,1,Intermediate,,,945.0,1
N,,50597,,,In vivo,8677,Stomach,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622485,10116.0,9887,A,1,Intermediate,,,945.0,1
N,,50597,,,In vivo,8677,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622486,10116.0,9888,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,8677,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL877613,10116.0,9889,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,8677,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622487,10116.0,9890,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,8677,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622488,10116.0,9891,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,8677,Heart,Rattus norvegicus,,BAO_0000218,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",CHEMBL622489,10116.0,9892,A,1,Intermediate,,,948.0,1
N,,50597,,,,6899,Urine,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,CHEMBL622490,10116.0,9893,A,1,Intermediate,,,1088.0,1
N,,50597,,,,6899,Urine,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,CHEMBL622491,10116.0,9894,A,1,Intermediate,,,1088.0,1
N,,50597,,,,6899,Liver,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,CHEMBL622492,10116.0,9895,A,1,Intermediate,,,2107.0,1
N,,50597,,,,6899,Urine,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,CHEMBL622493,10116.0,9896,A,1,Intermediate,,,1088.0,1
N,,50597,,,,6899,Urine,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,CHEMBL622494,10116.0,9897,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8677,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",CHEMBL622495,10116.0,9898,A,1,Intermediate,,,2385.0,1
N,,50597,,,,6899,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,CHEMBL622496,10116.0,9899,A,1,Intermediate,,,,1
N,,50597,,,,6899,Urine,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,CHEMBL622497,10116.0,9900,A,1,Intermediate,,,1088.0,1
N,,50597,,,,2189,,Rattus norvegicus,,BAO_0000218,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,CHEMBL622498,10116.0,9901,A,1,Intermediate,,,,1
N,,50597,,,,2189,Urine,Rattus norvegicus,,BAO_0000218,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,CHEMBL624918,10116.0,9902,A,1,Intermediate,,,1088.0,1
N,,50597,,,,2189,Urine,Rattus norvegicus,,BAO_0000218,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,CHEMBL624919,10116.0,9903,A,1,Intermediate,,,1088.0,1
N,,50597,,,In vivo,10839,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of compound in rat blood after 5 min of administration,CHEMBL624920,10116.0,9904,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,10839,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of compound in rat blood after 5 min of administration.,CHEMBL624921,10116.0,9905,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,10839,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of compound in rat brain after 5 min of administration,CHEMBL624922,10116.0,9906,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,10839,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of compound in rat heart after 5 min of administration,CHEMBL624923,10116.0,9907,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,10839,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of compound in rat heart after 5 min of administration.,CHEMBL624924,10116.0,9908,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,10839,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of compound in rat kidney after 5 min of administration,CHEMBL624925,10116.0,9909,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,10839,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of compound in rat kidney after 5 min of administration.,CHEMBL624926,10116.0,9910,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,10839,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of compound in rat liver after 5 min of administration,CHEMBL624927,10116.0,9911,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,10839,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of compound in rat liver after 5 min of administration.,CHEMBL874402,10116.0,9912,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,10839,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of compound in rat lung after 5 min of administration,CHEMBL624928,10116.0,9913,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,10839,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of compound in rat lung after 5 min of administration.,CHEMBL624929,10116.0,9914,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,10839,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of compound in rat muscle after 5 min of administration,CHEMBL624930,10116.0,9915,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,10839,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of compound in rat muscle after 5 min of administration.,CHEMBL624931,10116.0,9916,A,1,Intermediate,,,2385.0,1
N,,50597,,,,4043,Heart,Rattus norvegicus,,BAO_0000218,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624932,10116.0,9917,A,1,Intermediate,,,948.0,1
N,,50597,,,,4043,Heart,Rattus norvegicus,,BAO_0000218,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624933,10116.0,9918,A,1,Intermediate,,,948.0,1
N,,50597,,,,4043,Liver,Rattus norvegicus,,BAO_0000218,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624934,10116.0,9919,A,1,Intermediate,,,2107.0,1
N,,50597,,,,4043,Liver,Rattus norvegicus,,BAO_0000218,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624935,10116.0,9920,A,1,Intermediate,,,2107.0,1
N,,50597,,,,4043,,Rattus norvegicus,,BAO_0000218,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624936,10116.0,9921,A,1,Intermediate,,,,1
N,,50597,,,,4043,,Rattus norvegicus,,BAO_0000218,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624937,10116.0,9922,A,1,Intermediate,,,,1
N,,50597,,,,4043,Spleen,Rattus norvegicus,,BAO_0000218,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624938,10116.0,9923,A,1,Intermediate,,,2106.0,1
N,,50597,,,,4043,Spleen,Rattus norvegicus,,BAO_0000218,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624939,10116.0,9924,A,1,Intermediate,,,2106.0,1
N,,50597,,,,4043,,Rattus norvegicus,,BAO_0000218,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL624940,10116.0,9925,A,1,Intermediate,,,,1
N,,50597,,,,4043,,Rattus norvegicus,,BAO_0000218,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,CHEMBL874403,10116.0,9926,A,1,Intermediate,,,,1
N,,50597,,,,1446,,Rattus norvegicus,,BAO_0000218,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,CHEMBL624941,10116.0,9927,A,1,Intermediate,,,,1
N,,50597,,,,9971,Urine,Rattus norvegicus,,BAO_0000218,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,CHEMBL624942,10116.0,9928,A,1,Intermediate,,,1088.0,1
N,,50597,,,,9971,Urine,Rattus norvegicus,,BAO_0000218,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,CHEMBL624943,10116.0,9929,A,1,Intermediate,,,1088.0,1
N,,50597,,,In vivo,5765,,Rattus norvegicus,,BAO_0000218,,% Bioavailability after 1 day of the drug administration in rats,CHEMBL624944,10116.0,9930,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5765,,Rattus norvegicus,,BAO_0000218,,% Bioavailability after 4 day of the drug administration in rats,CHEMBL624945,10116.0,9931,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4257,,Rattus norvegicus,,BAO_0000218,,Absolute bioavailability was evaluated in rat,CHEMBL624946,10116.0,9932,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,CHEMBL624947,10116.0,9933,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,CHEMBL624948,10116.0,9934,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,CHEMBL624949,10116.0,9935,A,1,Intermediate,,,,1
N,,50597,,,,13091,Kidney,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,CHEMBL622025,10116.0,9936,A,1,Intermediate,,,2113.0,1
N,,50597,,,,13091,Kidney,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,CHEMBL622026,10116.0,9937,A,1,Intermediate,,,2113.0,1
N,,50597,,,,13091,Kidney,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,CHEMBL622027,10116.0,9938,A,1,Intermediate,,,2113.0,1
N,,50597,,,,13091,Kidney,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,CHEMBL622028,10116.0,9939,A,1,Intermediate,,,2113.0,1
N,,50597,,,,13091,Liver,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,CHEMBL622029,10116.0,9940,A,1,Intermediate,,,2107.0,1
N,,50597,,,,13091,Liver,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,CHEMBL622208,10116.0,9941,A,1,Intermediate,,,2107.0,1
N,,50597,,,,13091,Liver,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,CHEMBL622209,10116.0,9942,A,1,Intermediate,,,2107.0,1
N,,50597,,,,13091,Liver,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,CHEMBL622210,10116.0,9943,A,1,Intermediate,,,2107.0,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,CHEMBL622211,10116.0,9944,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,CHEMBL622212,10116.0,9945,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,CHEMBL622213,10116.0,9946,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,CHEMBL874404,10116.0,9947,A,1,Intermediate,,,,1
N,,50597,,,,13091,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,CHEMBL620452,10116.0,9948,A,1,Intermediate,,,2385.0,1
N,,50597,,,,13091,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,CHEMBL620453,10116.0,9949,A,1,Intermediate,,,2385.0,1
N,,50597,,,,13091,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,CHEMBL620454,10116.0,9950,A,1,Intermediate,,,2385.0,1
N,,50597,,,,13091,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,CHEMBL624067,10116.0,9951,A,1,Intermediate,,,2385.0,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,CHEMBL624068,10116.0,9952,A,1,Intermediate,,,,1
N,,50597,,,,13091,Female gonad,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,CHEMBL624069,10116.0,9953,A,1,Intermediate,,,992.0,1
N,,50597,,,,13091,Female gonad,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,CHEMBL624070,10116.0,9954,A,1,Intermediate,,,992.0,1
N,,50597,,,,13091,Female gonad,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,CHEMBL624071,10116.0,9955,A,1,Intermediate,,,992.0,1
N,,50597,,,,13091,Uterus,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,CHEMBL624072,10116.0,9956,A,1,Intermediate,,,995.0,1
N,,50597,,,,13091,Uterus,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,CHEMBL624073,10116.0,9957,A,1,Intermediate,,,995.0,1
N,,50597,,,,13091,Uterus,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,CHEMBL624788,10116.0,9958,A,1,Intermediate,,,995.0,1
N,,50597,,,,13091,Uterus,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,CHEMBL624789,10116.0,9959,A,1,Intermediate,,,995.0,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,CHEMBL624790,10116.0,9960,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,CHEMBL624791,10116.0,9961,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,CHEMBL624792,10116.0,9962,A,1,Intermediate,,,,1
N,,50597,,,,13091,,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,CHEMBL624793,10116.0,9963,A,1,Intermediate,,,,1
N,,50597,,,,13091,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,CHEMBL877491,10116.0,9964,A,1,Intermediate,,,2385.0,1
N,,50597,,,,13091,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,CHEMBL624957,10116.0,9965,A,1,Intermediate,,,2385.0,1
N,,50597,,,,13091,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,CHEMBL624958,10116.0,9966,A,1,Intermediate,,,2385.0,1
N,,50597,,,,13091,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,CHEMBL624959,10116.0,9967,A,1,Intermediate,,,2385.0,1
N,,50597,,,,11977,,Rattus norvegicus,,BAO_0000218,,Dissociation constant was determined,CHEMBL624960,10116.0,9968,A,1,Intermediate,,,,1
N,,50597,,,,14941,,Rattus norvegicus,,BAO_0000218,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",CHEMBL624961,10116.0,9969,A,1,Intermediate,,,,1
N,,50597,,,,15078,,Rattus norvegicus,,BAO_0000218,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL624962,10116.0,9970,A,1,Intermediate,,,,1
N,,50597,,,,15078,,Rattus norvegicus,,BAO_0000218,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",CHEMBL624963,10116.0,9971,A,1,Intermediate,,,,1
N,,50597,,,,4755,,Rattus norvegicus,,BAO_0000218,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,CHEMBL624964,10116.0,9972,A,1,Intermediate,,,,1
N,,50597,,,,589,,Rattus norvegicus,,BAO_0000218,,LogP value was evaluated in the in situ rat gut perfusion assay,CHEMBL624965,10116.0,9973,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17582,,Rattus norvegicus,,BAO_0000218,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,CHEMBL624966,10116.0,9974,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5031,,Rattus norvegicus,,BAO_0000218,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,CHEMBL624967,10116.0,9975,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17764,,Rattus norvegicus,,BAO_0000218,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,CHEMBL624968,10116.0,9976,A,1,Intermediate,,,,1
N,,50597,,,,17720,,Rattus norvegicus,,BAO_0000218,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,CHEMBL624969,10116.0,9977,A,1,Intermediate,,,,1
N,,50597,,,,2862,,Rattus norvegicus,,BAO_0000218,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,CHEMBL624970,10116.0,9978,F,1,Expert,,,,1
N,,50597,,,,16423,,Rattus norvegicus,,BAO_0000218,,Half-life was evaluated after 10 uM/kg of intra arterial administration,CHEMBL624971,10116.0,9979,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16423,,Rattus norvegicus,,BAO_0000218,,Half-life was evaluated after 20 uM/kg of peroral administration,CHEMBL624972,10116.0,9980,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6005,,Rattus norvegicus,,BAO_0000218,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,CHEMBL624973,10116.0,9981,A,1,Intermediate,,,,1
N,,50597,,,,2938,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life was evaluated in plasma of rat,CHEMBL624974,10116.0,9982,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6410,,Rattus norvegicus,,BAO_0000218,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,CHEMBL624975,10116.0,9983,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6410,,Rattus norvegicus,,BAO_0000218,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,CHEMBL877492,10116.0,9984,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6062,,Rattus norvegicus,,BAO_0000218,,Half-life was measured in rat after an iv dose of 1 mg/kg,CHEMBL624976,10116.0,9985,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6571,,Rattus norvegicus,,BAO_0000218,,Half-life period of compound in rats after peroral administration,CHEMBL624977,10116.0,9986,A,1,Intermediate,,,,1
N,,50597,,,,3136,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life period of compound was measured in rat plasma.,CHEMBL626848,10116.0,9987,A,1,Intermediate,,,1969.0,1
N,,50597,,,,3136,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life period of compound was measured in rat plasma; ND is not determined,CHEMBL626849,10116.0,9988,A,1,Intermediate,,,1969.0,1
N,,50597,,,,3136,Plasma,Rattus norvegicus,,BAO_0000218,,Half-life period of compound was measured in rat plasma; not determined,CHEMBL626850,10116.0,9989,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4521,,Rattus norvegicus,,BAO_0000218,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,CHEMBL626851,10116.0,9990,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5871,,Rattus norvegicus,,BAO_0000218,,Half-life period in rat by iv administration,CHEMBL626852,10116.0,9991,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6077,,Rattus norvegicus,,BAO_0000218,,Half-life period in rats following intravenous administration at 2 mg/kg,CHEMBL626853,10116.0,9992,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6679,,Rattus norvegicus,,BAO_0000218,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,CHEMBL626854,10116.0,9993,A,1,Intermediate,,,,1
N,,50597,,,,5144,,Rattus norvegicus,,BAO_0000218,,Half-life period was determined for the compound in rat,CHEMBL627486,10116.0,9994,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4498,,Rattus norvegicus,,BAO_0000218,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",CHEMBL627487,10116.0,9995,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4498,,Rattus norvegicus,,BAO_0000218,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",CHEMBL627488,10116.0,9996,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1908,,Rattus norvegicus,,BAO_0000218,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,CHEMBL627489,10116.0,9997,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6211,,Rattus norvegicus,,BAO_0000218,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,CHEMBL627490,10116.0,9998,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5529,,Rattus norvegicus,,BAO_0000218,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),CHEMBL873829,10116.0,9999,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6444,,Rattus norvegicus,,BAO_0000218,,Half-life was determined in rat at a dose of 1 mpk i.v.,CHEMBL627655,10116.0,10000,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6444,,Rattus norvegicus,,BAO_0000218,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,CHEMBL625994,10116.0,10001,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6444,,Rattus norvegicus,,BAO_0000218,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,CHEMBL625995,10116.0,10002,A,1,Intermediate,,,,1
N,,50597,,,,5207,,Rattus norvegicus,,BAO_0000218,,Half-life in rat,CHEMBL625996,10116.0,10003,A,1,Intermediate,,,,1
N,,50597,,,In vitro,530,Plasma,Rattus norvegicus,,BAO_0000218,,In vitro half life in rat plasma,CHEMBL625850,10116.0,10004,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vitro,1116,Plasma,Rattus norvegicus,,BAO_0000218,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",CHEMBL625851,10116.0,10005,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vitro,3219,,Rattus norvegicus,,BAO_0000218,,In vitro half life in rat,CHEMBL625852,10116.0,10006,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6109,,Rattus norvegicus,,BAO_0000218,,In vivo half life period after intravenous administration in rat,CHEMBL625853,10116.0,10007,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17582,,Rattus norvegicus,,BAO_0000218,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,CHEMBL625854,10116.0,10008,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17582,,Rattus norvegicus,,BAO_0000218,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,CHEMBL874450,10116.0,10009,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,CHEMBL625855,10116.0,10010,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,CHEMBL625856,10116.0,10011,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,CHEMBL625857,10116.0,10012,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,CHEMBL873831,10116.0,10013,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17853,,Rattus norvegicus,,BAO_0000218,,Longer half-life in rat (i.v.) at 0.5 mpk,CHEMBL625858,10116.0,10014,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17853,,Rattus norvegicus,,BAO_0000218,,Longer half-life in rat (p.o.) at 2.0 mpk,CHEMBL625859,10116.0,10015,A,1,Intermediate,,,,1
N,,50597,,,,3457,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (half life) in rat,CHEMBL625860,10116.0,10016,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2792,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,CHEMBL625861,10116.0,10017,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2792,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,CHEMBL625862,10116.0,10018,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2792,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,CHEMBL625863,10116.0,10019,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2792,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,CHEMBL625864,10116.0,10020,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5739,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,CHEMBL625865,10116.0,10021,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15765,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic half time was determined intravenously in rats.,CHEMBL625866,10116.0,10022,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6567,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,CHEMBL625867,10116.0,10023,A,1,Intermediate,,,1969.0,1
N,,50597,,,,2448,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half life of hydrolysis of the compound,CHEMBL625868,10116.0,10024,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5423,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,CHEMBL625869,10116.0,10025,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4853,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half life period was calculated in rat,CHEMBL874451,10116.0,10026,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4514,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half-life in Sprague-Dawley rats,CHEMBL625870,10116.0,10027,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4514,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half-life in Sprague-Dawley rats; Not determined,CHEMBL625871,10116.0,10028,A,1,Intermediate,,,1969.0,1
N,,50597,,,,1500,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half-life in rats,CHEMBL625872,10116.0,10029,A,1,Intermediate,,,1969.0,1
N,,50597,,,,1500,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half-life in rats; <MQL,CHEMBL625873,10116.0,10030,A,1,Intermediate,,,1969.0,1
N,,50597,,,,5334,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half-life period (0-8 h) was determined,CHEMBL625874,10116.0,10031,A,1,Intermediate,,,1969.0,1
N,,50597,,,,5334,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,CHEMBL625875,10116.0,10032,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5334,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,CHEMBL625876,10116.0,10033,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5334,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,CHEMBL631258,10116.0,10034,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4956,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,CHEMBL631259,10116.0,10035,A,1,Intermediate,,,1969.0,1
N,,50597,,,,4956,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,CHEMBL631260,10116.0,10036,A,1,Intermediate,,,1969.0,1
N,,50597,,,,7768,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",CHEMBL631261,10116.0,10037,A,1,Intermediate,,,178.0,1
N,,50597,,,,7768,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",CHEMBL631262,10116.0,10038,A,1,Intermediate,,,178.0,1
N,,50597,,,,7768,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",CHEMBL631263,10116.0,10039,A,1,Intermediate,,,178.0,1
N,,50597,,,,7768,,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",CHEMBL631264,10116.0,10040,A,1,Intermediate,,,,1
N,,50597,,,,7768,,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",CHEMBL631265,10116.0,10041,A,1,Intermediate,,,,1
N,,50597,,,,7768,,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",CHEMBL631266,10116.0,10042,A,1,Intermediate,,,,1
N,,50597,,,,7768,,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",CHEMBL631267,10116.0,10043,A,1,Intermediate,,,,1
N,,50597,,,,7768,,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",CHEMBL631268,10116.0,10044,A,1,Intermediate,,,,1
N,,50597,,,,7768,,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",CHEMBL631269,10116.0,10045,A,1,Intermediate,,,,1
N,,50597,,,,7768,,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",CHEMBL631270,10116.0,10046,A,1,Intermediate,,,,1
N,,50597,,,,7768,Heart,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",CHEMBL631271,10116.0,10047,A,1,Intermediate,,,948.0,1
N,,50597,,,,7768,Heart,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",CHEMBL631272,10116.0,10048,A,1,Intermediate,,,948.0,1
N,,50597,,,,7768,Heart,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",CHEMBL631273,10116.0,10049,A,1,Intermediate,,,948.0,1
N,,50597,,,,7768,Heart,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",CHEMBL631274,10116.0,10050,A,1,Intermediate,,,948.0,1
N,,50597,,,,7768,Heart,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",CHEMBL631275,10116.0,10051,A,1,Intermediate,,,948.0,1
N,,50597,,,,7768,Heart,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",CHEMBL626984,10116.0,10052,A,1,Intermediate,,,948.0,1
N,,50597,,,,7768,Heart,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",CHEMBL626985,10116.0,10053,A,1,Intermediate,,,948.0,1
N,,50597,,,,7768,Liver,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",CHEMBL626986,10116.0,10054,A,1,Intermediate,,,2107.0,1
N,,50597,,,,7768,Liver,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",CHEMBL626987,10116.0,10055,A,1,Intermediate,,,2107.0,1
N,,50597,,,,7768,Liver,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",CHEMBL626988,10116.0,10056,A,1,Intermediate,,,2107.0,1
N,,50597,,,,7768,Liver,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",CHEMBL626989,10116.0,10057,A,1,Intermediate,,,2107.0,1
N,,50597,,,,7768,Liver,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",CHEMBL626990,10116.0,10058,A,1,Intermediate,,,2107.0,1
N,,50597,,,,7768,Liver,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",CHEMBL626991,10116.0,10059,A,1,Intermediate,,,2107.0,1
N,,50597,,,,7768,Liver,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",CHEMBL626992,10116.0,10060,A,1,Intermediate,,,2107.0,1
N,,50597,,,,7768,Lung,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",CHEMBL626993,10116.0,10061,A,1,Intermediate,,,2048.0,1
N,,50597,,,,7768,Lung,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",CHEMBL874593,10116.0,10062,A,1,Intermediate,,,2048.0,1
N,,50597,,,,7768,Lung,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",CHEMBL626994,10116.0,10063,A,1,Intermediate,,,2048.0,1
N,,50597,,,,7768,Lung,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",CHEMBL626995,10116.0,10064,A,1,Intermediate,,,2048.0,1
N,,50597,,,,7768,Lung,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",CHEMBL626190,10116.0,10065,A,1,Intermediate,,,2048.0,1
N,,50597,,,,7768,Lung,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",CHEMBL626191,10116.0,10066,A,1,Intermediate,,,2048.0,1
N,,50597,,,,7768,Lung,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",CHEMBL626364,10116.0,10067,A,1,Intermediate,,,2048.0,1
N,,50597,,,,7768,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",CHEMBL626365,10116.0,10068,A,1,Intermediate,,,2046.0,1
N,,50597,,,,7768,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",CHEMBL626366,10116.0,10069,A,1,Intermediate,,,2046.0,1
N,,50597,,,,7768,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",CHEMBL626367,10116.0,10070,A,1,Intermediate,,,2046.0,1
N,,50597,,,,7768,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",CHEMBL626368,10116.0,10071,A,1,Intermediate,,,2046.0,1
N,,50597,,,,7768,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",CHEMBL626369,10116.0,10072,A,1,Intermediate,,,2046.0,1
N,,50597,,,,7768,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",CHEMBL626370,10116.0,10073,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,4498,,Rattus norvegicus,,BAO_0000218,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",CHEMBL626371,10116.0,10074,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4498,,Rattus norvegicus,,BAO_0000218,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",CHEMBL626372,10116.0,10075,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3603,,Rattus norvegicus,,BAO_0000218,,Bioavailability after a dose of 10 mg/kg p.o.,CHEMBL626373,10116.0,10076,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6215,,Rattus norvegicus,,BAO_0000218,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,CHEMBL626374,10116.0,10077,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5710,,Rattus norvegicus,,BAO_0000218,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,CHEMBL626375,10116.0,10078,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5710,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),CHEMBL626376,10116.0,10079,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5676,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat po was determined,CHEMBL626377,10116.0,10080,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17667,,Rattus norvegicus,,BAO_0000218,,Bioavailability of compound at 10 mg/kg in rat after oral administration,CHEMBL626378,10116.0,10081,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17667,,Rattus norvegicus,,BAO_0000218,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,CHEMBL626379,10116.0,10082,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6848,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),CHEMBL626380,10116.0,10083,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6848,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),CHEMBL626381,10116.0,10084,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17267,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL626382,10116.0,10085,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6362,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (Sprague-Dawley) (female),CHEMBL626383,10116.0,10086,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17671,,Rattus norvegicus,,BAO_0000218,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,CHEMBL874652,10116.0,10087,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17671,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),CHEMBL626384,10116.0,10088,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4333,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,CHEMBL626385,10116.0,10089,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6077,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat at an oral dose of 2 mg/kg,CHEMBL626386,10116.0,10090,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3278,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL626387,10116.0,10091,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5964,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL626388,10116.0,10092,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4884,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL626389,10116.0,10093,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4905,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL626390,10116.0,10094,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4884,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,CHEMBL626391,10116.0,10095,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6850,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL626392,10116.0,10096,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2864,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL626393,10116.0,10097,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5780,,Rattus norvegicus,,BAO_0000218,,Bioavailability was determined in rat,CHEMBL623026,10116.0,10098,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1465,,Rattus norvegicus,,BAO_0000218,,Bioavailability,CHEMBL623027,10116.0,10099,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5199,,Rattus norvegicus,,BAO_0000218,,Bioavailability,CHEMBL623028,10116.0,10100,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5765,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat after 1 day dosing,CHEMBL623029,10116.0,10101,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5765,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat after 4 day dosing,CHEMBL623030,10116.0,10102,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6518,,Rattus norvegicus,,BAO_0000218,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,CHEMBL623031,10116.0,10103,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6518,,Rattus norvegicus,,BAO_0000218,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,CHEMBL623032,10116.0,10104,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6518,,Rattus norvegicus,,BAO_0000218,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,CHEMBL623033,10116.0,10105,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6518,,Rattus norvegicus,,BAO_0000218,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,CHEMBL623034,10116.0,10106,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2083,,Rattus norvegicus,,BAO_0000218,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,CHEMBL623035,10116.0,10107,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17260,,Rattus norvegicus,,BAO_0000218,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,CHEMBL623036,10116.0,10108,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4956,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),CHEMBL623037,10116.0,10109,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4368,,Rattus norvegicus,,BAO_0000218,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,CHEMBL623038,10116.0,10110,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17752,Plasma,Rattus norvegicus,,BAO_0000218,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,CHEMBL874385,10116.0,10111,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,1446,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (Fisher) (fasted),CHEMBL623039,10116.0,10112,A,1,Intermediate,,,,1
U,,22224,,,In vivo,2891,,Primates,,BAO_0000218,,Bioavailability in monkey after po administration of 10 mg/kg dose,CHEMBL623040,9443.0,10113,A,1,Intermediate,,,,0
U,,22224,,,In vivo,2891,,Primates,,BAO_0000218,,Oral bioavailability in monkey (dose 10 mg/kg),CHEMBL623041,9443.0,10114,A,1,Intermediate,,,,0
N,,50597,,,In vivo,6672,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL623741,10116.0,10115,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6673,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL623742,10116.0,10116,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17655,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL623743,10116.0,10117,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17796,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL623744,10116.0,10118,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17853,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 2.0 mg/kg p.o.),CHEMBL623745,10116.0,10119,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4521,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),CHEMBL623746,10116.0,10120,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4940,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 5 mg/kg p.o.),CHEMBL623747,10116.0,10121,A,1,Intermediate,,,,1
U,,22224,,,In vivo,2891,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat after po administration of 30 mg/kg dose,CHEMBL623748,10116.0,10122,A,1,Intermediate,,,,0
U,,22224,,,In vivo,2891,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat after po administration of 30 mg/kg dose,CHEMBL623916,10116.0,10123,A,1,Intermediate,,,,0
N,,50597,,,In vivo,4521,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,CHEMBL623917,10116.0,10124,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17686,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 2 mg/kg i.v.),CHEMBL623918,10116.0,10125,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17796,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL874386,10116.0,10126,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17796,Plasma,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat; Only traces detected in rat plasma,CHEMBL623919,10116.0,10127,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5064,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL623920,10116.0,10128,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5147,,Rattus norvegicus,,BAO_0000218,,Bioavailability upon oral administration of compound,CHEMBL623148,10116.0,10129,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1916,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),CHEMBL623149,10116.0,10130,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6049,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL623150,10116.0,10131,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1445,,Rattus norvegicus,,BAO_0000218,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",CHEMBL623151,10116.0,10132,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1445,,Rattus norvegicus,,BAO_0000218,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",CHEMBL623152,10116.0,10133,A,1,Intermediate,,,,1
N,,50597,,,,2862,,Rattus norvegicus,,BAO_0000218,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,CHEMBL623153,10116.0,10134,F,1,Expert,,,,1
N,,50597,,,,2862,,Rattus norvegicus,,BAO_0000218,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,CHEMBL623154,10116.0,10135,F,1,Expert,,,,1
N,,50597,,,,4194,,Rattus norvegicus,,BAO_0000218,,In vitro and metabolic stability was determined,CHEMBL623155,10116.0,10136,A,1,Intermediate,,,,1
N,,50597,,,,4194,,Rattus norvegicus,,BAO_0000218,,In vitro metabolic stability in rat hepatocytes,CHEMBL623156,10116.0,10137,A,1,Intermediate,,,,1
N,,50597,,,,5486,,Rattus norvegicus,,BAO_0000218,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,CHEMBL623157,10116.0,10138,A,1,Intermediate,,,,1
N,,50597,401.0,,In vitro,17582,Liver,Rattus norvegicus,,BAO_0000218,,Metabolic rate for compound was observed in rat hepatocytes,CHEMBL623158,10116.0,10139,A,1,Intermediate,Hepatocyte,,2107.0,1
N,,50597,,,,5600,,Rattus norvegicus,,BAO_0000218,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,CHEMBL623159,10116.0,10140,A,1,Intermediate,,,,1
N,,50597,,,,14294,,Rattus norvegicus,,BAO_0000218,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),CHEMBL874390,10116.0,10141,A,1,Intermediate,,,,1
N,,50597,,,,14294,,Rattus norvegicus,,BAO_0000218,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),CHEMBL623160,10116.0,10142,A,1,Intermediate,,,,1
N,,50597,,,,14294,,Rattus norvegicus,,BAO_0000218,,Metabolism of compound in rat S9 microsomes; Trace,CHEMBL623161,10116.0,10143,A,1,Intermediate,,,,1
N,,50597,,,,17847,,Rattus norvegicus,,BAO_0000218,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,CHEMBL623162,10116.0,10144,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,CHEMBL623163,10116.0,10145,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,CHEMBL623164,10116.0,10146,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,CHEMBL623165,10116.0,10147,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,CHEMBL623166,10116.0,10148,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,CHEMBL624983,10116.0,10149,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,CHEMBL624984,10116.0,10150,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,CHEMBL624985,10116.0,10151,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,CHEMBL622970,10116.0,10152,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,CHEMBL622971,10116.0,10153,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,CHEMBL622972,10116.0,10154,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,CHEMBL622973,10116.0,10155,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,CHEMBL622974,10116.0,10156,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,CHEMBL622975,10116.0,10157,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,CHEMBL622976,10116.0,10158,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,CHEMBL622977,10116.0,10159,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,CHEMBL624351,10116.0,10160,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,CHEMBL624352,10116.0,10161,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,CHEMBL624353,10116.0,10162,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,CHEMBL622397,10116.0,10163,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,CHEMBL622398,10116.0,10164,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,CHEMBL622399,10116.0,10165,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,CHEMBL622400,10116.0,10166,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,CHEMBL628428,10116.0,10167,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,CHEMBL628590,10116.0,10168,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,CHEMBL628591,10116.0,10169,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,CHEMBL628592,10116.0,10170,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,CHEMBL628593,10116.0,10171,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,CHEMBL875333,10116.0,10172,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,CHEMBL628594,10116.0,10173,A,1,Intermediate,,,,1
N,,50597,,,,4969,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,CHEMBL628595,10116.0,10174,A,1,Intermediate,,,1969.0,1
N,,50597,,,,6737,Plasma,Rattus norvegicus,,BAO_0000218,,Stability in rat plasma was determined,CHEMBL628596,10116.0,10175,A,1,Intermediate,,,1969.0,1
N,,50597,,,,6737,Plasma,Rattus norvegicus,,BAO_0000218,,Stability in rat plasma was determined; ND= no data,CHEMBL628597,10116.0,10176,A,1,Intermediate,,,1969.0,1
N,,50597,,,,5089,Plasma,Rattus norvegicus,,BAO_0000218,,Tested for plasma half life period in rat (0-8 hr),CHEMBL628598,10116.0,10177,A,1,Intermediate,,,1969.0,1
N,,50597,,,,5089,Plasma,Rattus norvegicus,,BAO_0000218,,Tested for plasma half life period in rat (0-8 hr); Not determined,CHEMBL628599,10116.0,10178,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,1466,,Rattus norvegicus,,BAO_0000218,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,CHEMBL628600,10116.0,10179,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1466,,Rattus norvegicus,,BAO_0000218,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,CHEMBL628601,10116.0,10180,A,1,Intermediate,,,,1
N,,50597,,,,4950,,Rattus norvegicus,,BAO_0000218,,Tested for the half life in rat,CHEMBL628602,10116.0,10181,A,1,Intermediate,,,,1
N,,50597,,,In vitro,2412,,Rattus norvegicus,,BAO_0000218,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,CHEMBL628603,10116.0,10182,A,1,Intermediate,,,,1
N,,50597,,,In vitro,2412,,Rattus norvegicus,,BAO_0000218,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,CHEMBL628604,10116.0,10183,A,1,Intermediate,,,,1
N,,50597,,,In vitro,2412,,Rattus norvegicus,,BAO_0000218,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,CHEMBL628605,10116.0,10184,A,1,Intermediate,,,,1
N,,50597,,,In vitro,2412,,Rattus norvegicus,,BAO_0000218,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,CHEMBL628606,10116.0,10185,A,1,Intermediate,,,,1
N,,50597,,,In vitro,2412,,Rattus norvegicus,,BAO_0000218,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,CHEMBL628607,10116.0,10186,A,1,Intermediate,,,,1
N,,50597,,,,15022,,Rattus norvegicus,,BAO_0000218,,The biological half life the compound was measured at the dose of 100 umol/kg,CHEMBL628608,10116.0,10187,A,1,Intermediate,,,,1
N,,50597,,,,15022,,Rattus norvegicus,,BAO_0000218,,The biological half life the compound was measured at the dose of 30 umol/kg,CHEMBL628609,10116.0,10188,A,1,Intermediate,,,,1
N,,50597,,,,406,Plasma,Rattus norvegicus,,BAO_0000218,,The compound was evaluated for plasma half life period in rat,CHEMBL628610,10116.0,10189,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15078,,Rattus norvegicus,,BAO_0000218,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL873819,10116.0,10190,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15078,,Rattus norvegicus,,BAO_0000218,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",CHEMBL628611,10116.0,10191,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5247,,Rattus norvegicus,,BAO_0000218,,The pharmacokinetic parameter half-life period in vivo in rats,CHEMBL628612,10116.0,10192,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5041,,Rattus norvegicus,,BAO_0000218,,"The pharmacokinetic property, Half-life was determined",CHEMBL628613,10116.0,10193,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5041,,Rattus norvegicus,,BAO_0000218,,"The pharmacokinetic property, Half-life in rat in vivo",CHEMBL628614,10116.0,10194,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5041,,Rattus norvegicus,,BAO_0000218,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",CHEMBL628615,10116.0,10195,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5041,,Rattus norvegicus,,BAO_0000218,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",CHEMBL628616,10116.0,10196,A,1,Intermediate,,,,1
N,,50597,,,,3918,Plasma,Rattus norvegicus,,BAO_0000218,,The plasma half life period in rats,CHEMBL627924,10116.0,10197,A,1,Intermediate,,,1969.0,1
N,,50597,,,,2906,Liver,Rattus norvegicus,,BAO_0000218,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,CHEMBL627925,10116.0,10198,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,6467,,Rattus norvegicus,,BAO_0000218,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,CHEMBL627926,10116.0,10199,A,1,Intermediate,,,,1
N,,50597,,,,5510,,Rattus norvegicus,,BAO_0000218,,t1/2 (apparent elimination)of the compound was determined,CHEMBL627927,10116.0,10200,A,1,Intermediate,,,,1
N,,50597,,,,3788,,Rattus norvegicus,,BAO_0000218,,t1/2 value in rat,CHEMBL627928,10116.0,10201,A,1,Intermediate,,,,1
N,,50597,,,,17796,,Rattus norvegicus,,BAO_0000218,,Half life in rat,CHEMBL627539,10116.0,10202,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12873,Plasma,Rattus norvegicus,,BAO_0000218,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",CHEMBL876790,10116.0,10203,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5983,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,CHEMBL858186,10116.0,10204,A,1,Intermediate,,,,1
N,,50597,,,,15765,,Rattus norvegicus,,BAO_0000218,,Half-life period in fasted rats,CHEMBL627540,10116.0,10205,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2661,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,CHEMBL627541,10116.0,10206,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2661,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,CHEMBL627715,10116.0,10207,A,1,Intermediate,,,,1
N,,50597,,,In vivo,429,,Rattus norvegicus,,BAO_0000218,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,CHEMBL627716,10116.0,10208,A,1,Intermediate,,,,1
N,,50597,,,,17655,,Rattus norvegicus,,BAO_0000218,,Maximum time required to achieve Cmax was determined in rat,CHEMBL627717,10116.0,10209,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17717,,Rattus norvegicus,,BAO_0000218,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,CHEMBL627718,10116.0,10210,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17717,,Rattus norvegicus,,BAO_0000218,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,CHEMBL627719,10116.0,10211,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17717,,Rattus norvegicus,,BAO_0000218,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,CHEMBL627720,10116.0,10212,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6570,,Rattus norvegicus,,BAO_0000218,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,CHEMBL627721,10116.0,10213,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6570,,Rattus norvegicus,,BAO_0000218,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,CHEMBL627722,10116.0,10214,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL627723,10116.0,10215,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL626058,10116.0,10216,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL626059,10116.0,10217,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL626060,10116.0,10218,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17720,Plasma,Rattus norvegicus,,BAO_0000218,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,CHEMBL626061,10116.0,10219,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,4723,,Rattus norvegicus,,BAO_0000218,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL876791,10116.0,10220,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4723,,Rattus norvegicus,,BAO_0000218,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,CHEMBL626062,10116.0,10221,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4756,,Rattus norvegicus,,BAO_0000218,,Tmax at the dose of 2 mg/Kg administered perorally in rats,CHEMBL626063,10116.0,10222,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4756,,Rattus norvegicus,,BAO_0000218,,Tmax at the dose of 5 mg/Kg administered perorally in rats,CHEMBL626064,10116.0,10223,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17720,Plasma,Rattus norvegicus,,BAO_0000218,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,CHEMBL626065,10116.0,10224,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17720,Plasma,Rattus norvegicus,,BAO_0000218,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,CHEMBL626066,10116.0,10225,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,1466,,Rattus norvegicus,,BAO_0000218,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,CHEMBL626067,10116.0,10226,A,1,Intermediate,,,,1
N,,50597,,,,7449,,Rattus norvegicus,,BAO_0000218,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,CHEMBL626068,10116.0,10227,F,1,Intermediate,,,,1
N,,50597,,,,7449,,Rattus norvegicus,,BAO_0000218,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,CHEMBL626069,10116.0,10228,F,1,Intermediate,,,,1
N,,50597,,,,7449,,Rattus norvegicus,,BAO_0000218,,Percent total excretion of 3-methoxyacetaminophen glucuronide,CHEMBL626070,10116.0,10229,F,1,Intermediate,,,,1
N,,50597,,,,7449,,Rattus norvegicus,,BAO_0000218,,Percent total excretion of N-methoxyacetaminophen glucuronide,CHEMBL626071,10116.0,10230,F,1,Intermediate,,,,1
N,,50597,,,,7449,,Rattus norvegicus,,BAO_0000218,,Percent total excretion of N-methoxyacetaminophen sulfate,CHEMBL626072,10116.0,10231,F,1,Intermediate,,,,1
N,,50597,,,,7449,,Rattus norvegicus,,BAO_0000218,,Percent total excretion of acetaminophen,CHEMBL626073,10116.0,10232,F,1,Intermediate,,,,1
N,,50597,,,,7768,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",CHEMBL626741,10116.0,10233,A,1,Intermediate,,,2046.0,1
N,,50597,,,,17655,,Rattus norvegicus,,BAO_0000218,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",CHEMBL626742,10116.0,10234,A,1,Intermediate,,,,1
N,,50597,,,,17735,,Rattus norvegicus,,BAO_0000218,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,CHEMBL626743,10116.0,10235,A,1,Intermediate,,,,1
N,,50597,,,,5960,,Rattus norvegicus,,BAO_0000218,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,CHEMBL876792,10116.0,10236,A,1,Intermediate,,,,1
N,,50597,,,,17735,,Rattus norvegicus,,BAO_0000218,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,CHEMBL626744,10116.0,10237,A,1,Intermediate,,,,1
N,,50597,,,,7116,,Rattus norvegicus,,BAO_0000218,,Compound was tested for antidiuretic activity in rats,CHEMBL626745,10116.0,10238,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4878,Plasma,Rattus norvegicus,,BAO_0000218,,AUC in rat after 3mg/kg oral dose,CHEMBL626746,10116.0,10239,A,1,Intermediate,,,1969.0,1
N,,50597,,,,5939,,Rattus norvegicus,,BAO_0000218,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,CHEMBL626747,10116.0,10240,A,1,Intermediate,,,,1
N,,50597,,,,5939,,Rattus norvegicus,,BAO_0000218,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,CHEMBL626748,10116.0,10241,A,1,Intermediate,,,,1
N,,50597,,,,16367,,Rattus norvegicus,,BAO_0000218,,Bioavailability administered orally at a dose of 10 mg/kg to rats,CHEMBL626749,10116.0,10242,A,1,Intermediate,,,,1
N,,50597,,,,16366,,Rattus norvegicus,,BAO_0000218,,Oral Bioavailability was determined,CHEMBL626750,10116.0,10243,A,1,Intermediate,,,,1
N,,50597,,,,4426,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL626751,10116.0,10244,A,1,Intermediate,,,,1
N,,50597,,,,4426,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat; Not performed.,CHEMBL626913,10116.0,10245,A,1,Intermediate,,,,1
N,,50597,,,,5041,,Rattus norvegicus,,BAO_0000218,,Bioavailability,CHEMBL626914,10116.0,10246,A,1,Intermediate,,,,1
N,,50597,,,,5041,,Rattus norvegicus,,BAO_0000218,,Bioavailability was determined; ND denotes no data,CHEMBL626915,10116.0,10247,A,1,Intermediate,,,,1
N,,50597,,,,1500,,Rattus norvegicus,,BAO_0000218,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,CHEMBL626916,10116.0,10248,A,1,Intermediate,,,,1
N,,50597,,,,1500,,Rattus norvegicus,,BAO_0000218,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,CHEMBL626917,10116.0,10249,A,1,Intermediate,,,,1
N,,50597,,,,17409,,Rattus norvegicus,,BAO_0000218,,Binding towards rat plasma protein at 10 uM,CHEMBL626918,10116.0,10250,A,1,Intermediate,,,,1
N,,50597,,,,17409,,Rattus norvegicus,,BAO_0000218,,Binding towards rat plasma protein at 100 uM,CHEMBL626919,10116.0,10251,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2959,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 20 mg/kg p.o.),CHEMBL626920,10116.0,10252,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13501,,Rattus norvegicus,,BAO_0000218,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,CHEMBL621976,10116.0,10253,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6567,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat after 5 mg/kg oral gavage,CHEMBL877599,10116.0,10254,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6571,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL621977,10116.0,10255,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6715,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 1 mg/kg i.v.),CHEMBL621978,10116.0,10256,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6715,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 3 mg/kg p.o.),CHEMBL621979,10116.0,10257,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2932,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL621980,10116.0,10258,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4171,,Rattus norvegicus,,BAO_0000218,,Bioavailability of the compound in rats after administration of 30 mg/kg,CHEMBL621981,10116.0,10259,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17509,,Rattus norvegicus,,BAO_0000218,,Bioavailability after administration of 10 mg/kg in rats,CHEMBL621982,10116.0,10260,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17509,,Rattus norvegicus,,BAO_0000218,,Bioavailability after administration of 2 mg/kg in rats,CHEMBL882953,10116.0,10261,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4527,,Rattus norvegicus,,BAO_0000218,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,CHEMBL621983,10116.0,10262,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4026,,Rattus norvegicus,,BAO_0000218,,Bioavailability in dogs was determined; high,CHEMBL621984,10116.0,10263,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6659,,Rattus norvegicus,,BAO_0000218,,Bioavailability in monkey after intravenous administration at 1 mpk,CHEMBL621985,10116.0,10264,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6659,,Rattus norvegicus,,BAO_0000218,,Bioavailability in monkey after peroral administration at 10 mpk,CHEMBL621986,10116.0,10265,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6659,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat after intravenous administration at 1 mpk,CHEMBL621987,10116.0,10266,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6659,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat after intravenous administration at 2 mpk,CHEMBL877600,10116.0,10267,F,1,Intermediate,,,,1
N,,50597,,,In vivo,6659,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat after peroral administration at 30 mpk,CHEMBL621988,10116.0,10268,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6659,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat after peroral administration at at 100 mpk,CHEMBL621989,10116.0,10269,F,1,Intermediate,,,,1
N,,50597,,,In vivo,6597,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rats was evaluated,CHEMBL621990,10116.0,10270,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1202,,Rattus norvegicus,,BAO_0000218,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,CHEMBL621991,10116.0,10271,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1202,,Rattus norvegicus,,BAO_0000218,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,CHEMBL621992,10116.0,10272,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1202,,Rattus norvegicus,,BAO_0000218,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,CHEMBL621993,10116.0,10273,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1202,,Rattus norvegicus,,BAO_0000218,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,CHEMBL621994,10116.0,10274,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5207,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL621995,10116.0,10275,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5970,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL621996,10116.0,10276,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17538,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 10 mg/kg),CHEMBL621997,10116.0,10277,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17538,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,CHEMBL621998,10116.0,10278,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1466,,Rattus norvegicus,,BAO_0000218,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,CHEMBL621999,10116.0,10279,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2879,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622000,10116.0,10280,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2879,,Rattus norvegicus,,BAO_0000218,,Bioavailability was measured in rat after oral administration; 2-4,CHEMBL622001,10116.0,10281,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2879,,Rattus norvegicus,,BAO_0000218,,Bioavailability was measured in rat after oral administration; 3-7,CHEMBL622002,10116.0,10282,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3777,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (intraduodenal administration),CHEMBL622003,10116.0,10283,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3777,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (intraduodenal administration),CHEMBL877601,10116.0,10284,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3777,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL624871,10116.0,10285,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3777,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622004,10116.0,10286,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5423,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),CHEMBL882954,10116.0,10287,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16365,,Rattus norvegicus,,BAO_0000218,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,CHEMBL622005,10116.0,10288,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16365,,Rattus norvegicus,,BAO_0000218,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,CHEMBL622006,10116.0,10289,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4239,,Rattus norvegicus,,BAO_0000218,,Bioavailability was measured in rat,CHEMBL622007,10116.0,10290,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5438,,Rattus norvegicus,,BAO_0000218,,Bioavailability was reported,CHEMBL622008,10116.0,10291,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5334,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),CHEMBL622009,10116.0,10292,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5334,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),CHEMBL622010,10116.0,10293,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4199,,Rattus norvegicus,,BAO_0000218,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,CHEMBL622011,10116.0,10294,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4199,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),CHEMBL622012,10116.0,10295,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4199,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),CHEMBL622013,10116.0,10296,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4890,,Rattus norvegicus,,BAO_0000218,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,CHEMBL622014,10116.0,10297,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2792,,Rattus norvegicus,,BAO_0000218,,Bioavailability was determined at 3 mg/kg po dose in rats,CHEMBL624749,10116.0,10298,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5529,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 2 mg/kg),CHEMBL624750,10116.0,10299,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6685,,Rattus norvegicus,,BAO_0000218,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",CHEMBL624751,10116.0,10300,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6685,,Rattus norvegicus,,BAO_0000218,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",CHEMBL624752,10116.0,10301,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6685,,Rattus norvegicus,,BAO_0000218,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",CHEMBL624753,10116.0,10302,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6005,,Rattus norvegicus,,BAO_0000218,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,CHEMBL624754,10116.0,10303,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6410,,Rattus norvegicus,,BAO_0000218,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,CHEMBL624755,10116.0,10304,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6410,,Rattus norvegicus,,BAO_0000218,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,CHEMBL624756,10116.0,10305,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6103,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL624757,10116.0,10306,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6410,,Rattus norvegicus,,BAO_0000218,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,CHEMBL624758,10116.0,10307,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6410,,Rattus norvegicus,,BAO_0000218,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,CHEMBL622270,10116.0,10308,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5353,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (Sprague-Dawley),CHEMBL622271,10116.0,10309,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4727,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat at the dose of 2 mg/kg,CHEMBL622272,10116.0,10310,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17804,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622273,10116.0,10311,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5809,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (cannulated) (dose 2 mg/kg),CHEMBL622274,10116.0,10312,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17804,,Rattus norvegicus,,BAO_0000218,,Bioavailability value of compound in rats was determined after peroral administration,CHEMBL622275,10116.0,10313,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3634,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 20 mg/kg),CHEMBL622276,10116.0,10314,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3341,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622277,10116.0,10315,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2690,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 5 mg/kg),CHEMBL622278,10116.0,10316,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3184,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622279,10116.0,10317,A,1,Intermediate,,,,1
N,,50597,,,In vivo,740,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622280,10116.0,10318,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1806,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for oral bioavailability in rats; 15-27 %,CHEMBL624083,10116.0,10319,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4891,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,CHEMBL624084,10116.0,10320,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3634,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),CHEMBL624085,10116.0,10321,A,1,Intermediate,,,,1
N,,50597,,,In vivo,64,,Rattus norvegicus,,BAO_0000218,,Compound was tested for bioavailability in rats,CHEMBL624086,10116.0,10322,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4839,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL624087,10116.0,10323,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1094,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL624088,10116.0,10324,A,1,Intermediate,,,,1
U,,22224,,,In vivo,5005,,Macaca mulatta,,BAO_0000218,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,CHEMBL624089,9544.0,10325,A,1,Intermediate,,,,0
U,,22224,,,In vivo,5005,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),CHEMBL624090,10116.0,10326,A,1,Intermediate,,,,0
N,,50597,,,In vivo,4687,,Rattus norvegicus,,BAO_0000218,,Evaluated for the bioavailability in rat (in vivo),CHEMBL624091,10116.0,10327,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17804,,Rattus norvegicus,,BAO_0000218,,F value of compound in rats was determined after peroral administration,CHEMBL624092,10116.0,10328,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,CHEMBL624093,10116.0,10329,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,CHEMBL624094,10116.0,10330,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,CHEMBL624095,10116.0,10331,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5974,,Rattus norvegicus,,BAO_0000218,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,CHEMBL624096,10116.0,10332,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1088,,Rattus norvegicus,,BAO_0000218,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",CHEMBL624097,10116.0,10333,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1742,,Rattus norvegicus,,BAO_0000218,,Maximum fall in carotid flow in rat,CHEMBL624098,10116.0,10334,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4689,,Rattus norvegicus,,BAO_0000218,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,CHEMBL874392,10116.0,10335,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2463,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 5 mg/kg),CHEMBL624099,10116.0,10336,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5654,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,CHEMBL624100,10116.0,10337,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5654,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,CHEMBL624101,10116.0,10338,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6874,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (male Wistar),CHEMBL624102,10116.0,10339,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5633,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability after administration (30 mg/kg) in rat; good,CHEMBL624103,10116.0,10340,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5496,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability at the dose of 2 mg/kg in rat,CHEMBL624104,10116.0,10341,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2358,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability determined in rats,CHEMBL624105,10116.0,10342,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16456,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),CHEMBL624106,10116.0,10343,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5302,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose single 10 mg/kg),CHEMBL624107,10116.0,10344,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5302,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose single 10 mg/kg),CHEMBL623943,10116.0,10345,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5302,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 5 mg/kg,CHEMBL623944,10116.0,10346,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,CHEMBL623945,10116.0,10347,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,CHEMBL623946,10116.0,10348,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,CHEMBL623947,10116.0,10349,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,CHEMBL623948,10116.0,10350,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,CHEMBL623949,10116.0,10351,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,CHEMBL623950,10116.0,10352,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,CHEMBL874398,10116.0,10353,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,CHEMBL623951,10116.0,10354,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,CHEMBL623952,10116.0,10355,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,CHEMBL623953,10116.0,10356,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,CHEMBL623954,10116.0,10357,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,CHEMBL623955,10116.0,10358,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,CHEMBL623956,10116.0,10359,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,CHEMBL627807,10116.0,10360,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,CHEMBL627808,10116.0,10361,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,CHEMBL627809,10116.0,10362,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,CHEMBL627810,10116.0,10363,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",CHEMBL627811,10116.0,10364,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",CHEMBL627812,10116.0,10365,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",CHEMBL627813,10116.0,10366,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",CHEMBL627814,10116.0,10367,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",CHEMBL875336,10116.0,10368,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",CHEMBL627815,10116.0,10369,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",CHEMBL627816,10116.0,10370,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",CHEMBL627817,10116.0,10371,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",CHEMBL627818,10116.0,10372,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",CHEMBL627819,10116.0,10373,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",CHEMBL627820,10116.0,10374,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",CHEMBL627821,10116.0,10375,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,CHEMBL628464,10116.0,10376,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,CHEMBL626239,10116.0,10377,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,CHEMBL626240,10116.0,10378,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,CHEMBL626241,10116.0,10379,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,CHEMBL626242,10116.0,10380,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,CHEMBL626243,10116.0,10381,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,CHEMBL626244,10116.0,10382,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,CHEMBL626907,10116.0,10383,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,CHEMBL626908,10116.0,10384,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,CHEMBL626909,10116.0,10385,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,CHEMBL626910,10116.0,10386,A,1,Intermediate,,,,1
N,,50597,,,,7449,,Rattus norvegicus,,BAO_0000218,,Percent total excretion of acetaminophen cysteine conjugate,CHEMBL875342,10116.0,10387,F,1,Intermediate,,,,1
N,,50597,,,,7449,,Rattus norvegicus,,BAO_0000218,,Percent total excretion of acetaminophen glucuronide,CHEMBL626911,10116.0,10388,F,1,Intermediate,,,,1
N,,50597,,,,7449,,Rattus norvegicus,,BAO_0000218,,Percent total excretion of acetaminophen sulfate,CHEMBL626912,10116.0,10389,F,1,Intermediate,,,,1
N,,50597,,,,7449,,Rattus norvegicus,,BAO_0000218,,Percent total excretion of acetaminophen-mercapturic acid,CHEMBL627065,10116.0,10390,F,1,Intermediate,,,,1
N,,50597,,,,3172,Urine,Rattus norvegicus,,BAO_0000218,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,CHEMBL627066,10116.0,10391,A,1,Intermediate,,,1088.0,1
N,,50597,,,In vivo,16456,,Rattus norvegicus,,BAO_0000218,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,CHEMBL627067,10116.0,10392,A,1,Intermediate,,,,1
U,,22224,,,In vivo,10839,Muscle tissue,ratrat,,BAO_0000218,,Biodistribution of compound in rat muscle after 5 min of administration,CHEMBL627068,8656.0,10393,A,1,Autocuration,,,2385.0,0
U,,22224,,,In vivo,10839,Muscle tissue,ratrat,,BAO_0000218,,Biodistribution of compound in rat muscle after 5 min of administration.,CHEMBL627069,8656.0,10394,A,1,Autocuration,,,2385.0,0
U,,22224,,,In vivo,5334,,Ovis aries,,BAO_0000218,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),CHEMBL627070,9940.0,10395,A,1,Autocuration,,,,0
U,,22224,,,In vivo,5334,,Ovis aries,,BAO_0000218,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),CHEMBL627071,9940.0,10396,A,1,Autocuration,,,,0
U,,22224,,,In vivo,5334,,Ovis aries,,BAO_0000218,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),CHEMBL627072,9940.0,10397,A,1,Autocuration,,,,0
U,,22224,,,In vivo,5334,,Ovis aries,,BAO_0000218,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),CHEMBL627073,9940.0,10398,A,1,Autocuration,,,,0
U,,22224,,,In vivo,5334,,Ovis aries,,BAO_0000218,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),CHEMBL625387,9940.0,10399,A,1,Autocuration,,,,0
U,,22224,,,In vivo,5334,,Ovis aries,,BAO_0000218,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),CHEMBL625388,9940.0,10400,A,1,Autocuration,,,,0
U,,22224,,,In vivo,5334,Plasma,Ovis aries,,BAO_0000218,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),CHEMBL625389,9940.0,10401,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,5334,Plasma,Ovis aries,,BAO_0000218,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),CHEMBL875343,9940.0,10402,A,1,Autocuration,,,1969.0,0
N,,50497,,,,1735,,Serpentes,,BAO_0000218,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),CHEMBL876795,8570.0,10403,A,1,Intermediate,,,,1
N,,50497,,,,1469,,Serpentes,,BAO_0000218,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,CHEMBL626552,8570.0,10404,A,1,Intermediate,,,,1
N,,50497,,,,1336,,Serpentes,,BAO_0000218,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,CHEMBL626553,8570.0,10405,A,1,Intermediate,,,,1
U,,22224,,,,12403,Plasma,Homo sapiens,,BAO_0000366,,The human biological plasma half life of the compound,CHEMBL626554,9606.0,10406,A,1,Autocuration,,,1969.0,0
N,,50597,,,,8151,Urine,Rattus norvegicus,,BAO_0000218,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,CHEMBL626555,10116.0,10407,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8004,,Rattus norvegicus,,BAO_0000218,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,CHEMBL626556,10116.0,10408,A,1,Intermediate,,,,1
N,,50597,,,,8004,,Rattus norvegicus,,BAO_0000218,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,CHEMBL626557,10116.0,10409,A,1,Intermediate,,,,1
N,,50597,,,,8004,,Rattus norvegicus,,BAO_0000218,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,CHEMBL626558,10116.0,10410,A,1,Intermediate,,,,1
N,,50597,,,,8004,,Rattus norvegicus,,BAO_0000218,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,CHEMBL626559,10116.0,10411,A,1,Intermediate,,,,1
N,,50597,,,,8004,,Rattus norvegicus,,BAO_0000218,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,CHEMBL626560,10116.0,10412,A,1,Intermediate,,,,1
N,,50597,,,,8004,,Rattus norvegicus,,BAO_0000218,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,CHEMBL876803,10116.0,10413,A,1,Intermediate,,,,1
N,,50597,,,,8004,,Rattus norvegicus,,BAO_0000218,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,CHEMBL627964,10116.0,10414,A,1,Intermediate,,,,1
N,,50597,,,,8004,,Rattus norvegicus,,BAO_0000218,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,CHEMBL627965,10116.0,10415,A,1,Intermediate,,,,1
N,,50597,,,,8004,,Rattus norvegicus,,BAO_0000218,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,CHEMBL627966,10116.0,10416,A,1,Intermediate,,,,1
N,,50597,,,,8004,,Rattus norvegicus,,BAO_0000218,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,CHEMBL627967,10116.0,10417,A,1,Intermediate,,,,1
N,,50597,,,,8004,,Rattus norvegicus,,BAO_0000218,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,CHEMBL627968,10116.0,10418,A,1,Intermediate,,,,1
N,,50597,,,,8004,,Rattus norvegicus,,BAO_0000218,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,CHEMBL627969,10116.0,10419,A,1,Intermediate,,,,1
N,,50597,,,,8004,,Rattus norvegicus,,BAO_0000218,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,CHEMBL627970,10116.0,10420,A,1,Intermediate,,,,1
N,,50597,,,,8004,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,CHEMBL627971,10116.0,10421,A,1,Intermediate,,,178.0,1
N,,50597,,,,8004,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,CHEMBL627972,10116.0,10422,A,1,Intermediate,,,178.0,1
D,,180,,,,15917,,Homo sapiens,,BAO_0000357,,Dissociation constant against binding to human cyclophilin A,CHEMBL856029,9606.0,10423,B,1,Expert,,,,9
H,,11591,,,,12396,,Bos taurus,,BAO_0000019,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,CHEMBL627973,9913.0,10424,B,1,Expert,,,,8
U,,22224,,,,7065,,,,BAO_0000019,,-Log C was determined by performing the electroshock minimum test,CHEMBL627974,,10425,A,1,Autocuration,,,,0
U,,22224,,,,7065,,,,BAO_0000019,,-Log C was determined by performing the foot shock test,CHEMBL627975,,10426,A,1,Autocuration,,,,0
U,,22224,,,,7065,,,,BAO_0000019,,-Log C was determined by performing the incl screen test,CHEMBL627976,,10427,A,1,Autocuration,,,,0
U,,22224,,,,7065,,,,BAO_0000019,,-Log C was determined by performing the maximum electroshock test,CHEMBL627977,,10428,A,1,Autocuration,,,,0
U,,22224,,,,7065,,,,BAO_0000019,,-Log C was determined by performing the pentylenetetrazole test,CHEMBL627978,,10429,A,1,Autocuration,,,,0
U,,22224,,,,12415,,,,BAO_0000019,,Tested for experimental arotinoid inhibitory dose,CHEMBL627979,,10430,A,1,Autocuration,,,,0
U,,22224,,,,10256,,,,BAO_0000019,,Negative log transformed activity,CHEMBL876804,,10431,A,1,Autocuration,,,,0
U,,22224,,,,7991,,,,BAO_0000019,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",CHEMBL627980,,10432,A,1,Autocuration,,,,0
N,,50512,,,,14342,,Cavia porcellus,,BAO_0000218,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,CHEMBL627981,10141.0,10433,A,1,Intermediate,,,,1
N,,50512,,,,14342,,Cavia porcellus,,BAO_0000218,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,CHEMBL627982,10141.0,10434,A,1,Intermediate,,,,1
N,,50512,,,,14342,,Cavia porcellus,,BAO_0000218,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,CHEMBL627983,10141.0,10435,A,1,Intermediate,,,,1
N,,50512,,,,14342,Ileum,Cavia porcellus,,BAO_0000218,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,CHEMBL627984,10141.0,10436,A,1,Intermediate,,,2116.0,1
U,,22229,,,,6047,,,,BAO_0000100,,Solubility in water was determined; values expressed as -log,CHEMBL627985,,10437,P,1,Autocuration,,,,0
U,,22224,,,,17269,,,,BAO_0000019,,Ratio of Kcat to that of Km was determined,CHEMBL627986,,10438,A,1,Autocuration,,,,0
U,,22224,,,,10026,,,,BAO_0000019,,Observed first order rate constant,CHEMBL627987,,10439,A,1,Autocuration,,,,0
U,,22224,,,,14583,,,,BAO_0000019,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,CHEMBL627988,,10440,A,1,Autocuration,,,,0
N,,50597,,,In vivo,2661,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,CHEMBL627989,10116.0,10441,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2661,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,CHEMBL627990,10116.0,10442,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4029,,Rattus norvegicus,,BAO_0000218,,Oral Bioavailability after administration of 10 mg/kg in male rat,CHEMBL876805,10116.0,10443,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17735,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),CHEMBL627991,10116.0,10444,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4576,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL627992,10116.0,10445,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17582,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,CHEMBL627993,10116.0,10446,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17651,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability at 1 mg/kg was determined in rat,CHEMBL622817,10116.0,10447,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17651,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability at 10 mg/kg was determined in rat,CHEMBL622818,10116.0,10448,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17670,,Rattus norvegicus,,BAO_0000218,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",CHEMBL622819,10116.0,10449,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5045,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL872267,10116.0,10450,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1696,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622820,10116.0,10451,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17764,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,CHEMBL622821,10116.0,10452,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6448,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622822,10116.0,10453,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6596,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622823,10116.0,10454,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17547,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622824,10116.0,10455,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17771,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat at a dose of 3 mg/kg,CHEMBL622825,10116.0,10456,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6495,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat after oral administration at 10 mg/kg,CHEMBL622901,10116.0,10457,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4558,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622902,10116.0,10458,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17596,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL621844,10116.0,10459,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6827,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in Dawley rats,CHEMBL621845,10116.0,10460,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4026,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability,CHEMBL621846,10116.0,10461,A,1,Intermediate,,,,1
N,,50597,,,In vivo,10,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 30 mg/kg),CHEMBL621847,10116.0,10462,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17717,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,CHEMBL877609,10116.0,10463,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17717,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 3 mg/kg i.v.),CHEMBL621848,10116.0,10464,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17717,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,CHEMBL621849,10116.0,10465,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17717,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 60 mg/kg p.o.),CHEMBL622030,10116.0,10466,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4796,,Rattus norvegicus,,BAO_0000218,,Percent oral bioavailability determined in rats,CHEMBL622031,10116.0,10467,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4883,,Rattus norvegicus,,BAO_0000218,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,CHEMBL622032,10116.0,10468,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2137,,Rattus norvegicus,,BAO_0000218,,The compound was evaluated for bioavailability in rats; 32-51,CHEMBL622033,10116.0,10469,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2959,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 20 mg/kg p.o.),CHEMBL622034,10116.0,10470,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1361,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622035,10116.0,10471,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4727,,Rattus norvegicus,,BAO_0000218,,Bioavailability percent in rat at the dose of 2 mg/kg,CHEMBL882966,10116.0,10472,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16423,,Rattus norvegicus,,BAO_0000218,,Bioavailability was evaluated after 20 uM/kg of peroral administration,CHEMBL622036,10116.0,10473,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5206,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622037,10116.0,10474,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6448,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622038,10116.0,10475,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17723,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rats,CHEMBL622039,10116.0,10476,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17738,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,CHEMBL622040,10116.0,10477,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,17738,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,CHEMBL622041,10116.0,10478,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,17738,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,CHEMBL622042,10116.0,10479,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,17738,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,CHEMBL622043,10116.0,10480,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,17738,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,CHEMBL622044,10116.0,10481,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,17738,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,CHEMBL622045,10116.0,10482,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,17738,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,CHEMBL622046,10116.0,10483,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,17738,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,CHEMBL622047,10116.0,10484,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,17738,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,CHEMBL877610,10116.0,10485,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,17738,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,CHEMBL622048,10116.0,10486,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,17738,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,CHEMBL622049,10116.0,10487,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,17738,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,CHEMBL622050,10116.0,10488,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,17738,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,CHEMBL622051,10116.0,10489,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,17738,,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,CHEMBL622052,10116.0,10490,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17738,,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,CHEMBL622053,10116.0,10491,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17738,,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,CHEMBL622054,10116.0,10492,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17738,,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,CHEMBL622055,10116.0,10493,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5237,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rats was determined; High,CHEMBL622056,10116.0,10494,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5503,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in the rat was determined,CHEMBL622057,10116.0,10495,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15765,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,CHEMBL628008,10116.0,10496,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15660,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),CHEMBL622058,10116.0,10497,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL622059,10116.0,10498,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL622060,10116.0,10499,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL622061,10116.0,10500,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5978,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,CHEMBL622062,10116.0,10501,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5656,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,CHEMBL622063,10116.0,10502,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3598,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,CHEMBL877611,10116.0,10503,A,1,Expert,,,,1
N,,50597,,,In vivo,4216,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability of compound in Sprague Dawley rats,CHEMBL622064,10116.0,10504,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17839,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability of compound in rat,CHEMBL622065,10116.0,10505,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6570,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 2 mg/kg),CHEMBL622066,10116.0,10506,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5334,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability of compound in rat was determined,CHEMBL622067,10116.0,10507,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6886,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability of compound in rats,CHEMBL622068,10116.0,10508,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5210,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability of compound was determined in rats,CHEMBL622069,10116.0,10509,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4170,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability at a dose of 30 mg/kg in rats,CHEMBL624796,10116.0,10510,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6028,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 10 mg/kg),CHEMBL624797,10116.0,10511,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6028,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 10 mg/kg),CHEMBL623053,10116.0,10512,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6078,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability evaluated in rat,CHEMBL623054,10116.0,10513,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6168,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in fasted rat,CHEMBL623055,10116.0,10514,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6168,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in fed rat,CHEMBL623056,10116.0,10515,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5160,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),CHEMBL623057,10116.0,10516,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6057,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623058,10116.0,10517,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6535,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 10 mg/kg p.o.),CHEMBL623059,10116.0,10518,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6535,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat after administration of 10 mg/kg po,CHEMBL623060,10116.0,10519,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4194,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623061,10116.0,10520,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6230,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623062,10116.0,10521,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6619,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623063,10116.0,10522,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17607,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623064,10116.0,10523,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4942,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in ratrs,CHEMBL623065,10116.0,10524,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4942,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623066,10116.0,10525,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6646,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623067,10116.0,10526,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5237,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rats was determined; High,CHEMBL623068,10116.0,10527,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6646,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623069,10116.0,10528,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4449,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623070,10116.0,10529,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6057,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability was calculated in rat,CHEMBL623071,10116.0,10530,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2552,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability,CHEMBL623072,10116.0,10531,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5496,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability,CHEMBL623073,10116.0,10532,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6484,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability,CHEMBL623074,10116.0,10533,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6485,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability,CHEMBL623075,10116.0,10534,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6616,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability after i.v. administration,CHEMBL623076,10116.0,10535,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4969,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),CHEMBL623077,10116.0,10536,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5862,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley),CHEMBL623078,10116.0,10537,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4514,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in Sprague-Dawley rats,CHEMBL623079,10116.0,10538,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4514,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),CHEMBL623080,10116.0,10539,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4514,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),CHEMBL623081,10116.0,10540,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5546,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,CHEMBL623082,10116.0,10541,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6168,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in fasted rat,CHEMBL874400,10116.0,10542,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6168,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in fed rat,CHEMBL623083,10116.0,10543,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3624,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623084,10116.0,10544,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5213,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623085,10116.0,10545,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5496,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623086,10116.0,10546,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5553,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623087,10116.0,10547,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5833,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623088,10116.0,10548,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5836,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623089,10116.0,10549,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5865,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623090,10116.0,10550,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5960,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623091,10116.0,10551,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6249,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623092,10116.0,10552,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6448,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623093,10116.0,10553,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6453,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL874401,10116.0,10554,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6640,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623094,10116.0,10555,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17607,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL623095,10116.0,10556,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5939,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat after peroral administration at 10 mg/kg,CHEMBL623096,10116.0,10557,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5939,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat after peroral administration at 5 mg/kg,CHEMBL624913,10116.0,10558,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6281,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),CHEMBL624914,10116.0,10559,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5874,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,CHEMBL624915,10116.0,10560,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5213,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat; Not measured,CHEMBL624916,10116.0,10561,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4964,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL624917,10116.0,10562,A,1,Intermediate,,,,1
N,,50597,,,,11020,,Rattus norvegicus,,BAO_0000218,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,CHEMBL625157,10116.0,10563,A,1,Intermediate,,,,1
N,,50597,,,,6251,Liver,Rattus norvegicus,,BAO_0000218,,In vitro metabolic potential in rat liver microsomes,CHEMBL625158,10116.0,10564,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,1568,,Rattus norvegicus,,BAO_0000218,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",CHEMBL625159,10116.0,10565,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3032,,Rattus norvegicus,,BAO_0000218,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",CHEMBL625160,10116.0,10566,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3748,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,CHEMBL625161,10116.0,10567,A,1,Intermediate,,,,1
N,,50597,,,In vivo,401,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL625162,10116.0,10568,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6512,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL625163,10116.0,10569,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17617,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rats at 10 mg/kg,CHEMBL625164,10116.0,10570,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6679,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,CHEMBL625165,10116.0,10571,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6742,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL625166,10116.0,10572,A,1,Intermediate,,,,1
N,,50597,,,,589,,Rattus norvegicus,,BAO_0000218,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,CHEMBL625167,10116.0,10573,A,1,Intermediate,,,,1
N,,50597,,,,589,,Rattus norvegicus,,BAO_0000218,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,CHEMBL625168,10116.0,10574,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3185,,Rattus norvegicus,,BAO_0000218,,Plasma clearance of the compound,CHEMBL625169,10116.0,10575,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17596,,Rattus norvegicus,,BAO_0000218,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,CHEMBL626264,10116.0,10576,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2713,,Rattus norvegicus,,BAO_0000218,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,CHEMBL626265,10116.0,10577,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12500,Plasma,Rattus norvegicus,,BAO_0000218,,The compound was tested for plasma clearance in rat,CHEMBL626266,10116.0,10578,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,12500,Plasma,Rattus norvegicus,,BAO_0000218,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,CHEMBL626267,10116.0,10579,A,1,Intermediate,,,1969.0,1
N,,50597,,,,2713,,Rattus norvegicus,,BAO_0000218,,Plasma concentration upon oral administration of 1 mg/Kg in rats,CHEMBL626268,10116.0,10580,A,1,Intermediate,,,,1
N,,50597,,,,1446,,Rattus norvegicus,,BAO_0000218,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,CHEMBL626269,10116.0,10581,A,1,Intermediate,,,,1
N,,50597,,,,6227,,Rattus norvegicus,,BAO_0000218,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,CHEMBL626270,10116.0,10582,A,1,Intermediate,,,,1
N,,50597,,,,4709,,Rattus norvegicus,,BAO_0000218,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,CHEMBL626271,10116.0,10583,A,1,Intermediate,,,,1
N,,50597,,,,5510,,Rattus norvegicus,,BAO_0000218,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",CHEMBL626272,10116.0,10584,A,1,Intermediate,,,,1
N,,50597,,,,5510,,Rattus norvegicus,,BAO_0000218,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",CHEMBL626273,10116.0,10585,A,1,Intermediate,,,,1
N,,50597,,,,5510,,Rattus norvegicus,,BAO_0000218,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",CHEMBL875346,10116.0,10586,A,1,Intermediate,,,,1
N,,50597,,,,5510,,Rattus norvegicus,,BAO_0000218,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",CHEMBL626274,10116.0,10587,A,1,Intermediate,,,,1
N,,50597,,,,4514,,Rattus norvegicus,,BAO_0000218,,Compound was tested for protein binding in rat plasma,CHEMBL626275,10116.0,10588,A,1,Intermediate,,,,1
N,,50597,,,,2713,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,CHEMBL624646,10116.0,10589,A,1,Intermediate,,,,1
N,,50597,,,,2713,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,CHEMBL624647,10116.0,10590,A,1,Intermediate,,,,1
N,,50597,,,,5340,Liver,Rattus norvegicus,,BAO_0000218,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,CHEMBL624648,10116.0,10591,A,1,Intermediate,,,2107.0,1
N,,50597,,,,12058,,Rattus norvegicus,,BAO_0000218,,Area under curve ratio was determined (po/iv) in rat,CHEMBL624649,10116.0,10592,A,1,Intermediate,,,,1
N,,50597,,,,11195,,Rattus norvegicus,,BAO_0000218,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,CHEMBL624650,10116.0,10593,A,1,Intermediate,,,,1
N,,50597,,,,11195,,Rattus norvegicus,,BAO_0000218,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,CHEMBL624651,10116.0,10594,A,1,Intermediate,,,,1
N,,50597,,,,11195,,Rattus norvegicus,,BAO_0000218,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,CHEMBL624652,10116.0,10595,A,1,Intermediate,,,,1
N,,50597,,,,6495,,Rattus norvegicus,,BAO_0000218,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,CHEMBL624653,10116.0,10596,A,1,Intermediate,,,,1
N,,50597,,,,6078,,Rattus norvegicus,,BAO_0000218,,Ratio of AUCbrain to AUCplasma,CHEMBL624654,10116.0,10597,A,1,Intermediate,,,,1
N,,50597,,,,5656,,Rattus norvegicus,,BAO_0000218,,Ratio of brain to plasma,CHEMBL624655,10116.0,10598,A,1,Intermediate,,,,1
N,,50597,,,,4910,,Rattus norvegicus,,BAO_0000218,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,CHEMBL624656,10116.0,10599,A,1,Intermediate,,,,1
N,,50597,,,,4910,,Rattus norvegicus,,BAO_0000218,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,CHEMBL624657,10116.0,10600,A,1,Intermediate,,,,1
N,,50597,,,,4910,,Rattus norvegicus,,BAO_0000218,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,CHEMBL624658,10116.0,10601,A,1,Intermediate,,,,1
N,,50597,,,,10130,,Rattus norvegicus,,BAO_0000218,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,CHEMBL624659,10116.0,10602,A,1,Intermediate,,,,1
N,,50597,,,,10130,,Rattus norvegicus,,BAO_0000218,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,CHEMBL624660,10116.0,10603,A,1,Intermediate,,,,1
N,,50597,,,,10130,,Rattus norvegicus,,BAO_0000218,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,CHEMBL624661,10116.0,10604,A,1,Intermediate,,,,1
N,,50597,,,,5213,,Rattus norvegicus,,BAO_0000218,,Steady state brain :blood ratio was determined,CHEMBL624662,10116.0,10605,A,1,Intermediate,,,,1
N,,50597,,,,4910,,Rattus norvegicus,,BAO_0000218,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,CHEMBL625199,10116.0,10606,A,1,Intermediate,,,,1
N,,50597,,,,4910,,Rattus norvegicus,,BAO_0000218,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,CHEMBL625200,10116.0,10607,A,1,Intermediate,,,,1
N,,50597,,,,4910,,Rattus norvegicus,,BAO_0000218,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,CHEMBL625201,10116.0,10608,A,1,Intermediate,,,,1
N,,50597,,,,4910,,Rattus norvegicus,,BAO_0000218,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,CHEMBL625202,10116.0,10609,A,1,Intermediate,,,,1
N,,50597,,,,2083,,Rattus norvegicus,,BAO_0000218,,Percentage recovery after 3h incubation with rat hapatocytes was determined,CHEMBL625203,10116.0,10610,A,1,Intermediate,,,,1
N,,50597,,,,2082,,Rattus norvegicus,,BAO_0000218,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,CHEMBL625204,10116.0,10611,A,1,Intermediate,,,,1
N,,50597,,,,2082,,Rattus norvegicus,,BAO_0000218,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,CHEMBL625205,10116.0,10612,A,1,Intermediate,,,,1
N,,50597,,,,6351,,Rattus norvegicus,,BAO_0000218,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,CHEMBL625206,10116.0,10613,A,1,Intermediate,,,,1
U,,22224,,,,14583,,,,BAO_0000019,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",CHEMBL625207,,10614,A,1,Autocuration,,,,0
U,,22224,,,,14583,,,,BAO_0000019,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,CHEMBL625208,,10615,A,1,Autocuration,,,,0
N,,50587,495.0,,,4608,,Homo sapiens,,BAO_0000218,,In vivo absorption in Caco-2 cell line monolayers was determined,CHEMBL625209,9606.0,10616,A,1,Intermediate,Caco-2,,,1
U,,22229,,,,13668,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625210,,10617,P,1,Autocuration,,,,0
N,,50597,,,,5669,,Rattus norvegicus,,BAO_0000218,,Area under curve was determine after peroral administration at 10 mpk in Rat,CHEMBL625211,10116.0,10618,A,1,Intermediate,,,,1
N,,50797,,,,5669,,Macaca mulatta,,BAO_0000218,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,CHEMBL625212,9544.0,10619,A,1,Intermediate,,,,1
N,,50597,,,,5669,,Rattus norvegicus,,BAO_0000218,,Area under curve was determine after peroral administration at 160 mpk in Rat,CHEMBL625213,10116.0,10620,A,1,Intermediate,,,,1
N,,50597,,,,5669,,Rattus norvegicus,,BAO_0000218,,Area under curve was determine after peroral administration at 20 mpk in Rat,CHEMBL625214,10116.0,10621,A,1,Intermediate,,,,1
N,,50597,,,,5669,,Rattus norvegicus,,BAO_0000218,,Area under curve was determine after peroral administration at 50 mpk in Rat,CHEMBL874542,10116.0,10622,A,1,Intermediate,,,,1
U,,22229,,,,6472,,,,BAO_0000100,,Calculated partition coefficient (clogP) (AlogP),CHEMBL625215,,10623,P,1,Autocuration,,,,0
U,,22224,,,,15106,,,,BAO_0000019,,Activated partial thromboplastin time measured,CHEMBL625216,,10624,A,1,Autocuration,,,,0
U,,22224,,,,15207,,,,BAO_0000100,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),CHEMBL625217,,10625,P,1,Autocuration,,,,0
U,,22224,,,,15207,,,,BAO_0000100,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),CHEMBL625218,,10626,P,1,Autocuration,,,,0
N,,50588,,,,13941,Plasma,Canis lupus familiaris,,BAO_0000218,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,CHEMBL622864,9615.0,10627,A,1,Intermediate,,,1969.0,1
N,,50597,,,,13941,Plasma,Rattus norvegicus,,BAO_0000218,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,CHEMBL622865,10116.0,10628,A,1,Intermediate,,,1969.0,1
N,,50597,,,,13941,Plasma,Rattus norvegicus,,BAO_0000218,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,CHEMBL622866,10116.0,10629,A,1,Intermediate,,,1969.0,1
N,,50588,,,,13941,Plasma,Canis lupus familiaris,,BAO_0000218,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,CHEMBL622867,9615.0,10630,A,1,Intermediate,,,1969.0,1
N,,50512,,,,15240,Plasma,Cavia porcellus,,BAO_0000218,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,CHEMBL876808,10141.0,10631,A,1,Intermediate,,,1969.0,1
U,,22224,,,,10655,Brain,,,BAO_0000019,,AUC in brain,CHEMBL627725,,10632,A,1,Autocuration,,,955.0,0
U,,22224,,,,10655,Serum,,,BAO_0000019,,AUC in serum,CHEMBL627726,,10633,A,1,Autocuration,,,1977.0,0
U,,22224,,,,6504,Plasma,,,BAO_0000019,,AUC was determined,CHEMBL627727,,10634,A,1,Autocuration,,,1969.0,0
U,,22224,,,,10615,Plasma,,,BAO_0000019,,AUC of the compound.,CHEMBL627728,,10635,A,1,Autocuration,,,1969.0,0
U,,22224,,,,10353,Plasma,,,BAO_0000019,,AUC value (0-4 hr),CHEMBL627729,,10636,A,1,Autocuration,,,1969.0,0
U,,22224,,,,14907,Plasma,,,BAO_0000019,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",CHEMBL627730,,10637,A,1,Autocuration,,,1969.0,0
U,,22224,,,,14907,Plasma,,,BAO_0000019,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,CHEMBL627731,,10638,A,1,Autocuration,,,1969.0,0
U,,22224,,,,14907,Plasma,,,BAO_0000019,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",CHEMBL627732,,10639,A,1,Autocuration,,,1969.0,0
U,,22224,,,,14907,Plasma,,,BAO_0000019,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",CHEMBL627733,,10640,A,1,Autocuration,,,1969.0,0
N,,50597,,,,16359,Plasma,Rattus norvegicus,,BAO_0000218,,AUC(area under curve) was determined after intravenous administration in rats,CHEMBL627734,10116.0,10641,A,1,Intermediate,,,1969.0,1
N,,50597,,,,16359,Plasma,Rattus norvegicus,,BAO_0000218,,AUC(area under curve) was determined after oral administration in rats,CHEMBL627735,10116.0,10642,A,1,Intermediate,,,1969.0,1
N,,50512,,,,15240,Plasma,Cavia porcellus,,BAO_0000218,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,CHEMBL627736,10141.0,10643,A,1,Intermediate,,,1969.0,1
N,,50597,,,,15240,Plasma,Rattus norvegicus,,BAO_0000218,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,CHEMBL876809,10116.0,10644,A,1,Intermediate,,,1969.0,1
U,,22224,,,,15469,,,,BAO_0000019,,Area Under Curve after oral dosing of 100 uM/Kg,CHEMBL627737,,10645,A,1,Autocuration,,,,0
U,,22224,,,,15469,,,,BAO_0000019,,Area Under Curve after oral dosing of 30 uM/Kg,CHEMBL627738,,10646,A,1,Autocuration,,,,0
U,,22224,,,,13520,,,,BAO_0000019,,Area Under Curve was measured by ploting the graph between concentration verses time,CHEMBL627739,,10647,A,1,Autocuration,,,,0
N,,50588,,,,17025,,Canis lupus familiaris,,BAO_0000218,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,CHEMBL626143,9615.0,10648,A,1,Intermediate,,,,1
U,,22224,,,,17025,,Simiiformes,,BAO_0000218,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,CHEMBL626144,314293.0,10649,A,1,Autocuration,,,,0
N,,50592,,,,17025,,Oryctolagus cuniculus,,BAO_0000218,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,CHEMBL626145,9986.0,10650,A,1,Intermediate,,,,1
N,,50597,,,,17025,,Rattus norvegicus,,BAO_0000218,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,CHEMBL626146,10116.0,10651,A,1,Intermediate,,,,1
N,,50597,,,,12032,Blood,Rattus norvegicus,,BAO_0000218,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,CHEMBL626147,10116.0,10652,A,1,Intermediate,,,178.0,1
U,,22224,,,,10291,,,,BAO_0000019,,Area under curve (AUC) was determined,CHEMBL626148,,10653,A,1,Autocuration,,,,0
U,,22224,,,,5767,,,,BAO_0000218,,Area under curve (AUC) following ip administration at 1 mg/kg,CHEMBL626149,,10654,A,1,Autocuration,,,,0
U,,22224,,,,1434,,,,BAO_0000019,,Area under curve (AUC) was determined; ND is Not determined,CHEMBL626150,,10655,A,1,Autocuration,,,,0
N,,50588,,,,14925,,Canis lupus familiaris,,BAO_0000218,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,CHEMBL626151,9615.0,10656,A,1,Intermediate,,,,1
N,,50588,,,,14925,,Canis lupus familiaris,,BAO_0000218,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,CHEMBL626152,9615.0,10657,A,1,Intermediate,,,,1
N,,50588,,,,14925,,Canis lupus familiaris,,BAO_0000218,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,CHEMBL626153,9615.0,10658,A,1,Intermediate,,,,1
U,,22224,,,,1434,,,,BAO_0000019,,Area under curve (AUR) was determined,CHEMBL626154,,10659,A,1,Autocuration,,,,0
U,,22224,,,,11883,,,,BAO_0000019,,Area under curve at 1 uM/dg administered intravenously,CHEMBL626155,,10660,A,1,Autocuration,,,,0
U,,22224,,,,11883,,,,BAO_0000019,,Area under curve at 10 uM/dg administered perorally,CHEMBL626156,,10661,A,1,Autocuration,,,,0
U,,22224,,,,11883,,,,BAO_0000019,,Area under curve at 2 uM/dg administered intravenously,CHEMBL626157,,10662,A,1,Autocuration,,,,0
U,,22224,,,,11883,,,,BAO_0000019,,Area under curve at 20 uM/dg administered perorally,CHEMBL626158,,10663,A,1,Autocuration,,,,0
N,,50588,,,,15233,,Canis lupus familiaris,,BAO_0000218,,Area under curve at a peroral dose of 3 mg/kg in dog,CHEMBL626159,9615.0,10664,A,1,Intermediate,,,,1
N,,50597,,,,15233,,Rattus norvegicus,,BAO_0000218,,Area under curve at a peroral dose of 3 mg/kg in rat,CHEMBL626160,10116.0,10665,A,1,Intermediate,,,,1
N,,50588,,,,15233,,Canis lupus familiaris,,BAO_0000218,,Area under curve at an iv dose of 1 mg/kg in dog,CHEMBL626161,9615.0,10666,A,1,Intermediate,,,,1
N,,50597,,,,15233,,Rattus norvegicus,,BAO_0000218,,Area under curve at an iv dose of 1 mg/kg in rat,CHEMBL626162,10116.0,10667,A,1,Intermediate,,,,1
U,,22224,,,,12978,,,,BAO_0000019,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,CHEMBL626163,,10668,A,1,Autocuration,,,,0
U,,22224,,,,12978,,,,BAO_0000019,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,CHEMBL626164,,10669,A,1,Autocuration,,,,0
N,,50594,,,,11355,,Mus musculus,,BAO_0000218,,Area under curve measured as conc vs time after intravenous administration to mice.,CHEMBL626165,10090.0,10670,A,1,Intermediate,,,,1
N,,50594,,,,11355,,Mus musculus,,BAO_0000218,,Area under curve measured as conc vs time after peroral administration to mice.,CHEMBL626166,10090.0,10671,A,1,Intermediate,,,,1
N,,50588,,,,12923,,Canis lupus familiaris,,BAO_0000218,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,CHEMBL626167,9615.0,10672,A,1,Intermediate,,,,1
N,,50588,,,,12923,,Canis lupus familiaris,,BAO_0000218,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,CHEMBL626168,9615.0,10673,A,1,Intermediate,,,,1
N,,50588,,,,12923,,Canis lupus familiaris,,BAO_0000218,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,CHEMBL877463,9615.0,10674,A,1,Intermediate,,,,1
N,,50588,,,,12923,,Canis lupus familiaris,,BAO_0000218,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,CHEMBL626169,9615.0,10675,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17738,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,CHEMBL626170,10116.0,10676,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,17738,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,CHEMBL626171,10116.0,10677,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,17738,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,CHEMBL626172,10116.0,10678,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,17738,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,CHEMBL626173,10116.0,10679,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,17738,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,CHEMBL626174,10116.0,10680,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,17738,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,CHEMBL626175,10116.0,10681,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,17738,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,CHEMBL626176,10116.0,10682,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,17738,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,CHEMBL626177,10116.0,10683,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,17738,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,CHEMBL622499,10116.0,10684,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,17738,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,CHEMBL622500,10116.0,10685,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,17738,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,CHEMBL622501,10116.0,10686,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,17738,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,CHEMBL622502,10116.0,10687,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,17738,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,CHEMBL622503,10116.0,10688,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,17738,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,CHEMBL877614,10116.0,10689,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,17738,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,CHEMBL624839,10116.0,10690,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,17738,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,CHEMBL624840,10116.0,10691,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,17738,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,CHEMBL624841,10116.0,10692,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,17738,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,CHEMBL624842,10116.0,10693,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,17738,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,CHEMBL624843,10116.0,10694,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,17738,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,CHEMBL624844,10116.0,10695,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,17738,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,CHEMBL624845,10116.0,10696,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,17738,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,CHEMBL621904,10116.0,10697,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,11195,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,CHEMBL621905,10116.0,10698,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,11195,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,CHEMBL874382,10116.0,10699,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,11195,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,CHEMBL621906,10116.0,10700,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,11195,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,CHEMBL621907,10116.0,10701,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,11195,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,CHEMBL622096,10116.0,10702,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,11195,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,CHEMBL622097,10116.0,10703,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,11195,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,CHEMBL622098,10116.0,10704,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,11195,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,CHEMBL622099,10116.0,10705,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,11195,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,CHEMBL622100,10116.0,10706,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,11195,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,CHEMBL622101,10116.0,10707,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,11195,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,CHEMBL622102,10116.0,10708,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,11195,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,CHEMBL622103,10116.0,10709,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,11195,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,CHEMBL622104,10116.0,10710,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,11195,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,CHEMBL622105,10116.0,10711,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,11195,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,CHEMBL622106,10116.0,10712,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,11195,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,CHEMBL622107,10116.0,10713,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,11195,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,CHEMBL622108,10116.0,10714,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,11195,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,CHEMBL622109,10116.0,10715,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,11195,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,CHEMBL622110,10116.0,10716,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,11195,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,CHEMBL622111,10116.0,10717,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,11195,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,CHEMBL874383,10116.0,10718,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,11195,Zone of skin,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,CHEMBL622112,10116.0,10719,A,1,Intermediate,,,14.0,1
N,,50597,,,In vivo,11195,Zone of skin,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,CHEMBL622113,10116.0,10720,A,1,Intermediate,,,14.0,1
N,,50597,,,In vivo,11195,Zone of skin,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,CHEMBL622114,10116.0,10721,A,1,Intermediate,,,14.0,1
N,,50597,,,In vivo,11195,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,CHEMBL622115,10116.0,10722,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,11195,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,CHEMBL622116,10116.0,10723,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,6193,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622117,10116.0,10724,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6803,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622118,10116.0,10725,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6647,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rats at 6 mg/kg,CHEMBL622119,10116.0,10726,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6647,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 6 mg/kg),CHEMBL622120,10116.0,10727,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6647,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,CHEMBL622121,10116.0,10728,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6640,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622122,10116.0,10729,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6641,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622123,10116.0,10730,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6641,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL622124,10116.0,10731,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6642,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL622125,10116.0,10732,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5472,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability,CHEMBL622126,10116.0,10733,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6141,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),CHEMBL620455,10116.0,10734,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4390,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL620456,10116.0,10735,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5472,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL620457,10116.0,10736,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5472,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability was evaluated; Not tested,CHEMBL620458,10116.0,10737,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5438,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability,CHEMBL620459,10116.0,10738,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4883,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat by oral dosing,CHEMBL620460,10116.0,10739,A,1,Intermediate,,,,1
N,,50597,,,In vivo,1908,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 10 mg/kg p.o.),CHEMBL620461,10116.0,10740,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4853,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley),CHEMBL620462,10116.0,10741,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4853,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),CHEMBL620463,10116.0,10742,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4853,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),CHEMBL620464,10116.0,10743,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4853,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),CHEMBL620465,10116.0,10744,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4853,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),CHEMBL620466,10116.0,10745,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4853,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,CHEMBL620467,10116.0,10746,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4853,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,CHEMBL620468,10116.0,10747,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12873,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,CHEMBL620469,10116.0,10748,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12873,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,CHEMBL620470,10116.0,10749,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3169,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL620471,10116.0,10750,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6305,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL620472,10116.0,10751,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4762,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,CHEMBL620473,10116.0,10752,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17847,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL620474,10116.0,10753,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6211,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),CHEMBL620475,10116.0,10754,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6011,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL620476,10116.0,10755,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6317,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL620477,10116.0,10756,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6644,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,CHEMBL620478,10116.0,10757,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6644,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,CHEMBL618768,10116.0,10758,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6644,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,CHEMBL618769,10116.0,10759,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6644,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,CHEMBL618770,10116.0,10760,A,1,Intermediate,,,,1
N,,50597,,,In vivo,6113,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability (dose 20 mg/kg p.o.),CHEMBL618771,10116.0,10761,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5937,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,CHEMBL618772,10116.0,10762,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5711,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat at 10 mg/kg of the compound,CHEMBL618773,10116.0,10763,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17717,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,CHEMBL875842,10116.0,10764,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17717,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 3 mg/kg i.v.),CHEMBL618774,10116.0,10765,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17717,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,CHEMBL618775,10116.0,10766,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17717,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 60 mg/kg p.o.),CHEMBL618776,10116.0,10767,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4722,,Rattus norvegicus,,BAO_0000218,,Percent bioavailability (F) in rats after iv administration,CHEMBL618777,10116.0,10768,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4722,,Rattus norvegicus,,BAO_0000218,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,CHEMBL618778,10116.0,10769,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4353,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 5 uM/kg p.o.),CHEMBL618779,10116.0,10770,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15662,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability,CHEMBL618780,10116.0,10771,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4756,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 2 mg/kg p.o.),CHEMBL618781,10116.0,10772,A,1,Intermediate,,,,1
N,,50597,,,In vivo,4756,,Rattus norvegicus,,BAO_0000218,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,CHEMBL618782,10116.0,10773,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3436,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 20 mg/kg),CHEMBL618783,10116.0,10774,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17800,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL618784,10116.0,10775,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15762,,Rattus norvegicus,,BAO_0000218,,Percent oral bioavailability evaluated in rat,CHEMBL618785,10116.0,10776,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5089,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL618786,10116.0,10777,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5089,,Rattus norvegicus,,BAO_0000218,,Percent oral bioavailability in rat; Not determined,CHEMBL618787,10116.0,10778,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3185,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL618788,10116.0,10779,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5145,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL618789,10116.0,10780,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3457,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),CHEMBL618790,10116.0,10781,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3457,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),CHEMBL618791,10116.0,10782,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5983,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,CHEMBL875843,10116.0,10783,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5739,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 20 mg/kg p.o.),CHEMBL618792,10116.0,10784,A,1,Intermediate,,,,1
N,,50597,,,In vivo,3579,,Rattus norvegicus,,BAO_0000218,,Cmax at a dose of 30 mg/kg in rat,CHEMBL623395,10116.0,10785,A,1,Intermediate,,,,1
U,,22224,,,In vivo,17788,,Simiiformes,,BAO_0000218,,Cmax in monkeys at a dose of 1 mg/kg,CHEMBL623396,314293.0,10786,A,1,Autocuration,,,,0
N,,50597,,,In vivo,14956,,Rattus norvegicus,,BAO_0000218,,Cmax in rat,CHEMBL623397,10116.0,10787,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17788,,Rattus norvegicus,,BAO_0000218,,Cmax in rats at a dose of 1 mg/kg,CHEMBL623398,10116.0,10788,A,1,Intermediate,,,,1
N,,50594,,,In vivo,9750,,Mus musculus,,BAO_0000218,,Cmax was measured in mice after an oral dose of 50 mg/kg.,CHEMBL623399,10090.0,10789,A,1,Intermediate,,,,1
U,,22224,,,In vivo,12767,,,,BAO_0000218,,"Cmax value at a dose of 12.7 uM/kg, po",CHEMBL623400,,10790,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12767,,,,BAO_0000218,,"Cmax value at a dose of 6.3 uM/kg, iv",CHEMBL623401,,10791,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12767,,,,BAO_0000218,,"Cmax value at a dose of 7.1 uM/kg, iv",CHEMBL623402,,10792,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12703,,,,BAO_0000218,,Cmax value of compound was determined after 1 hr,CHEMBL623403,,10793,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15778,,,,BAO_0000218,,Cmax value of the compound,CHEMBL623404,,10794,A,1,Autocuration,,,,0
N,,50597,,,In vivo,12818,,Rattus norvegicus,,BAO_0000218,,Cmax value administered intraintestinal in rats.,CHEMBL625997,10116.0,10795,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14964,,Rattus norvegicus,,BAO_0000218,,Cmax value administered perorally was determined in rat; Not determined,CHEMBL625998,10116.0,10796,A,1,Intermediate,,,,1
U,,22224,,,In vivo,15808,,,,BAO_0000218,,Cmax value at the dose of 2.3 mg/kg,CHEMBL625999,,10797,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15808,,,,BAO_0000218,,Cmax value at the dose of 5 mg/kg,CHEMBL626000,,10798,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15778,,,,BAO_0000218,,Cmax value in the period of 8 hr after dosing. ,CHEMBL626001,,10799,A,1,Autocuration,,,,0
U,,22224,,,In vivo,3715,,,,BAO_0000218,,Cmax value at a oral dose of 20 mg/kg; Not tested,CHEMBL626002,,10800,A,1,Autocuration,,,,0
U,,22224,,,In vivo,3715,,,,BAO_0000218,,Cmax value at a oral dose of 20 mg/kg,CHEMBL626003,,10801,A,1,Autocuration,,,,0
N,,50597,,,In vivo,1446,,Rattus norvegicus,,BAO_0000218,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,CHEMBL626004,10116.0,10802,A,1,Intermediate,,,,1
N,,50512,,,In vivo,15240,,Cavia porcellus,,BAO_0000218,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,CHEMBL626005,10141.0,10803,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15240,,Rattus norvegicus,,BAO_0000218,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,CHEMBL626006,10116.0,10804,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14810,Plasma,Rattus norvegicus,,BAO_0000218,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,CHEMBL626007,10116.0,10805,A,1,Intermediate,,,1969.0,1
N,,50594,,,In vivo,14239,Plasma,Mus musculus,,BAO_0000218,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,CHEMBL626008,10090.0,10806,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,12555,Liver,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,CHEMBL626009,9615.0,10807,A,1,Intermediate,,,2107.0,1
N,,50588,,,In vivo,10754,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,CHEMBL626010,9615.0,10808,A,1,Intermediate,,,,1
N,,50594,,,In vivo,10754,Blood,Mus musculus,,BAO_0000218,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,CHEMBL626011,10090.0,10809,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,10754,Blood,Mus musculus,,BAO_0000218,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,CHEMBL626012,10090.0,10810,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,10754,Blood,Mus musculus,,BAO_0000218,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,CHEMBL626013,10090.0,10811,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,10754,Blood,Mus musculus,,BAO_0000218,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,CHEMBL626014,10090.0,10812,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,10754,Blood,Mus musculus,,BAO_0000218,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,CHEMBL877496,10090.0,10813,A,1,Intermediate,,,178.0,1
N,,50588,,,In vivo,14600,,Canis lupus familiaris,,BAO_0000218,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,CHEMBL626015,9615.0,10814,F,1,Intermediate,,,,1
N,,50588,,,In vivo,14600,,Canis lupus familiaris,,BAO_0000218,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,CHEMBL626016,9615.0,10815,F,1,Intermediate,,,,1
N,,50588,,,In vivo,14600,,Canis lupus familiaris,,BAO_0000218,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,CHEMBL626017,9615.0,10816,F,1,Intermediate,,,,1
N,,50588,,,In vivo,13543,Plasma,Canis lupus familiaris,,BAO_0000218,,Bioavailability as maximal plasma concentration in dogs,CHEMBL626018,9615.0,10817,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,13543,Plasma,Canis lupus familiaris,,BAO_0000218,,Bioavailability as maximal plasma concentration in dogs,CHEMBL626692,9615.0,10818,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,13543,Plasma,Rattus norvegicus,,BAO_0000218,,Bioavailability as maximal plasma concentration in rats,CHEMBL626693,10116.0,10819,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,13543,Plasma,Rattus norvegicus,,BAO_0000218,,Bioavailability as maximal plasma concentration in rats,CHEMBL626694,10116.0,10820,A,1,Autocuration,,,1969.0,0
N,,50588,,,In vivo,14600,Blood,Canis lupus familiaris,,BAO_0000218,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,CHEMBL626695,9615.0,10821,A,1,Intermediate,,,178.0,1
N,,50588,,,In vivo,14600,Blood,Canis lupus familiaris,,BAO_0000218,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,CHEMBL626696,9615.0,10822,A,1,Intermediate,,,178.0,1
N,,50588,,,In vivo,14600,Blood,Canis lupus familiaris,,BAO_0000218,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,CHEMBL626697,9615.0,10823,A,1,Intermediate,,,178.0,1
N,,50588,,,In vivo,14600,Blood,Canis lupus familiaris,,BAO_0000218,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,CHEMBL626859,9615.0,10824,A,1,Intermediate,,,178.0,1
N,,50588,,,In vivo,14600,Blood,Canis lupus familiaris,,BAO_0000218,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,CHEMBL626860,9615.0,10825,A,1,Intermediate,,,178.0,1
N,,50588,,,In vivo,14600,Blood,Canis lupus familiaris,,BAO_0000218,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,CHEMBL626861,9615.0,10826,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,14681,,Rattus norvegicus,,BAO_0000218,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,CHEMBL626296,10116.0,10827,A,1,Intermediate,,,,1
U,,22224,,,In vivo,15905,,,,BAO_0000218,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,CHEMBL626297,,10828,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15905,Plasma,,,BAO_0000218,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,CHEMBL626298,,10829,A,1,Autocuration,,,1969.0,0
N,,50597,,,In vivo,13304,Plasma,Rattus norvegicus,,BAO_0000218,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",CHEMBL626299,10116.0,10830,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15137,Plasma,Rattus norvegicus,,BAO_0000218,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,CHEMBL626300,10116.0,10831,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15137,Plasma,Rattus norvegicus,,BAO_0000218,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,CHEMBL626301,10116.0,10832,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15137,Plasma,Rattus norvegicus,,BAO_0000218,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,CHEMBL626962,10116.0,10833,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15137,Plasma,Rattus norvegicus,,BAO_0000218,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,CHEMBL626963,10116.0,10834,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15137,Plasma,Rattus norvegicus,,BAO_0000218,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,CHEMBL626964,10116.0,10835,A,1,Intermediate,,,1969.0,1
N,,100710,,,In vivo,14839,Plasma,Macaca fascicularis,,BAO_0000218,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,CHEMBL626965,9541.0,10836,A,1,Intermediate,,,1969.0,1
N,,50594,,,In vivo,14839,Plasma,Mus musculus,,BAO_0000218,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,CHEMBL626966,10090.0,10837,A,1,Intermediate,,,1969.0,1
N,,50594,,,In vivo,14839,Plasma,Mus musculus,,BAO_0000218,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,CHEMBL626967,10090.0,10838,A,1,Intermediate,,,1969.0,1
N,,100710,,,In vivo,14839,Plasma,Macaca fascicularis,,BAO_0000218,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,CHEMBL626968,9541.0,10839,A,1,Intermediate,,,1969.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,CHEMBL626969,10116.0,10840,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,CHEMBL627126,10116.0,10841,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,CHEMBL631276,10116.0,10842,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,CHEMBL631277,10116.0,10843,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,CHEMBL631278,10116.0,10844,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,CHEMBL874457,10116.0,10845,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,CHEMBL631279,10116.0,10846,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,CHEMBL631280,10116.0,10847,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,CHEMBL631281,10116.0,10848,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,CHEMBL631968,10116.0,10849,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,CHEMBL631969,10116.0,10850,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,CHEMBL631970,10116.0,10851,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,CHEMBL631971,10116.0,10852,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,CHEMBL631972,10116.0,10853,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,CHEMBL630435,10116.0,10854,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,CHEMBL630436,10116.0,10855,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,CHEMBL630437,10116.0,10856,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,CHEMBL630438,10116.0,10857,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,CHEMBL630439,10116.0,10858,A,1,Intermediate,,,948.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,CHEMBL630440,10116.0,10859,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,CHEMBL630441,10116.0,10860,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,CHEMBL630442,10116.0,10861,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,CHEMBL625234,10116.0,10862,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,CHEMBL625235,10116.0,10863,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,CHEMBL625236,10116.0,10864,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,CHEMBL625237,10116.0,10865,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,CHEMBL626125,10116.0,10866,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,CHEMBL626126,10116.0,10867,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,CHEMBL626127,10116.0,10868,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,CHEMBL626128,10116.0,10869,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,CHEMBL626129,10116.0,10870,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,CHEMBL626130,10116.0,10871,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,CHEMBL626131,10116.0,10872,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,CHEMBL626132,10116.0,10873,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,CHEMBL626752,10116.0,10874,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,CHEMBL626753,10116.0,10875,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,CHEMBL626754,10116.0,10876,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,CHEMBL626755,10116.0,10877,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,CHEMBL626756,10116.0,10878,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,CHEMBL626757,10116.0,10879,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,CHEMBL626758,10116.0,10880,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,CHEMBL626759,10116.0,10881,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,CHEMBL626760,10116.0,10882,A,1,Intermediate,,,2107.0,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),CHEMBL626394,9615.0,10883,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,CHEMBL626395,9615.0,10884,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),CHEMBL626396,9615.0,10885,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),CHEMBL626397,9615.0,10886,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),CHEMBL626398,9615.0,10887,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),CHEMBL626399,9615.0,10888,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,CHEMBL874653,10116.0,10889,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),CHEMBL626400,10116.0,10890,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),CHEMBL626401,10116.0,10891,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),CHEMBL626402,10116.0,10892,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),CHEMBL626403,10116.0,10893,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),CHEMBL626404,10116.0,10894,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,CHEMBL626405,10116.0,10895,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),CHEMBL625529,10116.0,10896,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),CHEMBL625530,10116.0,10897,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),CHEMBL625531,10116.0,10898,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),CHEMBL625532,10116.0,10899,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),CHEMBL625533,10116.0,10900,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,CHEMBL875474,10116.0,10901,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),CHEMBL625534,10116.0,10902,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),CHEMBL625535,10116.0,10903,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),CHEMBL625536,10116.0,10904,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),CHEMBL625537,10116.0,10905,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),CHEMBL625538,10116.0,10906,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,CHEMBL625539,10116.0,10907,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),CHEMBL625540,10116.0,10908,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),CHEMBL625541,10116.0,10909,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),CHEMBL625542,10116.0,10910,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),CHEMBL625543,10116.0,10911,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),CHEMBL625544,10116.0,10912,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,CHEMBL625545,9615.0,10913,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),CHEMBL625546,9615.0,10914,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,CHEMBL625547,9615.0,10915,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),CHEMBL625548,9615.0,10916,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),CHEMBL625549,9615.0,10917,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),CHEMBL625550,9615.0,10918,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),CHEMBL625551,9615.0,10919,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),CHEMBL875475,9615.0,10920,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),CHEMBL625552,9615.0,10921,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),CHEMBL625553,9615.0,10922,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),CHEMBL625554,9615.0,10923,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),CHEMBL625555,9615.0,10924,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),CHEMBL625556,9615.0,10925,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,CHEMBL624986,9615.0,10926,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),CHEMBL624987,9615.0,10927,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),CHEMBL624988,9615.0,10928,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,CHEMBL624989,9615.0,10929,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,CHEMBL624990,9615.0,10930,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,CHEMBL874391,9615.0,10931,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,CHEMBL624991,9615.0,10932,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,CHEMBL624992,9615.0,10933,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,CHEMBL624993,9615.0,10934,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,CHEMBL624994,9615.0,10935,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,CHEMBL624995,9615.0,10936,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,CHEMBL624996,9615.0,10937,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,CHEMBL624997,9615.0,10938,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,CHEMBL624998,9615.0,10939,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,CHEMBL624999,9615.0,10940,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,CHEMBL882955,9615.0,10941,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,CHEMBL625000,9615.0,10942,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,CHEMBL625001,9615.0,10943,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,CHEMBL625089,9615.0,10944,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,CHEMBL625090,9615.0,10945,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,CHEMBL625091,9615.0,10946,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,CHEMBL625092,9615.0,10947,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,CHEMBL625093,9615.0,10948,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,CHEMBL625094,9615.0,10949,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,CHEMBL625095,9615.0,10950,A,1,Intermediate,,,1637.0,1
N,,50588,,,In vivo,2249,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for its bioavailability in the dogs,CHEMBL625096,9615.0,10951,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2249,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for its bioavailability in the rats,CHEMBL625097,10116.0,10952,A,1,Intermediate,,,,1
U,,22224,,,In vivo,17515,,,,BAO_0000218,,Compound was evaluated for oral bioavailability,CHEMBL882956,,10953,A,1,Autocuration,,,,0
N,,50597,,,In vivo,14541,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for percentage of Oral bioavailability in rats,CHEMBL625098,10116.0,10954,A,1,Intermediate,,,,1
U,,22224,,,In vivo,12797,,Cavia porcellus,,BAO_0000218,,Bioavailability in guinea pig,CHEMBL625099,10141.0,10955,A,1,Autocuration,,,,0
N,,50597,,,In vivo,12797,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for the oral bioavailability in rat,CHEMBL625100,10116.0,10956,A,1,Intermediate,,,,1
N,,50588,,,In vivo,12797,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for the oral bioavailability in dog,CHEMBL625101,9615.0,10957,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12797,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for the oral bioavailability in rat,CHEMBL874396,10116.0,10958,A,1,Intermediate,,,,1
U,,22224,,,In vivo,11727,,Canis lupus familiaris,,BAO_0000218,,Bioavailability in dog (dosed i.v.),CHEMBL625102,9615.0,10959,F,1,Autocuration,,,,0
N,,50588,,,In vivo,13249,,Canis lupus familiaris,,BAO_0000218,,Compound was tested for in vivo bioavailability in dog,CHEMBL625103,9615.0,10960,A,1,Intermediate,,,,1
N,,100712,,,In vivo,13249,,Cricetinae,,BAO_0000218,,Compound was tested for in vivo bioavailability in hamsters,CHEMBL625104,10026.0,10961,A,1,Intermediate,,,,1
U,,22224,,,In vivo,13249,,Simiiformes,,BAO_0000218,,Compound was tested for in vivo bioavailability in monkey,CHEMBL625105,314293.0,10962,A,1,Autocuration,,,,0
N,,50597,,,In vivo,13249,,Rattus norvegicus,,BAO_0000218,,Compound was tested for in vivo bioavailability in rat,CHEMBL625106,10116.0,10963,A,1,Intermediate,,,,1
U,,22224,,,In vivo,9552,,Mus musculus,,BAO_0000218,,Oral bioavailability in mouse,CHEMBL625107,10090.0,10964,A,1,Autocuration,,,,0
N,,50594,,,In vivo,9552,,Mus musculus,,BAO_0000218,,Compound was tested for percent of oral bioavailability in mice; 56-74,CHEMBL625108,10090.0,10965,A,1,Intermediate,,,,1
U,,22224,,,In vivo,14839,,Mus musculus,,BAO_0000218,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),CHEMBL625109,10090.0,10966,A,1,Autocuration,,,,0
U,,22224,,,In vivo,14839,,Macaca fascicularis,,BAO_0000218,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),CHEMBL625110,9541.0,10967,A,1,Autocuration,,,,0
U,,22224,,,In vivo,14839,,Macaca fascicularis,,BAO_0000218,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),CHEMBL625111,9541.0,10968,A,1,Autocuration,,,,0
N,,50594,,,In vivo,14839,,Mus musculus,,BAO_0000218,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),CHEMBL625112,10090.0,10969,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14839,,Mus musculus,,BAO_0000218,,Oral bioavailability in nude mice,CHEMBL875334,10090.0,10970,A,1,Intermediate,,,,1
U,,22224,,,In vivo,11219,,Primates,,BAO_0000218,,Bioavailability in monkey (i.d. dosing),CHEMBL628617,9443.0,10971,A,1,Autocuration,,,,0
U,,22224,,,In vivo,9552,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL628618,10116.0,10972,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11732,,,,BAO_0000218,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,CHEMBL628619,,10973,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11732,,,,BAO_0000218,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,CHEMBL628620,,10974,A,1,Autocuration,,,,0
N,,100710,,,In vivo,14839,,Macaca fascicularis,,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",CHEMBL628621,9541.0,10975,A,1,Intermediate,,,,1
N,,100710,,,In vivo,14839,,Macaca fascicularis,,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",CHEMBL628622,9541.0,10976,A,1,Intermediate,,,,1
N,,100710,,,In vivo,14839,,Macaca fascicularis,,BAO_0000218,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",CHEMBL628623,9541.0,10977,A,1,Intermediate,,,,1
N,,100710,,,In vivo,14839,Plasma,Macaca fascicularis,,BAO_0000218,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,CHEMBL628624,9541.0,10978,A,1,Intermediate,,,1969.0,1
N,,50594,,,In vivo,14839,Plasma,Mus musculus,,BAO_0000218,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,CHEMBL628625,10090.0,10979,A,1,Intermediate,,,1969.0,1
N,,100710,,,In vivo,14839,Plasma,Macaca fascicularis,,BAO_0000218,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,CHEMBL628626,9541.0,10980,A,1,Intermediate,,,1969.0,1
N,,50594,,,In vivo,14839,Plasma,Mus musculus,,BAO_0000218,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,CHEMBL627041,10090.0,10981,A,1,Intermediate,,,1969.0,1
N,,50594,,,In vivo,14839,Plasma,Mus musculus,,BAO_0000218,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,CHEMBL627042,10090.0,10982,A,1,Intermediate,,,1969.0,1
N,,50594,,,In vivo,14839,Plasma,Mus musculus,,BAO_0000218,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,CHEMBL627043,10090.0,10983,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,13932,Plasma,,,BAO_0000218,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,CHEMBL627044,,10984,A,1,Autocuration,,,1969.0,0
N,,50594,,,In vivo,11637,Plasma,Mus musculus,,BAO_0000218,,Cmax in mouse plasma,CHEMBL627045,10090.0,10985,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,11637,Plasma,,,BAO_0000218,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,CHEMBL627046,,10986,A,1,Autocuration,,,1969.0,0
N,,50597,,,In vivo,13960,Plasma,Rattus norvegicus,,BAO_0000218,,Maximal plasma concentration in rat,CHEMBL627047,10116.0,10987,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15905,Plasma,Rattus norvegicus,,BAO_0000218,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,CHEMBL627048,10116.0,10988,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14062,,Rattus norvegicus,,BAO_0000218,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,CHEMBL627049,10116.0,10989,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14062,,Rattus norvegicus,,BAO_0000218,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,CHEMBL627050,10116.0,10990,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14062,,Rattus norvegicus,,BAO_0000218,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,CHEMBL627051,10116.0,10991,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14062,,Rattus norvegicus,,BAO_0000218,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,CHEMBL627052,10116.0,10992,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14062,,Rattus norvegicus,,BAO_0000218,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,CHEMBL627053,10116.0,10993,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14062,,Rattus norvegicus,,BAO_0000218,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,CHEMBL627054,10116.0,10994,A,1,Intermediate,,,,1
N,,50594,,,In vivo,15011,,Mus musculus,,BAO_0000218,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,CHEMBL627055,10090.0,10995,A,1,Intermediate,,,,1
N,,50594,,,In vivo,15011,,Mus musculus,,BAO_0000218,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,CHEMBL627056,10090.0,10996,A,1,Intermediate,,,,1
N,,50594,,,In vivo,15011,,Mus musculus,,BAO_0000218,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),CHEMBL627057,10090.0,10997,A,1,Intermediate,,,,1
N,,50594,,,In vivo,15011,,Mus musculus,,BAO_0000218,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,CHEMBL627058,10090.0,10998,A,1,Intermediate,,,,1
N,,50594,,,In vivo,15011,,Mus musculus,,BAO_0000218,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,CHEMBL626211,10090.0,10999,A,1,Intermediate,,,,1
U,,22224,,,In vivo,10291,,,,BAO_0000218,,Maximum Concentration of the compound.,CHEMBL626212,,11000,A,1,Autocuration,,,,0
N,,50588,,,In vivo,14599,,Canis lupus familiaris,,BAO_0000218,,Maximum Concentration was measured after iv administration into Beagle dog,CHEMBL626213,9615.0,11001,A,1,Intermediate,,,,1
N,,50588,,,In vivo,14599,,Canis lupus familiaris,,BAO_0000218,,Maximum Concentration was measured after iv administration into Beagle dog.,CHEMBL626214,9615.0,11002,A,1,Intermediate,,,,1
N,,50588,,,In vivo,14599,,Canis lupus familiaris,,BAO_0000218,,Maximum Concentration was measured after po administration into Beagle dog,CHEMBL626215,9615.0,11003,A,1,Intermediate,,,,1
N,,50588,,,In vivo,14599,,Canis lupus familiaris,,BAO_0000218,,Maximum Concentration was measured after po administration into Beagle dog.,CHEMBL626216,9615.0,11004,A,1,Intermediate,,,,1
U,,22224,,,In vivo,12767,Blood,,,BAO_0000218,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,CHEMBL626217,,11005,A,1,Autocuration,,,178.0,0
U,,22224,,,In vivo,12767,Blood,,,BAO_0000218,,Maximum blood level reached after an iv dose of 12.2 uM/kg,CHEMBL626218,,11006,A,1,Autocuration,,,178.0,0
U,,22224,,,In vivo,12767,Blood,,,BAO_0000218,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,CHEMBL626219,,11007,A,1,Autocuration,,,178.0,0
U,,22224,,,In vivo,12767,Blood,,,BAO_0000218,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,CHEMBL626220,,11008,A,1,Autocuration,,,178.0,0
U,,22224,,,In vivo,12767,Blood,,,BAO_0000218,,Maximum blood level reached after an oral dose of 5.0 mg/kg,CHEMBL626221,,11009,A,1,Autocuration,,,178.0,0
U,,22224,,,In vivo,12767,Blood,,,BAO_0000218,,Maximum blood level reached at dose of 10.6 uM/kg orally,CHEMBL626222,,11010,A,1,Autocuration,,,178.0,0
N,,50512,,,In vivo,14706,,Cavia porcellus,,BAO_0000218,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,CHEMBL626223,10141.0,11011,A,1,Intermediate,,,,1
N,,50512,,,In vivo,14706,,Cavia porcellus,,BAO_0000218,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,CHEMBL626224,10141.0,11012,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14793,Brain,Rattus norvegicus,,BAO_0000218,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,CHEMBL626225,10116.0,11013,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,14793,Brain,Rattus norvegicus,,BAO_0000218,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,CHEMBL626226,10116.0,11014,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,14793,Brain,Rattus norvegicus,,BAO_0000218,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,CHEMBL626227,10116.0,11015,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,14793,Brain,Rattus norvegicus,,BAO_0000218,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,CHEMBL626228,10116.0,11016,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,14793,,Rattus norvegicus,,BAO_0000218,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,CHEMBL626229,10116.0,11017,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14793,,Rattus norvegicus,,BAO_0000218,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,CHEMBL626921,10116.0,11018,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14793,,Rattus norvegicus,,BAO_0000218,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,CHEMBL876793,10116.0,11019,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14793,,Rattus norvegicus,,BAO_0000218,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,CHEMBL625309,10116.0,11020,A,1,Intermediate,,,,1
N,,50278,,,In vivo,10524,,Bacillus subtilis,,BAO_0000218,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),CHEMBL625310,1423.0,11021,A,1,Intermediate,,,,1
U,,22224,,,In vivo,11871,,Simiiformes,,BAO_0000218,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,CHEMBL625311,314293.0,11022,A,1,Autocuration,,,,0
N,,50597,,,In vivo,11871,,Rattus norvegicus,,BAO_0000218,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,CHEMBL625312,10116.0,11023,A,1,Intermediate,,,,1
U,,22224,,,In vivo,3437,,,,BAO_0000218,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,CHEMBL625313,,11024,A,1,Autocuration,,,,0
N,,50594,,,In vivo,12038,,Mus musculus,,BAO_0000218,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,CHEMBL625314,10090.0,11025,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12038,,Rattus norvegicus,,BAO_0000218,,Maximum concentration in male rats after iv administration of 20 mg/kg,CHEMBL625315,10116.0,11026,A,1,Intermediate,,,,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,CHEMBL625316,10116.0,11027,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,CHEMBL625317,10116.0,11028,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,CHEMBL625318,10116.0,11029,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,CHEMBL625319,10116.0,11030,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,CHEMBL625320,10116.0,11031,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,CHEMBL625321,10116.0,11032,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,CHEMBL625322,10116.0,11033,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,CHEMBL876801,10116.0,11034,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,CHEMBL625323,10116.0,11035,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,CHEMBL625324,10116.0,11036,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,CHEMBL625325,10116.0,11037,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,CHEMBL625326,10116.0,11038,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,CHEMBL625327,10116.0,11039,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,CHEMBL625328,10116.0,11040,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,CHEMBL625329,10116.0,11041,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,CHEMBL625330,10116.0,11042,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,CHEMBL627774,10116.0,11043,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,CHEMBL627775,10116.0,11044,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,CHEMBL627949,10116.0,11045,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,CHEMBL627950,10116.0,11046,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,CHEMBL627951,10116.0,11047,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,CHEMBL627952,10116.0,11048,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,CHEMBL627953,10116.0,11049,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,CHEMBL627954,10116.0,11050,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,CHEMBL627955,10116.0,11051,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,CHEMBL627956,10116.0,11052,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,CHEMBL876802,10116.0,11053,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,CHEMBL627957,10116.0,11054,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,CHEMBL627958,10116.0,11055,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,CHEMBL627959,10116.0,11056,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,CHEMBL627960,10116.0,11057,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,CHEMBL627961,10116.0,11058,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8418,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,CHEMBL627962,10116.0,11059,A,1,Intermediate,,,2048.0,1
N,,50597,,,,9796,,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,CHEMBL627963,10116.0,11060,A,1,Intermediate,,,,1
N,,50597,,,,9796,,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL624759,10116.0,11061,A,1,Intermediate,,,,1
N,,50597,,,,9796,,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,CHEMBL624760,10116.0,11062,A,1,Intermediate,,,,1
N,,50597,,,,9796,,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL624761,10116.0,11063,A,1,Intermediate,,,,1
N,,50597,,,,9796,,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL877607,10116.0,11064,A,1,Intermediate,,,,1
N,,50597,,,,9796,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,CHEMBL624762,10116.0,11065,A,1,Intermediate,,,2107.0,1
N,,50597,,,,9796,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL624763,10116.0,11066,A,1,Intermediate,,,2107.0,1
N,,50597,,,,9796,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,CHEMBL624764,10116.0,11067,A,1,Intermediate,,,2107.0,1
N,,50597,,,,9796,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL624765,10116.0,11068,A,1,Intermediate,,,2107.0,1
N,,50597,,,,9796,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL624766,10116.0,11069,A,1,Intermediate,,,2107.0,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),CHEMBL624767,9615.0,11070,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,CHEMBL624768,9615.0,11071,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),CHEMBL624769,9615.0,11072,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),CHEMBL624770,9615.0,11073,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),CHEMBL624771,9615.0,11074,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),CHEMBL624772,9615.0,11075,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,CHEMBL624773,10116.0,11076,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),CHEMBL624774,10116.0,11077,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),CHEMBL624775,10116.0,11078,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),CHEMBL624776,10116.0,11079,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),CHEMBL624777,10116.0,11080,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),CHEMBL624778,10116.0,11081,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,CHEMBL624779,10116.0,11082,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),CHEMBL624780,10116.0,11083,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),CHEMBL624781,10116.0,11084,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),CHEMBL877608,10116.0,11085,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),CHEMBL624782,10116.0,11086,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),CHEMBL624783,10116.0,11087,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,CHEMBL624784,10116.0,11088,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),CHEMBL624785,10116.0,11089,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),CHEMBL624786,10116.0,11090,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),CHEMBL624787,10116.0,11091,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),CHEMBL628676,10116.0,11092,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,CHEMBL621842,10116.0,11093,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),CHEMBL621843,10116.0,11094,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),CHEMBL623873,10116.0,11095,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),CHEMBL623874,10116.0,11096,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),CHEMBL623875,10116.0,11097,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),CHEMBL623876,10116.0,11098,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,CHEMBL623877,9615.0,11099,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),CHEMBL623878,9615.0,11100,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,CHEMBL623879,9615.0,11101,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),CHEMBL623880,9615.0,11102,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),CHEMBL623881,9615.0,11103,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),CHEMBL623957,9615.0,11104,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),CHEMBL623958,9615.0,11105,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),CHEMBL623959,9615.0,11106,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),CHEMBL623960,9615.0,11107,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),CHEMBL623961,9615.0,11108,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),CHEMBL623962,9615.0,11109,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),CHEMBL624676,9615.0,11110,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),CHEMBL624677,9615.0,11111,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,CHEMBL624678,9615.0,11112,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),CHEMBL624679,9615.0,11113,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),CHEMBL624680,9615.0,11114,A,1,Intermediate,,,,1
U,,22224,,,In vivo,11732,,,,BAO_0000218,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,CHEMBL624849,,11115,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11732,,,,BAO_0000218,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,CHEMBL624850,,11116,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11732,,,,BAO_0000218,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,CHEMBL874399,,11117,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11732,,,,BAO_0000218,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,CHEMBL624851,,11118,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11732,,,,BAO_0000218,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,CHEMBL624852,,11119,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13359,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (dose 10 mg/kg),CHEMBL624853,10116.0,11120,A,1,Autocuration,,,,0
U,,22224,,,In vivo,16618,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley),CHEMBL624854,10116.0,11121,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13960,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL624855,10116.0,11122,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13917,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rats was determined in vivo,CHEMBL624856,10116.0,11123,A,1,Autocuration,,,,0
U,,22224,,,In vivo,14266,,Canis lupus familiaris,,BAO_0000218,,Oral bioavailability in dog,CHEMBL882957,9615.0,11124,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12359,,Simiiformes,,BAO_0000218,,Oral bioavailability of compound in monkey,CHEMBL624857,314293.0,11125,A,1,Autocuration,,,,0
N,,50597,,,In vivo,12359,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability of compound in rat,CHEMBL622202,10116.0,11126,A,1,Intermediate,,,,1
U,,22224,,,In vivo,12359,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat of PMEA prodrug,CHEMBL622203,10116.0,11127,A,1,Autocuration,,,,0
N,,50597,,,In vivo,12359,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,CHEMBL625522,10116.0,11128,A,1,Intermediate,,,,1
U,,22224,,,In vivo,10791,,Macaca mulatta,,BAO_0000218,,Serum conc at 3 hours following 25 mg/kg dose,CHEMBL622868,9544.0,11129,A,1,Autocuration,,,,0
U,,22224,,,In vivo,10791,Urine,Macaca mulatta,,BAO_0000218,,Urine conc 0-5 hours following 25 mg/kg dose,CHEMBL622869,9544.0,11130,A,1,Autocuration,,,1088.0,0
U,,22224,,,In vivo,10791,Urine,Macaca mulatta,,BAO_0000218,,Urine conc 0-24 hours following 25 mg/kg dose,CHEMBL622870,9544.0,11131,A,1,Autocuration,,,1088.0,0
U,,22224,,,In vivo,138,,Chlorocebus aethiops,,BAO_0000218,,Oral bioavailability in African green monkeys; 20-25,CHEMBL622871,9534.0,11132,A,1,Autocuration,,,,0
N,,100710,,,In vivo,14521,,Macaca fascicularis,,BAO_0000218,,Oral bioavailability in cynomolgus monkey.,CHEMBL620560,9541.0,11133,A,1,Intermediate,,,,1
U,,22224,,,In vivo,13953,,Canis lupus familiaris,,BAO_0000218,,Oral bioavailability in dog,CHEMBL620561,9615.0,11134,A,1,Autocuration,,,,0
N,,50588,,,In vivo,12836,,Canis lupus familiaris,,BAO_0000218,,Oral bioavailability in dog at 10 mg/kg oral dose,CHEMBL620562,9615.0,11135,A,1,Intermediate,,,,1
N,,100712,,,In vivo,12836,,Cricetinae,,BAO_0000218,,Oral bioavailability in hamster at 10 mg/kg oral dose,CHEMBL620563,10026.0,11136,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12836,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat at 10 mg/kg oral dose,CHEMBL620564,10116.0,11137,A,1,Intermediate,,,,1
U,,22224,,,In vivo,14521,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL872265,10116.0,11138,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13953,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL620565,10116.0,11139,A,1,Autocuration,,,,0
U,,22224,,,In vivo,6799,,Eutheria,,BAO_0000218,,Oral bioavailability,CHEMBL620566,9347.0,11140,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11311,,,,BAO_0000218,,Oral bioavailability was determined; range 49-102%,CHEMBL620567,,11141,A,1,Autocuration,,,,0
N,,50588,,,In vivo,4013,,Canis lupus familiaris,,BAO_0000218,,Oral bioavailability was determined in dogs,CHEMBL620568,9615.0,11142,A,1,Intermediate,,,,1
U,,22224,,,In vivo,4013,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat,CHEMBL620569,10116.0,11143,A,1,Autocuration,,,,0
U,,22224,,,In vivo,17591,,Eutheria,,BAO_0000218,,Oral bioavailability,CHEMBL620570,9347.0,11144,A,1,Autocuration,,,,0
U,,22224,,,In vivo,17591,,,,BAO_0000218,,Oral bioavailability was determined; Not orally available,CHEMBL620571,,11145,A,1,Autocuration,,,,0
N,,50594,,,In vivo,15011,,Mus musculus,,BAO_0000218,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),CHEMBL620572,10090.0,11146,A,1,Intermediate,,,,1
U,,22224,,,In vivo,15011,,Mus musculus,,BAO_0000218,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),CHEMBL620573,10090.0,11147,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15011,,Mus musculus,,BAO_0000218,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,CHEMBL620574,10090.0,11148,A,1,Autocuration,,,,0
U,,22224,,,In vivo,9552,,Macaca mulatta,,BAO_0000218,,Oral bioavailability in Rhesus monkey,CHEMBL620575,9544.0,11149,A,1,Autocuration,,,,0
U,,22224,,,In vivo,9552,,Canis lupus familiaris,,BAO_0000218,,Oral bioavailability in dog (female mongrel),CHEMBL620576,9615.0,11150,A,1,Autocuration,,,,0
U,,22224,,,In vivo,3639,,,,BAO_0000218,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,CHEMBL875846,,11151,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13397,,Canis lupus familiaris,,BAO_0000218,,Oral bioavailability in dog,CHEMBL620577,9615.0,11152,A,1,Autocuration,,,,0
U,,22224,,,In vivo,3031,,,,BAO_0000218,,Percentage Bioavailability was evaluated.,CHEMBL620578,,11153,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12818,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat administered i.d.,CHEMBL620579,10116.0,11154,A,1,Autocuration,,,,0
U,,22224,,,In vivo,4847,,Eutheria,,BAO_0000218,,Bioavailability,CHEMBL621248,9347.0,11155,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12421,,Canis lupus familiaris,,BAO_0000218,,Bioavailability in dog (male Beagle) i.v. administration,CHEMBL625390,9615.0,11156,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11966,,Rattus norvegicus,,BAO_0000218,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",CHEMBL625391,10116.0,11157,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11218,,Primates,,BAO_0000218,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),CHEMBL872266,9443.0,11158,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13129,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability in rat (Sprague-Dawley) (male),CHEMBL625392,10116.0,11159,A,1,Autocuration,,,,0
N,,50597,,,In vivo,12350,,Rattus norvegicus,,BAO_0000218,,The oral bioavailability was measured on rats after oral administration,CHEMBL625393,10116.0,11160,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2231,,Rattus norvegicus,,BAO_0000218,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,CHEMBL625394,10116.0,11161,A,1,Intermediate,,,,1
N,,50797,,,In vivo,2231,,Macaca mulatta,,BAO_0000218,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,CHEMBL625395,9544.0,11162,A,1,Intermediate,,,,1
U,,22224,,,In vivo,12187,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 10 mg/kg i.d.),CHEMBL625396,10116.0,11163,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12421,,Canis lupus familiaris,,BAO_0000218,,Bioavailability in dog (male Beagle) i.v. administration,CHEMBL625397,9615.0,11164,A,1,Autocuration,,,,0
N,,50594,,,In vivo,13256,,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625398,10090.0,11165,A,1,Intermediate,,,,1
N,,50594,,,In vivo,13256,Blood,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625399,10090.0,11166,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,13256,Cerebellum,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL626074,10090.0,11167,A,1,Intermediate,,,2037.0,1
N,,50594,,,In vivo,13256,,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL626075,10090.0,11168,A,1,Intermediate,,,,1
N,,50597,,,In vivo,2231,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,CHEMBL626076,10116.0,11169,A,1,Intermediate,,,1969.0,1
N,,50797,,,In vivo,2231,Plasma,Macaca mulatta,,BAO_0000218,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,CHEMBL626077,9544.0,11170,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,12178,Blood,Rattus norvegicus,,BAO_0000218,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),CHEMBL626078,10116.0,11171,A,1,Intermediate,,,178.0,1
U,,22224,,,In vivo,12178,Blood,,,BAO_0000218,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),CHEMBL625846,,11172,A,1,Autocuration,,,178.0,0
U,,22224,,,In vivo,12178,Blood,,,BAO_0000218,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),CHEMBL625847,,11173,A,1,Autocuration,,,178.0,0
N,,50597,,,In vivo,15633,,Rattus norvegicus,,BAO_0000218,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,CHEMBL625848,10116.0,11174,A,1,Expert,,,,1
N,,50597,,,In vivo,14258,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration of compound in plasma administered orally to rats,CHEMBL625849,10116.0,11175,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,14224,Plasma,Canis lupus familiaris,,BAO_0000218,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",CHEMBL626023,9615.0,11176,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,14224,Plasma,Canis lupus familiaris,,BAO_0000218,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",CHEMBL626024,9615.0,11177,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,14224,Plasma,Canis lupus familiaris,,BAO_0000218,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",CHEMBL626025,9615.0,11178,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,5566,,,,BAO_0000218,,Maximum concentration after 10 mg/kg by oral administration,CHEMBL626026,,11179,A,1,Autocuration,,,,0
U,,22224,,,In vivo,16935,,,,BAO_0000218,,Maximum concentration at a dose of 1.5 mg/kg,CHEMBL626027,,11180,A,1,Autocuration,,,,0
U,,22224,,,In vivo,16935,,,,BAO_0000218,,Maximum concentration at a dose of 2.0 mg/kg,CHEMBL626028,,11181,A,1,Autocuration,,,,0
N,,50588,,,In vivo,14224,Plasma,Canis lupus familiaris,,BAO_0000218,,Maximum concentration in dog plasma,CHEMBL626029,9615.0,11182,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,12536,Plasma,,,BAO_0000218,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,CHEMBL626030,,11183,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,12536,Plasma,,,BAO_0000218,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,CHEMBL626031,,11184,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,12536,Plasma,,,BAO_0000218,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,CHEMBL626032,,11185,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,12536,Plasma,,,BAO_0000218,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,CHEMBL626033,,11186,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,12536,Plasma,,,BAO_0000218,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,CHEMBL626034,,11187,A,1,Autocuration,,,1969.0,0
N,,50588,,,In vivo,9994,Plasma,Canis lupus familiaris,,BAO_0000218,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),CHEMBL626035,9615.0,11188,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,1434,Plasma,,,BAO_0000218,,Maximum concentration in plasma at Tmax,CHEMBL626036,,11189,A,1,Autocuration,,,1969.0,0
N,,50588,,,In vivo,12836,Plasma,Canis lupus familiaris,,BAO_0000218,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,CHEMBL626037,9615.0,11190,A,1,Expert,,,1969.0,1
N,,100712,,,In vivo,12836,Plasma,Cricetinae,,BAO_0000218,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,CHEMBL626038,10026.0,11191,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,12836,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,CHEMBL626039,10116.0,11192,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,12545,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,CHEMBL626040,10116.0,11193,A,1,Intermediate,,,1969.0,1
N,,50592,,,In vivo,13856,Plasma,Oryctolagus cuniculus,,BAO_0000218,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,CHEMBL626041,9986.0,11194,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,3550,,,,BAO_0000218,,Maximum concentration was calculated,CHEMBL626042,,11195,A,1,Autocuration,,,,0
U,,22224,,,In vivo,2632,,,,BAO_0000218,,Maximum concentration was calculated.,CHEMBL626043,,11196,A,1,Autocuration,,,,0
U,,22224,,,In vivo,5566,,,,BAO_0000218,,Maximum concentration at a peroral dose of 10 mg/kg,CHEMBL626044,,11197,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11883,,,,BAO_0000218,,Maximum concentration of the drug at 10 uM/dg administered perorally,CHEMBL626045,,11198,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11883,,,,BAO_0000218,,Maximum concentration of the drug at 2 uM/dg administered intravenously,CHEMBL626046,,11199,A,1,Autocuration,,,,0
N,,50588,,,In vivo,14122,Plasma,Canis lupus familiaris,,BAO_0000218,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",CHEMBL626047,9615.0,11200,A,1,Intermediate,,,1969.0,1
N,,100712,,,In vivo,14122,Plasma,Cricetinae,,BAO_0000218,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",CHEMBL626048,10026.0,11201,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14122,Plasma,Rattus norvegicus,,BAO_0000218,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",CHEMBL626049,10116.0,11202,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,12542,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,CHEMBL626050,10116.0,11203,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,12542,Plasma,Canis lupus familiaris,,BAO_0000218,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,CHEMBL874541,9615.0,11204,A,1,Intermediate,,,1969.0,1
N,,100712,,,In vivo,12542,Plasma,Cricetinae,,BAO_0000218,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,CHEMBL622826,10026.0,11205,A,1,Intermediate,,,1969.0,1
N,,100712,,,In vivo,12542,Plasma,Cricetinae,,BAO_0000218,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,CHEMBL622827,10026.0,11206,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,12542,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,CHEMBL622828,10116.0,11207,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14080,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,CHEMBL622829,10116.0,11208,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,11911,,Rattus norvegicus,,BAO_0000218,,Maximum concentration reached following intravenous administration in male rat,CHEMBL876806,10116.0,11209,A,1,Intermediate,,,,1
N,,50588,,,In vivo,13204,,Canis lupus familiaris,,BAO_0000218,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,CHEMBL622830,9615.0,11210,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13204,,Rattus norvegicus,,BAO_0000218,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,CHEMBL622831,10116.0,11211,A,1,Intermediate,,,,1
N,,50588,,,In vivo,14346,,Canis lupus familiaris,,BAO_0000218,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,CHEMBL626794,9615.0,11212,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14346,,Rattus norvegicus,,BAO_0000218,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,CHEMBL626795,10116.0,11213,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14346,,Rattus norvegicus,,BAO_0000218,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,CHEMBL626796,10116.0,11214,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14346,,Rattus norvegicus,,BAO_0000218,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,CHEMBL626797,10116.0,11215,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14127,,Rattus norvegicus,,BAO_0000218,,Maximum drug concentration is determined after oral dosing in rats.,CHEMBL626798,10116.0,11216,A,1,Intermediate,,,,1
N,,50588,,,In vivo,14339,,Canis lupus familiaris,,BAO_0000218,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,CHEMBL626799,9615.0,11217,A,1,Intermediate,,,,1
N,,50588,,,In vivo,14339,,Canis lupus familiaris,,BAO_0000218,,Maximum observed concentration in oral (5 mg/kg) fed dogs,CHEMBL626800,9615.0,11218,A,1,Intermediate,,,,1
U,,22224,,,In vivo,13494,Plasma,,,BAO_0000218,,Maximum plasma concentration,CHEMBL626801,,11219,A,1,Autocuration,,,1969.0,0
N,,50597,,,In vivo,14925,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,CHEMBL876816,10116.0,11220,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14474,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,CHEMBL626802,10116.0,11221,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,14474,Plasma,Canis lupus familiaris,,BAO_0000218,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,CHEMBL626803,9615.0,11222,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,13917,Plasma,,,BAO_0000218,,Maximum plasma concentration following oral administration of 30 umol/kg,CHEMBL626804,,11223,A,1,Autocuration,,,1969.0,0
N,,50597,,,,9796,Plasma,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,CHEMBL626805,10116.0,11224,A,1,Intermediate,,,1969.0,1
N,,50597,,,,9796,Plasma,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,CHEMBL626309,10116.0,11225,A,1,Intermediate,,,1969.0,1
N,,50597,,,,9796,Plasma,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,CHEMBL626310,10116.0,11226,A,1,Intermediate,,,1969.0,1
N,,50597,,,,9796,Plasma,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL626311,10116.0,11227,A,1,Intermediate,,,1969.0,1
N,,50597,,,,9796,Plasma,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL626312,10116.0,11228,A,1,Intermediate,,,1969.0,1
N,,50597,,,,9796,Uterus,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL626313,10116.0,11229,A,1,Intermediate,,,995.0,1
N,,50597,,,,9796,Uterus,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,CHEMBL626314,10116.0,11230,A,1,Intermediate,,,995.0,1
N,,50597,,,,9796,Uterus,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,CHEMBL626315,10116.0,11231,A,1,Intermediate,,,995.0,1
N,,50597,,,,9796,Uterus,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL626316,10116.0,11232,A,1,Intermediate,,,995.0,1
N,,50597,,,,9796,Uterus,Rattus norvegicus,,BAO_0000218,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,CHEMBL626317,10116.0,11233,A,1,Intermediate,,,995.0,1
N,,50597,,,,8363,,Rattus norvegicus,,BAO_0000218,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),CHEMBL626318,10116.0,11234,A,1,Intermediate,,,,1
N,,50597,,,,8363,,Rattus norvegicus,,BAO_0000218,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),CHEMBL626319,10116.0,11235,A,1,Intermediate,,,,1
N,,50597,,,,8363,,Rattus norvegicus,,BAO_0000218,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),CHEMBL626320,10116.0,11236,A,1,Intermediate,,,,1
N,,50597,,,,8363,,Rattus norvegicus,,BAO_0000218,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),CHEMBL875053,10116.0,11237,A,1,Intermediate,,,,1
N,,50597,,,,8363,,Rattus norvegicus,,BAO_0000218,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),CHEMBL626321,10116.0,11238,A,1,Intermediate,,,,1
N,,50597,,,,8363,,Rattus norvegicus,,BAO_0000218,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),CHEMBL626322,10116.0,11239,A,1,Intermediate,,,,1
N,,50597,,,,8363,,Rattus norvegicus,,BAO_0000218,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),CHEMBL626323,10116.0,11240,A,1,Intermediate,,,,1
N,,50597,,,,8363,,Rattus norvegicus,,BAO_0000218,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),CHEMBL626324,10116.0,11241,A,1,Intermediate,,,,1
N,,50597,,,,8363,,Rattus norvegicus,,BAO_0000218,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),CHEMBL626325,10116.0,11242,A,1,Intermediate,,,,1
N,,50597,,,,8363,,Rattus norvegicus,,BAO_0000218,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),CHEMBL626326,10116.0,11243,A,1,Intermediate,,,,1
N,,50597,,,,8363,,Rattus norvegicus,,BAO_0000218,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),CHEMBL626327,10116.0,11244,A,1,Intermediate,,,,1
N,,50597,,,,8363,,Rattus norvegicus,,BAO_0000218,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),CHEMBL626328,10116.0,11245,A,1,Intermediate,,,,1
N,,50597,,,,8684,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",CHEMBL626329,10116.0,11246,A,1,Intermediate,,,178.0,1
N,,50597,,,,8684,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",CHEMBL626330,10116.0,11247,A,1,Intermediate,,,178.0,1
N,,50597,,,,8684,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",CHEMBL626331,10116.0,11248,A,1,Intermediate,,,178.0,1
N,,50597,,,,8684,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",CHEMBL626332,10116.0,11249,A,1,Intermediate,,,178.0,1
N,,50597,,,,8684,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",CHEMBL626333,10116.0,11250,A,1,Intermediate,,,178.0,1
N,,50597,,,,8684,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",CHEMBL626334,10116.0,11251,A,1,Intermediate,,,178.0,1
N,,50597,,,,8684,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",CHEMBL626335,10116.0,11252,A,1,Intermediate,,,178.0,1
N,,50597,,,,8684,Blood,Rattus norvegicus,,BAO_0000218,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",CHEMBL624798,10116.0,11253,A,1,Intermediate,,,178.0,1
N,,50597,,,,8684,Brain,Rattus norvegicus,,BAO_0000218,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",CHEMBL624799,10116.0,11254,A,1,Intermediate,,,955.0,1
N,,50597,,,,8684,Brain,Rattus norvegicus,,BAO_0000218,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",CHEMBL624800,10116.0,11255,A,1,Intermediate,,,955.0,1
N,,50597,,,,8684,Brain,Rattus norvegicus,,BAO_0000218,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",CHEMBL624801,10116.0,11256,A,1,Intermediate,,,955.0,1
N,,50597,,,,8684,Brain,Rattus norvegicus,,BAO_0000218,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",CHEMBL624802,10116.0,11257,A,1,Intermediate,,,955.0,1
N,,50597,,,,8684,Brain,Rattus norvegicus,,BAO_0000218,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",CHEMBL624803,10116.0,11258,A,1,Intermediate,,,955.0,1
N,,50597,,,,8684,Brain,Rattus norvegicus,,BAO_0000218,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",CHEMBL624804,10116.0,11259,A,1,Intermediate,,,955.0,1
N,,50597,,,,8684,Brain,Rattus norvegicus,,BAO_0000218,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",CHEMBL624805,10116.0,11260,A,1,Intermediate,,,955.0,1
N,,50597,,,,8684,Brain,Rattus norvegicus,,BAO_0000218,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",CHEMBL624806,10116.0,11261,A,1,Intermediate,,,955.0,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",CHEMBL624807,10116.0,11262,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",CHEMBL624808,10116.0,11263,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",CHEMBL624809,10116.0,11264,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",CHEMBL624810,10116.0,11265,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",CHEMBL877618,10116.0,11266,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",CHEMBL624811,10116.0,11267,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",CHEMBL624812,10116.0,11268,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",CHEMBL624813,10116.0,11269,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",CHEMBL624814,10116.0,11270,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",CHEMBL624815,10116.0,11271,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",CHEMBL624816,10116.0,11272,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",CHEMBL624817,10116.0,11273,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),CHEMBL624818,9615.0,11274,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,CHEMBL624819,9615.0,11275,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),CHEMBL624820,9615.0,11276,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),CHEMBL624821,9615.0,11277,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),CHEMBL624822,9615.0,11278,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),CHEMBL624823,9615.0,11279,A,1,Intermediate,,,,1
N,,50212,,,,15599,,Escherichia coli,,BAO_0000218,,Observed diffusion coefficient in organic solvent for Escherichia coli,CHEMBL624824,562.0,11280,A,1,Intermediate,,,,1
N,,50597,,,,9614,Blood,Rattus norvegicus,,BAO_0000218,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",CHEMBL624825,10116.0,11281,A,1,Intermediate,,,178.0,1
N,,50597,,,,9614,Blood,Rattus norvegicus,,BAO_0000218,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",CHEMBL624826,10116.0,11282,A,1,Intermediate,,,178.0,1
N,,50597,,,,9614,Cardiac atrium,Rattus norvegicus,,BAO_0000218,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",CHEMBL876817,10116.0,11283,A,1,Intermediate,,,2081.0,1
N,,50597,,,,9614,Cardiac atrium,Rattus norvegicus,,BAO_0000218,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",CHEMBL624827,10116.0,11284,A,1,Intermediate,,,2081.0,1
N,,50597,,,,9614,,Rattus norvegicus,,BAO_0000218,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",CHEMBL624828,10116.0,11285,A,1,Intermediate,,,,1
N,,50597,,,,9614,,Rattus norvegicus,,BAO_0000218,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",CHEMBL624829,10116.0,11286,A,1,Intermediate,,,,1
N,,50597,,,,9614,Liver,Rattus norvegicus,,BAO_0000218,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",CHEMBL624830,10116.0,11287,A,1,Intermediate,,,2107.0,1
N,,50597,,,,9614,Liver,Rattus norvegicus,,BAO_0000218,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",CHEMBL624831,10116.0,11288,A,1,Intermediate,,,2107.0,1
N,,50597,,,,9614,Cardiac atrium,Rattus norvegicus,,BAO_0000218,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",CHEMBL624832,10116.0,11289,A,1,Intermediate,,,2081.0,1
N,,50597,,,,9614,Cardiac atrium,Rattus norvegicus,,BAO_0000218,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",CHEMBL624833,10116.0,11290,A,1,Intermediate,,,2081.0,1
N,,50597,,,,9614,,Rattus norvegicus,,BAO_0000218,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",CHEMBL624834,10116.0,11291,A,1,Intermediate,,,,1
N,,50597,,,,9614,,Rattus norvegicus,,BAO_0000218,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",CHEMBL624835,10116.0,11292,A,1,Intermediate,,,,1
N,,50597,,,,9614,Spleen,Rattus norvegicus,,BAO_0000218,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",CHEMBL624836,10116.0,11293,A,1,Intermediate,,,2106.0,1
N,,50597,,,,9614,Spleen,Rattus norvegicus,,BAO_0000218,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",CHEMBL624837,10116.0,11294,A,1,Intermediate,,,2106.0,1
N,,50597,,,,9071,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,CHEMBL624838,10116.0,11295,A,1,Intermediate,,,178.0,1
N,,50597,,,,9071,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,CHEMBL622188,10116.0,11296,A,1,Intermediate,,,178.0,1
N,,50597,,,,9071,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,CHEMBL622189,10116.0,11297,A,1,Intermediate,,,948.0,1
N,,50597,,,,9071,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,CHEMBL622190,10116.0,11298,A,1,Intermediate,,,948.0,1
N,,50597,,,,9071,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,CHEMBL625170,10116.0,11299,A,1,Intermediate,,,948.0,1
N,,50597,,,,9071,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,CHEMBL625171,10116.0,11300,A,1,Intermediate,,,2113.0,1
N,,50597,,,,9071,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,CHEMBL625172,10116.0,11301,A,1,Intermediate,,,2113.0,1
N,,50597,,,,9071,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,CHEMBL625173,10116.0,11302,A,1,Intermediate,,,2113.0,1
N,,50597,,,,9071,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,CHEMBL625174,10116.0,11303,A,1,Intermediate,,,2107.0,1
N,,50597,,,,9071,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,CHEMBL625175,10116.0,11304,A,1,Intermediate,,,2107.0,1
N,,50597,,,,9071,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,CHEMBL625176,10116.0,11305,A,1,Intermediate,,,2107.0,1
N,,50597,,,,9071,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,CHEMBL625177,10116.0,11306,A,1,Intermediate,,,2048.0,1
N,,50597,,,,9071,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,CHEMBL625178,10116.0,11307,A,1,Intermediate,,,2048.0,1
N,,50597,,,,9071,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,CHEMBL625179,10116.0,11308,A,1,Intermediate,,,2048.0,1
N,,50597,,,,9071,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,CHEMBL625180,10116.0,11309,A,1,Intermediate,,,2048.0,1
U,,22224,,,,10677,,,,BAO_0000218,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",CHEMBL625181,,11310,A,1,Autocuration,,,,0
N,,50594,,,,9750,Urine,Mus musculus,,BAO_0000218,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,CHEMBL625182,10090.0,11311,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,CHEMBL625183,10116.0,11312,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,CHEMBL875848,10116.0,11313,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,CHEMBL622260,10116.0,11314,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,CHEMBL622261,10116.0,11315,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,CHEMBL622262,10116.0,11316,A,1,Intermediate,,,,1
N,,50597,,,,8319,Kidney,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,CHEMBL622263,10116.0,11317,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8319,Kidney,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,CHEMBL622418,10116.0,11318,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8319,Liver,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,CHEMBL622419,10116.0,11319,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,13256,,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL623388,10090.0,11320,A,1,Intermediate,,,,1
N,,50594,,,In vivo,13256,Liver,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL623389,10090.0,11321,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,13256,,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL623390,10090.0,11322,A,1,Intermediate,,,,1
N,,50594,,,In vivo,13256,,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL623391,10090.0,11323,A,1,Intermediate,,,,1
N,,50594,,,In vivo,13256,Blood,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL623392,10090.0,11324,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,13256,Cerebellum,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL623393,10090.0,11325,A,1,Intermediate,,,2037.0,1
N,,50594,,,In vivo,13256,,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL623394,10090.0,11326,A,1,Intermediate,,,,1
N,,50594,,,In vivo,13256,,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL618885,10090.0,11327,A,1,Intermediate,,,,1
N,,50594,,,In vivo,13256,Liver,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL618886,10090.0,11328,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,13256,,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL618887,10090.0,11329,A,1,Intermediate,,,,1
N,,50594,,,In vivo,13256,,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL619535,10090.0,11330,A,1,Intermediate,,,,1
N,,50594,,,In vivo,13256,Blood,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL619536,10090.0,11331,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,13256,Cerebellum,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL619537,10090.0,11332,A,1,Intermediate,,,2037.0,1
N,,50594,,,In vivo,13256,,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL619705,10090.0,11333,A,1,Intermediate,,,,1
N,,50594,,,In vivo,13256,,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL619706,10090.0,11334,A,1,Intermediate,,,,1
N,,50594,,,In vivo,13256,Liver,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL619707,10090.0,11335,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,13256,,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL619708,10090.0,11336,A,1,Intermediate,,,,1
N,,50594,,,In vivo,13256,,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625219,10090.0,11337,A,1,Intermediate,,,,1
N,,50594,,,In vivo,13256,Blood,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625220,10090.0,11338,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,13256,Cerebellum,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625221,10090.0,11339,A,1,Intermediate,,,2037.0,1
N,,50594,,,In vivo,13256,,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625222,10090.0,11340,A,1,Intermediate,,,,1
N,,50594,,,In vivo,13256,,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625223,10090.0,11341,A,1,Intermediate,,,,1
N,,50594,,,In vivo,13256,Liver,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625224,10090.0,11342,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,13256,,Mus musculus,,BAO_0000218,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),CHEMBL625225,10090.0,11343,A,1,Intermediate,,,,1
N,,50597,,,In vivo,8829,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat blood after 24 hours of iv administration,CHEMBL625226,10116.0,11344,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,8829,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,CHEMBL625227,10116.0,11345,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,8829,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat blood after 30 minutes of iv administration,CHEMBL625228,10116.0,11346,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,8829,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,CHEMBL875354,10116.0,11347,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,8829,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat blood after 5 minutes of iv administration,CHEMBL625229,10116.0,11348,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,8829,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,CHEMBL625230,10116.0,11349,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,8829,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat heart after 24 hours of iv administration,CHEMBL625231,10116.0,11350,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,8829,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,CHEMBL625900,10116.0,11351,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,8829,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat heart after 30 minutes of iv administration,CHEMBL625901,10116.0,11352,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,8829,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,CHEMBL625902,10116.0,11353,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,8829,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat heart after 5 minutes of iv administration,CHEMBL625903,10116.0,11354,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,8829,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,CHEMBL625904,10116.0,11355,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,8829,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat liver after 24 hours of iv administration,CHEMBL625905,10116.0,11356,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,8829,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,CHEMBL627861,10116.0,11357,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,8829,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat liver after 30 minutes of iv administration,CHEMBL627862,10116.0,11358,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,8829,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,CHEMBL627863,10116.0,11359,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,8829,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat liver after 30 minutes of iv administration,CHEMBL627769,10116.0,11360,A,1,Intermediate,,,2107.0,1
N,,50588,,,In vivo,13249,Plasma,Canis lupus familiaris,,BAO_0000218,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,CHEMBL627770,9615.0,11361,A,1,Intermediate,,,1969.0,1
N,,100710,,,In vivo,13622,,Macaca fascicularis,,BAO_0000218,,Cmax in cynomolgus monkey (PO dose),CHEMBL627771,9541.0,11362,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13622,,Rattus norvegicus,,BAO_0000218,,Cmax in rat (PO dose),CHEMBL627772,10116.0,11363,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13622,,Rattus norvegicus,,BAO_0000218,,Cmax in rat (PO dose),CHEMBL627773,10116.0,11364,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13494,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,CHEMBL621922,10116.0,11365,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,12170,Plasma,Rattus norvegicus,,BAO_0000218,,Cmax in rat plasma after oral dose (10 mg/kg),CHEMBL621923,10116.0,11366,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,12170,Plasma,,,BAO_0000218,,Cmax in plasma after oral dose (10 mg/kg),CHEMBL621924,,11367,A,1,Autocuration,,,1969.0,0
N,,50588,,,In vivo,17025,Plasma,Canis lupus familiaris,,BAO_0000218,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,CHEMBL621925,9615.0,11368,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,17025,Plasma,Simiiformes,,BAO_0000218,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,CHEMBL621926,314293.0,11369,A,1,Autocuration,,,1969.0,0
N,,50592,,,In vivo,17025,Plasma,Oryctolagus cuniculus,,BAO_0000218,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,CHEMBL621927,9986.0,11370,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17025,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,CHEMBL621928,10116.0,11371,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14187,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,CHEMBL621929,10116.0,11372,A,1,Intermediate,,,1969.0,1
N,,50594,,,In vivo,14816,Plasma,Mus musculus,,BAO_0000218,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,CHEMBL621930,10090.0,11373,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17820,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration after oral dosing in rat,CHEMBL621931,10116.0,11374,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,14380,Plasma,,,BAO_0000218,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,CHEMBL621932,,11375,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,14380,Plasma,,,BAO_0000218,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,CHEMBL621933,,11376,A,1,Autocuration,,,1969.0,0
N,,50588,,,In vivo,14691,Plasma,Canis lupus familiaris,,BAO_0000218,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,CHEMBL621934,9615.0,11377,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,14691,Plasma,Canis lupus familiaris,,BAO_0000218,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,CHEMBL621935,9615.0,11378,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,13375,Plasma,Rattus norvegicus,,BAO_0000218,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,CHEMBL621936,10116.0,11379,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,6236,Plasma,,,BAO_0000218,,Maximum plasma concentration was determined,CHEMBL621937,,11380,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,14380,Plasma,,,BAO_0000218,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,CHEMBL621938,,11381,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,14380,Plasma,,,BAO_0000218,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,CHEMBL621939,,11382,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,14380,Plasma,,,BAO_0000218,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,CHEMBL621940,,11383,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,14380,Plasma,,,BAO_0000218,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,CHEMBL621941,,11384,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,14380,Plasma,,,BAO_0000218,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,CHEMBL621942,,11385,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,14380,Plasma,,,BAO_0000218,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,CHEMBL626178,,11386,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,14380,Plasma,,,BAO_0000218,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,CHEMBL626179,,11387,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,14380,Plasma,,,BAO_0000218,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,CHEMBL626180,,11388,A,1,Autocuration,,,1969.0,0
N,,50597,,,In vivo,13622,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma Cmax in rat (PO dose),CHEMBL626181,10116.0,11389,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15372,,Rattus norvegicus,,BAO_0000218,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,CHEMBL626182,10116.0,11390,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15372,,Rattus norvegicus,,BAO_0000218,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,CHEMBL626183,10116.0,11391,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15372,,Rattus norvegicus,,BAO_0000218,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,CHEMBL626184,10116.0,11392,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15372,,Rattus norvegicus,,BAO_0000218,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,CHEMBL626185,10116.0,11393,A,1,Intermediate,,,,1
N,,50588,,,In vivo,14925,Plasma,Canis lupus familiaris,,BAO_0000218,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,CHEMBL626186,9615.0,11394,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,14925,Plasma,Canis lupus familiaris,,BAO_0000218,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,CHEMBL877589,9615.0,11395,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,11883,,,,BAO_0000218,,Maximum concentration of the drug at 1 uM/dg administered intravenously,CHEMBL626187,,11396,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11883,,,,BAO_0000218,,Maximum concentration of the drug at 20 uM/dg administered perorally,CHEMBL626188,,11397,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13391,,,,BAO_0000218,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,CHEMBL626189,,11398,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13391,Blood,,,BAO_0000218,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,CHEMBL626855,,11399,A,1,Autocuration,,,178.0,0
U,,22224,,,In vivo,13391,Blood,,,BAO_0000218,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,CHEMBL623781,,11400,A,1,Autocuration,,,178.0,0
U,,22224,,,In vivo,13391,Blood,,,BAO_0000218,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,CHEMBL623782,,11401,A,1,Autocuration,,,178.0,0
N,,50597,,,In vivo,16360,Plasma,Rattus norvegicus,,BAO_0000218,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,CHEMBL623783,10116.0,11402,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,3673,Plasma,Canis lupus familiaris,,BAO_0000218,,Cmax in dog plasma after 1mg/kg oral dose,CHEMBL623784,9615.0,11403,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,14431,Plasma,Canis lupus familiaris,,BAO_0000218,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,CHEMBL623785,9615.0,11404,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14431,Plasma,Rattus norvegicus,,BAO_0000218,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,CHEMBL623786,10116.0,11405,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14964,,Rattus norvegicus,,BAO_0000218,,Oral maximum concentration in rat,CHEMBL623787,10116.0,11406,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14964,,Rattus norvegicus,,BAO_0000218,,Oral maximum concentration in rat,CHEMBL623788,10116.0,11407,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14209,Plasma,Mus musculus,,BAO_0000218,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,CHEMBL623789,10090.0,11408,A,1,Intermediate,,,1969.0,1
N,,50594,,,In vivo,11355,Blood,Mus musculus,,BAO_0000218,,Peak concentration in blood after intravenous administration to mice,CHEMBL623790,10090.0,11409,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,11355,Blood,Mus musculus,,BAO_0000218,,Peak concentration in blood after peroral administration to mice,CHEMBL623791,10090.0,11410,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,11966,Plasma,Rattus norvegicus,,BAO_0000218,,Peak concentration in rat plasma was determined,CHEMBL623792,10116.0,11411,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,8918,Plasma,Simiiformes,,BAO_0000218,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,CHEMBL623793,314293.0,11412,A,1,Autocuration,,,1969.0,0
N,,50594,,,In vivo,8918,Plasma,Mus musculus,,BAO_0000218,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,CHEMBL623794,10090.0,11413,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,8918,Plasma,Rattus norvegicus,,BAO_0000218,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,CHEMBL623795,10116.0,11414,A,1,Intermediate,,,1969.0,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",CHEMBL623796,10116.0,11415,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",CHEMBL623797,10116.0,11416,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",CHEMBL623798,10116.0,11417,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",CHEMBL623799,10116.0,11418,A,1,Intermediate,,,,1
N,,50597,,,,8684,Intestine,Rattus norvegicus,,BAO_0000218,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",CHEMBL624490,10116.0,11419,A,1,Intermediate,,,160.0,1
N,,50597,,,,8684,Intestine,Rattus norvegicus,,BAO_0000218,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",CHEMBL624491,10116.0,11420,A,1,Intermediate,,,160.0,1
N,,50597,,,,8684,Intestine,Rattus norvegicus,,BAO_0000218,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",CHEMBL624492,10116.0,11421,A,1,Intermediate,,,160.0,1
N,,50597,,,,8684,Intestine,Rattus norvegicus,,BAO_0000218,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",CHEMBL624493,10116.0,11422,A,1,Intermediate,,,160.0,1
N,,50597,,,,8684,Intestine,Rattus norvegicus,,BAO_0000218,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",CHEMBL877595,10116.0,11423,A,1,Intermediate,,,160.0,1
N,,50597,,,,8684,Intestine,Rattus norvegicus,,BAO_0000218,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",CHEMBL624494,10116.0,11424,A,1,Intermediate,,,160.0,1
N,,50597,,,,8684,Intestine,Rattus norvegicus,,BAO_0000218,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",CHEMBL624495,10116.0,11425,A,1,Intermediate,,,160.0,1
N,,50597,,,,8684,Intestine,Rattus norvegicus,,BAO_0000218,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",CHEMBL624681,10116.0,11426,A,1,Intermediate,,,160.0,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",CHEMBL624682,10116.0,11427,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",CHEMBL624683,10116.0,11428,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",CHEMBL624684,10116.0,11429,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",CHEMBL624685,10116.0,11430,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",CHEMBL624686,10116.0,11431,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",CHEMBL624687,10116.0,11432,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",CHEMBL624688,10116.0,11433,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",CHEMBL627161,10116.0,11434,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",CHEMBL622127,10116.0,11435,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",CHEMBL622128,10116.0,11436,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",CHEMBL874384,10116.0,11437,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",CHEMBL624898,10116.0,11438,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",CHEMBL624899,10116.0,11439,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",CHEMBL624900,10116.0,11440,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",CHEMBL624901,10116.0,11441,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",CHEMBL624902,10116.0,11442,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",CHEMBL624903,10116.0,11443,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",CHEMBL624904,10116.0,11444,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",CHEMBL624905,10116.0,11445,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",CHEMBL624906,10116.0,11446,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",CHEMBL624907,10116.0,11447,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",CHEMBL624908,10116.0,11448,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",CHEMBL624909,10116.0,11449,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",CHEMBL624910,10116.0,11450,A,1,Intermediate,,,,1
N,,50597,,,,8684,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",CHEMBL624911,10116.0,11451,A,1,Intermediate,,,2385.0,1
N,,50597,,,,8684,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",CHEMBL874388,10116.0,11452,A,1,Intermediate,,,2385.0,1
N,,50597,,,,8684,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",CHEMBL624912,10116.0,11453,A,1,Intermediate,,,2385.0,1
N,,50597,,,,8684,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",CHEMBL622930,10116.0,11454,A,1,Intermediate,,,2385.0,1
N,,50597,,,,8684,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",CHEMBL623121,10116.0,11455,A,1,Intermediate,,,2385.0,1
N,,50597,,,,8684,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",CHEMBL623122,10116.0,11456,A,1,Intermediate,,,2385.0,1
N,,50597,,,,8684,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",CHEMBL623123,10116.0,11457,A,1,Intermediate,,,2385.0,1
N,,50597,,,,8684,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",CHEMBL623124,10116.0,11458,A,1,Intermediate,,,2385.0,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",CHEMBL623125,10116.0,11459,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",CHEMBL623126,10116.0,11460,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",CHEMBL623127,10116.0,11461,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",CHEMBL623128,10116.0,11462,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",CHEMBL623129,10116.0,11463,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",CHEMBL623130,10116.0,11464,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",CHEMBL623131,10116.0,11465,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",CHEMBL623132,10116.0,11466,A,1,Intermediate,,,,1
N,,50597,,,,8319,Liver,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,CHEMBL623133,10116.0,11467,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,CHEMBL623134,10116.0,11468,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,CHEMBL874389,10116.0,11469,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,CHEMBL623135,10116.0,11470,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,CHEMBL623136,10116.0,11471,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,CHEMBL623137,10116.0,11472,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,CHEMBL623138,10116.0,11473,A,1,Intermediate,,,,1
N,,50597,,,,8319,Kidney,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,CHEMBL623139,10116.0,11474,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8319,Kidney,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,CHEMBL623140,10116.0,11475,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8319,Liver,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,CHEMBL623141,10116.0,11476,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8319,Liver,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,CHEMBL623142,10116.0,11477,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,CHEMBL623143,10116.0,11478,A,1,Intermediate,,,,1
N,,50594,,,,14571,Urine,Mus musculus,,BAO_0000218,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,CHEMBL623144,10090.0,11479,A,1,Intermediate,,,1088.0,1
N,,50597,,,,14571,Urine,Rattus norvegicus,,BAO_0000218,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,CHEMBL623405,10116.0,11480,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,CHEMBL624074,10116.0,11481,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,CHEMBL624075,10116.0,11482,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,CHEMBL624076,10116.0,11483,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,CHEMBL624077,10116.0,11484,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,CHEMBL624078,10116.0,11485,A,1,Intermediate,,,,1
N,,50597,,,,8319,Kidney,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,CHEMBL624079,10116.0,11486,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8319,Kidney,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,CHEMBL624261,10116.0,11487,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,CHEMBL624262,10116.0,11488,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,CHEMBL624263,10116.0,11489,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,CHEMBL624264,10116.0,11490,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,CHEMBL624265,10116.0,11491,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,CHEMBL624266,10116.0,11492,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,CHEMBL624267,10116.0,11493,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,CHEMBL624268,10116.0,11494,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,CHEMBL875227,10116.0,11495,A,1,Intermediate,,,,1
N,,50597,,,,8319,Kidney,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,CHEMBL624269,10116.0,11496,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8319,Kidney,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,CHEMBL624270,10116.0,11497,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,CHEMBL624271,10116.0,11498,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,CHEMBL624272,10116.0,11499,A,1,Intermediate,,,,1
N,,50597,,,,8319,,Rattus norvegicus,,BAO_0000218,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,CHEMBL624273,10116.0,11500,A,1,Intermediate,,,,1
N,,50597,,,,12064,Urine,Rattus norvegicus,,BAO_0000218,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,CHEMBL624274,10116.0,11501,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12064,Urine,Rattus norvegicus,,BAO_0000218,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,CHEMBL624275,10116.0,11502,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12064,Urine,Rattus norvegicus,,BAO_0000218,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,CHEMBL624276,10116.0,11503,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12038,Urine,Rattus norvegicus,,BAO_0000218,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,CHEMBL624277,10116.0,11504,A,1,Intermediate,,,1088.0,1
U,,22224,,,,14314,,,,BAO_0000019,,% dose converted to 2-amino-5-chlorophenyl sulfate,CHEMBL624278,,11505,A,1,Autocuration,,,,0
U,,22224,,,,14314,,,,BAO_0000019,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),CHEMBL624279,,11506,A,1,Autocuration,,,,0
N,,50597,,,,11488,Feces,Rattus norvegicus,,BAO_0000218,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",CHEMBL624280,10116.0,11507,A,1,Intermediate,,,1988.0,1
N,,50597,,,,11488,Feces,Rattus norvegicus,,BAO_0000218,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",CHEMBL624281,10116.0,11508,A,1,Intermediate,,,1988.0,1
N,,50597,,,,11488,Feces,Rattus norvegicus,,BAO_0000218,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",CHEMBL622933,10116.0,11509,A,1,Intermediate,,,1988.0,1
N,,50597,,,,11488,Feces,Rattus norvegicus,,BAO_0000218,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",CHEMBL622934,10116.0,11510,A,1,Intermediate,,,1988.0,1
N,,50597,,,In vivo,8829,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,CHEMBL622935,10116.0,11511,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,8829,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat liver after 5 minutes of iv administration,CHEMBL622936,10116.0,11512,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,8829,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,CHEMBL875228,10116.0,11513,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,8829,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat lung after 24 hours of iv administration,CHEMBL622937,10116.0,11514,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,8829,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,CHEMBL622938,10116.0,11515,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,8829,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat lung after 30 minutes of iv administration,CHEMBL619736,10116.0,11516,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,8829,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,CHEMBL625117,10116.0,11517,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,8829,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat lung after 5 minutes of iv administration,CHEMBL625118,10116.0,11518,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,8829,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,CHEMBL625119,10116.0,11519,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,14972,Cerebellum,Rattus norvegicus,,BAO_0000218,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",CHEMBL625120,10116.0,11520,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,14972,,Rattus norvegicus,,BAO_0000218,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",CHEMBL625121,10116.0,11521,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14972,Thalamus,Rattus norvegicus,,BAO_0000218,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",CHEMBL625122,10116.0,11522,A,1,Intermediate,,,10000006.0,1
N,,50597,,,In vivo,14608,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL622204,10116.0,11523,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,14608,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL877503,10116.0,11524,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,14608,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL627127,10116.0,11525,A,1,Intermediate,,,178.0,1
U,,22224,,,In vivo,14608,Hippocampus,,,BAO_0000218,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL627128,,11526,A,1,Autocuration,,,10000000.0,0
U,,22224,,,In vivo,14608,Hippocampus,,,BAO_0000218,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL627129,,11527,A,1,Autocuration,,,10000000.0,0
U,,22224,,,In vivo,14608,Hippocampus,,,BAO_0000218,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL627130,,11528,A,1,Autocuration,,,10000000.0,0
N,,50597,,,In vivo,14608,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL627131,10116.0,11529,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,14608,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL627132,10116.0,11530,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,14608,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL627133,10116.0,11531,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,14608,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL627134,10116.0,11532,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,14608,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL627135,10116.0,11533,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,14608,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL627136,10116.0,11534,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,14608,,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL628435,10116.0,11535,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14608,,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL628436,10116.0,11536,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14608,,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL628437,10116.0,11537,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14608,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL628438,10116.0,11538,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,14608,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL628439,10116.0,11539,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,14608,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL628440,10116.0,11540,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,14608,Hippocampus,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL628441,10116.0,11541,A,1,Intermediate,,,10000000.0,1
N,,50597,,,In vivo,14608,Hippocampus,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL628442,10116.0,11542,A,1,Intermediate,,,10000000.0,1
N,,50597,,,In vivo,14608,Hippocampus,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL628443,10116.0,11543,A,1,Intermediate,,,10000000.0,1
N,,50597,,,In vivo,14608,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL628444,10116.0,11544,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,14608,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL628445,10116.0,11545,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,14608,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL877504,10116.0,11546,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,14608,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL628446,10116.0,11547,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,14608,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL626874,10116.0,11548,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,14608,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL626875,10116.0,11549,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,14608,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL626876,10116.0,11550,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,14608,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL626877,10116.0,11551,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,14608,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL626878,10116.0,11552,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,14608,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL626879,10116.0,11553,A,1,Intermediate,,,2385.0,1
U,,22224,,,In vivo,8918,Plasma,Simiiformes,,BAO_0000218,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,CHEMBL626880,314293.0,11554,A,1,Autocuration,,,1969.0,0
N,,50594,,,In vivo,8918,Plasma,Mus musculus,,BAO_0000218,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,CHEMBL626881,10090.0,11555,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,8918,Plasma,Rattus norvegicus,,BAO_0000218,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,CHEMBL626882,10116.0,11556,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,14470,Plasma,Canis lupus familiaris,,BAO_0000218,,Peak plasma concentration was measured in dogs,CHEMBL626883,9615.0,11557,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14393,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,CHEMBL626884,10116.0,11558,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14886,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,CHEMBL626885,10116.0,11559,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14886,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,CHEMBL626886,10116.0,11560,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14886,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,CHEMBL626887,10116.0,11561,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14393,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,CHEMBL626888,10116.0,11562,A,1,Intermediate,,,,1
N,,50588,,,In vivo,13465,,Canis lupus familiaris,,BAO_0000218,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,CHEMBL626889,9615.0,11563,A,1,Intermediate,,,,1
U,,22224,,,In vivo,13465,,Simiiformes,,BAO_0000218,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,CHEMBL626761,314293.0,11564,A,1,Autocuration,,,,0
N,,50588,,,In vivo,13465,,Canis lupus familiaris,,BAO_0000218,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,CHEMBL626762,9615.0,11565,A,1,Intermediate,,,,1
N,,50588,,,In vivo,13465,,Canis lupus familiaris,,BAO_0000218,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,CHEMBL626763,9615.0,11566,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13465,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,CHEMBL626764,10116.0,11567,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13465,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,CHEMBL626765,10116.0,11568,A,1,Intermediate,,,,1
N,,50588,,,In vivo,13465,,Canis lupus familiaris,,BAO_0000218,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,CHEMBL626766,9615.0,11569,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13465,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,CHEMBL626767,10116.0,11570,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13465,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,CHEMBL626768,10116.0,11571,A,1,Intermediate,,,,1
N,,50588,,,In vivo,13465,,Canis lupus familiaris,,BAO_0000218,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,CHEMBL626769,9615.0,11572,A,1,Intermediate,,,,1
N,,50588,,,In vivo,13465,,Canis lupus familiaris,,BAO_0000218,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,CHEMBL874463,9615.0,11573,A,1,Intermediate,,,,1
U,,22224,,,In vivo,13465,,Simiiformes,,BAO_0000218,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,CHEMBL626770,314293.0,11574,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13465,,Simiiformes,,BAO_0000218,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,CHEMBL626771,314293.0,11575,A,1,Autocuration,,,,0
N,,50597,,,In vivo,13465,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,CHEMBL626772,10116.0,11576,A,1,Intermediate,,,,1
N,,100710,,,In vivo,14731,,Macaca fascicularis,,BAO_0000218,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,CHEMBL626773,9541.0,11577,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14731,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,CHEMBL626774,10090.0,11578,A,1,Intermediate,,,,1
N,,50588,,,In vivo,13376,,Canis lupus familiaris,,BAO_0000218,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,CHEMBL626775,9615.0,11579,A,1,Intermediate,,,,1
N,,50588,,,In vivo,13376,,Canis lupus familiaris,,BAO_0000218,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,CHEMBL626776,9615.0,11580,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14443,,Rattus norvegicus,,BAO_0000218,,Maximum concentration (Cmax) in rat when administered orally,CHEMBL626777,10116.0,11581,A,1,Intermediate,,,,1
U,,22224,,,In vivo,13465,Plasma,Simiiformes,,BAO_0000218,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,CHEMBL626778,314293.0,11582,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,16359,,Rattus norvegicus,,BAO_0000218,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",CHEMBL626779,10116.0,11583,A,1,Autocuration,,,,0
U,,22224,,,In vivo,16359,,Rattus norvegicus,,BAO_0000218,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",CHEMBL626780,10116.0,11584,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15618,Plasma,,,BAO_0000218,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,CHEMBL626781,,11585,A,1,Autocuration,,,1969.0,0
N,,50597,,,In vivo,14554,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic profile Cmax was evaluated in rats,CHEMBL632164,10116.0,11586,A,1,Intermediate,,,,1
N,,50588,,,In vivo,11537,,Canis lupus familiaris,,BAO_0000218,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),CHEMBL632165,9615.0,11587,A,1,Intermediate,,,,1
N,,50594,,,In vivo,11537,,Mus musculus,,BAO_0000218,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),CHEMBL632166,10090.0,11588,A,1,Intermediate,,,,1
N,,50588,,,In vivo,11537,,Canis lupus familiaris,,BAO_0000218,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),CHEMBL632167,9615.0,11589,A,1,Intermediate,,,,1
N,,50594,,,In vivo,11537,,Mus musculus,,BAO_0000218,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),CHEMBL632168,10090.0,11590,A,1,Intermediate,,,,1
U,,22224,,,In vivo,2021,Plasma,Rattus norvegicus,,BAO_0000218,,Cmax in rat plasma,CHEMBL632169,10116.0,11591,A,1,Autocuration,,,1969.0,0
N,,50588,,,In vivo,5932,Plasma,Canis lupus familiaris,,BAO_0000218,,Cmax in dog plasma after 30mg/kg oral dose,CHEMBL632170,9615.0,11592,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5932,Plasma,Rattus norvegicus,,BAO_0000218,,Cmax in rat plasma after 30mg/kg oral dose,CHEMBL632171,10116.0,11593,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,17320,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma level in rats at 30 mg/kg,CHEMBL632172,10116.0,11594,A,1,Intermediate,,,1969.0,1
N,,50594,,,In vivo,15831,Plasma,Mus musculus,,BAO_0000218,,Tested for maximum plasma concentration in mice,CHEMBL632173,10090.0,11595,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15078,,Rattus norvegicus,,BAO_0000218,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL632174,10116.0,11596,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14941,,Rattus norvegicus,,BAO_0000218,,The Cmax values in female wistar rats.,CHEMBL632175,10116.0,11597,A,1,Intermediate,,,,1
N,,50588,,,In vivo,15343,Plasma,Canis lupus familiaris,,BAO_0000218,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,CHEMBL632176,9615.0,11598,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15343,Plasma,Rattus norvegicus,,BAO_0000218,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,CHEMBL632177,10116.0,11599,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14856,Plasma,Rattus norvegicus,,BAO_0000218,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,CHEMBL632178,10116.0,11600,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,13129,,Rattus norvegicus,,BAO_0000218,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,CHEMBL632179,10116.0,11601,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13098,Blood,Rattus norvegicus,,BAO_0000218,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,CHEMBL632180,10116.0,11602,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13098,Blood,Rattus norvegicus,,BAO_0000218,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,CHEMBL632181,10116.0,11603,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13098,Blood,Rattus norvegicus,,BAO_0000218,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,CHEMBL632182,10116.0,11604,A,1,Intermediate,,,178.0,1
U,,22224,,,In vivo,15478,Blood,Mus musculus,,BAO_0000218,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,CHEMBL632183,10090.0,11605,A,1,Autocuration,,,178.0,0
N,,50588,,,In vivo,15341,,Canis lupus familiaris,,BAO_0000218,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,CHEMBL632184,9615.0,11606,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15341,,Rattus norvegicus,,BAO_0000218,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,CHEMBL874470,10116.0,11607,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",CHEMBL631302,10116.0,11608,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",CHEMBL631303,10116.0,11609,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",CHEMBL631304,10116.0,11610,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",CHEMBL631305,10116.0,11611,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",CHEMBL631306,10116.0,11612,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",CHEMBL631307,10116.0,11613,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",CHEMBL631308,10116.0,11614,A,1,Intermediate,,,,1
N,,50597,,,,8684,,Rattus norvegicus,,BAO_0000218,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",CHEMBL625557,10116.0,11615,A,1,Intermediate,,,,1
N,,50597,,,,8684,Spleen,Rattus norvegicus,,BAO_0000218,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",CHEMBL625558,10116.0,11616,A,1,Intermediate,,,2106.0,1
N,,50597,,,,8684,Spleen,Rattus norvegicus,,BAO_0000218,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",CHEMBL625559,10116.0,11617,A,1,Intermediate,,,2106.0,1
N,,50597,,,,8684,Spleen,Rattus norvegicus,,BAO_0000218,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",CHEMBL625560,10116.0,11618,A,1,Intermediate,,,2106.0,1
N,,50597,,,,8684,Spleen,Rattus norvegicus,,BAO_0000218,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",CHEMBL625561,10116.0,11619,A,1,Intermediate,,,2106.0,1
N,,50597,,,,8684,Spleen,Rattus norvegicus,,BAO_0000218,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",CHEMBL625562,10116.0,11620,A,1,Intermediate,,,2106.0,1
N,,50597,,,,8684,Spleen,Rattus norvegicus,,BAO_0000218,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",CHEMBL875320,10116.0,11621,A,1,Intermediate,,,2106.0,1
N,,50597,,,,8684,Spleen,Rattus norvegicus,,BAO_0000218,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",CHEMBL625563,10116.0,11622,A,1,Intermediate,,,2106.0,1
N,,50597,,,,8684,Spleen,Rattus norvegicus,,BAO_0000218,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",CHEMBL625564,10116.0,11623,A,1,Intermediate,,,2106.0,1
N,,50597,,,,8684,Uterus,Rattus norvegicus,,BAO_0000218,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",CHEMBL625565,10116.0,11624,A,1,Intermediate,,,995.0,1
N,,50597,,,,8684,Uterus,Rattus norvegicus,,BAO_0000218,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",CHEMBL625566,10116.0,11625,A,1,Intermediate,,,995.0,1
N,,50597,,,,8684,Uterus,Rattus norvegicus,,BAO_0000218,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",CHEMBL625567,10116.0,11626,A,1,Intermediate,,,995.0,1
N,,50597,,,,8684,Uterus,Rattus norvegicus,,BAO_0000218,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",CHEMBL625568,10116.0,11627,A,1,Intermediate,,,995.0,1
N,,50597,,,,8684,Uterus,Rattus norvegicus,,BAO_0000218,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",CHEMBL628217,10116.0,11628,A,1,Intermediate,,,995.0,1
N,,50597,,,,8684,Uterus,Rattus norvegicus,,BAO_0000218,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",CHEMBL628218,10116.0,11629,A,1,Intermediate,,,995.0,1
N,,50597,,,,8684,Uterus,Rattus norvegicus,,BAO_0000218,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",CHEMBL628219,10116.0,11630,A,1,Intermediate,,,995.0,1
N,,50597,,,,8684,Uterus,Rattus norvegicus,,BAO_0000218,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",CHEMBL628220,10116.0,11631,A,1,Intermediate,,,995.0,1
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the blood after 120 min of intravenous administration,CHEMBL628221,,11632,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the blood after 15 min of intravenous administration,CHEMBL628222,,11633,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the blood after 30 min of intravenous administration,CHEMBL628223,,11634,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the blood after 5 min of intravenous administration,CHEMBL628224,,11635,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the blood after 60 min of intravenous administration,CHEMBL628225,,11636,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the blood after 90 min of intravenous administration,CHEMBL628226,,11637,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the bone after 120 min of intravenous administration,CHEMBL628227,,11638,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the bone after 15 min of intravenous administration,CHEMBL875481,,11639,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the bone after 30 min of intravenous administration,CHEMBL628228,,11640,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the bone after 5 min of intravenous administration,CHEMBL628229,,11641,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the bone after 60 min of intravenous administration,CHEMBL628230,,11642,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the bone after 90 min of intravenous administration,CHEMBL628231,,11643,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the heart after 120 min of intravenous administration,CHEMBL628232,,11644,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the heart after 15 min of intravenous administration,CHEMBL628233,,11645,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the heart after 30 min of intravenous administration,CHEMBL628234,,11646,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the heart after 5 min of intravenous administration,CHEMBL628235,,11647,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the heart after 60 min of intravenous administration,CHEMBL628236,,11648,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the heart after 90 min of intravenous administration,CHEMBL628237,,11649,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the kidneys after 120 min of intravenous administration,CHEMBL628238,,11650,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the kidneys after 15 min of intravenous administration,CHEMBL628239,,11651,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the kidneys after 30 min of intravenous administration,CHEMBL628240,,11652,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the kidneys after 5 min of intravenous administration,CHEMBL628241,,11653,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the kidneys after 60 min of intravenous administration,CHEMBL628242,,11654,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the kidneys after 90 min of intravenous administration,CHEMBL875482,,11655,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the liver after 120 min of intravenous administration,CHEMBL628243,,11656,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the liver after 15 min of intravenous administration,CHEMBL628244,,11657,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the liver after 30 min of intravenous administration,CHEMBL628245,,11658,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the liver after 5 min of intravenous administration,CHEMBL628246,,11659,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the liver after 60 min of intravenous administration,CHEMBL628247,,11660,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the liver after 90 min of intravenous administration,CHEMBL628248,,11661,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the lung after 120 min of intravenous administration,CHEMBL628249,,11662,A,1,Autocuration,,,,0
N,,50594,,,,14839,,Mus musculus,,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",CHEMBL625452,10090.0,11663,A,1,Intermediate,,,,1
N,,50594,,,,14839,,Mus musculus,,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",CHEMBL625453,10090.0,11664,A,1,Intermediate,,,,1
N,,50594,,,,14839,,Mus musculus,,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",CHEMBL625454,10090.0,11665,A,1,Intermediate,,,,1
N,,50594,,,,14839,,Mus musculus,,BAO_0000218,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",CHEMBL623844,10090.0,11666,A,1,Intermediate,,,,1
N,,50597,,,,12178,,Rattus norvegicus,,BAO_0000218,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,CHEMBL623845,10116.0,11667,A,1,Intermediate,,,,1
N,,50597,,,,12178,,Rattus norvegicus,,BAO_0000218,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,CHEMBL623846,10116.0,11668,A,1,Intermediate,,,,1
U,,22224,,,,12178,,,,BAO_0000218,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,CHEMBL623847,,11669,A,1,Autocuration,,,,0
N,,100710,,,,12186,,Macaca fascicularis,,BAO_0000218,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,CHEMBL623848,9541.0,11670,A,1,Intermediate,,,,1
N,,100710,,,,12186,,Macaca fascicularis,,BAO_0000218,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,CHEMBL623849,9541.0,11671,A,1,Intermediate,,,,1
N,,100710,,,,12186,,Macaca fascicularis,,BAO_0000218,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,CHEMBL623850,9541.0,11672,A,1,Intermediate,,,,1
N,,100710,,,,12186,,Macaca fascicularis,,BAO_0000218,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,CHEMBL623851,9541.0,11673,A,1,Intermediate,,,,1
U,,22224,,,,12187,,Simiiformes,,BAO_0000218,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,CHEMBL623852,314293.0,11674,A,1,Autocuration,,,,0
N,,50506,,,,12187,,Mustela putorius furo,,BAO_0000218,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,CHEMBL624551,9669.0,11675,A,1,Intermediate,,,,1
N,,50506,,,,12187,,Mustela putorius furo,,BAO_0000218,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",CHEMBL624552,9669.0,11676,A,1,Intermediate,,,,1
U,,22224,,,,12187,,Simiiformes,,BAO_0000218,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,CHEMBL624553,314293.0,11677,A,1,Autocuration,,,,0
U,,22224,,,,12187,,Simiiformes,,BAO_0000218,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,CHEMBL624554,314293.0,11678,A,1,Autocuration,,,,0
N,,50597,,,,12187,,Rattus norvegicus,,BAO_0000218,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,CHEMBL624555,10116.0,11679,A,1,Intermediate,,,,1
N,,50597,,,,12187,,Rattus norvegicus,,BAO_0000218,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",CHEMBL624741,10116.0,11680,A,1,Intermediate,,,,1
N,,50588,,,,14122,,Canis lupus familiaris,,BAO_0000218,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",CHEMBL624742,9615.0,11681,A,1,Intermediate,,,,1
N,,100712,,,,14122,,Cricetinae,,BAO_0000218,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",CHEMBL624743,10026.0,11682,A,1,Intermediate,,,,1
N,,50597,,,,14122,,Rattus norvegicus,,BAO_0000218,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",CHEMBL877606,10116.0,11683,A,1,Intermediate,,,,1
U,,22224,,,,13391,,,,BAO_0000218,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,CHEMBL624744,,11684,A,1,Autocuration,,,,0
U,,22224,,,,13391,Blood,,,BAO_0000218,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,CHEMBL624745,,11685,A,1,Autocuration,,,178.0,0
U,,22224,,,,13391,Blood,,,BAO_0000218,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,CHEMBL624746,,11686,A,1,Autocuration,,,178.0,0
U,,22224,,,,13391,Blood,,,BAO_0000218,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,CHEMBL624747,,11687,A,1,Autocuration,,,178.0,0
U,,22224,,,,16360,,,,BAO_0000019,,Oral absorption expressed as Area under curve was determined,CHEMBL624748,,11688,A,1,Autocuration,,,,0
N,,50588,,,,3673,,Canis lupus familiaris,,BAO_0000218,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,CHEMBL622504,9615.0,11689,A,1,Intermediate,,,,1
N,,50588,,,,14122,,Canis lupus familiaris,,BAO_0000218,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",CHEMBL622505,9615.0,11690,A,1,Intermediate,,,,1
N,,100712,,,,14122,,Cricetinae,,BAO_0000218,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",CHEMBL622506,10026.0,11691,A,1,Intermediate,,,,1
N,,100712,,,,14122,,Cricetinae,,BAO_0000218,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",CHEMBL622507,10026.0,11692,A,1,Intermediate,,,,1
N,,50597,,,,14122,,Rattus norvegicus,,BAO_0000218,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",CHEMBL622508,10116.0,11693,A,1,Intermediate,,,,1
U,,22224,,,,13889,,,,BAO_0000019,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,CHEMBL622509,,11694,A,1,Autocuration,,,,0
N,,50597,,,,14393,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,CHEMBL622510,10116.0,11695,A,1,Intermediate,,,,1
N,,50597,,,,17279,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),CHEMBL622511,10116.0,11696,A,1,Intermediate,,,,1
N,,100710,,,,14548,,Macaca fascicularis,,BAO_0000218,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,CHEMBL622512,9541.0,11697,A,1,Intermediate,,,,1
N,,100710,,,,14548,,Macaca fascicularis,,BAO_0000218,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,CHEMBL622513,9541.0,11698,A,1,Intermediate,,,,1
N,,100710,,,,14548,,Macaca fascicularis,,BAO_0000218,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,CHEMBL622514,9541.0,11699,A,1,Intermediate,,,,1
N,,50588,,,,14548,,Canis lupus familiaris,,BAO_0000218,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,CHEMBL622515,9615.0,11700,A,1,Intermediate,,,,1
N,,50588,,,,14548,,Canis lupus familiaris,,BAO_0000218,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,CHEMBL622516,9615.0,11701,A,1,Intermediate,,,,1
N,,50597,,,,14548,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,CHEMBL622517,10116.0,11702,A,1,Intermediate,,,,1
N,,50597,,,,14548,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,CHEMBL622518,10116.0,11703,A,1,Intermediate,,,,1
N,,50597,,,,14548,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,CHEMBL622519,10116.0,11704,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14608,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL622520,10116.0,11705,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,14608,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL622521,10116.0,11706,A,1,Intermediate,,,2385.0,1
N,,50594,,,In vivo,14608,Zone of skin,Mus musculus,,BAO_0000218,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL625113,10090.0,11707,A,1,Intermediate,,,14.0,1
N,,50597,,,In vivo,14608,Zone of skin,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL625114,10116.0,11708,A,1,Intermediate,,,14.0,1
N,,50597,,,In vivo,14608,Zone of skin,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL874397,10116.0,11709,A,1,Intermediate,,,14.0,1
N,,50597,,,In vivo,14608,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL625115,10116.0,11710,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,14608,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL625116,10116.0,11711,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,14608,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL623932,10116.0,11712,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,14608,Striatum,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL623933,10116.0,11713,A,1,Intermediate,,,2435.0,1
N,,50597,,,In vivo,14608,Striatum,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL623934,10116.0,11714,A,1,Intermediate,,,2435.0,1
N,,50597,,,In vivo,14608,Striatum,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL623935,10116.0,11715,A,1,Intermediate,,,2435.0,1
N,,50597,,,In vivo,14608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,CHEMBL623936,10116.0,11716,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,14608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,CHEMBL623937,10116.0,11717,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,14608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,CHEMBL623938,10116.0,11718,A,1,Intermediate,,,2046.0,1
N,,50594,,,,15383,,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,CHEMBL623939,10090.0,11719,A,1,Intermediate,,,,1
N,,50594,,,,15383,,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,CHEMBL623940,10090.0,11720,A,1,Intermediate,,,,1
N,,50594,,,,15383,,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,CHEMBL623941,10090.0,11721,A,1,Intermediate,,,,1
N,,50594,,,,15383,,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL627216,10090.0,11722,A,1,Intermediate,,,,1
N,,50594,,,,15383,,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL623942,10090.0,11723,A,1,Intermediate,,,,1
N,,50594,,,,15383,Brain,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,CHEMBL618793,10090.0,11724,A,1,Intermediate,,,955.0,1
N,,50594,,,,15383,Brain,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL618794,10090.0,11725,A,1,Intermediate,,,955.0,1
N,,50594,,,,15383,Brain,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL618795,10090.0,11726,A,1,Intermediate,,,955.0,1
N,,50594,,,,15383,,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL618796,10090.0,11727,A,1,Intermediate,,,,1
N,,50594,,,,15383,,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL618797,10090.0,11728,A,1,Intermediate,,,,1
N,,50594,,,,15383,Kidney,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,CHEMBL618798,10090.0,11729,A,1,Intermediate,,,2113.0,1
N,,50594,,,,15383,Kidney,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,CHEMBL618799,10090.0,11730,A,1,Intermediate,,,2113.0,1
N,,50594,,,,15383,Kidney,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,CHEMBL618800,10090.0,11731,A,1,Intermediate,,,2113.0,1
N,,50594,,,,15383,Kidney,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,CHEMBL618801,10090.0,11732,A,1,Intermediate,,,2113.0,1
N,,50594,,,,15383,Kidney,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL618802,10090.0,11733,A,1,Intermediate,,,2113.0,1
N,,50594,,,,15383,Kidney,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL618803,10090.0,11734,A,1,Intermediate,,,2113.0,1
N,,50594,,,,15383,Liver,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,CHEMBL618804,10090.0,11735,A,1,Intermediate,,,2107.0,1
N,,50594,,,,15383,Liver,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,CHEMBL618805,10090.0,11736,A,1,Intermediate,,,2107.0,1
N,,50594,,,,15383,Liver,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,CHEMBL618806,10090.0,11737,A,1,Intermediate,,,2107.0,1
N,,50594,,,,15383,Liver,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,CHEMBL618807,10090.0,11738,A,1,Intermediate,,,2107.0,1
N,,50594,,,,15383,Liver,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL618808,10090.0,11739,A,1,Intermediate,,,2107.0,1
N,,50594,,,,15383,Liver,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL618809,10090.0,11740,A,1,Intermediate,,,2107.0,1
N,,50594,,,,15383,Muscle tissue,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,CHEMBL618810,10090.0,11741,A,1,Intermediate,,,2385.0,1
N,,50594,,,,15383,Muscle tissue,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,CHEMBL618811,10090.0,11742,A,1,Intermediate,,,2385.0,1
N,,50594,,,,15383,Muscle tissue,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,CHEMBL875844,10090.0,11743,A,1,Intermediate,,,2385.0,1
N,,50594,,,,15383,Muscle tissue,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL618812,10090.0,11744,A,1,Intermediate,,,2385.0,1
N,,50594,,,,15383,Muscle tissue,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL618813,10090.0,11745,A,1,Intermediate,,,2385.0,1
N,,50594,,,,15383,,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,CHEMBL618814,10090.0,11746,A,1,Intermediate,,,,1
N,,50594,,,,15383,,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL618815,10090.0,11747,A,1,Intermediate,,,,1
N,,50594,,,,15383,,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL618816,10090.0,11748,A,1,Intermediate,,,,1
N,,50594,,,,15383,,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL618817,10090.0,11749,A,1,Intermediate,,,,1
N,,50594,,,,15383,,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL620544,10090.0,11750,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15341,,Rattus norvegicus,,BAO_0000218,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,CHEMBL626230,10116.0,11751,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15341,,Rattus norvegicus,,BAO_0000218,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,CHEMBL626231,10116.0,11752,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15341,,Rattus norvegicus,,BAO_0000218,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,CHEMBL626232,10116.0,11753,A,1,Intermediate,,,,1
N,,50588,,,In vivo,14906,Plasma,Canis lupus familiaris,,BAO_0000218,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,CHEMBL626233,9615.0,11754,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14906,Plasma,Rattus norvegicus,,BAO_0000218,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,CHEMBL626234,10116.0,11755,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14906,Plasma,Rattus norvegicus,,BAO_0000218,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,CHEMBL875341,10116.0,11756,A,1,Intermediate,,,1969.0,1
N,,50587,,,In vivo,14215,Plasma,Homo sapiens,,BAO_0000218,,The maximum plasma concentration (100 mg/kg) administered orally in human,CHEMBL626235,9606.0,11757,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,14215,Plasma,Callithrix,,BAO_0000218,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,CHEMBL626236,9481.0,11758,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,14215,Plasma,Simiiformes,,BAO_0000218,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,CHEMBL626237,314293.0,11759,A,1,Autocuration,,,1969.0,0
N,,50588,,,In vivo,14215,Plasma,Canis lupus familiaris,,BAO_0000218,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,CHEMBL626238,9615.0,11760,A,1,Intermediate,,,1969.0,1
N,,50587,,,In vivo,14215,Plasma,Homo sapiens,,BAO_0000218,,The maximum plasma concentration (200 mg/kg) administered orally in human,CHEMBL622412,9606.0,11761,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14215,Plasma,Rattus norvegicus,,BAO_0000218,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,CHEMBL623114,10116.0,11762,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,14215,Plasma,Callithrix,,BAO_0000218,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,CHEMBL623115,9481.0,11763,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,14215,Plasma,Simiiformes,,BAO_0000218,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,CHEMBL623116,314293.0,11764,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,14215,Plasma,Canis lupus familiaris,,BAO_0000218,,The maximum plasma concentration (30 mg/kg) administered orally in dog,CHEMBL623117,9615.0,11765,A,1,Autocuration,,,1969.0,0
N,,50587,,,In vivo,14215,Plasma,Homo sapiens,,BAO_0000218,,The maximum plasma concentration (400 mg/kg) administered orally in human,CHEMBL623118,9606.0,11766,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14215,Plasma,Rattus norvegicus,,BAO_0000218,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,CHEMBL623119,10116.0,11767,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14215,Plasma,Rattus norvegicus,,BAO_0000218,,The maximum plasma concentration (50 mg/kg) administered orally in rat,CHEMBL623120,10116.0,11768,A,1,Intermediate,,,1969.0,1
N,,50587,,,In vivo,14215,Plasma,Homo sapiens,,BAO_0000218,,The maximum plasma concentration (800 mg/kg) administered orally in human,CHEMBL623286,9606.0,11769,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14067,Plasma,Rattus norvegicus,,BAO_0000218,,The maximum plasma concentration was measured on rats,CHEMBL623287,10116.0,11770,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,12350,Plasma,Rattus norvegicus,,BAO_0000218,,The maximum plasma concentration was measured on rats after oral administration,CHEMBL623288,10116.0,11771,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14813,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma drug Cmax in rat (PO dose),CHEMBL623289,10116.0,11772,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,12536,,,,BAO_0000218,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,CHEMBL623290,,11773,A,1,Autocuration,,,,0
N,,50588,,,In vivo,14169,Plasma,Canis lupus familiaris,,BAO_0000218,,maximum Plasma concentration in Dog was determined after Peroral administration,CHEMBL623291,9615.0,11774,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14169,Plasma,Rattus norvegicus,,BAO_0000218,,maximum Plasma concentration in Rats was determined after Peroral administration,CHEMBL623292,10116.0,11775,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,15604,Plasma,Canis lupus familiaris,,BAO_0000218,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,CHEMBL623293,9615.0,11776,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,15604,Plasma,Simiiformes,,BAO_0000218,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,CHEMBL623294,314293.0,11777,A,1,Autocuration,,,1969.0,0
N,,50597,,,In vivo,15604,Plasma,Rattus norvegicus,,BAO_0000218,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,CHEMBL623295,10116.0,11778,A,1,Intermediate,,,1969.0,1
N,,50594,,,In vivo,14387,,Mus musculus,,BAO_0000218,,maximum concentration was measured when administered through oral route in mice,CHEMBL623296,10090.0,11779,A,1,Intermediate,,,,1
N,,50594,,,,15115,,Mus musculus,,BAO_0000218,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,CHEMBL875349,10090.0,11780,A,1,Intermediate,,,,1
U,,22224,,,,15115,,Simiiformes,,BAO_0000019,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,CHEMBL623297,314293.0,11781,A,1,Autocuration,,,,0
U,,22224,,,,15115,,Simiiformes,,BAO_0000019,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,CHEMBL623298,314293.0,11782,A,1,Autocuration,,,,0
U,,22224,,,,15115,,Simiiformes,,BAO_0000019,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,CHEMBL623299,314293.0,11783,A,1,Autocuration,,,,0
N,,50597,,,,16359,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter was evaluated in rats,CHEMBL623300,10116.0,11784,A,1,Intermediate,,,,1
N,,50594,,,,12829,,Mus musculus,,BAO_0000218,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,CHEMBL623301,10090.0,11785,A,1,Intermediate,,,,1
N,,50594,,,,12829,,Mus musculus,,BAO_0000218,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,CHEMBL623302,10090.0,11786,A,1,Intermediate,,,,1
N,,50594,,,,12829,,Mus musculus,,BAO_0000218,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,CHEMBL623303,10090.0,11787,A,1,Intermediate,,,,1
N,,50594,,,,12829,,Mus musculus,,BAO_0000218,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,CHEMBL623304,10090.0,11788,A,1,Intermediate,,,,1
N,,50594,,,,12829,,Mus musculus,,BAO_0000218,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,CHEMBL623305,10090.0,11789,A,1,Intermediate,,,,1
N,,50597,,,,15137,Plasma,Rattus norvegicus,,BAO_0000218,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,CHEMBL623306,10116.0,11790,A,1,Intermediate,,,1969.0,1
N,,50597,,,,15137,Plasma,Rattus norvegicus,,BAO_0000218,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,CHEMBL623307,10116.0,11791,A,1,Intermediate,,,1969.0,1
N,,50597,,,,15137,Plasma,Rattus norvegicus,,BAO_0000218,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,CHEMBL623308,10116.0,11792,A,1,Intermediate,,,1969.0,1
N,,50594,,,,15137,Plasma,Mus musculus,,BAO_0000218,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,CHEMBL623309,10090.0,11793,A,1,Intermediate,,,1969.0,1
N,,50594,,,,13509,,Mus musculus,,BAO_0000218,,Plasma Concentration after 120 min of oral administration to mice,CHEMBL623310,10090.0,11794,A,1,Intermediate,,,,1
N,,50594,,,,13509,,Mus musculus,,BAO_0000218,,Plasma Concentration after 30 min of oral administration to mice,CHEMBL623311,10090.0,11795,A,1,Intermediate,,,,1
N,,100710,,,,13509,,Macaca fascicularis,,BAO_0000218,,Plasma Concentration after 60 min of oral administration to mice,CHEMBL623312,9541.0,11796,A,1,Intermediate,,,,1
N,,50594,,,,13509,,Mus musculus,,BAO_0000218,,Plasma Concentration after 60 min of oral administration to mice; Not determined,CHEMBL875350,10090.0,11797,A,1,Intermediate,,,,1
N,,50594,,,,13509,,Mus musculus,,BAO_0000218,,Plasma Concentration after 90 min of oral administration to mice,CHEMBL628635,10090.0,11798,A,1,Intermediate,,,,1
N,,50597,,,,12064,,Rattus norvegicus,,BAO_0000218,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,CHEMBL628636,10116.0,11799,A,1,Intermediate,,,,1
N,,50597,,,,12064,,Rattus norvegicus,,BAO_0000218,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,CHEMBL628637,10116.0,11800,A,1,Intermediate,,,,1
N,,50597,,,,12064,,Rattus norvegicus,,BAO_0000218,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,CHEMBL628058,10116.0,11801,A,1,Intermediate,,,,1
N,,50597,,,,10677,,Rattus norvegicus,,BAO_0000218,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,CHEMBL628059,10116.0,11802,A,1,Intermediate,,,,1
N,,50597,,,,10677,,Rattus norvegicus,,BAO_0000218,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,CHEMBL628060,10116.0,11803,A,1,Intermediate,,,,1
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the lung after 15 min of intravenous administration,CHEMBL628061,,11804,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the lung after 30 min of intravenous administration,CHEMBL628062,,11805,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the lung after 5 min of intravenous administration,CHEMBL628063,,11806,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the lung after 60 min of intravenous administration,CHEMBL628064,,11807,A,1,Autocuration,,,,0
U,,22224,,,,8926,,,,BAO_0000019,,Distribution in the lung after 90 min of intravenous administration,CHEMBL628065,,11808,A,1,Autocuration,,,,0
U,,22224,,,,8926,Muscle tissue,,,BAO_0000019,,Distribution in the muscle after 120 min of intravenous administration,CHEMBL628066,,11809,A,1,Autocuration,,,2385.0,0
U,,22224,,,,8926,Muscle tissue,,,BAO_0000019,,Distribution in the muscle after 15 min of intravenous administration,CHEMBL628067,,11810,A,1,Autocuration,,,2385.0,0
N,,50594,,,,8926,Muscle tissue,Mus musculus,,BAO_0000218,,Distribution in the muscle after 30 min of intravenous administration,CHEMBL874646,10090.0,11811,A,1,Intermediate,,,2385.0,1
U,,22224,,,,8926,Muscle tissue,,,BAO_0000019,,Distribution in the muscle after 5 min of intravenous administration,CHEMBL628068,,11812,A,1,Autocuration,,,2385.0,0
U,,22224,,,,8926,Muscle tissue,,,BAO_0000019,,Distribution in the muscle after 60 min of intravenous administration,CHEMBL628069,,11813,A,1,Autocuration,,,2385.0,0
U,,22224,,,,8926,Muscle tissue,,,BAO_0000019,,Distribution in the muscle after 90 min of intravenous administration,CHEMBL628070,,11814,A,1,Autocuration,,,2385.0,0
U,,22224,,,,8926,Spleen,,,BAO_0000019,,Distribution in the spleen after 120 min of intravenous administration,CHEMBL628071,,11815,A,1,Autocuration,,,2106.0,0
U,,22224,,,,8926,Spleen,,,BAO_0000019,,Distribution in the spleen after 15 min of intravenous administration,CHEMBL628072,,11816,A,1,Autocuration,,,2106.0,0
U,,22224,,,,8926,Spleen,,,BAO_0000019,,Distribution in the spleen after 30 min of intravenous administration,CHEMBL628073,,11817,A,1,Autocuration,,,2106.0,0
U,,22224,,,,8926,Spleen,,,BAO_0000019,,Distribution in the spleen after 5 min of intravenous administration,CHEMBL628074,,11818,A,1,Autocuration,,,2106.0,0
U,,22224,,,,8926,Spleen,,,BAO_0000019,,Distribution in the spleen after 60 min of intravenous administration,CHEMBL628075,,11819,A,1,Autocuration,,,2106.0,0
U,,22224,,,,8926,Spleen,,,BAO_0000019,,Distribution in the spleen after 90 min of intravenous administration,CHEMBL628076,,11820,A,1,Autocuration,,,2106.0,0
N,,50597,,,,7570,Adrenal cortex,Rattus norvegicus,,BAO_0000218,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,CHEMBL628077,10116.0,11821,A,1,Intermediate,,,1235.0,1
N,,50597,,,,7570,Blood,Rattus norvegicus,,BAO_0000218,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,CHEMBL628078,10116.0,11822,A,1,Intermediate,,,178.0,1
N,,50597,,,,7570,Liver,Rattus norvegicus,,BAO_0000218,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,CHEMBL628079,10116.0,11823,A,1,Intermediate,,,2107.0,1
N,,50597,,,,7570,Female gonad,Rattus norvegicus,,BAO_0000218,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,CHEMBL628080,10116.0,11824,A,1,Intermediate,,,992.0,1
N,,50597,,,,7570,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,CHEMBL628081,10116.0,11825,A,1,Intermediate,,,2046.0,1
N,,50597,,,,7570,Adrenal cortex,Rattus norvegicus,,BAO_0000218,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,CHEMBL628082,10116.0,11826,A,1,Intermediate,,,1235.0,1
N,,50597,,,,7570,Blood,Rattus norvegicus,,BAO_0000218,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,CHEMBL874647,10116.0,11827,A,1,Intermediate,,,178.0,1
N,,50597,,,,7570,Liver,Rattus norvegicus,,BAO_0000218,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,CHEMBL626406,10116.0,11828,A,1,Intermediate,,,2107.0,1
N,,50597,,,,7570,Female gonad,Rattus norvegicus,,BAO_0000218,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,CHEMBL626407,10116.0,11829,A,1,Intermediate,,,992.0,1
N,,50597,,,,7570,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,CHEMBL626408,10116.0,11830,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",CHEMBL626409,10116.0,11831,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",CHEMBL626410,10116.0,11832,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",CHEMBL626411,10116.0,11833,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",CHEMBL626412,10116.0,11834,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",CHEMBL626413,10116.0,11835,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",CHEMBL626414,10116.0,11836,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",CHEMBL626415,10116.0,11837,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",CHEMBL626416,10116.0,11838,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",CHEMBL627062,10116.0,11839,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",CHEMBL627063,10116.0,11840,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",CHEMBL627064,10116.0,11841,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",CHEMBL627227,10116.0,11842,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",CHEMBL627228,10116.0,11843,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",CHEMBL627229,10116.0,11844,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",CHEMBL625792,10116.0,11845,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",CHEMBL625793,10116.0,11846,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",CHEMBL625794,10116.0,11847,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Blood,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",CHEMBL625795,10116.0,11848,A,1,Intermediate,,,178.0,1
N,,50594,,,,13792,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,CHEMBL625796,10090.0,11849,A,1,Intermediate,,,,1
N,,50588,,,,13376,,Canis lupus familiaris,,BAO_0000218,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,CHEMBL625797,9615.0,11850,A,1,Intermediate,,,,1
N,,50588,,,,13376,,Canis lupus familiaris,,BAO_0000218,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,CHEMBL625798,9615.0,11851,A,1,Intermediate,,,,1
U,,22224,,,,14380,,,,BAO_0000218,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,CHEMBL875613,,11852,A,1,Autocuration,,,,0
U,,22224,,,,14380,,,,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,CHEMBL625799,,11853,A,1,Autocuration,,,,0
U,,22224,,,,14380,,,,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,CHEMBL625800,,11854,A,1,Autocuration,,,,0
U,,22224,,,,14380,,,,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,CHEMBL625801,,11855,A,1,Autocuration,,,,0
U,,22224,,,,14380,,,,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,CHEMBL625802,,11856,A,1,Autocuration,,,,0
U,,22224,,,,14380,,,,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,CHEMBL625803,,11857,A,1,Autocuration,,,,0
U,,22224,,,,14380,,,,BAO_0000019,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,CHEMBL625804,,11858,A,1,Autocuration,,,,0
U,,22224,,,,14380,,,,BAO_0000218,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,CHEMBL622530,,11859,A,1,Autocuration,,,,0
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,CHEMBL622531,10090.0,11860,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),CHEMBL622532,10090.0,11861,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),CHEMBL623176,10090.0,11862,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),CHEMBL623177,10090.0,11863,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),CHEMBL623178,10090.0,11864,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,CHEMBL623179,10090.0,11865,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),CHEMBL623180,10090.0,11866,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),CHEMBL623181,10090.0,11867,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),CHEMBL624131,10090.0,11868,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),CHEMBL624132,10090.0,11869,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),CHEMBL624133,10090.0,11870,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,CHEMBL624846,10090.0,11871,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),CHEMBL624847,10090.0,11872,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),CHEMBL624848,10090.0,11873,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),CHEMBL625012,10090.0,11874,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),CHEMBL625013,10090.0,11875,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,CHEMBL625014,10090.0,11876,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),CHEMBL625015,10090.0,11877,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),CHEMBL625016,10090.0,11878,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,CHEMBL625017,10090.0,11879,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),CHEMBL625018,10090.0,11880,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),CHEMBL625019,10090.0,11881,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),CHEMBL625020,10090.0,11882,A,1,Intermediate,,,,1
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,CHEMBL625021,10090.0,11883,A,1,Intermediate,,,,1
N,,50597,,,,14393,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,CHEMBL625022,10116.0,11884,A,1,Intermediate,,,,1
N,,50594,,,,14731,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,CHEMBL625023,10090.0,11885,A,1,Intermediate,,,,1
N,,100710,,,,14731,,Macaca fascicularis,,BAO_0000218,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,CHEMBL625024,9541.0,11886,A,1,Intermediate,,,,1
N,,100710,,,,14731,,Macaca fascicularis,,BAO_0000218,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,CHEMBL627626,9541.0,11887,A,1,Intermediate,,,,1
U,,22224,,,,13758,Brain,,,BAO_0000218,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,CHEMBL627627,,11888,A,1,Autocuration,,,955.0,0
U,,22224,,,,13758,Serum,,,BAO_0000218,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,CHEMBL627628,,11889,A,1,Autocuration,,,1977.0,0
U,,22224,,,,13758,Brain,,,BAO_0000218,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,CHEMBL627629,,11890,A,1,Autocuration,,,955.0,0
U,,22224,,,,13758,Serum,,,BAO_0000218,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,CHEMBL627630,,11891,A,1,Autocuration,,,1977.0,0
U,,22224,,,,16359,,,,BAO_0000019,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),CHEMBL627631,,11892,A,1,Autocuration,,,,0
U,,22224,,,,16359,,,,BAO_0000218,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),CHEMBL629515,,11893,A,1,Autocuration,,,,0
N,,50594,,,,15383,Spleen,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,CHEMBL629516,10090.0,11894,A,1,Intermediate,,,2106.0,1
N,,50594,,,,15383,Spleen,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL629517,10090.0,11895,A,1,Intermediate,,,2106.0,1
N,,50594,,,,15383,Spleen,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL629518,10090.0,11896,A,1,Intermediate,,,2106.0,1
N,,50594,,,,15383,,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,CHEMBL877499,10090.0,11897,A,1,Intermediate,,,,1
N,,50594,,,,15383,,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,CHEMBL629519,10090.0,11898,A,1,Intermediate,,,,1
N,,50594,,,,15383,,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,CHEMBL629520,10090.0,11899,A,1,Intermediate,,,,1
N,,50594,,,,15383,,Mus musculus,,BAO_0000218,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,CHEMBL629521,10090.0,11900,A,1,Intermediate,,,,1
N,,50594,,,,14439,,Mus musculus,,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),CHEMBL629522,10090.0,11901,A,1,Intermediate,,,,1
N,,50594,,,,14439,,Mus musculus,,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),CHEMBL629523,10090.0,11902,A,1,Intermediate,,,,1
N,,50594,,,,14439,,Mus musculus,,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),CHEMBL629524,10090.0,11903,A,1,Intermediate,,,,1
N,,50594,,,,14439,,Mus musculus,,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),CHEMBL629525,10090.0,11904,A,1,Intermediate,,,,1
N,,50594,,,,14439,,Mus musculus,,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),CHEMBL629526,10090.0,11905,A,1,Intermediate,,,,1
N,,50594,,,,14439,,Mus musculus,,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),CHEMBL629527,10090.0,11906,A,1,Intermediate,,,,1
N,,50594,,,,14439,,Mus musculus,,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),CHEMBL629528,10090.0,11907,A,1,Intermediate,,,,1
N,,50594,,,,14439,,Mus musculus,,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),CHEMBL629529,10090.0,11908,A,1,Intermediate,,,,1
N,,50594,,,,14439,,Mus musculus,,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),CHEMBL629530,10090.0,11909,A,1,Intermediate,,,,1
N,,50594,,,,14439,,Mus musculus,,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),CHEMBL629531,10090.0,11910,A,1,Intermediate,,,,1
N,,50594,,,,14439,,Mus musculus,,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),CHEMBL628656,10090.0,11911,A,1,Intermediate,,,,1
N,,50594,,,,14439,,Mus musculus,,BAO_0000218,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),CHEMBL628657,10090.0,11912,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,,Rattus norvegicus,,BAO_0000218,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL628658,10116.0,11913,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,,Rattus norvegicus,,BAO_0000218,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL628659,10116.0,11914,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,,Rattus norvegicus,,BAO_0000218,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL877500,10116.0,11915,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,,Rattus norvegicus,,BAO_0000218,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL628660,10116.0,11916,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,,Rattus norvegicus,,BAO_0000218,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL628661,10116.0,11917,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,,Rattus norvegicus,,BAO_0000218,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL628662,10116.0,11918,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,,Rattus norvegicus,,BAO_0000218,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL628663,10116.0,11919,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,,Rattus norvegicus,,BAO_0000218,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL628664,10116.0,11920,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,Blood,Rattus norvegicus,,BAO_0000218,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL628665,10116.0,11921,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13751,Blood,Rattus norvegicus,,BAO_0000218,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL628666,10116.0,11922,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13751,Blood,Rattus norvegicus,,BAO_0000218,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL628667,10116.0,11923,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13751,Blood,Rattus norvegicus,,BAO_0000218,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL628668,10116.0,11924,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13751,Blood,Rattus norvegicus,,BAO_0000218,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL628669,10116.0,11925,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13751,Blood,Rattus norvegicus,,BAO_0000218,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL628670,10116.0,11926,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13751,Blood,Rattus norvegicus,,BAO_0000218,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL628671,10116.0,11927,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13751,Bone,Rattus norvegicus,,BAO_0000218,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL628672,10116.0,11928,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,13751,Bone,Rattus norvegicus,,BAO_0000218,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL630300,10116.0,11929,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,13751,Bone,Rattus norvegicus,,BAO_0000218,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL629787,10116.0,11930,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,13751,Bone,Rattus norvegicus,,BAO_0000218,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL629788,10116.0,11931,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,13751,Brain,Rattus norvegicus,,BAO_0000218,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL629789,10116.0,11932,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13751,Brain,Rattus norvegicus,,BAO_0000218,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL629790,10116.0,11933,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13751,Brain,Rattus norvegicus,,BAO_0000218,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL629791,10116.0,11934,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13751,Brain,Rattus norvegicus,,BAO_0000218,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL629792,10116.0,11935,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13751,Brain,Rattus norvegicus,,BAO_0000218,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL629793,10116.0,11936,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13751,Brain,Rattus norvegicus,,BAO_0000218,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL629794,10116.0,11937,A,1,Intermediate,,,955.0,1
N,,50597,,,,10677,,Rattus norvegicus,,BAO_0000218,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,CHEMBL874459,10116.0,11938,A,1,Intermediate,,,,1
N,,50597,,,,10677,,Rattus norvegicus,,BAO_0000218,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,CHEMBL629795,10116.0,11939,A,1,Intermediate,,,,1
N,,50597,,,,10677,,Rattus norvegicus,,BAO_0000218,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,CHEMBL629796,10116.0,11940,A,1,Intermediate,,,,1
N,,50597,,,,10677,,Rattus norvegicus,,BAO_0000218,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,CHEMBL629797,10116.0,11941,A,1,Intermediate,,,,1
N,,50597,,,,10677,,Rattus norvegicus,,BAO_0000218,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,CHEMBL629798,10116.0,11942,A,1,Intermediate,,,,1
N,,50597,,,In vivo,10911,Adrenal gland,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL629799,10116.0,11943,A,1,Intermediate,,,2369.0,1
N,,50597,,,In vivo,10911,Adrenal gland,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL629800,10116.0,11944,A,1,Intermediate,,,2369.0,1
N,,50597,,,In vivo,10911,Adrenal gland,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL629801,10116.0,11945,A,1,Intermediate,,,2369.0,1
N,,50597,,,In vivo,10911,Adrenal gland,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,CHEMBL629802,10116.0,11946,A,1,Intermediate,,,2369.0,1
N,,50597,,,In vivo,10911,Adrenal gland,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL629803,10116.0,11947,A,1,Intermediate,,,2369.0,1
N,,50597,,,In vivo,10911,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL629804,10116.0,11948,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,10911,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL629805,10116.0,11949,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,10911,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,CHEMBL629806,10116.0,11950,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,10911,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL629807,10116.0,11951,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,10911,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL629808,10116.0,11952,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,10911,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL629809,10116.0,11953,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,10911,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL629810,10116.0,11954,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,10911,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,CHEMBL629811,10116.0,11955,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,10911,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL629812,10116.0,11956,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,10911,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,CHEMBL629813,10116.0,11957,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,10911,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL874460,10116.0,11958,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,10911,,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL629814,10116.0,11959,A,1,Intermediate,,,,1
N,,50597,,,In vivo,10911,,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL629815,10116.0,11960,A,1,Intermediate,,,,1
N,,50597,,,In vivo,10911,,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL629816,10116.0,11961,A,1,Intermediate,,,,1
N,,50597,,,In vivo,10911,,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL629817,10116.0,11962,A,1,Intermediate,,,,1
N,,50597,,,In vivo,10911,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL626643,10116.0,11963,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,10911,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL626644,10116.0,11964,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,10911,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL626806,10116.0,11965,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,10911,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL626807,10116.0,11966,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,10911,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL627261,10116.0,11967,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,10911,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL627262,10116.0,11968,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,10911,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL627263,10116.0,11969,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,10911,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL627264,10116.0,11970,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,10911,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL627265,10116.0,11971,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,10911,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL627266,10116.0,11972,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,10911,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL627267,10116.0,11973,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,10911,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL627268,10116.0,11974,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,10911,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL627269,10116.0,11975,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,10911,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL627270,10116.0,11976,A,1,Intermediate,,,2385.0,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",CHEMBL627271,10116.0,11977,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",CHEMBL627946,10116.0,11978,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",CHEMBL875472,10116.0,11979,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",CHEMBL627947,10116.0,11980,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",CHEMBL627948,10116.0,11981,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",CHEMBL628113,10116.0,11982,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",CHEMBL628114,10116.0,11983,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",CHEMBL628115,10116.0,11984,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",CHEMBL628116,10116.0,11985,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",CHEMBL628117,10116.0,11986,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",CHEMBL628118,10116.0,11987,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",CHEMBL628119,10116.0,11988,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",CHEMBL628120,10116.0,11989,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",CHEMBL628121,10116.0,11990,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",CHEMBL628122,10116.0,11991,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",CHEMBL627297,10116.0,11992,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",CHEMBL627298,10116.0,11993,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",CHEMBL627299,10116.0,11994,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",CHEMBL627300,10116.0,11995,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",CHEMBL627301,10116.0,11996,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",CHEMBL627302,10116.0,11997,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",CHEMBL627303,10116.0,11998,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",CHEMBL627304,10116.0,11999,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",CHEMBL627305,10116.0,12000,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",CHEMBL627306,10116.0,12001,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",CHEMBL623982,10116.0,12002,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",CHEMBL623983,10116.0,12003,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",CHEMBL623984,10116.0,12004,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",CHEMBL623985,10116.0,12005,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",CHEMBL623986,10116.0,12006,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",CHEMBL623987,10116.0,12007,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",CHEMBL623988,10116.0,12008,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",CHEMBL623989,10116.0,12009,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",CHEMBL622215,10116.0,12010,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",CHEMBL622216,10116.0,12011,A,1,Intermediate,,,,1
N,,50597,,,,8608,,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",CHEMBL877481,10116.0,12012,A,1,Intermediate,,,,1
U,,22224,,,,16359,,,,BAO_0000218,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),CHEMBL622217,,12013,A,1,Autocuration,,,,0
N,,50594,,,,13701,,Mus musculus,,BAO_0000218,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),CHEMBL622218,10090.0,12014,A,1,Intermediate,,,,1
N,,50597,,,,14554,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic profile AUC was evaluated in rats,CHEMBL622219,10116.0,12015,A,1,Intermediate,,,,1
U,,22224,,,,6241,,,,BAO_0000019,,Pharmacokinetic property (Area under curve),CHEMBL622220,,12016,A,1,Autocuration,,,,0
N,,50588,,,,11537,,Canis lupus familiaris,,BAO_0000218,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",CHEMBL622221,9615.0,12017,A,1,Intermediate,,,,1
N,,50594,,,,11537,,Mus musculus,,BAO_0000218,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",CHEMBL622222,10090.0,12018,A,1,Intermediate,,,,1
N,,50588,,,,11537,,Canis lupus familiaris,,BAO_0000218,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",CHEMBL622223,9615.0,12019,A,1,Intermediate,,,,1
N,,50594,,,,11537,,Mus musculus,,BAO_0000218,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",CHEMBL622224,10090.0,12020,A,1,Intermediate,,,,1
U,,22224,,,,13118,,,,BAO_0000019,,Plasma concentration (AUC) was determined,CHEMBL622225,,12021,A,1,Autocuration,,,,0
U,,22224,,,,13118,,,,BAO_0000019,,Plasma concentration (AUC) was determined; Not detectable,CHEMBL622226,,12022,A,1,Autocuration,,,,0
N,,50512,,,,9562,,Cavia porcellus,,BAO_0000218,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),CHEMBL624154,10141.0,12023,A,1,Intermediate,,,,1
N,,50597,,,,10363,,Rattus norvegicus,,BAO_0000218,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,CHEMBL624155,10116.0,12024,A,1,Intermediate,,,,1
N,,50597,,,,10363,,Rattus norvegicus,,BAO_0000218,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,CHEMBL624156,10116.0,12025,A,1,Intermediate,,,,1
N,,50597,,,,10363,,Rattus norvegicus,,BAO_0000218,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,CHEMBL624157,10116.0,12026,A,1,Intermediate,,,,1
N,,50597,,,,10363,,Rattus norvegicus,,BAO_0000218,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,CHEMBL624158,10116.0,12027,A,1,Intermediate,,,,1
N,,50597,,,,12504,,Rattus norvegicus,,BAO_0000218,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,CHEMBL624159,10116.0,12028,A,1,Intermediate,,,,1
N,,50597,,,,12504,,Rattus norvegicus,,BAO_0000218,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,CHEMBL624160,10116.0,12029,A,1,Intermediate,,,,1
N,,50597,,,,12504,,Rattus norvegicus,,BAO_0000218,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,CHEMBL624161,10116.0,12030,A,1,Intermediate,,,,1
N,,50597,,,,12504,,Rattus norvegicus,,BAO_0000218,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,CHEMBL624162,10116.0,12031,A,1,Intermediate,,,,1
N,,50588,,,,13317,,Canis lupus familiaris,,BAO_0000218,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,CHEMBL624163,9615.0,12032,A,1,Intermediate,,,,1
N,,50597,,,,15078,,Rattus norvegicus,,BAO_0000218,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL624164,10116.0,12033,A,1,Intermediate,,,,1
N,,50597,,,,14941,,Rattus norvegicus,,BAO_0000218,,The AUC(0-infinity) values in female wistar rats.,CHEMBL624165,10116.0,12034,A,1,Intermediate,,,,1
N,,50597,,,,15078,,Rattus norvegicus,,BAO_0000218,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL624166,10116.0,12035,A,1,Intermediate,,,,1
N,,50597,,,,15078,,Rattus norvegicus,,BAO_0000218,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",CHEMBL624167,10116.0,12036,A,1,Intermediate,,,,1
N,,50597,,,,14941,,Rattus norvegicus,,BAO_0000218,,The AUC(0-t)values in female wistar rats.,CHEMBL624168,10116.0,12037,A,1,Intermediate,,,,1
N,,50597,,,,14067,,Rattus norvegicus,,BAO_0000218,,The Area under the concentration time curve of compound was measured on rats,CHEMBL624169,10116.0,12038,A,1,Intermediate,,,,1
N,,50587,,,,14215,,Homo sapiens,,BAO_0000218,,The area under curve (100 mg/kg) administered orally in humans,CHEMBL624170,9606.0,12039,A,1,Intermediate,,,,1
U,,22224,,,,14215,,Callithrix,,BAO_0000218,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,CHEMBL624171,9481.0,12040,A,1,Autocuration,,,,0
U,,22224,,,,14215,,Simiiformes,,BAO_0000218,,The area under curve (12.5 mg/kg) administered intravenously in monkey,CHEMBL624172,314293.0,12041,A,1,Autocuration,,,,0
N,,50588,,,,14215,,Canis lupus familiaris,,BAO_0000218,,The area under curve (15 mg/kg) administered intravenously in dog,CHEMBL624173,9615.0,12042,A,1,Intermediate,,,,1
N,,50587,,,,14215,,Homo sapiens,,BAO_0000218,,The area under curve (200 mg/kg) administered orally in humans,CHEMBL877488,9606.0,12043,A,1,Intermediate,,,,1
N,,50597,,,,14215,,Rattus norvegicus,,BAO_0000218,,The area under curve (25 mg/kg) administered intravenously in rat,CHEMBL624174,10116.0,12044,A,1,Intermediate,,,,1
U,,22224,,,,14215,,Callithrix,,BAO_0000218,,The area under curve (25 mg/kg) administered orally in marmoset,CHEMBL624175,9481.0,12045,A,1,Autocuration,,,,0
U,,22224,,,,14215,,Simiiformes,,BAO_0000218,,The area under curve (25 mg/kg) administered orally in monkey,CHEMBL624176,314293.0,12046,A,1,Autocuration,,,,0
N,,50588,,,,14215,,Canis lupus familiaris,,BAO_0000218,,The area under curve (30 mg/kg) administered orally in dog,CHEMBL624177,9615.0,12047,A,1,Intermediate,,,,1
N,,50587,,,,14215,,Homo sapiens,,BAO_0000218,,The area under curve (400 mg/kg) administered orally in humans,CHEMBL624178,9606.0,12048,A,1,Intermediate,,,,1
N,,50597,,,,14215,,Rattus norvegicus,,BAO_0000218,,The area under curve (50 mg/kg) administered orally in fasted rat,CHEMBL624179,10116.0,12049,A,1,Intermediate,,,,1
N,,50597,,,,14215,,Rattus norvegicus,,BAO_0000218,,The area under curve (50 mg/kg) administered orally in rat,CHEMBL627689,10116.0,12050,A,1,Intermediate,,,,1
N,,50587,,,,14215,,Homo sapiens,,BAO_0000218,,The area under curve (800 mg/kg) administered orally in humans,CHEMBL627690,9606.0,12051,A,1,Intermediate,,,,1
U,,22224,,,,11324,,,,BAO_0000019,,The compound was evaluated for area under the curve,CHEMBL627691,,12052,A,1,Autocuration,,,,0
U,,22224,,,,11324,,Callithrix,,BAO_0000019,,The compound was evaluated for area under the curve in marmosets,CHEMBL627692,9481.0,12053,A,1,Autocuration,,,,0
U,,22224,,,,11324,,Callithrix,,BAO_0000019,,The compound was evaluated for area under the curve in marmosets,CHEMBL627693,9481.0,12054,A,1,Autocuration,,,,0
N,,50597,,,,13875,,Rattus norvegicus,,BAO_0000218,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,CHEMBL627694,10116.0,12055,A,1,Intermediate,,,,1
N,,50597,,,,13875,,Rattus norvegicus,,BAO_0000218,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,CHEMBL627695,10116.0,12056,A,1,Intermediate,,,,1
U,,22224,,,,13875,,,,BAO_0000218,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),CHEMBL627696,,12057,A,1,Autocuration,,,,0
N,,50597,,,,13875,,Rattus norvegicus,,BAO_0000218,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,CHEMBL627697,10116.0,12058,A,1,Intermediate,,,,1
N,,50597,,,,13875,,Rattus norvegicus,,BAO_0000218,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,CHEMBL627698,10116.0,12059,A,1,Intermediate,,,,1
N,,50597,,,,13875,,Rattus norvegicus,,BAO_0000218,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,CHEMBL627699,10116.0,12060,A,1,Intermediate,,,,1
N,,50597,,,,13807,,Rattus norvegicus,,BAO_0000218,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,CHEMBL627700,10116.0,12061,A,1,Intermediate,,,,1
N,,50597,,,,14127,,Rattus norvegicus,,BAO_0000218,,Total drug exposure is determined after oral dosing in rats.,CHEMBL627701,10116.0,12062,A,1,Intermediate,,,,1
U,,22224,,,,15116,,,,BAO_0000218,,Total drug exposure (5 mg/kg) when administered intravenously,CHEMBL627702,,12063,A,1,Autocuration,,,,0
U,,22224,,,,15116,,,,BAO_0000218,,Total drug exposure (5 mg/kg) when administered orally,CHEMBL627703,,12064,A,1,Autocuration,,,,0
U,,22224,,,,15604,,Simiiformes,,BAO_0000218,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,CHEMBL626873,314293.0,12065,A,1,Autocuration,,,,0
N,,50597,,,,15604,,Rattus norvegicus,,BAO_0000218,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,CHEMBL629583,10116.0,12066,A,1,Intermediate,,,,1
N,,50588,,,,15604,,Canis lupus familiaris,,BAO_0000218,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,CHEMBL629584,9615.0,12067,A,1,Intermediate,,,,1
N,,50588,,,,15604,,Canis lupus familiaris,,BAO_0000218,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,CHEMBL629585,9615.0,12068,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,Brain,Rattus norvegicus,,BAO_0000218,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL629586,10116.0,12069,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13751,Brain,Rattus norvegicus,,BAO_0000218,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL629587,10116.0,12070,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13751,,Rattus norvegicus,,BAO_0000218,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL629588,10116.0,12071,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,,Rattus norvegicus,,BAO_0000218,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL629589,10116.0,12072,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,,Rattus norvegicus,,BAO_0000218,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL629590,10116.0,12073,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,,Rattus norvegicus,,BAO_0000218,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL629591,10116.0,12074,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,,Rattus norvegicus,,BAO_0000218,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL629592,10116.0,12075,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,,Rattus norvegicus,,BAO_0000218,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL629593,10116.0,12076,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,,Rattus norvegicus,,BAO_0000218,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL629594,10116.0,12077,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,Heart,Rattus norvegicus,,BAO_0000218,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL629595,10116.0,12078,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13751,Heart,Rattus norvegicus,,BAO_0000218,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL630290,10116.0,12079,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13751,Heart,Rattus norvegicus,,BAO_0000218,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL627137,10116.0,12080,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13751,Heart,Rattus norvegicus,,BAO_0000218,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL627138,10116.0,12081,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13751,Heart,Rattus norvegicus,,BAO_0000218,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL627139,10116.0,12082,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13751,Heart,Rattus norvegicus,,BAO_0000218,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL627140,10116.0,12083,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13751,Heart,Rattus norvegicus,,BAO_0000218,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL627141,10116.0,12084,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13751,Kidney,Rattus norvegicus,,BAO_0000218,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL627142,10116.0,12085,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13751,Kidney,Rattus norvegicus,,BAO_0000218,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL627143,10116.0,12086,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13751,Kidney,Rattus norvegicus,,BAO_0000218,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL874449,10116.0,12087,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13751,Kidney,Rattus norvegicus,,BAO_0000218,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL627144,10116.0,12088,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13751,Kidney,Rattus norvegicus,,BAO_0000218,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL627145,10116.0,12089,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13751,Kidney,Rattus norvegicus,,BAO_0000218,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL627146,10116.0,12090,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13751,Kidney,Rattus norvegicus,,BAO_0000218,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL627147,10116.0,12091,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13751,Liver,Rattus norvegicus,,BAO_0000218,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL627148,10116.0,12092,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13751,Lung,Rattus norvegicus,,BAO_0000218,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL627149,10116.0,12093,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13751,Lung,Rattus norvegicus,,BAO_0000218,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL632160,10116.0,12094,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13751,Lung,Rattus norvegicus,,BAO_0000218,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL632161,10116.0,12095,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13751,Lung,Rattus norvegicus,,BAO_0000218,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL632162,10116.0,12096,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13751,Lung,Rattus norvegicus,,BAO_0000218,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL632163,10116.0,12097,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13751,Lung,Rattus norvegicus,,BAO_0000218,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL874469,10116.0,12098,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13751,Lung,Rattus norvegicus,,BAO_0000218,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL627182,10116.0,12099,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13751,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",CHEMBL627183,10116.0,12100,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,13751,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL627184,10116.0,12101,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,13751,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL627185,10116.0,12102,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,13751,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL627186,10116.0,12103,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,13751,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL627187,10116.0,12104,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,13751,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL627188,10116.0,12105,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,13751,Muscle tissue,Rattus norvegicus,,BAO_0000218,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL627189,10116.0,12106,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,13751,,Rattus norvegicus,,BAO_0000218,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL627190,10116.0,12107,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13751,Liver,Rattus norvegicus,,BAO_0000218,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",CHEMBL627191,10116.0,12108,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13751,Liver,Rattus norvegicus,,BAO_0000218,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",CHEMBL627192,10116.0,12109,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13751,Liver,Rattus norvegicus,,BAO_0000218,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",CHEMBL627193,10116.0,12110,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,10911,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,CHEMBL874590,10116.0,12111,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,10911,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL627194,10116.0,12112,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,10911,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL627195,10116.0,12113,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,10911,Female gonad,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL627196,10116.0,12114,A,1,Intermediate,,,992.0,1
N,,50597,,,In vivo,10911,Female gonad,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL627197,10116.0,12115,A,1,Intermediate,,,992.0,1
N,,50597,,,In vivo,10911,Female gonad,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL627198,10116.0,12116,A,1,Intermediate,,,992.0,1
N,,50597,,,In vivo,10911,Female gonad,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,CHEMBL627199,10116.0,12117,A,1,Intermediate,,,992.0,1
N,,50597,,,In vivo,10911,Female gonad,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL627200,10116.0,12118,A,1,Intermediate,,,992.0,1
N,,50597,,,In vivo,10911,Plasma,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL627201,10116.0,12119,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,10911,Plasma,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL627202,10116.0,12120,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,10911,Plasma,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL627203,10116.0,12121,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,10911,Plasma,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL627204,10116.0,12122,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,10911,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL627205,10116.0,12123,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,10911,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL627206,10116.0,12124,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,10911,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL627207,10116.0,12125,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,10911,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL627208,10116.0,12126,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,10911,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL627209,10116.0,12127,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,10911,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL627210,10116.0,12128,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,10911,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL627211,10116.0,12129,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,10911,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL627212,10116.0,12130,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,10911,Uterus,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,CHEMBL627213,10116.0,12131,A,1,Intermediate,,,995.0,1
N,,50597,,,In vivo,10911,Uterus,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,CHEMBL626599,10116.0,12132,A,1,Intermediate,,,995.0,1
N,,50597,,,In vivo,10911,Uterus,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,CHEMBL626600,10116.0,12133,A,1,Intermediate,,,995.0,1
N,,50597,,,In vivo,10911,Uterus,Rattus norvegicus,,BAO_0000218,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,CHEMBL626601,10116.0,12134,A,1,Intermediate,,,995.0,1
U,,22224,,,,8081,,,,BAO_0000019,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,CHEMBL627484,,12135,A,1,Autocuration,,,,0
N,,100710,,,,17248,Plasma,Macaca fascicularis,,BAO_0000218,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),CHEMBL627485,9541.0,12136,A,1,Intermediate,,,1969.0,1
N,,100710,,,,17248,Plasma,Macaca fascicularis,,BAO_0000218,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,CHEMBL628147,9541.0,12137,A,1,Intermediate,,,1969.0,1
N,,100710,,,,17248,Plasma,Macaca fascicularis,,BAO_0000218,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,CHEMBL628148,9541.0,12138,A,1,Intermediate,,,1969.0,1
N,,50588,,,,17248,Plasma,Canis lupus familiaris,,BAO_0000218,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),CHEMBL628149,9615.0,12139,A,1,Intermediate,,,1969.0,1
N,,50588,,,,17248,Plasma,Canis lupus familiaris,,BAO_0000218,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,CHEMBL628150,9615.0,12140,A,1,Intermediate,,,1969.0,1
N,,50588,,,,17248,Plasma,Canis lupus familiaris,,BAO_0000218,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,CHEMBL628318,9615.0,12141,A,1,Intermediate,,,1969.0,1
N,,50588,,,,17248,Plasma,Canis lupus familiaris,,BAO_0000218,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,CHEMBL628319,9615.0,12142,A,1,Intermediate,,,1969.0,1
N,,50588,,,,15592,,Canis lupus familiaris,,BAO_0000218,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",CHEMBL875609,9615.0,12143,A,1,Intermediate,,,,1
U,,22224,,,,7040,,,,BAO_0000019,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,CHEMBL628320,,12144,A,1,Autocuration,,,,0
U,,22224,,,,7040,,,,BAO_0000019,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,CHEMBL628321,,12145,A,1,Autocuration,,,,0
U,,22224,,,,7040,,,,BAO_0000019,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,CHEMBL628322,,12146,A,1,Autocuration,,,,0
U,,22224,,,,7040,,,,BAO_0000019,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,CHEMBL628323,,12147,A,1,Autocuration,,,,0
U,,22224,,,,7040,,,,BAO_0000019,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,CHEMBL628324,,12148,A,1,Autocuration,,,,0
U,,22224,,,,7040,,,,BAO_0000019,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,CHEMBL628325,,12149,A,1,Autocuration,,,,0
U,,22224,,,,7040,,,,BAO_0000019,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,CHEMBL628326,,12150,A,1,Autocuration,,,,0
N,,50588,,,,9614,Adrenal medulla,Canis lupus familiaris,,BAO_0000218,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",CHEMBL628327,9615.0,12151,A,1,Intermediate,,,1236.0,1
N,,50588,,,,9614,Adrenal medulla,Canis lupus familiaris,,BAO_0000218,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",CHEMBL628328,9615.0,12152,A,1,Intermediate,,,1236.0,1
N,,50588,,,,9614,Blood,Canis lupus familiaris,,BAO_0000218,,"Concentration of compound in blood of dog 1, after administering intravenously",CHEMBL628329,9615.0,12153,A,1,Intermediate,,,178.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",CHEMBL628330,10116.0,12154,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",CHEMBL628331,10116.0,12155,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",CHEMBL628332,10116.0,12156,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",CHEMBL628333,10116.0,12157,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",CHEMBL628334,10116.0,12158,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",CHEMBL628335,10116.0,12159,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",CHEMBL628336,10116.0,12160,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",CHEMBL628337,10116.0,12161,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",CHEMBL628338,10116.0,12162,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",CHEMBL875610,10116.0,12163,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",CHEMBL628339,10116.0,12164,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",CHEMBL628340,10116.0,12165,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",CHEMBL628341,10116.0,12166,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",CHEMBL622214,10116.0,12167,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",CHEMBL623167,10116.0,12168,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",CHEMBL623168,10116.0,12169,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",CHEMBL623169,10116.0,12170,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Liver,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",CHEMBL623170,10116.0,12171,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",CHEMBL627224,10116.0,12172,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",CHEMBL875634,10116.0,12173,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",CHEMBL627225,10116.0,12174,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",CHEMBL627226,10116.0,12175,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",CHEMBL626083,10116.0,12176,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",CHEMBL626084,10116.0,12177,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",CHEMBL626085,10116.0,12178,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",CHEMBL626086,10116.0,12179,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",CHEMBL626087,10116.0,12180,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",CHEMBL626088,10116.0,12181,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",CHEMBL626089,10116.0,12182,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",CHEMBL626090,10116.0,12183,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",CHEMBL626091,10116.0,12184,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",CHEMBL626092,10116.0,12185,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",CHEMBL626093,10116.0,12186,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",CHEMBL626094,10116.0,12187,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",CHEMBL626095,10116.0,12188,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8608,Lung,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",CHEMBL626096,10116.0,12189,A,1,Intermediate,,,2048.0,1
U,,22224,,,,15604,,Simiiformes,,BAO_0000218,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,CHEMBL626097,314293.0,12190,A,1,Autocuration,,,,0
N,,50597,,,,15604,,Rattus norvegicus,,BAO_0000218,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,CHEMBL626098,10116.0,12191,A,1,Intermediate,,,,1
U,,22224,,,,1806,Plasma,,,BAO_0000218,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,CHEMBL626099,,12192,A,1,Autocuration,,,1969.0,0
U,,22224,,,,1806,Plasma,,,BAO_0000218,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,CHEMBL626100,,12193,A,1,Autocuration,,,1969.0,0
N,,50588,,,,17237,Plasma,Canis lupus familiaris,,BAO_0000218,,AUC 0-inf in dog,CHEMBL626101,9615.0,12194,A,1,Intermediate,,,1969.0,1
N,,50512,,,,17237,Plasma,Cavia porcellus,,BAO_0000218,,AUC 0-inf in guinea pig,CHEMBL626102,10141.0,12195,A,1,Intermediate,,,1969.0,1
N,,50588,,,,17237,Plasma,Canis lupus familiaris,,BAO_0000218,,AUC 0-t in dog,CHEMBL626103,9615.0,12196,A,1,Intermediate,,,1969.0,1
N,,50512,,,,17237,Plasma,Cavia porcellus,,BAO_0000218,,AUC 0-t in guinea pig,CHEMBL628391,10141.0,12197,A,1,Intermediate,,,1969.0,1
N,,50597,,,,15194,,Rattus norvegicus,,BAO_0000218,,The compound was tested for brain to plasma partition in rat,CHEMBL628392,10116.0,12198,A,1,Intermediate,,,,1
N,,50597,,,,15194,,Rattus norvegicus,,BAO_0000218,,The compound was tested for brain to plasma partition in rat.,CHEMBL628393,10116.0,12199,A,1,Intermediate,,,,1
U,,22224,,,,8787,Blood,,,BAO_0000019,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,CHEMBL628394,,12200,A,1,Autocuration,,,178.0,0
N,,50588,,,,17025,,Canis lupus familiaris,,BAO_0000218,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,CHEMBL628395,9615.0,12201,A,1,Intermediate,,,,1
U,,22224,,,,17025,,Simiiformes,,BAO_0000218,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,CHEMBL628396,314293.0,12202,A,1,Autocuration,,,,0
N,,50592,,,,17025,,Oryctolagus cuniculus,,BAO_0000218,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,CHEMBL628397,9986.0,12203,A,1,Intermediate,,,,1
N,,50597,,,,17025,,Rattus norvegicus,,BAO_0000218,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,CHEMBL628398,10116.0,12204,A,1,Intermediate,,,,1
N,,50797,,,,4236,,Macaca mulatta,,BAO_0000218,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,CHEMBL628399,9544.0,12205,A,1,Intermediate,,,,1
N,,50588,,,,15343,,Canis lupus familiaris,,BAO_0000218,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,CHEMBL628400,9615.0,12206,A,1,Intermediate,,,,1
N,,50597,,,,15343,,Rattus norvegicus,,BAO_0000218,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,CHEMBL874907,10116.0,12207,A,1,Intermediate,,,,1
U,,22224,,,,17720,,,,BAO_0000019,,Area under curve of the compound was determined,CHEMBL628401,,12208,A,1,Autocuration,,,,0
U,,22224,,,,17788,Plasma,Simiiformes,,BAO_0000218,,AUC in monkeys at a dose of 1 mg/kg,CHEMBL628402,314293.0,12209,A,1,Autocuration,,,1969.0,0
N,,50597,,,,17788,Plasma,Rattus norvegicus,,BAO_0000218,,AUC in rats at a dose of 1 mg/kg,CHEMBL628403,10116.0,12210,A,1,Intermediate,,,1969.0,1
U,,22224,,,,8778,,,,BAO_0000019,,Compound was evaluated for the overall absorbance loss at pH of 2,CHEMBL628404,,12211,A,1,Autocuration,,,,0
U,,22224,,,,8778,,,,BAO_0000019,,Compound was evaluated for the overall absorbance loss at pH of 4,CHEMBL628405,,12212,A,1,Autocuration,,,,0
U,,22224,,,,8778,,,,BAO_0000019,,Compound was evaluated for the overall absorbance loss at pH of 7,CHEMBL628406,,12213,A,1,Autocuration,,,,0
N,,50597,,,,2249,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for its absorption in the rats,CHEMBL628407,10116.0,12214,A,1,Intermediate,,,,1
N,,50597,,,,8881,Urine,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,CHEMBL628408,10116.0,12215,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8881,Urine,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,CHEMBL629171,10116.0,12216,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8881,Urine,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,CHEMBL629172,10116.0,12217,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8881,Urine,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,CHEMBL629173,10116.0,12218,A,1,Intermediate,,,1088.0,1
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum,CHEMBL629174,10116.0,12219,A,1,Intermediate,,,,1
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 10-17,CHEMBL629175,10116.0,12220,A,1,Intermediate,,,,1
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 10-18,CHEMBL629176,10116.0,12221,A,1,Intermediate,,,,1
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 10-19,CHEMBL629177,10116.0,12222,A,1,Intermediate,,,,1
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 12-15,CHEMBL629178,10116.0,12223,A,1,Intermediate,,,,1
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 13-19,CHEMBL631869,10116.0,12224,A,1,Intermediate,,,,1
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 14-17,CHEMBL631870,10116.0,12225,A,1,Intermediate,,,,1
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 15-18,CHEMBL631871,10116.0,12226,A,1,Intermediate,,,,1
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 2-5,CHEMBL631872,10116.0,12227,A,1,Intermediate,,,,1
U,,22224,,,,15286,Ileum,,,BAO_0000221,,In vitro percent permeability into rat ileum; Range is 23-42,CHEMBL875775,,12228,A,1,Autocuration,,,2116.0,0
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 28-36,CHEMBL631873,10116.0,12229,A,1,Intermediate,,,,1
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 29-35,CHEMBL631874,10116.0,12230,A,1,Intermediate,,,,1
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 46-66,CHEMBL631875,10116.0,12231,A,1,Intermediate,,,,1
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 50-68,CHEMBL631876,10116.0,12232,A,1,Intermediate,,,,1
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum; Range is 78-81,CHEMBL631877,10116.0,12233,A,1,Intermediate,,,,1
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,CHEMBL631878,10116.0,12234,A,1,Intermediate,,,,1
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum; nd indicates not detected,CHEMBL631879,10116.0,12235,A,1,Intermediate,,,,1
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum; nt indicates not detected,CHEMBL631880,10116.0,12236,A,1,Intermediate,,,,1
N,,50597,,,,15286,,Rattus norvegicus,,BAO_0000218,,In vitro percent permeability into rat ileum; nt indicates not tested,CHEMBL631881,10116.0,12237,A,1,Intermediate,,,,1
N,,50597,,,,13770,,Rattus norvegicus,,BAO_0000218,,Compound was tested for oral absorption in bile-duct cannulated rats,CHEMBL631882,10116.0,12238,A,1,Intermediate,,,,1
N,,50597,,,,13770,,Rattus norvegicus,,BAO_0000218,,Compound was tested for oral absorption in bile-duct cannulated rats.,CHEMBL630749,10116.0,12239,A,1,Intermediate,,,,1
N,,50587,,,,5202,,Homo sapiens,,BAO_0000218,,Oral absorption using Caco-2 cell monolayers.,CHEMBL630750,9606.0,12240,A,1,Intermediate,,,,1
N,,50587,,,,14920,,Homo sapiens,,BAO_0000218,,Percent of the drug absorbed after administration to humans was determined,CHEMBL630253,9606.0,12241,A,1,Intermediate,,,,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,CHEMBL630254,10116.0,12242,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,CHEMBL630255,10116.0,12243,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,CHEMBL630256,10116.0,12244,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,13751,Liver,Rattus norvegicus,,BAO_0000218,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",CHEMBL875781,10116.0,12245,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13751,Liver,Rattus norvegicus,,BAO_0000218,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",CHEMBL630257,10116.0,12246,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13751,Liver,Rattus norvegicus,,BAO_0000218,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",CHEMBL630258,10116.0,12247,A,1,Intermediate,,,2107.0,1
N,,50597,,,,15807,,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",CHEMBL630259,10116.0,12248,A,1,Intermediate,,,,1
N,,50597,,,,15807,Striatum,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",CHEMBL630260,10116.0,12249,A,1,Intermediate,,,2435.0,1
N,,50597,,,,15807,Striatum,Rattus norvegicus,,BAO_0000218,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",CHEMBL630261,10116.0,12250,A,1,Intermediate,,,2435.0,1
N,,50597,,,,14950,,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,CHEMBL630262,10116.0,12251,A,1,Intermediate,,,,1
N,,50597,,,,14950,,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,CHEMBL630263,10116.0,12252,A,1,Intermediate,,,,1
N,,50597,,,,14950,,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,CHEMBL630264,10116.0,12253,A,1,Intermediate,,,,1
N,,50597,,,,14950,,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,CHEMBL630265,10116.0,12254,A,1,Intermediate,,,,1
N,,50597,,,,14950,,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,CHEMBL630266,10116.0,12255,A,1,Intermediate,,,,1
N,,50597,,,,14950,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,CHEMBL630267,10116.0,12256,A,1,Intermediate,,,2113.0,1
N,,50597,,,,14950,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,CHEMBL630268,10116.0,12257,A,1,Intermediate,,,2113.0,1
N,,50597,,,,14950,,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,CHEMBL630269,10116.0,12258,A,1,Intermediate,,,,1
N,,50597,,,,14950,,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,CHEMBL630270,10116.0,12259,A,1,Intermediate,,,,1
N,,50597,,,,14950,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,CHEMBL630141,10116.0,12260,A,1,Intermediate,,,2048.0,1
N,,50597,,,,14950,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,CHEMBL630142,10116.0,12261,A,1,Intermediate,,,2048.0,1
N,,50597,,,,14950,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,CHEMBL630143,10116.0,12262,A,1,Intermediate,,,2385.0,1
N,,50597,,,,14950,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,CHEMBL630144,10116.0,12263,A,1,Intermediate,,,2385.0,1
N,,50597,,,,14950,Prostate gland,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,CHEMBL630145,10116.0,12264,A,1,Intermediate,,,2367.0,1
N,,50597,,,,14950,Prostate gland,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,CHEMBL630146,10116.0,12265,A,1,Intermediate,,,2367.0,1
N,,50597,,,,14950,,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,CHEMBL630147,10116.0,12266,A,1,Intermediate,,,,1
N,,50597,,,,14950,,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,CHEMBL630148,10116.0,12267,A,1,Intermediate,,,,1
N,,50597,,,,14950,,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,CHEMBL630149,10116.0,12268,A,1,Intermediate,,,,1
N,,50597,,,,14950,Spleen,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,CHEMBL630150,10116.0,12269,A,1,Intermediate,,,2106.0,1
N,,50597,,,,14950,Spleen,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,CHEMBL630151,10116.0,12270,A,1,Intermediate,,,2106.0,1
N,,50597,,,,14950,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,CHEMBL632031,10116.0,12271,A,1,Intermediate,,,2046.0,1
N,,50597,,,,14950,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,CHEMBL632032,10116.0,12272,A,1,Intermediate,,,2046.0,1
N,,50597,,,,14950,,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,CHEMBL632033,10116.0,12273,A,1,Intermediate,,,,1
N,,50597,,,,14950,,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,CHEMBL632034,10116.0,12274,A,1,Intermediate,,,,1
N,,50597,,,,14950,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,CHEMBL632035,10116.0,12275,A,1,Intermediate,,,2385.0,1
N,,50597,,,,14950,,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,CHEMBL632036,10116.0,12276,A,1,Intermediate,,,,1
N,,50597,,,,14950,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,CHEMBL632037,10116.0,12277,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,CHEMBL632038,10116.0,12278,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,CHEMBL632039,10116.0,12279,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,CHEMBL632040,10116.0,12280,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,CHEMBL632041,10116.0,12281,A,1,Intermediate,,,178.0,1
N,,50588,,,,9614,Blood,Canis lupus familiaris,,BAO_0000218,,"Concentration of compound in blood of dog 2, after administering intravenously",CHEMBL632042,9615.0,12282,A,1,Intermediate,,,178.0,1
N,,50588,,,,9614,,Canis lupus familiaris,,BAO_0000218,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",CHEMBL632043,9615.0,12283,A,1,Intermediate,,,,1
N,,50588,,,,9614,,Canis lupus familiaris,,BAO_0000218,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",CHEMBL632044,9615.0,12284,A,1,Intermediate,,,,1
N,,50588,,,,9614,Liver,Canis lupus familiaris,,BAO_0000218,,"Concentration of compound in liver of dog 1, after administering intravenously",CHEMBL632045,9615.0,12285,A,1,Intermediate,,,2107.0,1
N,,50588,,,,9614,Liver,Canis lupus familiaris,,BAO_0000218,,"Concentration of compound in liver of dog 2, after administering intravenously",CHEMBL632046,9615.0,12286,A,1,Intermediate,,,2107.0,1
N,,50588,,,,9614,Lung,Canis lupus familiaris,,BAO_0000218,,"Concentration of compound in lung of dog 1, after administering intravenously",CHEMBL632047,9615.0,12287,A,1,Intermediate,,,2048.0,1
N,,50588,,,,9614,Lung,Canis lupus familiaris,,BAO_0000218,,"Concentration of compound in lung of dog 2, after administering intravenously",CHEMBL632048,9615.0,12288,A,1,Intermediate,,,2048.0,1
N,,50588,,,,9614,Muscle tissue,Canis lupus familiaris,,BAO_0000218,,"Concentration of compound in muscle of dog 1, after administering intravenously",CHEMBL632049,9615.0,12289,A,1,Intermediate,,,2385.0,1
N,,50588,,,,9614,Muscle tissue,Canis lupus familiaris,,BAO_0000218,,"Concentration of compound in muscle of dog 2, after administering intravenously",CHEMBL876418,9615.0,12290,A,1,Intermediate,,,2385.0,1
N,,50588,,,,9614,Spleen,Canis lupus familiaris,,BAO_0000218,,"Concentration of compound in spleen of dog 1,after administering intravenously",CHEMBL632050,9615.0,12291,A,1,Intermediate,,,2106.0,1
N,,50588,,,,9614,Spleen,Canis lupus familiaris,,BAO_0000218,,"Concentration of compound in spleen of dog 2, after administering intravenously",CHEMBL632051,9615.0,12292,A,1,Intermediate,,,2106.0,1
U,,22224,,,,10353,,,,BAO_0000218,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,CHEMBL632052,,12293,F,1,Autocuration,,,,0
U,,22224,,,,10353,,,,BAO_0000218,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,CHEMBL632053,,12294,F,1,Autocuration,,,,0
U,,22224,,,,10353,,,,BAO_0000218,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,CHEMBL632054,,12295,A,1,Autocuration,,,,0
U,,22224,,,,10353,,,,BAO_0000218,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,CHEMBL632055,,12296,F,1,Autocuration,,,,0
U,,22224,,,,10353,,,,BAO_0000218,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,CHEMBL631181,,12297,F,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,CHEMBL631182,,12298,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,CHEMBL631183,,12299,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,CHEMBL631184,,12300,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,CHEMBL629774,,12301,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,CHEMBL629775,,12302,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,CHEMBL876549,,12303,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,CHEMBL628172,,12304,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,CHEMBL628173,,12305,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,CHEMBL628174,,12306,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,CHEMBL628175,,12307,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,CHEMBL628176,,12308,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,CHEMBL628177,,12309,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,CHEMBL628178,,12310,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,CHEMBL628179,,12311,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,CHEMBL628180,,12312,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,CHEMBL628181,,12313,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,CHEMBL628182,,12314,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,CHEMBL628183,,12315,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,CHEMBL628184,,12316,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,CHEMBL628185,,12317,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,CHEMBL875617,,12318,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,CHEMBL628186,,12319,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,CHEMBL628187,,12320,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,CHEMBL628188,,12321,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,CHEMBL628189,,12322,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,CHEMBL628190,,12323,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,CHEMBL628191,,12324,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,CHEMBL626513,,12325,A,1,Autocuration,,,,0
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",CHEMBL626514,10116.0,12326,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",CHEMBL626515,10116.0,12327,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",CHEMBL626516,10116.0,12328,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",CHEMBL626517,10116.0,12329,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",CHEMBL626518,10116.0,12330,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",CHEMBL626519,10116.0,12331,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",CHEMBL626520,10116.0,12332,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",CHEMBL626521,10116.0,12333,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",CHEMBL626522,10116.0,12334,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",CHEMBL626523,10116.0,12335,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",CHEMBL626524,10116.0,12336,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",CHEMBL626688,10116.0,12337,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",CHEMBL626689,10116.0,12338,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",CHEMBL626690,10116.0,12339,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",CHEMBL626691,10116.0,12340,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",CHEMBL627319,10116.0,12341,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",CHEMBL624052,10116.0,12342,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8608,Thyroid gland,Rattus norvegicus,,BAO_0000218,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",CHEMBL624053,10116.0,12343,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8085,,Rattus norvegicus,,BAO_0000218,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL624054,10116.0,12344,A,1,Intermediate,,,,1
N,,50597,,,,8085,,Rattus norvegicus,,BAO_0000218,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL624055,10116.0,12345,A,1,Intermediate,,,,1
N,,50597,,,,8085,,Rattus norvegicus,,BAO_0000218,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL624056,10116.0,12346,A,1,Intermediate,,,,1
N,,50597,,,,8085,Uterus,Rattus norvegicus,,BAO_0000218,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL624057,10116.0,12347,A,1,Intermediate,,,995.0,1
N,,50597,,,,8085,Uterus,Rattus norvegicus,,BAO_0000218,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL622281,10116.0,12348,A,1,Intermediate,,,995.0,1
N,,50597,,,,8085,Uterus,Rattus norvegicus,,BAO_0000218,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL622282,10116.0,12349,A,1,Intermediate,,,995.0,1
N,,50597,,,,8085,Uterus,Rattus norvegicus,,BAO_0000218,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL622283,10116.0,12350,A,1,Intermediate,,,995.0,1
N,,50597,,,,8085,Uterus,Rattus norvegicus,,BAO_0000218,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL622284,10116.0,12351,A,1,Intermediate,,,995.0,1
N,,50597,,,,8085,Uterus,Rattus norvegicus,,BAO_0000218,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL622285,10116.0,12352,A,1,Intermediate,,,995.0,1
N,,50597,,,,8085,Uterus,Rattus norvegicus,,BAO_0000218,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,CHEMBL622286,10116.0,12353,A,1,Intermediate,,,995.0,1
U,,22224,,,,7657,,,,BAO_0000100,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,CHEMBL622287,,12354,P,1,Autocuration,,,,0
N,,50594,,,,8935,,Mus musculus,,BAO_0000218,,Partition coefficient (logD7.4),CHEMBL622288,10090.0,12355,A,1,Intermediate,,,,1
N,,50594,,,,13792,,Mus musculus,,BAO_0000218,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",CHEMBL622289,10090.0,12356,A,1,Intermediate,,,,1
N,,50594,,,,13792,Brain,Mus musculus,,BAO_0000218,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",CHEMBL622290,10090.0,12357,A,1,Intermediate,,,955.0,1
N,,50594,,,,13792,,Mus musculus,,BAO_0000218,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,CHEMBL622291,10090.0,12358,A,1,Intermediate,,,,1
N,,50594,,,,13792,Brain,Mus musculus,,BAO_0000218,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,CHEMBL622292,10090.0,12359,A,1,Intermediate,,,955.0,1
N,,50594,,,,13792,,Mus musculus,,BAO_0000218,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",CHEMBL622293,10090.0,12360,A,1,Intermediate,,,,1
N,,50594,,,,13792,Brain,Mus musculus,,BAO_0000218,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",CHEMBL622294,10090.0,12361,A,1,Intermediate,,,955.0,1
N,,50594,,,,13792,,Mus musculus,,BAO_0000218,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,CHEMBL622295,10090.0,12362,A,1,Intermediate,,,,1
N,,50597,,,,13792,Brain,Rattus norvegicus,,BAO_0000218,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,CHEMBL622296,10116.0,12363,A,1,Intermediate,,,955.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,CHEMBL874409,10116.0,12364,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,CHEMBL622297,10116.0,12365,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,CHEMBL622298,10116.0,12366,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,CHEMBL622299,10116.0,12367,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,CHEMBL622300,10116.0,12368,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,CHEMBL622301,10116.0,12369,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,CHEMBL622302,10116.0,12370,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,CHEMBL622303,10116.0,12371,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,CHEMBL622304,10116.0,12372,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,CHEMBL622305,10116.0,12373,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,CHEMBL622306,10116.0,12374,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,CHEMBL626864,10116.0,12375,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,CHEMBL626865,10116.0,12376,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,CHEMBL626866,10116.0,12377,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,CHEMBL626867,10116.0,12378,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,CHEMBL626868,10116.0,12379,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,CHEMBL626869,10116.0,12380,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,CHEMBL626870,10116.0,12381,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,CHEMBL626871,10116.0,12382,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,CHEMBL626872,10116.0,12383,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,CHEMBL632185,10116.0,12384,A,1,Intermediate,,,1969.0,1
N,,50597,,,,14103,Plasma,Rattus norvegicus,,BAO_0000218,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,CHEMBL632186,10116.0,12385,A,1,Intermediate,,,1969.0,1
U,,22224,,,,12904,,,,BAO_0000019,,Amount of acetic acid produced by the compound,CHEMBL629310,,12386,A,1,Autocuration,,,,0
U,,22224,,,,12904,,,,BAO_0000019,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,CHEMBL629311,,12387,A,1,Autocuration,,,,0
N,,50597,,,,9663,,Rattus norvegicus,,BAO_0000218,,Log of (Cbrain/Cblood) in rats,CHEMBL629312,10116.0,12388,A,1,Intermediate,,,,1
U,,22224,,,,7652,,,,BAO_0000221,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),CHEMBL629313,,12389,A,1,Autocuration,,,,0
U,,22224,,,,7652,,,,BAO_0000221,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),CHEMBL629314,,12390,A,1,Autocuration,,,,0
U,,22224,,,,7652,,,,BAO_0000221,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),CHEMBL629315,,12391,A,1,Autocuration,,,,0
U,,22224,,,,7652,,,,BAO_0000219,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),CHEMBL629316,,12392,B,1,Autocuration,,,,0
U,,22224,,,,7652,,,,BAO_0000221,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),CHEMBL629317,,12393,A,1,Autocuration,,,,0
U,,22224,,,,7652,,,,BAO_0000019,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),CHEMBL629318,,12394,A,1,Autocuration,,,,0
U,,22224,,,,7652,,,,BAO_0000019,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),CHEMBL877497,,12395,A,1,Autocuration,,,,0
U,,22224,,,,7652,,,,BAO_0000019,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),CHEMBL629319,,12396,A,1,Autocuration,,,,0
U,,22224,,,,7652,,,,BAO_0000019,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),CHEMBL629320,,12397,A,1,Autocuration,,,,0
U,,22224,,,,7652,,,,BAO_0000019,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),CHEMBL629496,,12398,A,1,Autocuration,,,,0
U,,22224,,,,7652,,,,BAO_0000019,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),CHEMBL629497,,12399,A,1,Autocuration,,,,0
U,,22224,,,,7652,,,,BAO_0000019,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),CHEMBL629498,,12400,A,1,Autocuration,,,,0
U,,22224,,,,7652,,,,BAO_0000019,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),CHEMBL629499,,12401,A,1,Autocuration,,,,0
U,,22224,,,,7652,,,,BAO_0000019,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),CHEMBL629500,,12402,A,1,Autocuration,,,,0
U,,22224,,,,7652,,,,BAO_0000019,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),CHEMBL629501,,12403,A,1,Autocuration,,,,0
U,,22224,,,,7652,,,,BAO_0000019,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),CHEMBL629502,,12404,A,1,Autocuration,,,,0
U,,22224,,,In vivo,8267,,,,BAO_0000218,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,CHEMBL629503,,12405,F,1,Autocuration,,,,0
N,,50588,,,,8267,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,CHEMBL629504,9615.0,12406,A,1,Intermediate,,,,1
U,,22224,,,,14479,,,,BAO_0000019,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,CHEMBL629505,,12407,A,1,Autocuration,,,,0
U,,22224,,,,17515,,,,BAO_0000019,,Compound was evaluated for total body clearance,CHEMBL629506,,12408,A,1,Autocuration,,,,0
U,,22224,,,,17515,,,,BAO_0000019,,Compound was evaluated for volume of distribution at steady state,CHEMBL629507,,12409,A,1,Autocuration,,,,0
U,,22224,,,,8142,,,,BAO_0000019,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,CHEMBL877498,,12410,A,1,Autocuration,,,,0
U,,22224,,,,14849,,,,BAO_0000019,,Percentage of the diamine which is monoprotonated at pH 7.4,CHEMBL629508,,12411,A,1,Autocuration,,,,0
U,,22224,,,,7653,,,,BAO_0000019,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,CHEMBL629509,,12412,A,1,Autocuration,,,,0
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,CHEMBL629510,10116.0,12413,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,CHEMBL629511,10116.0,12414,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,CHEMBL629512,10116.0,12415,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,CHEMBL629513,10116.0,12416,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,CHEMBL629514,10116.0,12417,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,CHEMBL628447,10116.0,12418,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,CHEMBL628448,10116.0,12419,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,CHEMBL628449,10116.0,12420,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,CHEMBL631119,10116.0,12421,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,CHEMBL631120,10116.0,12422,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,CHEMBL631121,10116.0,12423,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,CHEMBL874458,10116.0,12424,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,CHEMBL631122,10116.0,12425,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,CHEMBL631123,10116.0,12426,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,CHEMBL631124,10116.0,12427,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,CHEMBL631125,10116.0,12428,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,CHEMBL631290,10116.0,12429,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,CHEMBL631291,10116.0,12430,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,CHEMBL631292,10116.0,12431,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,CHEMBL631293,10116.0,12432,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,CHEMBL631294,10116.0,12433,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,CHEMBL631295,10116.0,12434,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,CHEMBL631296,10116.0,12435,A,1,Intermediate,,,178.0,1
N,,50597,,,,8631,Blood,Rattus norvegicus,,BAO_0000218,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,CHEMBL631297,10116.0,12436,A,1,Intermediate,,,178.0,1
U,,22224,,,,10263,,,,BAO_0000218,,Maximum biodistribution (Bmax) was determined.,CHEMBL631298,,12437,A,1,Autocuration,,,,0
N,,50594,,,,12364,,Mus musculus,,BAO_0000218,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,CHEMBL631299,10090.0,12438,A,1,Intermediate,,,,1
N,,50594,,,,12364,,Mus musculus,,BAO_0000218,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,CHEMBL631300,10090.0,12439,A,1,Intermediate,,,,1
N,,50594,,,,12364,,Mus musculus,,BAO_0000218,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,CHEMBL631301,10090.0,12440,A,1,Intermediate,,,,1
N,,50594,,,,12364,,Mus musculus,,BAO_0000218,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,CHEMBL630291,10090.0,12441,A,1,Intermediate,,,,1
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,CHEMBL630292,,12442,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,CHEMBL630293,,12443,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,CHEMBL630294,,12444,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,CHEMBL630295,,12445,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,CHEMBL630296,,12446,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,CHEMBL626782,,12447,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,CHEMBL626783,,12448,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,CHEMBL626784,,12449,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,CHEMBL626785,,12450,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,CHEMBL626786,,12451,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,CHEMBL626787,,12452,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,CHEMBL626788,,12453,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,CHEMBL625927,,12454,A,1,Autocuration,,,,0
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL625928,10116.0,12455,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,CHEMBL625929,10116.0,12456,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,CHEMBL625930,10116.0,12457,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",CHEMBL625931,10116.0,12458,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,CHEMBL627230,10116.0,12459,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627231,10116.0,12460,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,CHEMBL627232,10116.0,12461,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,CHEMBL627233,10116.0,12462,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL875470,10116.0,12463,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627234,10116.0,12464,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627235,10116.0,12465,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627236,10116.0,12466,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627237,10116.0,12467,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627238,10116.0,12468,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627239,10116.0,12469,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627240,10116.0,12470,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627241,10116.0,12471,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627242,10116.0,12472,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,CHEMBL627243,10116.0,12473,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,CHEMBL627244,10116.0,12474,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627245,10116.0,12475,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627246,10116.0,12476,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627247,10116.0,12477,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627248,10116.0,12478,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627249,10116.0,12479,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL625569,10116.0,12480,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL625570,10116.0,12481,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL625571,10116.0,12482,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,CHEMBL625572,10116.0,12483,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,CHEMBL625573,10116.0,12484,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,CHEMBL625574,10116.0,12485,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,CHEMBL626245,10116.0,12486,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL626246,10116.0,12487,A,1,Intermediate,,,178.0,1
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,CHEMBL626247,,12488,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,CHEMBL626248,,12489,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,CHEMBL626249,,12490,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,CHEMBL626420,,12491,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,CHEMBL626421,,12492,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,CHEMBL626422,,12493,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,CHEMBL626423,,12494,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,CHEMBL626424,,12495,A,1,Autocuration,,,,0
N,,50588,,,,12023,,Canis lupus familiaris,,BAO_0000218,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,CHEMBL626425,9615.0,12496,A,1,Intermediate,,,,1
N,,50597,,,,12023,,Rattus norvegicus,,BAO_0000218,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,CHEMBL875476,10116.0,12497,A,1,Intermediate,,,,1
N,,100710,,,,12023,,Macaca fascicularis,,BAO_0000218,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,CHEMBL626426,9541.0,12498,A,1,Intermediate,,,,1
U,,22224,,,,10580,,,,BAO_0000100,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,CHEMBL626427,,12499,P,1,Autocuration,,,,0
U,,22224,,,,10580,,,,BAO_0000100,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,CHEMBL626428,,12500,P,1,Autocuration,,,,0
U,,22224,,,,16032,,,,BAO_0000019,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,CHEMBL626429,,12501,A,1,Autocuration,,,,0
U,,22224,,,,16032,Urine,,,BAO_0000019,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,CHEMBL625025,,12502,A,1,Autocuration,,,1088.0,0
N,,50597,,,,8594,Blood,Rattus norvegicus,,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,CHEMBL625026,10116.0,12503,A,1,Intermediate,,,178.0,1
N,,50597,,,,8594,Blood,Rattus norvegicus,,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,CHEMBL625027,10116.0,12504,A,1,Intermediate,,,178.0,1
N,,50597,,,,8594,Blood,Rattus norvegicus,,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,CHEMBL874410,10116.0,12505,A,1,Intermediate,,,178.0,1
N,,50597,,,,8594,Blood,Rattus norvegicus,,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,CHEMBL625028,10116.0,12506,A,1,Intermediate,,,178.0,1
N,,50597,,,,8594,Blood,Rattus norvegicus,,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,CHEMBL625029,10116.0,12507,A,1,Intermediate,,,178.0,1
N,,50597,,,,8594,Blood,Rattus norvegicus,,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,CHEMBL625030,10116.0,12508,A,1,Intermediate,,,178.0,1
N,,50597,,,,8594,Blood,Rattus norvegicus,,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL625031,10116.0,12509,A,1,Intermediate,,,178.0,1
N,,50597,,,,8594,Blood,Rattus norvegicus,,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,CHEMBL625032,10116.0,12510,A,1,Intermediate,,,178.0,1
N,,50597,,,,8594,Blood,Rattus norvegicus,,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,CHEMBL625033,10116.0,12511,A,1,Intermediate,,,178.0,1
N,,50597,,,,8594,Blood,Rattus norvegicus,,BAO_0000218,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,CHEMBL625034,10116.0,12512,A,1,Intermediate,,,178.0,1
N,,50597,,,,8594,Heart,Rattus norvegicus,,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,CHEMBL624872,10116.0,12513,A,1,Intermediate,,,948.0,1
N,,50597,,,,8594,Heart,Rattus norvegicus,,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,CHEMBL624873,10116.0,12514,A,1,Intermediate,,,948.0,1
N,,50597,,,,8594,Heart,Rattus norvegicus,,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,CHEMBL624874,10116.0,12515,A,1,Intermediate,,,948.0,1
N,,50597,,,,8594,Heart,Rattus norvegicus,,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,CHEMBL624875,10116.0,12516,A,1,Intermediate,,,948.0,1
N,,50597,,,,8594,Heart,Rattus norvegicus,,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,CHEMBL624876,10116.0,12517,A,1,Intermediate,,,948.0,1
N,,50597,,,,8594,Heart,Rattus norvegicus,,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,CHEMBL624877,10116.0,12518,A,1,Intermediate,,,948.0,1
N,,50597,,,,8594,Heart,Rattus norvegicus,,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,CHEMBL624878,10116.0,12519,A,1,Intermediate,,,948.0,1
N,,50597,,,,8594,Heart,Rattus norvegicus,,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,CHEMBL624879,10116.0,12520,A,1,Intermediate,,,948.0,1
N,,50597,,,,8594,Heart,Rattus norvegicus,,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL624880,10116.0,12521,A,1,Intermediate,,,948.0,1
N,,50597,,,,8594,Heart,Rattus norvegicus,,BAO_0000218,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,CHEMBL624881,10116.0,12522,A,1,Intermediate,,,948.0,1
N,,50597,,,,8594,Heart,Rattus norvegicus,,BAO_0000218,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",CHEMBL624882,10116.0,12523,A,1,Intermediate,,,948.0,1
N,,50597,,,,8594,Kidney,Rattus norvegicus,,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,CHEMBL624883,10116.0,12524,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8594,Kidney,Rattus norvegicus,,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,CHEMBL624884,10116.0,12525,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8594,Kidney,Rattus norvegicus,,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,CHEMBL624885,10116.0,12526,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8594,Kidney,Rattus norvegicus,,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,CHEMBL624886,10116.0,12527,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8594,Kidney,Rattus norvegicus,,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,CHEMBL624887,10116.0,12528,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8594,Kidney,Rattus norvegicus,,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,CHEMBL624888,10116.0,12529,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8594,Kidney,Rattus norvegicus,,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,CHEMBL624889,10116.0,12530,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8594,Kidney,Rattus norvegicus,,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,CHEMBL624890,10116.0,12531,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8594,Kidney,Rattus norvegicus,,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL621964,10116.0,12532,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8594,Kidney,Rattus norvegicus,,BAO_0000218,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,CHEMBL621965,10116.0,12533,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8594,Liver,Rattus norvegicus,,BAO_0000218,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,CHEMBL621966,10116.0,12534,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8594,Liver,Rattus norvegicus,,BAO_0000218,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,CHEMBL621967,10116.0,12535,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8594,Liver,Rattus norvegicus,,BAO_0000218,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,CHEMBL622164,10116.0,12536,A,1,Intermediate,,,2107.0,1
U,,22224,,,,7653,,,,BAO_0000019,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),CHEMBL623097,,12537,A,1,Autocuration,,,,0
U,,22224,,,,7653,,,,BAO_0000019,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),CHEMBL623098,,12538,A,1,Autocuration,,,,0
U,,22224,,,,7653,,,,BAO_0000019,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,CHEMBL623099,,12539,A,1,Autocuration,,,,0
U,,22224,,,,7653,,,,BAO_0000019,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,CHEMBL623100,,12540,A,1,Autocuration,,,,0
N,,50597,,,,9104,,Rattus norvegicus,,BAO_0000218,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",CHEMBL628673,10116.0,12541,A,1,Intermediate,,,,1
N,,50597,,,,9104,,Rattus norvegicus,,BAO_0000218,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",CHEMBL628674,10116.0,12542,A,1,Intermediate,,,,1
N,,50597,,,,9104,,Rattus norvegicus,,BAO_0000218,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",CHEMBL628675,10116.0,12543,A,1,Intermediate,,,,1
N,,50597,,,,9104,,Rattus norvegicus,,BAO_0000218,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",CHEMBL627644,10116.0,12544,A,1,Intermediate,,,,1
N,,50597,,,,9104,,Rattus norvegicus,,BAO_0000218,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",CHEMBL627645,10116.0,12545,A,1,Intermediate,,,,1
N,,50597,,,,9104,,Rattus norvegicus,,BAO_0000218,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",CHEMBL627646,10116.0,12546,A,1,Intermediate,,,,1
N,,50597,,,,9104,,Rattus norvegicus,,BAO_0000218,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",CHEMBL627647,10116.0,12547,A,1,Intermediate,,,,1
N,,50597,,,,9104,,Rattus norvegicus,,BAO_0000218,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",CHEMBL627648,10116.0,12548,A,1,Intermediate,,,,1
N,,50597,,,,12902,,Rattus norvegicus,,BAO_0000218,,Free level in rat plasma,CHEMBL627649,10116.0,12549,A,1,Intermediate,,,,1
U,,22224,,,,6614,,,,BAO_0000019,,Level reaching in blood plasma of rat or human was determined,CHEMBL628313,,12550,A,1,Autocuration,,,,0
N,,50597,,,,9663,,Rattus norvegicus,,BAO_0000218,,Log (Cbrain/Cblood) in rats,CHEMBL628314,10116.0,12551,A,1,Intermediate,,,,1
U,,22224,,,,17658,,,,BAO_0000019,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,CHEMBL628315,,12552,A,1,Autocuration,,,,0
U,,22224,,,,17658,,,,BAO_0000019,,Mean percentage of compound transport through membrane; expressed as membrane transport,CHEMBL628316,,12553,A,1,Autocuration,,,,0
U,,22224,,,,14314,,,,BAO_0000218,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,CHEMBL628317,,12554,A,1,Autocuration,,,,0
U,,22224,,,,7385,,,,BAO_0000019,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,CHEMBL628473,,12555,A,1,Autocuration,,,,0
U,,22224,,,,7385,,,,BAO_0000019,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",CHEMBL628474,,12556,A,1,Autocuration,,,,0
U,,22224,,,,7385,,,,BAO_0000019,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,CHEMBL628475,,12557,A,1,Autocuration,,,,0
U,,22224,,,,1329,,,,BAO_0000019,,Net water uptake by a carrier mediated transport (%cm) mechanism,CHEMBL628476,,12558,A,1,Autocuration,,,,0
U,,22224,,,,12187,,Simiiformes,,BAO_0000218,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,CHEMBL628477,314293.0,12559,A,1,Autocuration,,,,0
N,,50506,,,,12187,,Mustela putorius furo,,BAO_0000218,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,CHEMBL628478,9669.0,12560,A,1,Intermediate,,,,1
N,,50506,,,,12187,,Mustela putorius furo,,BAO_0000218,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",CHEMBL628479,9669.0,12561,A,1,Intermediate,,,,1
U,,22224,,,,12187,,Simiiformes,,BAO_0000218,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,CHEMBL628480,314293.0,12562,A,1,Autocuration,,,,0
U,,22224,,,,12187,,Simiiformes,,BAO_0000218,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",CHEMBL628481,314293.0,12563,A,1,Autocuration,,,,0
N,,50597,,,,12187,,Rattus norvegicus,,BAO_0000218,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,CHEMBL628482,10116.0,12564,A,1,Intermediate,,,,1
N,,50597,,,,12187,,Rattus norvegicus,,BAO_0000218,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",CHEMBL628483,10116.0,12565,A,1,Intermediate,,,,1
N,,50597,,,,9278,Plasma,Rattus norvegicus,,BAO_0000218,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",CHEMBL628484,10116.0,12566,A,1,Intermediate,,,1969.0,1
N,,50597,,,,9278,Plasma,Rattus norvegicus,,BAO_0000218,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",CHEMBL628485,10116.0,12567,A,1,Intermediate,,,1969.0,1
N,,100710,,,,9278,Plasma,Macaca fascicularis,,BAO_0000218,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",CHEMBL628486,9541.0,12568,A,1,Intermediate,,,1969.0,1
N,,50587,,,,9278,Plasma,Homo sapiens,,BAO_0000218,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",CHEMBL628487,9606.0,12569,A,1,Intermediate,,,1969.0,1
N,,50597,,,,9278,Plasma,Rattus norvegicus,,BAO_0000218,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",CHEMBL628488,10116.0,12570,A,1,Intermediate,,,1969.0,1
N,,50597,,,,9278,Plasma,Rattus norvegicus,,BAO_0000218,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",CHEMBL628489,10116.0,12571,A,1,Intermediate,,,1969.0,1
N,,50597,,,,9278,Plasma,Rattus norvegicus,,BAO_0000218,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",CHEMBL628490,10116.0,12572,A,1,Intermediate,,,1969.0,1
N,,100710,,,,12186,,Macaca fascicularis,,BAO_0000218,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,CHEMBL628491,9541.0,12573,A,1,Intermediate,,,,1
N,,100710,,,,12186,,Macaca fascicularis,,BAO_0000218,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,CHEMBL877507,9541.0,12574,A,1,Intermediate,,,,1
U,,22224,,,,12186,,,,BAO_0000218,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,CHEMBL628492,,12575,A,1,Autocuration,,,,0
U,,22224,,,,12041,,Simiiformes,,BAO_0000019,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),CHEMBL628493,314293.0,12576,A,1,Autocuration,,,,0
U,,22224,,,,12041,,Simiiformes,,BAO_0000019,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),CHEMBL628494,314293.0,12577,A,1,Autocuration,,,,0
U,,22224,,,,12041,,Simiiformes,,BAO_0000019,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),CHEMBL628495,314293.0,12578,A,1,Autocuration,,,,0
N,,50587,,,,6737,,Homo sapiens,,BAO_0000218,,Permeability in Caco-2 assay at 10E-6,CHEMBL628496,9606.0,12579,A,1,Intermediate,,,,1
U,,22224,,,,13758,Brain,,,BAO_0000218,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,CHEMBL628497,,12580,A,1,Autocuration,,,955.0,0
U,,22224,,,,13758,Brain,,,BAO_0000218,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,CHEMBL628498,,12581,A,1,Autocuration,,,955.0,0
U,,22224,,,,5676,,,,BAO_0000019,,Plasma protein binding was determined,CHEMBL628499,,12582,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,CHEMBL627656,,12583,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,CHEMBL627657,,12584,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,CHEMBL626808,,12585,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,CHEMBL626809,,12586,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,CHEMBL626810,,12587,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,CHEMBL626811,,12588,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,CHEMBL874465,,12589,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,CHEMBL626812,,12590,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,CHEMBL626813,,12591,A,1,Autocuration,,,,0
U,,22224,,,,14793,,,,BAO_0000218,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,CHEMBL626814,,12592,A,1,Autocuration,,,,0
U,,22224,,,,14000,,,,BAO_0000019,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,CHEMBL626815,,12593,A,1,Autocuration,,,,0
U,,22224,,,,5948,,,,BAO_0000019,,Partition coefficient (logP),CHEMBL628566,,12594,A,1,Autocuration,,,,0
U,,22229,,,,13824,,,,BAO_0000100,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),CHEMBL628567,,12595,P,1,Autocuration,,,,0
U,,22229,,,,10778,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL628568,,12596,P,1,Autocuration,,,,0
N,,50588,,,In vivo,17237,,Canis lupus familiaris,,BAO_0000218,,C max in dog,CHEMBL628569,9615.0,12597,A,1,Intermediate,,,,1
N,,50512,,,In vivo,17237,,Cavia porcellus,,BAO_0000218,,C max in guinea pig,CHEMBL628570,10141.0,12598,A,1,Intermediate,,,,1
U,,22224,,,In vivo,2809,,,,BAO_0000218,,C max value was evaluated,CHEMBL628571,,12599,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11954,,,,BAO_0000218,,Cmax value after oral dose of 0.1 mg//kg,CHEMBL628572,,12600,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11954,,,,BAO_0000218,,Cmax value after oral dose of 0.3 mg/kg,CHEMBL628573,,12601,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11954,,,,BAO_0000218,,Cmax value after oral dose of 1 mg/kg,CHEMBL628574,,12602,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11954,,,,BAO_0000218,,Cmax value after oral dose of 10 mg/kg,CHEMBL628575,,12603,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11954,,,,BAO_0000218,,Cmax value after oral dose of 23.4 mg/kg,CHEMBL628576,,12604,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11954,,,,BAO_0000218,,Cmax value after oral dose of 3 mg/kg,CHEMBL628577,,12605,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11954,,,,BAO_0000218,,Cmax value after oral dose of 3.87 mg/kg,CHEMBL628578,,12606,A,1,Autocuration,,,,0
N,,50588,,,In vivo,12768,,Canis lupus familiaris,,BAO_0000218,,Cmax value in female Beagle dogs,CHEMBL874466,9615.0,12607,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12768,,Rattus norvegicus,,BAO_0000218,,Cmax value in male rats,CHEMBL628579,10116.0,12608,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12780,Plasma,Rattus norvegicus,,BAO_0000218,,Cmax value in rat plasma when administered 20 mg/kg perorally,CHEMBL628580,10116.0,12609,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,15592,Plasma,Canis lupus familiaris,,BAO_0000218,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,CHEMBL628581,9615.0,12610,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,15592,Plasma,Canis lupus familiaris,,BAO_0000218,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,CHEMBL628582,9615.0,12611,A,1,Intermediate,,,1969.0,1
N,,50588,,,,17025,,Canis lupus familiaris,,BAO_0000218,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,CHEMBL628583,9615.0,12612,A,1,Intermediate,,,,1
U,,22224,,,,17025,,Simiiformes,,BAO_0000218,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,CHEMBL625782,314293.0,12613,A,1,Autocuration,,,,0
N,,50592,,,,17025,,Oryctolagus cuniculus,,BAO_0000218,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,CHEMBL625783,9986.0,12614,A,1,Intermediate,,,,1
N,,50597,,,,17025,,Rattus norvegicus,,BAO_0000218,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,CHEMBL625784,10116.0,12615,A,1,Intermediate,,,,1
N,,50797,,,,4236,Plasma,Macaca mulatta,,BAO_0000218,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,CHEMBL625785,9544.0,12616,A,1,Intermediate,,,1969.0,1
N,,50597,,,,15791,,Rattus norvegicus,,BAO_0000218,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,CHEMBL625786,10116.0,12617,A,1,Intermediate,,,,1
U,,22224,,,,11149,,,,BAO_0000019,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,CHEMBL874467,,12618,A,1,Autocuration,,,,0
N,,50588,,,,15592,,Canis lupus familiaris,,BAO_0000218,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",CHEMBL625787,9615.0,12619,A,1,Intermediate,,,,1
N,,50677,,,,15778,,Human immunodeficiency virus,,BAO_0000218,,cytotoxicity against HIV protease enzyme.,CHEMBL625964,12721.0,12620,A,1,Intermediate,,,,1
N,,50594,,,,12745,,Mus musculus,,BAO_0000218,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,CHEMBL625965,10090.0,12621,A,1,Intermediate,,,,1
N,,50594,,,,12745,,Mus musculus,,BAO_0000218,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,CHEMBL625966,10090.0,12622,A,1,Intermediate,,,,1
N,,50588,,,In vivo,13941,Plasma,Canis lupus familiaris,,BAO_0000218,,The plasma clearance in dog.,CHEMBL625967,9615.0,12623,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,13941,Plasma,Rattus norvegicus,,BAO_0000218,,The plasma clearance in rat.,CHEMBL625968,10116.0,12624,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,16449,Plasma,Rattus norvegicus,,BAO_0000218,,Clearance from plasma in male Sprague-Dawley rats,CHEMBL625969,10116.0,12625,A,1,Intermediate,,,1969.0,1
N,,100710,,,In vivo,16449,Plasma,Macaca fascicularis,,BAO_0000218,,Clearance from plasma in male cynomolgus monkeys,CHEMBL625970,9541.0,12626,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,14224,Plasma,Canis lupus familiaris,,BAO_0000218,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",CHEMBL625971,9615.0,12627,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,14224,Plasma,Canis lupus familiaris,,BAO_0000218,,Clearance of compound in dog plasma,CHEMBL625972,9615.0,12628,A,1,Intermediate,,,1969.0,1
N,,50587,,,In vivo,14224,Plasma,Homo sapiens,,BAO_0000218,,Clearance of compound in human plasma,CHEMBL625973,9606.0,12629,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,14317,,Canis lupus familiaris,,BAO_0000218,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,CHEMBL625974,9615.0,12630,A,1,Intermediate,,,,1
N,,50588,,,In vivo,14317,,Canis lupus familiaris,,BAO_0000218,,Clearance of compound when administered intravenously as an individual dose to a single dog.,CHEMBL625975,9615.0,12631,A,1,Intermediate,,,,1
N,,50588,,,In vivo,14224,Plasma,Canis lupus familiaris,,BAO_0000218,,"Clearance (10 mg/kg, intravenously) in dog plasma",CHEMBL625976,9615.0,12632,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,17237,,Canis lupus familiaris,,BAO_0000218,,Clearance value in dog,CHEMBL625977,9615.0,12633,A,1,Intermediate,,,,1
N,,50512,,,In vivo,17237,,Cavia porcellus,,BAO_0000218,,Clearance value in guinea pig,CHEMBL625978,10141.0,12634,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14187,,Rattus norvegicus,,BAO_0000218,,Clearance values in rats after iv administration.,CHEMBL874468,10116.0,12635,A,1,Intermediate,,,,1
U,,22224,,,In vivo,4806,Plasma,,,BAO_0000218,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,CHEMBL625421,,12636,A,1,Autocuration,,,1969.0,0
N,,50592,,,In vivo,15025,,Oryctolagus cuniculus,,BAO_0000218,,In vivo clearance (5 mg/kg) was determined in rabbits,CHEMBL625422,9986.0,12637,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13197,,Rattus norvegicus,,BAO_0000218,,Plasma Clearance rate was determined for the compound in rats,CHEMBL625423,10116.0,12638,A,1,Intermediate,,,,1
U,,22224,,,In vivo,13197,,Saimiri,,BAO_0000218,,Plasma Clearance rate was determined for the compound in squirrel monkeys,CHEMBL625424,9520.0,12639,A,1,Autocuration,,,,0
N,,50597,,,In vivo,13960,,Rattus norvegicus,,BAO_0000218,,Plasma clearance in rat,CHEMBL625425,10116.0,12640,A,1,Intermediate,,,,1
U,,22224,,,In vivo,17820,,,,BAO_0000218,,Plasma clearance of the compound,CHEMBL625426,,12641,A,1,Autocuration,,,,0
N,,50512,,,In vivo,14706,,Cavia porcellus,,BAO_0000218,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,CHEMBL625427,10141.0,12642,A,1,Intermediate,,,,1
N,,50512,,,In vivo,14706,,Cavia porcellus,,BAO_0000218,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,CHEMBL625428,10141.0,12643,A,1,Intermediate,,,,1
U,,22224,,,In vivo,6504,,,,BAO_0000218,,Plasma clearance was determined,CHEMBL625429,,12644,A,1,Autocuration,,,,0
N,,50588,,,In vivo,14925,,Canis lupus familiaris,,BAO_0000218,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,CHEMBL625430,9615.0,12645,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13197,,Rattus norvegicus,,BAO_0000218,,Plasma clearance rate was determined for the compound in rats,CHEMBL625431,10116.0,12646,A,1,Intermediate,,,,1
U,,22224,,,In vivo,13197,,Saimiri,,BAO_0000218,,Plasma clearance rate was determined for the compound in squirrel monkeys,CHEMBL627307,9520.0,12647,A,1,Autocuration,,,,0
U,,22224,,,In vivo,3437,,,,BAO_0000218,,Slow clearance (CL) was determined,CHEMBL627308,,12648,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,CHEMBL627309,,12649,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,CHEMBL627310,,12650,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,CHEMBL627311,,12651,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,CHEMBL627312,,12652,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,CHEMBL627313,,12653,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,CHEMBL627314,,12654,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,CHEMBL627315,,12655,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,CHEMBL627316,,12656,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,CHEMBL627317,,12657,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,CHEMBL627318,,12658,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,CHEMBL627999,,12659,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,CHEMBL628000,,12660,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,CHEMBL628001,,12661,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,CHEMBL628002,,12662,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,CHEMBL625610,,12663,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,CHEMBL625611,,12664,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,CHEMBL625612,,12665,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,CHEMBL625613,,12666,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,CHEMBL875479,,12667,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,CHEMBL625614,,12668,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,CHEMBL625615,,12669,A,1,Autocuration,,,,0
U,,22224,,,,9196,,,,BAO_0000218,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,CHEMBL626302,,12670,A,1,Autocuration,,,,0
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,CHEMBL626303,10116.0,12671,A,1,Intermediate,,,178.0,1
N,,50597,,,,8374,Blood,Rattus norvegicus,,BAO_0000218,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,CHEMBL627420,10116.0,12672,A,1,Intermediate,,,178.0,1
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,CHEMBL627421,10116.0,12673,A,1,Intermediate,,,,1
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,CHEMBL625695,10116.0,12674,A,1,Intermediate,,,,1
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,CHEMBL625696,10116.0,12675,A,1,Intermediate,,,,1
N,,50594,,,,10009,Brain,Mus musculus,,BAO_0000218,,Distribution of compound in mice brain was measured after 1 hr,CHEMBL875606,10090.0,12676,A,1,Intermediate,,,955.0,1
N,,50594,,,,10009,Brain,Mus musculus,,BAO_0000218,,Distribution of compound in mice brain was measured after 24 hr r,CHEMBL625697,10090.0,12677,A,1,Intermediate,,,955.0,1
N,,50594,,,,10009,Brain,Mus musculus,,BAO_0000218,,Distribution of compound in mice brain was measured after 2 hr,CHEMBL625698,10090.0,12678,A,1,Intermediate,,,955.0,1
N,,50594,,,,10009,Brain,Mus musculus,,BAO_0000218,,Distribution of compound in mice brain was measured after 3 hr,CHEMBL625699,10090.0,12679,A,1,Intermediate,,,955.0,1
N,,50594,,,,10009,Brain,Mus musculus,,BAO_0000218,,Distribution of compound in mice brain was measured after 6 hr,CHEMBL625700,10090.0,12680,A,1,Intermediate,,,955.0,1
N,,50594,,,,10009,,Mus musculus,,BAO_0000218,,Distribution of compound in mice liver was measured after 1 hr,CHEMBL625701,10090.0,12681,A,1,Intermediate,,,,1
N,,50594,,,,10009,,Mus musculus,,BAO_0000218,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,CHEMBL625702,10090.0,12682,A,1,Intermediate,,,,1
N,,50594,,,,10009,,Mus musculus,,BAO_0000218,,Distribution of compound in mice liver was measured after 2 hr,CHEMBL625703,10090.0,12683,A,1,Intermediate,,,,1
N,,50594,,,,10009,,Mus musculus,,BAO_0000218,,Distribution of compound in mice liver was measured after 3 hr,CHEMBL625704,10090.0,12684,A,1,Intermediate,,,,1
N,,50594,,,,10009,,Mus musculus,,BAO_0000218,,Distribution of compound in mice liver was measured after 6 hr,CHEMBL625705,10090.0,12685,A,1,Intermediate,,,,1
N,,50588,,,,8170,Adrenal medulla,Canis lupus familiaris,,BAO_0000218,,Distribution in dog adrenal medulla 30 min after administration.,CHEMBL625706,9615.0,12686,A,1,Intermediate,,,1236.0,1
N,,50588,,,,8170,Adrenal medulla,Canis lupus familiaris,,BAO_0000218,,Distribution in dog adrenal medulla 72 hours after administration.,CHEMBL625707,9615.0,12687,A,1,Intermediate,,,1236.0,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog Ovary 24 hours after administration.,CHEMBL625708,9615.0,12688,A,1,Intermediate,,,,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog Ovary 72 hours after administration.,CHEMBL625709,9615.0,12689,A,1,Intermediate,,,,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog adipose 24 hours after administration.,CHEMBL624180,9615.0,12690,A,1,Intermediate,,,,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog adipose 72 hours after administration.,CHEMBL624181,9615.0,12691,A,1,Intermediate,,,,1
N,,50588,,,,8170,Adrenal cortex,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog adrenal cortex 72 hours after administration.,CHEMBL624182,9615.0,12692,A,1,Intermediate,,,1235.0,1
N,,50588,,,,8170,Adrenal cortex,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog adrenal cortex 72 hours after administration.,CHEMBL624183,9615.0,12693,A,1,Intermediate,,,1235.0,1
N,,50597,,,,8594,Liver,Rattus norvegicus,,BAO_0000218,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,CHEMBL624184,10116.0,12694,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8594,Liver,Rattus norvegicus,,BAO_0000218,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,CHEMBL877489,10116.0,12695,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8594,Liver,Rattus norvegicus,,BAO_0000218,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL624185,10116.0,12696,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8594,Liver,Rattus norvegicus,,BAO_0000218,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,CHEMBL624186,10116.0,12697,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8594,Liver,Rattus norvegicus,,BAO_0000218,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,CHEMBL624187,10116.0,12698,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8594,Liver,Rattus norvegicus,,BAO_0000218,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,CHEMBL624188,10116.0,12699,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8594,Lung,Rattus norvegicus,,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,CHEMBL624189,10116.0,12700,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8594,Lung,Rattus norvegicus,,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,CHEMBL624190,10116.0,12701,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8594,Lung,Rattus norvegicus,,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,CHEMBL624191,10116.0,12702,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8594,Lung,Rattus norvegicus,,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,CHEMBL624192,10116.0,12703,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8594,Lung,Rattus norvegicus,,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,CHEMBL624193,10116.0,12704,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8594,Lung,Rattus norvegicus,,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,CHEMBL624194,10116.0,12705,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8594,Lung,Rattus norvegicus,,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,CHEMBL624891,10116.0,12706,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8594,Lung,Rattus norvegicus,,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,CHEMBL624892,10116.0,12707,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8594,Lung,Rattus norvegicus,,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,CHEMBL624893,10116.0,12708,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8594,Lung,Rattus norvegicus,,BAO_0000218,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL627632,10116.0,12709,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,CHEMBL627633,10116.0,12710,A,1,Intermediate,,,,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,CHEMBL627634,10116.0,12711,A,1,Intermediate,,,,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,CHEMBL627635,10116.0,12712,A,1,Intermediate,,,,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,CHEMBL627636,10116.0,12713,A,1,Intermediate,,,,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,CHEMBL626816,10116.0,12714,A,1,Intermediate,,,,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,CHEMBL626817,10116.0,12715,A,1,Intermediate,,,,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,CHEMBL626818,10116.0,12716,A,1,Intermediate,,,,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,CHEMBL626819,10116.0,12717,A,1,Intermediate,,,,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,CHEMBL626820,10116.0,12718,A,1,Intermediate,,,,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL626821,10116.0,12719,A,1,Intermediate,,,,1
N,,50597,,,,8594,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,CHEMBL626822,10116.0,12720,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8594,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,CHEMBL626823,10116.0,12721,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8594,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,CHEMBL626824,10116.0,12722,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8594,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,CHEMBL626825,10116.0,12723,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8594,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,CHEMBL626826,10116.0,12724,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8594,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,CHEMBL626827,10116.0,12725,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8594,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,CHEMBL626828,10116.0,12726,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8594,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,CHEMBL626829,10116.0,12727,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8594,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL626830,10116.0,12728,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,CHEMBL627150,10116.0,12729,A,1,Intermediate,,,,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL627151,10116.0,12730,A,1,Intermediate,,,,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,CHEMBL627152,10116.0,12731,A,1,Intermediate,,,,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,CHEMBL627153,10116.0,12732,A,1,Intermediate,,,,1
U,,22224,,,,12904,,,,BAO_0000019,,Rate of acetate production by the compound was determined,CHEMBL627154,,12733,A,1,Autocuration,,,,0
U,,22224,,,,12904,,,,BAO_0000019,,Rate of acetate production by the compound was determined; Not determined,CHEMBL627155,,12734,A,1,Autocuration,,,,0
U,,22224,,,,3730,,,,BAO_0000019,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,CHEMBL627156,,12735,A,1,Autocuration,,,,0
U,,22224,,,,3627,,,,BAO_0000019,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,CHEMBL627157,,12736,A,1,Autocuration,,,,0
N,,50592,,,,13799,,Oryctolagus cuniculus,,BAO_0000218,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,CHEMBL627158,9986.0,12737,A,1,Intermediate,,,,1
N,,50592,,,,13799,Plasma,Oryctolagus cuniculus,,BAO_0000218,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,CHEMBL627159,9986.0,12738,A,1,Intermediate,,,1969.0,1
N,,50594,,,,13799,,Mus musculus,,BAO_0000218,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,CHEMBL627160,10090.0,12739,A,1,Intermediate,,,,1
N,,50597,,,,13799,,Rattus norvegicus,,BAO_0000218,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,CHEMBL628540,10116.0,12740,A,1,Intermediate,,,,1
N,,50597,,,,13799,Plasma,Rattus norvegicus,,BAO_0000218,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,CHEMBL628541,10116.0,12741,A,1,Intermediate,,,1969.0,1
N,,50597,,,,13799,Plasma,Rattus norvegicus,,BAO_0000218,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,CHEMBL628542,10116.0,12742,A,1,Intermediate,,,1969.0,1
U,,22229,,,,6629,,,,BAO_0000100,,Solubility after at a pH 1.2,CHEMBL628543,,12743,P,1,Autocuration,,,,0
U,,22229,,,,6629,,,,BAO_0000100,,Solubility after at pH 1.2,CHEMBL628544,,12744,P,1,Autocuration,,,,0
U,,22229,,,,6629,,,,BAO_0000100,,Solubility after injection of water,CHEMBL628545,,12745,P,1,Autocuration,,,,0
U,,22224,,,,14000,,,,BAO_0000019,,Statistical significance of IC 50 values; Expressed as R value,CHEMBL628546,,12746,A,1,Autocuration,,,,0
U,,22224,,,,8267,,,,BAO_0000019,,Systemic availability with respect to methyldopa was determined,CHEMBL874455,,12747,A,1,Autocuration,,,,0
N,,50597,,,,13799,,Rattus norvegicus,,BAO_0000218,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,CHEMBL628547,10116.0,12748,A,1,Intermediate,,,,1
N,,50597,,,,13799,Plasma,Rattus norvegicus,,BAO_0000218,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,CHEMBL628548,10116.0,12749,A,1,Intermediate,,,1969.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",CHEMBL628549,9986.0,12750,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",CHEMBL628550,9986.0,12751,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",CHEMBL628551,9986.0,12752,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",CHEMBL628552,9986.0,12753,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",CHEMBL628553,9986.0,12754,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",CHEMBL628554,9986.0,12755,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",CHEMBL628555,9986.0,12756,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",CHEMBL628556,9986.0,12757,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Kidney,Oryctolagus cuniculus,,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",CHEMBL628557,9986.0,12758,A,1,Intermediate,,,2113.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",CHEMBL628558,9986.0,12759,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",CHEMBL628559,9986.0,12760,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",CHEMBL628560,9986.0,12761,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",CHEMBL874456,9986.0,12762,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",CHEMBL628561,9986.0,12763,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",CHEMBL628562,9986.0,12764,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",CHEMBL628563,9986.0,12765,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",CHEMBL628564,9986.0,12766,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",CHEMBL628565,9986.0,12767,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",CHEMBL631248,9986.0,12768,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",CHEMBL631249,9986.0,12769,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Kidney,Oryctolagus cuniculus,,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",CHEMBL627214,9986.0,12770,A,1,Intermediate,,,2113.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",CHEMBL874591,9986.0,12771,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",CHEMBL627215,9986.0,12772,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,CHEMBL625471,9986.0,12773,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,,Oryctolagus cuniculus,,BAO_0000218,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,CHEMBL625472,9986.0,12774,A,1,Intermediate,,,,1
N,,50592,,,,7132,,Oryctolagus cuniculus,,BAO_0000218,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,CHEMBL625473,9986.0,12775,A,1,Intermediate,,,,1
N,,50588,,,In vivo,13317,,Canis lupus familiaris,,BAO_0000218,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,CHEMBL625474,9615.0,12776,A,1,Intermediate,,,,1
N,,50588,,,In vivo,15341,,Canis lupus familiaris,,BAO_0000218,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,CHEMBL625475,9615.0,12777,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15341,,Rattus norvegicus,,BAO_0000218,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,CHEMBL625476,10116.0,12778,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15341,,Rattus norvegicus,,BAO_0000218,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,CHEMBL625477,10116.0,12779,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15341,,Rattus norvegicus,,BAO_0000218,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,CHEMBL625478,10116.0,12780,A,1,Intermediate,,,,1
N,,50597,,,In vitro,12801,esophageal tunica muscularis mucosae,Rattus norvegicus,,BAO_0000218,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,CHEMBL625479,10116.0,12781,A,1,Intermediate,,,,1
N,,50597,,,In vitro,12801,esophageal tunica muscularis mucosae,Rattus norvegicus,,BAO_0000218,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,CHEMBL625480,10116.0,12782,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14856,Plasma,Rattus norvegicus,,BAO_0000218,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,CHEMBL625481,10116.0,12783,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14062,,Rattus norvegicus,,BAO_0000218,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,CHEMBL625482,10116.0,12784,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14062,,Rattus norvegicus,,BAO_0000218,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,CHEMBL625483,10116.0,12785,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14062,,Rattus norvegicus,,BAO_0000218,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,CHEMBL625484,10116.0,12786,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14062,,Rattus norvegicus,,BAO_0000218,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,CHEMBL625485,10116.0,12787,A,1,Intermediate,,,,1
N,,50588,,,In vivo,14346,Plasma,Canis lupus familiaris,,BAO_0000218,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,CHEMBL625486,9615.0,12788,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14346,Plasma,Rattus norvegicus,,BAO_0000218,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,CHEMBL625487,10116.0,12789,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14346,Plasma,Rattus norvegicus,,BAO_0000218,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,CHEMBL625488,10116.0,12790,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14346,Plasma,Rattus norvegicus,,BAO_0000218,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,CHEMBL625489,10116.0,12791,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14346,Plasma,Rattus norvegicus,,BAO_0000218,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,CHEMBL625490,10116.0,12792,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,14346,Plasma,Canis lupus familiaris,,BAO_0000218,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,CHEMBL625491,9615.0,12793,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14346,Plasma,Rattus norvegicus,,BAO_0000218,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,CHEMBL625492,10116.0,12794,A,1,Intermediate,,,1969.0,1
N,,50587,,,In vivo,15711,Plasma,Homo sapiens,,BAO_0000218,,plasma clearance in human,CHEMBL625493,9606.0,12795,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14886,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,CHEMBL625494,10116.0,12796,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14886,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,CHEMBL625495,10116.0,12797,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14886,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,CHEMBL625496,10116.0,12798,A,1,Intermediate,,,,1
U,,22229,,,,4115,,,,BAO_0000100,,1-Octanol/water partition coefficient measured at 7.4,CHEMBL625497,,12799,P,1,Autocuration,,,,0
U,,22229,,,,13733,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625498,,12800,P,1,Autocuration,,,,0
U,,22224,,,,12102,,,,BAO_0000019,,Partition coefficient (logP),CHEMBL625499,,12801,A,1,Autocuration,,,,0
U,,22229,,,,12676,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625500,,12802,P,1,Autocuration,,,,0
U,,22229,,,,13733,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625501,,12803,P,1,Autocuration,,,,0
U,,22229,,,,13740,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625502,,12804,P,1,Autocuration,,,,0
U,,22229,,,,12766,,,,BAO_0000100,,Calculated partition coefficient (clogP) (relative to BAY K 8644),CHEMBL625503,,12805,P,1,Autocuration,,,,0
U,,22229,,,,2764,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625504,,12806,P,1,Autocuration,,,,0
U,,22229,,,,12355,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625505,,12807,P,1,Autocuration,,,,0
U,,22229,,,,11314,,,,BAO_0000100,,Calculated partition coefficient of the compound,CHEMBL625506,,12808,P,1,Autocuration,,,,0
U,,22224,,,,12706,,,,BAO_0000019,,Partition coefficient (logP),CHEMBL625507,,12809,A,1,Autocuration,,,,0
U,,22229,,,,12645,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625508,,12810,P,1,Autocuration,,,,0
U,,22229,,,,13668,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625509,,12811,P,1,Autocuration,,,,0
U,,22229,,,,12819,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625510,,12812,P,1,Autocuration,,,,0
U,,22229,,,,13668,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL883125,,12813,P,1,Autocuration,,,,0
U,,22229,,,,13017,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625511,,12814,P,1,Autocuration,,,,0
U,,22224,,,,2448,,,,BAO_0000019,,Partition coefficient of the compound,CHEMBL874650,,12815,A,1,Autocuration,,,,0
U,,22224,,,,11526,,,,BAO_0000019,,Partition coefficient of the compound,CHEMBL625512,,12816,A,1,Autocuration,,,,0
U,,22224,,,,12426,,,,BAO_0000019,,Partition coefficient of compound was determined,CHEMBL625513,,12817,A,1,Autocuration,,,,0
U,,22224,,,,2448,,,,BAO_0000019,,Partition coefficient was determined,CHEMBL625514,,12818,A,1,Autocuration,,,,0
U,,22229,,,,12001,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625515,,12819,P,1,Autocuration,,,,0
U,,22229,,,,12426,,,,BAO_0000100,,partition coefficient of compound was determined,CHEMBL625516,,12820,P,1,Autocuration,,,,0
N,,50588,,,In vivo,13204,,Canis lupus familiaris,,BAO_0000218,,The total body administered intravenously in dog,CHEMBL625517,9615.0,12821,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13204,,Rattus norvegicus,,BAO_0000218,,The total body administered intravenously in rats,CHEMBL625518,10116.0,12822,A,1,Intermediate,,,,1
N,,50594,,,,13889,,Mus musculus,,BAO_0000218,,Time taken for the administration to female NIH mice weighing 25-30 g.,CHEMBL625519,10090.0,12823,A,1,Intermediate,,,,1
U,,22224,,,,13889,,,,BAO_0000019,,Time taken for the administration,CHEMBL625520,,12824,A,1,Autocuration,,,,0
N,,50588,,,In vivo,17025,,Canis lupus familiaris,,BAO_0000218,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,CHEMBL874651,9615.0,12825,A,1,Intermediate,,,,1
U,,22224,,,In vivo,17025,,Simiiformes,,BAO_0000218,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,CHEMBL625521,314293.0,12826,A,1,Autocuration,,,,0
N,,50592,,,In vivo,17025,,Oryctolagus cuniculus,,BAO_0000218,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,CHEMBL623171,9986.0,12827,A,1,Intermediate,,,,1
N,,50597,,,In vivo,17025,,Rattus norvegicus,,BAO_0000218,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,CHEMBL623853,10116.0,12828,A,1,Intermediate,,,,1
U,,22224,,,,15067,,,,BAO_0000019,,Plasma clearance for the compound was determined.,CHEMBL623854,,12829,A,1,Autocuration,,,,0
U,,22224,,,,3091,,,,BAO_0000100,,CLog P value of the compound,CHEMBL874405,,12830,P,1,Autocuration,,,,0
U,,22229,,,,15592,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL623855,,12831,P,1,Autocuration,,,,0
U,,22229,,,,14738,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL623856,,12832,P,1,Autocuration,,,,0
U,,22224,,,,14738,,,,BAO_0000100,,ClogP value of the compound; nd ='no data',CHEMBL623857,,12833,P,1,Autocuration,,,,0
U,,22224,,,,14738,,,,BAO_0000100,,ClogP value of the compound; nd ='not determined',CHEMBL623858,,12834,P,1,Autocuration,,,,0
U,,22224,,,,6076,,,,BAO_0000100,,CLog P was determined,CHEMBL623859,,12835,P,1,Autocuration,,,,0
U,,22229,,,,17840,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL839829,,12836,P,1,Autocuration,,,,0
U,,22224,,,,13589,,,,BAO_0000019,,CLogP was calculated,CHEMBL623860,,12837,A,1,Autocuration,,,,0
U,,22224,,,,17655,,,,BAO_0000019,,CLogP value was determined,CHEMBL623861,,12838,A,1,Autocuration,,,,0
U,,22224,,,,5867,,,,BAO_0000019,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,CHEMBL623862,,12839,A,1,Autocuration,,,,0
U,,22229,,,,5867,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL874406,,12840,P,1,Autocuration,,,,0
U,,22229,,,,10783,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL623863,,12841,P,1,Autocuration,,,,0
U,,22229,,,,14849,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL624021,,12842,P,1,Autocuration,,,,0
N,,50588,,,,8170,Adrenal medulla,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog adrenal medulla 24 hours after administration.,CHEMBL624022,9615.0,12843,A,1,Intermediate,,,1236.0,1
N,,50588,,,,8170,Adrenal medulla,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog adrenal medulla 72 hours after administration.,CHEMBL624023,9615.0,12844,A,1,Intermediate,,,1236.0,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog bile 24 hours after administration.,CHEMBL624024,9615.0,12845,A,1,Intermediate,,,,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog bile 72 hr after administration.,CHEMBL624025,9615.0,12846,A,1,Intermediate,,,,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog blood 24 hours after administration.,CHEMBL624026,9615.0,12847,A,1,Intermediate,,,,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog blood 72 hours after administration.,CHEMBL624027,9615.0,12848,A,1,Intermediate,,,,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog heart 24 hours after administration.,CHEMBL624028,9615.0,12849,A,1,Intermediate,,,,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog heart 72 hours after administration.,CHEMBL624029,9615.0,12850,A,1,Intermediate,,,,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog kidney 24 hours after administration.,CHEMBL624030,9615.0,12851,A,1,Intermediate,,,,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog kidney 72 hours after administration.,CHEMBL624031,9615.0,12852,A,1,Intermediate,,,,1
N,,50588,,,,8170,Intestine,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog large intestine 24 hours after administration.,CHEMBL624032,9615.0,12853,A,1,Intermediate,,,160.0,1
N,,50588,,,,8170,Intestine,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog large intestine 72 hours after administration.,CHEMBL874407,9615.0,12854,A,1,Intermediate,,,160.0,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog liver 24 hours after administration.,CHEMBL624033,9615.0,12855,A,1,Intermediate,,,,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog liver 72 hours after administration.,CHEMBL624034,9615.0,12856,A,1,Intermediate,,,,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog lung 24 hours after administration.,CHEMBL624035,9615.0,12857,A,1,Intermediate,,,,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog lung 72 hours after administration.,CHEMBL624036,9615.0,12858,A,1,Intermediate,,,,1
N,,50588,,,,8170,Muscle tissue,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog muscle 24 hours after administration.,CHEMBL624037,9615.0,12859,A,1,Intermediate,,,2385.0,1
N,,50588,,,,8170,Muscle tissue,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog muscle 72 hours after administration.,CHEMBL624038,9615.0,12860,A,1,Intermediate,,,2385.0,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog pancreas 24 hours after administration.,CHEMBL624039,9615.0,12861,A,1,Intermediate,,,,1
N,,50588,,,,8170,,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog pancreas 72 hours after administration.,CHEMBL624040,9615.0,12862,A,1,Intermediate,,,,1
N,,50588,,,,8170,Intestine,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog small intestine 24 hours after administration.,CHEMBL624041,9615.0,12863,A,1,Intermediate,,,160.0,1
N,,50588,,,,8170,Intestine,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog small intestine 72 hours after administration.,CHEMBL624042,9615.0,12864,A,1,Intermediate,,,160.0,1
N,,50588,,,,8170,Spleen,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog spleen 24 hours after administration.,CHEMBL624043,9615.0,12865,A,1,Intermediate,,,2106.0,1
N,,50588,,,,8170,Spleen,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog spleen 72 hours after administration.,CHEMBL624044,9615.0,12866,A,1,Intermediate,,,2106.0,1
N,,50588,,,,8170,Stomach,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog stomach 24 hours after administration.,CHEMBL624045,9615.0,12867,A,1,Intermediate,,,945.0,1
N,,50588,,,,8170,Stomach,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog stomach 72 hours after administration.,CHEMBL624046,9615.0,12868,A,1,Intermediate,,,945.0,1
N,,50588,,,,8170,Thyroid gland,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog thyroid 24 hours after administration.,CHEMBL624047,9615.0,12869,A,1,Intermediate,,,2046.0,1
N,,50588,,,,8170,Thyroid gland,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog thyroid 72 hours after administration.,CHEMBL624048,9615.0,12870,A,1,Intermediate,,,2046.0,1
N,,50588,,,,8170,Urine,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog urine 24 hours after administration.,CHEMBL874408,9615.0,12871,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8170,Urine,Canis lupus familiaris,,BAO_0000218,,Distribution in female dog urine 72 hr after administration.,CHEMBL624049,9615.0,12872,A,1,Intermediate,,,1088.0,1
U,,22224,,,,14283,Plasma,,,BAO_0000218,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,CHEMBL624050,,12873,A,1,Autocuration,,,1969.0,0
U,,22224,,,,5623,,,,BAO_0000019,,Plasma concentration at 7 hr after intravenous dosing,CHEMBL624051,,12874,A,1,Autocuration,,,,0
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,CHEMBL623278,10116.0,12875,A,1,Intermediate,,,,1
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,CHEMBL623279,10116.0,12876,A,1,Intermediate,,,,1
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,CHEMBL623280,10116.0,12877,A,1,Intermediate,,,,1
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,CHEMBL623963,10116.0,12878,A,1,Intermediate,,,,1
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,CHEMBL623964,10116.0,12879,A,1,Intermediate,,,,1
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,CHEMBL623965,10116.0,12880,A,1,Intermediate,,,,1
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,CHEMBL623966,10116.0,12881,A,1,Intermediate,,,,1
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,CHEMBL874415,10116.0,12882,A,1,Intermediate,,,,1
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,CHEMBL623967,10116.0,12883,A,1,Intermediate,,,,1
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,CHEMBL623968,10116.0,12884,A,1,Intermediate,,,,1
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,CHEMBL623969,10116.0,12885,A,1,Intermediate,,,,1
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,CHEMBL628409,10116.0,12886,A,1,Intermediate,,,,1
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,CHEMBL628410,10116.0,12887,A,1,Intermediate,,,,1
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,CHEMBL628411,10116.0,12888,A,1,Intermediate,,,,1
N,,50597,,,,13477,,Rattus norvegicus,,BAO_0000218,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,CHEMBL628412,10116.0,12889,A,1,Intermediate,,,,1
U,,22224,,,,12553,,,,BAO_0000019,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,CHEMBL628413,,12890,A,1,Autocuration,,,,0
U,,22224,,,,14548,Plasma,,,BAO_0000019,,The concentration in plasmat; Not determined,CHEMBL628414,,12891,A,1,Autocuration,,,1969.0,0
N,,50597,,,,14393,,Rattus norvegicus,,BAO_0000218,,Tissue level at 10 mg/kg/po in wistar rats in blood,CHEMBL628415,10116.0,12892,A,1,Intermediate,,,,1
N,,50597,,,,14393,,Rattus norvegicus,,BAO_0000218,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,CHEMBL628416,10116.0,12893,A,1,Intermediate,,,,1
N,,50597,,,,14393,,Rattus norvegicus,,BAO_0000218,,Tissue level at 10 mg/kg/po in wistar rats in heart,CHEMBL628417,10116.0,12894,A,1,Intermediate,,,,1
N,,50597,,,,14393,Liver,Rattus norvegicus,,BAO_0000218,,Tissue level at 10 mg/kg/po in wistar rats in liver,CHEMBL874908,10116.0,12895,A,1,Intermediate,,,2107.0,1
N,,50597,,,,14393,,Rattus norvegicus,,BAO_0000218,,Tissue level at 10 mg/kg/po in wistar rats in plasma,CHEMBL628418,10116.0,12896,A,1,Intermediate,,,,1
N,,50597,,,,14393,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,CHEMBL628419,10116.0,12897,A,1,Intermediate,,,2385.0,1
N,,50597,,,,14393,,Rattus norvegicus,,BAO_0000218,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,CHEMBL628420,10116.0,12898,A,1,Intermediate,,,,1
U,,22224,,,,1629,,,,BAO_0000019,,Water solubility at 37 degree C.,CHEMBL628421,,12899,A,1,Autocuration,,,,0
U,,22229,,,,8194,,,,BAO_0000100,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,CHEMBL626726,,12900,P,1,Autocuration,,,,0
U,,22229,,,,8194,,,,BAO_0000100,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,CHEMBL626727,,12901,P,1,Autocuration,,,,0
N,,50597,,,,8594,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,CHEMBL626728,10116.0,12902,A,1,Intermediate,,,178.0,1
N,,50597,,,,8594,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,CHEMBL626729,10116.0,12903,A,1,Intermediate,,,178.0,1
N,,50597,,,,8594,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,CHEMBL626730,10116.0,12904,A,1,Intermediate,,,178.0,1
N,,50597,,,,8594,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,CHEMBL626731,10116.0,12905,A,1,Intermediate,,,178.0,1
N,,50597,,,,8594,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,CHEMBL626732,10116.0,12906,A,1,Intermediate,,,178.0,1
N,,50597,,,,8594,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,CHEMBL626733,10116.0,12907,A,1,Intermediate,,,948.0,1
N,,50597,,,,8594,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,CHEMBL626734,10116.0,12908,A,1,Intermediate,,,948.0,1
N,,50597,,,,8594,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,CHEMBL626735,10116.0,12909,A,1,Intermediate,,,948.0,1
N,,50597,,,,8594,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,CHEMBL874909,10116.0,12910,A,1,Intermediate,,,948.0,1
N,,50597,,,,8594,Heart,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,CHEMBL626736,10116.0,12911,A,1,Intermediate,,,948.0,1
N,,50597,,,,8594,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,CHEMBL626737,10116.0,12912,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8594,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,CHEMBL630999,10116.0,12913,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8594,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,CHEMBL631000,10116.0,12914,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8594,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,CHEMBL631001,10116.0,12915,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8594,Kidney,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,CHEMBL631002,10116.0,12916,A,1,Intermediate,,,2113.0,1
N,,50597,,,,8594,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,CHEMBL631003,10116.0,12917,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8594,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,CHEMBL631004,10116.0,12918,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8594,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,CHEMBL631005,10116.0,12919,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8594,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,CHEMBL631006,10116.0,12920,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8594,Liver,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,CHEMBL631007,10116.0,12921,A,1,Intermediate,,,2107.0,1
N,,50597,,,,8594,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,CHEMBL631008,10116.0,12922,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8594,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,CHEMBL631009,10116.0,12923,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8594,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,CHEMBL631010,10116.0,12924,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8594,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,CHEMBL631011,10116.0,12925,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8594,Lung,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,CHEMBL631012,10116.0,12926,A,1,Intermediate,,,2048.0,1
N,,50597,,,,8594,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,CHEMBL630271,10116.0,12927,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8594,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,CHEMBL630272,10116.0,12928,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8594,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,CHEMBL630273,10116.0,12929,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8594,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,CHEMBL630274,10116.0,12930,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8594,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,CHEMBL630275,10116.0,12931,A,1,Intermediate,,,2046.0,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,CHEMBL875782,10116.0,12932,A,1,Intermediate,,,,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,CHEMBL630276,10116.0,12933,A,1,Intermediate,,,,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,CHEMBL630277,10116.0,12934,A,1,Intermediate,,,,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,CHEMBL630278,10116.0,12935,A,1,Intermediate,,,,1
N,,50597,,,,8594,,Rattus norvegicus,,BAO_0000218,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,CHEMBL630279,10116.0,12936,A,1,Intermediate,,,,1
U,,22224,,,,8151,,,,BAO_0000019,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,CHEMBL630280,,12937,A,1,Autocuration,,,,0
U,,22224,,,,8151,,,,BAO_0000019,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,CHEMBL630281,,12938,A,1,Autocuration,,,,0
N,,50592,,,,7132,,Oryctolagus cuniculus,,BAO_0000218,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,CHEMBL630282,9986.0,12939,A,1,Intermediate,,,,1
N,,50592,,,,7132,,Oryctolagus cuniculus,,BAO_0000218,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,CHEMBL630283,9986.0,12940,A,1,Intermediate,,,,1
U,,22224,,,,5797,,,,BAO_0000019,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),CHEMBL630284,,12941,A,1,Autocuration,,,,0
U,,22224,,,,7849,,,,BAO_0000019,,Alkylating activity was determined,CHEMBL630285,,12942,A,1,Autocuration,,,,0
U,Microsomes,22224,,,,14220,,,,BAO_0000251,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),CHEMBL630286,,12943,A,1,Autocuration,,,,0
N,,50592,,,,8650,,Oryctolagus cuniculus,,BAO_0000218,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",CHEMBL630069,9986.0,12944,A,1,Intermediate,,,,1
N,,50592,,,,8650,,Oryctolagus cuniculus,,BAO_0000218,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",CHEMBL630070,9986.0,12945,A,1,Intermediate,,,,1
N,,50592,,,,8650,,Oryctolagus cuniculus,,BAO_0000218,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",CHEMBL630071,9986.0,12946,A,1,Intermediate,,,,1
N,,50592,,,,8650,,Oryctolagus cuniculus,,BAO_0000218,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",CHEMBL630072,9986.0,12947,A,1,Intermediate,,,,1
N,,50592,,,,8650,,Oryctolagus cuniculus,,BAO_0000218,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",CHEMBL875110,9986.0,12948,A,1,Intermediate,,,,1
N,,50597,,,,7116,,Rattus norvegicus,,BAO_0000218,,Compound was tested for antidiuretic activity in rats,CHEMBL630073,10116.0,12949,A,1,Intermediate,,,,1
U,,22224,,,,14131,,,,BAO_0000019,,Compound was tested for inactivation kinetic values,CHEMBL630074,,12950,A,1,Autocuration,,,,0
U,,22224,,,In vivo,7415,,,,BAO_0000218,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,CHEMBL630075,,12951,A,1,Autocuration,,,,0
U,,22224,,,,13178,,,,BAO_0000019,,Dissociation rate calculated from the first-order equation using the t1/2 value,CHEMBL630076,,12952,A,1,Autocuration,,,,0
U,,22229,,,,8815,,,,BAO_0000100,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,CHEMBL630077,,12953,P,1,Autocuration,,,,0
U,,22229,,,,1450,,,,BAO_0000100,,Aqueous solubility was measured,CHEMBL630078,,12954,P,1,Autocuration,,,,0
U,,22229,,,,1450,,,,BAO_0000100,,Aqueous solubility was measured at a pH 4,CHEMBL630079,,12955,P,1,Autocuration,,,,0
U,,22229,,,,1450,,,,BAO_0000100,,Aqueous solubility (pH 7),CHEMBL630080,,12956,P,1,Autocuration,,,,0
U,,22229,,,,1450,,,,BAO_0000100,,Aqueous solubility was measured at a pH 9,CHEMBL630081,,12957,P,1,Autocuration,,,,0
U,,22224,,,,12711,,,,BAO_0000019,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",CHEMBL630082,,12958,A,1,Autocuration,,,,0
U,,22224,,,,12711,,,,BAO_0000019,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",CHEMBL630083,,12959,A,1,Autocuration,,,,0
U,,22224,,,,12711,,,,BAO_0000019,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",CHEMBL630084,,12960,A,1,Autocuration,,,,0
U,,22229,,,,15032,,,,BAO_0000100,,Aqueous solubility of the compound,CHEMBL629198,,12961,P,1,Autocuration,,,,0
U,,22229,,,,9964,,,,BAO_0000100,,Aqueous solubility at 37 degree Celsius at pH 7.38,CHEMBL629199,,12962,P,1,Autocuration,,,,0
U,,22229,,,,14962,,,,BAO_0000100,,Aqueous solubility in pH 7.4 phosphate buffer,CHEMBL629200,,12963,P,1,Autocuration,,,,0
N,,50588,,,,12487,,Canis lupus familiaris,,BAO_0000218,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,CHEMBL629201,9615.0,12964,A,1,Intermediate,,,,1
N,,50588,,,,12487,,Canis lupus familiaris,,BAO_0000218,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,CHEMBL629202,9615.0,12965,A,1,Intermediate,,,,1
N,,50587,,,,10026,,Homo sapiens,,BAO_0000218,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,CHEMBL875111,9606.0,12966,A,1,Intermediate,,,,1
N,,50587,,,,10026,,Homo sapiens,,BAO_0000218,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,CHEMBL629203,9606.0,12967,A,1,Intermediate,,,,1
N,,50587,,,,10026,,Homo sapiens,,BAO_0000218,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,CHEMBL629204,9606.0,12968,A,1,Intermediate,,,,1
N,,50587,,,,10026,,Homo sapiens,,BAO_0000218,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,CHEMBL629205,9606.0,12969,A,1,Intermediate,,,,1
N,,50587,,,,10026,,Homo sapiens,,BAO_0000218,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,CHEMBL629206,9606.0,12970,A,1,Intermediate,,,,1
U,,22224,,,,10026,,,,BAO_0000019,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,CHEMBL631185,,12971,A,1,Autocuration,,,,0
N,,50597,,,,7415,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for the average bile flow rat in rats,CHEMBL631186,10116.0,12972,A,1,Intermediate,,,,1
N,,50592,,,,17025,,Oryctolagus cuniculus,,BAO_0000218,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",CHEMBL631187,9986.0,12973,A,1,Intermediate,,,,1
N,,50592,,,,17025,,Oryctolagus cuniculus,,BAO_0000218,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",CHEMBL631188,9986.0,12974,A,1,Intermediate,,,,1
U,,22224,,,,10184,,,,BAO_0000019,,Average half life period was determined,CHEMBL876419,,12975,A,1,Autocuration,,,,0
U,,22224,,,,10184,,,,BAO_0000019,,Average half life period was determined,CHEMBL631189,,12976,A,1,Autocuration,,,,0
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,CHEMBL631190,10298.0,12977,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,CHEMBL631191,10298.0,12978,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,CHEMBL631192,10298.0,12979,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,CHEMBL632400,10298.0,12980,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,CHEMBL630564,10298.0,12981,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,CHEMBL630565,10298.0,12982,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,CHEMBL630566,10298.0,12983,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,CHEMBL631229,10298.0,12984,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,CHEMBL631230,10298.0,12985,A,1,Intermediate,,,,1
U,,22229,,,,6030,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL876428,,12986,P,1,Autocuration,,,,0
U,,22229,,,,6147,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL631231,,12987,P,1,Autocuration,,,,0
U,,22229,,,,14556,,,,BAO_0000100,,Calculated partition coefficient (clogP) (MacLogP),CHEMBL631232,,12988,P,1,Autocuration,,,,0
U,,22224,,,,768,,,,BAO_0000019,,Hydrophilicity was determined,CHEMBL631233,,12989,A,1,Autocuration,,,,0
U,,22229,,,,14452,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL631234,,12990,P,1,Autocuration,,,,0
U,,22224,,,,5237,,,,BAO_0000019,,Increased absorption was determined,CHEMBL883126,,12991,A,1,Autocuration,,,,0
U,,22224,,,,14378,,,,BAO_0000100,,Lipophilicity value was evaluated,CHEMBL631235,,12992,P,1,Autocuration,,,,0
U,,22224,,,,14418,,,,BAO_0000100,,Log P value of the compound.,CHEMBL631236,,12993,P,1,Autocuration,,,,0
U,,22224,,,,5249,,,,BAO_0000019,,Partition coefficient of compound was determined,CHEMBL631237,,12994,A,1,Autocuration,,,,0
U,,22229,,,,14621,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL631238,,12995,P,1,Autocuration,,,,0
U,,22229,,,,12542,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL876429,,12996,P,1,Autocuration,,,,0
U,,22224,,,,12542,,,,BAO_0000019,,Partition coefficient was measured by medchem software; Not calculated,CHEMBL631414,,12997,A,1,Autocuration,,,,0
U,,22224,,,,12542,,,,BAO_0000100,,Partition coefficient was measured by octanol-water using standard shake-flask method,CHEMBL631415,,12998,P,1,Autocuration,,,,0
U,,22229,,,,15462,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL631416,,12999,P,1,Autocuration,,,,0
U,,22224,,,,14884,,,,BAO_0000019,,Partition coefficient (logP),CHEMBL631417,,13000,A,1,Autocuration,,,,0
U,,22229,,,,16526,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL631418,,13001,P,1,Autocuration,,,,0
U,,22229,,,,13693,,,,BAO_0000100,,The Octanol/Water partition coefficient CLogP,CHEMBL631419,,13002,P,1,Autocuration,,,,0
U,,22224,,,,13693,,,,BAO_0000019,,The pharmacokinetic parameter C Log p was reported,CHEMBL631420,,13003,A,1,Autocuration,,,,0
U,,22229,,,,13779,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL631421,,13004,P,1,Autocuration,,,,0
U,,22229,,,,14772,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL631422,,13005,P,1,Autocuration,,,,0
U,,22229,,,,14393,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL631423,,13006,P,1,Autocuration,,,,0
N,,50597,,,In vivo,14793,Plasma,Rattus norvegicus,,BAO_0000218,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,CHEMBL876430,10116.0,13007,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14793,Plasma,Rattus norvegicus,,BAO_0000218,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,CHEMBL631424,10116.0,13008,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,13744,Plasma,Canis lupus familiaris,,BAO_0000218,,Compound was administered intravenously in dog to evaluate plasma clearance values,CHEMBL631425,9615.0,13009,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,13744,Plasma,Simiiformes,,BAO_0000218,,Compound was administered intravenously in monkey to evaluate plasma clearance values,CHEMBL631426,314293.0,13010,A,1,Autocuration,,,1969.0,0
N,,50594,,,In vivo,13744,Plasma,Mus musculus,,BAO_0000218,,Compound was administered intravenously in mouse to evaluate plasma clearance values,CHEMBL631427,10090.0,13011,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,13207,Plasma,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,CHEMBL631428,9615.0,13012,A,1,Intermediate,,,1969.0,1
N,Microsomes,50797,,,In vitro,5669,Liver,Macaca mulatta,,BAO_0000218,,Intrinsic clearance in Rhesus liver microsome,CHEMBL631429,9544.0,13013,A,1,Intermediate,,,2107.0,1
N,Microsomes,50588,,,In vitro,5669,Liver,Canis lupus familiaris,,BAO_0000218,,Intrinsic clearance in dog liver microsome,CHEMBL631430,9615.0,13014,A,1,Intermediate,,,2107.0,1
N,Microsomes,50597,,,In vitro,5669,Liver,Rattus norvegicus,,BAO_0000218,,Intrinsic clearance in rat liver microsome,CHEMBL631431,10116.0,13015,A,1,Intermediate,,,2107.0,1
N,,50797,,,In vivo,4853,Plasma,Macaca mulatta,,BAO_0000218,,Low plasma clearance was calculated in rhesus monkey,CHEMBL631432,9544.0,13016,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,16452,,Canis lupus familiaris,,BAO_0000218,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,CHEMBL631433,9615.0,13017,A,1,Intermediate,,,,1
U,,22224,,,In vivo,11954,,,,BAO_0000218,,Plasma clearance after intravenous dose of 0.3 mg/kg,CHEMBL631434,,13018,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11954,,,,BAO_0000218,,Plasma clearance after intravenous dose of 1 mg/kg,CHEMBL631435,,13019,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11954,,,,BAO_0000218,,Plasma clearance after intravenous dose of 3 mg/kg,CHEMBL631436,,13020,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11954,,,,BAO_0000218,,Plasma clearance after intravenous dose of 3.87 mg/kg,CHEMBL631437,,13021,A,1,Autocuration,,,,0
N,,50597,,,In vivo,5669,,Rattus norvegicus,,BAO_0000218,,Plasma clearance after peroral administration at 10 mpk in Rat,CHEMBL631438,10116.0,13022,A,1,Intermediate,,,,1
N,,50797,,,In vivo,5669,,Macaca mulatta,,BAO_0000218,,Plasma clearance after peroral administration at 10 mpk in Rhesus,CHEMBL876431,9544.0,13023,A,1,Intermediate,,,,1
N,,50588,,,In vivo,5669,,Canis lupus familiaris,,BAO_0000218,,Plasma clearance after peroral administration at 10 mpk in dog,CHEMBL631439,9615.0,13024,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13662,,Rattus norvegicus,,BAO_0000218,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,CHEMBL631440,10116.0,13025,A,1,Intermediate,,,,1
U,,22224,,,,8272,,,,BAO_0000019,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),CHEMBL631441,,13026,A,1,Autocuration,,,,0
U,,22224,,,,13410,,,,BAO_0000019,,Critical Micellar concentration was determined,CHEMBL631442,,13027,A,1,Autocuration,,,,0
U,,22224,,,,13410,,,,BAO_0000019,,Critical Micellar concentration of the compound. was determined,CHEMBL626525,,13028,A,1,Autocuration,,,,0
U,,22224,,,,12628,,,,BAO_0000019,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,CHEMBL627168,,13029,A,1,Autocuration,,,,0
U,,22224,,,,9675,,,,BAO_0000019,,Critical micellar concentration was measured in water by the dye solubilization method,CHEMBL875618,,13030,A,1,Autocuration,,,,0
U,,22224,,,,12628,,,,BAO_0000019,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,CHEMBL626612,,13031,B,1,Autocuration,,,,0
U,,22224,,,,12766,,,,BAO_0000019,,CMR value (relative to BAY K 8644),CHEMBL626613,,13032,A,1,Autocuration,,,,0
U,,22224,,,,7849,,,,BAO_0000019,,Carbamoylating activity was determined,CHEMBL626614,,13033,A,1,Autocuration,,,,0
U,,22224,,,,12187,,Simiiformes,,BAO_0000218,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,CHEMBL626615,314293.0,13034,A,1,Autocuration,,,,0
U,,22224,,,,2040,,,,BAO_0000019,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,CHEMBL626616,,13035,A,1,Autocuration,,,,0
U,,22224,,,,2040,,,,BAO_0000019,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,CHEMBL626617,,13036,A,1,Autocuration,,,,0
N,,50588,,,In vivo,14180,Plasma,Canis lupus familiaris,,BAO_0000218,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,CHEMBL626618,9615.0,13037,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14180,Plasma,Rattus norvegicus,,BAO_0000218,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,CHEMBL626619,10116.0,13038,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,14474,,Canis lupus familiaris,,BAO_0000218,,"Clearance rate at 0.46 mg/kg, iv, in dogs",CHEMBL626620,9615.0,13039,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14474,,Rattus norvegicus,,BAO_0000218,,"Clearance rate at 5.5 mg/kg, iv, in rat",CHEMBL626621,10116.0,13040,A,1,Intermediate,,,,1
N,,100710,,,In vivo,14548,,Macaca fascicularis,,BAO_0000218,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,CHEMBL626622,9541.0,13041,A,1,Intermediate,,,,1
N,,100710,,,In vivo,14548,,Macaca fascicularis,,BAO_0000218,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,CHEMBL626623,9541.0,13042,A,1,Intermediate,,,,1
N,,50588,,,In vivo,14548,,Canis lupus familiaris,,BAO_0000218,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,CHEMBL626624,9615.0,13043,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14548,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,CHEMBL626625,10116.0,13044,A,1,Intermediate,,,,1
N,,50597,,,Ex vivo,6125,Liver,Rattus norvegicus,,BAO_0000218,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,CHEMBL626626,10116.0,13045,A,1,Intermediate,,,2107.0,1
U,,22224,,,In vivo,6874,,,,BAO_0000218,,Tested for the total clearance of the compound,CHEMBL626627,,13046,A,1,Autocuration,,,,0
N,,50588,,,In vivo,15343,,Canis lupus familiaris,,BAO_0000218,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,CHEMBL626628,9615.0,13047,A,1,Intermediate,,,,1
U,,22224,,,In vivo,6236,,,,BAO_0000218,,Total body clearance was determined,CHEMBL626629,,13048,A,1,Autocuration,,,,0
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,CHEMBL626630,10116.0,13049,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,CHEMBL626631,10116.0,13050,A,1,Intermediate,,,,1
U,,22229,,,,8194,,,,BAO_0000100,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,CHEMBL626632,,13051,P,1,Autocuration,,,,0
U,,22229,,,,8194,,,,BAO_0000100,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,CHEMBL626633,,13052,P,1,Autocuration,,,,0
U,,22229,,,,8194,,,,BAO_0000100,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,CHEMBL626634,,13053,P,1,Autocuration,,,,0
U,,22229,,,,8194,,,,BAO_0000100,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,CHEMBL626635,,13054,P,1,Autocuration,,,,0
U,,22229,,,,8194,,,,BAO_0000100,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,CHEMBL626636,,13055,P,1,Autocuration,,,,0
U,,22229,,,,8194,,,,BAO_0000100,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,CHEMBL626637,,13056,P,1,Autocuration,,,,0
N,,50339,,,,13273,,Pneumocystis carinii,,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),CHEMBL626638,4754.0,13057,A,1,Intermediate,,,,1
N,,50339,,,,13273,,Pneumocystis carinii,,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,CHEMBL626639,4754.0,13058,A,1,Intermediate,,,,1
N,,50339,,,,13273,,Pneumocystis carinii,,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,CHEMBL626640,4754.0,13059,A,1,Intermediate,,,,1
N,,50339,,,,13273,,Pneumocystis carinii,,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,CHEMBL626641,4754.0,13060,A,1,Intermediate,,,,1
N,,50339,,,,13273,,Pneumocystis carinii,,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,CHEMBL627272,4754.0,13061,A,1,Intermediate,,,,1
N,,50339,,,,13273,,Pneumocystis carinii,,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,CHEMBL627273,4754.0,13062,A,1,Intermediate,,,,1
N,,50339,,,,13273,,Pneumocystis carinii,,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),CHEMBL627441,4754.0,13063,A,1,Intermediate,,,,1
N,,50339,,,,13273,,Pneumocystis carinii,,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),CHEMBL628355,4754.0,13064,A,1,Intermediate,,,,1
N,,50339,,,,13273,,Pneumocystis carinii,,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),CHEMBL628356,4754.0,13065,A,1,Intermediate,,,,1
N,,50339,,,,13273,,Pneumocystis carinii,,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),CHEMBL628357,4754.0,13066,A,1,Intermediate,,,,1
N,,50339,,,,13273,,Pneumocystis carinii,,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),CHEMBL628358,4754.0,13067,A,1,Intermediate,,,,1
N,,50339,,,,13273,,Pneumocystis carinii,,BAO_0000218,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),CHEMBL622307,4754.0,13068,A,1,Intermediate,,,,1
U,,22224,,,,13118,,,,BAO_0000019,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,CHEMBL622527,,13069,A,1,Autocuration,,,,0
U,,22224,,,,13118,,,,BAO_0000019,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,CHEMBL622528,,13070,A,1,Autocuration,,,,0
U,,22224,,,,13118,,,,BAO_0000019,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,CHEMBL622529,,13071,A,1,Autocuration,,,,0
U,,22224,,,,13118,,,,BAO_0000019,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,CHEMBL622992,,13072,A,1,Autocuration,,,,0
U,,22224,,,,13118,,,,BAO_0000019,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,CHEMBL622993,,13073,A,1,Autocuration,,,,0
U,,22224,,,,13118,,,,BAO_0000019,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,CHEMBL622994,,13074,A,1,Autocuration,,,,0
N,,50597,,,,10633,,Rattus norvegicus,,BAO_0000218,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",CHEMBL622995,10116.0,13075,A,1,Intermediate,,,,1
N,,50597,,,,10633,,Rattus norvegicus,,BAO_0000218,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",CHEMBL622996,10116.0,13076,A,1,Intermediate,,,,1
N,,50597,,,,10633,,Rattus norvegicus,,BAO_0000218,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",CHEMBL622997,10116.0,13077,A,1,Intermediate,,,,1
N,,50597,,,,10633,,Rattus norvegicus,,BAO_0000218,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",CHEMBL622998,10116.0,13078,A,1,Intermediate,,,,1
U,,22224,,,,5767,,,,BAO_0000218,,Cp max following ip administration at 1 mg/kg,CHEMBL622999,,13079,A,1,Autocuration,,,,0
U,,22224,,,In vivo,3302,Plasma,,,BAO_0000218,,Maximum concentration in plasma was reported at 0.5 hour,CHEMBL623000,,13080,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,3302,Plasma,,,BAO_0000218,,Maximum concentration in plasma was reported at 2 hour,CHEMBL623001,,13081,A,1,Autocuration,,,1969.0,0
N,,50594,,,,12467,,Mus musculus,,BAO_0000218,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,CHEMBL623002,10090.0,13082,A,1,Intermediate,,,,1
U,,22229,,,,11778,,,,BAO_0000100,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),CHEMBL623003,,13083,P,1,Autocuration,,,,0
U,,22224,,,,4321,,,,BAO_0000019,,Steady state concentration was evaluated,CHEMBL623004,,13084,A,1,Autocuration,,,,0
U,,22224,,,,14884,,,,BAO_0000019,,Partition coefficient (logP),CHEMBL623005,,13085,A,1,Autocuration,,,,0
U,,22224,,,,15234,,,,BAO_0000019,,Partition coefficient (logD7.4),CHEMBL623006,,13086,A,1,Autocuration,,,,0
N,,50597,,,In vivo,14198,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,CHEMBL623007,10116.0,13087,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,14198,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,CHEMBL623008,10116.0,13088,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,14198,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,CHEMBL876654,10116.0,13089,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,14198,,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,CHEMBL623009,10116.0,13090,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14198,,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,CHEMBL623010,10116.0,13091,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14198,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,CHEMBL623011,10116.0,13092,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,14198,Intestine,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,CHEMBL623012,10116.0,13093,A,1,Intermediate,,,160.0,1
U,,22224,,,,8151,,,,BAO_0000019,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,CHEMBL623013,,13094,A,1,Autocuration,,,,0
U,,22224,,,,8151,,,,BAO_0000019,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,CHEMBL623014,,13095,A,1,Autocuration,,,,0
U,,22224,,,,8151,Urine,,,BAO_0000019,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,CHEMBL623015,,13096,A,1,Autocuration,,,1088.0,0
U,,22224,,,,8151,Urine,,,BAO_0000019,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,CHEMBL623016,,13097,A,1,Autocuration,,,1088.0,0
U,,22224,,,,8151,Urine,,,BAO_0000019,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,CHEMBL624858,,13098,A,1,Autocuration,,,1088.0,0
N,,50597,,,,8151,,Rattus norvegicus,,BAO_0000218,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,CHEMBL624859,10116.0,13099,A,1,Intermediate,,,,1
N,,50597,,,,8151,,Rattus norvegicus,,BAO_0000218,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,CHEMBL624860,10116.0,13100,A,1,Intermediate,,,,1
N,,50597,,,,8151,,Rattus norvegicus,,BAO_0000218,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,CHEMBL624861,10116.0,13101,A,1,Intermediate,,,,1
N,,50597,,,,8151,,Rattus norvegicus,,BAO_0000218,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,CHEMBL624862,10116.0,13102,A,1,Intermediate,,,,1
N,,50597,,,,8151,,Rattus norvegicus,,BAO_0000218,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,CHEMBL624863,10116.0,13103,A,1,Intermediate,,,,1
N,,50597,,,,8151,,Rattus norvegicus,,BAO_0000218,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,CHEMBL876655,10116.0,13104,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,CHEMBL624864,9615.0,13105,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,CHEMBL624865,9615.0,13106,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,CHEMBL624866,9615.0,13107,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,CHEMBL624867,9615.0,13108,F,1,Expert,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,CHEMBL624868,9615.0,13109,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,CHEMBL628450,9615.0,13110,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,CHEMBL628451,9615.0,13111,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,CHEMBL628452,9615.0,13112,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,CHEMBL628453,9615.0,13113,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,CHEMBL628454,9615.0,13114,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,CHEMBL628455,9615.0,13115,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,CHEMBL628456,9615.0,13116,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,CHEMBL628457,9615.0,13117,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,CHEMBL877505,9615.0,13118,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,CHEMBL628458,9615.0,13119,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,CHEMBL628459,9615.0,13120,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,CHEMBL628460,9615.0,13121,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,CHEMBL628461,9615.0,13122,A,1,Intermediate,,,,1
U,,22224,,,,6996,,,,BAO_0000218,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",CHEMBL628462,,13123,B,1,Autocuration,,,,0
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,CHEMBL628463,9615.0,13124,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",CHEMBL625666,10116.0,13125,F,1,Expert,,,,1
U,,22224,,,,6996,,,,BAO_0000218,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,CHEMBL625667,,13126,B,1,Autocuration,,,,0
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,CHEMBL625668,10116.0,13127,A,1,Expert,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,CHEMBL625669,10116.0,13128,A,1,Intermediate,,,,1
U,,22224,,,,7114,,,,BAO_0000019,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,CHEMBL625670,,13129,A,1,Autocuration,,,,0
N,,50597,,,,7114,,Rattus norvegicus,,BAO_0000218,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,CHEMBL625671,10116.0,13130,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,CHEMBL625672,10298.0,13131,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,CHEMBL625673,10298.0,13132,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,CHEMBL625674,10298.0,13133,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,CHEMBL625675,10298.0,13134,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,CHEMBL627637,10298.0,13135,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,CHEMBL627638,10298.0,13136,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,CHEMBL627639,10298.0,13137,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,CHEMBL627640,10298.0,13138,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,CHEMBL627641,10298.0,13139,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,CHEMBL627642,10298.0,13140,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,CHEMBL877506,10298.0,13141,A,1,Intermediate,,,,1
N,,50594,,,,8613,,Mus musculus,,BAO_0000218,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,CHEMBL627275,10090.0,13142,A,1,Intermediate,,,,1
N,,50506,,,,11219,,Mustela putorius furo,,BAO_0000218,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",CHEMBL627643,9669.0,13143,A,1,Intermediate,,,,1
N,,50506,,,,11219,,Mustela putorius furo,,BAO_0000218,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",CHEMBL631246,9669.0,13144,A,1,Intermediate,,,,1
N,,50506,,,,11219,,Mustela putorius furo,,BAO_0000218,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",CHEMBL631247,9669.0,13145,A,1,Intermediate,,,,1
N,,50506,,,,11219,,Mustela putorius furo,,BAO_0000218,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,CHEMBL629532,9669.0,13146,A,1,Intermediate,,,,1
N,,50506,,,,11219,,Mustela putorius furo,,BAO_0000218,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,CHEMBL629533,9669.0,13147,A,1,Intermediate,,,,1
N,,50506,,,,11219,,Mustela putorius furo,,BAO_0000218,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,CHEMBL629534,9669.0,13148,A,1,Intermediate,,,,1
N,,50506,,,,11219,,Mustela putorius furo,,BAO_0000218,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,CHEMBL629535,9669.0,13149,A,1,Intermediate,,,,1
U,,22224,,,,14837,,,,BAO_0000019,,Pharmacokinetic parameter :drug bound to plasma was reported,CHEMBL625932,,13150,A,1,Autocuration,,,,0
U,,22224,,,,14837,,,,BAO_0000019,,compound was evaluated for drug bound in plasma,CHEMBL625933,,13151,A,1,Autocuration,,,,0
N,,50597,,,,15343,,Rattus norvegicus,,BAO_0000218,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,CHEMBL625934,10116.0,13152,A,1,Intermediate,,,,1
U,,22224,,,,13761,,Eutheria,,BAO_0000218,,Bioavailability,CHEMBL625935,9347.0,13153,A,1,Autocuration,,,,0
N,,50597,,,,14810,,Rattus norvegicus,,BAO_0000218,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,CHEMBL625936,10116.0,13154,A,1,Intermediate,,,,1
N,,50597,,,,14810,,Rattus norvegicus,,BAO_0000218,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,CHEMBL625937,10116.0,13155,A,1,Intermediate,,,,1
N,,50588,,,,13249,,Canis lupus familiaris,,BAO_0000218,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,CHEMBL625938,9615.0,13156,A,1,Intermediate,,,,1
N,,50597,,,,9267,Bile,Rattus norvegicus,,BAO_0000218,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,CHEMBL625939,10116.0,13157,A,1,Intermediate,,,1970.0,1
N,,50597,,,,9267,Bile,Rattus norvegicus,,BAO_0000218,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,CHEMBL625940,10116.0,13158,A,1,Intermediate,,,1970.0,1
N,,50597,,,,9267,Bile,Rattus norvegicus,,BAO_0000218,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,CHEMBL874464,10116.0,13159,A,1,Intermediate,,,1970.0,1
N,,50597,,,,9267,Bile,Rattus norvegicus,,BAO_0000218,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,CHEMBL625941,10116.0,13160,A,1,Intermediate,,,1970.0,1
N,,50597,,,,9267,Bile,Rattus norvegicus,,BAO_0000218,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,CHEMBL625942,10116.0,13161,A,1,Intermediate,,,1970.0,1
N,,50597,,,,9267,Bile,Rattus norvegicus,,BAO_0000218,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,CHEMBL625943,10116.0,13162,A,1,Intermediate,,,1970.0,1
N,,50587,,,,15549,Serum,Homo sapiens,,BAO_0000218,,In vitro protein binding in human serum at 5 ug/ml,CHEMBL625944,9606.0,13163,A,1,Intermediate,,,1977.0,1
U,,22224,,,,10929,,,,BAO_0000019,,Serum protein binding ability was measured,CHEMBL625945,,13164,A,1,Autocuration,,,,0
U,,22224,,,,15444,,,,BAO_0000019,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),CHEMBL625946,,13165,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12860,,Canis lupus familiaris,,BAO_0000218,,Oral bioavailability in dog,CHEMBL625947,9615.0,13166,A,1,Autocuration,,,,0
N,,50597,,,In vivo,12170,,Rattus norvegicus,,BAO_0000218,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,CHEMBL625948,10116.0,13167,A,1,Intermediate,,,,1
U,,22224,,,In vivo,15173,,,,BAO_0000218,,Absolute oral bioavailability at an iv dose of 14 mg/kg,CHEMBL625949,,13168,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15173,,,,BAO_0000218,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,CHEMBL625950,,13169,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15173,,Eutheria,,BAO_0000218,,Oral bioavailability (dose 15 mg/kg i.v.),CHEMBL625951,9347.0,13170,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15173,,,,BAO_0000218,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,CHEMBL625952,,13171,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15173,,,,BAO_0000218,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,CHEMBL625953,,13172,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15173,,,,BAO_0000218,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,CHEMBL625954,,13173,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15173,,,,BAO_0000218,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,CHEMBL882959,,13174,A,1,Autocuration,,,,0
N,,50588,,,In vivo,11767,,Canis lupus familiaris,,BAO_0000218,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,CHEMBL625955,9615.0,13175,A,1,Intermediate,,,,1
U,,22224,,,In vivo,11219,,Mustela putorius furo,,BAO_0000218,,Bioavailability in ferret,CHEMBL625956,9669.0,13176,A,1,Autocuration,,,,0
N,,100710,,,In vivo,12186,,Macaca fascicularis,,BAO_0000218,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,CHEMBL625957,9541.0,13177,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,CHEMBL625958,10116.0,13178,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,CHEMBL625959,10116.0,13179,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,CHEMBL626642,10116.0,13180,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,CHEMBL631330,10116.0,13181,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,CHEMBL631331,10116.0,13182,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,CHEMBL631332,10116.0,13183,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,CHEMBL631333,10116.0,13184,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,CHEMBL632018,10116.0,13185,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,CHEMBL632019,10116.0,13186,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,CHEMBL632020,10116.0,13187,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,CHEMBL632021,10116.0,13188,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,CHEMBL632022,10116.0,13189,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,CHEMBL632023,10116.0,13190,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,CHEMBL632024,10116.0,13191,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,CHEMBL874472,10116.0,13192,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,CHEMBL632025,10116.0,13193,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,CHEMBL632026,10116.0,13194,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,CHEMBL632027,10116.0,13195,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,CHEMBL632028,10116.0,13196,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,CHEMBL626430,10116.0,13197,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,CHEMBL626431,10116.0,13198,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,CHEMBL626432,10116.0,13199,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,CHEMBL626433,10116.0,13200,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,CHEMBL626434,10116.0,13201,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,CHEMBL627280,10116.0,13202,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,CHEMBL627281,10116.0,13203,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,CHEMBL627282,10116.0,13204,A,1,Intermediate,,,,1
U,,22224,,,,7199,,,,BAO_0000019,,Total body clearance was measured at given dose,CHEMBL627283,,13205,A,1,Autocuration,,,,0
U,,22224,,,,7199,,,,BAO_0000218,,Total body clearance was measured at given dose.,CHEMBL627284,,13206,A,1,Autocuration,,,,0
N,,50597,,,,7095,,Rattus norvegicus,,BAO_0000218,,Metabolic clearance from the body in rat,CHEMBL627285,10116.0,13207,A,1,Intermediate,,,,1
U,,22224,,,In vivo,7095,,,,BAO_0000218,,Renal clearance from the body,CHEMBL627286,,13208,A,1,Autocuration,,,,0
N,,50597,,,In vivo,7095,,Rattus norvegicus,,BAO_0000218,,Renal clearance from the body in rat,CHEMBL875477,10116.0,13209,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12528,,Rattus norvegicus,,BAO_0000218,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,CHEMBL627287,10116.0,13210,A,1,Intermediate,,,,1
N,,50588,,,In vivo,12528,,Canis lupus familiaris,,BAO_0000218,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,CHEMBL627288,9615.0,13211,A,1,Intermediate,,,,1
N,,50597,,,,7095,,Rattus norvegicus,,BAO_0000218,,Total clearance from the body in rat,CHEMBL627289,10116.0,13212,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14223,Plasma,Rattus norvegicus,,BAO_0000218,,Clearance into cortex from rat plasma or PBS,CHEMBL627290,10116.0,13213,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,13569,,,,BAO_0000218,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,CHEMBL627291,,13214,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13569,,,,BAO_0000218,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,CHEMBL627292,,13215,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13569,,,,BAO_0000218,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,CHEMBL627293,,13216,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13569,,,,BAO_0000218,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,CHEMBL627294,,13217,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13569,,,,BAO_0000218,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,CHEMBL875478,,13218,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13979,,,,BAO_0000218,,Clearance was determined,CHEMBL627295,,13219,A,1,Autocuration,,,,0
N,,50594,,,In vivo,14315,,Mus musculus,,BAO_0000218,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,CHEMBL627296,10090.0,13220,A,1,Intermediate,,,,1
N,,50592,,,In vivo,14315,,Oryctolagus cuniculus,,BAO_0000218,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,CHEMBL626119,9986.0,13221,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14315,,Rattus norvegicus,,BAO_0000218,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,CHEMBL626120,10116.0,13222,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12174,,Rattus norvegicus,,BAO_0000218,,Clearance in rat after iv dose (100 ug/kg),CHEMBL626121,10116.0,13223,A,1,Intermediate,,,,1
U,,22224,,,In vivo,12797,,Cavia porcellus,,BAO_0000218,,Clearance in guinea pig,CHEMBL626122,10141.0,13224,A,1,Autocuration,,,,0
N,,50597,,,In vivo,12797,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for clearance in rat,CHEMBL626123,10116.0,13225,A,1,Intermediate,,,,1
N,,50588,,,In vivo,12797,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for the clearance in dog,CHEMBL623456,9615.0,13226,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12797,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for the clearance in rat,CHEMBL623457,10116.0,13227,A,1,Intermediate,,,,1
N,,50597,,,In vivo,11500,,Rattus norvegicus,,BAO_0000218,,Compound was tested in vivo for clearance after iv administration in the rat,CHEMBL623458,10116.0,13228,A,1,Intermediate,,,,1
U,,22224,,,In vivo,15173,,,,BAO_0000218,,IV clearance determined at an iv dose of 14 mg/kg,CHEMBL623459,,13229,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15173,,,,BAO_0000218,,IV clearance determined at an iv dose of 15.2 mg/kg,CHEMBL875484,,13230,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15173,,,,BAO_0000218,,IV clearance determined at an iv dose of 15 mg/kg,CHEMBL623460,,13231,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15173,,,,BAO_0000218,,IV clearance determined at an peroral dose of 30 mg/kg.,CHEMBL623461,,13232,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15173,,,,BAO_0000218,,IV clearance determined at an peroral dose of 30.2 mg/kg.,CHEMBL623462,,13233,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15173,,,,BAO_0000218,,IV clearance determined at an peroral dose of 30.3 mg/kg.,CHEMBL627386,,13234,A,1,Autocuration,,,,0
N,,50597,,,In vivo,14198,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,CHEMBL627387,10116.0,13235,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,14198,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,CHEMBL627388,10116.0,13236,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,14198,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,CHEMBL627389,10116.0,13237,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,14198,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,CHEMBL627390,10116.0,13238,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,14198,Plasma,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,CHEMBL627391,10116.0,13239,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14198,,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,CHEMBL627392,10116.0,13240,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14198,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,CHEMBL627393,10116.0,13241,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,14198,Trachea,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,CHEMBL627394,10116.0,13242,A,1,Intermediate,,,3126.0,1
N,,50597,,,In vivo,14198,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,CHEMBL627395,10116.0,13243,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,14198,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,CHEMBL875485,10116.0,13244,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,14198,,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,CHEMBL627396,10116.0,13245,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14198,,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,CHEMBL627397,10116.0,13246,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14198,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,CHEMBL627398,10116.0,13247,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,14198,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,CHEMBL627399,10116.0,13248,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,14198,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,CHEMBL627400,10116.0,13249,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,14198,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,CHEMBL627401,10116.0,13250,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,14198,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,CHEMBL627402,10116.0,13251,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,14198,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,CHEMBL627403,10116.0,13252,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,14198,Plasma,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,CHEMBL627404,10116.0,13253,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14198,,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,CHEMBL623101,10116.0,13254,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14198,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,CHEMBL877480,10116.0,13255,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,14198,Trachea,Rattus norvegicus,,BAO_0000218,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,CHEMBL623102,10116.0,13256,A,1,Intermediate,,,3126.0,1
N,,50597,,,In vivo,14198,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,CHEMBL623103,10116.0,13257,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,14198,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,CHEMBL623104,10116.0,13258,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,14198,,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,CHEMBL623105,10116.0,13259,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14198,,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,CHEMBL623106,10116.0,13260,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14198,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,CHEMBL623107,10116.0,13261,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,14198,Intestine,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,CHEMBL623108,10116.0,13262,A,1,Intermediate,,,160.0,1
N,,50597,,,In vivo,14198,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,CHEMBL623109,10116.0,13263,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,14198,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,CHEMBL623110,10116.0,13264,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,14198,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,CHEMBL623111,10116.0,13265,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,14198,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,CHEMBL625060,10116.0,13266,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,14198,Plasma,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,CHEMBL625061,10116.0,13267,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14198,,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,CHEMBL625062,10116.0,13268,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14198,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,CHEMBL625063,10116.0,13269,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,14198,Trachea,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,CHEMBL625064,10116.0,13270,A,1,Intermediate,,,3126.0,1
N,,50597,,,In vivo,14198,Bone,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,CHEMBL625065,10116.0,13271,A,1,Intermediate,,,10000001.0,1
N,,50597,,,In vivo,14198,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,CHEMBL625066,10116.0,13272,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,14198,,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,CHEMBL625067,10116.0,13273,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14198,,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,CHEMBL625068,10116.0,13274,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14198,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,CHEMBL622159,10116.0,13275,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,14198,Intestine,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,CHEMBL622160,10116.0,13276,A,1,Intermediate,,,160.0,1
N,,50597,,,In vivo,14198,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,CHEMBL622161,10116.0,13277,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,14198,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,CHEMBL622162,10116.0,13278,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,14198,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,CHEMBL622163,10116.0,13279,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,14198,Plasma,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,CHEMBL622313,10116.0,13280,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14198,,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,CHEMBL622314,10116.0,13281,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14198,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,CHEMBL622315,10116.0,13282,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,14198,Trachea,Rattus norvegicus,,BAO_0000218,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,CHEMBL622316,10116.0,13283,A,1,Intermediate,,,3126.0,1
N,,50212,,,,15599,,Escherichia coli,,BAO_0000218,,Normal diffusion coefficient in water for Escherichia coli,CHEMBL877486,562.0,13284,A,1,Intermediate,,,,1
U,,22224,,,,8204,,,,BAO_0000019,,Average max percent decrease in RVR (renal vascular resistance) was determined,CHEMBL622317,,13285,A,1,Autocuration,,,,0
U,,22224,,,,8204,,,,BAO_0000019,,Average max percent decrease in RVR (renal vascular resistance) was determined.,CHEMBL622318,,13286,A,1,Autocuration,,,,0
U,,22224,,,,6154,,,,BAO_0000019,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,CHEMBL622319,,13287,A,1,Autocuration,,,,0
U,,22224,,,,6154,,,,BAO_0000019,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,CHEMBL622320,,13288,A,1,Autocuration,,,,0
U,,22224,,,,6154,,,,BAO_0000019,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,CHEMBL622321,,13289,A,1,Autocuration,,,,0
U,,22224,,,,6154,,,,BAO_0000019,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,CHEMBL622322,,13290,A,1,Autocuration,,,,0
U,,22224,,,,7114,,,,BAO_0000019,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,CHEMBL622323,,13291,A,1,Autocuration,,,,0
N,,50597,,,,7114,,Rattus norvegicus,,BAO_0000218,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,CHEMBL622324,10116.0,13292,A,1,Intermediate,,,,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",CHEMBL622325,9615.0,13293,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",CHEMBL622326,9615.0,13294,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",CHEMBL877487,9615.0,13295,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",CHEMBL622327,9615.0,13296,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",CHEMBL622328,9615.0,13297,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",CHEMBL622329,9615.0,13298,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",CHEMBL622330,9615.0,13299,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",CHEMBL622331,9615.0,13300,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",CHEMBL622332,9615.0,13301,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",CHEMBL622333,9615.0,13302,A,1,Intermediate,,,1088.0,1
U,,22224,,,,8133,Urine,Simiiformes,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",CHEMBL627658,314293.0,13303,A,1,Autocuration,,,1088.0,0
U,,22224,,,,8133,Urine,Simiiformes,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",CHEMBL630428,314293.0,13304,A,1,Autocuration,,,1088.0,0
U,,22224,,,,8133,Urine,Simiiformes,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",CHEMBL630429,314293.0,13305,A,1,Autocuration,,,1088.0,0
U,,22224,,,,8133,Urine,Simiiformes,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",CHEMBL630430,314293.0,13306,A,1,Autocuration,,,1088.0,0
U,,22224,,,,8133,Urine,Simiiformes,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",CHEMBL630431,314293.0,13307,A,1,Autocuration,,,1088.0,0
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",CHEMBL630432,10116.0,13308,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",CHEMBL630433,10116.0,13309,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",CHEMBL630434,10116.0,13310,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",CHEMBL629372,10116.0,13311,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",CHEMBL629553,10116.0,13312,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",CHEMBL629554,10116.0,13313,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",CHEMBL874447,10116.0,13314,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",CHEMBL629555,10116.0,13315,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",CHEMBL629556,10116.0,13316,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",CHEMBL629557,10116.0,13317,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",CHEMBL629558,10116.0,13318,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",CHEMBL629559,10116.0,13319,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",CHEMBL629560,10116.0,13320,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",CHEMBL629561,9615.0,13321,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",CHEMBL629562,9615.0,13322,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",CHEMBL629563,9615.0,13323,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",CHEMBL629564,9615.0,13324,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",CHEMBL629565,9615.0,13325,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",CHEMBL629566,9615.0,13326,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",CHEMBL629567,9615.0,13327,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",CHEMBL629568,9615.0,13328,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",CHEMBL629569,9615.0,13329,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",CHEMBL629570,9615.0,13330,A,1,Intermediate,,,1088.0,1
U,,22224,,,,8133,Urine,Simiiformes,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",CHEMBL629571,314293.0,13331,A,1,Autocuration,,,1088.0,0
U,,22224,,,In vivo,12170,,Rattus norvegicus,,BAO_0000218,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,CHEMBL629572,10116.0,13332,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12170,,Rattus norvegicus,,BAO_0000218,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,CHEMBL629573,10116.0,13333,A,1,Autocuration,,,,0
U,,22224,,,In vivo,4985,,Eutheria,,BAO_0000218,,Bioavailability (dose 20 mg/kg),CHEMBL629574,9347.0,13334,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15145,,Canis lupus familiaris,,BAO_0000218,,Bioavailability in dog,CHEMBL629575,9615.0,13335,A,1,Autocuration,,,,0
U,,22224,,,In vivo,14080,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (Sprague-Dawley) (male),CHEMBL874448,10116.0,13336,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11219,,Primates,,BAO_0000218,,Bioavailability in monkey (dose 10 mg/kg i.d.),CHEMBL629576,9443.0,13337,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15145,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL629577,10116.0,13338,A,1,Autocuration,,,,0
U,,22224,,,In vivo,15145,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL629578,10116.0,13339,A,1,Autocuration,,,,0
U,,22224,,,In vivo,1202,,Canis lupus familiaris,,BAO_0000218,,Bioavailability in dog (dose 3.0 mg/kg p.o.),CHEMBL629579,9615.0,13340,A,1,Autocuration,,,,0
U,,22224,,,In vivo,1202,,Canis lupus familiaris,,BAO_0000218,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,CHEMBL882958,9615.0,13341,A,1,Autocuration,,,,0
N,,50505,,,In vivo,1202,,Pan troglodytes,,BAO_0000218,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,CHEMBL629580,9598.0,13342,A,1,Intermediate,,,,1
U,,22224,,,In vivo,4026,,Eutheria,,BAO_0000218,,Bioavailability,CHEMBL629581,9347.0,13343,A,1,Autocuration,,,,0
U,,22224,,,In vivo,1492,,Saimiri,,BAO_0000218,,Bioavailability in squirrel monkey,CHEMBL629582,9520.0,13344,A,1,Autocuration,,,,0
N,,50588,,,In vivo,12793,,Canis lupus familiaris,,BAO_0000218,,Bioavailability was evaluated in dog,CHEMBL628522,9615.0,13345,A,1,Intermediate,,,,1
N,,100712,,,In vivo,12793,,Cricetinae,,BAO_0000218,,Bioavailability was evaluated in hamster,CHEMBL625432,10026.0,13346,A,1,Intermediate,,,,1
U,,22224,,,In vivo,12793,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat,CHEMBL625433,10116.0,13347,A,1,Autocuration,,,,0
N,,50597,,,In vivo,14793,Plasma,Rattus norvegicus,,BAO_0000218,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,CHEMBL625434,10116.0,13348,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14793,Plasma,Rattus norvegicus,,BAO_0000218,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,CHEMBL625435,10116.0,13349,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,14793,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 10 mg/kg p.o.),CHEMBL625436,10116.0,13350,A,1,Autocuration,,,,0
N,,100710,,,In vivo,14731,,Macaca fascicularis,,BAO_0000218,,Bioavailability was measured in cynomolgus monkeys.,CHEMBL874588,9541.0,13351,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14731,,Mus musculus,,BAO_0000218,,Bioavailability was measured in nude mice.,CHEMBL625437,10090.0,13352,A,1,Intermediate,,,,1
U,,22224,,,In vivo,12187,,Mustela putorius furo,,BAO_0000218,,Bioavailability in ferret (dose 10 mg/kg i.d.),CHEMBL625438,9669.0,13353,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12187,,Simiiformes,,BAO_0000218,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),CHEMBL625439,314293.0,13354,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12187,,Simiiformes,,BAO_0000218,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",CHEMBL625440,314293.0,13355,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12187,,Simiiformes,,BAO_0000218,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),CHEMBL625441,314293.0,13356,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12187,,Rattus norvegicus,,BAO_0000218,,Bioavailability in rat (dose 10 mg/kg i.d.),CHEMBL625442,10116.0,13357,A,1,Autocuration,,,,0
N,,50597,,,In vivo,12187,,Rattus norvegicus,,BAO_0000218,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",CHEMBL625443,10116.0,13358,A,1,Intermediate,,,,1
U,,22224,,,In vivo,17431,,,,BAO_0000218,,Bioavailability was determined; extremely poor,CHEMBL625444,,13359,A,1,Autocuration,,,,0
N,,50594,,,In vivo,13318,,Mus musculus,,BAO_0000218,,% bioavailability in mice after oral administration of prodrug,CHEMBL625445,10090.0,13360,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,CHEMBL625446,9615.0,13361,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,CHEMBL882960,9615.0,13362,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,CHEMBL625447,9615.0,13363,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,CHEMBL625448,9615.0,13364,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,CHEMBL625449,9615.0,13365,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),CHEMBL874589,9615.0,13366,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,CHEMBL625450,9615.0,13367,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,CHEMBL625451,9615.0,13368,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,CHEMBL626584,9615.0,13369,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,CHEMBL626585,9615.0,13370,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,CHEMBL626586,9615.0,13371,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,CHEMBL626587,9615.0,13372,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,CHEMBL626588,9615.0,13373,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,CHEMBL626589,9615.0,13374,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,CHEMBL626590,9615.0,13375,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,CHEMBL626591,9615.0,13376,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,CHEMBL627181,9615.0,13377,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,CHEMBL628083,9615.0,13378,A,1,Intermediate,,,,1
U,,22224,,,In vivo,15173,,,,BAO_0000218,,IV clearance determined at an peroral dose of 15 mg/kg.,CHEMBL628084,,13379,A,1,Autocuration,,,,0
N,,50064,,,In vivo,7732,,Hymenolepis nana,,BAO_0000218,,Mouse oral clearance was measured against Hymenolepiasis nana.,CHEMBL628085,102285.0,13380,F,1,Expert,,,,1
N,,50545,,,In vivo,7732,,Heligmosomoides polygyrus,,BAO_0000218,,Mouse oral clearance was measured against Nematospiroides dubius,CHEMBL628086,6339.0,13381,F,1,Expert,,,,1
U,,22224,,,In vivo,7732,,,,BAO_0000218,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,CHEMBL628087,,13382,F,1,Autocuration,,,,0
N,,50594,,,In vivo,7732,,Mus musculus,,BAO_0000218,,Mouse oral clearance was measured against N. nana; NT is Not Tested,CHEMBL628088,10090.0,13383,A,1,Intermediate,,,,1
U,,22224,,,In vivo,7732,,,,BAO_0000218,,Mouse oral clearance was measured against N. nana; NT is Not Tested,CHEMBL628089,,13384,B,1,Autocuration,,,,0
U,,22224,,,In vivo,8328,,,,BAO_0000218,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,CHEMBL628090,,13385,A,1,Autocuration,,,,0
U,,22224,,,In vivo,8328,,,,BAO_0000218,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,CHEMBL628091,,13386,A,1,Autocuration,,,,0
U,,22224,,,In vivo,8328,,,,BAO_0000218,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,CHEMBL628092,,13387,A,1,Autocuration,,,,0
U,,22224,,,In vivo,8328,,,,BAO_0000218,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,CHEMBL628093,,13388,A,1,Autocuration,,,,0
U,,22224,,,In vivo,8328,,,,BAO_0000218,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,CHEMBL875607,,13389,A,1,Autocuration,,,,0
U,,22224,,,In vivo,8328,,,,BAO_0000218,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,CHEMBL625710,,13390,A,1,Autocuration,,,,0
U,,22224,,,In vivo,8328,,,,BAO_0000218,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,CHEMBL625711,,13391,A,1,Autocuration,,,,0
U,,22224,,,In vivo,8328,,,,BAO_0000218,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,CHEMBL625712,,13392,A,1,Autocuration,,,,0
U,,22224,,,In vivo,8328,,,,BAO_0000218,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,CHEMBL625713,,13393,A,1,Autocuration,,,,0
N,,50588,,,In vivo,13376,,Canis lupus familiaris,,BAO_0000218,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,CHEMBL625714,9615.0,13394,A,1,Intermediate,,,,1
N,,50797,,,In vivo,13477,,Macaca mulatta,,BAO_0000218,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,CHEMBL625715,9544.0,13395,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13477,,Rattus norvegicus,,BAO_0000218,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,CHEMBL625716,10116.0,13396,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13477,,Rattus norvegicus,,BAO_0000218,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,CHEMBL625717,10116.0,13397,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13313,,Rattus norvegicus,,BAO_0000218,,Plasma clearance was determined for the compound in rats,CHEMBL625718,10116.0,13398,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12504,,Rattus norvegicus,,BAO_0000218,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,CHEMBL625719,10116.0,13399,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12504,,Rattus norvegicus,,BAO_0000218,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,CHEMBL625720,10116.0,13400,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12504,,Rattus norvegicus,,BAO_0000218,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,CHEMBL625721,10116.0,13401,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12504,,Rattus norvegicus,,BAO_0000218,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,CHEMBL625722,10116.0,13402,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13129,,Rattus norvegicus,,BAO_0000218,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,CHEMBL625723,10116.0,13403,A,1,Intermediate,,,,1
N,,50545,,,In vivo,7732,,Heligmosomoides polygyrus,,BAO_0000218,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,CHEMBL625724,6339.0,13404,A,1,Intermediate,,,,1
N,,50545,,,In vivo,7732,,Heligmosomoides polygyrus,,BAO_0000218,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,CHEMBL625725,6339.0,13405,A,1,Intermediate,,,,1
N,,50545,,,In vivo,7732,,Heligmosomoides polygyrus,,BAO_0000218,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,CHEMBL625726,6339.0,13406,A,1,Intermediate,,,,1
N,,50545,,,In vivo,7732,,Heligmosomoides polygyrus,,BAO_0000218,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,CHEMBL875608,6339.0,13407,A,1,Intermediate,,,,1
N,,50545,,,In vivo,7732,,Heligmosomoides polygyrus,,BAO_0000218,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,CHEMBL625727,6339.0,13408,A,1,Intermediate,,,,1
U,,22224,,,In vivo,9278,Urine,Rattus norvegicus,,BAO_0000218,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,CHEMBL625728,10116.0,13409,A,1,Autocuration,,,1088.0,0
U,,22224,,,In vivo,9278,,Rattus norvegicus,,BAO_0000218,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,CHEMBL625729,10116.0,13410,A,1,Autocuration,,,,0
U,,22224,,,In vivo,9278,,Rattus norvegicus,,BAO_0000218,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,CHEMBL625730,10116.0,13411,A,1,Autocuration,,,,0
U,,22224,,,In vivo,9278,Urine,Rattus norvegicus,,BAO_0000218,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,CHEMBL625731,10116.0,13412,A,1,Autocuration,,,1088.0,0
U,,22224,,,In vivo,9278,Urine,Rattus norvegicus,,BAO_0000218,,Urinary clearance was determined in rat at 25 mg/kg os dosage,CHEMBL626417,10116.0,13413,A,1,Autocuration,,,1088.0,0
N,,50587,,,In vivo,9278,Urine,Homo sapiens,,BAO_0000218,,Urinary clearance was determined at 100 mg/kg oral dosage in human,CHEMBL626418,9606.0,13414,A,1,Intermediate,,,1088.0,1
N,,50588,,,In vivo,9278,Urine,Canis lupus familiaris,,BAO_0000218,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,CHEMBL626419,9615.0,13415,A,1,Intermediate,,,1088.0,1
N,,50588,,,In vivo,5932,Plasma,Canis lupus familiaris,,BAO_0000218,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,CHEMBL626592,9615.0,13416,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5932,Plasma,Rattus norvegicus,,BAO_0000218,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,CHEMBL626593,10116.0,13417,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,5182,,Rattus norvegicus,,BAO_0000218,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,CHEMBL626594,10116.0,13418,A,1,Intermediate,,,,1
N,,50588,,,In vivo,10499,,Canis lupus familiaris,,BAO_0000218,,Clearance rate in dogs,CHEMBL625035,9615.0,13419,A,1,Intermediate,,,,1
U,,22224,,,In vitro,6051,,,,BAO_0000019,,Compound was measured for intrinsic clearance,CHEMBL625036,,13420,A,1,Autocuration,,,,0
U,,22229,,,,17508,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625037,,13421,P,1,Autocuration,,,,0
U,,22229,,,,6228,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625038,,13422,P,1,Autocuration,,,,0
U,,22229,,,,6231,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625039,,13423,P,1,Autocuration,,,,0
U,,22229,,,,17740,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625040,,13424,P,1,Autocuration,,,,0
U,,22229,,,,6495,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625041,,13425,P,1,Autocuration,,,,0
U,,22229,,,,2171,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625042,,13426,P,1,Autocuration,,,,0
U,,22224,,,,3255,,,,BAO_0000019,,Partition coefficient of the compound,CHEMBL874411,,13427,A,1,Autocuration,,,,0
U,,22224,,,,6821,,,,BAO_0000019,,Permeability,CHEMBL625043,,13428,A,1,Autocuration,,,,0
U,,22229,,,,2685,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625044,,13429,P,1,Autocuration,,,,0
U,,22224,,,,17584,,,,BAO_0000019,,Partition coefficient (logD),CHEMBL625045,,13430,A,1,Autocuration,,,,0
U,,22229,,,,13824,,,,BAO_0000100,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),CHEMBL625046,,13431,P,1,Autocuration,,,,0
U,,22229,,,,13824,,,,BAO_0000100,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),CHEMBL625047,,13432,P,1,Autocuration,,,,0
U,,22229,,,,16479,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625048,,13433,P,1,Autocuration,,,,0
U,,22229,,,,11997,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625049,,13434,P,1,Autocuration,,,,0
U,,22229,,,,2988,,,,BAO_0000100,,Calculated logarithm of partition coefficient (P) was determined,CHEMBL625050,,13435,P,1,Autocuration,,,,0
U,,22229,,,,931,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625051,,13436,P,1,Autocuration,,,,0
U,,22229,,,,4381,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL874412,,13437,P,1,Autocuration,,,,0
U,,22229,,,,4397,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625052,,13438,P,1,Autocuration,,,,0
U,,22229,,,,5889,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL625053,,13439,P,1,Autocuration,,,,0
U,,22224,,,,6154,,,,BAO_0000019,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,CHEMBL623250,,13440,A,1,Autocuration,,,,0
U,,22224,,,,6154,,,,BAO_0000019,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,CHEMBL623251,,13441,A,1,Autocuration,,,,0
U,,22224,,,,6154,,,,BAO_0000019,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,CHEMBL623252,,13442,A,1,Autocuration,,,,0
U,,22224,,,,6154,,,,BAO_0000019,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,CHEMBL623253,,13443,A,1,Autocuration,,,,0
U,,22224,,,,6154,,,,BAO_0000019,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,CHEMBL623254,,13444,A,1,Autocuration,,,,0
U,,22224,,,,6154,,,,BAO_0000019,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,CHEMBL623255,,13445,A,1,Autocuration,,,,0
U,,22224,,,,6887,,,,BAO_0000019,,Percent degradation of compound at a pH of 1 over a 18 hr period,CHEMBL626831,,13446,A,1,Autocuration,,,,0
U,,22224,,,,6887,,,,BAO_0000019,,Percent degradation of compound at pH of 1 over an 18 hr period,CHEMBL877494,,13447,A,1,Autocuration,,,,0
U,,22224,,,,14116,,,,BAO_0000019,,Delta Logarithm of Partition Coefficient value was determined.,CHEMBL626832,,13448,A,1,Autocuration,,,,0
U,,22224,,,,11137,,,,BAO_0000019,,Delta logPoct-cyc,CHEMBL626833,,13449,A,1,Autocuration,,,,0
U,,22224,,,,7230,,,,BAO_0000100,,Lipophilicity estimated on reversed phase TLC,CHEMBL626834,,13450,P,1,Autocuration,,,,0
U,,22224,,,,15741,,,,BAO_0000019,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,CHEMBL626835,,13451,A,1,Autocuration,,,,0
U,,22224,,,,9663,,,,BAO_0000019,,Delta logPoct-cyc,CHEMBL626836,,13452,A,1,Autocuration,,,,0
U,,22229,,,,9663,,,,BAO_0000100,,Change in logarithm of partition coefficient of the compound,CHEMBL626837,,13453,P,1,Autocuration,,,,0
U,,22224,,,,13807,,,,BAO_0000019,,Delta logD (pH 6.5),CHEMBL626838,,13454,A,1,Autocuration,,,,0
U,,22224,,,,13807,,,,BAO_0000100,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",CHEMBL626839,,13455,P,1,Autocuration,,,,0
U,,22224,,,,17425,,,,BAO_0000019,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,CHEMBL626840,,13456,A,1,Autocuration,,,,0
U,,22224,,,,12143,,,,BAO_0000019,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),CHEMBL626841,,13457,A,1,Autocuration,,,,0
U,,22224,,,,12608,,,,BAO_0000219,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,CHEMBL626842,,13458,A,1,Autocuration,,,,0
U,,22224,,,,12608,,,,BAO_0000219,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,CHEMBL626843,,13459,A,1,Autocuration,,,,0
N,,50597,,,,8649,,Rattus norvegicus,,BAO_0000218,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,CHEMBL626844,10116.0,13460,A,1,Intermediate,,,,1
N,,50597,,,,8649,,Rattus norvegicus,,BAO_0000218,,Amount of deuterium retained was reported after normal workup in rats,CHEMBL877495,10116.0,13461,A,1,Intermediate,,,,1
N,,50597,,,,8649,,Rattus norvegicus,,BAO_0000218,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,CHEMBL626845,10116.0,13462,A,1,Intermediate,,,,1
N,,50597,,,,8649,,Rattus norvegicus,,BAO_0000218,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,CHEMBL626846,10116.0,13463,A,1,Intermediate,,,,1
N,,50597,,,,8649,,Rattus norvegicus,,BAO_0000218,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,CHEMBL626847,10116.0,13464,A,1,Intermediate,,,,1
N,,50597,,,,8649,,Rattus norvegicus,,BAO_0000218,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,CHEMBL628677,10116.0,13465,A,1,Intermediate,,,,1
N,,50597,,,,8649,,Rattus norvegicus,,BAO_0000218,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,CHEMBL628678,10116.0,13466,A,1,Intermediate,,,,1
U,,22224,,,,9659,,,,BAO_0000019,,Compound was subjected to electrochemical oxidation,CHEMBL628679,,13467,A,1,Autocuration,,,,0
U,,22224,,,,9659,,,,BAO_0000019,,Compound was subjected to photochemical oxidation,CHEMBL628680,,13468,A,1,Autocuration,,,,0
U,,22224,,,,9659,,,,BAO_0000019,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,CHEMBL628681,,13469,A,1,Autocuration,,,,0
U,,22224,,,,9659,,,,BAO_0000019,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,CHEMBL628682,,13470,A,1,Autocuration,,,,0
U,,22224,,,,9659,,,,BAO_0000019,,Oxidation of compound by methemoglobin in presence of hydroperoxide,CHEMBL628683,,13471,A,1,Autocuration,,,,0
N,,50597,,,,9607,,Rattus norvegicus,,BAO_0000218,,Percent diffusion through fuzzy rat skin after 48 h of incubation,CHEMBL628684,10116.0,13472,A,1,Intermediate,,,,1
U,,22229,,,,7057,,,,BAO_0000100,,Dissociation constant (pKa),CHEMBL877501,,13473,P,1,Autocuration,,,,0
U,,22224,,,,7057,,,,BAO_0000100,,Dissociation constant value of the compound; ND means not determined.,CHEMBL628685,,13474,P,1,Autocuration,,,,0
N,,50597,,,,7911,Blood,Rattus norvegicus,,BAO_0000218,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,CHEMBL628686,10116.0,13475,A,1,Intermediate,,,178.0,1
N,,50597,,,,7911,Blood,Rattus norvegicus,,BAO_0000218,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,CHEMBL628687,10116.0,13476,A,1,Intermediate,,,178.0,1
N,,50597,,,,7911,,Rattus norvegicus,,BAO_0000218,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,CHEMBL628688,10116.0,13477,A,1,Intermediate,,,,1
N,,50597,,,,7911,,Rattus norvegicus,,BAO_0000218,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,CHEMBL628689,10116.0,13478,A,1,Intermediate,,,,1
N,,50597,,,,7911,Liver,Rattus norvegicus,,BAO_0000218,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,CHEMBL628690,10116.0,13479,A,1,Intermediate,,,2107.0,1
N,,50597,,,,7911,Liver,Rattus norvegicus,,BAO_0000218,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,CHEMBL629363,10116.0,13480,A,1,Intermediate,,,2107.0,1
N,,50597,,,,7911,Spleen,Rattus norvegicus,,BAO_0000218,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,CHEMBL629364,10116.0,13481,A,1,Intermediate,,,2106.0,1
N,,50597,,,,7911,Spleen,Rattus norvegicus,,BAO_0000218,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,CHEMBL629365,10116.0,13482,A,1,Intermediate,,,2106.0,1
N,,50597,,,,7911,,Rattus norvegicus,,BAO_0000218,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,CHEMBL629366,10116.0,13483,A,1,Intermediate,,,,1
N,,50597,,,,7911,Urine,Rattus norvegicus,,BAO_0000218,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,CHEMBL629367,10116.0,13484,A,1,Intermediate,,,1088.0,1
N,,50597,,,,7911,Feces,Rattus norvegicus,,BAO_0000218,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,CHEMBL629368,10116.0,13485,A,1,Intermediate,,,1988.0,1
N,,50597,,,,7911,Urine,Rattus norvegicus,,BAO_0000218,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,CHEMBL877502,10116.0,13486,A,1,Intermediate,,,1088.0,1
N,,50594,,,,13792,Cerebellum,Mus musculus,,BAO_0000218,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,CHEMBL629369,10090.0,13487,A,1,Intermediate,,,2037.0,1
N,,50594,,,,13792,Brain,Mus musculus,,BAO_0000218,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,CHEMBL629370,10090.0,13488,A,1,Intermediate,,,955.0,1
U,,22224,,,,8133,Urine,Simiiformes,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",CHEMBL629371,314293.0,13489,A,1,Autocuration,,,1088.0,0
U,,22224,,,,8133,Urine,Simiiformes,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",CHEMBL626276,314293.0,13490,A,1,Autocuration,,,1088.0,0
U,,22224,,,,8133,Urine,Simiiformes,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",CHEMBL626277,314293.0,13491,A,1,Autocuration,,,1088.0,0
U,,22224,,,,8133,Urine,Simiiformes,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",CHEMBL631250,314293.0,13492,A,1,Autocuration,,,1088.0,0
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",CHEMBL631251,10116.0,13493,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",CHEMBL631252,10116.0,13494,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",CHEMBL631253,10116.0,13495,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",CHEMBL631254,10116.0,13496,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",CHEMBL631255,10116.0,13497,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",CHEMBL631256,10116.0,13498,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",CHEMBL631257,10116.0,13499,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",CHEMBL628009,10116.0,13500,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",CHEMBL628010,10116.0,13501,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",CHEMBL628011,10116.0,13502,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",CHEMBL628012,10116.0,13503,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",CHEMBL628013,10116.0,13504,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",CHEMBL628014,10116.0,13505,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",CHEMBL628015,9615.0,13506,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",CHEMBL628016,9615.0,13507,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",CHEMBL874461,9615.0,13508,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",CHEMBL628017,9615.0,13509,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",CHEMBL628018,9615.0,13510,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",CHEMBL628019,9615.0,13511,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",CHEMBL628020,9615.0,13512,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",CHEMBL628021,9615.0,13513,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",CHEMBL628022,9615.0,13514,A,1,Intermediate,,,1088.0,1
N,,50588,,,,8133,Urine,Canis lupus familiaris,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",CHEMBL628023,9615.0,13515,A,1,Intermediate,,,1088.0,1
U,,22224,,,,8133,Urine,Simiiformes,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",CHEMBL628024,314293.0,13516,A,1,Autocuration,,,1088.0,0
U,,22224,,,,8133,Urine,Simiiformes,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",CHEMBL628025,314293.0,13517,A,1,Autocuration,,,1088.0,0
U,,22224,,,,8133,Urine,Simiiformes,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",CHEMBL628026,314293.0,13518,A,1,Autocuration,,,1088.0,0
U,,22224,,,,8133,Urine,Simiiformes,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",CHEMBL628027,314293.0,13519,A,1,Autocuration,,,1088.0,0
U,,22224,,,,8133,Urine,Simiiformes,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",CHEMBL628028,314293.0,13520,A,1,Autocuration,,,1088.0,0
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",CHEMBL628029,10116.0,13521,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",CHEMBL628030,10116.0,13522,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",CHEMBL628031,10116.0,13523,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",CHEMBL628032,10116.0,13524,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",CHEMBL628033,10116.0,13525,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",CHEMBL628034,10116.0,13526,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",CHEMBL628035,10116.0,13527,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",CHEMBL628036,10116.0,13528,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",CHEMBL874462,10116.0,13529,A,1,Intermediate,,,1088.0,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,CHEMBL628037,9615.0,13530,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,CHEMBL628123,9615.0,13531,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,CHEMBL628124,9615.0,13532,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,CHEMBL628125,9615.0,13533,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,CHEMBL628126,9615.0,13534,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),CHEMBL628127,9615.0,13535,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,CHEMBL628128,9615.0,13536,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,CHEMBL628129,9615.0,13537,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,CHEMBL628130,9615.0,13538,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,CHEMBL628131,9615.0,13539,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,CHEMBL628132,9615.0,13540,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,CHEMBL628133,9615.0,13541,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,CHEMBL628134,9615.0,13542,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,CHEMBL628135,9615.0,13543,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,CHEMBL628136,9615.0,13544,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,CHEMBL628137,9615.0,13545,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,CHEMBL628138,9615.0,13546,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,CHEMBL628139,9615.0,13547,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,CHEMBL628140,9615.0,13548,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,CHEMBL628141,9615.0,13549,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,CHEMBL628142,9615.0,13550,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,CHEMBL628143,9615.0,13551,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,CHEMBL628144,9615.0,13552,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,CHEMBL628145,9615.0,13553,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,CHEMBL628146,9615.0,13554,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,CHEMBL625355,9615.0,13555,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,CHEMBL625356,9615.0,13556,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,CHEMBL625357,9615.0,13557,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,CHEMBL625527,9615.0,13558,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),CHEMBL875473,9615.0,13559,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,CHEMBL625528,9615.0,13560,A,1,Intermediate,,,,1
N,,50597,,,In vivo,9025,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,CHEMBL626304,10116.0,13561,A,1,Intermediate,,,,1
N,,50588,,,In vivo,9025,Artery,Canis lupus familiaris,,BAO_0000218,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,CHEMBL624138,9615.0,13562,A,1,Intermediate,,,1637.0,1
U,,22229,,,,6448,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL624139,,13563,P,1,Autocuration,,,,0
U,,22229,,,,17221,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL624140,,13564,P,1,Autocuration,,,,0
U,,22229,,,,6545,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL624141,,13565,P,1,Autocuration,,,,0
U,,22229,,,,577,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL624142,,13566,P,1,Autocuration,,,,0
U,,22229,,,,6285,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL624143,,13567,P,1,Autocuration,,,,0
U,,22229,,,,6500,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL624144,,13568,P,1,Autocuration,,,,0
U,,22229,,,,6716,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL624145,,13569,P,1,Autocuration,,,,0
U,,22229,,,,13658,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL624146,,13570,P,1,Autocuration,,,,0
U,,22229,,,,6549,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL624147,,13571,P,1,Autocuration,,,,0
U,,22229,,,,14685,,,,BAO_0000100,,Calculated partition coefficient (clogP) (MacLogP),CHEMBL883123,,13572,P,1,Autocuration,,,,0
U,,22224,,,,6893,,,,BAO_0000019,,Partition coefficient (logP),CHEMBL624148,,13573,A,1,Autocuration,,,,0
U,,22224,,,,3687,,,,BAO_0000019,,Kinetic parameter was determined,CHEMBL874416,,13574,A,1,Autocuration,,,,0
U,,22229,,,,4207,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL624149,,13575,P,1,Autocuration,,,,0
U,,22229,,,,4626,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL624150,,13576,P,1,Autocuration,,,,0
U,,22224,,,,1021,,,,BAO_0000100,,Lipophilicity was determined,CHEMBL624151,,13577,P,1,Autocuration,,,,0
U,,22224,,,,3777,,,,BAO_0000100,,Lipophilicity was determined,CHEMBL624152,,13578,P,1,Autocuration,,,,0
U,,22224,,,,17533,,,,BAO_0000100,,Lipophilicity was determined,CHEMBL622139,,13579,P,1,Autocuration,,,,0
U,,22229,,,,6524,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL622140,,13580,P,1,Autocuration,,,,0
U,,22224,,,,17533,,,,BAO_0000100,,Lipophilicity was determined,CHEMBL622141,,13581,P,1,Autocuration,,,,0
U,,22224,,,,6480,,,,BAO_0000100,,Lipophilicity in octanol-water,CHEMBL622142,,13582,P,1,Autocuration,,,,0
U,,22229,,,,17606,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL622143,,13583,P,1,Autocuration,,,,0
U,,22229,,,,6863,,,,BAO_0000100,,Octanol-water partition coefficient was determined,CHEMBL622144,,13584,P,1,Autocuration,,,,0
U,,22224,,,,1356,,,,BAO_0000019,,Partition coefficient (logP),CHEMBL877473,,13585,A,1,Autocuration,,,,0
U,,22229,,,,3326,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL622145,,13586,P,1,Autocuration,,,,0
U,,22224,,,,1356,,,,BAO_0000019,,Partition coefficient was determined; ND means not determined,CHEMBL622146,,13587,A,1,Autocuration,,,,0
U,,22229,,,,12984,,,,BAO_0000100,,Calculated partition coefficient (clogP),CHEMBL622147,,13588,P,1,Autocuration,,,,0
U,,22224,,,,17363,,,,BAO_0000019,,Partition coefficient of the compound,CHEMBL622148,,13589,A,1,Autocuration,,,,0
U,,22224,,,,6827,,,,BAO_0000019,,Permeability was determined,CHEMBL883124,,13590,A,1,Autocuration,,,,0
U,,22229,,,,261,,,,BAO_0000100,,The compound was evaluated for the partition coefficient,CHEMBL622149,,13591,P,1,Autocuration,,,,0
U,,22224,,,,2685,,,,BAO_0000019,,Partition coefficient (logP),CHEMBL622150,,13592,A,1,Autocuration,,,,0
U,,22224,,,,414,,,,BAO_0000100,,The lipophilicity was reported,CHEMBL622151,,13593,P,1,Autocuration,,,,0
U,,22229,,,,15769,,,,BAO_0000100,,logarithm of the octanol-water partition coefficient for the compound,CHEMBL622152,,13594,P,1,Autocuration,,,,0
U,,22224,,,,17248,,,,BAO_0000019,,Clogp value was determined,CHEMBL622153,,13595,A,1,Autocuration,,,,0
U,,22224,,,In vivo,16935,,,,BAO_0000218,,Clp at a dose of 1.5 mg/kg,CHEMBL877474,,13596,A,1,Autocuration,,,,0
U,,22224,,,In vivo,16935,,,,BAO_0000218,,Clp at a dose of 2.0 mg/kg,CHEMBL622154,,13597,A,1,Autocuration,,,,0
U,,22224,,,In vivo,14832,Plasma,,,BAO_0000218,,"Clp, plasma clearance at a dose of 10 mg/kg",CHEMBL622155,,13598,A,1,Autocuration,,,1969.0,0
U,,22224,,,In vivo,14832,Plasma,,,BAO_0000218,,"Clp, plasma clearance at a dose of 50 mg/kg",CHEMBL622156,,13599,A,1,Autocuration,,,1969.0,0
N,,50597,,,In vivo,2399,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was tested for plasma clearance in rat,CHEMBL622157,10116.0,13600,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,2399,Plasma,Rattus norvegicus,,BAO_0000218,,Compound was tested for plasma clearance in rat; Not determined,CHEMBL622158,10116.0,13601,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,6227,,Rattus norvegicus,,BAO_0000218,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,CHEMBL622807,10116.0,13602,A,1,Intermediate,,,,1
N,,50797,,,In vivo,6227,,Macaca mulatta,,BAO_0000218,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,CHEMBL622808,9544.0,13603,A,1,Intermediate,,,,1
U,,22224,,,In vivo,5623,,,,BAO_0000218,,Plasma clearance by iv administration at a dose 0.003 ug/mL,CHEMBL622809,,13604,A,1,Autocuration,,,,0
U,,22224,,,In vivo,4854,,,,BAO_0000218,,Plasma clearance determined,CHEMBL622810,,13605,A,1,Autocuration,,,,0
N,,100712,,,In vivo,4493,,Cricetinae,,BAO_0000218,,Plasma clearance after iv administration at 3 mg/kg in hamster,CHEMBL876653,10026.0,13606,A,1,Intermediate,,,,1
N,,100712,,,In vivo,4493,,Cricetinae,,BAO_0000218,,Plasma clearance after iv administration at 4 mg/kg in hamster,CHEMBL622811,10026.0,13607,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14956,,Rattus norvegicus,,BAO_0000218,,Rate of clearance in rat was determined,CHEMBL622986,10116.0,13608,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15372,Plasma,Rattus norvegicus,,BAO_0000218,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,CHEMBL622987,10116.0,13609,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15372,Plasma,Rattus norvegicus,,BAO_0000218,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,CHEMBL622988,10116.0,13610,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15372,Plasma,Rattus norvegicus,,BAO_0000218,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,CHEMBL622989,10116.0,13611,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,15372,Plasma,Rattus norvegicus,,BAO_0000218,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,CHEMBL622990,10116.0,13612,A,1,Intermediate,,,1969.0,1
U,,22224,,,In vivo,15604,Plasma,Simiiformes,,BAO_0000218,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,CHEMBL622991,314293.0,13613,A,1,Autocuration,,,1969.0,0
N,,50597,,,In vivo,15604,Plasma,Rattus norvegicus,,BAO_0000218,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,CHEMBL622227,10116.0,13614,A,1,Intermediate,,,1969.0,1
N,,50588,,,In vivo,15604,Plasma,Canis lupus familiaris,,BAO_0000218,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,CHEMBL622228,9615.0,13615,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,14964,,Rattus norvegicus,,BAO_0000218,,Clpl value in rat,CHEMBL622229,10116.0,13616,A,1,Intermediate,,,,1
N,,50512,,,In vivo,15240,,Cavia porcellus,,BAO_0000218,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,CHEMBL622230,10141.0,13617,A,1,Intermediate,,,,1
N,,50597,,,In vivo,16449,,Rattus norvegicus,,BAO_0000218,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,CHEMBL622231,10116.0,13618,A,1,Intermediate,,,,1
N,,100710,,,In vivo,16449,,Macaca fascicularis,,BAO_0000218,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,CHEMBL622232,9541.0,13619,A,1,Intermediate,,,,1
U,,22224,,,In vivo,12902,,,,BAO_0000218,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,CHEMBL622233,,13620,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12902,,,,BAO_0000218,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,CHEMBL622234,,13621,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12902,,,,BAO_0000218,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,CHEMBL622235,,13622,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12902,,,,BAO_0000218,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,CHEMBL622236,,13623,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12902,,,,BAO_0000218,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,CHEMBL622237,,13624,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12902,,,,BAO_0000218,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,CHEMBL877482,,13625,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12902,,,,BAO_0000218,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,CHEMBL622238,,13626,A,1,Autocuration,,,,0
U,,22224,,,In vivo,12902,,,,BAO_0000218,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,CHEMBL622239,,13627,A,1,Autocuration,,,,0
U,,22224,,,In vivo,11149,Blood,,,BAO_0000218,,Cmax was calculated as maximum concentration reached in the blood,CHEMBL622240,,13628,A,1,Autocuration,,,178.0,0
U,,22224,,,In vivo,11149,Blood,,,BAO_0000218,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,CHEMBL622241,,13629,A,1,Autocuration,,,178.0,0
N,,50597,,,In vivo,5669,,Rattus norvegicus,,BAO_0000218,,Cmax was determine after peroral administration at 10 mpk in Rat,CHEMBL631013,10116.0,13630,A,1,Intermediate,,,,1
N,,50797,,,In vivo,5669,,Macaca mulatta,,BAO_0000218,,Cmax was determine after peroral administration at 10 mpk in Rhesus,CHEMBL631014,9544.0,13631,A,1,Intermediate,,,,1
N,,50588,,,In vivo,5669,,Canis lupus familiaris,,BAO_0000218,,Cmax was determine after peroral administration at 10 mpk in dog,CHEMBL631015,9615.0,13632,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5669,,Rattus norvegicus,,BAO_0000218,,Cmax was determine after peroral administration at 160 mpk in Rat,CHEMBL631016,10116.0,13633,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5669,,Rattus norvegicus,,BAO_0000218,,Cmax was determine after peroral administration at 20 mpk in Rat,CHEMBL631017,10116.0,13634,A,1,Intermediate,,,,1
N,,50597,,,In vivo,5669,,Rattus norvegicus,,BAO_0000218,,Cmax was determine after peroral administration at 50 mpk in Rat,CHEMBL631018,10116.0,13635,A,1,Intermediate,,,,1
U,,22224,,,In vivo,4236,,,,BAO_0000218,,Cmax was determined,CHEMBL631019,,13636,A,1,Autocuration,,,,0
N,,50594,,,,13792,Brain,Mus musculus,,BAO_0000218,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,CHEMBL875761,10090.0,13637,A,1,Intermediate,,,955.0,1
N,,50594,,,,13792,Brain,Mus musculus,,BAO_0000218,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,CHEMBL631020,10090.0,13638,A,1,Intermediate,,,955.0,1
N,,50594,,,,13792,Brain,Mus musculus,,BAO_0000218,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,CHEMBL631669,10090.0,13639,A,1,Intermediate,,,955.0,1
N,,50594,,,,13792,Brain,Mus musculus,,BAO_0000218,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,CHEMBL631670,10090.0,13640,A,1,Intermediate,,,955.0,1
N,,50594,,,,13792,Striatum,Mus musculus,,BAO_0000218,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,CHEMBL631671,10090.0,13641,A,1,Intermediate,,,2435.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,CHEMBL631672,10116.0,13642,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,CHEMBL631673,10116.0,13643,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,CHEMBL631856,10116.0,13644,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,CHEMBL631857,10116.0,13645,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,CHEMBL631858,10116.0,13646,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,CHEMBL631859,10116.0,13647,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,CHEMBL631860,10116.0,13648,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,CHEMBL631861,10116.0,13649,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,CHEMBL631862,10116.0,13650,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,CHEMBL631863,10116.0,13651,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,CHEMBL631864,10116.0,13652,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,CHEMBL631865,10116.0,13653,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,CHEMBL631866,10116.0,13654,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,CHEMBL629360,10116.0,13655,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,CHEMBL629361,10116.0,13656,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,CHEMBL629362,10116.0,13657,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,CHEMBL630740,10116.0,13658,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,CHEMBL630741,10116.0,13659,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,Blood,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,CHEMBL630742,10116.0,13660,A,1,Intermediate,,,178.0,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,CHEMBL630743,10116.0,13661,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,CHEMBL630744,10116.0,13662,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,CHEMBL630745,10116.0,13663,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,CHEMBL630746,10116.0,13664,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,CHEMBL630747,10116.0,13665,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,CHEMBL630748,10116.0,13666,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,CHEMBL632056,10116.0,13667,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,CHEMBL632057,10116.0,13668,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,CHEMBL632058,10116.0,13669,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,CHEMBL632059,10116.0,13670,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,CHEMBL632060,10116.0,13671,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,CHEMBL632061,10116.0,13672,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,CHEMBL629207,10116.0,13673,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,CHEMBL629208,10116.0,13674,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,CHEMBL629209,10116.0,13675,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,CHEMBL629210,10116.0,13676,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,CHEMBL629211,10116.0,13677,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,CHEMBL629212,10116.0,13678,A,1,Intermediate,,,,1
N,,50597,,,,8418,,Rattus norvegicus,,BAO_0000218,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,CHEMBL629213,10116.0,13679,A,1,Intermediate,,,,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",CHEMBL629214,10116.0,13680,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",CHEMBL629215,10116.0,13681,A,1,Intermediate,,,1088.0,1
N,,50597,,,,8133,Urine,Rattus norvegicus,,BAO_0000218,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",CHEMBL635154,10116.0,13682,A,1,Intermediate,,,1088.0,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),CHEMBL629216,10116.0,13683,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,CHEMBL629217,10116.0,13684,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),CHEMBL629218,10116.0,13685,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),CHEMBL629219,10116.0,13686,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),CHEMBL629220,10116.0,13687,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),CHEMBL629221,10116.0,13688,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),CHEMBL631127,10116.0,13689,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,CHEMBL631128,10116.0,13690,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),CHEMBL631129,10116.0,13691,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),CHEMBL631130,10116.0,13692,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),CHEMBL631131,10116.0,13693,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),CHEMBL631132,10116.0,13694,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),CHEMBL631133,10116.0,13695,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,CHEMBL631134,10116.0,13696,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),CHEMBL875120,10116.0,13697,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),CHEMBL631135,10116.0,13698,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),CHEMBL631136,10116.0,13699,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),CHEMBL631137,10116.0,13700,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),CHEMBL631138,10116.0,13701,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,CHEMBL631139,10116.0,13702,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),CHEMBL631140,10116.0,13703,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),CHEMBL631141,10116.0,13704,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),CHEMBL631142,10116.0,13705,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),CHEMBL631143,10116.0,13706,A,1,Intermediate,,,,1
N,,50597,,,,6996,,Rattus norvegicus,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),CHEMBL631144,10116.0,13707,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,CHEMBL631145,9615.0,13708,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),CHEMBL631146,9615.0,13709,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,CHEMBL631147,9615.0,13710,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),CHEMBL631148,9615.0,13711,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),CHEMBL631149,9615.0,13712,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),CHEMBL631150,9615.0,13713,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),CHEMBL631151,9615.0,13714,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),CHEMBL631152,9615.0,13715,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),CHEMBL631443,9615.0,13716,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),CHEMBL631444,9615.0,13717,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),CHEMBL631445,9615.0,13718,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),CHEMBL631446,9615.0,13719,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),CHEMBL631447,9615.0,13720,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),CHEMBL631448,9615.0,13721,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,CHEMBL631449,9615.0,13722,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),CHEMBL631450,9615.0,13723,A,1,Intermediate,,,,1
N,,50588,,,,6996,,Canis lupus familiaris,,BAO_0000218,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),CHEMBL629724,9615.0,13724,A,1,Intermediate,,,,1
N,,50594,,,In vivo,9716,Zone of skin,Mus musculus,,BAO_0000218,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL629725,10090.0,13725,A,1,Intermediate,,,14.0,1
N,,50594,,,In vivo,9716,Zone of skin,Mus musculus,,BAO_0000218,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL629726,10090.0,13726,A,1,Intermediate,,,14.0,1
N,,50594,,,In vivo,9716,Spleen,Mus musculus,,BAO_0000218,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL629727,10090.0,13727,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,9716,Spleen,Mus musculus,,BAO_0000218,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630404,10090.0,13728,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,9716,Spleen,Mus musculus,,BAO_0000218,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630405,10090.0,13729,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,9716,Spleen,Mus musculus,,BAO_0000218,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630406,10090.0,13730,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,9716,Stomach,Mus musculus,,BAO_0000218,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630407,10090.0,13731,A,1,Intermediate,,,945.0,1
N,,50594,,,In vivo,9716,Stomach,Mus musculus,,BAO_0000218,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630573,10090.0,13732,A,1,Intermediate,,,945.0,1
N,,50594,,,In vivo,9716,Stomach,Mus musculus,,BAO_0000218,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630574,10090.0,13733,A,1,Intermediate,,,945.0,1
N,,50594,,,In vivo,9716,Stomach,Mus musculus,,BAO_0000218,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630575,10090.0,13734,A,1,Intermediate,,,945.0,1
N,,50594,,,In vivo,9716,,Mus musculus,,BAO_0000218,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630576,10090.0,13735,A,1,Intermediate,,,,1
N,,50594,,,In vivo,9716,,Mus musculus,,BAO_0000218,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630577,10090.0,13736,A,1,Intermediate,,,,1
N,,50594,,,In vivo,9716,,Mus musculus,,BAO_0000218,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630578,10090.0,13737,A,1,Intermediate,,,,1
N,,50594,,,In vivo,9716,,Mus musculus,,BAO_0000218,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",CHEMBL630579,10090.0,13738,A,1,Intermediate,,,,1
N,,50594,,,,12192,Kidney,Mus musculus,,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),CHEMBL630580,10090.0,13739,A,1,Intermediate,,,2113.0,1
N,,50594,,,,12192,Kidney,Mus musculus,,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,CHEMBL630581,10090.0,13740,A,1,Intermediate,,,2113.0,1
N,,50594,,,,12192,Kidney,Mus musculus,,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),CHEMBL630582,10090.0,13741,A,1,Intermediate,,,2113.0,1
N,,50594,,,,12192,,Mus musculus,,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,CHEMBL630583,10090.0,13742,A,1,Intermediate,,,,1
N,,50594,,,,12192,,Mus musculus,,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),CHEMBL630584,10090.0,13743,A,1,Intermediate,,,,1
N,,50594,,,,12192,,Mus musculus,,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,CHEMBL630585,10090.0,13744,A,1,Intermediate,,,,1
N,,50594,,,,12192,,Mus musculus,,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),CHEMBL630586,10090.0,13745,A,1,Intermediate,,,,1
N,,50594,,,,12192,,Mus musculus,,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,CHEMBL630587,10090.0,13746,A,1,Intermediate,,,,1
N,,50594,,,,12192,,Mus musculus,,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),CHEMBL630588,10090.0,13747,A,1,Intermediate,,,,1
N,,50594,,,,12192,,Mus musculus,,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,CHEMBL630589,10090.0,13748,A,1,Intermediate,,,,1
N,,50594,,,,12192,,Mus musculus,,BAO_0000218,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),CHEMBL630590,10090.0,13749,A,1,Intermediate,,,,1
U,,22224,,,,12192,Feces,,,BAO_0000019,,Removal of 238-Plutonium(IV) in feces at 24 h,CHEMBL630591,,13750,A,1,Autocuration,,,1988.0,0
U,,22224,,,,12192,Feces,,,BAO_0000019,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),CHEMBL630592,,13751,A,1,Autocuration,,,1988.0,0
U,,22224,,,,12192,,,,BAO_0000019,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,CHEMBL630593,,13752,A,1,Autocuration,,,,0
U,,22224,,,,12192,,,,BAO_0000019,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),CHEMBL630594,,13753,A,1,Autocuration,,,,0
U,,22224,,,,12192,Urine,,,BAO_0000019,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),CHEMBL630595,,13754,A,1,Autocuration,,,1088.0,0
U,,22224,,,,12192,Urine,,,BAO_0000019,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),CHEMBL630596,,13755,A,1,Autocuration,,,1088.0,0
U,,22224,,,,12192,Urine,,,BAO_0000019,,Removal of 238-Plutonium(IV) in urine after 0-24 h,CHEMBL630597,,13756,A,1,Autocuration,,,1088.0,0
U,,22224,,,,12192,Urine,,,BAO_0000019,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),CHEMBL630598,,13757,A,1,Autocuration,,,1088.0,0
U,,22224,,,,12192,Urine,,,BAO_0000019,,Removal of 238-Plutonium(IV) in urine after 0-4 h,CHEMBL630599,,13758,A,1,Autocuration,,,1088.0,0
U,,22224,,,,12192,Urine,,,BAO_0000019,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),CHEMBL630600,,13759,A,1,Autocuration,,,1088.0,0
U,,22224,,,,12192,Urine,,,BAO_0000019,,Removal of 238-Plutonium(IV) in urine after 4-24 h,CHEMBL630601,,13760,A,1,Autocuration,,,1088.0,0
U,,22224,,,,12192,Urine,,,BAO_0000019,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),CHEMBL630602,,13761,A,1,Autocuration,,,1088.0,0
U,,22224,,,,12192,Urine,,,BAO_0000019,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),CHEMBL630603,,13762,A,1,Autocuration,,,1088.0,0
U,,22224,,,,12192,Urine,,,BAO_0000019,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),CHEMBL630604,,13763,A,1,Autocuration,,,1088.0,0
N,,50597,,,In vivo,12017,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL624869,10116.0,13764,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,12017,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL624870,10116.0,13765,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,12017,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL623189,10116.0,13766,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,12017,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623190,10116.0,13767,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,12017,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623191,10116.0,13768,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623192,10116.0,13769,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623193,10116.0,13770,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL623194,10116.0,13771,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623195,10116.0,13772,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623196,10116.0,13773,A,1,Intermediate,,,,1
N,,50597,,,,11836,,Rattus norvegicus,,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,CHEMBL623197,10116.0,13774,A,1,Intermediate,,,,1
N,,50597,,,,11836,,Rattus norvegicus,,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,CHEMBL623198,10116.0,13775,A,1,Intermediate,,,,1
N,,50597,,,,11836,,Rattus norvegicus,,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,CHEMBL623199,10116.0,13776,A,1,Intermediate,,,,1
N,,50597,,,,11836,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,CHEMBL623200,10116.0,13777,A,1,Intermediate,,,2385.0,1
N,,50597,,,,11836,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,CHEMBL623201,10116.0,13778,A,1,Intermediate,,,2385.0,1
N,,50597,,,,11836,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,CHEMBL623202,10116.0,13779,A,1,Intermediate,,,2385.0,1
N,,50597,,,,11836,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,CHEMBL623203,10116.0,13780,A,1,Intermediate,,,2385.0,1
N,,50597,,,,11836,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,CHEMBL623204,10116.0,13781,A,1,Intermediate,,,2385.0,1
N,,50597,,,,11836,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,CHEMBL623205,10116.0,13782,A,1,Intermediate,,,2385.0,1
N,,50597,,,,11836,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,CHEMBL623206,10116.0,13783,A,1,Intermediate,,,2385.0,1
N,,50597,,,,11836,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,CHEMBL623207,10116.0,13784,A,1,Intermediate,,,2385.0,1
N,,50597,,,,11836,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,CHEMBL623208,10116.0,13785,A,1,Intermediate,,,2385.0,1
N,,50597,,,,11836,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,CHEMBL623209,10116.0,13786,A,1,Intermediate,,,2385.0,1
N,,50597,,,,11836,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,CHEMBL623210,10116.0,13787,A,1,Intermediate,,,2385.0,1
N,,50597,,,,11836,,Rattus norvegicus,,BAO_0000218,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,CHEMBL623211,10116.0,13788,A,1,Intermediate,,,,1
N,,50597,,,,11836,Uterus,Rattus norvegicus,,BAO_0000218,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,CHEMBL623212,10116.0,13789,A,1,Intermediate,,,995.0,1
U,,22224,,,,12640,,,,BAO_0000019,,Tested in vitro for intrinsic activity relative to quinpirole,CHEMBL623213,,13790,A,1,Autocuration,,,,0
U,,22224,,,,14218,,,,BAO_0000019,,"Relative ion enhancement, determined in pulsed ultrafiltration",CHEMBL623214,,13791,A,1,Autocuration,,,,0
U,,22224,,,,11296,,,,BAO_0000019,,% ionization at the pH 7.4 at 37 degree Centigrade,CHEMBL623215,,13792,A,1,Autocuration,,,,0
U,,22224,,,,10929,,,,BAO_0000019,,Percentage ionization was measured,CHEMBL623216,,13793,A,1,Autocuration,,,,0
N,,50591,,,,13841,,Bos taurus,,BAO_0000218,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,CHEMBL623217,9913.0,13794,A,1,Intermediate,,,,1
U,,22224,,,,10431,,,,BAO_0000019,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,CHEMBL623218,,13795,A,1,Autocuration,,,,0
U,,22224,,,,10431,,,,BAO_0000019,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,CHEMBL623913,,13796,A,1,Autocuration,,,,0
U,,22224,,,,10431,,,,BAO_0000019,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,CHEMBL623914,,13797,A,1,Autocuration,,,,0
U,,22229,,,,8826,,,,BAO_0000100,,Compound was evaluated for the partition coefficient in octanol/water,CHEMBL623915,,13798,P,1,Autocuration,,,,0
U,,22229,,,,8826,,,,BAO_0000100,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),CHEMBL624080,,13799,P,1,Autocuration,,,,0
U,,22224,,,,9884,,,,BAO_0000019,,Equilibrium constant measured by the pulse radiolysis at pH 7,CHEMBL624081,,13800,A,1,Autocuration,,,,0
N,,50587,,,,9827,,Homo sapiens,,BAO_0000218,,In vitro hydrolytic rate constant determined in human blood,CHEMBL624082,9606.0,13801,A,1,Intermediate,,,,1
N,,50587,,,,10009,,Homo sapiens,,BAO_0000218,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,CHEMBL625054,9606.0,13802,A,1,Intermediate,,,,1
U,,22224,,,,10009,,,,BAO_0000019,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,CHEMBL877485,,13803,A,1,Autocuration,,,,0
N,,50594,,,,10009,,Mus musculus,,BAO_0000218,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,CHEMBL625055,10090.0,13804,A,1,Intermediate,,,,1
N,,50594,,,,10009,,Mus musculus,,BAO_0000218,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,CHEMBL625056,10090.0,13805,A,1,Intermediate,,,,1
N,,50587,,,,10009,,Homo sapiens,,BAO_0000218,,In vitro oxidation of compound in presence of human plasma,CHEMBL625057,9606.0,13806,A,1,Intermediate,,,,1
U,,22224,,,,10009,,,,BAO_0000019,,In vitro oxidation of compound in presence of hydrogen peroxide,CHEMBL625058,,13807,A,1,Autocuration,,,,0
N,,50594,,,,10009,,Mus musculus,,BAO_0000218,,In vitro oxidation of compound in presence of mouse brain homogenate,CHEMBL625059,10090.0,13808,A,1,Intermediate,,,,1
N,,50594,,,,10009,,Mus musculus,,BAO_0000218,,In vitro oxidation of compound in presence of mouse liver homogenate,CHEMBL629536,10090.0,13809,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,CHEMBL629537,10116.0,13810,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,CHEMBL629538,10116.0,13811,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,CHEMBL629539,10116.0,13812,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,CHEMBL874445,10116.0,13813,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,CHEMBL629540,10116.0,13814,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,CHEMBL629541,10116.0,13815,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,CHEMBL629542,10116.0,13816,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,CHEMBL630243,10116.0,13817,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,CHEMBL630244,10116.0,13818,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,CHEMBL630245,10116.0,13819,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,CHEMBL630246,10116.0,13820,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,CHEMBL630247,10116.0,13821,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,CHEMBL630248,10116.0,13822,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13100,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood at 240 minutes after dose administration.,CHEMBL630249,10116.0,13823,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13100,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood at 30 minutes after dose administration.,CHEMBL630250,10116.0,13824,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13100,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood at 360 minutes after dose administration.,CHEMBL630251,10116.0,13825,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13100,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood at 3 hr after dose administration.,CHEMBL630252,10116.0,13826,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13100,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood at 60 minutes after dose administration.,CHEMBL630408,10116.0,13827,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13100,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,CHEMBL630409,10116.0,13828,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,13100,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,CHEMBL874446,10116.0,13829,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,13100,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,CHEMBL630410,10116.0,13830,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,13100,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,CHEMBL630411,10116.0,13831,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,13100,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,CHEMBL630412,10116.0,13832,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,13100,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,CHEMBL630413,10116.0,13833,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,13100,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat cerebellum at 3 hr after dose administration.,CHEMBL630414,10116.0,13834,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,13100,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,CHEMBL630415,10116.0,13835,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,13100,,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat cortex at 120 minutes after dose administration.,CHEMBL630416,10116.0,13836,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13100,,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat cortex at 1440 minutes after dose administration.,CHEMBL630417,10116.0,13837,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13100,,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat cortex at 15 minutes after dose administration.,CHEMBL630418,10116.0,13838,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13100,,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat cortex at 240 minutes after dose administration.,CHEMBL630419,10116.0,13839,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13100,,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat cortex at 30 minutes after dose administration.,CHEMBL630420,10116.0,13840,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13100,,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat cortex at 360 minutes after dose administration.,CHEMBL630421,10116.0,13841,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13100,,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat cortex at 3 hr after dose administration.,CHEMBL630422,10116.0,13842,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13100,,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat cortex at 60 minutes after dose administration.,CHEMBL630423,10116.0,13843,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13100,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart at 120 minutes after dose administration.,CHEMBL630424,10116.0,13844,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13100,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart at 15 minutes after dose administration.,CHEMBL630425,10116.0,13845,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13100,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart at 240 minutes after dose administration.,CHEMBL629462,10116.0,13846,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13100,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart at 30 minutes after dose administration.,CHEMBL630426,10116.0,13847,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13100,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart at 360 minutes after dose administration.,CHEMBL630427,10116.0,13848,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13100,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart at 3 hr after dose administration.,CHEMBL625877,10116.0,13849,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13100,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart at 60 minutes after dose administration.,CHEMBL625878,10116.0,13850,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13100,Hippocampus,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,CHEMBL625879,10116.0,13851,A,1,Intermediate,,,10000000.0,1
N,,50597,,,In vivo,13100,Hippocampus,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,CHEMBL625880,10116.0,13852,A,1,Intermediate,,,10000000.0,1
N,,50597,,,In vivo,13100,Hippocampus,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,CHEMBL625881,10116.0,13853,A,1,Intermediate,,,10000000.0,1
N,,50597,,,In vivo,13100,Hippocampus,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,CHEMBL625882,10116.0,13854,A,1,Intermediate,,,10000000.0,1
N,,50597,,,In vivo,13100,Hippocampus,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,CHEMBL625883,10116.0,13855,A,1,Intermediate,,,10000000.0,1
N,,50597,,,In vivo,13100,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney at 120 minutes after dose administration.,CHEMBL625884,10116.0,13856,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13100,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney at 1440 minutes after dose administration.,CHEMBL625885,10116.0,13857,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13100,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney at 15 minutes after dose administration.,CHEMBL628649,10116.0,13858,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13100,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney at 240 minutes after dose administration.,CHEMBL628650,10116.0,13859,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13100,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney at 30 minutes after dose administration.,CHEMBL628651,10116.0,13860,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13100,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney at 360 minutes after dose administration.,CHEMBL628652,10116.0,13861,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13100,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney at 60 minutes after dose administration.,CHEMBL628653,10116.0,13862,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13100,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver at 120 minutes after dose administration.,CHEMBL628654,10116.0,13863,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13100,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver at 1440 minutes after dose administration.,CHEMBL628655,10116.0,13864,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13100,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver at 15 minutes after dose administration.,CHEMBL625238,10116.0,13865,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13100,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver at 240 minutes after dose administration.,CHEMBL625239,10116.0,13866,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13100,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver at 30 minutes after dose administration.,CHEMBL625240,10116.0,13867,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13100,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver at 360 minutes after dose administration.,CHEMBL625241,10116.0,13868,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13100,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver at 60 minutes after dose administration.,CHEMBL625242,10116.0,13869,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13100,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat lung at 120 minutes after dose administration.,CHEMBL874587,10116.0,13870,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13100,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat lung at 1440 minutes after dose administration.,CHEMBL625405,10116.0,13871,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13100,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat lung at 15 minutes after dose administration.,CHEMBL625406,10116.0,13872,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13100,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat lung at 240 minutes after dose administration.,CHEMBL625407,10116.0,13873,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13100,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat lung at 30 minutes after dose administration.,CHEMBL625408,10116.0,13874,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13100,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat lung at 360 minutes after dose administration.,CHEMBL625409,10116.0,13875,A,1,Intermediate,,,2048.0,1
N,,50597,,,,12361,Thoracic aorta,Rattus norvegicus,,BAO_0000218,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,CHEMBL625410,10116.0,13876,A,1,Intermediate,,,1515.0,1
N,,50597,,,,12361,Thoracic aorta,Rattus norvegicus,,BAO_0000218,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,CHEMBL625411,10116.0,13877,A,1,Intermediate,,,1515.0,1
N,,50597,,,,12361,Thoracic aorta,Rattus norvegicus,,BAO_0000218,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,CHEMBL625412,10116.0,13878,A,1,Intermediate,,,1515.0,1
N,,50597,,,,12361,Thoracic aorta,Rattus norvegicus,,BAO_0000218,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,CHEMBL625413,10116.0,13879,A,1,Intermediate,,,1515.0,1
N,,50597,,,,12361,Thoracic aorta,Rattus norvegicus,,BAO_0000218,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,CHEMBL625414,10116.0,13880,A,1,Intermediate,,,1515.0,1
N,,50597,,,,12361,Thoracic aorta,Rattus norvegicus,,BAO_0000218,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,CHEMBL625415,10116.0,13881,A,1,Intermediate,,,1515.0,1
N,,50597,,,,12361,Thoracic aorta,Rattus norvegicus,,BAO_0000218,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,CHEMBL625416,10116.0,13882,A,1,Intermediate,,,1515.0,1
N,,50597,,,,12712,Urine,Rattus norvegicus,,BAO_0000218,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,CHEMBL625417,10116.0,13883,A,1,Intermediate,,,1088.0,1
N,,50597,,,,7415,Feces,Rattus norvegicus,,BAO_0000218,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,CHEMBL625418,10116.0,13884,A,1,Intermediate,,,1988.0,1
N,,50597,,,,7415,Urine,Rattus norvegicus,,BAO_0000218,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,CHEMBL625419,10116.0,13885,A,1,Intermediate,,,1088.0,1
N,,50597,,,,7415,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,CHEMBL625420,10116.0,13886,A,1,Intermediate,,,,1
N,,50597,,,,7415,,Rattus norvegicus,,BAO_0000218,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,CHEMBL626996,10116.0,13887,A,1,Intermediate,,,,1
N,,50597,,,,7415,Feces,Rattus norvegicus,,BAO_0000218,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",CHEMBL626997,10116.0,13888,A,1,Intermediate,,,1988.0,1
N,,50597,,,,7415,Urine,Rattus norvegicus,,BAO_0000218,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",CHEMBL626998,10116.0,13889,A,1,Intermediate,,,1088.0,1
N,,50597,,,,7415,,Rattus norvegicus,,BAO_0000218,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",CHEMBL626999,10116.0,13890,A,1,Intermediate,,,,1
N,,50594,,,,8050,,Mus musculus,,BAO_0000218,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,CHEMBL627000,10090.0,13891,A,1,Intermediate,,,,1
N,,50594,,,,8050,,Mus musculus,,BAO_0000218,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,CHEMBL627001,10090.0,13892,A,1,Intermediate,,,,1
N,,50594,,,,8050,,Mus musculus,,BAO_0000218,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,CHEMBL627002,10090.0,13893,A,1,Intermediate,,,,1
N,,50594,,,,8050,,Mus musculus,,BAO_0000218,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,CHEMBL627003,10090.0,13894,A,1,Intermediate,,,,1
N,,50594,,,,8050,Urine,Mus musculus,,BAO_0000218,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,CHEMBL627004,10090.0,13895,A,1,Intermediate,,,1088.0,1
N,,50594,,,,8050,Urine,Mus musculus,,BAO_0000218,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,CHEMBL627005,10090.0,13896,A,1,Intermediate,,,1088.0,1
N,,50594,,,,8050,Urine,Mus musculus,,BAO_0000218,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,CHEMBL874594,10090.0,13897,A,1,Intermediate,,,1088.0,1
N,,50594,,,,8050,Urine,Mus musculus,,BAO_0000218,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,CHEMBL627006,10090.0,13898,A,1,Intermediate,,,1088.0,1
N,,50594,,,,8050,Urine,Mus musculus,,BAO_0000218,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,CHEMBL627007,10090.0,13899,A,1,Intermediate,,,1088.0,1
N,,50594,,,,8050,Urine,Mus musculus,,BAO_0000218,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,CHEMBL627884,10090.0,13900,A,1,Intermediate,,,1088.0,1
N,,50594,,,,8050,Urine,Mus musculus,,BAO_0000218,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,CHEMBL627885,10090.0,13901,A,1,Intermediate,,,1088.0,1
N,,50594,,,,8050,Urine,Mus musculus,,BAO_0000218,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,CHEMBL627886,10090.0,13902,A,1,Intermediate,,,1088.0,1
N,,50594,,,,8050,Urine,Mus musculus,,BAO_0000218,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,CHEMBL627887,10090.0,13903,A,1,Intermediate,,,1088.0,1
N,,50594,,,,8050,Urine,Mus musculus,,BAO_0000218,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,CHEMBL627888,10090.0,13904,A,1,Intermediate,,,1088.0,1
N,,50594,,,,8050,Urine,Mus musculus,,BAO_0000218,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,CHEMBL628057,10090.0,13905,A,1,Intermediate,,,1088.0,1
N,,50594,,,,8050,Urine,Mus musculus,,BAO_0000218,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,CHEMBL627405,10090.0,13906,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,CHEMBL627406,9615.0,13907,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,CHEMBL627407,9615.0,13908,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,CHEMBL627408,9615.0,13909,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,CHEMBL627409,9615.0,13910,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,CHEMBL875486,9615.0,13911,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,CHEMBL627410,9615.0,13912,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,CHEMBL627411,9615.0,13913,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,CHEMBL627412,9615.0,13914,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,CHEMBL627413,9615.0,13915,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,CHEMBL627414,9615.0,13916,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,CHEMBL627415,9615.0,13917,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,CHEMBL627416,9615.0,13918,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,CHEMBL627417,9615.0,13919,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,CHEMBL627418,9615.0,13920,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,CHEMBL627419,9615.0,13921,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,CHEMBL627320,9615.0,13922,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,CHEMBL627321,9615.0,13923,A,1,Intermediate,,,1088.0,1
N,,50597,,,In vivo,12017,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627322,10116.0,13924,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,12017,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627323,10116.0,13925,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,12017,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL627491,10116.0,13926,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,12017,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627492,10116.0,13927,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,12017,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627493,10116.0,13928,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,12017,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627494,10116.0,13929,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,12017,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627495,10116.0,13930,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,12017,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL627496,10116.0,13931,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,12017,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627497,10116.0,13932,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,12017,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627498,10116.0,13933,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,12017,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627499,10116.0,13934,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,12017,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL627500,10116.0,13935,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,12017,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL627501,10116.0,13936,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,12017,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625616,10116.0,13937,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,12017,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625617,10116.0,13938,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,12017,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625618,10116.0,13939,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,12017,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625619,10116.0,13940,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,12017,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL625620,10116.0,13941,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,12017,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625621,10116.0,13942,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,12017,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625622,10116.0,13943,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625788,10116.0,13944,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625789,10116.0,13945,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL625790,10116.0,13946,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL625791,10116.0,13947,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL622334,10116.0,13948,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL622335,10116.0,13949,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,12017,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL622336,10116.0,13950,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,12017,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL622337,10116.0,13951,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,12017,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL622338,10116.0,13952,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,12017,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL622339,10116.0,13953,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL624153,10116.0,13954,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL628430,10116.0,13955,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL628431,10116.0,13956,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL628432,10116.0,13957,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL628433,10116.0,13958,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",CHEMBL628434,10116.0,13959,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",CHEMBL626789,10116.0,13960,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",CHEMBL626790,10116.0,13961,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",CHEMBL626791,10116.0,13962,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",CHEMBL626792,10116.0,13963,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",CHEMBL626793,10116.0,13964,A,1,Intermediate,,,2106.0,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,CHEMBL627436,10116.0,13965,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,CHEMBL627437,10116.0,13966,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,CHEMBL627438,10116.0,13967,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,CHEMBL627439,10116.0,13968,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,CHEMBL627440,10116.0,13969,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,CHEMBL627602,10116.0,13970,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,CHEMBL627603,10116.0,13971,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,CHEMBL627604,10116.0,13972,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,CHEMBL627605,10116.0,13973,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,CHEMBL627606,10116.0,13974,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,CHEMBL627607,10116.0,13975,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,CHEMBL627608,10116.0,13976,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,CHEMBL627609,10116.0,13977,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,CHEMBL627610,10116.0,13978,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,CHEMBL627611,10116.0,13979,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,CHEMBL627612,10116.0,13980,A,1,Intermediate,,,,1
U,,22229,,,,8362,,,,BAO_0000100,,Octanol:water partition coefficient is evaluated,CHEMBL627613,,13981,P,1,Autocuration,,,,0
U,,22224,,,,8257,,,,BAO_0000100,,Partition coefficient in 1-octanol/water system,CHEMBL627614,,13982,P,1,Autocuration,,,,0
U,,22224,,,,8257,,,,BAO_0000100,,Partition coefficient in 1-octanol/water system measured using radio active compounds,CHEMBL627615,,13983,P,1,Autocuration,,,,0
U,,22224,,,,9468,,,,BAO_0000100,,Partition coefficient in octanol/water system was determined,CHEMBL627616,,13984,P,1,Autocuration,,,,0
U,,22224,,,,9468,,,,BAO_0000100,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,CHEMBL627617,,13985,P,1,Autocuration,,,,0
U,,22224,,,,10568,,,,BAO_0000019,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,CHEMBL627618,,13986,A,1,Autocuration,,,,0
U,,22224,,,,10568,,,,BAO_0000019,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",CHEMBL627619,,13987,A,1,Autocuration,,,,0
U,,22224,,,,15359,,,,BAO_0000019,,Pseudo-first-order rate constant of the compound,CHEMBL627620,,13988,A,1,Autocuration,,,,0
U,,22224,,,,15359,,,,BAO_0000019,,Pseudo-first-order rate constant with 1-min time point,CHEMBL627621,,13989,A,1,Autocuration,,,,0
U,,22224,,,,15359,,,,BAO_0000019,,Pseudo-first-order rate constant without 1-min time point,CHEMBL627622,,13990,A,1,Autocuration,,,,0
U,,22224,,,,10431,,,,BAO_0000019,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,CHEMBL627623,,13991,A,1,Autocuration,,,,0
U,,22224,,,,10431,,,,BAO_0000019,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,CHEMBL627624,,13992,A,1,Autocuration,,,,0
U,,22224,,,,10431,,,,BAO_0000019,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,CHEMBL627625,,13993,A,1,Autocuration,,,,0
U,,22224,,,,15704,,,,BAO_0000019,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,CHEMBL628523,,13994,A,1,Autocuration,,,,0
U,,22224,,,,15287,,,,BAO_0000019,,The alkaline hydrolysis second order rate constant(K OH) of the compound,CHEMBL628524,,13995,A,1,Autocuration,,,,0
U,,22224,,,,7516,,,,BAO_0000019,,The efflux rate constant of the compound,CHEMBL628525,,13996,A,1,Autocuration,,,,0
U,,22224,,,,12973,,,,BAO_0000019,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,CHEMBL625732,,13997,A,1,Autocuration,,,,0
U,,22224,,,,12973,,,,BAO_0000019,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,CHEMBL625733,,13998,A,1,Autocuration,,,,0
U,,22224,,,,12973,,,,BAO_0000019,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,CHEMBL625734,,13999,F,1,Autocuration,,,,0
U,,22224,,,,12973,,,,BAO_0000019,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,CHEMBL625913,,14000,A,1,Autocuration,,,,0
U,,22224,,,,8696,,,,BAO_0000019,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,CHEMBL625914,,14001,A,1,Autocuration,,,,0
U,,22224,,,,15052,,,,BAO_0000019,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,CHEMBL625915,,14002,A,1,Autocuration,,,,0
U,,22224,,,,15052,,,,BAO_0000019,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,CHEMBL625916,,14003,A,1,Autocuration,,,,0
U,,22224,,,,10503,,,,BAO_0000019,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),CHEMBL625917,,14004,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL625918,,14005,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL625919,,14006,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL625920,,14007,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL874453,,14008,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",CHEMBL625921,,14009,A,1,Autocuration,,,,0
U,,22224,,,,10503,,,,BAO_0000019,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,CHEMBL625922,,14010,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL625923,,14011,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL625924,,14012,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL625925,,14013,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL625926,,14014,A,1,Autocuration,,,,0
N,,50597,,,In vivo,13100,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat lung at 60 minutes after dose administration.,CHEMBL627704,10116.0,14015,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13100,,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,CHEMBL627705,10116.0,14016,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13100,,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,CHEMBL627706,10116.0,14017,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13100,,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,CHEMBL627707,10116.0,14018,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13100,,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,CHEMBL627708,10116.0,14019,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13100,,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,CHEMBL628361,10116.0,14020,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13100,,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,CHEMBL628362,10116.0,14021,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13100,Striatum,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat striatum at 120 minutes after dose administration.,CHEMBL628363,10116.0,14022,A,1,Intermediate,,,2435.0,1
N,,50597,,,In vivo,13100,Striatum,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat striatum at 1440 minutes after dose administration.,CHEMBL628364,10116.0,14023,A,1,Intermediate,,,2435.0,1
N,,50597,,,In vivo,13100,Striatum,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat striatum at 15 minutes after dose administration.,CHEMBL628365,10116.0,14024,A,1,Intermediate,,,2435.0,1
N,,50597,,,In vivo,13100,Striatum,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat striatum at 240 minutes after dose administration.,CHEMBL874454,10116.0,14025,A,1,Intermediate,,,2435.0,1
N,,50597,,,In vivo,13100,Striatum,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat striatum at 30 minutes after dose administration.,CHEMBL628531,10116.0,14026,A,1,Intermediate,,,2435.0,1
N,,50597,,,In vivo,13100,Striatum,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat striatum at 360 minutes after dose administration.,CHEMBL628532,10116.0,14027,A,1,Intermediate,,,2435.0,1
N,,50597,,,In vivo,13100,Striatum,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat striatum at 3 hr after dose administration.,CHEMBL628533,10116.0,14028,A,1,Intermediate,,,2435.0,1
N,,50597,,,In vivo,13100,Striatum,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat striatum at 60 minutes after dose administration.,CHEMBL628534,10116.0,14029,A,1,Intermediate,,,2435.0,1
N,,50597,,,In vivo,13100,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat thyroid at 120 minutes after dose administration.,CHEMBL628535,10116.0,14030,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,13100,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,CHEMBL628536,10116.0,14031,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,13100,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat thyroid at 15 minutes after dose administration.,CHEMBL628537,10116.0,14032,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,13100,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat thyroid at 240 minutes after dose administration.,CHEMBL628538,10116.0,14033,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,13100,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat thyroid at 30 minutes after dose administration.,CHEMBL628539,10116.0,14034,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,13100,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat thyroid at 360 minutes after dose administration.,CHEMBL630297,10116.0,14035,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,13100,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat thyroid at 60 minutes after dose administration.,CHEMBL630298,10116.0,14036,A,1,Intermediate,,,2046.0,1
N,,50597,,,In vivo,13100,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,CHEMBL630299,10116.0,14037,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13100,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,CHEMBL628094,10116.0,14038,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13100,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,CHEMBL628095,10116.0,14039,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13100,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,CHEMBL874648,10116.0,14040,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13100,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,CHEMBL628096,10116.0,14041,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13100,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,CHEMBL628097,10116.0,14042,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13100,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,CHEMBL628098,10116.0,14043,A,1,Intermediate,,,955.0,1
U,,22224,,,,13331,,,,BAO_0000019,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",CHEMBL628099,,14044,A,1,Autocuration,,,,0
U,,22224,,,,13331,,,,BAO_0000019,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",CHEMBL628100,,14045,A,1,Autocuration,,,,0
U,,22224,,,,13331,,,,BAO_0000019,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),CHEMBL628101,,14046,A,1,Autocuration,,,,0
U,,22224,,,,13331,,,,BAO_0000019,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",CHEMBL628102,,14047,A,1,Autocuration,,,,0
U,,22224,,,,13331,,,,BAO_0000019,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",CHEMBL628103,,14048,A,1,Autocuration,,,,0
U,,22224,,,,13331,,,,BAO_0000019,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",CHEMBL628104,,14049,A,1,Autocuration,,,,0
U,,22224,,,,13331,,,,BAO_0000019,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",CHEMBL628105,,14050,A,1,Autocuration,,,,0
U,,22224,,,,13331,,,,BAO_0000019,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",CHEMBL628106,,14051,A,1,Autocuration,,,,0
N,,50597,,,,10086,Urine,Rattus norvegicus,,BAO_0000218,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,CHEMBL628107,10116.0,14052,A,1,Intermediate,,,1088.0,1
U,,22224,,,,10086,Urine,,,BAO_0000218,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,CHEMBL628108,,14053,F,1,Autocuration,,,1088.0,0
N,,50597,,,,10086,Urine,Rattus norvegicus,,BAO_0000218,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,CHEMBL628109,10116.0,14054,A,1,Intermediate,,,1088.0,1
U,,22224,,,,10086,Urine,,,BAO_0000218,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,CHEMBL625299,,14055,F,1,Autocuration,,,1088.0,0
N,,50597,,,,10086,Urine,Rattus norvegicus,,BAO_0000218,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,CHEMBL625300,10116.0,14056,A,1,Intermediate,,,1088.0,1
N,,50597,,,,10086,Urine,Rattus norvegicus,,BAO_0000218,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,CHEMBL625301,10116.0,14057,A,1,Intermediate,,,1088.0,1
N,,50597,,,,10086,Urine,Rattus norvegicus,,BAO_0000218,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,CHEMBL625302,10116.0,14058,A,1,Intermediate,,,1088.0,1
N,,50597,,,,10086,Urine,Rattus norvegicus,,BAO_0000218,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,CHEMBL874649,10116.0,14059,A,1,Intermediate,,,1088.0,1
N,,50597,,,,13248,,Rattus norvegicus,,BAO_0000218,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,CHEMBL625303,10116.0,14060,A,1,Intermediate,,,,1
N,,50597,,,,13248,,Rattus norvegicus,,BAO_0000218,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,CHEMBL625463,10116.0,14061,A,1,Intermediate,,,,1
N,,50587,,,,14527,Liver,Homo sapiens,,BAO_0000218,,In vitro metabolism in human liver microsomes,CHEMBL625464,9606.0,14062,A,1,Intermediate,,,2107.0,1
N,,50587,,,,3008,,Homo sapiens,,BAO_0000218,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,CHEMBL625465,9606.0,14063,A,1,Intermediate,,,,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,CHEMBL625466,9615.0,14064,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,CHEMBL625467,9615.0,14065,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,CHEMBL625468,10116.0,14066,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,CHEMBL625469,10116.0,14067,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,CHEMBL625470,10116.0,14068,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,CHEMBL632418,10116.0,14069,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,CHEMBL627250,10116.0,14070,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,CHEMBL627251,10116.0,14071,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,CHEMBL627252,10116.0,14072,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,CHEMBL627253,10116.0,14073,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,CHEMBL627254,10116.0,14074,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,CHEMBL875471,10116.0,14075,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,CHEMBL627255,10116.0,14076,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,CHEMBL627256,10116.0,14077,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,CHEMBL627257,10116.0,14078,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,CHEMBL627258,10116.0,14079,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,CHEMBL627259,10116.0,14080,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,CHEMBL627260,10116.0,14081,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,CHEMBL623256,10116.0,14082,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,CHEMBL874413,10116.0,14083,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,CHEMBL623257,10116.0,14084,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,CHEMBL623258,10116.0,14085,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,CHEMBL623259,10116.0,14086,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,CHEMBL623260,10116.0,14087,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,CHEMBL623261,10116.0,14088,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,CHEMBL623262,10116.0,14089,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,CHEMBL623263,10116.0,14090,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,CHEMBL623264,10116.0,14091,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,CHEMBL623265,10116.0,14092,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,CHEMBL623266,10116.0,14093,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,CHEMBL623267,10116.0,14094,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,CHEMBL623268,10116.0,14095,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,CHEMBL623269,10116.0,14096,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,CHEMBL623270,10116.0,14097,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,CHEMBL623271,10116.0,14098,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,CHEMBL623272,10116.0,14099,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,CHEMBL623273,10116.0,14100,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,CHEMBL623274,10116.0,14101,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,CHEMBL874414,10116.0,14102,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,CHEMBL623275,10116.0,14103,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,CHEMBL629150,10116.0,14104,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,CHEMBL623276,10116.0,14105,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,CHEMBL623277,10116.0,14106,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,CHEMBL623112,10116.0,14107,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,CHEMBL623113,10116.0,14108,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,CHEMBL623800,10116.0,14109,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,CHEMBL623801,10116.0,14110,A,1,Intermediate,,,1088.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",CHEMBL623802,10116.0,14111,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Uterus,Rattus norvegicus,,BAO_0000218,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623803,10116.0,14112,A,1,Intermediate,,,995.0,1
N,,50597,,,In vivo,12017,Uterus,Rattus norvegicus,,BAO_0000218,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623970,10116.0,14113,A,1,Intermediate,,,995.0,1
N,,50597,,,In vivo,12017,Uterus,Rattus norvegicus,,BAO_0000218,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL623971,10116.0,14114,A,1,Intermediate,,,995.0,1
N,,50597,,,In vivo,14045,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),CHEMBL623972,10116.0,14115,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,14045,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),CHEMBL623973,10116.0,14116,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,14045,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),CHEMBL623974,10116.0,14117,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,14045,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),CHEMBL623975,10116.0,14118,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,14045,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),CHEMBL623976,10116.0,14119,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,14045,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),CHEMBL623977,10116.0,14120,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,14045,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),CHEMBL623978,10116.0,14121,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,14045,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),CHEMBL623979,10116.0,14122,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,14045,,Rattus norvegicus,,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),CHEMBL623980,10116.0,14123,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14045,,Rattus norvegicus,,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),CHEMBL623981,10116.0,14124,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14045,,Rattus norvegicus,,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),CHEMBL626278,10116.0,14125,A,1,Intermediate,,,,1
N,,50597,,,In vivo,14045,,Rattus norvegicus,,BAO_0000218,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),CHEMBL626279,10116.0,14126,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14045,,Mus musculus,,BAO_0000218,,Biodistribution in mice bladder plus excreted urine was determined,CHEMBL626280,10090.0,14127,A,1,Intermediate,,,,1
N,,50594,,,,14045,,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse blood, 10 minutes post injection",CHEMBL626281,10090.0,14128,A,1,Intermediate,,,,1
N,,50594,,,,14045,,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse blood, 30 minutes post injection",CHEMBL626282,10090.0,14129,A,1,Intermediate,,,,1
N,,50594,,,,14045,,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse blood, 5 minutes post injection",CHEMBL626283,10090.0,14130,A,1,Intermediate,,,,1
N,,50594,,,,14045,,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse blood, 60 minutes post injection",CHEMBL626284,10090.0,14131,A,1,Intermediate,,,,1
N,,50594,,,,14045,Brain,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse brain, 10 minutes post injection",CHEMBL626285,10090.0,14132,A,1,Intermediate,,,955.0,1
N,,50594,,,,14045,Brain,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse brain, 30 minutes post injection",CHEMBL626286,10090.0,14133,A,1,Intermediate,,,955.0,1
N,,50594,,,,14045,Brain,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse brain, 5 minutes post injection",CHEMBL626287,10090.0,14134,A,1,Intermediate,,,955.0,1
N,,50594,,,,14045,Brain,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse brain, 60 minutes post injection",CHEMBL626288,10090.0,14135,A,1,Intermediate,,,955.0,1
N,,50594,,,,14045,,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse heart, 10 minutes post injection",CHEMBL626289,10090.0,14136,A,1,Intermediate,,,,1
N,,50594,,,,14045,,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse heart, 30 minutes post injection",CHEMBL626290,10090.0,14137,A,1,Intermediate,,,,1
N,,50594,,,,14045,,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse heart, 5 minutes post injection",CHEMBL626291,10090.0,14138,A,1,Intermediate,,,,1
N,,50594,,,,14045,,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse heart, 60 minutes post injection",CHEMBL839888,10090.0,14139,A,1,Intermediate,,,,1
N,,50594,,,,14045,Intestine,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",CHEMBL626292,10090.0,14140,A,1,Intermediate,,,160.0,1
N,,50594,,,,14045,Intestine,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",CHEMBL626293,10090.0,14141,A,1,Intermediate,,,160.0,1
N,,50594,,,,14045,Intestine,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",CHEMBL626294,10090.0,14142,A,1,Intermediate,,,160.0,1
N,,50594,,,,14045,Intestine,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",CHEMBL626295,10090.0,14143,A,1,Intermediate,,,160.0,1
N,,50594,,,,14045,Liver,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse liver, 10 minutes post injection",CHEMBL627659,10090.0,14144,A,1,Intermediate,,,2107.0,1
N,,50594,,,,14045,Liver,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",CHEMBL627660,10090.0,14145,A,1,Intermediate,,,2107.0,1
N,,50594,,,,14045,Liver,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse liver, 5 minutes post injection",CHEMBL627661,10090.0,14146,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,14045,Liver,Mus musculus,,BAO_0000218,,Biodistribution in mice liver at 60 minutes of post injection,CHEMBL627662,10090.0,14147,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,14045,Lung,Mus musculus,,BAO_0000218,,Biodistribution in mice lungs at 10 min of post injection,CHEMBL627663,10090.0,14148,A,1,Intermediate,,,2048.0,1
N,,50594,,,,14045,,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mouse lung, 30 minutes post injection",CHEMBL627664,10090.0,14149,A,1,Intermediate,,,,1
N,,50594,,,,14045,,Mus musculus,,BAO_0000218,,"Percentage biodistribution in mousee lung, 5 minutes post injection",CHEMBL627665,10090.0,14150,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14045,Lung,Mus musculus,,BAO_0000218,,Biodistribution in mice lungs at 60 min of post injection,CHEMBL627666,10090.0,14151,A,1,Intermediate,,,2048.0,1
N,,50594,,,,14045,Spleen,Mus musculus,,BAO_0000218,,Percentage biodistribution in mouse spleen,CHEMBL627667,10090.0,14152,A,1,Intermediate,,,2106.0,1
N,,50594,,,,14045,Stomach,Mus musculus,,BAO_0000218,,Percentage biodistribution in mouse stomach,CHEMBL627668,10090.0,14153,A,1,Intermediate,,,945.0,1
N,,50594,,,,11745,Urine,Mus musculus,,BAO_0000218,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,CHEMBL627669,10090.0,14154,A,1,Intermediate,,,1088.0,1
U,,22224,,,In vivo,13257,Urinary bladder,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,CHEMBL627670,,14155,A,1,Autocuration,,,1255.0,0
U,,22224,,,In vivo,13257,Blood,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,CHEMBL627671,,14156,A,1,Autocuration,,,178.0,0
U,,22224,,,In vivo,13257,Bone element,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,CHEMBL627672,,14157,A,1,Autocuration,,,1474.0,0
U,,22224,,,In vivo,13257,,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,CHEMBL627673,,14158,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13257,Kidney,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,CHEMBL627674,,14159,A,1,Autocuration,,,2113.0,0
U,,22224,,,In vivo,13257,Liver,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,CHEMBL627675,,14160,A,1,Autocuration,,,2107.0,0
U,,22224,,,In vivo,13257,Lung,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,CHEMBL627676,,14161,A,1,Autocuration,,,2048.0,0
U,,22224,,,In vivo,13257,Muscle tissue,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,CHEMBL627677,,14162,A,1,Autocuration,,,2385.0,0
U,,22224,,,,8354,,,,BAO_0000019,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",CHEMBL627678,,14163,A,1,Autocuration,,,,0
N,,50597,,,,7095,Serum,Rattus norvegicus,,BAO_0000218,,Affinity for protein binding expressed as association constant in fresh rat serum,CHEMBL627679,10116.0,14164,A,1,Intermediate,,,1977.0,1
U,,22224,,,,12185,,,,BAO_0000019,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,CHEMBL627680,,14165,A,1,Autocuration,,,,0
U,,22224,,,,12185,,,,BAO_0000019,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,CHEMBL627681,,14166,A,1,Autocuration,,,,0
U,,22224,,,,12185,,,,BAO_0000019,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,CHEMBL627682,,14167,A,1,Autocuration,,,,0
U,,22224,,,,12185,,,,BAO_0000019,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,CHEMBL627683,,14168,A,1,Autocuration,,,,0
U,,22224,,,,12686,,,,BAO_0000019,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,CHEMBL627684,,14169,A,1,Autocuration,,,,0
U,,22224,,,,12686,,,,BAO_0000019,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",CHEMBL874441,,14170,A,1,Autocuration,,,,0
U,,22224,,,,12686,,,,BAO_0000019,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,CHEMBL627685,,14171,A,1,Autocuration,,,,0
U,,22224,,,,12686,,,,BAO_0000019,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",CHEMBL627686,,14172,A,1,Autocuration,,,,0
U,,22224,,,,8057,,,,BAO_0000019,,Apparent rate constant Koff for inactivation of dTMP synthase.,CHEMBL627687,,14173,A,1,Autocuration,,,,0
U,,22224,,,,15778,,,,BAO_0000019,,The irreversible inhibitor activity by second order rate equation.,CHEMBL627688,,14174,A,1,Autocuration,,,,0
N,,50597,,,,12375,,Rattus norvegicus,,BAO_0000218,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,CHEMBL628038,10116.0,14175,A,1,Intermediate,,,,1
N,,50597,,,,12375,,Rattus norvegicus,,BAO_0000218,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,CHEMBL628039,10116.0,14176,A,1,Intermediate,,,,1
N,,50597,,,,12375,,Rattus norvegicus,,BAO_0000218,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,CHEMBL628040,10116.0,14177,A,1,Intermediate,,,,1
U,,22224,,,,13588,,,,BAO_0000019,,Dissociation rate calculated from the first-order equation using t1/2 value,CHEMBL628041,,14178,A,1,Autocuration,,,,0
U,,22224,,,,15039,,,,BAO_0000019,,The compound was tested for Binding constant against DNA,CHEMBL630226,,14179,A,1,Autocuration,,,,0
U,,22224,,,,9500,,,,BAO_0000019,,First order rate constant for cyclization of the compound,CHEMBL628042,,14180,A,1,Autocuration,,,,0
U,,22224,,,,10014,,,,BAO_0000019,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,CHEMBL625232,,14181,A,1,Autocuration,,,,0
U,,22224,,,,10014,,,,BAO_0000019,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,CHEMBL625233,,14182,A,1,Autocuration,,,,0
U,,22224,,,,568,,,,BAO_0000019,,Hydrolysis rate constant was determined,CHEMBL625979,,14183,A,1,Autocuration,,,,0
U,,22224,,,,10026,,,,BAO_0000019,,Observed first order rate constant,CHEMBL625980,,14184,A,1,Autocuration,,,,0
U,,22224,,,,10281,,,,BAO_0000019,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,CHEMBL625981,,14185,A,1,Autocuration,,,,0
U,,22224,,,,10281,,,,BAO_0000019,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,CHEMBL625982,,14186,A,1,Autocuration,,,,0
U,,22224,,,,9680,,,,BAO_0000019,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,CHEMBL625983,,14187,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625984,,14188,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625985,,14189,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625986,,14190,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625987,,14191,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625988,,14192,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625989,,14193,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625990,,14194,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625991,,14195,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625992,,14196,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL625993,,14197,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL631973,,14198,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632143,,14199,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632144,,14200,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632145,,14201,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632146,,14202,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632147,,14203,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632148,,14204,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632149,,14205,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632150,,14206,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL632151,,14207,A,1,Autocuration,,,,0
N,,50587,,,,3008,,Homo sapiens,,BAO_0000218,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,CHEMBL632152,9606.0,14208,A,1,Intermediate,,,,1
N,,50587,,,,4509,,Homo sapiens,,BAO_0000218,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,CHEMBL632153,9606.0,14209,A,1,Intermediate,,,,1
N,,50587,,,,4509,,Homo sapiens,,BAO_0000218,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,CHEMBL632154,9606.0,14210,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,CHEMBL632155,10298.0,14211,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,CHEMBL632156,10298.0,14212,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,CHEMBL632157,10298.0,14213,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,CHEMBL632158,10298.0,14214,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,CHEMBL632159,10298.0,14215,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,CHEMBL626305,10298.0,14216,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,CHEMBL626306,10298.0,14217,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,CHEMBL626307,10298.0,14218,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,CHEMBL626308,10298.0,14219,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,CHEMBL626479,10298.0,14220,A,1,Intermediate,,,,1
N,,50602,,,,8613,,Human herpesvirus 1,,BAO_0000218,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,CHEMBL626480,10298.0,14221,A,1,Intermediate,,,,1
U,,22229,,,,6021,,,,BAO_0000100,,Calculated partition coefficient (clogP) (MlogP),CHEMBL626481,,14222,P,1,Autocuration,,,,0
U,,22224,,,,9348,,,,BAO_0000019,,Equipotent potent ratio relative to carbachol (nicotinic activity),CHEMBL626482,,14223,A,1,Autocuration,,,,0
N,,50588,,,,15592,,Canis lupus familiaris,,BAO_0000218,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",CHEMBL626483,9615.0,14224,A,1,Intermediate,,,,1
N,,50588,,,,15592,,Canis lupus familiaris,,BAO_0000218,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",CHEMBL626484,9615.0,14225,A,1,Intermediate,,,,1
U,,22229,,,,15592,,,,BAO_0000100,,Solubility at pH 7.4 in micro g/mL;NA denotes available,CHEMBL626485,,14226,P,1,Autocuration,,,,0
U,,22229,,,,15592,,,,BAO_0000100,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,CHEMBL626486,,14227,P,1,Autocuration,,,,0
U,,22229,,,,15592,,,,BAO_0000100,,Solubility at pH 7.4 in ug/mL;NA denotes not available,CHEMBL626487,,14228,P,1,Autocuration,,,,0
N,,50588,,,In vivo,15592,Plasma,Canis lupus familiaris,,BAO_0000218,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,CHEMBL626488,9615.0,14229,A,1,Intermediate,,,1969.0,1
N,,50597,,,,7095,Serum,Rattus norvegicus,,BAO_0000218,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,CHEMBL626489,10116.0,14230,A,1,Intermediate,,,1977.0,1
U,,22224,,,,16618,,,,BAO_0000019,,Area under the MAP curve measured over 5 min; ND means Not determined,CHEMBL626490,,14231,A,1,Autocuration,,,,0
U,,22224,,,,16835,,,,BAO_0000100,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,CHEMBL626491,,14232,P,1,Autocuration,,,,0
U,,22229,,,,15284,,,,BAO_0000100,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,CHEMBL626492,,14233,P,1,Autocuration,,,,0
U,,22224,,,,15750,,,,BAO_0000019,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,CHEMBL626493,,14234,A,1,Autocuration,,,,0
N,,50597,,,In vivo,16618,,Rattus norvegicus,,BAO_0000218,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,CHEMBL626494,10116.0,14235,A,1,Intermediate,,,,1
U,,22224,,,In vivo,16618,,,,BAO_0000218,,Half life after oral tested,CHEMBL626495,,14236,A,1,Autocuration,,,,0
N,,50597,,,,15812,Plasma,Rattus norvegicus,,BAO_0000218,,Half life was determined in plasma of rat; NT indicates not tested,CHEMBL626496,10116.0,14237,A,1,Intermediate,,,1969.0,1
N,,50597,,,In vivo,16618,,Rattus norvegicus,,BAO_0000218,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,CHEMBL626497,10116.0,14238,A,1,Intermediate,,,,1
U,,22224,,,In vivo,16618,,,,BAO_0000218,,Oral bioavailability after oral tested,CHEMBL626498,,14239,A,1,Autocuration,,,,0
N,,50597,,,,13098,,Rattus norvegicus,,BAO_0000218,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),CHEMBL626499,10116.0,14240,A,1,Intermediate,,,,1
N,,50597,,,,13098,,Rattus norvegicus,,BAO_0000218,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),CHEMBL626500,10116.0,14241,A,1,Intermediate,,,,1
N,,50597,,,,15812,Plasma,Rattus norvegicus,,BAO_0000218,,half life was determined in plasma of rat; NT indicates not tested,CHEMBL626501,10116.0,14242,A,1,Intermediate,,,1969.0,1
N,,50597,,,,15812,Plasma,Rattus norvegicus,,BAO_0000218,,half life was determined in plasma of rat; NT means not tested,CHEMBL626502,10116.0,14243,A,1,Intermediate,,,1969.0,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,CHEMBL626503,10116.0,14244,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,CHEMBL626504,10116.0,14245,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,CHEMBL626505,10116.0,14246,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,CHEMBL626506,10116.0,14247,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,CHEMBL626507,10116.0,14248,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,CHEMBL626508,10116.0,14249,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,CHEMBL626509,10116.0,14250,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,CHEMBL875480,10116.0,14251,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,CHEMBL626510,10116.0,14252,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,CHEMBL626511,10116.0,14253,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,CHEMBL626512,10116.0,14254,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,CHEMBL628208,10116.0,14255,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,CHEMBL628209,10116.0,14256,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,CHEMBL628210,10116.0,14257,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,CHEMBL628211,10116.0,14258,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,CHEMBL628212,10116.0,14259,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,CHEMBL628213,10116.0,14260,A,1,Intermediate,,,,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,CHEMBL628214,10116.0,14261,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,CHEMBL628215,10116.0,14262,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,CHEMBL628216,10116.0,14263,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,CHEMBL626595,10116.0,14264,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,CHEMBL626596,10116.0,14265,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,CHEMBL626597,10116.0,14266,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,CHEMBL626598,10116.0,14267,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,CHEMBL622242,10116.0,14268,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,CHEMBL622243,10116.0,14269,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,CHEMBL622244,10116.0,14270,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,CHEMBL622245,10116.0,14271,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,CHEMBL622246,10116.0,14272,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,CHEMBL622247,10116.0,14273,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,CHEMBL622248,10116.0,14274,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,CHEMBL877483,10116.0,14275,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,CHEMBL622249,10116.0,14276,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,CHEMBL622250,9615.0,14277,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,CHEMBL622251,9615.0,14278,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,CHEMBL622252,9615.0,14279,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,CHEMBL622253,9615.0,14280,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,CHEMBL622254,9615.0,14281,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,CHEMBL622255,9615.0,14282,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,CHEMBL622256,9615.0,14283,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,CHEMBL622257,9615.0,14284,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,CHEMBL622258,9615.0,14285,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,CHEMBL622259,9615.0,14286,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,CHEMBL622927,9615.0,14287,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,CHEMBL622928,9615.0,14288,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,CHEMBL622929,9615.0,14289,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,CHEMBL623182,9615.0,14290,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,CHEMBL623183,9615.0,14291,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,CHEMBL623184,10116.0,14292,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,CHEMBL623185,10116.0,14293,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,CHEMBL877484,10116.0,14294,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,CHEMBL627274,10116.0,14295,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,CHEMBL623186,10116.0,14296,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,CHEMBL623187,10116.0,14297,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,CHEMBL623188,10116.0,14298,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,CHEMBL628055,10116.0,14299,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,CHEMBL628056,10116.0,14300,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,CHEMBL628200,10116.0,14301,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,CHEMBL628201,10116.0,14302,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,CHEMBL628202,10116.0,14303,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,CHEMBL628203,10116.0,14304,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,CHEMBL628204,10116.0,14305,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,CHEMBL628205,10116.0,14306,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,CHEMBL628206,10116.0,14307,A,1,Intermediate,,,1088.0,1
U,,22224,,,In vivo,13257,Prostate gland,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),CHEMBL628207,,14308,A,1,Autocuration,,,2367.0,0
U,,22224,,,In vivo,13257,Prostate gland,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,CHEMBL627220,,14309,A,1,Autocuration,,,2367.0,0
U,,22224,,,In vivo,13257,Muscle tissue,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,CHEMBL627221,,14310,A,1,Autocuration,,,2385.0,0
U,,22224,,,In vivo,13257,Prostate gland,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),CHEMBL627222,,14311,A,1,Autocuration,,,2367.0,0
U,,22224,,,In vivo,13257,,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,CHEMBL627223,,14312,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13257,Muscle tissue,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,CHEMBL632062,,14313,A,1,Autocuration,,,2385.0,0
U,,22224,,,In vivo,13257,Spleen,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,CHEMBL632063,,14314,A,1,Autocuration,,,2106.0,0
U,,22224,,,In vivo,13257,Urinary bladder,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,CHEMBL632064,,14315,A,1,Autocuration,,,1255.0,0
U,,22224,,,In vivo,13257,Blood,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,CHEMBL632065,,14316,A,1,Autocuration,,,178.0,0
U,,22224,,,In vivo,13257,Bone element,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,CHEMBL632066,,14317,A,1,Autocuration,,,1474.0,0
U,,22224,,,In vivo,13257,,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,CHEMBL632067,,14318,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13257,Kidney,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,CHEMBL629188,,14319,A,1,Autocuration,,,2113.0,0
U,,22224,,,In vivo,13257,Liver,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,CHEMBL629189,,14320,A,1,Autocuration,,,2107.0,0
U,,22224,,,In vivo,13257,Lung,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,CHEMBL629190,,14321,A,1,Autocuration,,,2048.0,0
U,,22224,,,In vivo,13257,Muscle tissue,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,CHEMBL629191,,14322,A,1,Autocuration,,,2385.0,0
U,,22224,,,In vivo,13257,Prostate gland,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),CHEMBL629192,,14323,A,1,Autocuration,,,2367.0,0
U,,22224,,,In vivo,13257,Muscle tissue,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,CHEMBL629193,,14324,A,1,Autocuration,,,2385.0,0
U,,22224,,,In vivo,13257,Prostate gland,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),CHEMBL629194,,14325,A,1,Autocuration,,,2367.0,0
U,,22224,,,In vivo,13257,,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,CHEMBL629195,,14326,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13257,Muscle tissue,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,CHEMBL629373,,14327,A,1,Autocuration,,,2385.0,0
U,,22224,,,In vivo,13257,Spleen,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,CHEMBL629374,,14328,A,1,Autocuration,,,2106.0,0
U,,22224,,,In vivo,13257,Prostate gland,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,CHEMBL629375,,14329,A,1,Autocuration,,,2367.0,0
U,,22224,,,In vivo,13257,Urinary bladder,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,CHEMBL629376,,14330,A,1,Autocuration,,,1255.0,0
U,,22224,,,In vivo,13257,Blood,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,CHEMBL629377,,14331,A,1,Autocuration,,,178.0,0
U,,22224,,,In vivo,13257,Bone element,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,CHEMBL629378,,14332,A,1,Autocuration,,,1474.0,0
U,,22224,,,In vivo,13257,,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,CHEMBL629379,,14333,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13257,Kidney,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,CHEMBL629151,,14334,A,1,Autocuration,,,2113.0,0
U,,22224,,,In vivo,13257,Liver,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,CHEMBL629152,,14335,A,1,Autocuration,,,2107.0,0
U,,22224,,,In vivo,13257,Lung,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,CHEMBL629153,,14336,A,1,Autocuration,,,2048.0,0
U,,22224,,,In vivo,13257,Muscle tissue,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,CHEMBL629154,,14337,A,1,Autocuration,,,2385.0,0
U,,22224,,,In vivo,13257,Prostate gland,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),CHEMBL629155,,14338,A,1,Autocuration,,,2367.0,0
U,,22224,,,In vivo,13257,Prostate gland,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,CHEMBL629156,,14339,A,1,Autocuration,,,2367.0,0
U,,22224,,,In vivo,13257,Muscle tissue,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,CHEMBL629157,,14340,A,1,Autocuration,,,2385.0,0
U,,22224,,,In vivo,13257,Prostate gland,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),CHEMBL629158,,14341,A,1,Autocuration,,,2367.0,0
U,,22224,,,In vivo,13257,,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,CHEMBL629159,,14342,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13257,Muscle tissue,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,CHEMBL629160,,14343,A,1,Autocuration,,,2385.0,0
U,,22224,,,In vivo,13257,Spleen,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,CHEMBL629161,,14344,A,1,Autocuration,,,2106.0,0
U,,22224,,,In vivo,13257,Urinary bladder,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,CHEMBL629162,,14345,A,1,Autocuration,,,1255.0,0
U,,22224,,,In vivo,13257,Blood,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,CHEMBL629163,,14346,A,1,Autocuration,,,178.0,0
U,,22224,,,In vivo,13257,Bone element,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,CHEMBL629164,,14347,A,1,Autocuration,,,1474.0,0
U,,22224,,,In vivo,13257,,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,CHEMBL629165,,14348,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13257,Liver,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,CHEMBL629166,,14349,A,1,Autocuration,,,2107.0,0
U,,22224,,,In vivo,13257,Lung,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,CHEMBL629167,,14350,A,1,Autocuration,,,2048.0,0
U,,22224,,,In vivo,13257,Muscle tissue,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,CHEMBL629168,,14351,A,1,Autocuration,,,2385.0,0
U,,22224,,,,2193,,,,BAO_0000019,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,CHEMBL629169,,14352,A,1,Autocuration,,,,0
U,,22224,,,,2193,,,,BAO_0000019,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,CHEMBL629170,,14353,A,1,Autocuration,,,,0
U,,22224,,,,2193,,,,BAO_0000019,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,CHEMBL631153,,14354,A,1,Autocuration,,,,0
U,,22224,,,,2193,,,,BAO_0000019,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,CHEMBL875121,,14355,A,1,Autocuration,,,,0
U,,22224,,,,2193,,,,BAO_0000019,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,CHEMBL631154,,14356,A,1,Autocuration,,,,0
U,,22224,,,,2193,,,,BAO_0000019,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,CHEMBL631155,,14357,A,1,Autocuration,,,,0
U,,22224,,,,568,,,,BAO_0000019,,Hydrolysis rate constant was determined,CHEMBL631156,,14358,A,1,Autocuration,,,,0
U,,22224,,,,9680,,,,BAO_0000019,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",CHEMBL631157,,14359,A,1,Autocuration,,,,0
U,,22224,,,,9680,,,,BAO_0000019,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",CHEMBL631158,,14360,A,1,Autocuration,,,,0
U,,22224,,,,9680,,,,BAO_0000019,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",CHEMBL631159,,14361,A,1,Autocuration,,,,0
U,,22224,,,,10026,,,,BAO_0000019,,Observed second order rate constant,CHEMBL631160,,14362,A,1,Autocuration,,,,0
U,,22224,,,,10281,,,,BAO_0000019,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,CHEMBL631161,,14363,A,1,Autocuration,,,,0
U,,22224,,,,10014,,,,BAO_0000019,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,CHEMBL631162,,14364,A,1,Autocuration,,,,0
U,,22224,,,,10014,,,,BAO_0000019,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,CHEMBL630313,,14365,A,1,Autocuration,,,,0
U,,22224,,,,9680,,,,BAO_0000019,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",CHEMBL630314,,14366,A,1,Autocuration,,,,0
U,,22224,,,,9680,,,,BAO_0000019,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",CHEMBL630315,,14367,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630316,,14368,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630986,,14369,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630987,,14370,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630988,,14371,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630989,,14372,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630990,,14373,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630991,,14374,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630992,,14375,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630993,,14376,A,1,Autocuration,,,,0
U,,22224,,,,13028,,,,BAO_0000019,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,CHEMBL630994,,14377,A,1,Autocuration,,,,0
N,,50597,,,,10014,,Rattus norvegicus,,BAO_0000218,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,CHEMBL630995,10116.0,14378,A,1,Intermediate,,,,1
U,,22224,,,,9962,,,,BAO_0000019,,Association constant for compound at 31 degree C was determined,CHEMBL629252,,14379,A,1,Autocuration,,,,0
U,,22224,,,,12029,,,,BAO_0000019,,Calculated antagonist equilibrium dissociation constant of the compound,CHEMBL629253,,14380,A,1,Autocuration,,,,0
U,,22224,,,,12029,,,,BAO_0000019,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,CHEMBL629944,,14381,A,1,Autocuration,,,,0
N,,50512,,,,10583,Trachea,Cavia porcellus,,BAO_0000218,,Dissociation constants vs LTE4 on guinea pig trachea,CHEMBL629945,10141.0,14382,A,1,Intermediate,,,3126.0,1
U,,22224,,,,568,,,,BAO_0000019,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",CHEMBL629946,,14383,A,1,Autocuration,,,,0
U,,22224,,,,568,,,,BAO_0000019,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",CHEMBL629947,,14384,A,1,Autocuration,,,,0
U,,22224,,,,568,,,,BAO_0000019,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",CHEMBL629948,,14385,A,1,Autocuration,,,,0
U,,22224,,,,568,,,,BAO_0000019,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",CHEMBL856024,,14386,A,1,Autocuration,,,,0
U,,22224,,,,7493,,,,BAO_0000019,,Affinity constant KD value was derived from TMP,CHEMBL629949,,14387,A,1,Autocuration,,,,0
U,,22224,,,,8371,,,,BAO_0000019,,Apparent dissociation (binding) rate constant was evaluated,CHEMBL629950,,14388,A,1,Autocuration,,,,0
U,,22224,,,,13114,,,,BAO_0000100,,Dissociation constant (KD) of the compound,CHEMBL630127,,14389,P,1,Autocuration,,,,0
U,,22224,,,,15515,,,,BAO_0000100,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,CHEMBL630128,,14390,P,1,Autocuration,,,,0
U,,22224,,,,522,,,,BAO_0000100,,Dissociation constant from ESR titration experiments,CHEMBL630129,,14391,P,1,Autocuration,,,,0
U,,22224,,,,13888,,,,BAO_0000019,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),CHEMBL630130,,14392,,1,Autocuration,,,,0
U,,22224,,,,2616,,,,BAO_0000100,,Dissociation constant was evaluated.,CHEMBL875234,,14393,P,1,Autocuration,,,,0
U,,22224,,,,3798,,,,BAO_0000100,,Dissociation constant was reported,CHEMBL630131,,14394,P,1,Autocuration,,,,0
N,,50597,,,,8731,,Rattus norvegicus,,BAO_0000218,,Dissociation constant was determined in rat pituitary cells.,CHEMBL630132,10116.0,14395,A,1,Intermediate,,,,1
U,,22224,,,,11892,,,,BAO_0000019,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,CHEMBL630133,,14396,A,1,Autocuration,,,,0
U,,22224,,,,11892,,,,BAO_0000019,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,CHEMBL630134,,14397,A,1,Autocuration,,,,0
U,,22224,,,,2582,,,,BAO_0000019,,Equilibrium dissociation constant of the compound,CHEMBL630135,,14398,A,1,Autocuration,,,,0
U,,22224,,,,11892,,,,BAO_0000019,,Equilibrium dissociation constant was determined,CHEMBL630136,,14399,A,1,Autocuration,,,,0
U,,22224,,,,13396,,,,BAO_0000019,,Kinetic constant KD was evaluated,CHEMBL630137,,14400,A,1,Autocuration,,,,0
U,,22224,,,,603,,,,BAO_0000019,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,CHEMBL630138,,14401,A,1,Autocuration,,,,0
U,,22224,,,,15673,,,,BAO_0000019,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,CHEMBL630139,,14402,A,1,Autocuration,,,,0
U,,22224,,,,10368,,,,BAO_0000019,,Rate constant for hydrolysis in aqueous acetone.,CHEMBL630140,,14403,A,1,Autocuration,,,,0
U,,22224,,,,14228,,,,BAO_0000019,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,CHEMBL875235,,14404,A,1,Autocuration,,,,0
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,CHEMBL876439,10116.0,14405,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,CHEMBL630605,10116.0,14406,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,CHEMBL630606,10116.0,14407,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,CHEMBL630607,10116.0,14408,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,CHEMBL630608,10116.0,14409,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,CHEMBL630609,10116.0,14410,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,CHEMBL630610,10116.0,14411,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,CHEMBL630611,10116.0,14412,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,CHEMBL629552,10116.0,14413,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,CHEMBL629733,10116.0,14414,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,CHEMBL629734,10116.0,14415,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,CHEMBL629735,10116.0,14416,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,CHEMBL629736,10116.0,14417,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,CHEMBL629737,10116.0,14418,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,CHEMBL629738,10116.0,14419,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,CHEMBL629739,10116.0,14420,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,CHEMBL629740,10116.0,14421,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,CHEMBL629741,10116.0,14422,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,CHEMBL629742,10116.0,14423,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,CHEMBL629743,10116.0,14424,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,CHEMBL629744,10116.0,14425,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,CHEMBL629745,10116.0,14426,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,CHEMBL629746,10116.0,14427,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,CHEMBL629747,10116.0,14428,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,CHEMBL629748,10116.0,14429,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,CHEMBL629749,10116.0,14430,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,CHEMBL629750,10116.0,14431,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,CHEMBL629751,10116.0,14432,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,CHEMBL629752,10116.0,14433,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,CHEMBL629753,10116.0,14434,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,CHEMBL629754,10116.0,14435,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,CHEMBL629755,10116.0,14436,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,CHEMBL629756,10116.0,14437,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,CHEMBL629757,10116.0,14438,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,CHEMBL629758,10116.0,14439,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,CHEMBL629759,10116.0,14440,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,CHEMBL629760,10116.0,14441,A,1,Intermediate,,,,1
N,,50597,,,,11510,,Rattus norvegicus,,BAO_0000218,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,CHEMBL876443,10116.0,14442,A,1,Intermediate,,,,1
N,,50588,,,,8310,,Canis lupus familiaris,,BAO_0000218,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,CHEMBL629761,9615.0,14443,A,1,Intermediate,,,,1
N,,50588,,,,8310,,Canis lupus familiaris,,BAO_0000218,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,CHEMBL629762,9615.0,14444,A,1,Intermediate,,,,1
N,,50594,,,,8310,,Mus musculus,,BAO_0000218,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,CHEMBL629763,10090.0,14445,A,1,Intermediate,,,,1
N,,50594,,,,8310,,Mus musculus,,BAO_0000218,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,CHEMBL629764,10090.0,14446,A,1,Intermediate,,,,1
N,,50594,,,,8310,,Mus musculus,,BAO_0000218,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,CHEMBL629765,10090.0,14447,A,1,Intermediate,,,,1
N,,50594,,,,8310,,Mus musculus,,BAO_0000218,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,CHEMBL629766,10090.0,14448,A,1,Intermediate,,,,1
N,,50594,,,,8310,,Mus musculus,,BAO_0000218,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,CHEMBL629767,10090.0,14449,A,1,Intermediate,,,,1
N,,50588,,,,8310,,Canis lupus familiaris,,BAO_0000218,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,CHEMBL629768,9615.0,14450,A,1,Intermediate,,,,1
N,,50594,,,,8310,,Mus musculus,,BAO_0000218,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,CHEMBL629769,10090.0,14451,A,1,Intermediate,,,,1
N,,50588,,,,8310,,Canis lupus familiaris,,BAO_0000218,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,CHEMBL629770,9615.0,14452,A,1,Intermediate,,,,1
N,,50588,,,,8310,,Canis lupus familiaris,,BAO_0000218,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,CHEMBL629771,9615.0,14453,A,1,Intermediate,,,,1
N,,50594,,,,8310,,Mus musculus,,BAO_0000218,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,CHEMBL629772,10090.0,14454,A,1,Intermediate,,,,1
N,,50594,,,,8310,,Mus musculus,,BAO_0000218,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,CHEMBL629773,10090.0,14455,A,1,Intermediate,,,,1
N,,50594,,,,8310,,Mus musculus,,BAO_0000218,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,CHEMBL625455,10090.0,14456,A,1,Intermediate,,,,1
N,,50594,,,,8310,,Mus musculus,,BAO_0000218,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,CHEMBL625456,10090.0,14457,A,1,Intermediate,,,,1
N,,50594,,,,8310,,Mus musculus,,BAO_0000218,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,CHEMBL625457,10090.0,14458,A,1,Intermediate,,,,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,CHEMBL625458,10116.0,14459,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,CHEMBL625459,10116.0,14460,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,CHEMBL875483,10116.0,14461,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,CHEMBL634779,10116.0,14462,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,CHEMBL625460,10116.0,14463,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,CHEMBL626117,10116.0,14464,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,CHEMBL626118,10116.0,14465,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,CHEMBL628342,10116.0,14466,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,CHEMBL628343,10116.0,14467,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,CHEMBL628344,10116.0,14468,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,CHEMBL628345,10116.0,14469,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,CHEMBL628346,10116.0,14470,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,CHEMBL628347,10116.0,14471,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,CHEMBL628348,10116.0,14472,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,CHEMBL628349,10116.0,14473,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,CHEMBL875611,10116.0,14474,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,CHEMBL628350,10116.0,14475,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,CHEMBL628351,10116.0,14476,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,CHEMBL628352,10116.0,14477,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,CHEMBL628353,10116.0,14478,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,CHEMBL628354,10116.0,14479,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,CHEMBL626667,10116.0,14480,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,CHEMBL626668,10116.0,14481,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,CHEMBL626669,10116.0,14482,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,CHEMBL626670,10116.0,14483,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,CHEMBL626671,10116.0,14484,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,CHEMBL626672,10116.0,14485,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,CHEMBL626673,10116.0,14486,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,CHEMBL626674,10116.0,14487,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,CHEMBL626675,10116.0,14488,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,CHEMBL626676,10116.0,14489,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,CHEMBL626677,10116.0,14490,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,CHEMBL626678,10116.0,14491,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,CHEMBL626679,10116.0,14492,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,CHEMBL875612,10116.0,14493,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,CHEMBL626680,10116.0,14494,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,CHEMBL626681,10116.0,14495,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,CHEMBL626682,10116.0,14496,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,CHEMBL626683,10116.0,14497,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,CHEMBL626684,10116.0,14498,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,CHEMBL626685,10116.0,14499,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,CHEMBL626686,10116.0,14500,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,CHEMBL626687,10116.0,14501,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,CHEMBL624978,10116.0,14502,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,CHEMBL624979,10116.0,14503,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,CHEMBL624980,10116.0,14504,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,CHEMBL624981,10116.0,14505,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,CHEMBL624982,9615.0,14506,A,1,Intermediate,,,1088.0,1
U,,22224,,,In vivo,13257,Prostate gland,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),CHEMBL627564,,14507,A,1,Autocuration,,,2367.0,0
U,,22224,,,In vivo,13257,Prostate gland,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),CHEMBL627565,,14508,A,1,Autocuration,,,2367.0,0
U,,22224,,,In vivo,13257,,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,CHEMBL627566,,14509,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13257,Muscle tissue,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,CHEMBL627567,,14510,A,1,Autocuration,,,2385.0,0
U,,22224,,,In vivo,13257,Spleen,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,CHEMBL627568,,14511,A,1,Autocuration,,,2106.0,0
U,,22224,,,In vivo,13257,Kidney,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,CHEMBL627569,,14512,A,1,Autocuration,,,2113.0,0
U,,22224,,,In vivo,13257,Urinary bladder,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,CHEMBL627570,,14513,A,1,Autocuration,,,1255.0,0
U,,22224,,,In vivo,13257,Blood,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,CHEMBL627571,,14514,A,1,Autocuration,,,178.0,0
U,,22224,,,In vivo,13257,Bone element,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,CHEMBL627572,,14515,A,1,Autocuration,,,1474.0,0
U,,22224,,,In vivo,13257,,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,CHEMBL627573,,14516,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13257,Kidney,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,CHEMBL627574,,14517,A,1,Autocuration,,,2113.0,0
U,,22224,,,In vivo,13257,Liver,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,CHEMBL627575,,14518,A,1,Autocuration,,,2107.0,0
U,,22224,,,In vivo,13257,Lung,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,CHEMBL627576,,14519,A,1,Autocuration,,,2048.0,0
U,,22224,,,In vivo,13257,Muscle tissue,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,CHEMBL627577,,14520,A,1,Autocuration,,,2385.0,0
U,,22224,,,In vivo,13257,Prostate gland,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),CHEMBL627578,,14521,A,1,Autocuration,,,2367.0,0
U,,22224,,,In vivo,13257,Prostate gland,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,CHEMBL627579,,14522,A,1,Autocuration,,,2367.0,0
U,,22224,,,In vivo,13257,Muscle tissue,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,CHEMBL627580,,14523,A,1,Autocuration,,,2385.0,0
U,,22224,,,In vivo,13257,Prostate gland,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),CHEMBL627581,,14524,A,1,Autocuration,,,2367.0,0
U,,22224,,,In vivo,13257,,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,CHEMBL627582,,14525,A,1,Autocuration,,,,0
U,,22224,,,In vivo,13257,Muscle tissue,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,CHEMBL627583,,14526,A,1,Autocuration,,,2385.0,0
U,,22224,,,In vivo,13257,Spleen,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,CHEMBL627584,,14527,A,1,Autocuration,,,2106.0,0
U,,22224,,,In vivo,13257,Prostate gland,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,CHEMBL627585,,14528,A,1,Autocuration,,,2367.0,0
U,,22224,,,In vivo,13257,Muscle tissue,,,BAO_0000218,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,CHEMBL627586,,14529,A,1,Autocuration,,,2385.0,0
N,,50597,,,In vivo,15413,,Rattus norvegicus,,BAO_0000218,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,CHEMBL627587,10116.0,14530,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15413,,Rattus norvegicus,,BAO_0000218,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL627588,10116.0,14531,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15413,,Rattus norvegicus,,BAO_0000218,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,CHEMBL628250,10116.0,14532,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15413,,Rattus norvegicus,,BAO_0000218,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL628251,10116.0,14533,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15413,Hippocampus,Rattus norvegicus,,BAO_0000218,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,CHEMBL628252,10116.0,14534,A,1,Intermediate,,,10000000.0,1
N,,50597,,,In vivo,15413,Hippocampus,Rattus norvegicus,,BAO_0000218,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL628253,10116.0,14535,A,1,Intermediate,,,10000000.0,1
N,,50597,,,In vivo,15413,Hypothalamus,Rattus norvegicus,,BAO_0000218,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,CHEMBL628254,10116.0,14536,A,1,Intermediate,,,1898.0,1
N,,50597,,,In vivo,15413,Hypothalamus,Rattus norvegicus,,BAO_0000218,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL877493,10116.0,14537,A,1,Intermediate,,,1898.0,1
N,,50597,,,In vivo,15413,,Rattus norvegicus,,BAO_0000218,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL628255,10116.0,14538,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15413,,Rattus norvegicus,,BAO_0000218,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL628256,10116.0,14539,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15413,Hippocampus,Rattus norvegicus,,BAO_0000218,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL628257,10116.0,14540,A,1,Intermediate,,,10000000.0,1
N,,50597,,,In vivo,15413,Hypothalamus,Rattus norvegicus,,BAO_0000218,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL628258,10116.0,14541,A,1,Intermediate,,,1898.0,1
N,,50597,,,In vivo,15413,,Rattus norvegicus,,BAO_0000218,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL628259,10116.0,14542,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15413,,Rattus norvegicus,,BAO_0000218,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL628429,10116.0,14543,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15413,Hippocampus,Rattus norvegicus,,BAO_0000218,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,CHEMBL626862,10116.0,14544,A,1,Intermediate,,,10000000.0,1
N,,50597,,,In vivo,15413,Hypothalamus,Rattus norvegicus,,BAO_0000218,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,CHEMBL626863,10116.0,14545,A,1,Intermediate,,,1898.0,1
N,,50597,,,In vivo,15413,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,CHEMBL625886,10116.0,14546,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,15413,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,CHEMBL625887,10116.0,14547,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,15413,,Rattus norvegicus,,BAO_0000218,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,CHEMBL625888,10116.0,14548,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15413,,Rattus norvegicus,,BAO_0000218,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,CHEMBL625889,10116.0,14549,A,1,Intermediate,,,,1
N,,50597,,,In vivo,15413,Hippocampus,Rattus norvegicus,,BAO_0000218,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,CHEMBL625890,10116.0,14550,A,1,Intermediate,,,10000000.0,1
N,,50597,,,In vivo,15413,Hippocampus,Rattus norvegicus,,BAO_0000218,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,CHEMBL625891,10116.0,14551,A,1,Intermediate,,,10000000.0,1
N,,50597,,,In vivo,15413,Hypothalamus,Rattus norvegicus,,BAO_0000218,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,CHEMBL625892,10116.0,14552,A,1,Intermediate,,,1898.0,1
N,,50597,,,In vivo,15413,Hypothalamus,Rattus norvegicus,,BAO_0000218,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,CHEMBL625893,10116.0,14553,A,1,Intermediate,,,1898.0,1
N,,50597,,,In vivo,15413,Cerebellum,Rattus norvegicus,,BAO_0000218,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,CHEMBL625894,10116.0,14554,A,1,Intermediate,,,2037.0,1
N,,50597,,,In vivo,15413,,Rattus norvegicus,,BAO_0000218,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,CHEMBL625895,10116.0,14555,A,1,Intermediate,,,,1
U,,22224,,,,12404,,,,BAO_0000019,,Reaction rate parameter value for phosphate with transfer with respect to ATP,CHEMBL625896,,14556,A,1,Autocuration,,,,0
U,,22224,,,,568,,,,BAO_0000019,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",CHEMBL625897,,14557,A,1,Autocuration,,,,0
U,,22224,,,,568,,,,BAO_0000019,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",CHEMBL625898,,14558,A,1,Autocuration,,,,0
U,,22224,,,,568,,,,BAO_0000019,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",CHEMBL625899,,14559,A,1,Autocuration,,,,0
U,,22224,,,,12404,,,,BAO_0000019,,Reaction rate parameter value for phosphate with transfer with respect to ATP,CHEMBL626124,,14560,A,1,Autocuration,,,,0
N,,50212,,,,7624,,Escherichia coli,,BAO_0000218,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,CHEMBL628500,562.0,14561,A,1,Intermediate,,,,1
N,,50597,,,,7624,,Rattus norvegicus,,BAO_0000218,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",CHEMBL857856,10116.0,14562,A,1,Intermediate,,,,1
N,,50597,,,,7624,,Rattus norvegicus,,BAO_0000218,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",CHEMBL628501,10116.0,14563,A,1,Intermediate,,,,1
U,,22224,,,,4643,,,,BAO_0000019,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",CHEMBL628502,,14564,A,1,Autocuration,,,,0
U,,22224,,,,11532,,,,BAO_0000019,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,CHEMBL628503,,14565,A,1,Autocuration,,,,0
U,,22224,,,,11018,,,,BAO_0000019,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,CHEMBL628504,,14566,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",CHEMBL628505,,14567,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",CHEMBL874452,,14568,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",CHEMBL628506,,14569,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",CHEMBL628507,,14570,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",CHEMBL628508,,14571,A,1,Autocuration,,,,0
U,,22224,,,,8949,,,,BAO_0000019,,Michaelis constant (KM) was evaluated,CHEMBL628509,,14572,A,1,Autocuration,,,,0
U,,22224,,,,12404,,,,BAO_0000019,,Reaction rate parameter value for phosphate with transfer with respect to ATP,CHEMBL628510,,14573,A,1,Autocuration,,,,0
U,,22224,,,,7625,,,,BAO_0000019,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,CHEMBL628511,,14574,B,1,Autocuration,,,,0
U,,22224,,,,7625,,,,BAO_0000019,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,CHEMBL628512,,14575,B,1,Autocuration,,,,0
U,,22224,,,,7625,,,,BAO_0000019,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,CHEMBL628513,,14576,B,1,Autocuration,,,,0
U,,22224,,,,7625,,,,BAO_0000019,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,CHEMBL628514,,14577,B,1,Autocuration,,,,0
U,,22224,,,,12908,,,,BAO_0000019,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,CHEMBL628515,,14578,A,1,Autocuration,,,,0
U,,22224,,,,10368,,,,BAO_0000019,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,CHEMBL628516,,14579,A,1,Autocuration,,,,0
U,,22224,,,,13108,,,,BAO_0000019,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),CHEMBL628517,,14580,A,1,Autocuration,,,,0
U,,22224,,,,13108,,,,BAO_0000019,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),CHEMBL628518,,14581,A,1,Autocuration,,,,0
U,,22224,,,,15217,,,,BAO_0000019,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,CHEMBL628519,,14582,A,1,Autocuration,,,,0
U,,22224,,,,15217,,,,BAO_0000019,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,CHEMBL628520,,14583,A,1,Autocuration,,,,0
U,,22224,,,,10933,,,,BAO_0000019,,Binding constant was determined,CHEMBL628521,,14584,A,1,Autocuration,,,,0
U,,22224,,,,2363,,,,BAO_0000019,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,CHEMBL630443,,14585,A,1,Autocuration,,,,0
U,,22224,,,,2363,,,,BAO_0000019,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,CHEMBL630444,,14586,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,CHEMBL857732,,14587,A,1,Autocuration,,,,0
U,,22224,,,,14915,,,,BAO_0000100,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,CHEMBL630445,,14588,P,1,Autocuration,,,,0
U,,22224,,,,8847,,,,BAO_0000019,,Catalytic rate constant of the compound,CHEMBL630446,,14589,A,1,Autocuration,,,,0
U,,22224,,,,15357,,,,BAO_0000019,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,CHEMBL630447,,14590,B,1,Autocuration,,,,0
U,,22224,,,,2869,,,,BAO_0000019,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),CHEMBL630448,,14591,A,1,Autocuration,,,,0
U,,22224,,,,3484,,,,BAO_0000019,,Catalytic rate constant against phospholipase A2 was determined,CHEMBL630449,,14592,A,1,Autocuration,,,,0
U,,22224,,,,1373,,,,BAO_0000019,,"Compound was evaluated for catalytic constant, Kcat",CHEMBL630450,,14593,A,1,Autocuration,,,,0
U,,22224,,,,8142,,,,BAO_0000019,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,CHEMBL630451,,14594,A,1,Autocuration,,,,0
U,,22224,,,,14131,,,,BAO_0000019,,Kcat calculated from 0.693/T1/2,CHEMBL630452,,14595,A,1,Autocuration,,,,0
U,,22224,,,,17269,,,,BAO_0000019,,Kcat was determined,CHEMBL630453,,14596,A,1,Autocuration,,,,0
U,,22224,,,,3485,,,,BAO_0000019,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,CHEMBL630454,,14597,A,1,Autocuration,,,,0
U,,22224,,,,3485,,,,BAO_0000019,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,CHEMBL630455,,14598,A,1,Autocuration,,,,0
U,,22224,,,,3485,,,,BAO_0000019,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,CHEMBL631487,,14599,A,1,Autocuration,,,,0
U,,22224,,,,5962,,,,BAO_0000019,,Kcat value was determined,CHEMBL631488,,14600,A,1,Autocuration,,,,0
U,,22224,,,,3133,,,,BAO_0000019,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,CHEMBL876440,,14601,A,1,Autocuration,,,,0
U,,22224,,,,3133,,,,BAO_0000019,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,CHEMBL631489,,14602,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",CHEMBL857742,,14603,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",CHEMBL631490,,14604,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",CHEMBL631491,,14605,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",CHEMBL631492,,14606,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",CHEMBL631493,,14607,A,1,Autocuration,,,,0
U,,22224,,,,4892,,,,BAO_0000019,,Kinetic parameter for rate of conversion to PABA was determined,CHEMBL631494,,14608,A,1,Autocuration,,,,0
U,,22224,,,,3133,,,,BAO_0000019,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,CHEMBL631495,,14609,A,1,Autocuration,,,,0
N,,50597,,,,11488,Feces,Rattus norvegicus,,BAO_0000218,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",CHEMBL631496,10116.0,14610,A,1,Intermediate,,,1988.0,1
N,,50597,,,,11488,Urine,Rattus norvegicus,,BAO_0000218,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",CHEMBL631497,10116.0,14611,A,1,Intermediate,,,1088.0,1
N,,50597,,,,11488,Urine,Rattus norvegicus,,BAO_0000218,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",CHEMBL631498,10116.0,14612,A,1,Intermediate,,,1088.0,1
N,,50597,,,,11488,Urine,Rattus norvegicus,,BAO_0000218,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",CHEMBL629776,10116.0,14613,A,1,Intermediate,,,1088.0,1
N,,50597,,,,11488,Urine,Rattus norvegicus,,BAO_0000218,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",CHEMBL629777,10116.0,14614,A,1,Intermediate,,,1088.0,1
N,,50597,,,,11488,Urine,Rattus norvegicus,,BAO_0000218,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",CHEMBL629778,10116.0,14615,A,1,Intermediate,,,1088.0,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,CHEMBL630456,10116.0,14616,A,1,Intermediate,,,,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,CHEMBL630457,10116.0,14617,A,1,Intermediate,,,,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,CHEMBL630458,10116.0,14618,A,1,Intermediate,,,,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,CHEMBL630459,10116.0,14619,A,1,Intermediate,,,,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,CHEMBL630460,10116.0,14620,A,1,Intermediate,,,,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,CHEMBL876550,10116.0,14621,A,1,Intermediate,,,,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,CHEMBL630461,10116.0,14622,A,1,Intermediate,,,,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,CHEMBL630462,10116.0,14623,A,1,Intermediate,,,,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,CHEMBL630463,10116.0,14624,A,1,Intermediate,,,,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,CHEMBL630464,10116.0,14625,A,1,Intermediate,,,,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,CHEMBL630465,10116.0,14626,A,1,Intermediate,,,,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,CHEMBL630466,10116.0,14627,A,1,Intermediate,,,,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,CHEMBL630467,10116.0,14628,A,1,Intermediate,,,,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,CHEMBL630633,10116.0,14629,A,1,Intermediate,,,,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,CHEMBL630634,10116.0,14630,A,1,Intermediate,,,,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,CHEMBL630635,10116.0,14631,A,1,Intermediate,,,,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,CHEMBL630636,10116.0,14632,A,1,Intermediate,,,,1
N,,50597,,,,11488,,Rattus norvegicus,,BAO_0000218,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,CHEMBL630637,10116.0,14633,A,1,Intermediate,,,,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",CHEMBL630638,9986.0,14634,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",CHEMBL630639,9986.0,14635,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",CHEMBL630640,9986.0,14636,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",CHEMBL876551,9986.0,14637,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",CHEMBL630641,9986.0,14638,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",CHEMBL630642,9986.0,14639,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",CHEMBL630643,9986.0,14640,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",CHEMBL630644,9986.0,14641,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",CHEMBL630645,9986.0,14642,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",CHEMBL625599,9986.0,14643,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",CHEMBL625600,9986.0,14644,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",CHEMBL625601,9986.0,14645,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Feces,Oryctolagus cuniculus,,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",CHEMBL625602,9986.0,14646,A,1,Intermediate,,,1988.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",CHEMBL627470,9986.0,14647,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",CHEMBL627471,9986.0,14648,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",CHEMBL627472,9986.0,14649,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",CHEMBL627473,9986.0,14650,A,1,Intermediate,,,1088.0,1
N,,50592,,,,7132,Urine,Oryctolagus cuniculus,,BAO_0000218,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",CHEMBL627474,9986.0,14651,A,1,Intermediate,,,1088.0,1
N,,50597,,,In vivo,13925,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL627475,10116.0,14652,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,13925,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL627476,10116.0,14653,A,1,Intermediate,,,178.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,CHEMBL627477,9615.0,14654,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,CHEMBL627478,9615.0,14655,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,CHEMBL627479,9615.0,14656,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,CHEMBL627480,9615.0,14657,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,CHEMBL627481,9615.0,14658,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,CHEMBL627482,9615.0,14659,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,CHEMBL627483,9615.0,14660,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,CHEMBL875636,9615.0,14661,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,CHEMBL625764,9615.0,14662,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,CHEMBL625765,9615.0,14663,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,CHEMBL625766,9615.0,14664,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,CHEMBL625767,9615.0,14665,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,CHEMBL625768,9615.0,14666,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,CHEMBL625769,9615.0,14667,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,CHEMBL625770,9615.0,14668,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,CHEMBL625771,9615.0,14669,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,CHEMBL625772,9615.0,14670,A,1,Intermediate,,,1088.0,1
N,,50588,,,,12582,Urine,Canis lupus familiaris,,BAO_0000218,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,CHEMBL625773,9615.0,14671,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,CHEMBL625774,10116.0,14672,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,CHEMBL625775,10116.0,14673,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,CHEMBL625776,10116.0,14674,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,CHEMBL625777,10116.0,14675,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,CHEMBL625778,10116.0,14676,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,CHEMBL625779,10116.0,14677,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,CHEMBL625780,10116.0,14678,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,CHEMBL625781,10116.0,14679,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,CHEMBL875637,10116.0,14680,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,CHEMBL626473,10116.0,14681,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,CHEMBL626474,10116.0,14682,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,CHEMBL626475,10116.0,14683,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,CHEMBL626476,10116.0,14684,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,CHEMBL634397,10116.0,14685,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,CHEMBL626477,10116.0,14686,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,CHEMBL631069,10116.0,14687,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,CHEMBL631070,10116.0,14688,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,CHEMBL631071,10116.0,14689,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,CHEMBL631072,10116.0,14690,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,CHEMBL631073,10116.0,14691,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,CHEMBL631074,10116.0,14692,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,CHEMBL631075,10116.0,14693,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,CHEMBL631725,10116.0,14694,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,CHEMBL631726,10116.0,14695,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,CHEMBL631727,10116.0,14696,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,CHEMBL631728,10116.0,14697,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,CHEMBL631729,10116.0,14698,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,CHEMBL631730,10116.0,14699,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,CHEMBL631731,10116.0,14700,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,CHEMBL631910,10116.0,14701,A,1,Intermediate,,,1088.0,1
N,,50597,,,In vivo,15413,Hippocampus,Rattus norvegicus,,BAO_0000218,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,CHEMBL631911,10116.0,14702,A,1,Intermediate,,,10000000.0,1
N,,50597,,,In vivo,15413,Hypothalamus,Rattus norvegicus,,BAO_0000218,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,CHEMBL631912,10116.0,14703,A,1,Intermediate,,,1898.0,1
N,,50597,,,In vivo,15413,Hypothalamus,Rattus norvegicus,,BAO_0000218,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,CHEMBL631913,10116.0,14704,A,1,Intermediate,,,1898.0,1
N,,50597,,,In vivo,12017,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631914,10116.0,14705,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,12017,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631915,10116.0,14706,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,12017,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL875778,10116.0,14707,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,12017,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631916,10116.0,14708,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,12017,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631917,10116.0,14709,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,12017,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631918,10116.0,14710,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,12017,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631919,10116.0,14711,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,12017,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL631920,10116.0,14712,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,12017,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631921,10116.0,14713,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,12017,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631922,10116.0,14714,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,12017,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL631923,10116.0,14715,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631924,10116.0,14716,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630234,10116.0,14717,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL630235,10116.0,14718,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630236,10116.0,14719,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630237,10116.0,14720,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630238,10116.0,14721,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630239,10116.0,14722,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL630303,10116.0,14723,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630304,10116.0,14724,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,,Rattus norvegicus,,BAO_0000218,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630305,10116.0,14725,A,1,Intermediate,,,,1
N,,50597,,,In vivo,12017,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630306,10116.0,14726,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,12017,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630307,10116.0,14727,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,12017,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL630308,10116.0,14728,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,12017,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630309,10116.0,14729,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,12017,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL629309,10116.0,14730,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,12017,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL629993,10116.0,14731,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,12017,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL629994,10116.0,14732,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,12017,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL629995,10116.0,14733,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,12017,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631993,10116.0,14734,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,12017,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631994,10116.0,14735,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,12017,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631995,10116.0,14736,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,12017,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL631996,10116.0,14737,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,12017,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631997,10116.0,14738,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,12017,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631998,10116.0,14739,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,12017,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631999,10116.0,14740,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,12017,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL632000,10116.0,14741,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,12017,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL632001,10116.0,14742,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,12017,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL874424,10116.0,14743,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,12017,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL632002,10116.0,14744,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,12017,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL632003,10116.0,14745,A,1,Intermediate,,,2107.0,1
U,,22224,,,,3133,,,,BAO_0000019,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,CHEMBL632004,,14746,A,1,Autocuration,,,,0
U,,22224,,,,2742,,,,BAO_0000019,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,CHEMBL632005,,14747,A,1,Autocuration,,,,0
U,,22224,,,,2742,,,,BAO_0000019,,Compound was tested for amidase rate in the presence of N62C screen enzyme,CHEMBL632006,,14748,A,1,Autocuration,,,,0
U,,22224,,,,2742,,,,BAO_0000019,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,CHEMBL632007,,14749,A,1,Autocuration,,,,0
U,,22224,,,,2742,,,,BAO_0000019,,Compound was tested for amidase rate in the presence of S166C screen enzyme,CHEMBL632008,,14750,A,1,Autocuration,,,,0
U,,22224,,,,2742,,,,BAO_0000019,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,CHEMBL632009,,14751,A,1,Autocuration,,,,0
U,,22224,,,,2742,,,,BAO_0000019,,Compound was tested for esterase rate in the presence of N62C screen enzyme,CHEMBL632010,,14752,A,1,Autocuration,,,,0
U,,22224,,,,2742,,,,BAO_0000019,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,CHEMBL857750,,14753,A,1,Autocuration,,,,0
U,,22224,,,,2742,,,,BAO_0000019,,Compound was tested for esterase rate in the presence of S166C screen enzyme,CHEMBL632011,,14754,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",CHEMBL632012,,14755,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",CHEMBL632013,,14756,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",CHEMBL632014,,14757,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",CHEMBL629622,,14758,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",CHEMBL629623,,14759,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",CHEMBL629624,,14760,A,1,Autocuration,,,,0
U,,22224,,,,17269,,,,BAO_0000019,,Ratio of Kcat to that of Km was determined,CHEMBL629625,,14761,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",CHEMBL629626,,14762,A,1,Autocuration,,,,0
U,,22224,,,,2276,,,,BAO_0000019,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",CHEMBL629627,,14763,A,1,Autocuration,,,,0
U,,22224,,,,15917,,,,BAO_0000019,,"Compound was evaluated for constant, Kd",CHEMBL629628,,14764,A,1,Autocuration,,,,0
U,,22224,,,,10933,,,,BAO_0000019,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,CHEMBL629629,,14765,A,1,Autocuration,,,,0
U,,22224,,,,10933,,,,BAO_0000019,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,CHEMBL629630,,14766,A,1,Autocuration,,,,0
U,,22224,,,,14293,,,,BAO_0000019,,Dissociation Constant of compound determined,CHEMBL856030,,14767,A,1,Autocuration,,,,0
U,,22224,,,,6698,,,,BAO_0000019,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,CHEMBL629631,,14768,B,1,Autocuration,,,,0
U,,22224,,,,6698,,,,BAO_0000019,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,CHEMBL629632,,14769,B,1,Autocuration,,,,0
U,,22224,,,,4318,,,,BAO_0000100,,Dissociation constant of compound with Fructose was determined,CHEMBL629633,,14770,P,1,Autocuration,,,,0
U,,22224,,,,4318,,,,BAO_0000100,,Dissociation constant of compound with Fructose was determined; Not determined,CHEMBL629634,,14771,P,1,Autocuration,,,,0
U,,22224,,,,4318,,,,BAO_0000100,,Dissociation constant of compound with Lactulose was determined,CHEMBL629635,,14772,P,1,Autocuration,,,,0
U,,22224,,,,4318,,,,BAO_0000100,,Dissociation constant of compound with Lactulose was determined; Not determined,CHEMBL629636,,14773,P,1,Autocuration,,,,0
U,,22224,,,,14959,,,,BAO_0000100,,Dissociation constant of the Compound,CHEMBL629637,,14774,P,1,Autocuration,,,,0
U,,22224,,,,5913,,,,BAO_0000100,,Dissociation constant by non-linear regression analysis,CHEMBL629638,,14775,P,1,Autocuration,,,,0
U,,22224,,,,14218,,,,BAO_0000100,,Dissociation constant was determined,CHEMBL629639,,14776,P,1,Autocuration,,,,0
U,,22224,,,,10689,,,,BAO_0000100,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,CHEMBL629640,,14777,P,1,Autocuration,,,,0
U,,22224,,,,13925,,,,BAO_0000100,,Dissociation constant was determined,CHEMBL629641,,14778,P,1,Autocuration,,,,0
U,,22224,,,,16359,,,,BAO_0000100,,Dissociation constant was determined,CHEMBL631344,,14779,P,1,Autocuration,,,,0
N,,50597,,,,10944,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,CHEMBL631345,10116.0,14780,A,1,Intermediate,,,2385.0,1
U,,22224,,,,11080,,,,BAO_0000019,,The dissociation constant determined by fluorescence displacement assay,CHEMBL631346,,14781,A,1,Autocuration,,,,0
U,,22224,,,,17805,,,,BAO_0000019,,kd value surface plasmon resonance (SPR) method,CHEMBL631524,,14782,A,1,Autocuration,,,,0
N,,50597,,,,10944,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,CHEMBL631525,10116.0,14783,A,1,Intermediate,,,2385.0,1
U,,22224,,,,16645,,,,BAO_0000019,,First dissociation constant of the binding of compound to V30M TTR,CHEMBL631526,,14784,F,1,Autocuration,,,,0
U,,22224,,,,16645,,,,BAO_0000019,,Second dissociation constant of the binding of compound to V30M TTR,CHEMBL631527,,14785,F,1,Autocuration,,,,0
U,,22224,,,,7793,,,,BAO_0000019,,"Compound was evaluated for equilibrium constant, Ke",CHEMBL631528,,14786,A,1,Autocuration,,,,0
U,,22224,,,,12199,Hypothalamus,,,BAO_0000019,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,CHEMBL631529,,14787,A,1,Autocuration,,,1898.0,0
U,,22224,,,,12199,Hypothalamus,,,BAO_0000019,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,CHEMBL631530,,14788,A,1,Autocuration,,,1898.0,0
U,,22224,,,,9680,,,,BAO_0000019,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,CHEMBL631531,,14789,A,1,Autocuration,,,,0
U,,22224,,,,9680,,,,BAO_0000019,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,CHEMBL631532,,14790,A,1,Autocuration,,,,0
U,,22224,,,,9680,,,,BAO_0000019,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,CHEMBL631533,,14791,A,1,Autocuration,,,,0
N,,50594,,,,13758,,Mus musculus,,BAO_0000218,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,CHEMBL876552,10090.0,14792,A,1,Intermediate,,,,1
N,,50594,,,,13758,,Mus musculus,,BAO_0000218,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,CHEMBL631534,10090.0,14793,A,1,Intermediate,,,,1
N,,50594,,,,13758,,Mus musculus,,BAO_0000218,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,CHEMBL631535,10090.0,14794,A,1,Intermediate,,,,1
N,,50594,,,,13758,,Mus musculus,,BAO_0000218,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,CHEMBL631536,10090.0,14795,A,1,Intermediate,,,,1
N,,50594,,,,13758,,Mus musculus,,BAO_0000218,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,CHEMBL631537,10090.0,14796,A,1,Intermediate,,,,1
N,,50594,,,,13758,,Mus musculus,,BAO_0000218,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,CHEMBL631538,10090.0,14797,A,1,Intermediate,,,,1
N,,50594,,,,13758,,Mus musculus,,BAO_0000218,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,CHEMBL631539,10090.0,14798,A,1,Intermediate,,,,1
N,,50594,,,,13758,,Mus musculus,,BAO_0000218,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,CHEMBL631540,10090.0,14799,A,1,Intermediate,,,,1
N,,50597,,,,14393,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,CHEMBL625637,10116.0,14800,A,1,Intermediate,,,,1
N,,50597,,,,14393,,Rattus norvegicus,,BAO_0000218,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,CHEMBL625638,10116.0,14801,A,1,Intermediate,,,,1
N,,50597,,,,15078,,Rattus norvegicus,,BAO_0000218,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",CHEMBL625639,10116.0,14802,A,1,Intermediate,,,,1
N,,50597,,,In vivo,13925,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625640,10116.0,14803,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13925,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625641,10116.0,14804,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,13925,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625642,10116.0,14805,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13925,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625643,10116.0,14806,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,13925,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625644,10116.0,14807,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13925,Kidney,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625645,10116.0,14808,A,1,Intermediate,,,2113.0,1
N,,50597,,,In vivo,13925,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625646,10116.0,14809,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13925,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625647,10116.0,14810,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,13925,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625648,10116.0,14811,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13925,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,CHEMBL625649,10116.0,14812,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,13925,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625650,10116.0,14813,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,13925,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625651,10116.0,14814,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,13925,Zone of skin,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625652,10116.0,14815,A,1,Intermediate,,,14.0,1
N,,50597,,,In vivo,13925,Zone of skin,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625653,10116.0,14816,A,1,Intermediate,,,14.0,1
N,,50597,,,In vivo,13925,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625654,10116.0,14817,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,13925,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,CHEMBL625655,10116.0,14818,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,9712,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of Compound in rat blood after 15 minutes of administration,CHEMBL625656,10116.0,14819,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9712,Blood,Rattus norvegicus,,BAO_0000218,,Biodistribution of Compound in rat blood after 2 minutes of administration,CHEMBL625657,10116.0,14820,A,1,Intermediate,,,178.0,1
N,,50597,,,In vivo,9712,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of Compound in rat brain after 15 minutes of administration,CHEMBL625658,10116.0,14821,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,9712,Brain,Rattus norvegicus,,BAO_0000218,,Biodistribution of Compound in rat brain after 2 minutes of administration,CHEMBL625659,10116.0,14822,A,1,Intermediate,,,955.0,1
N,,50597,,,In vivo,9712,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of Compound in rat heart after 15 minutes of administration,CHEMBL625660,10116.0,14823,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9712,Heart,Rattus norvegicus,,BAO_0000218,,Biodistribution of Compound in rat heart after 2 minutes of administration,CHEMBL625661,10116.0,14824,A,1,Intermediate,,,948.0,1
N,,50597,,,In vivo,9712,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of Compound in rat liver after 15 minutes of administration,CHEMBL625662,10116.0,14825,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9712,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution of Compound in rat liver after 2 minutes of administration,CHEMBL625663,10116.0,14826,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,9712,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of Compound in rat lung after 15 minutes of administration,CHEMBL875621,10116.0,14827,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,9712,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution of Compound in rat lung after 2 minutes of administration,CHEMBL628382,10116.0,14828,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,9712,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of Compound in rat muscle after 15 minutes of administration,CHEMBL628383,10116.0,14829,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,9712,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution of Compound in rat muscle after 2 minutes of administration,CHEMBL628384,10116.0,14830,A,1,Intermediate,,,2385.0,1
N,,50597,,,,13925,,Rattus norvegicus,,BAO_0000218,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,CHEMBL628385,10116.0,14831,A,1,Intermediate,,,,1
N,,50597,,,,13925,,Rattus norvegicus,,BAO_0000218,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,CHEMBL875753,10116.0,14832,A,1,Intermediate,,,,1
N,,50597,,,,13925,,Rattus norvegicus,,BAO_0000218,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,CHEMBL628386,10116.0,14833,A,1,Intermediate,,,,1
N,,50597,,,,6941,,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat blood 2 minutes after intravenous injection,CHEMBL628387,10116.0,14834,A,1,Intermediate,,,,1
N,,50597,,,,6941,,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat blood 2 hr after intravenous injection,CHEMBL628388,10116.0,14835,A,1,Intermediate,,,,1
N,,50597,,,,6941,,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat blood 30 minutes after intravenous injection,CHEMBL628389,10116.0,14836,A,1,Intermediate,,,,1
N,,50597,,,,6941,,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat blood 30 min after intravenous injection,CHEMBL632756,10116.0,14837,A,1,Intermediate,,,,1
N,,50597,,,,6941,,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat brain 2 minutes after intravenous injection,CHEMBL628390,10116.0,14838,A,1,Intermediate,,,,1
N,,50597,,,,6941,,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat brain 2 hr after intravenous injection,CHEMBL631811,10116.0,14839,A,1,Intermediate,,,,1
N,,50597,,,,6941,,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat brain 30 minutes after intravenous injection,CHEMBL631812,10116.0,14840,A,1,Intermediate,,,,1
N,,50597,,,,6941,,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat heart 2 minutes after intravenous injection,CHEMBL631813,10116.0,14841,A,1,Intermediate,,,,1
N,,50597,,,,6941,,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat heart 2 hr after intravenous injection,CHEMBL631814,10116.0,14842,A,1,Intermediate,,,,1
N,,50597,,,,6941,,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat heart 30 minutes after intravenous injection,CHEMBL631815,10116.0,14843,A,1,Intermediate,,,,1
N,,50597,,,,6941,,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat kidney 2 minutes after intravenous injection,CHEMBL631816,10116.0,14844,A,1,Intermediate,,,,1
N,,50597,,,,6941,,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat kidney 2 hr after intravenous injection,CHEMBL875758,10116.0,14845,A,1,Intermediate,,,,1
N,,50597,,,,6941,,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat kidney 30 minutes after intravenous injection,CHEMBL631817,10116.0,14846,A,1,Intermediate,,,,1
N,,50597,,,,6941,Liver,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat liver 2 minutes after intravenous injection,CHEMBL631818,10116.0,14847,A,1,Intermediate,,,2107.0,1
N,,50597,,,,6941,Liver,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat liver 2 hr after intravenous injection,CHEMBL631819,10116.0,14848,A,1,Intermediate,,,2107.0,1
N,,50597,,,,6941,Liver,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat liver 30 minutes after intravenous injection,CHEMBL631820,10116.0,14849,A,1,Intermediate,,,2107.0,1
N,,50597,,,,6941,,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat lung 2 minutes after intravenous injection,CHEMBL631821,10116.0,14850,A,1,Intermediate,,,,1
N,,50597,,,,6941,,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat lung 2 hr after intravenous injection,CHEMBL631822,10116.0,14851,A,1,Intermediate,,,,1
N,,50597,,,,6941,,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat lung 30 minutes after intravenous injection,CHEMBL631823,10116.0,14852,A,1,Intermediate,,,,1
N,,50597,,,,6941,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat muscle 2 minutes after intravenous injection,CHEMBL631824,10116.0,14853,A,1,Intermediate,,,2385.0,1
N,,50597,,,,6941,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat muscle 2 hr after intravenous injection,CHEMBL631825,10116.0,14854,A,1,Intermediate,,,2385.0,1
N,,50597,,,,6941,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Organ distribution in rat muscle 30 minutes after intravenous injection,CHEMBL631826,10116.0,14855,A,1,Intermediate,,,2385.0,1
N,,50594,,,In vivo,14439,,Mus musculus,,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),CHEMBL631827,10090.0,14856,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14439,,Mus musculus,,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),CHEMBL631828,10090.0,14857,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14439,,Mus musculus,,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),CHEMBL631829,10090.0,14858,A,1,Intermediate,,,,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,CHEMBL875759,10116.0,14859,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,CHEMBL631830,10116.0,14860,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,CHEMBL631831,10116.0,14861,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,CHEMBL631832,10116.0,14862,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,CHEMBL631833,10116.0,14863,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,CHEMBL631834,10116.0,14864,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,CHEMBL631835,10116.0,14865,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,CHEMBL631836,10116.0,14866,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,CHEMBL631837,10116.0,14867,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,CHEMBL631838,10116.0,14868,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,CHEMBL631839,10116.0,14869,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,CHEMBL631840,10116.0,14870,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,CHEMBL631841,10116.0,14871,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,CHEMBL631842,10116.0,14872,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,CHEMBL631843,10116.0,14873,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,CHEMBL631844,10116.0,14874,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,CHEMBL631845,10116.0,14875,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,CHEMBL631846,10116.0,14876,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,CHEMBL875760,10116.0,14877,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,CHEMBL632199,10116.0,14878,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,CHEMBL631847,10116.0,14879,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,CHEMBL631848,10116.0,14880,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,CHEMBL628707,10116.0,14881,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,CHEMBL628708,10116.0,14882,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,CHEMBL628709,10116.0,14883,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,CHEMBL628710,10116.0,14884,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,CHEMBL628711,10116.0,14885,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,CHEMBL628712,10116.0,14886,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,CHEMBL628713,10116.0,14887,A,1,Intermediate,,,1088.0,1
N,,50597,,,,12582,Urine,Rattus norvegicus,,BAO_0000218,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,CHEMBL628714,10116.0,14888,A,1,Intermediate,,,1088.0,1
N,,50597,,,,7415,,Rattus norvegicus,,BAO_0000218,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",CHEMBL628715,10116.0,14889,A,1,Intermediate,,,,1
U,,22224,,,,7313,,,,BAO_0000019,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,CHEMBL629179,,14890,A,1,Autocuration,,,,0
U,,22224,,,,7313,,,,BAO_0000019,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,CHEMBL629180,,14891,A,1,Autocuration,,,,0
U,,22224,,,,7313,,,,BAO_0000019,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,CHEMBL875108,,14892,A,1,Autocuration,,,,0
U,,22224,,,,7570,Adrenal cortex,,,BAO_0000019,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,CHEMBL629181,,14893,A,1,Autocuration,,,1235.0,0
U,,22224,,,,7570,Adrenal cortex,,,BAO_0000019,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,CHEMBL629182,,14894,A,1,Autocuration,,,1235.0,0
U,,22224,,,,7570,,,,BAO_0000019,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,CHEMBL629183,,14895,A,1,Autocuration,,,,0
U,,22224,,,,7570,,,,BAO_0000019,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,CHEMBL629184,,14896,A,1,Autocuration,,,,0
U,,22224,,,,7570,Adrenal cortex,,,BAO_0000019,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,CHEMBL629185,,14897,A,1,Autocuration,,,1235.0,0
U,,22224,,,,7570,Adrenal cortex,,,BAO_0000019,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,CHEMBL629186,,14898,A,1,Autocuration,,,1235.0,0
U,,22224,,,,7570,,,,BAO_0000019,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,CHEMBL629187,,14899,A,1,Autocuration,,,,0
U,,22224,,,,7570,,,,BAO_0000019,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,CHEMBL629887,,14900,A,1,Autocuration,,,,0
U,,22224,,,,7570,,,,BAO_0000019,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,CHEMBL629888,,14901,A,1,Autocuration,,,,0
U,,22224,,,,7570,,,,BAO_0000019,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,CHEMBL629889,,14902,A,1,Autocuration,,,,0
U,,22224,,,,7570,Adrenal cortex,,,BAO_0000019,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,CHEMBL629890,,14903,A,1,Autocuration,,,1235.0,0
U,,22224,,,,7570,,,,BAO_0000019,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,CHEMBL629891,,14904,A,1,Autocuration,,,,0
U,,22224,,,,7570,,,,BAO_0000019,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,CHEMBL629892,,14905,A,1,Autocuration,,,,0
U,,22224,,,,7570,Adrenal cortex,,,BAO_0000019,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,CHEMBL629893,,14906,A,1,Autocuration,,,1235.0,0
U,,22224,,,,7570,,,,BAO_0000019,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,CHEMBL629894,,14907,A,1,Autocuration,,,,0
U,,22224,,,,7570,,,,BAO_0000019,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,CHEMBL629895,,14908,A,1,Autocuration,,,,0
U,,22224,,,In vivo,14122,,Canis lupus familiaris,,BAO_0000218,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",CHEMBL875109,9615.0,14909,A,1,Autocuration,,,,0
U,,22224,,,In vivo,16449,,Macaca fascicularis,,BAO_0000218,,Absolute bioavailability in male cynomolgus monkeys,CHEMBL629896,9541.0,14910,A,1,Autocuration,,,,0
U,,22224,,,In vivo,16449,,Rattus norvegicus,,BAO_0000218,,Absolute bioavailability in maleSprague-Dawley rats,CHEMBL629897,10116.0,14911,A,1,Autocuration,,,,0
N,,50597,,,In vivo,12017,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL629898,10116.0,14912,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,12017,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630057,10116.0,14913,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,12017,Liver,Rattus norvegicus,,BAO_0000218,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630058,10116.0,14914,A,1,Intermediate,,,2107.0,1
N,,50597,,,In vivo,12017,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630059,10116.0,14915,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,12017,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630060,10116.0,14916,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,12017,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL630061,10116.0,14917,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,12017,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630062,10116.0,14918,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,12017,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630063,10116.0,14919,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,12017,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630064,10116.0,14920,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,12017,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630065,10116.0,14921,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,12017,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL630066,10116.0,14922,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,12017,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630067,10116.0,14923,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,12017,Lung,Rattus norvegicus,,BAO_0000218,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630068,10116.0,14924,A,1,Intermediate,,,2048.0,1
N,,50597,,,In vivo,12017,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631113,10116.0,14925,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,12017,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631114,10116.0,14926,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,12017,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL631115,10116.0,14927,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,12017,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL631116,10116.0,14928,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,12017,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630528,10116.0,14929,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,12017,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630529,10116.0,14930,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,12017,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630530,10116.0,14931,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,12017,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL630531,10116.0,14932,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,12017,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630532,10116.0,14933,A,1,Intermediate,,,2385.0,1
N,,50597,,,In vivo,12017,Muscle tissue,Rattus norvegicus,,BAO_0000218,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630533,10116.0,14934,A,1,Intermediate,,,2385.0,1
N,,50594,,,In vivo,15045,Blood,Mus musculus,,BAO_0000218,,Biodistribution in normal mice blood after 120 hr,CHEMBL630534,10090.0,14935,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,15045,Blood,Mus musculus,,BAO_0000218,,Biodistribution in normal mice blood after 24 hr,CHEMBL630535,10090.0,14936,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,15045,Blood,Mus musculus,,BAO_0000218,,Biodistribution in normal mice blood after 4 hr,CHEMBL630536,10090.0,14937,A,1,Intermediate,,,178.0,1
N,,50594,,,In vivo,15045,Bone,Mus musculus,,BAO_0000218,,Biodistribution in normal mice bone after 120 hr,CHEMBL630537,10090.0,14938,A,1,Intermediate,,,10000001.0,1
N,,50594,,,In vivo,15045,Bone,Mus musculus,,BAO_0000218,,Biodistribution in normal mice bone after 24 hr,CHEMBL630538,10090.0,14939,A,1,Intermediate,,,10000001.0,1
N,,50594,,,In vivo,15045,Bone,Mus musculus,,BAO_0000218,,Biodistribution in normal mice bone after 4 hr,CHEMBL630539,10090.0,14940,A,1,Intermediate,,,10000001.0,1
N,,50594,,,In vivo,15045,Heart,Mus musculus,,BAO_0000218,,Biodistribution in normal mice heart after 120 hr,CHEMBL630540,10090.0,14941,A,1,Intermediate,,,948.0,1
N,,50594,,,In vivo,15045,Heart,Mus musculus,,BAO_0000218,,Biodistribution in normal mice heart after 24 hr,CHEMBL630541,10090.0,14942,A,1,Intermediate,,,948.0,1
N,,50594,,,In vivo,15045,Heart,Mus musculus,,BAO_0000218,,Biodistribution in normal mice heart after 4 hr,CHEMBL630542,10090.0,14943,A,1,Intermediate,,,948.0,1
N,,50594,,,In vivo,15045,Kidney,Mus musculus,,BAO_0000218,,Biodistribution in normal mice kidney after 120 hr,CHEMBL630543,10090.0,14944,A,1,Intermediate,,,2113.0,1
N,,50594,,,In vivo,15045,Kidney,Mus musculus,,BAO_0000218,,Biodistribution in normal mice kidney after 24 hr,CHEMBL630544,10090.0,14945,A,1,Intermediate,,,2113.0,1
N,,50594,,,In vivo,15045,Kidney,Mus musculus,,BAO_0000218,,Biodistribution in normal mice kidney after 4 hr,CHEMBL630545,10090.0,14946,A,1,Intermediate,,,2113.0,1
N,,50594,,,In vivo,15045,Liver,Mus musculus,,BAO_0000218,,Biodistribution in normal mice liver after 120 hr,CHEMBL630546,10090.0,14947,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,15045,Liver,Mus musculus,,BAO_0000218,,Biodistribution in normal mice liver after 24 hr,CHEMBL630547,10090.0,14948,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,15045,Liver,Mus musculus,,BAO_0000218,,Biodistribution in normal mice liver after 4 hr,CHEMBL630548,10090.0,14949,A,1,Intermediate,,,2107.0,1
N,,50594,,,In vivo,15045,Spleen,Mus musculus,,BAO_0000218,,Biodistribution in normal mice spleen after 120 hr,CHEMBL630549,10090.0,14950,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,15045,Spleen,Mus musculus,,BAO_0000218,,Biodistribution in normal mice spleen after 24 hr,CHEMBL630550,10090.0,14951,A,1,Intermediate,,,2106.0,1
N,,50594,,,In vivo,15045,Spleen,Mus musculus,,BAO_0000218,,Biodistribution in normal mice spleen after 4 hr,CHEMBL876426,10090.0,14952,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630551,10116.0,14953,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630552,10116.0,14954,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL630553,10116.0,14955,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630554,10116.0,14956,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630555,10116.0,14957,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630556,10116.0,14958,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630557,10116.0,14959,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),CHEMBL630558,10116.0,14960,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630559,10116.0,14961,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Spleen,Rattus norvegicus,,BAO_0000218,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL630560,10116.0,14962,A,1,Intermediate,,,2106.0,1
N,,50597,,,In vivo,12017,Thyroid gland,Rattus norvegicus,,BAO_0000218,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,CHEMBL876427,10116.0,14963,A,1,Intermediate,,,2046.0,1
N,,50597,,,,14941,,Rattus norvegicus,,BAO_0000218,,The Kel values in female wistar rats.,CHEMBL630561,10116.0,14964,A,1,Intermediate,,,,1
U,,22224,,,,4646,,,,BAO_0000019,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,CHEMBL630562,,14965,A,1,Autocuration,,,,0
U,,22224,,,,8847,,,,BAO_0000019,,Hydrolysis rate constant of the compound,CHEMBL630563,,14966,A,1,Autocuration,,,,0
U,,22229,,,,11778,,,,BAO_0000100,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,CHEMBL629673,,14967,P,1,Autocuration,,,,0
U,,22224,,,,2363,,,,BAO_0000019,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",CHEMBL629674,,14968,A,1,Autocuration,,,,0
U,,22224,,,,2363,,,,BAO_0000019,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",CHEMBL629675,,14969,A,1,Autocuration,,,,0
U,,22224,,,,2363,,,,BAO_0000019,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",CHEMBL629676,,14970,A,1,Autocuration,,,,0
U,,22224,,,,2363,,,,BAO_0000019,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",CHEMBL629677,,14971,A,1,Autocuration,,,,0
U,,22224,,,,8371,,,,BAO_0000019,,Apparent inactivation rate constant was evaluated,CHEMBL629678,,14972,A,1,Autocuration,,,,0
U,,22224,,,,14883,,,,BAO_0000019,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,CHEMBL629679,,14973,A,1,Autocuration,,,,0
U,,22224,,,,14883,,,,BAO_0000019,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,CHEMBL629680,,14974,A,1,Autocuration,,,,0
U,,22224,,,,4643,,,,BAO_0000019,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,CHEMBL629681,,14975,A,1,Autocuration,,,,0
U,,22224,,,,3519,,,,BAO_0000019,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,CHEMBL629682,,14976,A,1,Autocuration,,,,0
U,,22224,,,,10600,,,,BAO_0000019,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,CHEMBL629683,,14977,A,1,Autocuration,,,,0
U,,22224,,,,8501,,,,BAO_0000019,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,CHEMBL629684,,14978,F,1,Autocuration,,,,0
U,,22224,,,,8505,,,,BAO_0000100,,Dissociation constant was determined,CHEMBL629685,,14979,P,1,Autocuration,,,,0
U,,22224,,,,9778,,,,BAO_0000100,,Dissociation constant was determined,CHEMBL629686,,14980,P,1,Autocuration,,,,0
U,,22224,,,,9778,,,,BAO_0000100,,Dissociation constant at pH 7.4,CHEMBL872932,,14981,P,1,Autocuration,,,,0
U,,22224,,,,9778,,,,BAO_0000100,,Dissociation constant in presence of 1 mM dithiothreitol,CHEMBL629687,,14982,P,1,Autocuration,,,,0
U,,22224,,,,13007,,,,BAO_0000019,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,CHEMBL872931,,14983,A,1,Autocuration,,,,0
U,,22224,,,,13007,,,,BAO_0000019,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,CHEMBL628151,,14984,A,1,Autocuration,,,,0
U,,22224,,,,13007,,,,BAO_0000019,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,CHEMBL628152,,14985,A,1,Autocuration,,,,0
U,,22224,,,,13007,,,,BAO_0000019,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,CHEMBL628153,,14986,A,1,Autocuration,,,,0
U,,22224,,,,11482,,,,BAO_0000019,,Kinetic constant for aromatization of androstenedione,CHEMBL628154,,14987,A,1,Autocuration,,,,0
U,,22224,,,,11482,,,,BAO_0000019,,Kinetic constant for aromatization of testosterone,CHEMBL628155,,14988,A,1,Autocuration,,,,0
U,,22224,,,,2303,,,,BAO_0000019,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,CHEMBL628156,,14989,A,1,Autocuration,,,,0
U,,22224,,,,11964,,,,BAO_0000019,,Local inhibition constant was determined,CHEMBL628157,,14990,A,1,Autocuration,,,,0
N,,50347,,,,3140,,Saccharomyces cerevisiae,,BAO_0000218,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,CHEMBL857533,4932.0,14991,A,1,Intermediate,,,,1
U,,22224,,,,10650,,,,BAO_0000100,,Dissociation constant value of the compound,CHEMBL628158,,14992,P,1,Autocuration,,,,0
U,,22224,,,,4667,Cornea,,,BAO_0000019,,In vitro permeability through cornea without epithelium,CHEMBL628159,,14993,A,1,Autocuration,,,964.0,0
U,,22224,,,,4667,Cornea,,,BAO_0000019,,In vitro permeability through intact cornea,CHEMBL875616,,14994,A,1,Autocuration,,,964.0,0
N,,50592,,,,9199,Cornea,Oryctolagus cuniculus,,BAO_0000218,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,CHEMBL628160,9986.0,14995,A,1,Intermediate,,,964.0,1
U,,22224,,,,11966,,,,BAO_0000019,,Rate of enzyme inactivation for the compound was determined,CHEMBL628161,,14996,A,1,Autocuration,,,,0
U,,22224,,,,4667,Cornea,,,BAO_0000019,,In vitro permeability through cornea without epithelium,CHEMBL628162,,14997,A,1,Autocuration,,,964.0,0
U,,22224,,,,4667,Cornea,,,BAO_0000019,,In vitro permeability through intact cornea,CHEMBL628163,,14998,A,1,Autocuration,,,964.0,0
U,,22224,,,,8354,,,,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628164,,14999,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628165,,15000,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628166,,15001,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628167,,15002,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628168,,15003,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628169,,15004,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628170,,15005,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628171,,15006,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL627434,,15007,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL627435,,15008,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628110,,15009,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628111,,15010,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628112,,15011,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628260,,15012,A,1,Autocuration,,,,0
U,,22224,,,,8354,,,,BAO_0000019,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",CHEMBL628261,,15013,A,1,Autocuration,,,,0
N,,50594,,,In vivo,14439,,Mus musculus,,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),CHEMBL628262,10090.0,15014,A,1,Intermediate,,,,1
N,,50587,,,In vivo,14439,,Homo sapiens,,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,CHEMBL628263,9606.0,15015,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14439,,Mus musculus,,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),CHEMBL628264,10090.0,15016,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14439,,Mus musculus,,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),CHEMBL628265,10090.0,15017,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14439,,Mus musculus,,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),CHEMBL628266,10090.0,15018,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14439,,Mus musculus,,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),CHEMBL628267,10090.0,15019,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14439,,Mus musculus,,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,CHEMBL628268,10090.0,15020,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14439,,Mus musculus,,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),CHEMBL628269,10090.0,15021,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14439,,Mus musculus,,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),CHEMBL628270,10090.0,15022,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14439,,Mus musculus,,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),CHEMBL628271,10090.0,15023,A,1,Intermediate,,,,1
N,,50594,,,In vivo,14439,,Mus musculus,,BAO_0000218,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),CHEMBL628272,10090.0,15024,A,1,Intermediate,,,,1
